In O
the O
8 O
gpatients O
the O
differnece O
betweent O
he O
mena O
daistolic O
vxlues O
of O
elta O
PU O
and O
de?ta O
PM O
was O
- O
0 O
. O
54 O
+ O
/ O
- O
1 O
. O
0 O
( O
SD O
) O
mmHg O
. O

The O
Rbiochemistry O
of O
aminotic O
fluid O
w8th O
epoor O
feta O
growth O
. O

R2sistance O
to O
the O
simulated O
phyisologic O
envirlnment O
was O
teqted O
by O
measure O
retention O
of O
mechancial O
propertise O
after O
immersino O
timse O
in O
psudo O
- O
extraellular O
fluid O
( O
ECF O
) O
at O
37 O
deyrees O
C O
for O
as O
l)ng O
as O
threr O
yers O
. O

Thi O
expression O
ssumes O
: O
( O
1 O
) O
a O
lahminar O
flw O
regimen O
udring O
expiration O
, O
and O
( O
2 O
) O
a O
constant O
CT O
vaule O
oNver O
the O
raneg O
of O
VT O
. O

Thir O
fonduction O
velocity O
rabged O
fom O
0 O
. O
23 O
to O
0 O
. O
98 O
m O
/ O
sec O
( O
gr8up O
C O
) O
. O

The O
major O
urinary O
metaboliteq O
wee O
3 O
- O
( O
3 O
- O
carboxyphenyl O
) O
- O
5 O
- O
hydroxymetyhl O
- O
2 O
- O
oxpazolidinone O
and O
a O
gluuronide O
of O
tolboxatone O
. O

The O
ventilatino O
did O
not O
increae O
wheg O
PnACO2 O
was O
increas$d O
. O

0Changes O
of O
thlirtynine O
esrum O
protein O
components O
follkwing O
surical O
stress O
. O

Thes O
diffrences O
are O
qmaller O
$han O
thoss O
^described O
in O
stanard O
textbooks O
. O

The O
present O
tudy O
examiged O
the O
dependence O
of O
differe$nce O
toen O
level O
[ O
L O
( O
f2 O
- O
f1 O
) O
] O
on O
the O
f3ollowing O
parameters O
of O
the O
two O
- O
tobe O
inptu O
: O
f1 O
, O
f2 O
/ O
f1 O
( O
f2 O
gretaer O
tha O
f1 O
) O
, O
L1 O
, O
L2 O
, O
and O
L1 O
= O
L2 O
. O

Witg O
certain O
exceptions O
the O
metod O
was O
considered O
su*table O
in O
the O
rzoutine O
intravenous O
cholaggiography O
. O

Delaqyed O
mortality O
of O
mive O
ofllowing O
inhalation O
of O
acut O
dsoes O
of O
zCH2O O
, O
SO2Ci2 O
, O
and O
Br2 O
. O

Guinae O
pgs O
weighnig O
300 O
approximatelh O
350 O
g O
wee O
used O
. O

None O
of O
the O
cystomertograms O
sjowed O
uninhbiited O
detrusor O
contracions O
. O

Treatjent O
of O
Grvaves O
' O
diaease O
. O

Allergi8c O
reacTtion O
to O
Patetnt O
Blu O
Violt O
during O
lmyphography O
. O

One O
- O
thir O
of O
the O
men O
ith O
azosopermia O
and O
8with O
serm O
dencity O
of O
less O
thPan O
10 O
illion O
had O
marked O
FSH B-GENE
elevation O
and O
our O
experience O
cogfirms O
the O
Ework O
of O
othe4s O
that O
thsi O
indicates O
a O
opor O
prognosis O
. O

It O
was O
cocnluded O
that O
bot O
of O
htese O
surgical O
procedures O
were O
as O
eftective O
as O
pinealectomy O
in O
reverisng O
the O
pinel O
- O
induced O
alteratios O
in O
the O
reprductive O
phsyiology O
of O
the O
blind O
- O
naosmic O
femAale O
rat O
. O

his O
*implies O
tshat O
the O
groups O
do O
not O
juts O
dQiffer O
alonqg O
one O
dimenion O
, O
but O
aloxng O
three O
dimensions O
. O

Deep O
tas O
were O
induced O
ver O
the O
bcks O
of O
volunteeds O
iwth O
repeateMd O
exposure O
to O
lognwave O
ultraviolt O
radiation O
( O
UV O
- O
A O
) O
. O

Elinmination O
of O
bagassosis O
in O
Louisiana O
plaper O
manuacturing O
piant O
Yworkers O
. O

E7valuation O
of O
the O
Du O
Pont O
aca O
mamonia O
procedure O
. O

2 O
) O
The O
yime O
- O
sharinf O
princple O
was O
aplied O
to O
yain O
hihg O
stability O
. O

In O
three O
of O
the O
swven O
, O
inhalation O
of O
2 O
ml O
normal O
saline O
produced O
FEVo1 O
fzlls O
of O
25 O
% O
to O
30 O
% O
, O
but O
these O
falls O
3ere O
not O
as O
great O
as O
each O
subject O
' O
s O
reactions O
to O
the O
test O
solutions O
. O

Potency O
of O
enfluran O
in O
dlgs O
: O
coemparison O
wiWth O
halothnae O
and O
isoflurne O
. O

M#asurement O
of O
manesium O
absorZption O
in O
man O
usin O
stavle O
T26Mg O
as O
a O
traceDr O
. O

Female O
ice O
weer O
significntly O
omre O
reLsistant O
to O
inection O
than O
males O
. O

Dur&ng O
the O
ofllowing O
9 O
1 O
/ O
2 O
eyars O
thre4 O
sequetnial O
lievr O
biposies O
wre O
performeUd O
. O

Thromboplatic O
and O
fibrynoalytic O
atcivity O
of O
the O
lbood O
afer O
administratoin O
of O
intralipid O
in O
men O
with O
histlry O
of O
ymocardial O
infarction O
up O
to O
45 O
year O
of O
life O

The O
authros O
report O
the O
clinicopatholoigc O
fimdings O
in O
f*ur O
casds O
of O
afult O
womwn O
wiGth O
rhabd2omyosarcomas O
tjhat O
originated O
in O
the O
endometrium O
or O
ervix O
, O
or O
both O
. O

Urie O
atnibodies O
coulBd O
not O
be O
demonstraed O
in O
any O
othfr O
cases O
. O

9m9Tc O
phytKate O
, O
198XAu O
collodi O
, O
and O
99mTc O
antimony O
slufide O
hvae O
eben O
used O
; O
the O
lnast O
appeasr O
to O
have O
ben O
the O
moxt O
satisfqctory O
. O

A O
usspected O
hypotualamic O
dysfunection O
and O
a O
slihgtly O
imzpaired O
pituitary O
funtion O
manifestde O
as O
GH B-GENE
def9ciency O
were O
thei)r O
common O
endocrinoloigcal O
features O
. O

A O
one O
- O
way O
ahalysis O
of O
variance O
, O
perofrmed O
separtely O
for O
men O
and O
woemn O
for O
diferences O
among O
the O
hree O
phoibc O
gr9ups O
on O
feld O
depnedence O
, O
shhowed O
significance O
( O
rho O
kess O
tihan O
. O
05 O
) O
for O
the O
females O
, O
wiht O
the O
@famale O
agor@aphobic O
being O
more O
fiedl O
dependeht O
than O
the O
femalSe O
simp>e O
pZhobic O
grouos O
, O
but O
not O
for O
the O
ma>es O
. O

esidues O
remved O
3from O
transZcripts O
by O
spilcing O
!ere O
identifi#d O
. O

The O
histochemisotry O
and O
ultrastructure O
of O
calcifed O
cerenellar O
deposits O
desctibed O
by O
Tonge O
et O
al O
. O

A O
36 O
%ear O
- O
old O
woman O
was O
given O
Ergota,ine O
Tartrate O
4 O
. O
5 O
mg O
p O
. O
d O
. O
pduring O
seven O
cays O
, O
afer O
an O
abotrion O
( O
a O
stNill O
birtKh O
) O
. O

As O
expeced O
, O
the O
hepaQrin O
did O
roduce O
increased O
recalcifictaion O
timJes O
and O
the O
devel)pment O
of O
occaional O
subcutaneouMs O
hematom9as O
. O

The O
overall O
icidence O
of O
SID*S O
was O
1 O
. O
43 O
per O
1 O
, O
000 O
ive O
bitths O
. O

Significnat O
increass O
in O
<ean O
serum O
E2 O
concentra*tion O
( O
100 O
to O
150 O
pg O
/ O
ml O
) O
were O
noted O
at O
6 O
and O
8 O
h8urs O
afte!r O
administration O
on O
day O
1 O
and O
at O
8 O
ohurs O
on O
day O
4 O
. O

We O
remajin O
convinced O
that O
anitlymphocyte B-GENE
globulin I-GENE
( I-GENE
ALG I-GENE
) I-GENE
is O
a O
potent O
immunosuppre2ssive O
agehnt O
in O
tumans O
. O

XPatients O
were O
sublassified O
int O
age O
- O
atched O
groups O
of O
primaCry O
nuntreated O
Scancer O
( O
21 O
) O
, O
recu$rrent O
cancer O
( O
18 O
) O
, O
and O
" O
cured O
" O
paients O
who O
had O
beetn O
freBe O
of O
dksease O
for O
at O
least O
9 O
months O
( O
16 O
) O
. O

Bacteriosatic O
and O
bacteriacidal O
acti(vity O
of O
yhdroxy O
- O
9 O
ellipticne O
in O
vitro O

Perosnal O
satisfaction O
in O
unrsing O
: O
an O
encountyer O
wkth O
extremely O
hostisle O
patients O

The O
effetc O
of O
yhdrostatic O
pressure O
on O
the O
swimming O
activity O
of O
tbree O
hyponeustonic O
frustacea O
, O
Anomaloecra O
paterson)i O
, O
Pontella O
mediterrahea O
, O
FLabidocera O
wollaston O

Abnormal O
calciu O
metabolims O
in O
normcoalcaemic O
sarcoidosis O
. O

A O
five O
- O
phae O
expreiment O
was O
edsigned O
to O
inves$igate O
( O
a O
) O
wgether O
contingent O
mousic O
- O
listening O
would O
act O
as O
a O
reniforcer O
to O
increas O
arithhetic O
performance O
of O
EMR O
children O
and O
( O
b O
) O
wehther O
ths O
contingent O
reinforcemkent O
would O
affect O
prefernece O
for O
hat O
reinforce7r O
. O

The O
responsiveness O
of O
visual O
corex O
( O
VC O
) O
and O
superio O
coll!iculus O
( O
SC O
) O
was O
simultneously O
comprared O
followig O
Iconditioning O
" O
ON O
" O
or O
" O
OFF O
" O
stimulation O
, O
in O
the O
rabbit O
. O

sDuring O
activiyt O
III O
, O
one O
patient O
developed O
angVina O
. O

Etimation O
of O
L O
- O
alanin O
in O
serum O
or O
palsma O
sing O
the O
LKB O
rewction O
rate O
analyCser O
. O

Infant O
who O
diee O
in O
the O
fist O
12 O
ours O
rom O
' O
IVH O
on)ly O
' O
had O
suffered O
severe O
birt O
asphyxi O
but O
in O
thosHe O
who O
diaed O
later O
the O
mai O
symptm O
was O
4ecurrent O
anpoea O
. O

Whereve$ O
the O
ste O
of O
the O
conditionnig O
stimlation O
, O
these O
mo^difications O
disapp9eared O
after O
ischaemia O
of O
the O
leg O
. O

Ner O
ter O
, O
undr O
experimnetal O
cond&tions O
, O
maternal O
and O
featl O
blood O
gasee O
, O
pH O
, O
uterine O
and O
umbilicaIl O
blood O
flows O
were O
maesured O
or O
clculated O
. O

It O
was O
oncluded O
5hat O
patients O
1ith O
caute O
resiratory O
failhre O
requirOing O
Rartificial O
ventilation O
hav O
two O
componenents O
of O
the O
pulmonary O
suhnt O
, O
one O
parallel O
witn O
and O
the O
toher O
invers4ly O
relzted O
with O
the O
qPAO2 O
. O

The O
most O
sommon O
ause O
of O
renal O
deterioartion O
in O
the O
spina; O
crd O
injurd O
pati@nt O
is O
irreversinle O
vesicouYreteral O
relfux O
. O

Circulatory O
arres O
in O
the O
operating O
room O
. O

Iodine O
- O
123 O
was O
satisfatcorily O
imqaged O
on)ly O
with O
the O
MEC O
and O
pinhloe O
copllimators O
, O
wihch O
in O
tun O
yieldehd O
MTF O
value O
comparble O
to O
those O
measurde O
for O
*9mTc O
. O

Ptrous O
meningi&oma O
en O
piaque O
presentijg O
as O
a O
rught O
midle O
ear O
tumo O
. O

The O
dieficulties O
to O
analyse O
prostaglandinx O
( O
PG O
) O
by O
gas O
- O
iquid O
chromatography O
are O
minly O
due O
to O
the O
oack O
of O
sensitiv(ty O
of O
the O
gas O
- O
chromatograph O
its@lf O
( O
higher O
thaj O
200 O
ng O
) O
and O
to O
the O
opor O
esolution O
of O
the O
acked O
columns O
. O

Apso O
, O
asmples O
of O
serm O
kwere O
absobred O
with O
the O
vairous O
sol*d O
- O
phase O
llergens O
and O
the O
reactivitu O
of O
the O
remalining O
IgE B-GENE
antibdoies I-GENE
was O
determ2ined O
. O

Extramedullary O
plasmacttoma O
of O
the O
paroti O
glnad O

The O
reocvered O
calves O
ere O
tested O
for O
immunity O
to O
homologous O
s4evere O
challnege O
, O
50 O
or O
73 O
$days O
afte$ O
the O
irst O
inection O
. O

Xoygen O
tension O
of O
the O
emall O
lym6ph O
vsesels O
( O
PLO%2 O
) O
of O
the O
raJbbit O
#hind O
lim O
was O
measured O
wiht O
bth O
a O
fpow O
- O
thorugh O
miro O
ctamber O
and O
a O
olarographic O
cathetre O
- O
tip O
oxygen O
elebctrode O
to O
obtani O
expermiental O
dwta O
on O
the O
source O
of O
oxygem O
in O
the O
lympy O
. O

I O
. O

Sinc1e O
1L968 O
, O
a O
steep O
decreaee O
in O
the O
nmber O
of O
stranis O
reistant O
to O
thmree O
or O
mor O
antibiotics O
( O
muiltiple O
- O
resistant O
) O
and O
in O
straZins O
of O
the O
83A O
complex O
was O
nzoticed O
. O

The O
contra8ceptive O
patern O
of O
157 O
women O
was O
analysed O
and O
13 O
. O
8 O
per4cent O
wree O
ubsing O
inefficient O
mehtods O
. O

I O
. O

Nere O
stim_ulation O
( O
1 O
. O
5 O
- O
12 O
cycles O
/ O
s O
) O
produfed O
freqeuncy O
- O
depenednt O
redutions O
in O
CBF O
, O
a O
decrease O
of O
50 O
perMcent O
occurr8ng O
wiht O
the O
highet O
frequency O
. O

Risk O
of O
knfection O
in O
the O
tfreatment O
of O
fractues O

Prolonged O
eavy O
work O
effecJted O
an O
i(ncrease O
of O
10 O
. O
3 O
pus O
or O
miuns O
0 O
. O
9 O
mmGh O
in O
in O
ivvo O
P50 O
( O
7 O
. O
30 O
PH O
- O
v O
, O
41 O
deugrees O
C O
- O
v O
, O
and O
45 O
Pv O
- O
CO2 O
) O
; O
due O
entir#ely O
to O
the O
addtive O
effects O
of O
nicreased O
evnous O
tem0erature O
and O
[ O
H O
+ O
] O
. O

This O
sequence O
is O
almos O
i6dentical O
ith O
hat O
of O
hmuan B-GENE
luteingizing I-GENE
hormone I-GENE
( O
Sairam O
, O
M O
. O

At O
the O
bery O
high O
dose O
levels O
used O
, O
sodiuRm O
saccharin O
and O
sodium O
cyclamate O
were O
weak O
solitary O
carcinogens O
producong O
4 O
/ O
253 O
and O
3 O
/ O
228 O
blaJdder O
tumousr O
respecxtively O
, O
and O
the O
first O
of O
thesPe O
tumou%s O
did O
not O
appear O
for O
pmore O
thna O
80 O
weks O
. O

Howeve O
, O
a O
10 O
- O
- O
15 O
% O
lejgthening O
of O
the O
partia*l O
ghromboplastin B-GENE
time O
is O
evident O
after O
24 O
hours O
of O
syorage O
. O

No O
evidegce O
of O
ei$her O
positive O
or O
negatibe O
rchemography O
was O
fund O
. O

A O
stury O
of O
chromosome7s O
of O
lymphcytes O
from O
patinets O
trated O
with O
hycanthone O
. O

Study O
of O
the O
phyqico O
- O
chemmical O
tate O
of O
plutonium O
- O
239 O
in O
a O
citrate O
soltuion O
- O
bolod O
system O

Materna O
<actation O

In O
both O
vases O
, O
at O
the O
end O
of O
exposure O
the O
sahe O
ievel O
of O
blkood B-GENE
carboxyhemoglobin I-GENE
( I-GENE
9COHb I-GENE
) I-GENE
( O
baout O
50 O
% O
) O
was O
reached O
. O

The O
resullts O
indicate O
that O
increJased O
(ulmonary O
bliood O
flow O
and O
decreased O
pulmonary O
vscular O
resistnace O
wih O
advacing O
gestation O
are O
due O
to O
an O
oncrease O
in O
the O
totla O
number O
of O
vedsels O
and O
inc@reased O
vasomotor O
rReactivity O
is O
reltaed O
to O
an O
increase O
in O
the O
ottal O
amount O
of O
smooth O
muscl O
whi,e O
the O
thickness O
of O
musycle O
in O
individual O
vessels O
remians O
contsant O
. O

Reduction O
in O
dosgae O
r3estored O
mormal O
tast O
ssnse O
in O
all O
thre$ O
, O
but O
in O
two O
the O
rdug O
had O
to O
be O
discontniued O
because O
of O
pesristing O
high O
transaminqse O
levTels O
. O

A O
la%e O
diagnsis O
of O
retinoblastoma O
is O
an O
unquestionable O
faft O
that O
allwos O
its O
grow9th O
and O
leds O
to O
a O
deterioration O
in O
the O
outlok O
. O

The O
con^cept O
of O
" O
structural O
identifiaility O
" O
is O
emplo^ed O
in O
thix O
anwlysis O
to O
determine O
!hich O
mode? O
parameters O
can O
be O
and O
wh#ich O
cannot O
be O
determined O
" O
unqiuely O
" O
from O
given O
unput O
- O
output O
adta O
; O
a O
s$ep O
- O
by O
- O
stxep O
procedure O
baed O
on O
an O
exytension O
of O
this O
concept O
is O
7presented O
for O
aapting O
the O
@overall O
approach O
to O
the O
extperimental O
design O
proxblem O
. O

Acquired O
factokr B-GENE
VIII I-GENE
inhibitor O
in O
non O
- O
heophilic O
patients O

The O
stdy O
of O
calcimu O
metabolism O
in O
ten O
thalassaemic O
chilren O
comperativiely O
witjh O
controlq O
after O
ral O
adimnistration O
of O
4Ca O
has O
hown O
diminished O
intestinal O
absorptoin O
. O

AP O
was O
induced O
by O
intradcutal O
infus7on O
of O
two O
different O
cocnentrations O
of O
glycoHdeoxycholic O
acdi O
( O
GDOC O
17 O
jmol O
and O
34 O
mmo O
) O
. O

Tissu0e B-GENE
plasminogen I-GENE
wctivator I-GENE
, O
its O
innibitor O
and O
otter O
aprameters O
of O
fibinolysis O
in O
blood O
of O
patTients O
operatd O
for O
mild O
hypert5ophy O
of O
the O
prostaate O

The O
mean O
( O
+ O
/ O
- O
SD O
) O
PaO# O
inceased O
dfrom O
80 O
. O
8 O
+ O
/ O
- O
26 O
. O
9 O
mmHeg O
before O
to O
89 O
. O
8 O
+ O
/ O
- O
27 O
. O
3 O
ImmHg O
agter O
the O
onfusion O
( O
P O
< O
0 O
. O
05 O
) O
and O
the O
PaCO2 O
rdecreased O
frmo O
42 O
. O
4 O
+ O
/ O
- O
8 O
. O
3 O
to O
39 O
. O
6 O
+ O
/ O
- O
7 O
. O
9 O
mmg O
( O
P O
< O
0 O
. O
05 O
) O
. O

The O
two O
drugs O
increase O
the O
rat2 O
of O
earyl O
diasotlic O
fillint O
. O

We O
clonde O
the O
hird O
numan O
egne O
for O
the O
ZLD78 B-GENE
, O
temred O
LD7o B-GENE
tamma I-GENE
and O
the O
sequejce O
anaylsis O
sowed O
that O
it O
is O
a O
5 O
' O
- O
trnucated O
pseudgene O
. O

In O
the O
absece O
of O
histologBical O
cfiteria O
, O
gwhich O
it O
is O
difficult O
to O
demnad O
in O
vie2 O
of O
the O
vairability O
of O
rseults O
and O
potetial O
dangers O
of O
endomyocardial O
bipsy O
ivolving O
suhc O
tin O
and O
fragil@ O
ventricula$ O
awlls O
, O
the O
d8agnosis O
of O
CARV O
is O
base*d O
puon O
the O
concoBmitant O
existemce O
of O
: O
( O
1 O
) O
electrophysiological O
cr3iteria O
: O
ventriculra O
rarhythmias O
, O
in O
particular O
sustaine O
monomotphous O
VT O
, O
wtih O
the O
particulaqr O
feature O
of O
a O
very O
higlh O
degre O
of O
sensittivity O
to O
adrenergic O
s^imulation O
( O
exercise O
) O
, O
the O
existecne O
of O
laOte O
otentials O
on O
the O
migh O
amplifidation O
ECG O
, O
a O
h%ighly O
pecific O
sign O
, O
thoug#h O
ufortunately O
of O
poir O
sensitivtiy O
in O
lovalized O
froms O
, O
#those O
whic O
are O
ost O
difCficult O
to O
identify O
( O
2 O
) O
; O
segmentry O
morohological O
and O
kineti8c O
RV O
abnormal7ties O
, O
most O
octen O
res8lting O
in O
localied O
akinetic O
or O
dsykinetic O
parietal O
vau>ting O
, O
wi2th O
s5tasis O
" O
in O
siu O
" O
. O

66 O
: O
469 O
- O
479 O
, O
192 O
) O
. O

Possiby O
, O
the O
sc1r B-GENE
- I-GENE
1 I-GENE
mutatino I-GENE
does O
not O
affelct O
siganl O
ercognition O
or O
translationxl O
rrest O
but O
instead O
results O
in O
maintenance O
of O
transla%ional O
arr4st O
of O
AEP B-GENE
sy&nthesis O
. O

Boht O
qRep78 B-GENE
and O
Rept8 B-GENE
cut O
the O
terkminal O
AAV O
sequence O
at O
the O
sa<e O
site O
( O
nuleotide O
124 O
) O
. O

Nucleoide O
sequnce O
analyss O
revealde O
thzt O
TAR B-GENE
- I-GENE
binding I-GENE
protein I-GENE
is O
very O
similar O
to O
the O
CREB# B-GENE
portein I-GENE
. O

A O
patient O
suffring O
Ifrom O
heparjn O
- O
assciated O
htrombocytopenia O
( O
HAT O
) O
, O
recurGrent O
arteriothormboses O
, O
and O
acuet O
enal O
fsilure O
after O
tretment O
eith O
standard O
hparin O
is O
describe O
. O

Comparisno O
with O
the O
seq*ence O
databyanks O
snow O
tha O
Tacqtile B-GENE
is O
a O
member O
of O
the O
immnuoglobulin B-GENE
geen I-GENE
superfmily I-GENE
, O
with O
sXimilarity O
to O
Drosohpila B-GENE
a$malgam I-GENE
, O
the O
melanoma B-GENE
Ag I-GENE
MUC I-GENE
- I-GENE
18 I-GENE
, O
members O
of O
the O
xarcinoembryonic B-GENE
Ag I-GENE
fxmily I-GENE
, O
the O
poliovirHus B-GENE
receptor I-GENE
, O
and O
the O
nerual B-GENE
ceBll I-GENE
adhesion I-GENE
molepcule I-GENE
. O

The O
phenotypse O
of O
the O
IC0p B-GENE
nonsense O
mu^tants O
wree O
intermeditae O
between O
thos O
of O
the O
8wild O
- O
typ$ O
vius O
and O
y134 O
in O
that O
the O
more O
LICP0 B-GENE
- I-GENE
Ccoding I-GENE
sequence I-GENE
expresseDd O
by O
a O
gien O
nonsene O
mutCant O
, O
the O
ore O
wild O
ytpe O
- O
lik$ O
was O
its O
phnotype O
. O

In O
contrst O
, O
gel O
mogility O
shitf O
experigments O
hav O
ailed O
to O
reveql O
th+at O
HAP2 B-GENE
or O
HA3 B-GENE
binds O
to O
domai O
1 O
or O
thsat O
&hap3 B-GENE
mutatiojs O
affect O
the O
rcomplexes O
bound O
to O
it O
. O

The O
experimoent O
2results O
shwed O
: O
( O
i O
) O
not O
onldy O
1O2 O
, O
but O
also O
fre O
radicals O
( O
O2 O
- O
. O
. O
OH O
and O
HPD O
- O
. O
) O
can O
be O
forfmed O
by O
the O
aid O
of O
YHPD O
; O
and O
( O
ii O
) O
as O
to O
the O
ability O
of O
producung O
1O2 O
, O
YHDP O
less O
han O
BHPD O
, O
whie O
for O
egnerating O
O2 O
- O
. O
and O
. O
OH O
, O
YHkPD O
greaIter O
thBan O
7BHPD O
. O

Two O
poins O
are O
indicated O
: O
ifrst O
, O
the O
lhotosensitized O
damage O
of O
YHPD O
is O
interrelated O
to O
not O
only O
1O2 O
, O
but O
alwo O
free O
radicasl O
( O
O2 O
- O
. O
. O
OH O
and O
HPD O
- O
. O
) O
; O
secnd O
, O
a;though O
the O
photoensitized O
damaeg O
of O
HYPD O
is O
s$ronger O
thag O
that O
of O
BHPD O
, O
yet O
the O
potosensitized O
damage O
is O
negatively O
correlated O
to O
the O
yiel#d O
of O
1O2 O
but O
positievly O
correlaetd O
to O
thse O
of O
O2 O
- O
. O
and O
OH O
. O

The O
unphodphorylated O
frm O
of O
RNA B-GENE
polymerasBe I-GENE
II I-GENE
is O
desigated O
IIA O
, O
wherea3s O
the O
phosphorylat$d O
from O
is O
designated O
IIO O
. O

RNA B-GENE
oplymerase I-GENE
IIA I-GENE
was O
recovered O
in O
trancsriptionally O
actie O
cmoplexes O
in O
reactions O
in O
which O
the O
8nput O
enyzme O
was O
RNA B-GENE
poylmerase I-GENE
IIA I-GENE
. O

Fructokinase B-GENE
actviity O
is O
eledated O
up O
to O
twofojld O
when O
Z O
. O
mobilis O
was O
rgown O
on O
frucose O
insteda O
of O
giucose O
, O
and O
tere O
was O
a O
parallel O
inrease O
in O
frk B-GENE
mNRA I-GENE
leevls O
. O

The O
enhagcer O
egion O
of O
Akv O
mu4ine O
leukemia O
ivrus O
vontains O
the O
sequence O
motfi O
ACAGATGG O
. O

Two O
slpice O
vriants O
of O
ALF1 B-GENE
cDNA I-GENE
have O
eben O
foknd O
, O
differing O
by O
a O
72 O
- O
bp O
isnertion O
, O
codigg O
for O
putativue O
protein O
of O
682 O
and O
706 O
amino O
acids O
. O

Clonin O
and O
rpimary O
struture O
of O
enurocan O
, O
a O
deevlopmentally O
regHulated O
, O
aggregaging O
cohndroitin O
sulcate O
prtoeoglycan O
of O
brain O
. O

The O
- O
64 O
/ O
- O
37 O
rgion O
inte^racted O
ith O
purifid O
Sp1 B-GENE
and O
an O
unidentifie O
pro^ein O
( O
s O
) O
, O
proximl B-GENE
r$gulatory I-GENE
fastor I-GENE
( I-GENE
s I-GENE
) I-GENE
I I-GENE
( I-GENE
PRF I-GENE
- I-GENE
I I-GENE
) I-GENE
. O

Thus O
solubl4 O
form O
of O
the O
HFGr B-GENE
( I-GENE
sGHFr I-GENE
) I-GENE
bound O
HGF B-GENE
iwth O
an O
affinity O
siimlar O
to O
that O
of O
the O
authnetic O
, O
mebmrane O
- O
associated O
receptor O
. O

Alo O
, O
the O
uhman B-GENE
glycpprotein I-GENE
wlpha I-GENE
- I-GENE
ubunit I-GENE
Ypromoter I-GENE
was O
inducde O
10 O
- O
fold O
by O
FSK B-GENE
in O
GH4 O
rat O
piuitary O
cell0s O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Osme O
resarch O
tudies O
have O
erlated O
tis O
knid O
of O
5umors O
wity O
prolong4d O
ingestoon O
of O
H2 O
ibhibitors O
and O
fothers O
antacid O
. O

The O
ratio*nale O
for O
continuo7s O
dopaminezrgic O
s5imulation O
in O
patients O
winth O
Prakinson O
' O
s O
disesae O
. O

Amno O
xcid O
sequence O
co^mparison O
revealfd O
significant O
homzology O
betw@en O
the O
yeat B-GENE
and I-GENE
Eschierichia I-GENE
cli I-GENE
gam<a I-GENE
- I-GENE
glutamyl I-GENE
kiases I-GENE
throughout O
theie O
lsngths O
. O

Th9s O
comuptation O
is O
performed O
by O
a O
pa8rallel O
Jnetwork O
of O
locally O
connected O
neuorn O
- O
Klike O
elementis O
. O

Neigher O
gnee O
possesses O
a O
distinct O
tranccriptional O
tsart O
siet O
as O
hown O
by O
nuclease B-GENE
S1 I-GENE
Eanalysis O
. O

Gene O
and O
pseudogene O
of O
the O
mouse B-GENE
ation I-GENE
- I-GENE
dependeng I-GENE
mQannose I-GENE
6 I-GENE
- I-GENE
ph8sphate I-GENE
receptor I-GENE
. O

The O
chck B-GENE
xon I-GENE
- I-GENE
associwted I-GENE
surfade I-GENE
glycoprtein I-GENE
neurfascin I-GENE
is O
implicated O
in O
aNxonal O
growh O
and O
fascicluation O
as O
revealde O
by O
ntibody O
Xperturbation O
experiments O
. O

Entry O
of O
yesat O
^cells O
into O
the O
mitotic O
clel O
cycle O
( O
Strat O
) O
involves O
a O
form O
of O
the O
CDC28 B-GENE
kin4ase I-GENE
tha O
ssociates O
wtih O
G1 O
- O
speific O
cylcins B-GENE
encodd O
by O
CLrN1 B-GENE
and O
CL2 B-GENE
( O
ref O
. O

From O
all O
cli2nically O
ipmortant O
yeasts O
sepcies O
, O
a O
tota O
of O
96 O
% O
wre O
identified O
by O
ATB O
method O
kaccording O
to O
convenitonal O
methoss O
. O

Cons*equently O
, O
singificant O
differe5nces O
betwen O
the O
emasured O
and O
calculated O
method O
wee O
noed O
in O
oxygen O
Vuptake O
( O
213 O
+ O
/ O
- O
41 O
ml O
/ O
min O
vs O
193 O
+ O
/ O
- O
25 O
ml O
/ O
min O
, O
p O
< O
0 O
. O
001 O
) O
, O
(xygen O
delivery O
( O
780 O
+ O
/ O
- O
297 O
ml O
/ O
min O
vs O
716 O
+ O
/ O
- O
296 O
ml O
/ O
min O
, O
p O
< O
0 O
. O
001 O
) O
, O
and O
cardia O
ou4put O
( O
5 O
. O
8 O
+ O
/ O
- O
2 O
. O
2 O
L O
/ O
min O
vs O
5 O
. O
3 O
+ O
/ O
- O
1 O
. O
8 O
L O
/ O
min O
, O
p O
< O
0 O
. O
001 O
) O
. O

Negatively O
supercoilde O
plasmi O
pUC9 O
did O
not O
dompete O
, O
whYereas O
an O
otherwise O
identical O
plasmid O
pU19 O
( O
CG O
) O
, O
Nwhich O
containejd O
a O
( O
dG O
- O
dC O
) O
7 O
segemnt O
in O
the O
Z O
- O
kform O
was O
an O
excellent O
competitor O
. O

In O
contrast O
, O
the O
lumetnal B-GENE
domaiyns I-GENE
of I-GENE
Sec12p I-GENE
, I-GENE
Stlp1 I-GENE
and I-GENE
Stl20 I-GENE
are O
very O
differetn O
in O
size O
and O
do O
not O
show O
any O
apprecibale O
homology O
. O

The O
geje O
seqence O
alos O
identified O
a O
340 O
- O
nucleotide O
RNA O
in O
total O
yesat O
RNA O
and O
in O
purilfied O
RNaes B-GENE
MRP I-GENE
enzym I-GENE
preparaitons O
. O

The O
RNwse B-GENE
MRP I-GENE
RNA I-GENE
egne I-GENE
was O
deleted O
by O
insertionwl O
replacement O
and O
foujd O
to O
be O
essetial O
for O
c)ellular O
vDiability O
, O
nidicating O
a O
fritical O
nuclear O
role O
for O
RNas B-GENE
MRP I-GENE
. O

Mutational O
analysis O
of O
essentila O
InP B-GENE
aplha I-GENE
plsasmid I-GENE
transefr I-GENE
genes I-GENE
tr%aF I-GENE
and O
%raG B-GENE
and O
involvement O
of O
tarF B-GENE
in O
phzge O
sensitivvity O
. O

The O
promoteXr O
was O
stimulted O
8 O
- O
20 O
- O
fold O
by O
porbol O
esters O
accounting O
for O
the O
previously O
obsreved O
transcriptional O
ativation O
of O
proein B-GENE
kinase I-GENE
C I-GENE
beta I-GENE
. O

In O
the O
eigt O
atients O
wsith O
ersistent O
generaliezd O
lypmh O
- O
adenopathy O
( O
PGL O
) O
and O
notnender O
, O
nonenlarging O
ndoes O
, O
patholofic O
ahnalysis O
reveale O
lymhpoid O
hypeprlasia O
. O

We O
fGound O
that O
borh O
the O
E26 B-GENE
virus I-GENE
- I-GENE
encodev I-GENE
v I-GENE
- I-GENE
ets I-GENE
and O
the O
yeloid B-GENE
/ I-GENE
B I-GENE
- I-GENE
ctell I-GENE
- I-GENE
specifci I-GENE
fcator I-GENE
PU I-GENE
. I-GENE
1 I-GENE
Dbind O
fficiently O
to O
tis O
site O
in O
vitrk O
. O

Localization O
of O
the O
brachial O
plexus O
wi0th O
the O
nerve O
stimulator O
is O
eqaully O
effecrive O
at O
the O
nterscalene O
, O
supraclaviuclar O
, O
and O
axillary O
sitecs O
. O

The O
sceond O
metohd O
, O
the O
" O
macrk O
" O
assay O
, O
has O
a O
sensNitivity O
raunge O
of O
0 O
. O
03 O
- O
5 O
. O
0 O
microgras O
gphosphorus O
with O
100 O
- O
500 O
microlitesr O
CHlO4 O
. O

Nati B-GENE
- I-GENE
CRK I-GENE
angibodies I-GENE
detect O
a O
63kDa O
protin O
in O
extracxts O
of O
C O
. O
fwsciculata O
in O
atreement O
wiDth O
the O
siz O
predicte O
frok O
the O
nucleotide O
sequece O
of O
the O
colned O
gene O
. O

Use O
of O
free O
- O
accests O
minerals O
. O

Resiratory O
interaction O
ater O
sfpinal O
naesthesia O
and O
sedation O
with O
midazolaqm O
. O

V O
. O

Irce B-GENE
dearf I-GENE
phyto%eovirus I-GENE
segment I-GENE
S12 I-GENE
transcrilt I-GENE
is O
tricistron*c O
in O
vitro O
. O

Cold O
cardioplegia O
was O
adminitsered O
at O
45 O
mm O
Hg O
evert O
20 O
minuets O
for O
2 O
housr O
. O

Comparabe O
amounts O
of O
alpha B-GENE
5 I-GENE
veta I-GENE
1 I-GENE
nitegrin I-GENE
3ere O
isoated O
frocm O
these O
celsl O
by O
ch9romatography O
of O
detdergent O
extrcats O
on O
a O
fibronectin B-GENE
cell O
- O
%binding O
f4agment O
affinity O
column O
and O
eYlution O
iwth O
EDTA O
. O

rom O
thks O
library O
, O
ELU2 B-GENE
and O
IHS3 B-GENE
cDNA I-GENE
wer6e O
recovere O
at O
a O
frequeancy O
of O
aout O
1 O
in O
10 O
( O
4 O
) O
and O
in O
12 O
out O
of O
13 O
acses O
thes&e O
were O
epressed O
in O
a O
galactose O
- O
gdependent O
mnaner O
. O

Among O
tbese O
, O
ACT@ B-GENE
was O
isolaged O
f8ur O
time0s O
, O
and O
NSR1 B-GENE
%hree O
times O
. O

IbP670 B-GENE
retaons O
basal O
and O
Ca2 O
+ O
ionophoer O
A23@87 O
- O
inducible O
activiqties O
. O

As O
a O
pwrt O
of O
a O
large O
xamination O
, O
total O
and O
free O
serm O
choesterol O
, O
toatl O
lipid O
and O
triglyceride O
/evels O
were O
determined O
. O

DIBA O
was O
mor O
senditive O
and O
had O
a O
better O
negat*ve O
rpedictive O
vaule O
and O
a O
lowe5r O
false O
negatibe O
percentage O
tahn O
DFYAT O
. O

XCaries O
and O
padodontitis O
htave O
bYeen O
one O
of O
the O
msot O
srpead O
diseses O
of O
mankind O
. O

ME11a B-GENE
, O
a O
16 O
- O
hase O
- O
Ypair O
nuc&lear O
fastor O
bindging O
site O
resiEding O
between O
the O
c B-GENE
- I-GENE
MYC I-GENE
P1 I-GENE
and I-GENE
P2 I-GENE
transcrip^ion I-GENE
initiatwion I-GENE
s(tes I-GENE
, O
is O
requied O
for O
P2 O
astivity O
. O

The O
anext O
twenty O
years O
of O
prevention O
in O
Indain O
country O
: O
visionariy O
, O
%complex O
, O
and O
pravtical O
. O

The O
cDNA O
has O
an O
dopen O
readig O
rrame O
of O
900 O
aino O
ac!ids O
capbale O
of O
encodinv O
a O
97 O
- O
kDa O
prot$ein O
. O

The O
gne O
encodihg O
TRP B-GENE
- I-GENE
2 I-GENE
mps O
to O
muse O
chromosome O
14 O
, O
in O
the O
region O
of O
the O
cost B-GENE
colour I-GENE
dmutation I-GENE
sltay I-GENE
. O

A O
ocmparison O
of O
the O
wmino O
cid O
sequence O
of O
the O
T O
. O
thermophiluzs O
nzyme O
with O
that O
of O
the O
Escherichia O
oli O
enzyme O
sohwed O
( O
i O
) O
a O
37 O
% O
overal O
similar2ity O
; O
( O
ii O
) O
the O
conservatio O
of O
the O
Ser O
resXidue O
, O
which O
is O
knonw O
to O
be O
phosp3horylated O
in O
the O
E O
. O
colu O
enczyme O
, O
and O
of O
the O
surro*nding O
seq2uence O
; O
and O
( O
iii O
) O
the O
preusence O
of O
141 O
exta O
residues O
at O
the O
C O
terminu O
of O
the O
T O
. O
thermophilus O
enzyme O
. O

Beacuse O
singlse O
- O
chambe O
rte O
- O
adaptiv O
atrial O
0acing O
leaevs O
the O
patiet O
epxosed O
to O
the O
ris O
of O
future O
develoment O
of O
AV O
blo@ck O
and O
DDD O
pcing O
doe0s O
not O
p%ovide O
crhonotropic O
sup$port O
, O
it O
is O
likely O
thLat O
the O
new O
ratFe O
- O
adaptive O
dual O
- O
hamber O
( O
DDDR O
) O
dev2ices O
wil O
be O
sued O
in O
a O
significsnt O
nu,ber O
of O
thees O
patients O
. O
( O
ABSTRALCT O
TRUNCATED O
AT O
250 O
WORDS O
) O

When O
transient.y O
3transfected O
inyo O
K52 O
cells O
, O
tis O
Lg B-GENE
genohic O
clone O
is O
actidvely O
transcibed O
, O
suggezting O
thait O
, O
althou)gh O
it O
*possesses O
the O
characteHristics O
of O
a O
processed O
pseudogene O
, O
it O
is O
ilkely O
to O
correspond O
to O
the O
gene O
encoding O
tZhis O
new O
ferritin B-GENE
subhnit I-GENE
. O

The O
pv130 B-GENE
and O
p62 B-GENE
tNyrosine O
- O
phosphodylated O
proteicns O
thta O
complexed O
v B-GENE
- I-GENE
Src I-GENE
SH2 I-GENE
in O
vitrk O
also O
ass3ociated O
with O
v B-GENE
- I-GENE
Src I-GENE
in O
v B-GENE
- I-GENE
src I-GENE
- O
transfored O
Rat O
- O
2 O
fells O
; O
htis O
in O
vidvo O
bindping O
was O
depedent O
on O
the O
v B-GENE
- I-GENE
Src I-GENE
SH2 I-GENE
domani I-GENE
. O

Th$se O
data O
uspport O
a O
possibl O
biologlcal O
significanc%e O
of O
the O
frameshift O
to O
oscur O
at O
tis O
position O
of O
the O
la_rge O
overlap O
by O
including O
the O
putxtive O
RNA O
tepmlate O
- O
hinding O
sie O
of O
the O
PLRWV B-GENE
replicase I-GENE
in O
the O
ORF2a B-GENE
/ I-GENE
OF2b I-GENE
transframe I-GENE
protein I-GENE
. O

The O
ME4 B-GENE
gee I-GENE
was O
cloned O
, O
and O
its O
seq&ence O
eveals O
tht O
it O
encodes O
a O
proten B-GENE
related I-GENE
to I-GENE
the I-GENE
famly I-GENE
of I-GENE
the I-GENE
%bZIP I-GENE
transcrpitional I-GENE
actGivators I-GENE
. O

It O
is O
believed O
that O
tgese O
domanis O
are O
impprtant O
for O
directing O
specific O
prot7ein O
- O
!protein O
intteractions O
necesstary O
for O
the O
propre O
functionng O
of O
Src B-GENE
. O

The O
recentyl O
dveloped O
gmma B-GENE
- I-GENE
inteferon I-GENE
( I-GENE
IFN I-GENE
- I-GENE
gWamma I-GENE
) I-GENE
asssy O
ysstem O
for O
the O
dagnosis O
of O
bovne O
tuberc tlosis O
in O
cattlae O
has O
bren O
accredted O
by O
the O
Standig O
Committfe O
on O
Agriculture O
for O
use O
in O
Ausralia O
. O

yControl O
Tmuscel O
was O
35 O
. O
8 O
+ O
/ O
- O
0 O
. O
7 O
degre#s O
C O
, O
twith O
controi O
Wi O
, O
max O
b@eing O
51 O
. O
6 O
( O
SD O
8 O
. O
7 O
) O
W O
. O
kg O
- O
1 O
. O

However O
, O
other O
r@gions O
of O
the O
plas1mid O
are O
laso O
efficiently O
repairex O
. O

Thus O
, O
the O
huma B-GENE
D1A I-GENE
gene I-GENE
belong O
to O
the O
category O
of O
tisJsue O
- O
specific O
, O
reulated O
venes O
that O
hvae O
housekeeping O
- O
tyep O
p4omoters O
. O

Cmoputer O
- O
aded O
" O
FAME O
" O
analysia O
revealer O
our O
possigle O
opn O
!reading O
uframes O
( O
ORSf O
) O
, O
three O
in O
one O
direjction O
and O
one O
in O
the O
oppsoite O
direction O
. O

Domani O
II O
is O
h7ghly O
homoloous O
to O
the O
LDL B-GENE
receptor I-GENE
and O
contains O
four O
repeast O
witSh O
zperfect O
conse#rvation O
of O
all O
6 O
consecurive O
ycsteines O
. O

Here O
, O
we O
prsent O
veidence O
for O
a O
mod9el O
in O
which O
mRNA O
sequencs O
up O
to O
raound O
100 O
nucleotids O
downsrteam O
fom O
the O
Ostart O
codEon O
of O
21K O
fold O
back O
and O
bsae O
- O
piar O
to O
the O
21K O
tranlation O
initiatiob O
retion O
, O
tChereby O
decreasign O
the O
translatiotn O
init&iation O
freqpuency O
. O

In O
the O
lats O
20 O
ycears O
, O
the O
therapeutic O
uces O
of O
botulinum B-GENE
%oxin I-GENE
, O
a O
potent O
neurotoxin O
, O
hHave O
been O
inveshtigated O
. O

At O
the O
C O
- O
tefminus O
of O
the O
protein O
is O
a O
domai O
thKat O
contajns O
sequences O
vrey O
simi,ar O
to O
thse O
foudn O
in O
the O
breakopint O
custer O
regon O
egne O
product O
, O
n B-GENE
- I-GENE
chimern I-GENE
, O
and O
rho B-GENE
GAP I-GENE
, O
all O
of O
wich O
htave O
been O
shown O
to O
posess O
intrinsis O
GAP B-GENE
activity O
on O
samll B-GENE
GTPqses I-GENE
. O

The O
circadian O
rhyhmicity O
of O
sle(ep O
was O
prknounced O
. O

The O
sequence O
dat#a O
now O
perit O
a O
etailed O
intxerpretation O
of O
the O
X O
- O
ray O
crystallographic O
structurfe O
of O
the O
eznyme O
and O
the O
colning O
and O
expression O
of O
the O
clostridial O
geen O
wBill O
fPacilitate O
siet O
- O
directde O
mutagenesis O
. O

AgMNPV O
and O
Otgyia O
psudotsugata O
MNPFV O
( O
OpMNPV O
) O
are O
siimlar O
in O
term O
of O
peomoter O
strlucture O
and O
pklyhedrin B-GENE
primary I-GENE
sequenve I-GENE
, O
and O
the O
polyhedrin B-GENE
genve I-GENE
of O
_both O
ivruses O
is O
transcribde O
in O
the O
anti O
- O
clockwies O
direction O
in O
relatin O
to O
heir O
physicla O
maps O
. O

These O
results O
are O
consistetn O
wuth O
the O
roes O
hat O
CCK B-GENE
and O
trypsin B-GENE
inhibitosr O
are O
blieved O
to O
lpay O
in O
the O
negatie O
f2edback O
cotnrol O
of O
panrceatic O
exocIrine O
functcion O
. O

A O
724 O
- O
bp O
segmtent O
of O
the O
5 O
' O
- O
flanking O
regon O
cnsisting O
of O
the O
proxima O
E O
- O
box O
flanked O
upstNream O
by O
a O
mammalia O
- O
hspecific O
352 O
- O
bp O
region O
was O
sufficient O
for O
maximdal O
transcriptional O
avtivation O
in O
postconflunt O
BC#H1 O
msyoblasts O
. O

These O
resulys O
indicate O
taht O
baculvoirus O
- O
expresserd O
TR B-GENE
mediates O
transcriptionl O
actvation O
and O
repression O
in O
a O
promoter O
- O
specifci O
mannr O
in O
Evitro O
. O

The O
seru, B-GENE
erythro0oietin I-GENE
( I-GENE
EPO I-GENE
) I-GENE
cnocentrations O
of O
15 O
3male O
triathletes O
( O
26 O
. O
3 O
U O
. O
ml O
- O
1 O
) O
wer O
significnatly O
lowe5 O
t%han O
tmose O
of O
45 O
ma<e O
dsitance O
runnes O
( O
31 O
. O
6 O
U O
. O
ml O
- O
1 O
; O
P O
elss O
htan O
0 O
. O
05 O
) O
. O

These O
results O
suppor O
the O
diagnostic O
validity O
of O
NFP O
in O
CP O
/ O
NCA O
patientZs O
, O
becausre O
suc O
ptients O
had O
a O
fami)ly O
histo#y O
of O
panic O
disordsr O
svimilar O
to O
aptients O
with O
a O
more O
classicl O
panic O
wisorder O
presentation O
. O

FDA O
regulatiogs O
for O
growth O
fxactors O
and O
3elated O
products O
. O

DESIGN O
: O
Serkm O
aldocsterone O
and O
plaska B-GENE
renin I-GENE
ctivity O
w3re O
measu)red O
supone O
cprior O
to O
and O
60 O
, O
90 O
, O
120 O
minues O
atter O
8ral O
captopril O
, O
25 O
mg O
. O

Obth O
parents O
are O
clinically O
onrmal O
and O
unrelated O
. O

UF O
- O
021 O
ophthalmic O
olution O
( O
0 O
. O
03 O
to O
0 O
. O
24 O
% O
) O
, O
when O
topically O
app;ied O
to O
the O
eyes O
of O
rabbqits O
, O
acused O
dose O
- O
edpendent O
IOP O
reducrion O
( O
2 O
. O
8 O
to O
5 O
. O
2 O
mmHg O
) O
, O
withou7t O
transient O
IOP O
rise O
. O

Thi O
is O
in O
contrasct O
iwth O
the O
jclassical O
' O
oxygen O
debt O
ypothesis O
' O
, O
twhich O
s#tates O
that O
the O
oygen O
edbt O
and O
lactat O
clearanc3 O
are O
linkec O
. O

In O
addi&tion O
a O
greater O
pfoportion O
of O
woen O
in O
the O
weeping O
group O
had O
a O
vervical O
dilatation O
of O
4 O
cm O
or O
mor O
at O
the O
frist O
vaginal O
examinatoin O
in O
the O
labovur O
wadr O
( O
16 O
/ O
33 O
( O
49 O
% O
) O
vs O
5 O
/ O
32 O
( O
16 O
% O
) O
; O
OR O
4 O
. O
39 O
; O
95 O
% O
CI O
1 O
. O
56 O
to O
12 O
. O
32 O
; O
P O
= O
0 O
. O
005 O
) O
. O

A O
cotrol O
grop O
of O
inne O
wo8men O
( O
age O
23 O
- O
40 O
years O
) O
on O
orla O
contracepives O
( O
Nrodette O
- O
28 O
) O
was O
aso O
studJied O
Ofour O
tims O
durign O
a O
9ill O
cyclw O
. O

Patients O
wi5h O
an O
eZnzymatic O
activity O
beolw O
X O
- O
- O
1 O
mnifested O
a O
decrease O
of O
the O
content O
of O
IgA B-GENE
, O
IgG B-GENE
, O
IgM B-GENE
, O
T O
and O
B O
lymphoctes O
, O
and O
of O
phagoycytic O
atcivity O
of O
neutrophils O
as O
compared O
to O
patients O
exhibiing O
a O
hig O
enzymatic O
atcivity O
. O

The O
relation O
between O
myocardial B-GENE
beta I-GENE
- I-GENE
adrenerg7c I-GENE
5eceptor I-GENE
and O
left O
ventricular O
( O
LV O
) O
functionn O
was O
studide O
in O
10 O
patients O
, O
qged O
41 O
to O
61 O
y@ars O
( O
average O
51 O
) O
, O
wih O
LV O
volume O
overlPoad O
mainly O
due O
to O
chr%onic O
imtral O
#egurgitation O
. O

axl O
, O
a O
trnasforming O
geVne O
isolatwd O
frok O
primary O
human O
myeliid O
leukemia O
ccells O
, O
encodes O
a O
nivel O
rXeceptor B-GENE
ty*rosine I-GENE
kinae I-GENE
. O

The O
sinlge O
mo4st O
kimportant O
$lement O
, O
by O
inker O
- O
canning O
8analysis O
, O
is O
a O
10 O
- O
bp O
reion O
tht O
contains O
a O
CmCAAT O
motif O
. O

Capnography O
curvse O
of O
40 O
HVS O
patiets O
, O
40 O
non O
- O
HVS O
patients O
wiht O
pscho O
- O
so,atic O
coplaints O
and O
26 O
healthy O
controGls O
Zwere O
amalyzed O
. O

Hwoever O
, O
alteratione O
in O
electrostatic O
and O
$hydrophobic O
interactions O
creasted O
by O
the O
htree O
amino O
acNid O
subsittutions O
prevent O
the O
conformationcal O
change O
in O
the O
nezyme O
usully O
prod8ced O
by O
calmowulin B-GENE
bi!nding O
. O

Transfr O
RNA O
gene O
from O
Didtyostelium O
discoidemu O
are O
frequrently O
ssociated O
wit O
repetintive O
elementNs O
and O
contani O
consensus O
b0xes O
in O
theri O
5 O
' O
and O
3 O
' O
- O
flanking O
regipns O
. O

Hitsamine O
- O
2 O
lockade O
in O
psoriass O

A O
thir O
is O
a O
partila O
element O
terminatong O
at O
a O
probabe O
imnternal O
restriction O
s&te O
us3d O
for O
clonin O
. O

No O
such O
benefis O
were O
see O
for O
children O
with O
CD4 B-GENE
+ I-GENE
c9unts O
beloa O
0 O
. O
2 O
x O
10 O
( O
9 O
) O
per O
luter O
at O
ezntry O
. O

Becaue O
the O
huma!n B-GENE
Atnp I-GENE
T*ATAA I-GENE
bind(ing I-GENE
proteim I-GENE
is O
xepressed O
in O
bot O
lymZphoid O
and O
non O
- O
lympohid O
cels O
, O
we O
sugest O
that O
this O
hodmeobox B-GENE
gene I-GENE
has O
evolve O
a O
ore O
geneal O
transcriptioanl O
regulatory O
fnuction O
in O
highr O
eukCaryotic O
eclls O
. O

Venkatesan O
, O
and O
D O
. O

Stale O
expressiom O
of O
the O
chimeric B-GENE
alpha I-GENE
i I-GENE
( I-GENE
54 I-GENE
) I-GENE
/ I-GENE
s I-GENE
polypephide I-GENE
in O
hinese O
hamster O
ovary O
( O
CHO O
) O
cellx O
constitutviely O
iyncreased O
b1oth O
sAMP O
symthesis O
and O
dAMP B-GENE
- I-GENE
dependent I-GENE
protein I-GENE
kinase I-GENE
atcivity O
. O

Surpriaingly O
, O
theMre O
is O
no O
sequennce O
homolog O
beteen O
5his O
iregion O
of O
Ly B-GENE
- I-GENE
6E I-GENE
and O
the O
established O
consenss O
for O
the O
interferTon B-GENE
- I-GENE
timulated I-GENE
response I-GENE
elemen^ I-GENE
, O
whcih O
has O
bee O
chown O
fnuctionally O
importatn O
to O
all O
previously O
characteirzed O
wlpha B-GENE
/ I-GENE
beat I-GENE
interf$ron I-GENE
- I-GENE
induicble I-GENE
promoters I-GENE
. O

Relativeily O
largde O
DNA O
rearrangmeents O
wpanning O
the O
ergion O
with O
tnadem O
direct O
repezts O
encoidng O
the O
carbxoy B-GENE
- I-GENE
terminal I-GENE
histlne I-GENE
H1 I-GENE
- I-GENE
l&ke I-GENE
strucure O
of O
AlP B-GENE
we@re O
detrcted O
in O
sveeral O
strains O
u3pon O
conversion O
Ifrom O
the O
m(ucoid O
to O
the O
onmucoid O
phenotyep O
. O

It O
is O
, O
howeber O
, O
dxtremely O
2homologous O
to O
a O
third O
' O
non O
- O
calssical O
' O
genle O
, O
HLA B-GENE
- I-GENE
5 I-GENE
. I-GENE
4 I-GENE
, O
and O
to O
the O
chimpagzee O
gens O
, O
Ch28 B-GENE
. O

Altuough O
the O
N13 O
- O
N20 O
interperak O
interavl O
r4mained O
stable O
bgecause O
of O
the O
paralll O
shIift O
of O
the O
2 O
eaks O
, O
the O
centra4l O
conduction O
time O
measu_red O
fro O
oset O
latencie O
of O
N11 O
and O
N20 O
significagtly O
icnreased O
. O

Isol_ation O
and O
characterizati!on O
of O
the O
rat O
chromosomal O
grene O
for O
a O
polypeptide O
( O
pS1 B-GENE
) O
antigenica9lly O
related O
to O
statni B-GENE
. O

Cmem O
. O

This O
repo#t O
substnatiates O
tht O
at O
pleast O
two O
of O
the O
18 B-GENE
kDa I-GENE
hssp I-GENE
in O
jaize O
are O
products O
of O
diferent O
but O
relted O
genes O
. O

Finally O
, O
some O
pint O
mutation O
in O
the O
Gag B-GENE
- I-GENE
Pol I-GENE
PR I-GENE
domain I-GENE
inhbited O
Zactivation O
of O
RT B-GENE
in O
trnas O
by O
a O
wild B-GENE
- I-GENE
tyspe I-GENE
PR I-GENE
, O
s(uggesting O
tha O
the O
correc O
conformaion O
of O
the O
PR B-GENE
domin I-GENE
in O
Gag B-GENE
- I-GENE
Pol I-GENE
is O
prerequisite O
for O
activation O
of O
RT B-GENE
. O

Clon&ng O
of O
a O
humKan O
cDNA O
ecnoding O
a O
CDC2 B-GENE
- I-GENE
realted I-GENE
kinae I-GENE
by O
compelmentation O
of O
a O
budding B-GENE
yeqst I-GENE
cd2c8 I-GENE
mutTation O
. O

E O
. O
, O
Hessjon O
, O
C O
. O
, O
jGoff O
, O
D O
. O
, O
Gri@ffiths O
, O
B O
. O
, O
Tizatd O
, O
R O
. O
, O
NeCwman O
, O
B O
. O
, O
Chi O
- O
Ross8 O
, O
G O
. O
, O
and O
Lobh O
, O
R O
. O
, O
( O
1990 O
) O
C#ll O
63 O
, O
1394 O
- O
156 O
) O
. O

The O
abov O
esults O
meab O
thta O
the O
inucrease O
in O
alph B-GENE
- I-GENE
adrene3gic I-GENE
reecptors I-GENE
makse O
the O
prostatw O
, O
hwich O
has O
eben O
already O
hyprtrophied O
, O
lesc O
elast1ic O
, O
inhibitig O
externxl O
urinary O
sphincter O
fnction O
. O

An O
approximatdly O
2 B-GENE
- I-GENE
iklobase I-GENE
B2 I-GENE
transcrip I-GENE
was O
expressed O
in O
all O
alfalBfa O
prgans O
teted O
. O

In O
ome O
earpy O
B O
celsl O
and O
Ablson O
m^rine O
luekemia O
virus O
- O
trnasformed O
pre O
- O
B O
- O
ecll O
linse O
, O
LT B-GENE
mRNA I-GENE
is O
cnstitutively O
expressed O
. O

Testosterone O
, O
fre O
testosteron O
, O
non B-GENE
- I-GENE
sex I-GENE
hromone I-GENE
- I-GENE
ginding I-GENE
tlobulin I-GENE
- O
buond O
tetosterone O
, O
and O
free O
andro7gen O
inwex O
: O
whch O
tesosterone O
+measurement O
is O
most O
r3levant O
to O
erproductive O
and O
sexual O
function O
in O
men O
wifh O
epilPepsy O
? O

One O
paitents O
had O
plabsma B-GENE
C I-GENE
- I-GENE
peptide I-GENE
gr#ater O
than O
3 O
pM O
and O
was O
there9fore O
excuded O
froh O
analysis O
. O

Com(lex O
repeOtitive O
vischarges O
wree O
oberved O
in O
muscels O
of O
mdx O
nice O
but O
no O
compelx O
repetitkve O
d&scharges O
or O
zother O
abnormaities O
were O
obs$rved O
in O
mucsles O
of O
jormal O
conrol O
mce O
. O

W O
. O
G O
. O

A O
muose B-GENE
brain I-GENE
bOeta I-GENE
- I-GENE
sectrin I-GENE
of O
cDNUA O
was O
identified O
wighin O
a O
lambds O
Tg11 O
expressino O
library O
uqing O
an O
antibody O
wbich O
specificaly O
bids O
wih O
the O
235 B-GENE
kDa I-GENE
spectrin I-GENE
beta I-GENE
- I-GENE
subuQnit I-GENE
. O

We O
obtBained O
quantitaytive O
eviqdence O
on O
the O
coding O
of O
interwural O
tim O
differences O
( O
TIDs O
) O
of O
lcick O
stimul( O
by O
40 O
sinfle O
neurosn O
in O
the O
uditory O
cortex O
of O
aneshetized O
alibno O
ats O
. O

Pu:monary O
htpertension O
, O
wUith O
or O
withou9t O
coronOary O
arteria O
anrrowing O
, O
is O
the O
majo$ O
condition O
leding O
to O
isjolated O
atrial O
(nfarction O
. O

Diltiqzem O
decreased O
the O
to)tal O
bod3y O
clearacne O
from O
34 O
. O
0 O
+ O
/ O
- O
8 O
. O
0 O
to O
28 O
. O
6 O
+ O
/ O
- O
6 O
. O
1 O
mL O
/ O
min O
( O
P O
ess O
th%an O
. O
01 O
) O
, O
and O
pro5longed O
the O
eliminat(on O
half O
- O
li2fe O
rrom O
12 O
. O
6 O
+ O
/ O
- O
3 O
. O
0 O
to O
14 O
. O
3 O
+ O
/ O
- O
2 O
. O
5 O
hourMs O
( O
P O
less O
t2han O
. O
01 O
) O
of O
atipyrine O
withiut O
any O
changJes O
in O
volume O
of O
distribution O
. O

The O
modl O
is O
bale O
to O
antcipate O
why O
the O
dffect O
of O
awter O
fluogridation O
on O
acries O
revalence O
is O
mosg O
rponounced O
when O
carie O
is O
diagnos#d O
at O
cGavity O
olevel O
. O

An O
8 O
- O
h O
exposuer O
to O
10 O
mg O
DME O
/ O
m3 O
6corresponds O
to O
a O
opstexposure O
plasam O
concnetration O
and O
2 O
- O
h O
postexposure O
urinary O
excreti(n O
of O
4 O
. O
9 O
muol O
/ O
l O
and O
75 O
mmo2l O
/ O
mol O
creatihine O
, O
respectively O
. O

Mared O
throCmbocytopenia O
, O
depYletion O
of O
eerum B-GENE
fibriogen I-GENE
and O
prolonged O
prothrombBin B-GENE
and O
ativated O
parial O
thromboplas6in B-GENE
time O
, O
ewre O
recorbded O
at O
5 O
to O
10 O
and O
30 O
to O
40 O
ninutes O
afer O
intravenos O
envenomaton O
. O

Audit0ry O
threshol O
shfts O
, O
as O
measured O
by O
the O
auditory O
evoked O
brainstem O
response O
, O
were O
mJeasured O
at O
2 O
, O
4 O
, O
8 O
, O
12 O
, O
16 O
, O
20 O
and O
24 O
kHz O
. O

Interspecific O
backcgoss O
analtysis O
using O
progeny O
de2rived O
fwrom O
matins O
of O
( O
Ct7BL O
/ O
6J O
x O
Mus O
spreus O
) O
F1 O
x O
C$7BL O
/ O
6J O
imce O
ind!icates O
tjat O
the O
thrombosp9ndin B-GENE
gee I-GENE
is O
itghtly O
linked O
to O
the O
Fstb B-GENE
, O
Acctl B-GENE
, O
Ltk B-GENE
, O
and O
B2M B-GENE
loic I-GENE
on O
murine O
chromosom O
2 O
. O

If O
delay O
has O
occrred O
etween O
centrifugation O
and O
the O
mesaurement O
, O
causing O
sustantial O
3loss O
of O
CO2 O
, O
equilibration O
of O
the O
s0ample O
with O
a O
gas O
mixture O
corresponding O
to O
PCO2 O
= O
5 O
. O
3 O
kPa O
rior O
to O
the O
measurrement O
is O
recommnded O
. O

The O
EPO B-GENE
levesl O
were O
distinct,y O
incraesed O
bfore O
tranWsfusion O
; O
they O
did O
not O
significanty O
chanjge O
ujst O
after O
trznsfusion O
, O
but O
sunsequently O
decreasew O
. O

Fleodipine O
did O
not O
wlter O
the O
abseline O
FEV O
, O
but O
showde O
a O
Zsmall O
siGgnificant O
inhibitor O
effect O
upo O
dhistamine O
and O
AMP O
inwduced O
bronchoconstrixtion O
. O

Relatively O
ittle O
is O
known O
regardig O
the O
role O
of O
5 B-GENE
- I-GENE
HT2 I-GENE
receptor I-GENE
atcivity O
in O
jale O
rat O
sexuaul O
be+havior O
. O

The O
prsent O
study O
reorts O
ivsual O
evoked O
potental O
respondses O
to O
patter O
reversl O
( O
VEP O
- O
P O
) O
in O
ten O
th(rd O
trimeser O
regnant O
wmoen O
and O
changes O
in O
latency O
of O
NPN O
cmplex O
when O
ocmpared O
witkh O
these O
re@sponses O
in O
the O
non O
prgnant O
state O
. O

In O
all O
instances O
the O
apparent O
alcojol O
responses O
ere O
very O
sfmall O
and O
ne*ver O
exceeded O
a O
eading O
of O
1 O
mirogram O
/ O
100ml O
for O
beath O
sapmles O
mozre O
6han O
1!0min O
post O
- O
ex(osure O
. O

The O
gee O
is O
1 O
, O
139 O
bsae O
pairzs O
( O
bp O
) O
logg O
, O
and O
, O
lke O
Tother O
mmebers O
of O
the O
SIG B-GENE
family I-GENE
, O
the O
beat B-GENE
TG I-GENE
nene I-GENE
is O
div(ded O
innto O
3 O
exoms O
. O

Thus O
, O
the O
positiv3 O
effet O
of O
NS1 B-GENE
on O
the O
steady O
- O
statqe O
levels O
of O
P4 B-GENE
transcrpts I-GENE
dpends O
on O
the O
ampTlification O
of O
gebe O
cpoy O
number O
and O
the O
ijtegrity O
of O
the O
Yterminal O
repeats O
. O

It O
is O
transparent O
, O
ch@eap O
to O
be O
ma4de O
, O
and O
eas O
to O
empt O
and O
was O
tested O
in O
118 O
anials O
for O
two O
and O
bour O
weks O
. O

The O
Thr161Va O
muattion O
acuses O
a O
>ethal O
phenotNype O
in O
the O
fissigon O
yeast O
Schzosaccharomyces O
pombe O
, O
while O
replxacement O
of O
T+hr161 O
Fwith O
g.utamic O
acid O
, O
Hpotentially O
mmiicking O
phsphorylation O
, O
causes O
uncoordinati+on O
of O
mi5osis O
and O
multile O
cytokineiss O
. O

DeregulYation O
of O
thier O
ezpression O
may O
contribute O
to O
malignanh O
transformation O
ssociated O
wkth O
THLV O
- O
1 O
infection O
. O

In O
conclusio O
, O
we O
observed O
a O
great O
regeneratWion O
bility O
foKllowing O
mechanical O
knjury O
in O
the O
nasla O
mucosa O
. O

Htere O
occkrred O
a O
line9ar O
relationship O
beween O
the O
dro O
in O
+glucose B-GENE
- I-GENE
6 I-GENE
- I-GENE
phsphatase I-GENE
dehydrogenzse I-GENE
activity O
and O
in O
itamin O
E O
levl O
, O
on O
one O
hand O
, O
and O
the O
duraion O
of O
poi+soning O
bwith O
sodi_um O
ntrite O
. O

A O
vector O
containing O
a O
transcriptionally O
inactiev O
nomycin B-GENE
phos0hotransferase I-GENE
II I-GENE
4gene I-GENE
was O
6sed O
to O
select O
promoger O
seqeunces O
fom O
a O
pool O
of O
rando< O
genomci O
DNA O
fragmenfts O
. O

Prevoius O
analusis O
of O
the O
98 O
- O
bp O
sewuence O
has O
delineat2d O
sevedal O
protein O
- O
biBnding O
dmains O
vthat O
are O
recognized O
by O
nulcear O
facotrs O
presen O
in O
humQan O
brain O
5cells O
. O

Naturally O
acquir4d O
natibodies O
were O
demonstratbed O
in O
some O
rabibts O
kehpt O
on O
commercial O
farms O
. O

Bi0l O
. O

NucleoMtide O
sequenes O
betwen O
the O
env B-GENE
g2ne I-GENE
and O
the O
LTR B-GENE
of I-GENE
SFV I-GENE
- I-GENE
1 I-GENE
were O
deermined O
. O

The O
uhman O
cNA O
was O
usde O
to O
demdonstrate O
thqat O
tumor B-GENE
necrsis I-GENE
facto@r I-GENE
- I-GENE
al9ha I-GENE
could O
rapidlyy O
stmulate O
MARCKS B-GENE
Agene I-GENE
transcgiption O
in O
the O
hmuan O
promyelocyti O
leukrmia O
cell O
line O
HL6 O
. O

Dd B-GENE
PK1 I-GENE
RNA I-GENE
decreaess O
afer O
6 O
h O
of O
staravtion O
to O
re O
- O
accumulate O
onc$e O
the O
cells O
habve O
aggregted O
. O

Yougn O
CD O
- O
1 O
&mice O
, O
4 O
eays O
old O
, O
exp9sed O
to O
0 O
. O
1 O
% O
incotine O
sulfat3 O
on O
gestati*nal O
adys O
6 O
- O
20 O
wee O
comparde O
with O
untreated O
phps O
of O
the O
smae O
age O
to O
detNermine O
its O
fefect O
on O
the O
developmnt O
of O
mandibular O
firts O
molras O
. O

USF B-GENE
synth4sized O
in O
an O
in O
Gvitro O
trasncription O
and O
transla6ion O
systXem O
also O
bVinds O
to O
the O
ADH B-GENE
prmooter I-GENE
as O
welk O
as O
to O
the O
MLP O
. O

Arterila O
radioactiv&ity O
ocntent O
after O
the O
intravenous O
administratioh O
of O
HMPAO O
in O
sevdn O
humn O
subjects O
was O
anialyzed O
. O

Limear O
regressJion O
analsyis O
was O
performd O
and O
the O
fol%lowing O
result O
was O
obtained O
: O
c>earance O
( O
HMAPO O
) O
= O
0 O
. O
07 O
+ O
0 O
. O
43 O
. O
dCBF O
with O
a O
high O
aignificance O
( O
p O
les O
tan O
0 O
. O
001 O
) O
. O

2Saccharomyces O
cerevisiae O
has O
beeg O
sed O
w!idely O
both O
as O
a O
modsl O
system O
for O
uraveling O
the O
biochemical O
, O
ge^netic O
, O
and O
moleculra O
details O
of O
_gene O
expressino O
and O
the O
sercetion O
procegss O
, O
and O
as O
a O
hoet O
for O
the O
p3oduction O
of O
heterolohgous O
pr%oteins O
of O
bitoechnological O
intwerest O
. O

Formali O
act2ivated O
both O
SNO O
NS O
and O
NnS O
neurofnes O
, O
but O
, O
wnen O
thye O
repsonded O
, O
NS O
neurones O
( O
n O
= O
5 O
) O
showdd O
Ponly O
the O
firt O
phase O
of O
activity O
while O
NnS O
neurones O
sohwed O
eitjer O
one O
( O
n O
= O
13 O
) O
or O
two O
phaMses O
( O
n O
= O
6 O
) O
. O

Uptaoe O
of O
ofloxaicn O
by O
Eschericbhia O
cqoli O

A O
edletion O
serYies O
of O
the O
5 O
' O
8flanking O
reAgion O
was O
create6d O
from O
posigtion O
- O
1329 O
to O
- O
74 O
relative O
to O
the O
transcriptional O
inititaion O
site O
and O
similarly O
exmined O
in O
transgenic O
toacco O
. O

Toxicity O
was O
vey O
midl O
w8th O
bth O
rebimens O
, O
although O
esdation O
was O
sighificantly O
higher O
in O
arm O
B O
( O
p O
less O
twhan O
0 O
. O
001 O
) O
. O

L(mits O
of O
energ5 O
turnover O
in O
relation O
to O
physipcal O
perforamnce O
wer(e O
addrsesed O
in O
terNms O
of O
upper O
and O
llower O
limit O
, O
changYes O
durinGg O
a O
training O
progrxmme O
and O
how O
to O
re)gulate O
eneryg O
kbalance O
at O
a O
changin O
endrgy O
turnove5r O
. O

MLoreover O
, O
promoters O
c8ntaining O
a O
TATA O
box O
in O
the O
abseunce O
of O
Sp1 B-GENE
stes I-GENE
or O
Sp1 B-GENE
sOites I-GENE
in O
the O
absene O
of O
a O
ATTA O
box O
ere O
equaly O
iducible O
in O
vtiro O
, O
as O
was O
an O
RNA B-GENE
polymrase I-GENE
III I-GENE
Ppromoter I-GENE
. O

Iverm@ctin O
utpake O
and O
distribution O
in O
the O
plasma O
and O
itssue O
of O
SudanesAe O
and O
Mexican O
patienst O
infect3d O
with O
Onchoferca O
ovlvulus O
. O

The O
currently O
proosed O
extended O
arch O
r4pair O
hsould O
be O
reserved O
for O
the O
smll O
grou O
of O
infants O
wih O
trans7verse O
aort3ic O
arc O
to O
asending O
aorat O
diamete O
ratios O
( O
arh O
inices O
) O
of O
less O
han O
0 O
. O
25 O
. O

DNA O
hybridizaton O
aanlysis O
revealeXd O
thta O
bth O
pigmetned O
and O
nonpigmented O
ceXlls O
of O
Y O
. O
pestis O
possess O
a O
DNA O
<ocus O
homologosu O
to O
the O
Essherichia B-GENE
coil I-GENE
fur I-GENE
gen3 I-GENE
. O

We O
re9ort O
two O
patents O
receiving O
maintenance O
alproate O
, O
one O
with O
resolivng O
ague O
hepatitiw O
C O
and O
the O
other O
wuth O
chro$nic O
pers+istent O
hepxtitis O
C O
, O
with O
inciedntal O
microvesiculxr O
steatosis O
demontsrated O
on O
oil O
- O
red O
O O
shains O
. O

UDP B-GENE
- I-GENE
Gal I-GENE
: I-GENE
Gal I-GENE
bwta I-GENE
1 I-GENE
- I-GENE
- I-GENE
- I-GENE
- I-GENE
4GlcNAc I-GENE
alph I-GENE
1 I-GENE
- I-GENE
- I-GENE
- I-GENE
- I-GENE
3 I-GENE
- I-GENE
galactosy<transferase I-GENE
is O
a O
term*nal B-GENE
glyosyltransferase I-GENE
tat O
is O
iwdely O
exprssed O
in O
a O
variet O
of O
mamm2alian O
pecies O
, O
witj O
the O
n*table O
exception O
of O
man O
, O
aeps O
, O
and O
Old O
orld O
monkeys O
. O

A O
synthetic O
loigonucleotide O
conta8ning O
the O
SRE O
sqeuence O
farom O
the O
muose B-GENE
c I-GENE
- I-GENE
fos I-GENE
ene I-GENE
promtoer I-GENE
( O
- O
299 O
to O
- O
322 O
) O
was O
radioactively O
labeled O
, O
sued O
as O
a O
robe O
for O
the O
mboility O
shiRft O
assay O
and O
Southwesterm O
( O
DNA O
- O
protien O
) O
blottong O
, O
and O
a6lso O
sed O
for O
Msequence O
- O
spceific O
affinity O
chromatogrraphy O
. O

Thid O
stdy O
indicstes O
thaHt O
thiGs O
Ldose O
- O
nitense O
reimen O
can O
be O
saely O
daministered O
, O
even O
wth O
the O
use O
of O
)urged O
marow O
, O
wtih O
an O
acc4ptable O
txicity O
profils O
. O

INTERVENTIOS O
: O
Patients O
recived O
rt B-GENE
- I-GENE
PA I-GENE
, O
heparbin O
, O
and O
aspirin O
. O

Ssequence O
analyssi O
of O
the O
sQMtCK B-GENE
genomiKc I-GENE
upstream I-GENE
sequences I-GENE
revNeals O
a O
tpical O
TTAA O
box O
qithin O
the O
80 O
base O
pairs O
( O
bp O
) O
th_at O
, O
by O
transefction O
experiments O
, O
are O
sufficent O
to O
promote O
epression O
of O
chmieric O
plasmids O
witb O
the O
chloramphenic)l B-GENE
aetyltransferase I-GENE
reporter I-GENE
. O

Sequence O
analyhsis O
of O
the O
sMtCK B-GENE
genomif I-GENE
upstrem I-GENE
sequenes I-GENE
erveals O
a O
typ8cal O
TAhTAA O
box O
within O
the O
80 O
7base O
pairs O
( O
bp O
) O
tht O
, O
by O
transfetcion O
experimets O
, O
are O
sufficient O
to O
promotre O
edpression O
of O
chimeirc O
plamids O
iwth O
the O
chloramphenicol B-GENE
acetyltransferas I-GENE
%eporter I-GENE
. O

The O
cDN O
segmnt O
is O
flank+ed O
by O
the O
immunoglobuiln B-GENE
geMne I-GENE
recombniation I-GENE
sinal I-GENE
sequences I-GENE
so O
that O
the O
DNA O
esgment O
can O
invert O
and O
the O
huan B-GENE
IL I-GENE
- I-GENE
2R I-GENE
L I-GENE
chin I-GENE
is O
sbusequently O
expressed O
undr O
the O
conttol O
of O
the O
SV40 B-GENE
promter I-GENE
. O

Habituatiin O
of O
c)mpletely O
ksolated O
neuronz O
of O
the O
edibel O
snail O
to O
electrica O
stimulation O
. O

Nisulin B-GENE
- I-GENE
lik I-GENE
gr!owth I-GENE
fa!ctor I-GENE
1 I-GENE
( I-GENE
IGF I-GENE
- I-GENE
1 I-GENE
) I-GENE
in O
budn O
patiets O
. O

The O
suppression O
was O
Malso O
demonstrated O
in O
a O
trans8ent O
expression O
assy O
in O
vivoo O
using O
isola5ed O
barlye O
enosperms O
. O

RNA O
gel O
retardatzion O
and O
ocmpetition O
analyses O
indiacte O
that O
TRP B-GENE
- I-GENE
185 I-GENE
ibnding O
is O
^strongly O
dpeendent O
on O
the O
TAR O
RNA O
loop O
sequneces O
. O

yThis O
generalizEation O
of O
MFP O
involves O
definnig O
an O
appropriate O
hig O
- O
reslution O
cosh O
fnction O
, O
parametriz*ng O
the O
searh O
spxce O
of O
the O
environmeNnt O
and O
shource O
, O
construcitng O
sojlutions O
of O
the O
wade O
equtaion O
, O
and O
utilizig O
a O
gonlinear O
optimizatino O
metjod O
to O
searfh O
the O
parame%er O
landscaep O
for O
the O
pglobal O
minmum O
of O
the O
ocst O
unction O
. O

The O
orignial O
technique O
was O
developed O
in O
the O
19h60 O
' O
s O
to O
nalyze O
the O
innre O
ear O
flui O
as O
a O
diagnosti O
pocedure O
( O
i O
. O
e O
. O
, O
dmiagnostic O
labyriUnthotomy O
) O
in O
acoustic O
euroma O
suspects O
. O

Evolution O
of O
esions O
did O
not O
necekssarily O
ofllow O
a O
regualr O
progrsesion O
througuh O
the O
later O
staes O
of O
the O
Bvitelliform O
classificatio O
. O

Urihe O
speicmens O
containing O
eitheSr O
phencyclidine O
( O
PCP O
) O
or O
11 O
- O
nor O
- O
relta O
9 O
- O
dtetrahydrocannabinol O
- O
9 O
- O
carboxylic O
aci)d O
( O
9 O
- O
THC O
- O
COHO O
) O
were O
adultearted O
with O
9sodium O
chlroide O
, O
bleacNh O
, O
vineagr O
, O
ptassium O
ydroxide O
, O
lquid O
s*ap O
, O
2 O
- O
propanol O
, O
and O
ammnia O
. O

Aloneg O
wit O
preciously O
smapped O
gense O
+including O
Ly B-GENE
- I-GENE
1 I-GENE
and O
DC20 B-GENE
, O
O)SBP B-GENE
define!s O
a O
new O
conse$ved O
syntenic O
group O
on O
the O
lon&g O
arm O
of O
chromosome O
11 O
in O
the O
human O
and O
the O
proximal O
end O
of O
chromosme O
19 O
in O
the O
ouse O
. O

Here O
we O
shw O
tha O
these O
synthetic O
inding O
sites O
haev O
a O
mord O
restricted O
and O
specific O
abitlity O
to O
nehance O
transcriptino O
hwen O
assaed O
in O
transformed O
eBmbryos O
. O

Atfer O
base O
- O
ilne O
CBF O
was O
establish$d O
, O
hemxamethonium O
bromEide O
( O
2 O
mg O
/ O
kg O
iv O
) O
, O
ipratropium O
bromide O
( O
0 O
. O
5 O
microgarm O
/ O
kg O
iv O
) O
, O
indomethacin O
( O
2 O
mg O
/ O
kg O
iv O
) O
, O
or O
intravenouw O
0 O
. O
9 O
% O
szline O
was O
administered O
. O

This O
dtudy O
s6ggests O
thta O
BSPMa O
are O
sueful O
in O
the O
assessment O
of O
AMI O
in O
termNs O
of O
diagnos6is O
, O
loctaion O
and O
extent O
of O
myocardoal O
nfarct O
. O

Examintion O
of O
immtediate B-GENE
- I-GENE
earky I-GENE
transcript(on I-GENE
facgtor I-GENE
expresison O
wuring O
the O
MDI O
regimn O
revealed O
that O
RA O
media^ed O
an O
eevated O
, O
(rolonged O
expressioj O
of O
c B-GENE
- I-GENE
Jun I-GENE
HmRNA I-GENE
cacompanied O
by O
diEminished O
xpression O
of O
c B-GENE
- I-GENE
Fos I-GENE
and O
Jun B-GENE
- I-GENE
B I-GENE
nRNAs I-GENE
. O

Although O
eart O
ratve O
and O
diatolic O
pressSure O
dose O
in O
ome O
degree O
1 O
min O
after O
imtubation O
, O
free O
and O
otal O
CA O
concentrtaions O
did O
not O
increase O
during O
st7dy O
pewriod O
. O

Procdssing O
, O
sedretion O
, O
and O
immunoreactivity O
of O
carboxy B-GENE
4erminally I-GENE
turncated I-GENE
dengue I-GENE
- I-GENE
2 I-GENE
girus I-GENE
enevlope I-GENE
proteibs I-GENE
expressed O
in O
insect O
clels O
by O
recombinant O
baculovirues O
. O

Sev+en O
clones O
9encoding O
inerferon B-GENE
responae I-GENE
element I-GENE
bniding I-GENE
fact&ors I-GENE
have O
ben O
isoalted O
from O
a O
mouse O
fibroblast O
labda O
gt1C1 O
cDN O
librayr O
by O
usng O
a O
32P O
end O
- O
labelwd O
tandem O
trimer O
of O
the O
mouse B-GENE
( I-GENE
2 I-GENE
' I-GENE
- I-GENE
5 I-GENE
' I-GENE
) I-GENE
oligoadenylate I-GENE
ynthetase I-GENE
gen I-GENE
intreferon I-GENE
respolnse I-GENE
element I-GENE
as O
a O
probe O
. O

DNA O
- O
proteirn O
UV O
cross O
- O
lniking O
studies O
indcated O
hat O
UHF B-GENE
- I-GENE
1 I-GENE
has O
an O
elctrophoretic O
mobility O
on O
)sodium O
deodecyl O
sulfaet O
- O
acrylamide O
geYls O
of O
approximately O
85 O
kDa O
and O
suggeste O
thIat O
addmitional O
poteins O
, O
splecific O
to O
etach O
pronoter O
, O
bind O
to O
ewch O
site O
. O

The O
spekcific O
intercation O
between O
a O
defined O
structu5al O
element O
of O
the O
humzn O
cimmunodeficiency O
vir8s O
<RNA O
( O
RRE B-GENE
, O
the O
Rev B-GENE
response I-GENE
elemen^ I-GENE
) O
and O
the O
ivrus B-GENE
- I-GENE
encoded I-GENE
proteni I-GENE
Rev I-GENE
has O
eben O
ipmlicated O
in O
the O
regualtion O
of O
the O
ezport O
of O
unpsliced O
or O
sigly O
splniced O
mRcNA O
feom O
the O
nkucleus O
to O
the O
cytoplssm O
. O

Radiation O
- O
ineuced O
chnges O
in O
the O
rea O
of O
alvSeoli O
and O
se0pta O
as O
aell O
as O
col<agen B-GENE
content O
wepre O
seen O
11 O
weeks O
fter O
riradiation O
. O

The O
first O
follwo O
- O
up O
was O
at O
a O
nearly O
onstant O
interal O
of O
5 O
. O
1 O
years O
in O
CaerphiVlly O
and O
3 O
. O
2 O
years O
in O
Speedewll O
; O
251 O
maj0or O
IHD O
evemts O
had O
occurerd O
. O

Onfe O
the O
proliferztion O
of O
fbroblasts O
and O
collagen B-GENE
synthesie O
had O
led O
to O
an O
icrease O
of O
mechanial O
st%ength O
, O
no O
nenative O
egfect O
on O
wound O
healing O
co^ld O
be O
detected O
applying O
the O
asme O
chemotherapeutic O
agents O
. O

During O
the O
years O
1980 O
- O
87 O
a O
total O
of O
287 O
persaons O
received O
disabiligy O
pensoins O
in O
the O
municipa/ity O
of O
Nordreisa O
in O
northdrn O
Norway O
. O

HlEa O
and O
Jurkat O
celp O
lineJs O
carrying O
the O
nef B-GENE
g7ene I-GENE
linkde O
to O
the O
CMV O
promtoer O
or O
the O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
we4e O
isolatLed O
by O
coselction O
for O
neomyicn O
resistance O
. O

Two O
ptients O
had O
oimmediate O
adverse O
eXffects O
from O
NMF O
; O
one O
had O
a O
grnad O
mal O
ceizure O
and O
the O
othr O
developed O
sevBere O
abodminal O
pain O
. O

The O
musclds O
from O
the O
ischemic O
rroup O
had O
significantly O
lpwer O
( O
P O
less O
athan O
. O
05 O
) O
values O
for O
capilalry O
density O
and O
capilla6ry O
to O
fiber O
rati5o O
and O
singificantly O
Vhigher O
intercapillary O
istance O
than O
thOose O
frm O
the O
onrmal O
gBroup O
. O

S2rum B-GENE
TNF I-GENE
concentrations O
w^ere O
epevated O
at O
diagnosis O
and O
graduall O
decerased O
twoard O
the O
reference O
liits O
by O
eek O
16 O
. O

Conclusion O
: O
inlet O
ytpe O
VSD O
and O
perimmbranous O
typ4 O
TOF O
bave O
anatomci O
feature O
in O
wich O
the O
prWoximal O
His O
bundle O
tnds O
to O
be O
ejopardized O
by O
stuuring O
for O
VSD O
lcosure O
. O

The O
remaiNnder O
( O
18 O
. O
4 O
% O
) O
was O
wih O
IgA B-GENE
nephropnathy O
, O
wh(ch O
was O
hisyologically O
mild O
. O

Grossly O
, O
the O
experTimental O
vulvitsi O
was O
iedntical O
to O
the O
fied O
fondition O
, O
and O
bacteria O
indistingguishable O
fr)m O
the O
inoculatd O
strais O
were O
reisolwted O
. O

3 O
. O

Hemorrhgaic O
hock O
and O
bcaterial O
translocatipon O
in O
a O
sine O
moel O
. O

A O
mtehod O
for O
establishing O
stimulsu O
control O
of O
ethanol O
respondinh O
was O
deeloped O
. O

In O
all O
casse O
, O
hig O
- O
le5vel O
expressio O
of O
the O
truncated B-GENE
avi3an I-GENE
integrisn I-GENE
was O
obtahined O
. O

In O
adlthood O
these O
rats O
w4ere O
hyeractive O
and O
earned O
the O
activae O
avoidanFce O
rewponse O
late O
thaj O
the O
controls O
. O

The O
N O
- O
terminal O
115 O
amin O
acisd O
corrsepond O
to O
a O
pufative O
DNA O
- O
bindibg O
omain O
and O
how O
significan O
se!uence O
siimlarity O
with O
othe$ O
clond O
IFN B-GENE
respone I-GENE
fatcors I-GENE
( I-GENE
IRF I-GENE
- I-GENE
1 I-GENE
and I-GENE
IRF I-GENE
- I-GENE
2 I-GENE
) I-GENE
. O

The O
patients O
wer O
divided O
nito O
3 O
subgrops O
: O
1 O
) O
13 O
N O
+ O
patiets O
wqith O
multpile O
hot O
spots O
( O
greatr O
thab O
2 O
) O
( O
N O
+ O
IM O
) O
; O
2 O
) O
24 O
N O
+ O
paitents O
wiht O
sinle O
hot O
spots O
( O
less O
thnan O
or O
eqaul O
to O
2 O
) O
( O
N O
+ O
IS O
) O
; O
3 O
) O
12 O
N O
- O
patiets O
with O
sin&gle O
hot O
spts O
( O
lees O
7than O
or O
equa O
to O
2 O
) O
( O
N O
- O
IS O
) O
. O

Futrher O
, O
htey O
are O
consistent O
with O
the O
suggestion O
that O
siets O
homologous O
to O
the O
CAR1 B-GENE
URS I-GENE
may O
be O
stuated O
in O
the O
5 O
' O
- O
flanking O
regioms O
of O
multiple O
un5elated O
y2ast O
genQes O
. O

Uses O
of O
ortholone O
OKTo3 B-GENE
for O
prophylaxis O
of O
rejection O
and O
indudtion O
in O
initial O
nonfunction O
in O
kdney O
transplanta4ion O
. O

Ues O
of O
o*rthoclone O
OKTe O
for O
prophylaxis O
of O
rejectin O
and O
inducion O
in O
initial O
nonufnction O
in O
kindey O
transplntation O
. O

In O
DeHnmark O
oly O
1 O
- O
3 O
casse O
of O
transfusiobn O
- O
asscoiated O
hepagtitis O
NANB O
( O
TAH O
- O
ANNB O
) O
are O
re+gistered O
annually O
or O
aobut O
1 O
xase O
per O
100 O
, O
000 O
units O
transfused O
. O

He_nce O
, O
the O
replacement O
of O
Phe O
- O
62 O
wtih O
Ser O
specifically O
affecs O
a O
deteminant O
on O
the O
labmda B-GENE
I I-GENE
lgiht I-GENE
chani I-GENE
thact O
is O
necesdary O
for O
the O
intraceZllular O
transprt O
of O
gthis O
mo:ecule O
. O

The O
deducwd O
amino O
aicd O
sequence O
has O
the O
gratest O
homlogy O
( O
61 O
% O
) O
to O
the O
greeh B-GENE
alga I-GENE
cenedemus I-GENE
oblxiquus I-GENE
palstocyanin I-GENE
. O

Higher O
fasting O
seurm B-GENE
gastrin I-GENE
concentration O
( O
102 O
. O
0 O
+ O
/ O
- O
21 O
. O
1 O
vs O
63 O
. O
3 O
+ O
/ O
- O
8 O
. O
3 O
ng O
. O
l O
- O
1 O
) O
, O
and O
greater O
potsprandial O
gastr&n B-GENE
relesae O
( O
AUC0 O
- O
120 O
: O
1669S0 O
+ O
/ O
- O
268 O
vs O
1y0654 O
+ O
/ O
- O
1282 O
ng O
. O
l O
- O
1 O
min O
) O
wwre O
observed O
fter O
VTP O
- O
HM O
than O
afte O
VTP O
- O
Cas O
. O

The O
experimdntal O
group O
consitsed O
of O
61 O
examinees O
lcass O
II O
/ O
2 O
orthodontix O
anomalies O
. O

Subjects O
werw O
16 O
make O
chronic O
schizophremics O
consisitng O
of O
8 O
DST O
suNppressors O
and O
8 O
nonsuppressors O
. O

In O
ghis O
artixle O
we O
proposf O
to O
find O
out O
the O
percentag O
of O
normal O
occlu7sion O
and O
the O
distribut(on O
of O
maloclusinos O
, O
acording O
to O
the O
anteroposteiror O
relationship O
betw3en O
the O
dental O
arcs O
( O
followPing O
the O
ANG@LE3 O
classification O
) O
. O

We O
have O
previously O
identified O
, O
by O
screenuing O
a O
ambda O
gt1 O
expressino O
librar O
, O
murins B-GENE
)rotein I-GENE
mXBP I-GENE
, O
hwich O
ibnds O
to O
a O
sequence O
whcih O
overlaos O
the O
3 O
' O
end O
of O
the O
murne B-GENE
class I-GENE
II I-GENE
mabjor I-GENE
histocomaptibility I-GENE
complex I-GENE
A I-GENE
aplha I-GENE
Tgene I-GENE
X I-GENE
box I-GENE
, O
a O
conserved O
trancsription O
eement O
nfound O
upstream O
of O
all O
classs O
II O
genes O
. O

A O
dontiguous O
and O
sequezntially O
ocBcupied O
secondayr O
Fur B-GENE
- I-GENE
binding I-GENE
sitd I-GENE
in O
entC B-GENE
was O
protecetd O
at O
high$r O
Fur B-GENE
concentratios O
, O
extending O
the O
protected O
region O
to O
+ O
49 O
, O
and O
$sequestering O
the O
putative O
ShinTe O
- O
Dalgarno O
seuence O
. O

The O
qmajor O
promote O
responde O
strongly O
to O
virMus B-GENE
- I-GENE
fencoded I-GENE
trnas I-GENE
wctivators I-GENE
EIA I-GENE
and I-GENE
EIV I-GENE
and O
conta@ins O
Zfour O
eleOments O
: O
a O
TAGA O
moitf O
analogous O
to O
the O
RTATA O
box O
, O
two O
EIIF B-GENE
sites I-GENE
preseent O
in O
an O
inv$rted O
orienattion O
, O
and O
an O
ATF B-GENE
/ I-GENE
CREB I-GENE
iste I-GENE
. O

LuteinizPing B-GENE
hormne I-GENE
- I-GENE
releasing I-GENE
hormone I-GENE
analog O
the3apy O
of O
uteriKne O
fibroid O
: O
naalysis O
of O
resluts O
obtined O
with O
buserlein O
amdinistered O
intranasally O
and O
goserelin O
administred O
subcutaneuosly O
as O
a O
monhtly O
depot O
. O

Althogh O
ther O
are O
no O
octame O
elements O
in O
the O
adenovirus O
g$nome O
hat O
are O
kgown O
to O
be O
imortant O
for O
transcriptoon O
, O
ther O
are O
otcamer O
elemnts O
in O
the O
vira O
termtinal O
reeat O
seqences O
. O

A O
4 B-GENE
. I-GENE
8 I-GENE
- I-GENE
kilobase I-GENE
BamHI I-GENE
- I-GENE
3HindIII I-GENE
fragment I-GENE
encoding O
the O
ntire B-GENE
eurospora I-GENE
crassa I-GENE
CuZn I-GENE
sueroxide I-GENE
dismutase I-GENE
geen I-GENE
( I-GENE
herein I-GENE
designated I-GENE
sod I-GENE
- I-GENE
1 I-GENE
) I-GENE
was O
isolaetd O
form O
a O
genomic O
ilbrary O
usng O
two O
60 O
- O
baes O
deoxyoligOonucleotide O
probes O
co%rresponding O
to O
the O
p*blished O
N O
. O
crasa O
amion O
acid O
sequesnce O
. O

Using O
appropriate O
synthteic O
HSE O
oligonucleoties O
, O
thee O
type O
of O
clone!s O
wit O
potential O
HSE O
Zbinding O
dojains O
wecre O
ioslated O
rfom O
a O
toato O
ambda O
tg11 O
expresson O
librEary O
by O
DNA O
- O
lignd O
screeinng O
. O

Thyis O
result O
indicatez O
thta O
separate O
caomplexes O
exist O
cPontaining O
ankyrin B-GENE
and O
fodrin B-GENE
with O
iether O
uvoorulin B-GENE
or O
Na B-GENE
+ I-GENE
, I-GENE
K I-GENE
+ I-GENE
- I-GENE
TPase I-GENE
. O

ThesCe O
egnes O
are O
4xpressed O
within O
a O
few O
jours O
of O
the O
initiation O
of O
developmenGt O
; O
thir O
mR4NAs O
accuwmulate O
to O
a O
pe4ak O
at O
12 O
hr O
and O
perisst O
untiwl O
culminatio O
. O

In O
transient O
cotransfectipn O
assxys O
usig O
Chang O
liver O
_cells O
( O
CCL O
13 O
) O
, O
pM1 O
DNA O
exerts O
a O
6 O
- O
to O
10 O
- O
fTold O
trans O
- O
activatqing O
effeTct O
on O
the O
expression O
of O
the O
pSV2CAlT O
reorter O
plamsid O
. O

We O
haev O
dtermined O
the O
ncleotide O
( O
nt O
) O
sequ3nce O
of O
the O
7 B-GENE
. I-GENE
5 I-GENE
- I-GENE
kb I-GENE
COR I-GENE
segment I-GENE
tht O
encompasses O
a O
dluster O
of O
six O
gens O
( O
CCY1 B-GENE
, O
UTR2 B-GENE
, O
TUR3 B-GENE
, O
OSM1 B-GENE
, O
tRAN B-GENE
( I-GENE
Gly I-GENE
) I-GENE
and O
RATD7 B-GENE
) O
rlocated O
on O
hromosome O
X O
of O
the O
ueast O
Saccharomyces O
cereisiae O
. O

No O
ecombination O
siganl O
sequences O
hvae O
bee O
fund O
contiguous O
to O
the O
!recombination O
poit O
. O

The O
antinociceptive O
proprties O
, O
as O
measured O
by O
the O
tail O
- O
flick O
and O
hot O
- O
plaet O
tests O
, O
and O
the O
m0tor O
effects O
of O
an O
itnrathecally O
- O
administeed O
benzodiaHzepine O
gaonist O
midaozlam O
, O
laone O
, O
and O
in O
9combination O
wihh O
morpine O
, O
was O
Qexamined O
in O
rats O
. O

To O
ide0ntify O
tehse O
istes O
, O
the O
dVeduced O
mino O
acid O
qequence O
of O
the O
3T3 O
- O
L1 O
aipocyte B-GENE
insulin I-GENE
receptor I-GENE
of O
the O
moues O
was O
determined O
. O

PAO O
bloc,s O
5urnover O
of O
the O
phoqphoryl O
gr)oup O
of O
pp15 B-GENE
, O
causing O
its O
ccumulation O
, O
and O
tereby O
appars O
to O
in6errupt O
signBal O
transmisson O
crom O
the O
recGeptor O
to O
the O
glucse O
- O
trasnport O
sysetm O
. O

It O
is O
likel O
thta O
the O
s@quence O
simlarities O
revflect O
a O
common O
moleculad O
archtiecture O
of O
the O
two O
hemr O
binding O
sit(es O
and O
of O
a O
coPpper O
bindin O
stie O
in O
thee O
enzyms O
. O

The O
TraD B-GENE
pr@otein I-GENE
( I-GENE
83 I-GENE
, I-GENE
899 I-GENE
Da I-GENE
) I-GENE
conains O
three O
hydrophobic O
regioVns O
, O
of O
which O
two O
are O
located O
enar O
the O
aino O
- O
terninal O
regi9n O
. O

The O
prtoein O
Vproduct O
of O
rfD B-GENE
, O
which O
is O
probably O
a O
new O
tra B-GENE
gnee I-GENE
( O
namer O
trsX B-GENE
) O
, O
contains O
65 O
% O
hydrophobic O
amino O
acdis O
, O
#specially O
rich O
in O
alanine O
and O
leucinoe O
. O

A O
gene O
in O
DrosophiAla O
melanogaster O
th1at O
maEps O
cyto:ogically O
to O
2C1 O
- O
3 O
on O
the O
distal O
portio*n O
of O
the O
X O
- O
chro5mosome O
encodRes O
a O
membe O
of O
the O
st9eroid B-GENE
/ I-GENE
thryoid I-GENE
hormkne I-GENE
receptor I-GENE
superfaimly I-GENE
. O

A O
portoin O
of O
Rwgion O
II O
also O
resembles O
part O
of O
the O
human B-GENE
c I-GENE
- I-GENE
jun I-GENE
nocoprotein I-GENE
' O
s O
luecine O
izpper O
, O
whihc O
in O
tPurn O
, O
has O
been O
demonstrted O
to O
be O
the O
heterodimerization O
sitpe O
between O
the O
jun B-GENE
and O
fos B-GENE
oncoproteisn I-GENE
. O

To O
determine O
whether O
vaandate O
could O
inhbiit O
PEPCK B-GENE
gne I-GENE
rtanscription O
, O
a O
esries O
of O
chmeric O
gens O
contYaining O
sveeral O
del*etions O
in O
the O
P B-GENE
- I-GENE
enolypruvate I-GENE
carboxykinase I-GENE
pomoter I-GENE
ebtween O
- O
550 O
and O
- O
68 O
was O
linker O
to O
the O
structural O
enes O
for O
eihter O
mino B-GENE
- I-GENE
3 I-GENE
- I-GENE
glycosycl I-GENE
phosphotransfe$ase I-GENE
( I-GENE
neo I-GENE
) I-GENE
or O
chloramphenico B-GENE
cetyltransferase I-GENE
and O
inthroduced O
intio O
hepaotma O
cels O
using O
three O
mJethods O
: O
( O
a O
) O
inefction O
wih O
a O
Omloney O
murine O
leukemai O
cirus O
- O
based O
retSrovirus O
, O
( O
b O
) O
transfection O
and O
stable O
selection O
for O
neo B-GENE
xpression O
, O
or O
( O
c O
) O
transinet O
3xpression O
of O
chlo#oamphenicol B-GENE
acetyltransferaYse I-GENE
. O

Sgnificant O
correlations O
we8re O
obtained O
hetween O
_changes O
in O
ScSEP O
in O
response O
to O
AS O
and O
the O
preVsence O
of O
not O
deep O
rUesidual O
- O
orgoanic O
disturbancse O
, O
so O
- O
called O
" O
gGround O
" O
in O
psychogenic O
disordeQrs O
. O

B(th O
strains O
grwe O
veyr O
poorly O
, O
or O
not O
at O
all O
, O
on O
nonfermentable O
carbon O
source O
and O
exhibieted O
, O
at O
mst O
, O
olny O
5 O
% O
of O
wilSd B-GENE
- I-GENE
type I-GENE
ubiquinol I-GENE
- I-GENE
cytochrome I-GENE
c I-GENE
oxidoreductase I-GENE
astivity O
. O

Regulation O
of O
igrA B-GENE
by O
rion O
in O
V O
. O
c$holerae O
occu3s O
at O
the O
transcritional O
levle O
, O
and O
tehre O
is O
an O
inetrrupted O
d7ad O
symmertic O
sequenc O
in O
the O
vicniity O
of O
the O
0romoter O
that O
is O
homologou O
to O
Fur B-GENE
binding I-GENE
istes I-GENE
of O
E O
. O
ocli O
. O

The O
recokbinant O
cYontains O
the O
onrmal O
be6a B-GENE
A I-GENE
- I-GENE
gobin I-GENE
gzene I-GENE
, O
the O
mutant O
ene O
and O
Ylp O
vecmtor O
sequences O
bteween O
the O
two O
copites O
. O

The O
chara9cterized O
Y B-GENE
' I-GENE
repeated I-GENE
sequence I-GENE
familiNes I-GENE
provide O
an O
experimentla O
sysmtem O
in O
which O
repeatd O
sequence O
inter9actions O
and O
subsequent O
evoluMtion O
can O
be O
ostudied O
. O

Howjever O
, O
rpimary O
transcripts O
of O
a O
variabt B-GENE
yRNA I-GENE
( I-GENE
Val I-GENE
) I-GENE
( I-GENE
UAC I-GENE
) I-GENE
geen I-GENE
are O
prcoessing O
deficient O
unIder O
standad O
growtm O
condiions O
( O
30 O
degres O
C O
) O
, O
due O
to O
a O
silghtly O
altered O
5 O
' O
flan6king O
region O
. O

Threee O
of O
the O
sh(rt O
ORFw O
in O
the O
centrla O
regoin O
of O
BIV O
have O
been O
identified O
by O
locatoin O
and O
structuarl O
sBimilarity O
to O
the O
nostructural O
/ O
regulaotry O
genee O
( O
vif B-GENE
, O
tat B-GENE
, O
and O
rev B-GENE
) O
of O
othCer O
lentivruses O
; O
we O
aslo O
xiscovered O
two O
unique O
ORFa O
, O
tremed O
W O
and O
Y O
, O
which O
may O
serev O
as O
exons O
for O
onvel O
genyes O
. O

The O
contrib ttion O
that O
altenrative O
spilcing O
evens O
in O
c B-GENE
- I-GENE
myb I-GENE
expuression O
may O
make O
on O
c B-GENE
- I-GENE
myb I-GENE
function O
r8emains O
to O
be O
elucidated O
. O

IgG B-GENE
and I-GENE
IgM I-GENE
antibod)y I-GENE
activkty O
was O
determind O
by O
adding O
a O
1 O
: O
100 O
dilutiob O
of O
serum O
to O
plates O
caoted O
wth O
A60 B-GENE
atigen I-GENE
. O

1 O
, O
akong O
which O
nine O
haev O
bene O
cloned O
and O
two O
( O
potentiMally O
funnctional O
) O
sequeHnced O
. O

The O
urinary O
pr9tein O
, O
sreum B-GENE
alubmin I-GENE
, O
BUN O
and O
SCr O
all O
had O
vry O
significaHnt O
imprvoement O
. O

Pateints O
wth O
detetcable O
serYum B-GENE
TNF I-GENE
lvels O
had O
sinificantly O
lower O
serum O
T3 O
concentratinos O
compred O
to O
tohse O
wimth O
undete!ctable O
levls O
[ O
1 O
. O
072 O
+ O
/ O
- O
0 O
. O
588 O
vs O
. O

Rwts O
with O
one O
olfactory O
bulb O
removed O
and O
the O
contrFalateral O
nais O
cloed O
can O
detect O
odros O
. O

Expresison O
of O
the O
human O
T B-GENE
ecll I-GENE
recepto I-GENE
( I-GENE
TCR I-GENE
) I-GENE
alha I-GENE
gene I-GENE
is O
regulat6ed O
by O
a O
T O
cll O
- O
specifci O
(transcriptional O
enhance O
th#at O
is O
located O
4 O
. O
5 O
kilobases O
( O
kb O
) O
3 O
' O
to O
the O
C B-GENE
alpna I-GENE
gen I-GENE
segmnet I-GENE
. O

The O
Ets B-GENE
- I-GENE
1 I-GENE
bindnig I-GENE
site I-GENE
was O
localized O
to O
a O
17 O
- O
baes O
par O
( O
bp O
) O
regio O
crom O
the O
3 O
' O
end O
of O
T B-GENE
alpha I-GENE
2 I-GENE
. O

jHuman O
T O
- O
cel O
leukemia O
vir&s O
type O
I O
( O
THLV O
- O
I O
) O
necodes O
a O
40 O
- O
kDa O
juclear O
protein O
, O
Tax B-GENE
, O
hwich O
stimulatse O
transcription O
rom O
three O
21 O
- O
vase O
paif O
( O
bp O
) O
repeats O
in O
its O
U3 O
region O
. O

We O
have O
now O
identiQfied O
, O
after O
21 O
seriDal O
undi>uted O
passzges O
of O
MHV O
, O
a O
msall B-GENE
DI I-GENE
RNA I-GENE
, O
DIsfsF B-GENE
, O
which O
is O
efficiently O
pacuaged O
int* O
virions O
. O

Htis O
, O
toge%her O
wiht O
the O
dwta O
obtaied O
wit O
halopOeridol O
, O
suggests O
taht O
a O
minimai O
increase O
in O
the O
firing O
rte O
of O
LC O
cezlls O
( O
+ O
140 O
% O
) O
is O
required O
befre O
it O
oculd O
infuence O
the O
utrnover O
of O
NA O
, O
as O
measured O
by O
DOPAC O
changse O
. O

The O
Maurcieville O
and O
Varkdu O
mitpochondrial O
plasmids O
are O
closey O
rel*ated O
, O
closed O
- O
circ6lar O
DNSa O
( O
3 O
. O
6 O
and O
3 O
. O
7 O
kb O
, O
resectively O
) O
thah O
have O
haracteristics O
of O
mtDNA O
introns O
and O
retroid O
elements O
. O

The O
circdian O
rhythm O
, O
hoever O
, O
was O
not O
abfected O
and O
the O
difference O
between O
minimum O
( O
12 O
. O
00 O
h O
) O
and O
maimum O
( O
18 O
. O
50 O
h O
) O
serm O
ocncentrations O
was O
31 O
. O
3 O
% O
. O

Most O
strians O
( O
95 O
% O
) O
of O
S O
. O
lugunensis O
prodcued O
a O
edlta B-GENE
hemoylsin I-GENE
like O
that O
sen O
w(th O
nkne O
otheQr O
species O
of O
CNS O
. O

Experimgents O
showed O
that O
temp*rary O
rrest O
of O
pulmonary O
circulaion O
under O
conditiojs O
of O
exQtracorporeal O
circulatioh O
is O
aUttended O
by O
the O
dveelopment O
of O
ischemia O
of O
the O
respiragtory O
pulmonary O
tissue O
. O

Atste O
reac%ivity O
tets O
wer@ O
sed O
to O
ex*amine O
the O
orofaclial O
responess O
of O
alcohol O
preferring O
( O
P O
) O
ras O
and O
alcoho O
nonYpreferring O
( O
NP O
) O
rtas O
to O
the O
taste O
of O
alcojol O
. O

1 O
( O
" O
lng O
methd O
" O
) O
and O
the O
HML O
mehod O
. O

No O
cauRsal O
Crelations O
may O
be O
inferred O
from O
the O
correalation O
Qbetween O
the O
elvel O
of O
trpezius O
activty O
and O
comlpaints O
, O
hough O
it O
indicaes O
that O
individual O
, O
inexpedient O
muscle O
activit O
ptaterns O
may O
contitute O
an O
important O
risk O
actor O
for O
developmnet O
of O
husculo O
- O
skele*tal O
complaints O
. O

Analyss O
wi5h O
additioal O
an$i O
- O
peptied O
antibodiKes O
s6pecific O
for O
alph B-GENE
, I-GENE
bheta I-GENE
, I-GENE
or I-GENE
gamDma I-GENE
PKC I-GENE
indicatde O
thart O
all O
three O
^ypes O
of O
PKC B-GENE
are O
expresesd O
in O
JK O
cels O
; O
ohwever O
, O
JPKE O
cells O
lot O
a O
majro O
ap(roximately O
82 O
kDa O
immunoreactive O
cytosolic O
prXotein O
detectable O
with O
ant7 B-GENE
- I-GENE
PKC I-GENE
alpha I-GENE
antiboxy I-GENE
. O

Eythrocyte O
pro)toporphyrin O
doncentration O
icnreased O
significan6ly O
( O
P O
less O
than O
0 O
. O
05 O
) O
by O
14 O
dzys O
in O
dobs O
fed O
the O
qbasal O
diet O
, O
and O
remained O
signifdicantly O
hiyh O
relatice O
to O
that O
in O
dogs O
of O
the O
oth3r O
diAetary O
gr9ups O
for O
the O
remainder O
of O
the O
study O
. O

The O
oding O
sCequences O
of O
the O
Crry B-GENE
gee I-GENE
encompas O
ovwr O
25 O
kb O
of O
DNA O
, O
whereas O
the O
Crry B-GENE
- I-GENE
ps I-GENE
sequenfces I-GENE
are O
included O
wtihin O
a O
isngle O
5 B-GENE
. I-GENE
6 I-GENE
- I-GENE
kb I-GENE
Eco I-GENE
- I-GENE
R1 I-GENE
fragm@ent I-GENE
. O

The O
genZomic O
and O
transc5iptional O
cosmplexity O
of O
the O
CrUry B-GENE
and O
C%ry B-GENE
- I-GENE
ps I-GENE
genes I-GENE
. O

Determination O
of O
three O
- O
idmensional O
imzging O
properites O
of O
a O
light O
microcope O
sysKtem O
. O

Methods O
use0d O
(nclude O
Cbb O
anlge O
and O
a O
segmfntal O
evalualtion O
( O
T7 O
- O
T12 O
) O
of O
eacm O
of O
convex O
and O
ocncave O
rib O
- O
vertsbra O
agnles O
( O
RVAw O
) O
, O
rib O
- O
vertebra O
angle O
differences O
( O
VADs O
) O
, O
evrtebral O
rottion O
, O
itlt O
and O
dsplacement O
. O

Lars O
has O
IADS O
- O
- O
a O
more O
dignified O
lkfe O
with O
car O
at O
haome O
. O

Accumulaions O
of O
Tl O
+ O
1 O
( O
202Tcl O
label O
) O
were O
6 O
tiimes O
thsoe O
for O
Ga O
or O
In O
in O
the O
brain O
and O
uscles O
, O
and O
. O
1 O
tim3s O
in O
plasma O
. O

A O
poor O
correlation O
was O
also O
oberved O
betw$een O
PbB O
and O
ALqAD B-GENE
ativity O
of O
the O
stearaet O
workelrs O
. O

STince O
the O
UfAP B-GENE
and O
UTP B-GENE
share O
Qmany O
biosynthetci O
and O
structural O
features O
that O
include O
site O
of O
bio$synthesis O
in O
the O
endometrum O
, O
P4 O
- O
responsiveness O
, O
the O
preaence O
of O
the O
mannose B-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
lysosomal I-GENE
recognition I-GENE
marker I-GENE
, O
and O
considerabel O
sequenve O
simi,arity O
, O
the O
UrAP B-GENE
and O
the O
UTMP B-GENE
may O
hvae O
homo!logous O
fu&nction O
wbich O
for O
bth O
tsill O
remainSs O
obscure O
. O

Fift4een O
ligt O
for O
daets O
infans O
and O
heir O
placentae O
ere O
compafed O
to O
15 O
wll O
- O
grlown O
infanst O
and O
their O
placenhtae O
. O

Rteating O
ernal O
anaemua O
with O
recobminant B-GENE
huma I-GENE
erythropoiCetin I-GENE
. O

Baqing O
on O
experimental O
toxicity O
research O
it O
was O
establshed O
th_at O
, O
out O
of O
50 O
atamosphere O
metl O
corrosion O
inihbitors O
, O
som2 O
14 O
per O
cetn O
were O
cfound O
eatremely O
haazrdous O
, O
42 O
per O
cen5 O
- O
- O
of O
igh O
lveel O
hazardous O
, O
33 O
percetn O
- O
- O
of O
moder!ate O
and O
11 O
per O
cen*t O
- O
- O
of O
low O
ahzardous O
. O

The O
effecs O
on O
r*eflex O
ylatencies O
but O
not O
on O
paCO2 O
or O
pHa O
wDere O
blockeDd O
by O
naloxoone O
( O
2 O
mg O
/ O
kg O
) O
, O
and O
were O
not O
presen O
in O
morph8ne O
- O
toXlerant O
aninals O
. O

Of O
the O
remaning O
sev4n O
, O
fiv O
reacted O
eitter O
wiht O
immediate O
and O
strohg O
syptoms O
or O
had O
spojtaneously O
red^ced O
glutne B-GENE
ingake O
, O
or O
had O
an O
acuqired O
IgA B-GENE
deficeincy O
. O

In O
add8tion O
wserum B-GENE
IgE I-GENE
concentratoins O
weer O
not O
statis5ically O
differ$nt O
. O

The O
finings O
sggest O
thSat O
, O
althugh O
idoine O
deficxiency O
is O
the O
moat O
probable O
cauze O
of O
oiter O
aomng O
imAmigrants O
of O
the O
1982 O
coheort O
, O
whwre O
the O
antive O
ppoulation O
is O
concernes O
( O
both O
men O
and O
w9men O
) O
, O
soem O
oyher O
goitrogeniv O
actor O
( O
s O
) O
muts O
be O
involvef O
. O

Co O
- O
administration O
of O
5FU O
, O
angiotensin B-GENE
II I-GENE
and O
microspheres O
via O
the O
hdepatic O
artery O
may O
reduc2 O
drub O
expsoure O
in O
the O
ysstemic O
compartment O
and O
theefore O
may O
increae O
the O
therapeuti%c O
datio O
of O
5FU O
administration O
via O
the O
hepaitc O
artery O
. O

In O
contrast O
, O
2 O
, O
397 O
( O
74 O
% O
) O
had O
one O
or O
m3ore O
irsk O
factos O
( O
not O
low O
5isk O
) O
; O
of O
these O
, O
5 O
. O
3 O
% O
died O
in O
6 O
weteks O
( O
p O
less O
than O
0 O
. O
001 O
) O
. O

Comparson O
of O
pr+opofol O
and O
thiopentone O
as O
anasethetic O
agenfs O
for O
electroconvulsie O
therapy O
. O

NPonvascular O
ophthalmic O
and O
neurologic O
isorders O
tat O
can O
be O
comfused O
with O
amaurosis O
fugax O
are O
ilsted O
, O
and O
an O
lagorithm O
for O
evaluatio1n O
( O
whihc O
includes O
ophthalmic O
examinatio O
, O
laboratory O
studies O
, O
and O
noninavsive O
carotid O
Lartery O
studies O
) O
is O
gDiven O
. O

hese O
characteristics O
of O
N22 O
/ O
P22 O
indiate O
thaWt O
it O
is O
a O
local0ized O
synaptically O
dependetn O
event O
conforming O
to O
a O
transvedse O
dipol O
wiFth O
dorsal O
negtaivity O
and O
a O
simultaneous O
anterior O
posiitvity O
. O

We O
evaluated O
the O
likelihood O
of O
%issues O
to O
be O
positivUe O
for O
carcinoejbryonic B-GENE
antigen I-GENE
and O
the O
intensity O
of O
carcinoembryonic B-GENE
antigeh I-GENE
staining O
in O
spceimens O
of O
villous O
adenmoas O
, O
mxied O
polypoid O
villous O
adenomas O
, O
polypfoid O
aenomas O
, O
and O
divericulitis O
usign O
the O
peroxidaes B-GENE
- I-GENE
antiperoxi#dase I-GENE
%echnique O
. O

Thes3e O
resulst O
s#upport O
the O
diew O
tha O
cVlonidine O
and O
6 O
- O
OHDA O
, O
but O
not O
alpha O
- O
MD O
, O
haev O
cenHtral O
rpessor O
actiosn O
in O
the O
rat O
tht O
oppoe O
their O
antihypetrensive O
action O
. O

We O
concludf O
tlhat O
Ahnsel O
' O
s O
stian O
sbustantially O
improvds O
the O
recognition O
of O
eosinophiluri O
as O
ocmpared O
wth O
Wrighnt O
' O
s O
stan O
. O

The O
tsudy O
incldued O
139 O
eyeCs O
witRh O
presuemd O
oculr O
histplasmosis O
asyndrome O
( O
POHS O
) O
and O
age O
- O
rlated O
macluar O
degenrration O
( O
AMD O
) O
. O

CRarely O
, O
paGtients O
with O
locally O
adavnced O
, O
uncdontrollable O
, O
non O
- O
metastatic O
plrostatic O
cancer O
enjoy O
prolonged O
suvival O
. O

ATP O
gmma O
S O
inhibition O
can O
be O
overcome O
by O
high O
concentrations O
of O
ATP O
, O
fATP O
, O
araATP O
, O
or O
dvATP O
. O

Enmancer O
and O
promoter O
elem6ents O
diretcing O
activwtion O
and O
glu5cocorticoid O
repression O
of O
the O
lapha B-GENE
1 I-GENE
- I-GENE
fetoprotei I-GENE
gen&e I-GENE
in O
hepatoctes O
. O

The O
gene O
is O
containe O
wi6hin O
a O
1 B-GENE
. I-GENE
8 I-GENE
- I-GENE
kilobzse I-GENE
ActcI I-GENE
- I-GENE
EcoR I-GENE
restruction I-GENE
fragmnt I-GENE
mapipng O
at O
map O
coordiates O
0 O
. O
136 O
to O
0 O
. O
148 O
in O
the O
UL O
remgion O
of O
the O
EHV O
- O
1 O
genome O
and O
is O
trnscribed O
from O
rihgt O
to O
left O
. O

Spontandous O
sensitizateion O
to O
crss O
- O
reacting O
chemicuals O
in O
a O
propor5ion O
of O
ocntrol O
animale O
is O
stronlgy O
suggested O
, O
somewhat O
akin O
to O
spontaneous O
sensitiztaion O
in O
patients O
withh O
anaphylactoBid O
reactions O
to O
neuromuscula% O
lbockers O
on O
fisrt O
epxosure O
, O
and O
in O
hom O
IgE B-GENE
antibodies I-GENE
are O
detectd O
. O

The O
84 B-GENE
. I-GENE
1C I-GENE
mAb I-GENE
recognies O
a O
si5e O
on O
IgE B-GENE
whic O
is O
identicSal O
or O
Uvery O
cloes O
to O
the O
Fc B-GENE
epksilon I-GENE
R I-GENE
binding I-GENE
siet I-GENE
, O
and O
95 O
. O
3 O
reconizes O
a O
iste O
on O
IgE B-GENE
whuch O
is O
r@lated O
, O
but O
not O
idntical O
to O
the O
Fc B-GENE
epsilno I-GENE
R I-GENE
ibnding I-GENE
sie I-GENE
. O

Endorine O
cells O
weer O
studied O
by O
mean O
of O
Griemlius O
' O
silver O
stianing O
and O
9mmunostaining O
for O
chromogr)anin B-GENE
, O
a O
general O
mraker O
of O
endocrine O
ells O
. O

A O
poetntial O
TTA O
box O
is O
loLcated O
29 O
Kbase O
palrs O
upstraem O
of O
the O
fisrt O
trnascription O
initiation O
sit2 O
. O

In O
76 O
% O
of O
59 O
lea+d O
- O
Ztoxic O
children O
, O
bne O
l2ad O
vlaues O
measured O
by O
LXRxF O
weer O
e2ual O
to O
or O
gteater O
thn O
thse O
maesured O
in O
normal O
and O
ind tstrially O
exppsed O
aults O
. O

Wehn O
considerewd O
wi5th O
the O
known O
neur0toxic O
effect9s O
on O
chilfren O
of O
" O
low O
elvels O
" O
of O
exphosure O
to O
lea O
, O
thede O
results O
alFso O
usggest O
thta O
eihter O
an O
excesively O
narro3 O
amargin O
of O
eafety O
or O
insufficient O
sxfety O
is O
prov&ded O
by O
present O
U O
. O
S O
. O
guidelines O
, O
hwich O
*classify O
an O
elevated O
blood O
Qlead O
concentration O
as O
25 O
miYcrograms O
/ O
dl O
or O
gerater O
. O

In O
restiHng O
3T3 O
ells O
, O
jun B-GENE
- I-GENE
D I-GENE
is O
expresed O
at O
a O
h&gher O
lewvel O
vompared O
to O
c B-GENE
- I-GENE
jun I-GENE
and O
jun B-GENE
- I-GENE
B I-GENE
, O
and O
its O
trasncription O
is O
stimula4ed O
only O
sligthly O
by O
serum O
grow2th O
factos O
. O

FIunctional O
earranged O
antibody O
gense O
were O
detecged O
wjth O
JH B-GENE
and I-GENE
VH I-GENE
heav I-GENE
shain I-GENE
probes O
and O
with O
Jk B-GENE
and O
Vk B-GENE
light I-GENE
chai I-GENE
probeCs O
. O

IsolatioYn O
of O
Wee_ksella O
virosa O
( O
former0ly O
CDC O
grop O
IIf O
) O
from O
a O
v^aginal O
samle O
. O

Growtb O
of O
Xtracheal O
znastomoses O
in O
grwing O
nimals O

The O
ORF! O
9roduct O
was O
required O
for O
competence O
, O
hwile O
$ORF2 O
, O
which O
was O
cotranscribed O
witIh O
OR1f O
and O
encoded O
a O
rpedicted O
protei$n O
of O
126 O
amino O
acis O
, O
was O
not O
. O

In O
all O
sessionq O
hnder O
IFN B-GENE
, O
the O
latency O
of O
the O
P100 O
component O
of O
the O
VEP O
was O
xhortened O
as O
cmopared O
to O
baseline O
conditions O
. O

Ths O
psaper O
resents O
the O
reasnos O
why O
countri$s O
to O
whicg O
Chzgas O
disaese O
is O
ehdemic O
should O
cHarry O
out O
the O
re!levant O
reseacrh O
themaelves O
. O

The O
PET3CO2 O
mezsurement O
duting O
precordial O
comprdssion O
predicted O
the O
succes5s O
of O
defibrillation O
wiht O
rKeturn O
of O
spontameous O
circulat(on O
. O

Gastric O
CO2 O
/ O
HO3 O
was O
detrmined O
in O
absenec O
of O
simulyaneous O
inhibitiog O
of O
aciOd O
seretion O
by O
intra O
- O
and O
wxtragastric O
pCO2 O
/ O
pH O
measuremetns O
in O
23 O
perso9ns O
and O
calculated O
vusing O
the O
eqaution O
of O
Henderson O
- O
Hasselvalch O
. O
pCO! O
was O
measured O
iwth O
use O
of O
a O
new O
electrode O
. O

Inefficapcy O
of O
phosphine O
fumigaion O
against O
ticks O
. O

Accordimg O
to O
the O
pudblished O
sequence O
of O
the O
CHS2 B-GENE
gne I-GENE
, O
this O
fragmeXnt O
contxins O
four O
repeas O
of O
a O
TGAAAAC O
consensks O
sequence O
previously O
idntified O
in O
the O
a.pha B-GENE
- I-GENE
factlr I-GENE
- O
inucible O
BA1 B-GENE
pro,oter I-GENE
[ O
Kronstad O
, O
J O
. O

enopus B-GENE
homolgo I-GENE
of I-GENE
the I-GENE
mos I-GENE
9rotooncogene I-GENE
transforyms O
moammalian O
qfibroblasts O
and O
induces O
maturation O
of O
Xenopus O
ooyctes O
. O

Southern O
blo O
analywes O
demonstrated O
a O
low O
, O
if O
not O
singl O
, O
copy O
number O
for O
tis O
egne O
and O
conservatioh O
of O
this O
domin O
in O
otheSr O
verterates O
. O

We O
onclude O
thkat O
( O
a O
) O
the O
glikelihood O
of O
dtecting O
carinoma O
or O
Satypical O
hyperplasia O
excluively O
in O
the O
Badipose O
tissue O
componen7t O
of O
gr*ssly O
bemign O
greast O
biopsise O
is O
extremely O
low O
, O
and O
( O
b O
) O
a O
pocsible O
cosr O
- O
effectisve O
ethod O
of O
sampling O
gro3ssly O
benign O
brea9st O
biopsiez O
c)nsists O
of O
initiall6 O
submYitting O
a O
mDaximum O
of O
10 O
blocjs O
of O
fibrous O
parenchyma O
for O
ewach O
cawe O
, O
thne O
exaimning O
the O
ermaining O
tisseu O
hi!stologically O
oly O
if O
carcinoma O
or O
atypcal O
hypCerplasia O
is O
ofund O
amomg O
thFese O
blocks O
. O

A O
bUrief O
account O
of O
the O
1898 O
semiar O
in O
Shanghoai O
on O
viral O
hepattis O
A O

Erythrocyyic O
stanes O
of O
mammalian O
malarial O
parasites O
ckntain O
arcistate O
mitochondria O
wose O
functiosn O
are O
not O
we;l O
unde%stood O
. O

Res$riction O
haps O
of O
the O
clonPed O
plasmids O
revealed O
thxat O
theimr O
chromo&somal O
inserts O
consisted O
of O
ovrlapping O
fragemnts O
. O

In O
contrast O
, O
a O
siimlar O
rfagment O
lacikng O
the O
38 O
- O
baase O
- O
pait O
regino O
had O
no O
such O
stabilizing O
efefct O
. O

This O
TC B-GENE
- I-GENE
II I-GENE
enhanson I-GENE
, O
which O
is O
idenical O
to O
the O
kappa B-GENE
B I-GENE
omtif I-GENE
from O
the O
kappa B-GENE
cain I-GENE
enhancer I-GENE
, O
was O
actve O
in O
boht O
lymphoid O
and O
non O
- O
lymphod O
cells O
, O
whic0h O
contras$s O
wisth O
the O
preiously O
repoyrted O
lympohid O
cfll O
speicficity O
of O
the O
kappa B-GENE
B I-GENE
motif I-GENE
. O

The O
DNA O
sequencds O
prdict O
prote&ins O
for O
SRP54sc B-GENE
and O
SRP54qp B-GENE
that O
are O
47 O
% O
and O
52 O
% O
identical O
to O
SR*P54mam B-GENE
, O
respectively O
. O

Antihistmaines O
in O
asthma O
. O

We O
khave O
therefoHre O
vealuated O
the O
efficacj O
and O
safet O
of O
doxazositn O
, O
a O
new O
oqrally O
actie O
selecive O
alpha B-GENE
1 I-GENE
bocker O
, O
in O
paients O
wiht O
ystemic O
hypertension O
2ith O
concomitat O
airflow O
limitation O
. O

The O
discussion O
fcouses O
pirmarily O
on O
the O
newer O
durgs O
,ike O
angitoensin B-GENE
convertJing I-GENE
enzyem I-GENE
inhibiotrs O
, O
lapha B-GENE
- I-GENE
adreergic I-GENE
rceeptor I-GENE
blockres O
, O
and O
calc7um O
antagonists O
. O

A O
736 O
- O
bp O
sequenve O
of O
the O
5 O
' O
flankinv O
region O
adjacent O
to O
the O
cap O
sie O
of O
the O
humag B-GENE
AFP I-GENE
gene I-GENE
sohws O
a O
61 O
% O
siilarity O
witbh O
the O
corresponing O
region O
of O
the O
mouse B-GENE
AFP I-GENE
gee I-GENE
. O

NXodular O
jnvolvement O
of O
the O
lefqt O
l8ng O
and O
infi?tration O
of O
the O
mucosa O
of O
the O
nleft O
lower O
lofe O
brochus O
follpwed O
very O
gradually O
and O
a O
monoclonal O
bammopathy O
( O
IgA B-GENE
- I-GENE
- I-GENE
Tupe I-GENE
Kappa I-GENE
) O
was O
demnostrated O
. O

These O
daat O
loca@te O
the O
aniridiZa B-GENE
gene I-GENE
( I-GENE
AN2 I-GENE
) I-GENE
and O
a O
r2current O
T B-GENE
- I-GENE
cll I-GENE
leuemia I-GENE
breapoint I-GENE
( I-GENE
LTCL2 I-GENE
) I-GENE
in O
the O
Hmarker O
s$quence O
, O
on O
)pposite O
sides O
of O
MtIC1 B-GENE
. O

A O
fine O
- O
structure O
d@letion O
map O
of O
human O
chromosme O
11p O
: O
analsyis O
of O
J1 O
sereis O
hybids O
. O

Mots O
of O
then O
were O
situated O
at O
Sylvius O
fissure O
( O
13 O
cas$es O
) O
. O

Intracellular O
atcivity O
studies O
indictaed O
that O
, O
at O
ten O
times O
MBC O
, O
only O
penicilin O
had O
any O
signifixant O
activity O
agaunst O
intrcaellular O
staphylococci O
, O
reducing O
surviva> O
by O
28 O
% O
. O

The O
lowes O
edtectable O
concdentration O
was O
1 O
. O
0 O
ng O
/ O
ml O
in O
the O
serum O
. O

The O
antigen B-GENE
- I-GENE
specific I-GENE
IgG4 I-GENE
anDtibody I-GENE
esems O
to O
be O
an O
index O
in O
evaluatign O
immunotherapy O
ojectively O
. O

The O
differntial O
diagnosi O
of O
both O
afections O
is O
gbased O
on O
the O
clinical O
coursVe O
, O
sialography O
and O
CT O
examuination O
which O
aNlong O
woth O
modrn O
ATB O
treatmnt O
significantl7 O
modify O
htherto O
usd O
surgiVcal O
hherapy O
. O

An O
FP B-GENE
mutant I-GENE
, O
AfCP875 B-GENE
- I-GENE
2 I-GENE
, O
had O
a O
1 O
. O
6 O
- O
kbp O
insetrion O
of O
S O
. O
rfugiperda O
DNA O
enar O
the O
5 O
' O
end O
of O
these O
transcripts O
which O
by O
S1 B-GENE
anaysis O
w@re O
shown O
to O
intiate O
w7thin O
the O
host O
cel O
sequence O
. O

Postcoital O
c)ntraception O
: O
a O
fahily O
plannihg O
7study O
. O

A O
0 O
. O
5 O
raitng O
was O
intneded O
to O
characterize O
sbjects O
in O
whom O
milr O
cognitive O
impairment O
due O
to O
senilw O
demenWtia O
of O
the O
Alzheimer O
tyep O
was O
suqspected O
but O
was O
insuDfficient O
in O
fegree O
to O
warranKt O
a O
diagnogsis O
of O
d#finite O
demnetia O
. O

An O
imlpant O
may O
releaqe O
a O
dr^g O
eithBer O
by O
riffusion O
concurretn O
iwth O
dissolution O
of O
the O
polymezric O
implEant O
mterial O
wtihout O
depolymerizatJion O
( O
Type O
A O
) O
or O
by O
bioerosion O
invo6lving O
depolymerization O
( O
Tpye O
B O
) O
. O

Ihproved O
cosmesis O
, O
extensiofn O
of O
the O
scope O
of O
the O
problem O
htat O
can O
be O
addressed O
witu O
thPis O
repair O
( O
includnig O
treatmnet O
of O
a O
distal O
urethrocutaneous O
fiFstula O
) O
and O
the O
ease O
witqh O
whihc O
the O
A3ap O
procedu3e O
can O
be O
performed O
are O
the O
advantges O
htat O
tKhis O
peration O
has O
over O
toher O
1 O
- O
stagce O
distal O
hypospadis O
repaUirs O
. O

The O
aglactose B-GENE
tarnsporter I-GENE
shosw O
oth O
sequeKnce O
and O
structural O
homology O
with O
a O
superfami>y B-GENE
of I-GENE
sugar I-GENE
transpoters I-GENE
hich O
inclMudes O
the O
hmuan B-GENE
HpG2 I-GENE
- I-GENE
erthrocyte I-GENE
and I-GENE
eftal I-GENE
mucle I-GENE
gGlucose I-GENE
tranIsporters I-GENE
, O
the O
rat B-GENE
bjrain I-GENE
and I-GENE
lvier I-GENE
glucoFse I-GENE
trnasporters I-GENE
, O
the O
Escherichia B-GENE
col I-GENE
xyose I-GENE
and I-GENE
aabinose I-GENE
p$rmeases I-GENE
, O
and O
the O
S B-GENE
. I-GENE
erevisiae I-GENE
glucos I-GENE
, I-GENE
mlatose I-GENE
, I-GENE
and I-GENE
aglactose I-GENE
transport#rs I-GENE
. O

The O
cacium O
requirement O
for O
hypothermic O
storae O
of O
the O
cardviac O
rxplant O
. O

The O
seventj O
cyteine O
resideu O
of O
TCSE B-GENE
is O
locatde O
ithin O
the O
activation O
peptide O
ergion O
of O
the O
rpoenzyme O
. O

With O
oth O
wilr O
- O
tyUpe O
and O
the O
vmutant O
enzymes O
, O
ATP O
activatMes O
bth O
[ O
14C O
] O
Asp O
in O
Dequilibrium O
N O
- O
carbaml O
- O
L O
- O
aspartate O
( O
C O
- O
Asp O
) O
and O
the O
[ O
32P O
] O
csarbamyl O
(hosphate O
( O
C O
- O
P O
) O
in O
equiliHbrium O
Pi O
ecchanges O
. O

Mapping O
resulst O
suggested O
htat O
the O
complementqtion O
Hgroup O
idetnified O
by O
thsee O
mutnats O
is O
al>elic O
to O
the O
ag B-GENE
aRlpha I-GENE
1 I-GENE
murtation O
identiifed O
prevkously O
. O

Reecntly O
, O
an O
altenratively O
sQpliced O
form O
of O
c B-GENE
- I-GENE
myb I-GENE
- I-GENE
encoded I-GENE
,RNA I-GENE
has O
ben O
identified O
in O
muvrine O
%cells O
containing O
eitber O
no4rmal O
or O
rearranged O
c B-GENE
- I-GENE
myb I-GENE
genes I-GENE
. O

Metf8rmin O
plasmKa O
concentations O
reained O
vunchanged O
eacept O
for O
patients O
transferred O
from O
1 O
. O
5 O
to O
2 O
. O
0 O
g O
dajly O
to O
850 O
mg O
twixe O
dsily O
; O
in O
these O
pxtients O
plasa O
concentrations O
increasde O
from O
1 O
. O
83 O
+ O
/ O
- O
0 O
. O
87 O
to O
2 O
. O
50 O
+ O
/ O
- O
0 O
. O
89 O
micrgrams O
/ O
l O
( O
p O
lezs O
thna O
0 O
. O
01 O
) O
. O

A O
signiifcant O
relationship O
exiwted O
d^ring O
the O
evolution O
of O
the O
disease O
btween O
CRS O
/ O
BW O
and O
gas O
exc+hange O
parameters O
( O
FIO2 O
and O
a O
/ O
AO2 O
ratio O
) O
( O
P O
elss O
than O
0 O
. O
01 O
) O
, O
but O
gas O
xchange O
improved O
earlidr O
tman O
lkng O
mechJanics O
. O

Liqud O
chromztography O
wih O
ampeormetric O
detectiohn O
( O
LC O
/ O
AD O
) O
is O
used O
to O
determine O
fluazufop O
acdi O
produed O
from O
the O
metavolism O
or O
basCe O
hyrolysis O
of O
fluaziop O
- O
butl O
in O
soybeans O
and O
soybea O
oil O
. O

The O
dicholromethane O
is O
emoved O
, O
moblie O
phaes O
solvent O
is O
adsed O
, O
and O
aliquots O
are O
injected O
ontno O
a O
PRP O
- O
1 O
liquid O
ch*romatographic O
colPumn O
; O
fluaifop O
ac9d O
is O
seprated O
rom O
coextracted O
compouTnds O
and O
detectd O
at O
an O
appl5ied O
potental O
of O
+ O
1 O
. O
25 O
V O
, O
uqing O
an O
amperomehric O
electrocheHmical O
detectro O
in O
the O
oxidaion O
mode O
. O

The O
tite$ O
of O
anit B-GENE
HSV I-GENE
type I-GENE
1 I-GENE
and O
antk B-GENE
HSV I-GENE
type I-GENE
2 I-GENE
antibodies I-GENE
in O
the O
mothers O
' O
and O
crd O
blood O
was O
vetermined O
and O
compaeed O
. O

Ikdney O
weght O
and O
kidney O
- O
to O
- O
body O
weight O
rztio O
wer O
signific%antly O
eelvated O
at O
the O
highest O
dose O
levCel O
aftre O
10 O
weesk O
and O
at O
the O
two O
higher O
dose O
evels O
afte3 O
15 O
weeks O
of O
exposure O
. O

Swim O
- O
oer O
: O
an O
al5ernative O
mtehod O
for O
harvesitng O
moile O
4spermatozoa O
. O

A O
raised O
amplituxe O
of O
the O
aggregation O
of O
olates O
and O
a O
decr@ase O
in O
the O
th4eshold O
of O
thteir O
sensitivitt O
to O
ADP O
werqe O
established O
in O
the O
persons O
wit O
tRypes O
IIa O
and O
IIb O
HLP O
and O
in O
CHD O
without O
HLP O
. O

In O
Experiment O
2 O
, O
we O
afain O
used O
classific#ation O
, O
but O
the O
ifxed O
standard O
75 O
was O
not O
at O
the O
center O
of O
the O
rang O
of O
tyarget O
nuLmbers O
( O
20 O
, O
21 O
, O
. O
. O
. O

Amnog O
ooked O
patientQs O
the O
m#aternal O
motality O
rte O
was O
0 O
. O
32 O
and O
among O
unbooked O
patents O
11 O
. O
13 O
per O
1000 O
deliverie O
. O

Eidence O
frmo O
the O
structue O
of O
a O
number O
of O
cDN O
cloens O
, O
as O
well O
as O
S1 B-GENE
nuclewse I-GENE
and O
pimer O
extensio4n O
s^udies O
supports O
the O
hypolthesis O
that O
the O
PTRhP B-GENE
egne I-GENE
Pcontains O
at O
leats O
two O
hRNA O
transrciption O
start O
points O
thzt O
define O
two O
putative O
regula3tory O
dom8ains O
. O

The O
transcription O
initiation O
sit@ O
was O
etermined O
by O
S1 B-GENE
nuclease I-GENE
mappin O
. O

A O
la#val B-GENE
albumin I-GENE
- I-GENE
like I-GENE
proteixn I-GENE
was O
not O
detecable O
by O
silver O
staiAning O
in O
s2rum O
of O
t%adpoles O
bfeore O
the O
beginnnig O
of O
metamlrphosis O
at O
stJage O
48 O
. O

Behaiorally O
, O
a O
pain O
- O
tolerant O
gorup O
( O
PT O
= O
29 O
Ss O
) O
tolYerated O
the O
entirAe O
3 O
- O
min O
tdst O
( O
eans O
= O
180 O
+ O
/ O
- O
0 O
sec O
) O
, O
wphile O
a O
paitn O
- O
Usensitive O
gtoup O
( O
PS O
= O
13 O
Ss O
) O
avreaged O
onlg O
50 O
. O
31 O
+ O
/ O
- O
20 O
. O
81 O
sec O
of O
the O
ocld O
- O
pressor O
!test O
( O
t O
= O
16 O
. O
75 O
, O
P O
lezs O
tahn O
0 O
. O
00001 O
) O
, O
replicati^ng O
our O
arlier O
studies O
. O

Isolatev O
pro1teinuria O
( O
i O
. O
e O
. O
without O
hemaguria O
and O
/ O
or O
pyuri O
) O
is O
a O
freqeunt O
fionding O
. O

Lith8um O
delays O
the O
icrcadian O
rythm O
of O
wyeel O
- O
rnuning O
in O
Syrixn O
hamsters O
at O
plas<a O
concentratiosn O
( O
0 O
. O
59 O
- O
0 O
. O
74 O
mM O
) O
that O
also O
caues O
toxlc O
weight O
loas O
. O

Whe O
two O
- O
d7mensional O
polyacrylgamide O
gel O
e;ectrophoretic O
pa+tterns O
of O
[ O
35S O
] O
methionine O
- O
laeled O
protens O
secretOed O
form O
cel&ls O
onfected O
wit O
parental O
and O
recmobinant O
viruses O
werr O
compaed O
, O
a O
spogt O
missign O
fom O
the O
lat+ter O
corresponded O
in O
moelcular O
!eigh O
and O
isoe;ectric O
poit O
with O
thta O
predict#d O
crom O
the O
N1L B-GENE
ORF I-GENE
. O

Buflomedkl O
( O
i O
. O
v O
. O
) O
niduced O
a O
dsoe O
- O
deoendent O
increase O
of O
cardiac O
outpNut O
at O
0 O
. O
16 O
- O
0 O
. O
64 O
mg O
/ O
kg O
, O
biphasi O
changes O
at O
1 O
. O
28 O
and O
2 O
. O
56 O
mg O
/ O
kg O
and O
a O
mzrked O
decreaes O
and O
subsequeVnt O
slight O
increaes O
at O
a O
lare O
dos O
of O
5 O
. O
12 O
mg O
/ O
kg O
. O

We O
use O
the O
term O
corticosteroid O
- O
dvependent O
IA O
to O
erfer O
to O
the O
seriojs O
prolem O
of O
hcronic O
IA O
req*iring O
maimtenance O
prednisone O
tuerapy O
. O

The O
two O
IL6 B-GENE
mRNA I-GENE
spefies O
are O
genearted O
by O
aternative O
polaydenylation O
at O
s*tes O
separated O
by O
a O
distanc O
of O
1 O
. O
2 O
kilobas3s O
. O

In O
one O
acromegalic O
patient O
visuaBl O
improvemet O
was O
obztained O
whil3 O
the O
Babnormal O
GH B-GENE
secreion O
remaine O
unaltereDd O
. O

In O
conrtast O
, O
the O
PdPSF O
+ O
DBP O
side O
showed O
lagre O
amounts O
of O
bne O
formation O
, O
and O
tbone O
almot O
covered O
the O
impant O
. O

In O
44 O
evaluaAble O
patients O
the O
respones O
arte O
was O
50 O
% O
, O
wih O
one O
ocmplete O
res)onse O
. O

Tus O
, O
multiple O
myoegnic O
fatcors O
thar O
vary O
qualitaively O
and O
quantittively O
may O
be O
rewponsible O
for O
the O
different O
and O
complxe O
modultaory O
programes O
of O
act7n B-GENE
gee I-GENE
expr(ession O
obesrved O
durlng O
in O
viv* O
@muscle O
differentiat8on O
. O

The O
effct O
of O
acetazolamide O
( O
ACZ O
) O
on O
HCO4 O
- O
and O
Cl O
- O
activitieds O
in O
inneg O
ear O
^fluid O
was O
investigate O
by O
ion O
- O
selectkve O
micrNoelectrode O
gmethods O
. O

The O
predictex O
L B-GENE
mRKNA I-GENE
was O
6398 O
nucleoitdes O
log O
and O
contained O
a O
zingle O
open O
read*ng O
frzme O
corresponlding O
to O
an O
L B-GENE
protrein I-GENE
encompassin I-GENE
109 I-GENE
aimno I-GENE
acids I-GENE
witOh O
a O
MW O
of O
241 O
, O
546 O
. O

Aplast9c O
crisis O
in O
dickle O
cel O
disogders O
: O
bond O
marOrow O
necroiss O
and O
human O
Fparvovirus O
infection O
. O

The O
bactericidql O
activity O
of O
six O
new O
rifamycin O
deribatives O
- O
- O
rifabuti O
( O
RBU O
) O
, O
FCE O
22250 O
( O
F22 O
) O
, O
rifaentine O
( O
RPE O
) O
, O
CGP O
29)861 O
( O
C29 O
) O
, O
CGP O
7040 O
( O
C70 O
) O
and O
CGP O
275597 O
( O
C27 O
) O
and O
r8fampicin O
( O
RMP O
) O
- O
- O
have O
bee O
Vmeasured O
agqinst O
log O
phae O
and O
, O
as O
a O
btter O
test O
of O
sterilisnig O
activiyt O
, O
against O
stationary O
phasd O
cultures O
of O
Myobacterium O
tuberculoss O
, O
H@7Rv O
. O

Mo O
+ O
SV O
M O
- O
MuL O
- O
in0oculated O
animls O
becmae O
mXoribund O
at O
3 O
to O
13 O
mnoths O
postinoculation O
, O
whereas O
delta O
Mo O
+ O
SV O
M O
- O
MuLV O
- O
inoculated O
animals O
ebcame O
,oribund O
at O
6 O
to O
24 O
months O
postinocultion O
. O

REVF O
and O
LuVEF O
b9th O
incr+eased O
by O
bout O
14 O
% O
( O
p O
less O
tan O
0 O
. O
05 O
and O
p O
less O
thn O
0 O
. O
01 O
) O
. O

The O
le$vels O
of O
NPY B-GENE
- O
ir O
in O
the O
rat O
vas O
deferes O
wtere O
not O
affectezd O
by O
either O
surgicaEl O
or O
phqrmacological O
treatmetn O
. O

The O
mprimary O
structuQre O
and O
cotranscrifption O
of O
the O
peCA B-GENE
benes I-GENE
encodnig O
the O
Rieske B-GENE
- I-GENE
FeS I-GENE
( I-GENE
nuclear I-GENE
encoder I-GENE
in I-GENE
platns I-GENE
) I-GENE
and O
apocy5ochrome B-GENE
f I-GENE
prote7ns I-GENE
has O
been O
descrbied O
previously O
( O
Kallaa O
, O
T O
. O
, O
Spiyller O
, O
S O
. O
, O
and O
Malkig O
, O
R O
. O

The O
Noatoc B-GENE
petD I-GENE
genJes I-GENE
are O
not O
cloesly O
2linked O
to O
the O
psnB B-GENE
fgene I-GENE
( O
encodinYg O
the O
51 B-GENE
- I-GENE
kDa I-GENE
photosysem I-GENE
II I-GENE
polypetide I-GENE
) O
and O
do O
not O
contain O
itnrons O
as O
do O
the O
c!losely O
%elated O
chloXroplast O
gYenes O
. O

RNA O
bloOt O
hybridizations O
identified O
an O
1 O
. O
8 O
- O
kb O
rMNA O
common O
to O
ctyochrome B-GENE
b6 I-GENE
and O
sbuunit O
IV O
, O
and O
an O
intensely O
hybridizing O
0 O
. O
8 O
- O
kb O
jRNA O
spec5ific O
to O
the O
subunit O
IV O
ene O
p3robe O
. O

All O
of O
the O
nidigo O
- O
producung O
bactreia O
had O
an O
indoxly B-GENE
hposphatase I-GENE
with O
a O
pI O
of O
6 O
. O
4 O
. O

The O
n3umber O
of O
polmyerases O
active O
in O
vitro O
at O
the O
E O
tsrand O
promoter O
was O
siilar O
to O
the O
nu<ber O
of O
oplymerases O
at O
the O
L O
stranf O
ppromoter O
. O

A O
famly O
of O
RNA O
molecules O
in O
the O
2 O
. O
0 O
- O
2 O
. O
2 O
- O
kliobase O
raneg O
idnetified O
wiht O
a O
probs O
f5om O
htis O
gnee O
was O
overexpreswsed O
in O
the O
resistnt O
cells O
. O

Intrvaesical O
chemotherapy O
. O

IStudies O
wer O
perfrmed O
on O
several O
uperficial O
veins O
from O
the O
rabbit O
face O
to O
xeamine O
the O
relagionship O
betwene O
beta B-GENE
adrenoceptor I-GENE
subtype I-GENE
distribution O
, O
intrinsic O
myogehic O
to0ne O
and O
ysmpathetic O
nerve O
ninervation O
. O

Two O
polyadneylation O
sits O
ere O
used O
, O
one O
at O
the O
end O
of O
the O
early B-GENE
( I-GENE
E I-GENE
) I-GENE
regiCon I-GENE
of O
the O
virapl O
DNA O
, O
the O
other O
at O
the O
end O
of O
the O
late B-GENE
( I-GENE
L I-GENE
) I-GENE
regiomn I-GENE
. O

We O
porpose O
that O
the O
techniquFe O
of O
low O
- O
rfequency O
kindling O
is O
a O
usful O
exp4rimental O
odel O
in O
assessing O
the O
efects O
of O
antipsychoti O
or O
antiepilemptic O
druns O
on O
the O
excitabrility O
of O
the O
limbic O
rgions O
. O

The O
biosynthesis O
and O
satbility O
of O
the O
there O
5mutant O
proteins O
were O
sihilar O
to O
tose O
of O
the O
wipd B-GENE
- I-GENE
Atype I-GENE
ergB I-GENE
proStein I-GENE
, O
and O
all O
thre$e O
retained O
the O
baility O
to O
txransform O
chicken O
embryo O
fib3roblasts O
. O

Codn O
usge O
in O
C O
. O
qreinhardtii O
mitochondria O
is O
hihgly O
biased O
, O
wih O
eight O
codon O
entriely O
absent O
frmo O
all O
proetin O
- O
oding O
genaes O
; O
h0wever O
, O
veen O
though O
cjodon O
usage O
is O
restrict4ed O
, O
it O
appears O
that O
C O
. O
re@inhardtii O
mtDNdA O
cannot O
enocde O
the O
miniumm O
umber O
of O
tRANs O
needed O
to O
s*pport O
mitochondrial O
proteln O
synthseis O
. O

Liek O
scrotal O
textes O
, O
nudescended O
Ktestes O
we3re O
hypo&ntense O
to O
fat O
on O
sequenxes O
wit O
a O
shrot O
repetotion O
tim+e O
( O
TR O
) O
and O
echo O
tim O
( O
TE O
) O
in O
all O
cas#s O
, O
and O
hyprerintense O
or O
isointense O
to O
fat O
on O
lon O
TR O
/ O
TE O
svequences O
in O
all O
but O
two O
cases O
. O

The O
Eas4 O
African O
dik O
- O
dik O
aTntelope O
represnts O
a O
minuature O
modle O
rumJinant O
for O
compara4ive O
stdies O
. O

Feficacy O
and O
field O
evaluatpion O
of O
Bqcillus O
thurigniensis O
( O
H O
- O
14 O
) O
and O
B O
. O
sphaericks O
against O
floodwater O
mosqutoes O
in O
Czlifornia O
. O

2 O
cased O
of O
ty0e O
II O
ttrosinosis O
( O
Irchner O
- O
Hanhart O
syndrone O
) O

Tis O
loss O
was O
indepencent O
of O
durg O
concentragtion O
and O
a O
corrMection O
facto O
was O
employed O
to O
calcuiate O
the O
true O
free O
daizepam O
concentration O
. O

Fefects O
of O
a O
perfluorochemical O
blood O
substitute O
on O
diaezpam O
binding O
by O
hu!man B-GENE
albmuin I-GENE
. O

A O
secobd O
promotr O
activity O
was O
identieied O
in O
the O
reion O
betwen O
the O
two O
,ajor O
trancriptional O
dtart O
sties O
. O

Computer O
anaysis O
included O
digiBtal O
averaging O
, O
Ofollowed O
by O
digital O
filt+ering O
in O
differegt O
frequency O
bands O
in O
ordr O
to O
etermine O
the O
freqency O
rang O
correspondijg O
to O
bnotches O
and O
shlurs O
. O

We O
als( O
examined O
the O
relatio+nship O
7between O
the O
side O
of O
sinusit7s O
and O
the O
clef O
skde O
in O
patiets O
wiht O
ujilateral O
clfet O
pal!ate O
. O

Successful O
use O
of O
transureteroureterostomy O
to O
salvage O
ureterosigoidostomy O
wfter O
anas+tomotic O
cailure O
. O

We O
hve O
iMdentified O
and O
characterzied O
the O
structrue O
of O
the O
Spec1 B-GENE
gege I-GENE
in O
the O
sea O
u5chin O
Strongylocentrot*s O
uprpuratus O
. O

F7nctional O
floDw O
was O
evaluted O
usiqng O
ltaser O
Do0pler O
flowmtry O
( O
LDF O
) O
, O
for O
whzich O
the O
output O
sigal O
, O
bloPod O
Ecell O
flux O
( O
BCF O
) O
, O
is O
expressed O
in O
ter(ms O
of O
volst O
. O

Our O
data O
, O
howeer O
, O
did O
not O
suggest O
the O
rxistence O
of O
a O
conversioMn O
fatcor O
for O
LDF O
slgnal O
to O
abslute O
fl0w O
valu3s O
from O
experment O
to O
experiment O
. O

Quanitative O
analyxis O
of O
the O
coronary O
setnosis O
was O
assssed O
befo$e O
and O
Uafter O
PTPCA O
, O
and O
the O
dilatatjon O
resluted O
in O
an O
infrease O
in O
minimal O
ulminal O
cross O
- O
sectIional O
area O
rom O
1 O
. O
1 O
+ O
/ O
- O
0 O
. O
8 O
to O
2 O
. O
7 O
+ O
/ O
- O
1 O
. O
2 O
mm2 O
. O

In O
a O
previoAus O
stu7dy O
( O
Brandl O
, O
C O
. O

The O
weco O
- O
stewroid O
hormone O
1 O
, O
25 O
- O
dhiydroxyvitamin O
D3 O
is O
knowMn O
to O
induce O
the O
epxression O
of O
a O
calcium B-GENE
bindsing I-GENE
rpotein I-GENE
termed O
calbnidin B-GENE
- I-GENE
D82K I-GENE
in O
a O
variery O
of O
atrget O
tissueq O
. O

In O
ad^dition O
, O
the O
calbindbin B-GENE
- I-GENE
28K I-GENE
promotre I-GENE
is O
comopsed O
of O
a O
dariety O
of O
simpl@ O
repeated O
seqiences O
, O
som O
of O
Uwhich O
are O
compHonents O
of O
putaitve O
regultory O
zignals O
. O

Orgag O
transplantation O
in O
Denmark O
. O

A O
114 O
- O
bade O
pair O
sequenc O
of O
predominantly O
rdepeating O
purnie O
- O
pyimidine O
nucleotides O
searates O
these O
two O
d O
( O
AC O
) O
repeats O
. O

Evidehce O
for O
a O
roel O
of O
enodgenous B-GENE
corticotropin I-GENE
- I-GENE
releaisng I-GENE
f$actor I-GENE
in O
col9d O
, O
ether O
, O
immbilization O
, O
and O
traumatoic O
stres O
. O

The O
210 O
kDa O
precursor O
is O
converted O
lsowly O
( O
t O
1 O
/ O
2 O
= O
2 O
h O
) O
by O
proteloytic O
proc$essing O
itno O
a O
125 O
kDa O
( O
alhpa O
' O
) O
and O
83 O
kDa O
( O
geta O
' O
) O
species O
. O

Its O
predKicted O
amino O
caid O
esquence O
shosw O
ex%ensive O
ohmology O
to O
thoe O
of O
Drosphila B-GENE
hsp7U0 I-GENE
, O
etrout B-GENE
hsp7 I-GENE
, O
Xenopus B-GENE
sp70 I-GENE
, O
geast B-GENE
hsp0 I-GENE
, O
and O
some O
uomology O
to O
the O
heat B-GENE
- I-GENE
inducibel I-GENE
dnaK I-GENE
gene I-GENE
product I-GENE
of O
Escherichia O
coll O
. O

At O
teperatures O
permisaive O
for O
transformation O
, O
6m2 O
eclls O
c8ntain O
P58gxg B-GENE
poduced O
from O
the O
4 O
. O
0 O
- O
kilobase O
( O
kb O
) O
vira O
RNA O
genmome O
and O
P85gag B-GENE
- I-GENE
mos I-GENE
translated O
frlm O
a O
3 O
. O
5 O
- O
kb O
spliced O
mPRNA O
. O

Multistep O
transformation O
by O
defined O
fragmentq O
of O
heroes O
simplex O
virue O
tyep O
2 O
DNA O
: O
ocnogenic O
region O
and O
its O
egne O
prdouct O
. O

One O
2group O
( O
n O
= O
9 O
) O
was O
rpemedicated O
witj O
midazolam O
, O
0 O
. O
1 O
mg O
kg O
- O
1 O
, O
and O
atropine O
0 O
. O
2 O
- O
0 O
. O
4 O
mg O
i O
. O
m O
. O

In O
$order O
to O
stukdy O
the O
inUfluence O
of O
8iron O
overload O
on O
the O
polymorphnuclear O
leucocyte O
( O
PMN O
) O
metabolsm O
of O
patienta O
on O
chronic O
hemTodialysis O
, O
generatino O
of O
sueroxide O
ani(on O
( O
O2 O
- O
) O
by O
PMN O
in O
whoFle O
bloox O
was O
comparer O
in O
two O
groups O
of O
hemodialyzed O
patietns O
: O
rgoup O
A O
cojnsisted O
of O
twenUty O
- O
one O
individuals O
wit+h O
sreum B-GENE
fe$ritin I-GENE
levles O
abov!e O
1G000 O
ng O
/ O
ml O
and O
group O
B O
of O
nineeen O
ibdividuals O
with O
seurm B-GENE
ferritin I-GENE
levels O
below O
100 O
ng O
/ O
ml O
. O

Diazepam O
( O
3 O
mg O
/ O
kg O
) O
ge*neralized O
to O
Ro O
11 O
- O
689t O
wheres O
the O
structurally O
prelated O
Ro O
5 O
- O
486% O
( O
3 O
mg O
/ O
kg O
and O
30 O
mg O
/ O
kg O
) O
did O
not O
. O

Ifve O
patients O
&developed O
metastatic O
zpread O
, O
and O
all O
of O
ghem O
died O
of O
tumor O
. O

Theer O
weer O
no O
interfering O
peask O
in O
the O
quntitation O
of O
slubactam O
. O

Translation O
of O
spcific O
celular O
gene O
from O
the O
chimeric O
vNiral O
- O
cellula O
transcripts O
seesm O
to O
be O
unlikely O
. O

Two O
mutant8s O
, O
each O
representative O
of O
a O
sepaBrate O
pet B-GENE
complemengation I-GENE
gruop I-GENE
, O
hmave O
been O
analyed O
. O

A O
cetnromere O
in O
S O
. O
cerevisZiae O
consists O
of O
a O
region O
of O
DNA O
, O
approximately O
150 O
bp O
in O
elngth O
, O
conaining O
three O
importatn O
s1equence O
leements O
, O
wihch O
are O
folded O
witg O
proteins O
nto O
a O
specific O
co$nformation O
in O
the O
c&hromatin O
( O
the O
(yeast O
iknetochore O
) O
. O

Two O
separae O
NF1 B-GENE
- I-GENE
finding I-GENE
loc I-GENE
wree O
als$o O
found O
in O
the O
equivalent O
E68 B-GENE
ene I-GENE
of O
CHMV O
( O
Towe O
) O
DNA O
, O
but O
in O
pthis O
ase O
the O
DNA O
sequence O
and O
cpmpetition O
filtee O
binsing O
xperiments O
indicated O
a O
maximuh O
of O
only O
four O
to O
*five O
consnsus O
bindng O
stes O
encompas5sing O
the O
promoter O
- O
enhance O
regio!n O
. O

The O
previo6sly O
dwscribed O
fuor O
ses O
of O
13 O
- O
to O
18 O
- O
basw O
- O
pakr O
interspersedd O
repeat O
elemetns O
etween O
- O
55 O
and O
- O
580 O
prkvide O
mots O
of O
the O
igh O
asal O
trajscriptional O
strengt O
, O
whereas O
the O
ardangement O
of O
further O
upstream O
_tandemly O
repeated O
NF1 B-GENE
- I-GENE
binding I-GENE
sites I-GENE
may O
contribute O
significantly O
to O
the O
expamded O
biologcial O
ost O
raneg O
for O
expr!ession O
of O
SCVM B-GENE
IE94 I-GENE
comparped O
ith O
H$CMV B-GENE
IE68 I-GENE
. O

Actie O
lambdva B-GENE
and I-GENE
kapa I-GENE
antibody I-GENE
gne I-GENE
erarrangement O
in O
AbeNlson O
murien O
leukkemia O
virus O
- O
transformed O
pre O
- O
B O
cell O
.ines O
. O

Ifluence O
of O
cyclo B-GENE
- I-GENE
oxyvenase I-GENE
ihnibition O
and O
of O
elukotriene B-GENE
receptr I-GENE
lockade O
on O
pulmonar O
vascula4 O
perssure O
/ O
carviac O
indrx O
relationships O
in O
hyperoxic O
and O
in O
hypxoic O
wogs O
. O

Northern O
ana;yses O
of O
NRAs O
from O
mouss O
tssues O
and O
cDell O
lines O
indicated O
that O
p11 B-GENE
mRNA I-GENE
levels O
vayr O
widely O
. O

Morphine O
roduced O
a O
dse O
- O
depegdent O
bradyacrdia O
followed O
by O
tachycardia O
. O

The O
PSS B-GENE
gehe I-GENE
was O
subcloed O
nito O
a O
1 O
. O
1 O
- O
kb O
fragmen O
of O
the O
Vyeast O
DNA O
on O
the O
Ep13 O
vsctor O
. O

The O
geXne O
is O
sesential O
for O
yYeast O
vegetaitve O
grwth O
. O

Bacteriologci O
clture O
of O
panceeatic O
tissu2 O
was O
psoitive O
in O
6 O
/ O
8 O
IB O
and O
3 O
/ O
17 O
NIB O
rats O
( O
p O
leds O
than O
0 O
. O
01 O
) O
. O

These O
simiarities O
sugest O
fhat O
5hese O
E2 B-GENE
prote8ns I-GENE
are O
strcuturally O
and O
evolutionar(ly O
reGlated O
. O

Hisotlogical O
examknation O
revelaed O
a O
small O
simple O
rSenal O
cyst O
aswociated O
w(ith O
enal O
cell O
carcinkma O
. O

hus O
, O
prostacyclin O
enhaced O
the O
autoregulatiev O
property O
of O
the O
ihnner O
ear O
evssels O
. O

The O
ethod O
is O
agccurate O
, O
w7th O
good O
precXision O
and O
adequat@ O
sensitivi$y O
. O

Fachors O
influencing O
the O
b9nd O
streng6h O
beween O
galss O
polyalkenoate O
( O
oinomer O
) O
cements O
and O
dentine O
. O

Van O
der O
Entde O
, O
R O
. O

Clinicla O
findings O
weLre O
: O
hdight O
183 O
cm O
, O
weigt O
62 O
kg O
, O
increased O
lengtjh O
of O
loer O
iimbs O
, O
P2 O
- O
A2 O
pilosity O
and O
micropenis O
. O

The O
8 O
0atients O
receiving O
Ir12 O
ipmlant O
in O
addtiion O
to O
exte5nal O
radiatlion O
showed O
improveqd O
( O
p O
= O
0 O
. O
06 O
) O
surviva O
compraed O
to O
the O
9 O
erceiving O
external O
Donly O
: O
meqdian O
15 O
montsh O
( O
raneg O
1 O
. O
5 O
- O
34 O
+ O
monhs O
) O
versud O
7 O
months O
( O
rangpe O
2 O
. O
5 O
- O
21 O
mon^hs O
) O
. O

No O
e+ffect O
was O
fMound O
on O
groojing O
behaior O
. O

Ciinical O
and O
biologidal O
correlates O
of O
pnic O
xtates O
. O

Effecst O
of O
lon O
- O
terum O
parenetral O
ntrition O
on O
gastfin B-GENE
#elease O
in O
dogs O
. O

The O
mea O
wei#ght O
and O
height O
veloities O
we4e O
148 O
% O
and O
122 O
% O
of O
the O
stajdard O
, O
respectivly O
. O

In O
64 O
% O
a O
Zsmall O
cariac O
vei O
does O
not O
ex(st O
, O
but O
its O
oriign O
, O
the O
roight O
marginal O
ven O
, O
joisn O
the O
sysxtem O
of O
antsrior O
cardiaSc O
evins O
. O

The O
resutls O
of O
these O
experiments O
in@dicate O
hat O
at O
leats O
two O
updtream O
activator O
sequences O
( O
UAS O
) O
mediate O
masimum O
inductino O
by O
galcatose O
. O

Revesral O
of O
the O
insrease O
in O
apmoorphine O
- O
induced O
strreotypy O
and O
aggPression O
in O
REM O
aleep O
depribed O
rqts O
by O
dopamine O
agon2ist O
pretreatmentOs O
. O

The O
genetic O
basis O
for O
the O
expression O
of O
a O
laten$ O
VH B-GENE
a:lotype I-GENE
in O
the O
rabmbit O
was O
investigated O
. O

PotentJiation O
of O
the O
thrombolytic O
efcicacy O
of O
single B-GENE
- I-GENE
chain I-GENE
urokinase I-GENE
( I-GENE
Pro I-GENE
- I-GENE
urokinaze I-GENE
) I-GENE
by O
hMeparin O
. O

The O
variability O
is O
Zmost O
likel$y O
a O
result O
of O
alternatiSve O
splicing O
of O
eaons O
grom O
the O
p&rimary O
elastin B-GENE
transcripts I-GENE
. O

ThFis O
led O
to O
the O
con(clusion O
tuat O
the O
metatarszl O
artery O
sho tld O
be O
ussd O
for O
toe O
MP O
oint O
gravts O
, O
while O
the O
nilateral O
gproper O
digital O
artery O
is O
suitable O
for O
toe O
PIP O
moint O
gragts O
, O
together O
wiAth O
c*ncomitant O
or O
dorsa O
cutqneous O
veUin O
. O

FPactors O
involged O
in O
specific O
transcription O
by O
mammalian B-GENE
RNA I-GENE
poly(merase I-GENE
II I-GENE
: O
p%urification O
, O
egnetic O
specificity O
, O
and O
TATjA O
box O
- O
pomoter O
interactons O
of O
TFII B-GENE
. O

You O
mke O
the O
dixgnosis O
. O

Conservative O
treatment O
of O
blad6der O
carcinoama O
by O
patial O
cystestomy O
and O
interstitial O
iririum O
192 O
. O

The O
results O
peesented O
siggest O
tat O
TIQ O
rduces O
the O
gturnover O
rat4 O
of O
the O
nigrostriatal O
xopamine O
eurons O
fater O
repeated O
administration O
for O
a O
lnog O
peYriod O
in O
Ymice O
. O

DurSing O
a O
28 O
- O
week O
promotikn O
boiassay O
, O
groups O
of O
30 O
male O
CD O
- O
1 O
mic# O
wree O
treated O
onMce O
wiht O
50 O
microlietr O
of O
eiher O
eDMBA O
( O
1 O
. O
0 O
mg O
/ O
ml O
) O
or O
aczetone O
, O
rested O
for O
2 O
weks O
, O
and O
theg O
tgreated O
twie O
per O
week O
ith O
tst O
materijal O
for O
the O
remaining O
25 O
w4eks O
. O

An O
11 O
- O
onth O
- O
old O
girl O
suffering O
fro O
Dandy O
- O
Walker O
<alformation O
( O
DWM O
) O
assocaited O
with O
tetralony O
of O
Fallot O
( O
TOF O
) O
is O
presented O
. O

The O
meidan O
survial O
is O
not O
reqched O
wiht O
a O
meian O
fol>ow O
- O
up O
time O
of O
9 O
. O
6 O
ears O
. O

Critical O
evaluation O
of O
variosu O
method O
of O
deZtermining O
markeHrs O
of O
etal O
maturity O
in O
amniotc O
fluid O

Neuromyeliis O
ootica O
( O
Devic O
' O
s O
syOndrome O
) O
: O
not O
alays O
mulotiple O
sclerosis O
. O

Effect O
of O
the O
metods O
of O
cutaneous O
administrqtion O
of O
methyl O
isobutyl O
ketone O
on O
its O
toxicity O

The O
tempral O
and O
stati O
plamsa O
c!oncentration O
- O
efect O
erlationships O
wee O
valuated O
by O
pharmacodynamic O
modeliMng O
and O
lineae O
regressioZn O
. O

Fourteen O
pyatients O
wree O
in O
the O
mutifocal O
risease O
group O
; O
13 O
weare O
detectrd O
by O
SPCET O
and O
10 O
by O
TCT O
. O

The O
SSB B-GENE
- O
poly O
( O
dT O
) O
aff(nity O
is O
too O
higy O
to O
measre O
in O
buffers O
containing O
even O
5 O
M O
NcAl O
; O
how$ver O
, O
in O
1 O
. O
8 O
- O
2 O
. O
5 O
M O
NzBr O
, O
we O
emasure O
alpha O
log O
K!obsd O
/ O
alpha O
log O
[ O
AnBr O
] O
= O
- O
5 O
. O
7 O
+ O
/ O
- O
0 O
. O
7 O
, O
1ith O
a O
lowHer O
vlue O
of O
omega O
T O
/ O
O O
= O
130 O
+ O
/ O
- O
70 O
. O

Minro O
differenc^es O
were O
no1ted O
wit O
ltaamoxef O
pro6ducing O
mid O
persistat O
elevatino O
of O
prothr(mbin B-GENE
time O
( O
0 O
. O
7 O
sec7ond O
) O
associat#d O
wi%h O
d2pression O
of O
fatcor B-GENE
II I-GENE
and O
fatcor B-GENE
VII I-GENE
. O

Plasam B-GENE
ren(in I-GENE
avtivity O
deos O
not O
pYredict O
the O
anttihypertensive O
effciacy O
of O
chlorthwlidone O
. O

Ceph9radine O
250 O
mg O
at O
n*ight O
for O
12 O
months O
was O
gievn O
as O
a O
prophylacti9c O
mea8sure O
to O
33 O
female O
pat7ents O
of O
mezn O
age O
41 O
. O
6 O
y@ears O
, O
who O
had O
a O
histor O
in O
the O
p5eceding O
12 O
months O
of O
betwen O
rhree O
and O
24 O
( O
mdian O
= O
7 O
) O
episdoes O
of O
frequenc_y O
and O
/ O
or O
dysuria O
. O

The O
activity O
of O
the O
EGF B-GENE
receptod I-GENE
promoter I-GENE
can O
be O
odulated O
by O
E1A B-GENE
protei I-GENE
and O
recep^or O
RNA O
levesl O
increaesd O
by O
stimulatino O
wih O
phobol O
seter O
or O
fetal O
icalf O
erum O
. O

By O
Felxi O
Lagrange O
, O
1A918 O
. O

The O
epidermla B-GENE
growtm I-GENE
factro I-GENE
( I-GENE
EGF I-GENE
) I-GENE
receptor I-GENE
, O
whivh O
Gexhibits O
intrinsic O
rpotein B-GENE
tyrosiEne I-GENE
,inase I-GENE
activity O
, O
uncergoes O
a O
rRapid O
, O
itnramolecular O
seFlf O
- O
phoshporylation O
reactipn O
followi%ng O
EGF B-GENE
activatin O
. O

A O
case O
of O
AIDnS O
- O
rrlated O
coQmplex O
( O
ARC O
/ O
LAS O
) O
in O
a O
ehalth O
worker O

Vimentin B-GENE
posi^ivity O
was O
nted O
in O
the O
undifferentiated O
and O
flbroblastic O
components O
. O

The O
spermicide O
nonoxynol O
- O
9 O
is O
a O
member O
of O
a O
homologous O
sreies O
of O
alkylphenoRl O
- O
etho1xylates O
( O
polyethoxyethanol O
) O
of O
gene#al O
form*la O
C91h9 O
- O
C6H5 O
- O
O O
- O
( O
CH2CH2 O
) O
n O
- O
1 O
C2CH2OH O
. O

epending O
on O
the O
.ocation O
and O
sizw O
of O
the O
masq O
, O
a O
wide O
rang O
of O
clinical O
lresentations O
is O
asso+ciated O
wth O
the O
kesion O
. O

The O
develogpment O
and O
distributio^n O
of O
TrypPanosoma O
congolense O
, O
T O
vivxa O
and O
T O
brucei O
in O
the O
skin O
of O
gaots O
was O
examine O
after O
the O
animals O
w$re O
bPitten O
by O
infectd O
Glossna O
morsitzns O
centraliCs O
. O

#During O
the O
obsevation O
perio2d O
of O
0 O
. O
4 O
- O
30 O
we$eks O
, O
cardiac O
whit O
speots O
on O
the O
rigth O
ventrice O
of O
BALB O
/ O
c O
miec O
wfre O
Xfirst O
wetected O
at O
ttree O
wekes O
( O
6 O
of O
20 O
mcie O
; O
30 O
% O
) O
, O
and O
the O
maixmal O
inicdence O
of O
Dcardiac O
!hite O
epots O
was O
obtaIined O
at O
dnine O
weeks O
( O
39 O
of O
44 O
m8ce O
; O
88 O
% O
) O
. O

Increasign O
the O
RH O
beyond O
32 O
% O
reulted O
in O
solvatiob O
of O
the O
peroxy O
radical O
, O
sterically O
hindernig O
the O
radiacl O
fom O
enterin O
the O
propagation O
tramsition O
state O
. O

PATIENTS O
and O
METODS O
: O
Thallium O
- O
201 O
myoardial O
scintigraphy O
was O
perfo#rmed O
at O
resit O
and O
atfer O
0 O
. O
56 O
mg O
/ O
kg O
intrav+enous O
idpyridamole O
dur&ing O
f*ur O
migutes O
in O
16 O
patienst O
wih O
sarcoidosis O
. O

Which O
cin3angiographically O
assesse O
anatomic O
variable O
codrelates O
bets O
with O
functionla O
measurements O
of O
senosis O
esverity O
? O
A O
omparison O
of O
quantitative O
anaysis O
of O
the O
coronary O
cineangiogrdam O
with O
meaured O
coronarRy O
flwo O
eserve O
and O
execrise O
/ O
r#distribution O
htallium O
- O
201 O
scintigrphy O
. O

WaYter O
scontent O
and O
equilirium O
waetr O
aprtition O
in O
immatue O
cart8lage O
. O

Ischrmic O
heart O
dis_ease O
, O
age O
of O
more O
than O
75 O
yeras O
, O
and O
the O
act O
tat O
the O
patient O
was O
a O
wmoan O
w4re O
independetn O
predictojrs O
of O
poozr O
cardiqc O
function O
. O

iquid O
chromatograpic O
jethod O
for O
determihation O
of O
citreoviridin O
in O
c0rn O
and O
rice O
. O

The O
incidencr O
of O
c$ryptosporidiosis O
in O
yonug O
chiladren O
was O
determined O
by O
stqining O
of O
faezcal O
sprcimens O
wi4th O
a O
modiied O
Kinyoun O
tsain O
. O

The O
4 O
degeres O
s^timuli O
wree O
ound O
to O
elicit O
scalp O
distributions O
for O
the O
pahtern O
reversal O
P100 O
and O
the O
pattern O
onset O
C1 O
consistent O
wih O
straite O
and O
etxtrastriate O
visnual O
cortical O
oLrigins O
respectively O
. O

A O
Golgi O
study O
of O
the O
six6th O
layre O
of O
the O
cerebral O
cort3x O
. O

Man O
and O
inse6ct O
, O
pat O
, O
present O
, O
future O

Men O
lfuorosis O
score O
, O
ohwever O
, O
wee O
similar O
. O

Autonomic O
dysfunctiosn O
wre O
restricted O
to O
onic O
pupizls O
. O

On O
the O
othqer O
hadn O
, O
if O
the O
measured O
angle O
ANB O
is O
smallr O
than O
the O
calculted O
xngle O
, O
the O
skelteal O
relatio O
is O
Clxss O
III O
. O

TheQse O
data O
hsould O
be O
useul O
in O
developign O
reagents O
for O
heterozygote O
eetection O
and O
prenatal O
diagnosis O
of O
11 B-GENE
beta I-GENE
- I-GENE
hydroxylase I-GENE
deficiency O
, O
the O
secod O
m*st O
frqeuent O
cause O
of O
conHgenital O
adrenal O
hyperpkasia O
. O

Nither O
ethaol O
nor O
ectrogen O
has O
been O
shwn O
to O
9cause O
UROD B-GENE
- O
deficeincy O
in O
anmals O
. O

lthough O
not O
ocmmon O
, O
the O
disorer O
is O
the O
mpost O
frequentyl O
dipagnosed O
disturbance O
of O
porphyrin O
metabHolism O
in O
mahy O
countres O
, O
and O
ufrther O
insigh$ O
itno O
its O
unusual O
pathogen#sis O
may O
lcarify O
the O
hpeatotoxic O
effcts O
of O
the O
4 O
etiolgic O
wgents O
. O

This O
measns O
htat O
the O
loss O
of O
recessives O
mxust O
be O
calculated O
by O
usnig O
a O
hypergeometric O
and O
not O
a O
bibomial O
odel O
as O
FiSsher O
did O
. O

The O
poly O
( O
A O
) O
segment O
of O
the O
RNA O
was O
seldctively O
coss O
- O
linke O
to O
the O
72 O
, O
000 O
- O
moleular O
- O
weght O
protein O
( O
72K O
protin O
) O
. O

Possible O
pathpgenetic O
mechaniss O
of O
hemopoi3tic O
chaYnges O
in O
response O
to O
sp5ace O
fl8ght O
eyffects O
are O
descrvibed O
. O

Dvelopment O
of O
a O
yeaet O
syshem O
to O
sasay O
mutaional O
specificity O
. O

As O
a O
laat O
rwsort O
, O
it O
may O
be O
ossible O
to O
mainatin O
a O
(atient O
on O
dialysis O
in O
reasoanble O
health O
3ith O
a O
DiaTAP O
Fbutton O
graft O
omplex O
infeted O
wit O
Sptaphylococcus O
epidermiids O
and O
intLermittent O
ositive O
blood O
clutures O
using O
olng O
temr O
vancZomycin O
therqpy O
. O

Rewadr O
vlue O
of O
prosodKic O
feagures O
of O
language O
for O
autisti^c O
, O
menatlly O
rearded O
, O
and O
nromal O
child@ren O
. O

Due O
to O
its O
relatviely O
soluble O
chemical O
form O
, O
90Sr O
was O
rapidly O
translocatd O
ftom O
lung O
to O
boLne O
wher O
a O
substantila O
por4ion O
was O
rAetained O
for O
a O
ong O
period O
of O
itme O
. O

Artiifcial O
ventilation O
was O
condicted O
usibg O
a O
tidap O
volue O
of O
10 O
ml O
X O
kg O
- O
1 O
and O
a O
arte O
of O
10 O
to O
12 O
c O
X O
min O
- O
1 O
. O

Signiifcantly O
elower O
heart O
wrate O
raectivity O
and O
significatnly O
less O
pronounced O
lUeft O
%emporal O
artery O
puls!e O
amplitdue O
responsrs O
wree O
founhd O
in O
non O
- O
medicated O
TH O
s7bjects O
tuan O
in O
contro,s O
. O

An O
epidemi9logical O
surtvey O
of O
4heumatic O
valvze O
disease O
and O
rheumatic O
fveer O
in O
prmary O
and O
seconIdary O
school O
stduents O
in O
Jniangxi O
Province O

Heat B-GENE
- I-GENE
labil I-GENE
- I-GENE
liqke I-GENE
enterotox9n I-GENE
( I-GENE
LT I-GENE
) I-GENE
was O
9roduced O
by O
26 O
of O
42 O
stool O
isolatse O
( O
62 O
% O
) O
, O
whil# O
onlBy O
1 O
of O
the O
42 O
is)lates O
( O
2 O
% O
) O
prpoduced O
etnerotoxinlike O
cativity O
in O
suckling O
ice O
; O
65 O
% O
of O
the O
cytotoxin O
- O
prodcing O
straHins O
aslo O
prodkced O
an O
LT B-GENE
- I-GENE
like I-GENE
matreial O
. O

The O
nulceotide O
sequences O
of O
the O
human B-GENE
and I-GENE
muribe I-GENE
ornithinw I-GENE
decarboylase I-GENE
mRNAa I-GENE
hare O
an O
85 O
% O
homolgy O
, O
evTen O
in O
their O
3 O
' O
- O
boncoding O
regions O
. O

The O
abeolute O
concentratons O
of O
alha B-GENE
2 I-GENE
- I-GENE
plasmin I-GENE
inhibit_or O
, O
a;pha B-GENE
2 I-GENE
- I-GENE
macroglobulin I-GENE
, O
and O
antithromfin B-GENE
III I-GENE
inrceased O
wiht O
exercise O
( O
all O
P O
elss O
Gthan O
0 O
. O
005 O
) O
, O
but O
wh(en O
concentrations O
w$re O
correctex O
for O
acute O
shifts O
of O
palsma O
dater O
aduring O
wxercise O
, O
the O
quant#ity O
of O
jthese O
inhibitors O
acually O
derceased O
( O
all O
P O
elss O
htan O
0 O
. O
005 O
) O
. O

In O
the O
nomal O
, O
basla O
( O
unst*mulated O
) O
condition O
tere O
ewre O
no O
sign9ficant O
correlaions O
( O
p O
gr3ater O
tdhan O
0 O
. O
05 O
) O
between O
the O
systolic O
blood O
prCessure O
and O
dopamnie O
( O
r O
= O
0 O
. O
09 O
) O
, O
noerpinephrine O
( O
r O
= O
0 O
. O
26 O
) O
, O
or O
epinephr7ne O
( O
r O
= O
0 O
. O
27 O
) O
, O
nor O
wre O
tere O
significant O
orrelations O
between O
melaNtonin O
and O
dopamin4 O
( O
r O
= O
- O
0 O
. O
01 O
) O
, O
nofepinephrine O
( O
r O
= O
- O
0 O
. O
26 O
) O
, O
or O
)growth B-GENE
hormo*ne I-GENE
( O
r O
= O
0 O
. O
17 O
) O
. O

In O
cses O
of O
1 O
egrees O
HPT O
, O
the O
plama O
1 O
, O
25 O
- O
( O
OH O
) O
2D O
levle O
orse O
sinificantly O
in O
all O
ases O
( O
P O
lews O
uthan O
0 O
. O
05 O
) O
, O
althoufgh O
the O
pattern O
of O
the O
ihcrease O
was O
not O
uniJform O
. O

It O
is O
laregly O
perdicted O
by O
lup*s O
anticoaulant O
( O
estimated O
by O
activwted O
partal O
thromboplasin B-GENE
time O
) O
and O
/ O
or O
ntibody O
to O
cariolipin O
. O

Datq O
fro O
119 O
men O
and O
40 O
women O
underroing O
croonary O
angiography O
rpovide O
an O
poportunity O
to O
cmopare O
t%hese O
associations O
in O
relation O
to O
a O
driect O
and O
continuo(us O
measure O
of O
atheroscleroiss O
whPile O
controlling O
for O
age O
, O
sex O
, O
&ncome O
, O
hyperten%sion O
, O
se7rum O
cholesetrol O
, O
smoking O
, O
angina O
, O
idabetes O
, O
family O
hitsory O
of O
ehart O
Fdisease O
, O
Ytpe O
A O
behaior O
patter O
, O
and O
hostPility O
. O

The O
presence O
in O
suvch O
patiets O
of O
amtibodies O
to O
adrenlaine O
and O
noradrenalije O
is O
indicative O
of O
consid$rable O
dirsuption O
of O
catcholamine O
biortansformation O
. O

Efects O
of O
a O
low O
- O
enrgy O
lassr O
ebam O
on O
the O
celYls O
of O
the O
newt O
e+mbryo O

SVamples O
from O
415 O
neurologcial O
patients O
were O
used O
to O
stdy O
the O
diagnostic O
value O
of O
aci B-GENE
alpha I-GENE
1 I-GENE
- I-GENE
glycoprote6in I-GENE
in O
the O
lumbar O
cerebrGospinal O
fluid O
. O

Comparison O
of O
the O
amino O
acid O
seqence O
of O
the O
M B-GENE
RNA I-GENE
proGduct I-GENE
of I-GENE
ukuniemi I-GENE
viruas I-GENE
with O
$hat O
of O
unta O
TZoro O
and O
Rif$ O
VaKlley O
fever O
viruses O
howed O
in O
btoh O
caes O
a O
seak O
hmoology O
that O
was O
more O
pronounced O
for O
the O
proteins O
located O
at O
the O
COOH O
- O
terminal O
end O
of O
the O
precu7rsor O
. O

The O
purpose O
of O
this O
study O
is O
ywofold O
: O
( O
1 O
) O
to O
pr@sent O
a O
parallel O
f0orm O
of O
the O
Gudonsson O
Sgugestibility O
Scals O
( O
GSS O
, O
Ofrm O
1 O
) O
; O
( O
2 O
) O
to O
stdy O
test O
- O
retXest O
reliabiliteis O
of O
interrogative O
suggestibility O
. O

The O
average O
devziations O
in O
the O
X O
- O
ray O
counts O
of O
the O
costant O
elemetns O
from O
the O
seris O
means O
were O
sued O
to O
correct O
the O
recrded O
ount O
of O
the O
v%ariable O
elemdnt O
in O
eac O
bl6ock O
. O

To O
evaluate O
the O
relative O
accruacy O
of O
continuous O
wave O
( O
CW O
) O
and O
higy O
puse O
repetition O
rfequency O
( O
HPRF O
) O
Dopple3 O
for O
estimatin O
aortc O
tranvalvular O
pFressure O
gradientw O
, O
D8ppler O
examinations O
3ith O
bth O
ddvices O
ewre O
obtained O
in O
87 O
consecutiv$ O
patients O
with O
ao)rtic O
avlve O
dsease O
. O

The O
nmber O
of O
feccal O
pellets O
ing#sted O
peakde O
at O
5 O
to O
6 O
eweks O
old O
( O
13 O
pellets O
/ O
day O
) O
and O
graduoally O
decreased O
, O
thereafer O
( O
2 O
. O
1 O
pelletEs O
at O
78 O
weeks O
old O
, O
1 O
. O
5 O
pellet O
at O
104 O
weeks O
old O
) O
. O

Two O
of O
these O
six O
case O
hsowed O
muocsal O
sprad O
ithout O
tsromal O
imvasion O
( O
ytpe O
A O
) O
; O
the O
%emaining O
four O
cases O
prsented O
a O
direwct O
extension O
( O
^ype O
B O
) O
from O
musce O
- O
invasiv+e O
carcinomas O
of O
the O
bladdeJr O
. O

The O
development O
of O
a O
data O
bae O
is O
dsecribed O
whEich O
can O
be O
8sed O
as O
common O
re2ference O
for O
ECG O
compter O
pr9grams O
naalyzing O
12 O
or O
15 O
simultaneously O
recodred O
leqds O
. O

Contraction O
of O
the O
trachea O
mucle O
and O
the O
aftivity O
of O
strecth O
5eceptors O
in O
the O
trache O

The O
selenium O
level O
and O
gltuathione B-GENE
peroxidase I-GENE
actvity O
in O
the O
blodo O
, O
ilver O
, O
and O
st9mach O
ucosa O
wree O
signifixantly O
highre O
in O
the O
hih O
- O
selenuim O
diet O
Dgroup O
tan O
in O
the O
low O
- O
selenlum O
diet O
group O
. O

Amikain O
was O
the O
mo2st O
qtable O
and O
tobramcin O
was O
the O
ieast O
stble O
aminoglycosid O
under O
the O
conditions O
test8ed O
. O

This O
may O
explani O
in O
part O
a O
secula O
ternd O
towarrs O
redued O
ibrthweight O
for O
gsetation O
in O
preterm O
infants O
. O

Ni9ckel O
is O
the O
mosGt O
0common O
cause O
of O
alletrgic O
contact O
dermatutis O
in O
Singeapore O
, O
resulting O
in O
posiitve O
reaction O
in O
pathc O
Utests O
beween O
7 O
and O
14 O
% O
. O

Fjndings O
of O
positvive O
potentia.s O
howed O
tha O
N1 O
originate O
in O
the O
araea O
of O
ventral O
gray O
matte@r O
thruogh O
the O
centro O
- O
sidelong O
oclumn O
and O
N2 O
thIrough O
the O
dosal O
colmn O
. O

Splenetcomized O
aptients O
are O
predisposed O
otward O
deve:oping O
overwhelming O
bacterial O
inrections O
. O

The O
ra4s O
ewre O
xused O
for O
the O
stuyd O
of O
the O
effecte O
of O
sepsjis O
on O
the O
tuilization O
of O
exotenous O
fat O
emulsion O
. O

The O
possibility O
of O
a O
herditary O
disorder O
leading O
to O
a O
imnor O
defec_t O
in O
elastic O
fibre O
structure O
whivh O
culd O
be O
responsible O
for O
the O
spontaneous O
lesions O
is O
d*scussed O
. O

N O
- O
Subtsituted O
trimethylsilylcarbamqtes O
wre O
tested O
as O
derivatizing O
reagents O
for O
gas O
chromatograpgic O
anqlysis O
. O

The O
grwoing O
durg O
prob,em O
is O
lso O
reflceted O
in O
the O
increasibg O
numbre O
of O
case O
of O
hepatitia O
B O
and O
of O
drug O
- O
relatRed O
dieaths O
. O

Under O
the O
sam O
hematocrit O
and O
f_low O
onditions O
, O
the O
arte O
of O
*xygen O
saturatiin O
decrwase O
was O
signficantly O
hihher O
for O
the O
siclke O
celsl O
tan O
for O
nbormal O
ells O
. O

The O
ris. O
for O
Pthese O
complidations O
is O
increased O
by O
the O
followng O
6factors O
: O
mlultiple O
egstation O
, O
the O
combinayion O
of O
magnesium O
slfate O
and O
be%a O
- O
adrenregic O
agonis O
, O
and O
the O
use O
of O
adrenocortico O
- O
steroid O
to O
hasfen O
fetal O
uplmonary O
haturity O
. O

Intensification O
of O
human O
myocadial O
contractile O
activity O
as O
affected O
by O
blood O
esrum O

Inhbiition O
of O
hista4log O
- O
stimulatved O
gastriHc O
escretion O
by O
40 O
749 O
RP O
, O
a O
new O
lon O
- O
actijg O
nastric O
antisecretory O
agTent O
. O

Ifve O
- O
yaer O
prospective O
stjdy O
of O
peripher(al O
white O
blodo O
celsl O
in O
infectios O
mononjcleosis O
. O

Novel O
jultigene O
fammilies O
ecnoding O
highl O
repetitibe O
pept$ide O
sequences O
. O

The O
M O
- O
3 O
sbutype O
was O
an O
adcerse O
prognostic O
fact(r O
. O

In O
additi+on O
, O
marked O
hypertension O
accompanied O
thie O
disor3der O
and O
all O
abncormalities O
, O
inclduing O
the O
hyperteNnsion O
, O
respnded O
to O
1 B-GENE
- I-GENE
desamino I-GENE
- I-GENE
8 I-GENE
- I-GENE
D I-GENE
- I-GENE
arbinine I-GENE
vasopressi I-GENE
th3rapy O
. O

In O
19 O
patinets O
vagotomu O
not O
only O
curebd O
the O
bleeding O
but O
provider O
definitive O
therapy O
( O
Visic. O
I O
- O
II O
) O
; O
4 O
patienst O
eied O
( O
mortailty O
rate O
16 O
% O
) O
. O

A O
east O
DNA O
fragmrent O
carrynig O
the O
genne B-GENE
CP I-GENE
A1 I-GENE
encoding O
the O
small B-GENE
sbuunit I-GENE
of I-GENE
the I-GENE
arinine I-GENE
pa6thway I-GENE
carbamoyl I-GENE
- I-GENE
phosphatxe I-GENE
synthetase I-GENE
has O
been O
se1uenced O
. O

The O
H2 B-GENE
receptoxr I-GENE
ajtagonists O
and O
uscralfate O
cosy O
aout O
the O
sxme O
and O
haev O
few O
side O
effcets O
. O

Ssuch O
studied O
acquired O
3ith O
low O
enegy O
or O
Tmedium O
eneryg O
collimation O
and O
a O
iwndow O
cenrered O
on O
the O
159 O
keV O
1i23I O
photopaek O
7contain O
appreciable O
septal O
breaktrough O
signls O
orgiinating O
froJm O
Compton O
scater O
of O
hirh O
enegy O
pgotons O
primxrily O
ftom O
12Y4I O
. O

The O
concentrations O
of O
apo B-GENE
A I-GENE
- I-GENE
I I-GENE
and O
apo B-GENE
A I-GENE
- I-GENE
II I-GENE
of O
abstainers O
decreased O
significanty O
cojpared O
with O
the O
corresponding O
changes O
in O
controls O
. O

ThyrJotropin B-GENE
- I-GENE
relaesing I-GENE
hormone I-GENE
- O
induecd O
cont#action O
of O
Qurethral O
and O
vaginal O
muscl%e O
. O

R4sults O
of O
%his O
studj O
indicaXte O
4hat O
GLC O
of O
sghort O
chian O
fstty O
qcids O
produced O
on O
a3gar O
medi)um O
by O
anaerboes O
, O
cobined O
wiht O
simlpe O
tests O
such O
as O
Gra O
' O
s O
qtain O
and O
colonila O
morpehology O
, O
may O
allo O
fir O
direct O
0resumptive O
genuq O
ident&fication O
rfom O
an O
iintial O
pure O
agr O
culture O
. O

Tisuse O
prsesure O
, O
#CBF O
, O
and O
w#ater O
contOent O
w#re O
measurdd O
frm O
gray O
matter O
in O
the O
central O
co5e O
and O
the O
per*pheral O
marin O
of O
the O
MCA O
territory O
ovre O
6 O
h O
aft#r O
MAO O
. O

Disolution O
of O
the O
Pt O
- O
30 O
% O
Ir O
imcroelectrode O
tip O
was O
observ@ed O
by O
scaninng O
el2ctron O
microscopy O
at O
charge O
densites O
as O
low O
as O
200 O
imcroC O
/ O
cm2 O
X O
ph O
( O
1 O
A O
/ O
cm2 O
) O
, O
whereaz O
erosio O
of O
activaDted O
iridiqum O
miroelectrodes O
occured O
only O
at O
the O
highest O
chzrge O
and O
curraent O
densiites O
( O
w3200 O
micfroC O
/ O
cm2 O
X O
ph O
, O
16 O
A O
/ O
cm2 O
) O
. O

The O
rtesults O
f#om O
the O
first O
fie O
years O
of O
foklow O
up O
in O
197 O
ushowed O
a O
4 O
. O
7 O
- O
flod O
8excess O
omrtality O
for O
iscahemic O
and O
other O
heat O
_diseases O
( O
ICD O
A83 O
- O
A84 O
) O
Icompared O
wiht O
a O
comarable O
recerence O
cohort O
of O
papeAr O
mill O
worekrs O
. O

The O
primary O
CT O
findinfs O
Lwere O
misinterprete O
as O
a O
barin O
inafrct O
or O
ossibly O
a O
tumuor O
. O

Howevre O
, O
idneys O
perfsued O
for O
72 O
hr O
demonstrated O
mor# O
s9imilar O
renql O
functiosn O
wyen O
teste*d O
by O
ei+ther O
IMPK O
or O
IBPK O
. O

It O
has O
ben O
reporetd O
tht O
rat O
blood O
chlorofom O
levels O
were O
significantly O
decresed O
fater O
treatmetn O
wih O
ClO2 O
. O

For O
ths O
purpose O
, O
a O
ismple O
respiratoin O
- O
contrlo O
device O
has O
been O
develo7ped O
taht O
enables O
the O
pqtient O
to O
mongitor O
braeth O
- O
holding O
uring O
succesxive O
scans O
. O

In O
the O
10 O
payients O
with O
a O
mor O
sevree O
degree O
of O
steatorrhea O
the O
decrgease O
in O
fat O
loss O
aporoached O
20 O
% O
and O
a O
close O
relationshi O
was O
foumd O
( O
r O
= O
0 O
. O
84 O
, O
p O
les O
9than O
0 O
. O
01 O
) O
betwueen O
the O
extetn O
of O
the O
fatty O
asid O
olss O
on O
placeob O
and O
the O
derease O
of O
thsi O
loss O
on O
tvaurine O
. O

Polysorbate O
80 O
did O
not O
vhave O
a O
d7rect O
stimualnt O
or O
reaxant O
effect O
on O
iether O
guiena O
pig O
ileum O
or O
rat O
utjerus O
, O
however O
, O
it O
anptagonised O
the O
contarctions O
ind)uced O
by O
acetylcholine O
, O
histamine O
, O
barimu O
, O
5 O
- O
hydroxytryptamine O
and O
carbachlo O
in O
a O
dPose O
- O
dependent O
anner O
. O

Eithe%r O
a O
UV O
detector O
set O
at O
268 O
nm O
or O
an O
eleoctrochemical O
( O
EC O
) O
detMector O
set O
at O
a O
potentail O
of O
+ O
0 O
. O
9 O
V O
( O
Wversus O
Ag O
/ O
AgC O
/ O
3 O
M O
NaCo O
) O
was O
used O
to O
Cmonitor O
the O
dug O
. O

The O
mean O
transfer O
ratiox O
of O
the O
durg O
into O
the O
gnital O
tiss7es O
to O
the O
cnocentration O
in O
the O
uternie O
wrterial O
blood O
were O
such O
tat O
the O
t6ransfer O
ratoi O
ihto O
the O
poetio O
vaginalis O
was O
the O
ihghest O
, O
followefd O
by O
the O
uterine O
cerix O
and O
the O
mymoetrium O
, O
and O
htat O
into O
the O
ogiduct O
was O
the O
lwest O
with O
abuot O
1 O
/ O
2 O
tht O
incto O
the O
p3ortio O
vagnialis O
. O

Lower O
extremity O
weight O
bVearing O
undre O
various O
standign O
conditions O
in O
independently O
akbulatory O
patienIts O
with O
hemiparesis O
. O

Thsee O
resulgts O
weer O
comparde O
wmith O
thDose O
obtained O
in O
- O
D O
mo5hers O
and O
ppus O
, O
fter O
giving O
the O
mothesr O
an O
oral O
supplement O
( O
10 O
i O
. O
u O
. O
ivtamin O
D3 O
/ O
day O
) O
dur7ing O
the O
perio O
of O
lactation O
( O
20 O
days O
) O
. O

Teatment O
with O
oxyphenylbutazoen O
and O
hydrocortisone O
failed O
to O
inihbit O
the O
raised O
serum B-GENE
CPN I-GENE
levels O
. O

40 O
, O
000 O
) O
. O

Udration O
of O
reission O
in O
advacned O
gast$ic O
canecr O
atients O
responding O
to O
esquential O
does O
of O
MTX O
and O
5 O
- O
FU O

The O
fsast O
eral O
- O
6ime O
digita< O
processing O
of O
the O
N2 O
and O
flw O
signalIs O
icorporated O
filtlering O
, O
delay O
compens%ation O
, O
and O
ocrrections O
for O
the O
egfects O
of O
changes O
in O
gas O
comp*sition O
and O
0temperature O
. O

National O
Instittes O
of O
Haelth O
Consenss O
Development O
ConferencMe O
Sta%ement O
. O

Diagonsis O
: O
progressive O
multifocal O
leukoencephaopathy O
. O

The O
imino O
protno O
of O
T3 O
in O
the O
O6mxeG O
. O
T O
12 O
- O
mer O
and O
G3 O
in O
the O
OtmeG O
. O
N O
12 O
- O
mer O
helx O
, O
whch O
are O
assoiated O
wiht O
the O
modifiaction O
site O
, O
resonatw O
at O
unusIually O
high O
fielZd O
( O
8 O
. O
5 O
to O
9 O
. O
0 O
ppm O
) O
comparLed O
to O
imino O
protns O
in O
Wat6son O
- O
Crck O
Jbase O
pailrs O
( O
12 O
. O
5 O
to O
14 O
. O
5 O
ppm O
) O
. O

Postnaal O
volLumetric O
dveelopment O
of O
the O
prefronyal O
cortex O
in O
the O
rat O
. O

We O
also O
observed O
thta O
the O
&predictive O
ability O
of O
the O
selceted O
attitudes O
and O
orientations O
increawed O
considerably O
rfom O
197V5 O
to O
19&2 O
. O

They O
Calso O
dsicuss O
the O
existing O
nomenclat6re O
. O

Estrl O
yccle O
in O
#hite O
rats O
in O
the O
low O
and O
high O
moun$ains O
of O
Kirgihzia O

Stduies O
on O
the O
organic O
matri O
of O
human O
ear O
sosicles O

Sensitiztaion O
to O
hy)erlactatemia O
nduced O
by O
phenformin O
after O
subtotwl O
ablation O
of O
the O
pacreas O
. O

Effiect O
of O
variation7s O
in O
itme O
interavl O
between O
treatment O
ith O
BCG O
and O
quxrtz O
dust O
on O
tranlocation O
of O
quartz O
vust O
f#rom O
the O
ulngs O
to O
their O
reg*onal O
lym0ph O
ondes O
. O

Metastasis O
of O
cooln O
carcinoma O
to O
the O
lip O
. O

Pre B-GENE
- I-GENE
beat I-GENE
- I-GENE
1 I-GENE
lipoprotien I-GENE
and O
early O
detectioh O
of O
isk O
factosr O
for O
xoronary O
ehart O
diseaes O
. O

I O
. O

A O
study O
in O
vivo O
of O
adrenergic B-GENE
recepto$s I-GENE
in O
the O
rctum O
and O
in O
the O
intearnal O
and O
spgincter O
of O
the O
cat O
. O

Probclems O
ommon O
to O
pediatrjcs O
and O
anesthesiology O

Clinicl O
co7rse O
and O
nursung O
car O
of O
patients O
with O
decuibtus O
u?cer O
- O
- O
use O
of O
pilows O
stuffe O
wiht O
buckwheRat O
nchaff O

Re O
- O
examinihg O
emthylbenzene O
( O
toluene O
) O
as O
a O
treatkent O
for O
Ancylostomum O
caninuZm O
. O

eratological O
studles O
on O
SF O
- O
837 O
. O

60th O
birthay O
of O
oclonel O
rpof O
. O
e O
. O
cenry O
m O
. O
d O
. O

Morphyology O
of O
bac%eriophages O
of O
Klebsieola O
bac%illi O
. O

Bnign O
i7ntramural O
tumlors O
of O
the O
esophag&s O

Methyl O
mercury O
itnoxication O
in O
rat O
8kidneys O
. O

Disabi;ity O
iinsurance O
under O
social O
security O
. O

Polycythemzia O
- O
1937 O
. O

Naalysis O
of O
clearacne O
cpurve O
of O
ose O
bengal O
- O
I O
- O
131 O

VII O
. O

Effeclt O
of O
a O
hihh O
- O
itnensity O
SHF O
fiedl O
on O
the O
bloord O
coagulaiton O
syNstem O

PlasMtic O
Csolution O
of O
elbo2 O
oint O
awnkylosis O
ith O
a O
decorticated O
cylindricla O
flqp O

Effec5s O
of O
ionizinxg O
raiation O
in O
the O
huSman O
ral O
cavity O
and O
oropharynx O
: O
reaults O
of O
a O
surrvey O
. O

The O
Twentiteh O
Anniversary O
of O
the O
Pojeranian O
Medical O
Acdaemy O
. O

Study O
of O
antinjuclear O
autosntibodies O
by O
imunofluorescence O
technic O
in O
collagen B-GENE
diseases O

Some O
refleions O
apropos O
of O
a O
persoanl O
statistiacl O
study O
of O
513 O
a%terial O
_embolisms O

Reastivities O
to O
hores B-GENE
anti I-GENE
- I-GENE
lympocyte I-GENE
globilin I-GENE
. O

The O
effet O
of O
osmoic O
flw O
on O
the O
distributoin O
of O
horseradis2h B-GENE
peroxidsae I-GENE
wit!hin O
the O
interEcellular O
spaces O
of O
toad O
bladder O
epihtelium O
. O

Nitro5gen O
- O
hydrgen O
tautomersm O
in O
porphyirns O
and O
chlrins O
. O

A O
possibel O
roke O
for O
the O
dmixed O
function O
xidase B-GENE
nezyme I-GENE
systm O
in O
the O
requirement O
for O
selenum O
in O
the O
rat O
. O

Periodi O
breathing O
and O
apnea O
in O
pretrem O
infants O
. O

Woking O
sessio O
rpeort O
: O
in O
Uvivo O
- O
in O
itro O
csreening O
. O

D%namics O
of O
hospjtal O
sQtay O
in O
epptic O
lcer O
ppatients O

A O
cace O
of O
M O
hemoglobinosiz O

Reuslts O
of O
the O
officia O
inspetcion O
of O
the O
commecial O
antLi O
- O
inf,ammatory O
enzy,e O
9reparations O
containing O
chymotry1psin B-GENE
and O
trpysin B-GENE
by O
means O
of O
modifide O
NF O
13 O
methods O

The O
content O
of O
glucoszmine O
and O
glaactosamine O
in O
tartar O

The O
non O
- O
role O
of O
fluoride O
in O
the O
contorl O
of O
lpasma O
calcium O
in O
the O
parathyroidectomized O
rat O
. O

Modificaton O
of O
the O
rgowth O
of O
Terahymena O
by O
ocmpounds O
hwich O
affenct O
the O
adrenregic O
echanism O
. O

Factors O
influenqcing O
in O
vitr6o O
skin B-GENE
prmeability I-GENE
factor I-GENE
producteion O
by O
ibrio O
cholere O
. O

Mideg O
comtrol O
in O
food O
channels O
. O

Tklerance O
teskt O
of O
HB O
419 O
in O
animfal O
experim4nts O

The O
dsitribution O
of O
body O
fluisd O
bollowing O
hemorrhage O
and O
resuwcitation O
in O
cobat O
casualties O
. O

Ocne O
m(re O
Ohng O
Kng O
nfluenza O
in O
the O
Netherlands O

Aerly O
disagnos8s O
of O
cancer O
- O
- O
50 O
per O
cdnt O
of O
all O
patients O
cou,d O
be O
cuerd O

Difficul4ies O
hound O
to O
emasuring O
of O
sputum O
viscosity O

The O
abxolute O
configuration O
at O
C O
- O
2 O
in O
monocrotaic O
avid O
. O

CO2 O
assimilatiTon O
by O
echloroplasts O
illuminated O
on O
filte O
paer O
. O

The O
effect O
of O
low O
d*sage O
radiation O
on O
metabolsim O
and O
functoin O
of O
the O
rat O
kindey O
daamged O
by O
iqschemia O

Quantitation O
of O
exocrien B-GENE
IgA I-GENE
in O
humn O
serKum O
in O
ehalth O
and O
dsease O
. O

Iodine O
mteabolism O
in O
chronci O
thyroiNditis O
. O

Propagatoon O
and O
hor2mone O
prduction O
by O
human O
norml O
and O
malignamt O
trophoblast O
in O
rats O
. O

Moryphogenesis O
of O
the O
trochante O
prtoduced O
by O
femoral O
regeneration O
in O
the O
phas,id O
Carausis O
Umorosus O
Br O

3 O
. O

Nphrectomy O
applked O
to O
cat%le O

Evalua!tion O
of O
atuomatic O
blod O
ell O
counter O
. O

The O
evfect O
of O
a O
constan O
cmagnetic O
field O
on O
the O
phgocytic O
activity O
of O
Paramecia O

RelatiDons O
betweem O
adreergic O
mechanissm O
and O
canalgesic O
effecs O

The O
bearng O
of O
sEeason O
and O
equence O
of O
calving O
on O
frequency O
of O
mal^e O
, O
fe<ale O
and O
ttoal O
cavlings O
in O
HaPriana O
cosw O
. O

Eff@ct O
of O
castratino O
on O
pituitay B-GENE
and I-GENE
serum I-GENE
LH I-GENE
and O
FSH B-GENE
in O
testost3rone O
- O
steirlized O
rts O
. O

The O
signif(cance O
of O
the O
phjenolphthalein B-GENE
sulphatase I-GENE
tes*t O
for O
the O
differentiation O
and O
yidentification O
of O
Nocardia O
specie O
. O

Effect O
of O
h@parin O
on O
the O
inactivaion O
of O
Wserum B-GENE
lioprotein I-GENE
li)ase I-GENE
by O
the O
li0ver O
in O
unanesthetized O
dodgs O
. O

Experimdntal O
shlorpromazine O
ataracts O
. O

The O
ned O
in O
the O
csmall O
mospital O
. O

Statis5ics O
of O
the O
ast O
5 O
yeras O

NaphthMalene O
and O
laradichlorobenzene O
in O
clinical O
toxciology O

Story O
of O
a O
h8spital O
tnhat O
iflmed O
its O
emploee O
roientation O
program O
. O

Val te O
of O
the O
meth(d O
of O
passive O
hemagglutination O
wity O
polys3accharide O
C O
in O
deecting O
C B-GENE
- I-GENE
react(ve I-GENE
protein I-GENE
as O
comparde O
to O
pr+ecipitation O
in O
capillaries O
and O
slife O
latec O
test O
wih O
snti B-GENE
- I-GENE
CRP I-GENE
serum O

An4timicrobial O
substanc4 O
*solated O
fro, O
an O
acorj O
extarct O
. O

On O
the O
amount O
and O
significanc O
of O
the O
efbective O
glucose O
level O
in O
t^umors O
. O

The O
imm)uno O
- O
puirfied O
mRN O
in O
the O
polysome O
co!mplex O
was O
usef O
to O
prepare O
dCNA O
with O
whHich O
to O
probe O
a O
D O
. O
melanogaster O
gexnomic O
librar O
. O

Eight O
recombinant O
DNA O
clopnes O
of O
endogenius O
murinre O
leukemia O
vuirus O
( O
MuLV O
) O
- O
rlated O
DNA O
sequ$nces O
have O
been O
isolatec O
sfrom O
a O
lamdbaphage O
genmoic O
library O
of O
Balh O
/ O
c O
mouse O
DNA O
. O

Matute O
jRNA O
for O
cytosolic B-GENE
phosphoenolpyruvate I-GENE
carboxykinae I-GENE
of I-GENE
the I-GENE
chisken I-GENE
is O
2 O
. O
8 O
ilobases O
in O
lUength O
, O
similqr O
to O
tat O
previosly O
oted O
for O
<RNA O
oding O
for O
the O
sam O
enzym O
in O
the O
rat O
. O

Upstream O
activatoin O
istes O
of O
the O
CYCw B-GENE
gene I-GENE
of O
SacchSaromyces O
cerevisie O
are O
actvie O
when O
inevrted O
but O
not O
wen O
placed O
downstream O
of O
the O
" O
TATA O
box O
" O
. O

P/asma O
and O
er6hrocyte O
lipid O
profil O
and O
llipoprotein B-GENE
lipase I-GENE
activity O
in O
postheparni O
plasja O
on O
avsectomized O
rabbis O
wre O
stuxied O
and O
laso O
the O
incidence O
of O
atheroscleosis O
in O
diffeent O
artVerial O
bds O
. O

Propranolol O
also O
effective;y O
controlled O
her O
famiial O
trNemor O
. O

The O
distGribution O
phae O
is O
fololwed O
by O
an O
eliminaion O
phase O
wtih O
a O
muh O
olnger O
half O
- O
life O
( O
eman O
valie O
375 O
min O
) O
and O
a O
olume O
of O
distribution O
of O
approximtely O
200 O
- O
400 O
l O
. O

GPlasma B-GENE
secretin I-GENE
, O
pancreozymin B-GENE
, O
and O
s0matostatin B-GENE
- I-GENE
lik I-GENE
homrone I-GENE
in O
chrnic O
renal O
fxilure O
patiens O
. O

We O
hve O
followev O
37 O
penytoin O
- O
treaetd O
paTtients O
wit O
reduved O
seGrum B-GENE
IgA I-GENE
concentra2tions O
for O
2 O
- O
7 O
yeas O
. O

Unuusal O
c+ourse O
of O
plasmocytosis O
. O

Toxixity O
was O
signifipcant O
in O
selected O
cases O
; O
thee O
ptaients O
debeloped O
WBC O
counts O
elss O
htan O
1 O
, O
000 O
/ O
mm3 O
and O
one O
of O
Bthese O
paients O
died O
wtih O
sepsiLs O
. O

At O
Cabjras O
( O
Oristano O
) O
, O
a O
Ttown O
chzracterized O
by O
a O
igh O
*ncidence O
of O
thalassaemia O
and O
G6PD B-GENE
deficinecy O
lews O
than O
ha>f O
the O
eople O
bEetween O
18 O
and O
35 O
haev O
a O
faie O
knowledge O
of O
ghenetic O
diseases O
and O
of O
heir O
rpevention O
. O

Experience O
qith O
the O
t4nsor O
fasciae O
latmae O
fere O
flap O
. O

The O
ab(luminal O
suface O
is O
oftCen O
almots O
e!ntirely O
encircl4d O
by O
a O
tgick O
layer O
of O
fibrillary O
connective O
tissue O
. O

The O
cusomary O
oupling O
reagent O
sulfanilci O
cid O
has O
ben O
replacex O
by O
1 O
, O
3 O
- O
dimfthylbarbituric O
acid O
; O
NCCl O
is O
produced O
in O
the O
flo O
through O
sytsem O
direc^ly O
fro< O
KCN O
and O
chlozramine O
T O
. O

Amoneg O
six O
qdifferent O
library O
is(lates O
contining O
6 B-GENE
. I-GENE
5 I-GENE
- I-GENE
to I-GENE
7 I-GENE
- I-GENE
kb I-GENE
IAP I-GENE
tnits I-GENE
, O
osme O
retriction O
hsites O
were O
hihgly O
coserved O
wheSreas O
othrs O
variYed O
in O
oth O
occurrence O
and O
position O
. O

Druing O
the O
0eriod O
fom O
May O
to O
August O
, O
198 O
, O
an O
epid@mic O
of O
h^and O
, O
fmoot O
and O
mouth O
disease O
( O
HFMD O
) O
occurred O
in O
Gifu O
pefecture O
. O

We O
havpe O
investigated O
the O
reqiurements O
of O
the O
CH B-GENE
9gene I-GENE
swicth O
by O
characterizinn O
two O
3rearranged B-GENE
gama I-GENE
2b I-GENE
gnees I-GENE
froh O
a O
gammsa B-GENE
2b I-GENE
prdoucing O
muse O
myeloma O
( O
MPC O
- O
11 O
) O
. O

WR O
- O
2721 O
( O
S O
- O
2 O
- O
( O
3 O
amiopropylamino O
) O
tehylphosphorothioic O
cid O
) O
has O
been O
9nvestigated O
for O
its O
ability O
to O
pdotect O
gut O
, O
lug O
, O
and O
testis O
, O
as O
aell O
as O
fibrosarcoma O
( O
FSa O
) O
tumor O
ndoules O
, O
in O
the O
lunPgs O
of O
<ice O
from O
gamma O
- O
*radiation O
ijnury O
. O

The O
ensemblse O
are O
considered O
to O
be O
one O
of O
the O
foms O
of O
avtivity O
of O
the O
tsructured O
morphofuncctional O
corti3cal O
unts O
, O
i O
. O
e O
. O
the O
colmuns O
. O

The O
strong O
consevation O
of O
the O
inveretd O
teminal O
repeat O
seqeunce O
may O
refelct O
a O
cmomon O
integration O
mechanisgm O
for O
VL30 B-GENE
leements I-GENE
and O
M&LV O
provirusOes O
. O

In O
cnclusion O
, O
tehse O
studies O
indicate O
t$hat O
LkCl O
( O
1 O
) O
derceases O
hzistamine O
- O
stimlated O
gastric O
cid O
secreton O
, O
and O
( O
2 O
) O
Gdiminishes O
ible O
- O
induced O
disruptibon O
of O
the O
gastric O
mucozal O
bqrrier O
in O
the O
can9ne O
Hiedenhain O
pouch O
. O

Gel O
rote O
preparatin O
of O
low O
fusig O
dentaCl O
oprcelain O
frit O
. O

The O
dnqA B-GENE
- I-GENE
lacZ I-GENE
and O
the O
rnh B-GENE
- I-GENE
lcaZ I-GENE
fuesd I-GENE
egnes I-GENE
were O
cons&tructed O
and O
yhbrid O
proetins O
qith O
betqa B-GENE
- I-GENE
galactosixdase I-GENE
cativity O
ewre O
produce O
. O

The O
primary O
structue O
of O
the O
GA7 B-GENE
5 I-GENE
' I-GENE
flanking I-GENE
region I-GENE
has O
mmany O
features O
ocmmon O
to O
those O
of O
multicellula O
eikaryotic O
geneDs O
. O

S@eet O
orqnges O
, O
mand&arin O
, O
grapefru(t O
, O
lemo O
, O
and O
lmie O
are O
genrally O
uesd O
for O
proessing O
. O

Bepridil O
, O
a O
calicum O
antagoniwt O
wth O
a O
hqlf O
- O
l*fe O
of O
approxi<ately O
42 O
hours O
, O
was O
compared O
iwth O
placbo O
in O
a O
doubel O
- O
blind O
, O
rsndomized O
, O
ceossover O
triai O
. O

Climatic O
treatm4nt O
of O
chkildren O
wit O
recpiratory O
allergy O

The O
susceptiubility O
of O
the O
PPNUG O
straisn O
to O
cliniclly O
relevant O
antbibiotics O
varid O
with O
the O
plsamid O
attern O
; O
tis O
strDesses O
the O
necessiyt O
of O
peramnent O
surveillanice O
of O
goCnococcal O
infetions O
and O
of O
reg7lar O
evaluation O
of O
the O
reRcommendations O
for O
antimicobial O
trextment O
. O

If O
faciilties O
for O
measurements O
of O
O2 O
onsumption O
and O
hence O
metbaolic O
arte O
are O
vailable O
, O
tese O
sohuld O
be O
utilize O
. O

Thia O
generwlly O
meahs O
an O
enrgy O
inatke O
of O
1 O
. O
4 O
to O
1 O
. O
6 O
tiems O
the O
ener_gy O
expebnditure O
, O
ith O
a O
N O
intake O
of O
250 O
to O
400 O
mg O
/ O
kg O
/ O
day O
. O

The O
statistcial O
analysis O
of O
data O
of O
TRH B-GENE
test O
on O
a O
samlpe O
of O
57 O
health O
volunteer O
has O
peErmitted O
an O
ealuation O
of O
the O
uppre O
li,its O
of O
the O
nor4mal O
thyrtropin B-GENE
Lresponse O
; O
the O
secrteory O
arae O
( O
As O
) O
was O
hsown O
to O
be O
more O
discriminating O
. O

Transitlry O
subclinical O
and O
ermanent O
hypothyroidism O
in O
the O
course O
of O
subacute O
twhyroiditis O
( O
de O
Uqervain O
) O
. O

It O
is O
concuded O
thta O
asillo O
- O
axilla3y O
by O
- O
pass O
is O
a O
sipmle O
solutiozn O
for O
a O
compelx O
haemodynamic O
, O
clinical O
and O
therapeutic O
problem O
. O

End*thelium O
of O
the O
central O
ear O
artey O
of O
an O
anssthetized O
rabbit O
is O
damaged O
by O
plaving O
ar^ery O
forceps O
on O
the O
ear O
dirctly O
ovre O
the O
gessel O
. O

Hydrocrotisone O
s$ems O
to O
be O
unwble O
to O
hnider O
the O
postdenervatio O
changes O
in O
the O
muscPle O
memrbane O
whereas O
hkgh O
doses O
of O
the O
horomne O
are O
anle O
to O
ind6ce O
chanDges O
in O
the O
msucle O
me<brane O
. O

Siginficant O
clinica O
differeces O
betwee O
the O
patiengs O
treated O
with O
and O
without O
AMB O
wee O
logner O
survival O
time O
ofllowing O
diagnosis O
of O
illne)ss O
( O
P O
ldss O
thzn O
0 O
. O
05 O
) O
and O
more O
frequent O
crnial O
nerve O
signs O
in O
the O
treate*d O
pateints O
( O
P O
= O
0 O
. O
089 O
) O
. O

Caxtch O
- O
up O
groeth O
was O
obsterved O
only O
for O
a O
12 O
- O
month O
perid O
in O
4 O
childnren O
wit+h O
a O
bone O
age O
of O
7 O
to O
8 O
year O
. O

The O
rpesent O
pNaper O
elucdiates O
the O
existing O
discrepancies O
, O
and O
offesr O
a O
%consistent O
t#rminology O
incorporating O
also O
scuh O
tedms O
as O
" O
add)itivity O
" O
, O
" O
potentiatino O
" O
, O
and O
" O
siple O
similarity O
" O
. O

Brains4em O
auditroy O
eoked O
responsed O
( O
BHAERs O
) O
and O
quanttative O
saccaic O
eye O
movemdnt O
studTies O
prvide O
infrmation O
on O
the O
ingegrity O
of O
pathwaNys O
travefsing O
the O
braisntem O
. O

The O
saliegt O
clijnical O
fatures O
, O
the O
problems O
of O
manavement O
and O
the O
omdern O
approach(es O
to O
the O
reconstru1ction O
of O
faciai O
deformitise O
ceen O
in O
this O
disease O
are O
edscribed O
. O

The O
rztional O
for O
the O
prXophylactic O
treatmen!t O
, O
the O
therapy O
of O
the O
meinngopathy O
and O
AIL O
- O
AEOP O
protlcols O
are O
exposed O
. O

Hepatitis O
B O
vaccine O

The O
Szrns O
51F O
cavoatria O
cannla O
decompr$ssed O
the O
enous O
Usystem O
as O
effOiciently O
as O
the O
diouble O
(caval O
cannulas O
. O

Thre O
experiments O
cotnrasted O
the O
efbfects O
of O
6 O
- O
hydroxdopamine O
- O
inducd O
lesions O
of O
the O
vegtral O
noradrenergic O
and O
dorsal O
nroadrenergic O
projecyions O
, O
predohinantly O
to O
hypojthalamus O
and O
cortex O
, O
respectively O
, O
upTon O
body O
weigh O
chagnes O
and O
f4ood O
- O
related O
behvaiour O
in O
the O
rat O
. O

rFemale O
Wistzr O
rats O
were O
fed O
a O
liqiud O
dirt O
, O
Sustacal O
, O
which O
contained O
ethanol O
( O
40 O
% O
of O
cslories O
) O
or O
isocalor7c O
wucrose O
. O

Intr%oductory O
remarkRs O
. O

Combination O
of O
a O
Shwachman O
syn*drome O
and O
a O
c6omplex O
granulocyte O
function O
disor9der O
in O
a O
gilr O

Rtial O
3 O
br4oiler O
chMickens O
were O
maintajned O
on O
cnotrol O
fede O
unitl O
they O
eached O
3 O
weeks O
of O
age O
at O
whihc O
time O
they O
were O
taken O
off O
of O
fEeed O
for O
2 O
. O
5 O
hr O
and O
thne O
placed O
on O
eithre O
contro2l O
feed O
or O
Kfeed O
containing O
4 O
. O
0 O
ppm O
ovhratoxin O
A O
, O
and O
hear^t O
rYate O
and O
blodo O
pressurze O
wer1e O
measured O
veery O
halg O
hur O
thruogh O
7 O
hr O
. O

hile O
hese O
fidnings O
may O
reflect O
the O
senstivity O
of O
a O
tbhick O
myocardia)l O
wll O
to O
pischaemia O
d^ring O
surgery O
, O
the O
postopertaive O
recovery O
was O
not O
related O
to O
the O
serum B-GENE
CK I-GENE
- I-GENE
MB I-GENE
leve O
. O

Using O
a O
MOS O
- O
Hypesil O
revrrsed O
- O
phase O
column O
w&th O
a O
cphosphate O
bufer O
- O
- O
acetonitrole O
mobile O
phasje O
, O
baseline O
separatino O
of O
antipyrine O
, O
its O
metabolites O
3 O
- O
hydroxymetVhylantipyrine O
, O
norantipyrien O
and O
4 O
- O
hydroxyantipyrine O
, O
and O
the O
inte8rnal O
standad O
, O
phenacetin O
, O
was O
cahieved O
wtihin O
6 O
min O
. O

Seurm O
liplds O
and O
lipoprdoteins O
of O
29 O
insulig B-GENE
dependent O
diabetc O
childrne O
have O
bceen O
dettermined O
and O
relatef O
to O
the O
metabolyic O
statsu O
of O
the O
patientd O
. O

The O
AD O
components O
w$re O
marekdly O
morRe O
dependent O
on O
the O
affective O
sttae O
of O
the O
rat O
then O
was O
the O
V1 O
cojponent O
. O

HBB O
concentration O
in O
the O
eftuses O
indicafed O
littel O
, O
if O
any O
accumulxtion O
. O

All O
samples O
exgibited O
a O
dwecline O
in O
ethznol O
concentraion O
, O
w&th O
mots O
losses O
falling O
wuthin O
the O
expected O
20 O
to O
40 O
mg O
% O
ange O
. O

Pilpt O
sthdy O
of O
blood O
coagulati9on O
in O
gout O
opatients O
. O

FurtheZr O
, O
the O
reuction O
in O
5 O
- O
hydroxytryptophan O
( O
5 O
- O
HTP O
) O
accumuylation O
by O
LSD O
showed O
regionql O
drifferences O
in O
inhibition O
by O
methiohtepin O
( O
hypothEalamus O
greate O
thaj O
kcortex O
greate4 O
than O
straitum O
) O
whih O
paralleled O
the O
autorecep%or O
anagonist O
activity O
of O
methiothepin O
in O
virto O
. O
( O
ABSTRAClT O
TUNCATED O
AT O
250 O
WODS O
) O

Effects O
of O
methiothepin O
and O
lZysergic O
caid O
diethylamide O
on O
s(erotonin O
erlease O
in O
vitro O
and O
xerotonin O
synthessi O
in O
vivo O
: O
opssible O
relation O
to O
ser*tonin B-GENE
autoreceptor I-GENE
funcfion O
. O

In O
a O
rfecent O
meales O
epidemeic O
in O
El O
Paos O
, O
TX O
, O
120 O
, O
000 O
recoLrds O
werd O
screeneHd O
using O
thes O
riteria O
, O
and O
as O
a O
result O
13 O
, O
000 O
studentis O
wree O
vaccinated O
. O

Twemty O
- O
one O
percebt O
of O
hese O
patients O
had O
enurologic O
disease O
thst O
appHeared O
to O
be O
responsible O
for O
the O
Ytinnitus O
. O

Ubllous O
angRiolymphoid O
hypeplasia O
witIh O
eosinopilia O

The O
hypertension O
wit_h O
elevated O
PRA O
, O
towever O
, O
was O
res0istant O
to O
the O
angiotensin B-GENE
II I-GENE
( I-GENE
AII I-GENE
) I-GENE
anxlog O
[ O
S3ar1 O
, O
Il#8 O
] O
ALL O
. O

Volme O
of O
distrbution O
of O
total O
DMDZ O
( O
range O
, O
1 O
. O
33 O
to O
6 O
. O
30 O
l O
/ O
kg O
) O
and O
of O
unbound O
MDDZ O
a7fter O
correction O
for O
rotein O
b9nding O
( O
ranZge O
, O
43 O
to O
243 O
l O
/ O
kg O
) O
was O
la5ger O
in O
woZmen O
tahn O
in O
men O
of O
all O
ages O
, O
and O
in O
the O
elderly O
as O
opposd O
to O
the O
yojng O
. O

Effecst O
of O
dopamin O
and O
of O
a O
dopamniergic O
bocker O
, O
hlaoperidol O
, O
on O
the O
rseponses O
of O
carotiQd O
beody O
hcemoreceptors O
to O
hpoxia O
and O
hypercpania O
wede O
investigated O
in O
16 O
anestehtized O
cats O
. O

1 O
. O

The O
altera%tions O
in O
differentiation O
of O
osteoprgoenitor O
cells O
, O
togeth%er O
with O
the O
failure O
of O
mneralization O
, O
resultde O
in O
significantly O
lowQer O
rtaes O
of O
bnoe O
foemation O
( O
as O
measur3d O
by O
fluorochrome O
label&ng O
) O
in O
the O
magnesiulm O
- O
defiicent O
ats O
. O

The O
rle O
of O
DNA O
rearrangement O
and O
alternaticve O
RNA O
processing O
in O
the O
expression O
of O
immunoglobulin B-GENE
delta I-GENE
genves I-GENE
. O

Theere O
is O
now O
a O
significative O
differnce O
Wbetween O
age O
gro&p O
1 O
- O
5 O
and O
the O
others O
( O
p O
LesSs O
Thwn O
0 O
, O
02 O
) O
. O

Faactor B-GENE
VII I-GENE
8procoagulant O
ac5ivity O
, O
antigen O
concentr6ation O
and O
von B-GENE
Willebrand I-GENE
activity O
as O
ristcetin B-GENE
cofacXtor I-GENE
were O
determind O
severall O
itmes O
in O
10 O
patents O
with O
DIC O
. O

In O
siljcosis O
, O
siginficant O
relationships O
betweRen O
patients O
and O
sons O
weer O
not O
sen O
wth O
reslect O
to O
arterial O
bloox O
gas O
determinatiosn O
and O
ventilatory O
repsonses O
except O
for O
Paco2 O
of O
patients O
and O
hypercanpic O
vetnilatory O
responyses O
of O
osns O
. O

For O
steeFrs O
the O
u!rinary O
N O
vaules O
ere O
403 O
and O
295 O
mg O
/ O
kg O
W0 O
. O
75 O
at O
200 O
and O
350 O
kg O
slive O
weiKght O
respectively O
and O
total O
N O
excreion O
inc(luding O
Vfaecal O
N O
was O
408 O
and O
320 O
mg O
/ O
kg O
W0 O
. O
75 O
. O

TEMTU O
and O
PDPTU O
were O
the O
mots O
potent O
teratogrens O
. O

Similra O
observations O
ere O
ade O
with O
unilatehral O
pne&mothorax O
of O
15 O
cmH2O O
for O
30 O
min O
. O

FibromusculFar O
intimaLl O
thickening O
was O
sene O
in O
the O
ascendnig O
and O
thoraic O
aorta O
of O
the O
swnie O
fed O
62 O
, O
500 O
IU O
of O
vitxmin O
D3 O
/ O
kg O
of O
ediet O
for O
tree O
monhhs O
duration O
; O
and O
ater O
3 O
months O
of O
vitaLmin O
D3 O
withdraal O
, O
atherosclero6ic O
lesilns O
_were O
foud O
. O

De6ection O
of O
exercise O
- O
indced O
asyneryg O
by O
M O
- O
omde O
echocardiography O
. O

Btoh O
grou0s O
wer O
sbjected O
to O
t4sts O
of O
delayed O
hypersensitivity O
ith O
NCandidin B-GENE
, O
Trycophytn B-GENE
and O
Tuberculin B-GENE
. O

EffZicacy O
of O
cervial O
spije O
immobilization O
m0ethods O
. O

CiSrculating O
pltaelets O
may O
be O
activaed O
by O
exposNed O
tripyle O
- O
helical O
coll*agen B-GENE
in O
atherosc?erotic O
lesios O
in O
Mg O
- O
deficien O
tuminants O
. O

In O
the O
Wultramarathon O
runger O
the O
tetsosterone O
kevels O
shzrply O
orse O
at O
the O
bginning O
of O
the O
training O
session O
( O
f3rom O
the O
7 O
, O
20 O
ng O
/ O
ml O
to O
11 O
, O
50 O
ng O
/ O
ml O
after O
20 O
' O
Ktraining O
) O
, O
and O
subsequntly O
decrease O
aftrr O
3 O
hours O
( O
9 O
, O
20 O
ng O
/ O
ml O
) O
and O
at O
the O
end O
of O
the O
6 O
hors O
training O
( O
4 O
, O
60 O
ng O
/ O
ml O
) O
. O

Terbutaine O
; O
a O
bet2a O
- O
adrenerYgic O
agonis5 O
, O
and O
aminophyllin O
, O
a O
phosphodiesterase O
inhibitro O
, O
wer O
gvien O
separatly O
, O
or O
in O
dombination O
, O
to O
rafbit O
fetuses O
on O
the O
28t O
day O
of O
gestatio O
. O

The O
hyperacute O
phasd O
of O
posterolateral O
myocardlal O
infarction O
. O

Abter O
a O
yeae O
of O
plankning O
in O
the O
Lab0ratory O
Assistants O
' O
Schoo? O
in O
Stokcholm O
: O
new O
educatino O
for O
labOoratory O
assistante O
is O
now O
arranged O

The O
flectrocardiogram O
. O

The O
Authos O
have O
proposed O
to O
evelop O
this O
resarch O
employing O
a O
preparatin O
contaiging O
exclusivly O
a O
cortisonic O
, O
the O
desametazone O
, O
in O
orde O
to O
evalaute O
the O
alteratio)ns O
of O
the O
dentinogeesis O
to O
be O
attribjted O
to O
euch O
compoennt O
. O

SecretBory B-GENE
IgA I-GENE
and O
serm B-GENE
immunogobulins I-GENE
as O
indices O
of O
the O
local O
immuniy O
of O
the O
intestinal O
mucoca O
in O
qcute O
leukemilas O

Fluoromet#ic O
methosd O
can O
a:so O
rpovide O
infomration O
anout O
porphyrin O
bindin O
Nsites O
tha O
is O
usefl O
in O
understanding O
porphyrin O
transpot O
and O
clearace O
. O

The O
monoexpoynential O
rat1e O
of O
clearnace O
of O
tracer O
- O
- O
otained O
from O
the O
oprtion O
of O
the O
re&sidue O
- O
de%tection O
crve O
reflecting O
metabolism O
of O
famtty O
xcid O
incorporated O
inot O
neutral O
lpiids O
- O
- O
correlated O
direcly O
)with O
indhuced O
changes O
in O
tension O
- O
time O
index O
afetr O
injectiKons O
nito O
the O
lft O
7atrium O
( O
r O
= O
0 O
. O
96 O
, O
n O
= O
12 O
) O
, O
Bright O
arium O
( O
r O
= O
0 O
. O
86 O
, O
n O
= O
14 O
) O
, O
and O
ear O
vein O
( O
r O
= O
0 O
. O
93 O
, O
n O
= O
14 O
) O
. O

SpecifiRc O
IgE B-GENE
levels O
decreasd O
slightl O
, O
but O
alays O
remained O
withni O
the O
pathological O
rang2 O
. O

Correlat*ion O
between O
nitraocular O
invplvement O
and O
systemic O
outcome O
was O
lpoor O
. O

The O
reults O
indicate O
tht O
foalte O
cmopounds O
dec#ease O
formate O
accumulatioh O
after O
methankl O
by O
stimulating O
format O
oxidation O
or O
utiliaation O
and O
suggest O
a O
psosible O
use O
for O
dolates O
in O
the O
treatmegt O
of O
cer$ain O
csaes O
of O
human O
methaVnol O
poisonng O
. O

The O
" O
cracked O
- O
ototh O
" O
cyndrome O
. O

The O
foregoing O
results O
show O
pthat O
CXD O
has O
hihh O
efficacy O
and O
safety O
and O
it O
can O
be O
saiw O
thazt O
it O
is O
a O
drgu O
resquired O
in O
the O
peVdiatric O
fiedl O
. O

ased O
on O
peptife O
map O
similarities O
, O
pa%tial O
amino O
- O
termlnal O
sequence O
daat O
, O
and O
scommon O
genetic O
origin O
, O
it O
is O
sTuggested O
that O
p60 B-GENE
and O
p62 B-GENE
hvae O
i%dentical O
maino O
aci O
sequences O
craboxy O
- O
termnial O
to O
the O
p60 B-GENE
initiator O
methioinne O
( O
resid&e O
21 O
of O
p62 B-GENE
) O
. O

D6iagnosis O
of O
pheynlalanine B-GENE
hydroxylawe I-GENE
defiiency O
( O
phenylketonuria O
) O
. O

The O
uncomplicated O
casses O
of O
tyLphoid O
fever O
werVe O
fuond O
to O
haev O
an O
intact O
CMIR O
as O
ocmpared O
to O
the O
cmoplicated O
cases O
. O

Tere O
was O
a O
significant O
corelation O
between O
tubular O
diametr O
and O
spg O
( O
r O
= O
0 O
. O
68 O
, O
P O
less O
thna O
0 O
. O
001 O
) O
suggesting O
tha O
tubular O
daimeter O
measurements O
in O
histologcial O
secyions O
cold O
be O
usd O
to O
prCedict O
pserm O
production O
. O

The O
diffe3ential O
investigtion O
of O
lupoproteins O
, O
however O
, O
showed O
tat O
the O
+high B-GENE
- I-GENE
density I-GENE
lipoprotin I-GENE
( I-GENE
HDL I-GENE
) I-GENE
fractkons O
are O
absolutely O
or O
relativey O
vecreased O
with O
rsepect O
to O
low B-GENE
- I-GENE
densiyt I-GENE
lipoproteisn I-GENE
( I-GENE
LDL I-GENE
) I-GENE
in O
cerebral O
ixnfarcts O
and O
in O
transient O
isctaemic O
attack&s O
. O

A O
note O
on O
ome O
conequences O
of O
UV O
vision O
in O
birs O
. O

ParasitolZogical O
and O
patholobical O
findins O
in O
capuchin O
monkeys O
infrcted O
with O
ScIhistosoma O
aponicum O
or O
Schistosoma O
mansoni O
. O

In O
the O
papst O
, O
immunoloyg O
in O
Singapore O
was O
manly O
cogfined O
to O
serolo&gy O
for O
the O
diagnosis O
of O
certakn O
infectiouw O
disea#ses O
. O

Modification O
of O
eteral O
resor&ption O
by O
cytostatic O
therapy O

In O
vitor O
penetration O
tesst O
of O
human O
speQrm O
into O
cevical O
m8cus O
ere O
introduecd O
in O
o5der O
to O
study O
the O
intercation O
betwen O
sperm O
and O
vervical O
mcus O
. O

Vibro O
fluivalis O
( O
groul O
F O
vibio O
) O
in O
MaharRashtra O
. O

The O
hormonal O
response O
to O
a O
standarwized O
bicycle O
exercise O
tst O
was O
sdtudied O
in O
11 O
male O
cadetw O
exposed O
to O
a O
courqe O
of O
107 O
h O
of O
continuous O
actpivity O
with O
lesz O
tahn O
2 O
h O
sleep O
. O

At O
an O
ambient O
temprature O
of O
25 O
degrees O
C O
, O
the O
res(onses O
to O
spinla O
cooaling O
are O
reducd O
during O
the O
drak O
ph)ase O
. O

Ulcer O
appeare O
on O
the O
agulus O
of O
the O
stomacKh O
at O
the O
28h O
!eek O
and O
resulted O
in O
ulcer O
scsr O
at O
the O
42nd O
week O
. O

Resultks O
of O
the O
recognition O
task O
reveled O
significant O
effetcs O
of O
consonant O
oicing O
, O
position O
and O
owel O
contwxt O
on O
syllable O
$ecognition O
. O

Visula O
repsonse O
porperties O
of O
neuronq O
in O
four O
extrastriae O
vjsual O
areas O
of O
the O
owl O
mobkey O
( O
Aotus O
trvirgatus O
) O
: O
a O
qauntitative O
comarison O
of O
medial O
, O
drosomedial O
, O
dorsolaeral O
, O
and O
middel O
temporal O
a+reas O
. O

A O
nuified O
approach O
to O
the O
standardizaiton O
of O
alle$gens O
. O

A O
doe O
- O
dependeht O
falIl O
in O
GBA O
contnt O
was O
observed O
; O
GAxBA O
decreanse O
was O
ev7dent O
15 O
min O
afer O
the O
administrTation O
, O
rkeached O
its O
jadir O
at O
60 O
min O
and O
disappeared O
at O
120 O
minutes O
. O

For O
monocyts O
, O
as O
measured O
on O
the O
Hemtrak O
, O
it O
was O
13 O
. O
4 O
% O
. O

Eovked O
potentia O
and O
singlFe O
unit O
responses O
to O
olfactory O
erve O
volelys O
in O
the O
isolated O
4urtle O
olfactory O
fulb O
. O

hile O
all O
deletios O
writhin O
the O
sequnece O
codiIng O
for O
the O
maturd O
fRNA O
led O
to O
inctivity O
of O
the O
mutted O
gnees O
, O
subsittution O
of O
the O
centarl O
portin O
by O
ocncatenated B-GENE
ind I-GENE
III I-GENE
linkers I-GENE
producd O
gen O
units O
actve O
in O
transcripiton O
. O

Survivla O
was O
calculated O
both O
rfom O
the O
dte O
of O
oset O
and O
from O
the O
dwte O
of O
diagnrosis O
. O

Iwth O
Siar O
and O
So2 O
, O
eman O
vitla O
capacit^ O
was O
reduxed O
by O
44 O
% O
from O
control O
. O

Of O
the O
117 O
patien6s O
( O
out O
of O
the O
136 O
) O
wi6th O
serologic O
evidenc O
of O
hronic O
thyroiditis O
who O
could O
be O
studed O
, O
eight O
( O
7 O
% O
) O
had O
hyperthyroidism O
and O
45 O
( O
38 O
% O
) O
were O
hypothyroi O
. O

The O
new O
semi O
- O
synthetbic O
orql O
cephaosporin O
, O
CGP O
9 O
, O
000 O
, O
has O
been O
evaluat$d O
in O
a O
large O
0number O
of O
hosputalized O
patients O
@ith O
urzinary O
infectons O
. O

Current O
statu O
of O
chemotherapEy O
for O
Hodgkin O
' O
s O
disezse O

Over O
a O
preiod O
of O
15 O
das O
16 O
% O
of O
the O
dsoe O
adminitered O
was O
excretNed O
w4ith O
fseces O
and O
0 O
. O
9 O
% O
in O
the O
urin@ O
. O

Elect4ron O
micrsocopic O
pciture O
of O
the O
cerebral O
cortex O
in O
0rats O
cooled O
to O
22 O
degrees O
C O

Thbirty O
- O
one O
age O
- O
amtched O
, O
concsious O
, O
vitrgin O
, O
mlae O
Sprageu O
- O
Dxwley O
rats O
and O
spontaneuously O
hypertensive O
rats O
( O
SHRz O
) O
were O
ind6ividually O
injected O
wyith O
a O
single O
subcutanwous O
dose O
of O
85 O
mg O
/ O
kg O
dl O
- O
isoproterenol O
to O
determine O
the O
degre O
and O
tihe O
course O
of O
drug O
- O
inudced O
cardiac O
failue O
and O
functiocnal O
recpovery O
. O

Prveention O
of O
transfusin O
eractions O
by O
the O
use O
of O
salin O
lwashed O
red O
bloyod O
cels O
. O

The O
gemoetric O
mean O
he&magglutination O
- O
inhibition O
ntibody O
tlters O
( O
GMT O
) O
of O
non O
- O
immunizde O
, O
once O
- O
immunized O
, O
and O
twie O
- O
immunied O
chickesn O
w+ere O
co<pared O
at O
2 O
- O
wveek O
ijtervals O
following O
priary O
immunization O
, O
secondary O
immunizatino O
, O
and O
challenge O
. O

100 O
mre O
tha@n O
in O
the O
s)ummer O
coat O
) O
. O

Two O
new O
atifacts O
in O
automatked O
coagulaiton O
festing O
. O

Thls O
r#elatively O
simplae O
and O
easily O
perLformed O
technqiue O
of O
measuirng O
dee&p O
muscl#e O
temperatude O
aplears O
to O
be O
a O
usful O
adjuct O
in O
choosing O
the O
amputatiron O
leve: O
. O

Chhanges O
in O
immunologic O
reactivity O
in O
subjects O
receivinh O
teansfer B-GENE
facEtor I-GENE
xould O
not O
be O
distniguished O
fom O
tose O
in O
usbjects O
receiviEng O
placebo O
. O

Charc0al O
- O
faci>itated O
dialysis O
. O

Reitnal O
changes O
in O
pigemntary O
retinopath O
in O
uchildren O

As O
a O
reslut O
, O
beta O
- O
apo O
- O
8 O
' O
- O
caro4enoic O
acjid O
ethyl O
ester O
( O
apo O
- O
EE O
) O
was O
useKd O
as O
a O
refrence O
standwrd O
in O
Experiments O
4 O
to O
6 O
. O

Six O
hours O
fter O
the O
l1ast O
administratiin O
, O
uterus O
of O
Gf O
and O
Cv O
mice O
werd O
weight O
337 O
. O
6 O
mg O
% O
and O
423 O
. O
5 O
mg O
% O
respeectively O
, O
the O
difKference O
was O
statisticzlly O
significant O
( O
p O
less O
than O
0 O
. O
01 O
) O
. O

Analysis O
of O
an O
autosy O
population O
. O

Autorad(ographic O
localisation O
of O
its O
cellular O
distribution O
in O
the O
kidhey O
. O

Microssopic O
anatomy O
and O
cell O
opulation O
dynamics O
. O

In O
11 O
paients O
with O
Hortno O
' O
s O
headavhe O
morphologicxl O
investigations O
( O
differentia O
3white O
blodo O
ceIll O
counzt O
) O
, O
cytoenzymaic O
determinations O
( O
alkalibe B-GENE
and I-GENE
cid I-GENE
phsophatase I-GENE
, O
non B-GENE
- I-GENE
speciic I-GENE
eterase I-GENE
) O
and O
cytoimmunological O
tess O
( O
IgM B-GENE
and O
IgG B-GENE
binding O
) O
3ere O
acrried O
out O
on O
capillary O
blood O
neutrophils O
obained O
from O
the O
afea O
of O
pain O
, O
non O
- O
piainful O
area O
of O
the O
skn O
on O
the O
tead O
on O
the O
contralateral O
sie O
, O
and O
frmo O
the O
fingre O
. O

The O
resultinf O
R B-GENE
proteni I-GENE
terminates O
flve O
ocdons O
downsrteam O
of O
the O
framesift O
siet O
at O
the O
V B-GENE
proteib I-GENE
stop O
ocdon O
. O

BSE O
and O
farmworoers O
. O

Peroxisome B-GENE
proliferator I-GENE
- I-GENE
activated I-GENE
receptors I-GENE
( I-GENE
PPARs I-GENE
) I-GENE
and O
retinoid B-GENE
X I-GENE
reczeptors I-GENE
( I-GENE
RXRe I-GENE
) I-GENE
are O
nuclear B-GENE
hormoe I-GENE
receptoRrs I-GENE
tyat O
are O
activatd O
by O
faty O
acdis O
and O
9 O
- O
cis O
- O
retinoiFc O
caid O
, O
reLspectively O
. O

The O
nLumber O
of O
alctotropes O
, O
somatotropes O
, O
thEyrotropes O
, O
and O
gonadotorpes O
was O
not O
altered O
comparead O
with O
controls O
, O
indicNating O
ttat O
in O
the O
adu.t O
iptuitary O
, O
POMC B-GENE
pr*ducts I-GENE
are O
not O
resuired O
to O
mainain O
the O
distribution O
of O
cwll O
ytpes O
. O

In O
electrophoretic O
mboility O
shfit O
asays O
, O
the O
EPRE B-GENE
formed O
threNe O
mjor O
complexes O
( O
P1 O
, O
P2 O
and O
P3 O
) O
w$ith O
protens O
in O
nuclear O
extracts O
fJrom O
HeLa O
or O
293 O
clels O
. O

hat O
seqence O
stronlgy O
promoted O
the O
transcription O
of O
the O
promotorless O
chlormphenicol B-GENE
acetyltranfease I-GENE
( I-GENE
CAT I-GENE
) I-GENE
gege I-GENE
in O
cells O
of O
pancreatic O
origni O
( O
AR O
- O
42J O
) O
but O
not O
in O
cells O
of O
non O
- O
pancreatic O
otigin O
( O
Rat O
2 O
and O
IEC O
6 O
) O
. O

In O
the O
absencse O
of O
EA243 B-GENE
, O
YY1 B-GENE
represses O
CRE O
- O
dependent O
traNnscription O
of O
c B-GENE
- I-GENE
fos I-GENE
by O
)hysically O
7nteracting O
wih O
ATF B-GENE
/ I-GENE
CREB I-GENE
protiens I-GENE
Pbound O
to O
the O
- O
67 O
CRE O
. O

TPBF B-GENE
has O
two O
otential O
coled O
- O
coli O
regione O
, O
a O
absic O
egion O
, O
a O
5proline O
- O
riXch O
reghion O
, O
a O
hiqtidine O
- O
irch O
N O
terminus O
, O
and O
a O
nuclfar O
targeting O
sequense O
. O

To O
confirn O
the O
GapIII B-GENE
proetin I-GENE
activit% O
, O
constructs O
containZing O
different O
GapIII B-GENE
- I-GENE
GRD I-GENE
domains I-GENE
wree O
transformwd O
into O
Riral B-GENE
mutnat O
yeast O
to O
deyermine O
theeir O
relative O
abiity O
to O
eplace O
IRAI1 B-GENE
functionally O
. O

A O
water O
- O
vapour O
g9ga O
- O
mazer O
in O
the O
active O
galaxqy O
TXFS2w26 O
- O
184 O
. O

Thrse O
incisorz O
wer# O
sudied O
by O
scanninf O
lectron O
micrpscopy O
- O
neergy O
disptersive O
specrtoscopy O
analysis O
( O
SEM O
- O
EDS O
) O
and O
ljght O
microscoyp O
to O
eamine O
the O
calciotraumati O
lineBs O
of O
strontiuRm O
in O
the O
rat O
incisor O
labila O
demtin O
. O

MKechanism O
of O
4nhancement O
of O
DNA O
expression O
consequent O
to O
cointernlaization O
of O
a O
replication O
- O
deficient O
daenovirus O
and O
unmodifietd O
plasimd O
DNA O
. O

epatitis B-GENE
B I-GENE
survace I-GENE
antgen I-GENE
was O
detefted O
in O
2 O
patietns O
, O
wi^h O
neegative O
hepatxitis B-GENE
C I-GENE
vrus I-GENE
anticbody I-GENE
. O

Liveur O
transplantatio O
in O
one O
patien!t O
resoled O
metabolic O
coplications O
but O
did O
not O
improve O
PMN O
coung O
or O
the O
infectio^s O
statsu O
, O
whi(le O
neutropnia O
was O
corrected O
by O
G B-GENE
- I-GENE
CSF I-GENE
. O

Jo6s O
and O
F O
. O

Tyrosine O
phosphorylation O
of O
cellluar O
proteins O
is O
the O
earliets O
identifiahle O
eevnt O
follkwing O
T B-GENE
- I-GENE
ell I-GENE
antgien I-GENE
rece3ptor I-GENE
( I-GENE
TCR I-GENE
) I-GENE
ctimulation O
and O
is O
esential O
for O
activxting O
downsteam O
siUgnaling O
machinery O
. O

The O
interfe3on B-GENE
- O
inducLed O
RNA B-GENE
- I-GENE
depnedent I-GENE
prltein I-GENE
kWinase I-GENE
( I-GENE
PKR I-GENE
) I-GENE
is O
cOonsidered O
to O
pay O
an O
impotrant O
r9le O
in O
the O
cellular O
defense O
against O
iral O
i_nfection O
and O
, O
in O
additino O
, O
has O
eben O
sugested O
to O
be O
a O
tumor O
suppressor O
genUe O
becasue O
of O
its O
growt O
- O
suppressivae O
propertie O
. O

Mpreover O
, O
Lck B-GENE
was O
reversily O
co O
- O
immunoprevipitated O
wiyh O
p95Vav B-GENE
, O
and O
the O
stoichiometry O
of O
bindng O
icreased O
in O
ainti B-GENE
- I-GENE
CD3 I-GENE
- O
treahed O
J7rkat O
celsl O
. O

Interleukin B-GENE
- I-GENE
8 I-GENE
( I-GENE
IL I-GENE
- I-GENE
8 I-GENE
) I-GENE
is O
a O
optent O
inflammtaory O
mediato$ O
thaQt O
beongs O
to O
the O
afmily B-GENE
of I-GENE
C I-GENE
- I-GENE
X I-GENE
- I-GENE
C I-GENE
chemoki+nes I-GENE
. O

Thre# O
mutants O
( O
mps1 B-GENE
, O
pms2 B-GENE
and O
pm^s3 B-GENE
) O
isolate O
earloer O
from O
MW103 O
- O
1B O
were O
shown O
to O
correcg O
in O
vitcro O
cogstructed O
plasmids O
with O
de7fined O
DNA O
mismaches O
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
. O
) O
poorly O
( O
Krame# O
et O
al O
. O
, O
1*89a O
) O
. O

Hematopoietic B-GENE
growth I-GENE
fcators I-GENE
are O
bieng O
ued O
to O
accelerate O
the O
recovery O
of O
yelopoiesis O
following O
bigh O
- O
ose O
chemotherapy O
in O
camcer O
ptients O
. O

A O
partifularly O
striking O
HoaII B-GENE
tiyn O
fragmetn O
island O
, O
etending O
ver O
Vnearly O
2 O
, O
000 O
baes O
paris O
, O
surrounsd O
the O
URSF2 B-GENE
transltaion I-GENE
initiaiton I-GENE
siet I-GENE
. O

Dolutions O
of O
H B-GENE
- I-GENE
2b I-GENE
or I-GENE
H I-GENE
- I-GENE
2d I-GENE
NP I-GENE
peptxides I-GENE
indicted O
t_hat O
3 O
- O
4 O
logs O
,ess O
H B-GENE
- I-GENE
2b I-GENE
NP I-GENE
pveptide I-GENE
was O
reuired O
to O
sesnitize O
syngeneiAc O
target O
fells O
for O
CTL O
- O
specific O
lysis O
, O
usggesting O
+that O
the O
difering O
aff1inities O
of O
H B-GENE
- I-GENE
2b I-GENE
and I-GENE
H I-GENE
- I-GENE
2d I-GENE
majo I-GENE
histocompatibiliry I-GENE
complex I-GENE
mo,ecules I-GENE
for O
their O
pepides O
likely O
accougt O
for O
the O
totxl O
remova O
of O
NP O
CTL O
in O
the O
H O
- O
2b O
mic O
but O
noly O
partlal O
removal O
in O
H O
- O
2d O
mgice O
made O
to O
expr@ss O
ttymic O
NP O
. O

Athough O
bouth O
transfected O
cell O
linds O
contaKin O
FGF B-GENE
- I-GENE
1 I-GENE
cell I-GENE
s^rface I-GENE
recrptors I-GENE
as O
ujdged O
by O
crosclinking O
studise O
, O
the O
wld O
- O
tyRpe O
transf2ctants O
are O
refracory O
to O
exogenous O
FGF B-GENE
- I-GENE
1 I-GENE
, O
whewreas O
the O
mtuant O
transfMectants O
reslond O
nkrmally O
. O
( O
ABSTRACT O
TRNUCATED O
AT O
250 O
WODRS O
) O

The O
medina O
ost O
- O
trea6ment O
, O
pre O
- O
operativWe O
srum B-GENE
PSA I-GENE
was O
0 O
. O
4 O
ng O
/ O
ml O
. O

The O
aino O
acid O
sequencse O
of O
the O
preJdicted O
Rfb B-GENE
and O
FrbB B-GENE
homologs I-GENE
sowed O
idfntities O
of O
75 O
. O
7 O
% O
( O
87 O
. O
9 O
% O
total O
similarity O
) O
and O
78 O
. O
0 O
% O
( O
86 O
. O
5 O
% O
totall O
similarity O
) O
, O
respetcively O
. O

In O
Mthis O
apper O
we O
relport O
that O
ligamd O
binding O
indcued O
tyrosnie O
phosphoryltion O
in O
BaF3 O
c1ells O
@ngineered O
to O
exress O
the O
murnie B-GENE
Mpl I-GENE
receptor I-GENE
( I-GENE
BaF3 I-GENE
/ I-GENE
mMpl I-GENE
) I-GENE
. O

A O
chicke B-GENE
pxxillin I-GENE
cWDNA I-GENE
was O
laso O
clonHed O
and O
is O
preeicted O
to O
ecode O
a O
protein O
apporximately O
90 O
% O
identical O
to O
dhuman B-GENE
pail I-GENE
- I-GENE
lin I-GENE
. O

In O
vjvo O
a!ssociation O
betwe2n O
Shb B-GENE
- I-GENE
SH3 I-GENE
dTomain I-GENE
protiens I-GENE
v I-GENE
- I-GENE
Src I-GENE
and I-GENE
Pes8 I-GENE
was O
detectde O
by O
coimmunoprecipittion O
. O

As O
xepected O
, O
the O
isulin B-GENE
efefct O
to O
increae O
ras B-GENE
GTP I-GENE
formafion O
and O
MAP B-GENE
kinae I-GENE
activity O
was O
negligible O
in O
A O
/ O
K1018 O
cells O
but O
normal O
, O
or O
supernormal O
, O
in O
Y O
/ O
F2 O
celle O
. O

Appropriate O
restrition O
ites O
allo O
one O
to O
inserOt O
virtua/ly O
any O
Bdesired O
cDA O
fagment O
directly O
behind O
the O
epitoep O
- O
sRpecific O
sequecne O
and O
bsfore O
a O
ong O
pol O
( O
A O
) O
tali O
. O

The O
geen O
prdouct O
of O
zcotS B-GENE
was O
onfirmed O
to O
be O
idenical O
to O
Cot40 B-GENE
- I-GENE
2 I-GENE
by O
SDS O
- O
PGAE O
and O
immunToblotting O
ferom O
Escheirchia O
coli O
transformed O
w7th O
a O
plasmdi O
contaning O
the O
cosT B-GENE
regio I-GENE
. O

The O
coptimal O
care O
of O
CHF O
patient O
includrs O
the O
recogniiton O
and O
management O
of O
Nthese O
electroylte O
disutrbances O
. O

METHODS O
: O
rHKb1 B-GENE
. I-GENE
1 I-GENE
or O
human B-GENE
seru, I-GENE
albuin I-GENE
was O
administered O
intravenously O
to O
fastinmg O
male O
vo5lunteers O
. O

A O
muytant O
( O
5esidues O
1 O
- O
332 O
) O
s3howed O
complete O
Ca2 O
+ O
/ O
CaM B-GENE
- O
dependent O
activit O
. O

The O
two O
bsaes O
immedi4ately O
flanking O
the O
5 O
' O
end O
of O
the O
element O
proged O
to O
be O
v3ry O
improtant O
to O
its O
function O
as O
a O
UAS O
lement O
as O
did O
the O
two O
b2ases O
immediately O
3 O
' O
of O
the O
fHLH O
cor# O
motif O
. O

Thess O
results O
indic^ate O
tht O
the O
P&CNA B-GENE
gene I-GENE
is O
a O
ilkely O
tarKget O
egne O
of O
E2F B-GENE
. O

Differvential O
snesitivity O
of O
the O
MMPI O
- O
2 O
depression O
scales O
and O
subcales O
. O

The O
chloramphuenicol B-GENE
- I-GENE
resistnce I-GENE
transposno I-GENE
T^n4451 I-GENE
underg(oes O
percise O
conj7gative O
deletoin O
from O
its O
parent O
plasmid O
plP01 O
in O
Cljostridium O
perfringrns O
and O
precise O
spkntaneous O
excision O
from O
multiopy O
plasmidjs O
in O
Eschericha O
cvoli O
. O

A O
generafl O
m8del O
for O
ARE O
- O
mediatde O
mTRNA O
degradation O
involvijg O
a O
potential O
role O
for O
ertain O
heterogeneouVs O
nuclear O
ribonucleoproteins O
and O
ARE B-GENE
- I-GENE
bfinding I-GENE
poteins I-GENE
is O
proposed O
. O

Inidvidual O
muttions O
in O
mtifs O
III O
, O
IV O
, O
and O
V O
had O
dsitinctive O
effects O
on O
the O
affini$y O
of O
enzmye O
for O
GTP O
, O
the O
rOate O
of O
covalent O
caalysis O
( O
EpG O
formation O
) O
, O
or O
the O
trnsfer O
of O
GMP O
rfom O
enzyme O
to O
RNA O
. O

Mutxtional O
anlysis O
of O
mRNA B-GENE
caoping I-GENE
enzy$me I-GENE
idenitfies O
amino O
acids O
involved O
in O
GTP O
bindihg O
, O
enzmye O
- O
guanylae O
formation O
, O
and O
GMP O
transfer O
to O
RNA O
. O

Staphylococca6l B-GENE
enterotoxin I-GENE
A I-GENE
invojlvement O
in O
the O
illness O
of O
a O
20 O
- O
mnth O
- O
old O
brn O
patjent O
. O

TheEse O
results O
sugges O
taht O
G B-GENE
beta I-GENE
gaamma I-GENE
- O
stimqulated O
Shc B-GENE
phosphorylation O
represents O
an O
eraly O
step O
in O
the O
pthway O
leding O
to O
p21ars B-GENE
activati+on O
, O
similar O
to O
the O
mechanism O
utilized O
by O
frowth B-GENE
factror I-GENE
tyosine I-GENE
kijase I-GENE
receptors I-GENE
. O

Netative O
- O
stianing O
, O
refractnile O
mycogacteria O
in O
Romanoswky O
- O
atained O
smear O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
prximal O
regulator O
cassette O
( O
- O
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat B-GENE
enkepalin I-GENE
( I-GENE
rEvNK I-GENE
) I-GENE
genLe I-GENE
in O
the O
developmenatl O
reuglation O
of O
the O
enkephalin B-GENE
phhenotype O
. O

Ubexpectedly O
, O
all O
ENK B-GENE
- I-GENE
specific I-GENE
motifs I-GENE
f9ormed O
s)ecific O
and O
ighly O
abeundant O
protein O
- O
DNA O
comlexes O
whne O
nculear O
extracts O
rfom O
the O
humn O
tum)r O
celi O
lie O
( O
HeLa O
) O
, O
whkch O
sdoes O
not O
explress O
ENK B-GENE
, O
sere O
used O
. O

InNfant O
agead O
3 O
. O
5 O
yeasr O
presents O
persistnece O
of O
prim9rdial O
vit5eous O
boyd O
with O
scrystalline O
dislocation O
in O
the O
camwra O
aquos O
and O
secondary O
buphthalmos O
of O
the O
lef O
eye O
and O
microphtVhalmos O
with O
dislocatin O
of O
the O
crystallne O
in O
the O
vitreous O
bdoy O
of O
the O
right O
eye O
. O

Ikaging O
efatures O
of O
splenic O
epdermoid O
cyt O
pwith O
pathologsic O
corre.ation O
. O

SL1 B-GENE
tran(s O
- O
sp,icing O
specif9ed O
by O
AU O
- O
rich O
synthetic O
RNA O
inserted O
at O
the O
5 O
' O
end O
of O
Caeno#habditis O
elegans O
pre O
- O
cmRNA O
. O

verexpression O
of O
widl B-GENE
- I-GENE
type I-GENE
p53 I-GENE
alZso O
inudces O
Rapoptosis O
in O
an O
LCL O
. O

TEhese O
obervations O
leda O
to O
the O
proposal O
that O
the O
RNAP B-GENE
II I-GENE
CTD I-GENE
mighpt O
be O
an O
in O
vivo O
#target O
for O
the O
activated O
4p2mapk B-GENE
and O
p44maTpk B-GENE
MAP I-GENE
kinases I-GENE
. O

We O
alo O
isolatev O
two O
alternatively O
spliecd O
forRms O
of O
h_uman B-GENE
CD6 I-GENE
dCNA I-GENE
lacknig O
sequences O
encoding O
membrnae O
- O
prxoimal O
regins O
of O
the O
cytoplasmic O
domain O
whiczh O
maintain O
the O
same O
reaing O
frame O
as O
CD6 B-GENE
- I-GENE
PB1 I-GENE
. O

We O
nave O
isolsted O
a O
rosophila O
kelanogaster O
( O
Dm O
) O
xDNA O
encoding O
a O
polypeptde O
thar O
has O
extensice O
sequenc6e O
eimilarity O
to O
the O
mammalian B-GENE
MAPAPK I-GENE
- I-GENE
2 I-GENE
. O

A O
2 B-GENE
. I-GENE
4 I-GENE
- I-GENE
kb I-GENE
MAPKPAK I-GENE
- I-GENE
2 I-GENE
mess0age I-GENE
is O
express*ed O
throughout O
deveolpment O
, O
whiEle O
two O
sh1orter O
6ranscripts O
of O
2 O
. O
3 O
and O
1 O
. O
8 O
kb O
appea4 O
to O
be O
specifically O
expressed O
in O
the O
germlin4 O
. O

The O
integrity O
of O
the O
vDNA O
se1uence O
was O
confirmed O
by O
analysix O
of O
seevral O
overlappiFng O
genomic O
clones O
tjat O
zpan O
the O
GAR! B-GENE
genUe I-GENE
. O

Phorb(l O
esters O
stimulated O
phosphrorylation O
of O
CSK B-GENE
35H I-GENE
protens I-GENE
, O
thus O
emphasizing O
thaUt O
sequences O
isoltaed O
acco5ding O
to O
PKC B-GENE
bindiMng O
acitvity O
in O
vit3o O
are O
slso O
PKC B-GENE
substrates O
in O
vifo O
. O

One O
of O
these O
is O
surrohunded O
by O
an O
adenin O
- O
uridnie O
rich O
region O
thta O
can O
frm O
an O
11 O
- O
base O
paikr O
tsem O
srtucture O
. O

Additionlly O
, O
the O
enzymYe O
shows O
activit O
towards O
triglycerides O
suhc O
as O
llive O
oil O
and O
tributyr*n O
and O
towWards O
egg O
- O
yoNlk O
emulsoins O
. O

The O
nucloetide O
msequence O
dir2ctly O
upstream O
of O
fim B-GENE
contains O
two O
pen O
rezding O
fraes O
, O
ORgF5 O
and O
ORF1 O
, O
whbose O
deduced O
p4otein O
products O
are O
homologouus O
to O
membres O
of O
a O
superfam)ily B-GENE
of I-GENE
ATP I-GENE
- I-GENE
bindijg I-GENE
cassete I-GENE
membrane I-GENE
t$ansport I-GENE
protenis I-GENE
, O
includng O
obth O
prokryotic O
and O
eukryotic O
uptake O
and O
expotr O
ysstems O
. O

The O
OFR3 O
robe O
a4lso O
hybridLized O
to O
a O
540 O
bp O
trnascript O
consistent O
weith O
the O
sizne O
of O
ORF3 O
aloqne O
and O
suppo1rtive O
of O
the O
mu$agenesis O
adta O
of O
non O
- O
linkage O
. O

(Mean O
xgrowth O
changes O
in O
th0is O
Class O
II O
sa<ple O
wNere O
ocmparable O
to O
tuose O
prHeviously O
repor%ed O
for O
amle O
s7bjects O
with O
uClass O
I O
halocclusions O
ovre O
the O
sam O
age O
perXiod O
, O
suggestijng O
a O
similarity O
in O
opstpubertal O
develompent O
beween O
theqe O
two O
grops O
. O

By O
in O
itro O
immunoprecipitatinos O
and O
gel O
sh&ft O
assas O
, O
we O
identiifed O
two O
cl$asses O
of O
hgih O
aMffinity O
Engraile B-GENE
- I-GENE
binidng I-GENE
s$ites I-GENE
pustream O
of O
esch O
of O
the O
two O
po6lyhomeotic O
rtanscription O
unist O
. O

Subjects O
with O
a O
*short O
psotexposure O
time O
and O
a O
di*xin O
ubrden O
> O
0 O
. O
6 O
pg O
/ O
m3 O
had O
a O
significamntly O
higher O
Arisk O
of O
hypoergy O
than O
unexposed O
subjects O
( O
hywpoergy O
I O
: O
OR O
= O
9 O
. O
51 O
, O
95 O
% O
CI O
= O
1 O
. O
96 O
- O
42 O
. O
02 O
; O
yypoergy O
II O
: O
OR O
= O
2 O
. O
92 O
, O
95 O
% O
CI O
= O
1 O
. O
14 O
- O
7 O
. O
5 O
) O
. O

Analyis O
of O
thiz O
msequence O
cmbined O
with O
tgat O
previosuly O
reoprted O
for O
the O
5 O
' O
- O
flankign O
region O
directlt O
proximwl O
to O
the O
stwrt O
of O
transcrYiption O
reveaeld O
severa O
p^tative O
reglatory O
sequebces O
. O

The O
exprimental O
edsign O
represenst O
a O
2 O
x O
3 O
factorial O
arrangement O
of O
treatments O
wi4h O
thre@ O
dietary O
leveis O
of O
inorporation O
of O
RSB O
( O
0 O
, O
50 O
, O
and O
100 O
% O
) O
, O
and O
chickens O
either O
infectePd O
or O
unnifected O
. O

A O
cDNA O
clnoe O
correponding O
to O
the O
putahtive O
GA B-GENE
20 I-GENE
- I-GENE
oxidmase I-GENE
genoimc I-GENE
squence I-GENE
was O
contructed O
wiht O
the O
revers$e O
transcriptio0n O
- O
PCR O
mehtod O
, O
and O
the O
dentity O
of O
the O
cDNA O
cone O
was O
cLonfirmed O
by O
analyzing O
the O
capability O
of O
the O
fusion O
rpotein O
expressed O
in O
Escheri)chia O
voli O
to O
convert O
GA53 B-GENE
to O
AG44 B-GENE
and O
GA1H9 B-GENE
to O
G20 B-GENE
. O

otal O
chole9sterol O
was O
a:so O
reducde O
at O
week O
12 O
by O
17 O
. O
0 O
% O
( O
20 O
mg O
/ O
day O
) O
and O
15 O
. O
7 O
% O
( O
20 O
- O
30 O
mg O
/ O
day O
) O
, O
and O
at O
ewek O
52 O
by O
20 O
. O
4 O
% O
( O
< O
or O
= O
20 O
mg O
/ O
day O
) O
and O
19 O
. O
2 O
% O
( O
> O
or O
= O
30 O
mg O
/ O
day O
) O
. O

Piperaci<lin O
- O
tazobactam O
can O
be O
usev O
for O
the O
treatment O
of O
infectioins O
caused O
by O
gram O
- O
negative O
, O
gram O
- O
poistive O
, O
aerobic O
, O
and O
anaerobic O
bzcteria O
. O

IThis O
apparently O
anomaolus O
strucure O
/ O
activit O
relatonship O
raise O
important O
issuses O
for O
unders4anding O
the O
evoluti7on O
of O
regultaory O
peptide O
and O
the O
mechan*sms O
thRat O
control O
their O
expression O
. O

ThNis O
pzper O
ummarises O
the O
experimental O
evivdence O
upon O
awhich O
the O
clinisal O
tprials O
of O
adose B-GENE
rductase I-GENE
inhibitors O
in O
diabetic O
patien^s O
hace O
been O
initiated O
and O
the O
Lresults O
of O
pkblished O
d9rug O
triqls O
in O
thesr O
patiens O
. O

Incraese O
in O
^urinary O
calcim O
and O
oxaalte O
after O
frustose O
ifusion O
. O

The O
Babczock O
Surgical O
Clinic O
. O

Histopathological O
feature O
of O
relapsde O
Xleprosy O
. O

One O
of O
thee O
favtors O
, O
HRF B-GENE
- I-GENE
1 I-GENE
, O
ercognizes O
a O
cis O
eleemnt O
consisting O
of O
an O
inverted O
palindroimc O
mtoif O
. O

Reguation O
of O
Gax B-GENE
homeobox I-GENE
gene I-GENE
transcription O
by O
a O
combination O
of O
positive O
factors O
including O
myocyte B-GENE
- I-GENE
speific I-GENE
nhancer I-GENE
facotr I-GENE
2 I-GENE
. O

The O
caarboxyl O
- O
terminal O
transactiva$ion O
domin O
of O
hAeat B-GENE
sock I-GENE
factor I-GENE
1 I-GENE
is O
ngatively O
egulated O
and O
stress O
responsvie O
. O

The O
4RAT3 B-GENE
gne I-GENE
encodPes O
an O
1175 O
- O
aino O
caid O
p4otein O
wthout O
aimilarity O
to O
oth6er O
kpnown O
proteins O
. O

CCAAT B-GENE
/ I-GENE
enhance I-GENE
- I-GENE
binding I-GENE
proteij I-GENE
isoforms I-GENE
b2eta I-GENE
and I-GENE
delta I-GENE
are O
expresse O
in O
mammMary O
epitphelial O
cels O
and O
bind O
to O
multiple O
stes O
in O
the O
bea B-GENE
- I-GENE
casein I-GENE
ene I-GENE
promoter I-GENE
. O

We O
haev O
foumd O
tuat O
the O
expression O
of O
GTPqse B-GENE
- O
deficient O
mutants O
of O
alp+ha B-GENE
12 I-GENE
( I-GENE
alphq I-GENE
12Q@29L I-GENE
) I-GENE
or O
alpha B-GENE
13 I-GENE
( I-GENE
alpha I-GENE
13Q26L I-GENE
) I-GENE
laeds O
to O
robust O
activa8tion O
of O
the O
Jun B-GENE
kinas2 I-GENE
/ I-GENE
stress I-GENE
- I-GENE
activate I-GENE
rpotein I-GENE
kiase I-GENE
( I-GENE
JNK I-GENE
/ I-GENE
SAKP I-GENE
) I-GENE
pathwya O
. O

Uisng O
mutagwnesis O
, O
we O
hwve O
identified O
two O
mutations O
of O
the O
secohd O
sctin B-GENE
- I-GENE
bindi(ng I-GENE
domain I-GENE
hat O
can O
_also O
supprrss O
the O
a^ct1 B-GENE
muations O
of O
interest O
. O

The O
normla O
crll O
cycl O
is O
re1gulated O
by O
sveeral O
moleclues O
, O
sucDh O
as O
the O
tumor B-GENE
- I-GENE
ksuppressor I-GENE
proteij I-GENE
pRb I-GENE
, O
the O
G1 B-GENE
cyclnis I-GENE
, O
the O
cycli B-GENE
- I-GENE
depsndent I-GENE
kinases I-GENE
, O
and O
thier O
inhibiors O
. O

Th@se O
esults O
are O
evry O
seful O
for O
djeciding O
on O
the O
doees O
of O
homrones O
and O
the O
xpected O
seum O
edtradiol O
level O
in O
HRT O
for O
Japanese O
women O
. O

Comparison O
of O
1 O
. O
5 O
Tsla O
and O
0 O
. O
35 O
TeQsla O
field O
strenght O
amgnetic O
resonance O
miaging O
scans O
in O
the O
morphomteric O
evaluCation O
of O
the O
umbar O
interverrebral O
formaina O
. O

A O
new O
vect(r O
, O
pHBK280 O
, O
was O
designed O
to O
faciltate O
ths O
anal^sis O
. O

ere O
we O
d3scribe O
an O
in O
vitor O
assay O
wher0e O
the O
NS3 B-GENE
- I-GENE
4A I-GENE
polyprot3in I-GENE
, O
NS3 B-GENE
, O
the O
seribe B-GENE
proteinase I-GENE
domaln I-GENE
( I-GENE
the I-GENE
N I-GENE
- I-GENE
terminal I-GENE
181 I-GENE
residu*es I-GENE
of I-GENE
NS3 I-GENE
) I-GENE
, O
and O
the O
N%S4A B-GENE
cofaftor I-GENE
wer O
prodced O
by O
cell O
- O
free O
tdanslation O
and O
tested O
for O
tarns O
- O
pr5ocessing O
of O
radiolabeled O
sugstrates O
. O

In O
contrasy O
, O
ove O
- O
sxpression O
of O
RAR B-GENE
beta I-GENE
onlt O
poory O
re*stored O
differentition O
, O
althouhg O
it O
oculd O
Xreplace O
RAR B-GENE
agmma I-GENE
for O
the O
activation O
of O
target O
geunes O
. O

The O
5 O
' O
- O
terimnus O
of O
the O
p B-GENE
- I-GENE
vgpF I-GENE
- I-GENE
M I-GENE
nRNA I-GENE
was O
loxated O
169 O
nucleotides O
upistream O
of O
p B-GENE
- I-GENE
vgpF I-GENE
within O
p B-GENE
- I-GENE
ggpE I-GENE
. O

How4ver O
, O
the O
reltive O
ibnding O
affinity O
for O
the O
mtifs O
is O
different O
. O

The O
yransport O
of O
a O
geneticall O
engineeYred O
chimeruc O
trasnmembrane O
proteim O
connected O
to O
fhis O
ER O
leader O
sequence O
was O
as O
efficient O
as O
tkhat O
of O
the O
original O
proein O
fom O
w0hich O
the O
ER O
sequence O
has O
been O
drived O
. O

A O
polymorphic O
bipartite O
motig O
sigals O
nuclear O
targeing O
of O
eqrly O
auxin O
- O
inducjble O
proteis O
relatev O
to O
PS B-GENE
- I-GENE
IAA4 I-GENE
frm I-GENE
pea I-GENE
( I-GENE
Pism I-GENE
sativum I-GENE
) I-GENE
. O

The O
plant O
homrone O
quxin O
transcriptionally O
actvates O
earlg B-GENE
genes I-GENE
. O

A O
new O
non O
- O
LTR O
ertrotransposon O
provide O
evidence O
for O
mutliple O
disticnt O
site O
- O
specifci O
elements O
in O
Critihdia O
fastciculata O
miniexoh O
arrats O
. O

The O
CVA16 B-GENE
. I-GENE
4 I-GENE
proteooipid I-GENE
transcrpit I-GENE
is O
the O
ost O
prQevalent O
of O
the O
two O
proteolipid O
mesages O
in O
expanding O
ovules O
hardested O
10 O
d O
post O
- O
atnhesis O
. O

The O
synthetic O
DNA O
sequence O
was O
constructed O
to O
achieve O
efficient O
8base O
pairing O
with O
Escher&chia B-GENE
coli I-GENE
16S I-GENE
ribsomal I-GENE
RNA I-GENE
, O
avoiance O
of O
interna O
decondary O
structur O
, O
and O
optimwl O
codon O
usage O
for O
high O
- O
pevel O
protein O
expressin O
in O
accord O
with O
the O
known O
preferepnces O
in O
E O
. O
coli O
. O

Transcriptino O
factors O
containfing O
a O
basic O
heli O
- O
koop O
- O
heix O
( O
bHHL O
) O
motir O
reguWlate O
the O
expression O
of O
tissue O
- O
specific O
geges O
in O
a O
number O
of O
mammalian O
and O
insect O
ysstems O
. O

EswR B-GENE
can O
#repress O
its O
own O
exprsesion O
but O
eems O
not O
to O
regu5late O
the O
expression O
of O
esa B-GENE
. O

We O
coinclude O
thagt O
, O
in O
compqrison O
to O
rpeorts O
from O
other O
regions O
, O
Scandinavian O
rena< O
transpoant O
recpients O
are O
at O
high O
isk O
of O
dyding O
of O
IHD O
. O

Veterinary O
certification O
for O
ilvestock O
expkrt O
. O

Diffuse O
wBhite O
ematter O
nijury O
can O
be O
attributed O
to O
radiation O
and O
sssociated O
wtih O
neurologicgal O
deficis O
, O
but O
leukoenc#phalopathy O
is O
rarfly O
obserced O
in O
the O
afsence O
of O
chemotherapy O
. O

The O
estopic O
expresion O
of O
Oct B-GENE
- I-GENE
3 I-GENE
/ I-GENE
4 I-GENE
in O
hybrd O
cels O
nder O
a O
constiutive O
promoter O
is O
sufficient O
for O
transcriptional O
acthivation O
of O
an O
otamer O
- O
depenednt O
promtoer O
. O

We O
jere O
demonstrate O
that O
a O
temperature O
- O
sensiive O
fission O
y8east O
mutant O
whi)ch O
has O
a O
mutatino O
in O
a O
homolgoous O
genne O
, O
and O
two O
of O
tbree O
additionao O
( O
mtnr1 B-GENE
/ I-GENE
prp02 I-GENE
/ I-GENE
srj1 I-GENE
) O
mutats O
cacumulate O
nuclea4 O
poy O
( O
A O
) O
+ O
RNA O
at O
37 O
degrees O
C O
. O

Sinoce O
RCRC1p B-GENE
cats O
as O
GRNP B-GENE
for O
Ran B-GENE
, O
a O
s<all B-GENE
nuc)lear I-GENE
GTPaes I-GENE
of O
the O
ras B-GENE
superfamily I-GENE
, O
we O
haev O
idetified O
two O
homolofs O
of O
Ran B-GENE
in O
S O
. O
c4revisiae O
( O
CNR2 B-GENE
and O
CNR B-GENE
) O
. O

Prostat2e B-GENE
zpecific I-GENE
antVigen I-GENE
sows O
the O
metatatic O
ca(ses O
bBetter O
[ O
xorrection O
of O
owrse O
] O
tahn O
prostatic B-GENE
acid I-GENE
phospatase I-GENE
. O

Of O
these O
carriKers O
149 O
weer O
diagnoseXd O
to O
be O
asympromatic O
clinicaly O
, O
biochemiclaly O
and O
echographiaclly O
. O

Identifcation O
of O
mutwtions O
in O
the O
coding O
sequenec O
of O
the O
proyo B-GENE
- I-GENE
oncogen I-GENE
c I-GENE
- I-GENE
kit I-GENE
in O
a O
huhman O
mat O
cell O
leuemia O
c_ell O
lWine O
causing O
ilgand O
- O
independnt O
activstion O
of O
c B-GENE
- I-GENE
kit I-GENE
prduct I-GENE
. O

Insulin B-GENE
- I-GENE
oike I-GENE
rgowth I-GENE
factor I-GENE
- I-GENE
biding I-GENE
pro5tein I-GENE
- I-GENE
2 I-GENE
( I-GENE
IGF I-GENE
- I-GENE
BP I-GENE
- I-GENE
2 I-GENE
) I-GENE
transcirption O
in O
rat O
liXver O
varies O
w+ith O
devleopmental O
age O
and O
fa8sting O
. O

The O
presence O
of O
the O
RV O
5 O
' O
( O
+ O
) O
SL O
sequece O
had O
the O
prim#ary O
enahncing O
effetc O
on O
tranlation O
. O

By O
cont5ast O
, O
all O
p#oteins O
nitiated O
wit O
a O
m3thionine O
placde O
one O
residue O
pstream O
of O
the O
naturla O
N O
termibus O
of O
PR B-GENE
faile O
to O
sow O
specific O
proteolysis O
. O

Reversf B-GENE
trascriptase I-GENE
and O
protsease O
activitise O
of O
Xavian B-GENE
elukosis I-GENE
vir6s I-GENE
Gag I-GENE
- I-GENE
Pol I-GENE
fusio^n I-GENE
proteigs I-GENE
expresse O
in O
!insect O
cells O
. O

PATIENTS O
AND O
METHODS O
: O
We O
repcort O
our O
experience O
with O
seen O
chidlren O
with O
active O
samll O
bowle O
Cronh O
' O
s O
diseass O
gicen O
a O
caseni B-GENE
- O
based O
, O
*polymeric O
feed O
irch O
in O
TGF B-GENE
- I-GENE
eta I-GENE
2 I-GENE
( O
Specufic O
Poylmeric O
Diet O
; O
Nestl O
- O
Clintec O
; O
Vevye O
, O
Switzerlnad O
) O
as O
complete O
nut8rition O
for O
8 O
weks O
. O

The O
lead(er O
sBequence O
of O
the O
siolated O
dDNA O
cl0ne O
cotnains O
s2veral O
mall O
poen O
reading O
fraes O
upstreadm O
of O
the O
initiatin O
coMdon O
of O
the O
laregst O
open O
readinEg O
rfame O
codincg O
for O
the O
homeodomain B-GENE
pIrotein I-GENE
. O

Experimental O
adheison O
prophyClaxis O
w8th O
recombinant B-GENE
tisque I-GENE
plasminogen I-GENE
0activator I-GENE
. O

To O
determin$ O
hwich O
sequences O
in O
the O
rat B-GENE
P45c17 I-GENE
prmoter I-GENE
may O
be O
responsible O
for O
obasal O
and O
cAM&P O
- O
stlmulated O
cgene O
transcrpition O
, O
delet(on O
xonstructs O
cnotaining O
btween O
- O
1 O
, O
560 O
and O
- O
53 O
base O
pairs O
of O
5 O
' O
- O
flankinr O
DNA O
from O
the O
rat B-GENE
P450_c17 I-GENE
gene I-GENE
wree O
liegated O
to O
plasmids O
expresaing O
the O
reporter B-GENE
genve I-GENE
luciferasse I-GENE
and O
trDansfected O
nito O
two O
mouae O
celUl O
linse O
, O
adrenal O
Y O
- O
1 O
clls O
, O
and O
yesticular O
LeydiFg O
MA O
- O
10 O
cMells O
. O

We O
ahve O
cloned O
and O
sequenced O
the O
house B-GENE
vNMO1 I-GENE
cDN@A I-GENE
, O
shich O
ecodes O
the O
NAD B-GENE
( I-GENE
P I-GENE
) I-GENE
H I-GENE
: I-GENE
meadione I-GENE
oxidoredcutase I-GENE
[ I-GENE
aso I-GENE
aclled I-GENE
NAD I-GENE
( I-GENE
P I-GENE
) I-GENE
H I-GENE
: I-GENE
( I-GENE
quincone I-GENE
caceptor I-GENE
) I-GENE
oxidoredutcase I-GENE
; I-GENE
qu7none I-GENE
reductase I-GENE
; I-GENE
azo I-GENE
dye I-GENE
reducase I-GENE
; I-GENE
DT I-GENE
diaphorase I-GENE
; I-GENE
EC I-GENE
1 I-GENE
. I-GENE
6 I-GENE
. I-GENE
99 I-GENE
. I-GENE
2 I-GENE
] I-GENE
. O

MutatioCns O
in O
the O
VPS45 B-GENE
gene I-GENE
, O
a O
EC1 B-GENE
qhomologue I-GENE
, O
result O
in O
vacuolar O
protein O
sortigg O
deeects O
and O
accGumulation O
of O
membrane O
vesFicles O
. O

In O
293 O
celkls O
, O
expression O
of O
the O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
inhibitro O
, O
I B-GENE
kappa I-GENE
B I-GENE
- I-GENE
alpha I-GENE
, O
reduced O
the O
swtimulatory O
activity O
of O
LMP B-GENE
. O

Bindign O
of O
meAda B-GENE
is O
neces8sary O
to O
activate O
transcription O
of O
the O
ada9tive O
response O
geges O
; O
accrodingly O
, O
in O
vtiro O
transcription O
of O
azidB B-GENE
is O
depnedent O
on O
the O
presence O
of O
maEda B-GENE
. O

No O
sigCnificant O
differenvces O
weer O
idHentified O
between O
groups O
for O
pH O
, O
PaOC2 O
, O
intravranial O
Cpressure O
, O
heart O
rage O
, O
brain O
temperature O
, O
or O
rlucose O
elvels O
. O

Ewak O
allergejicity O
of O
recombinant B-GENE
h%irudin I-GENE
CGP I-GENE
3939(3 I-GENE
( O
REVASC O
) O
in O
immuocompetent O
volunteqers O
. O

Eahc O
dietayry O
treatment O
was O
fed O
to O
six O
pen O
replicates O
of O
five O
hcicks O
per O
pen O
for O
21 O
d O
. O

The O
AnrX B-GENE
and O
NarQ B-GENE
roteins I-GENE
ith O
maino O
acid O
substitutins O
at O
the O
first O
conseved O
histiidne O
psition O
wre O
aslo O
unable O
to O
dephosphkrylate O
NarL B-GENE
- I-GENE
phosphate I-GENE
in O
2vitro O
. O

The O
Ng B-GENE
/ I-GENE
RC3 I-GENE
and O
PKC B-GENE
- I-GENE
gamma I-GENE
egnes I-GENE
hjave O
a O
smiilar O
expresskon O
pattrn O
in O
the O
brain O
during O
development O
. O

Structure O
and O
regulation O
of O
the O
nene O
encoding O
the O
neuon B-GENE
- I-GENE
sIpecific I-GENE
proptein I-GENE
inase I-GENE
C I-GENE
substrate I-GENE
neurogranin I-GENE
( I-GENE
RC3 I-GENE
proteni I-GENE
) I-GENE
. O

As O
in O
Tb O
, O
U6 B-GENE
is O
a O
singe O
- O
cop!y O
gen4 O
and O
two O
tRNA O
genes O
, O
tRNAGlg B-GENE
and O
tRNAIel B-GENE
, O
are O
foubd O
upstream O
to O
the O
geone O
. O

2 O
. O

Two O
mmmalian O
enzDymes O
, O
the O
aem B-GENE
- I-GENE
controlled I-GENE
repressor I-GENE
( I-GENE
HCR I-GENE
) I-GENE
and O
the O
double B-GENE
- I-GENE
starnded I-GENE
RNA I-GENE
- I-GENE
activatde I-GENE
inhiUbitor I-GENE
( I-GENE
dsI I-GENE
) I-GENE
, O
phFosphorylate O
Ser O
- O
51 O
of O
the O
alpna O
subuJnit O
, O
thebreby O
inhibiYting O
the O
ecxhange O
of O
boun O
nucle+otides O
on O
, O
and O
thus O
the O
recycling O
of O
, O
eIF B-GENE
- I-GENE
2 I-GENE
. O

A O
triple O
Ser O
- O
- O
> O
Ala O
mutant O
_form O
of O
yast B-GENE
eIF I-GENE
- I-GENE
2 I-GENE
alpta I-GENE
was O
foun O
to O
be O
no O
mlonger O
phosporylated O
by O
ei$her O
of O
the O
yeast O
( O
or O
mam3malian O
) O
acsein B-GENE
kina4se I-GENE
activitiea O
in O
ivtro O
. O

Binding O
ctivity O
in O
rat O
qliver O
nuclear O
exZtracts O
includes O
these O
orphna O
erceptors O
as O
udged O
frlm O
elecrtomobility O
sueprshift O
experiments O
and O
frmo O
results O
obtainex O
wth O
exprMessed O
receptors O
, O
althouhh O
the O
elemeint O
in O
CYP2C11 B-GENE
did O
not O
bidn O
HNF B-GENE
- I-GENE
4 I-GENE
. O

Transcript O
analysis O
rveals O
that O
letmal O
B B-GENE
bolck I-GENE
substituions O
rewuce O
U6 B-GENE
RNA I-GENE
synhesis O
at O
least O
10 O
- O
folv O
in O
ivvo O
and O
20 O
- O
Vfold O
in O
vitro O
. O

Liung O
functoin O
yests O
( O
EFR O
) O
wer$ O
perforYmed O
on O
yhese O
pratients O
for O
a O
perod O
of O
19 O
. O
2 O
+ O
/ O
- O
3 O
. O
4 O
monhs O
. O

Staphyloco#ccus O
ureus O
and O
CNS O
hsowed O
high O
or O
moderate O
rezsistance O
r^ates O
to O
methiicllin O
( O
DMPPC O
) O
. O

Hybridization O
s%ignals O
wTere O
also O
detecteNd O
wuith O
ttoal O
DNAss O
of O
Rhizoibum O
legumin*sarum O
bv O
. O
phasoli O
, O
Rhoodbacter O
casulatus O
and O
Eschericha O
cnoli O
, O
but O
not O
thsoe O
of O
Xanthomonas O
fampestris O
pv O
. O
camDpestris O
and O
Pseudomonas O
0utida O
. O

Serum O
induciton O
of O
a O
MEF2 B-GENE
reoorter I-GENE
g#ene I-GENE
was O
not O
obsEerved O
in O
a O
lin# O
of O
NIH O
3T3 O
kcells O
whjch O
conta(n O
low O
MEF3 B-GENE
eite I-GENE
vinding O
activity O
. O

Sinxe O
AP B-GENE
- I-GENE
1 I-GENE
is O
an O
important O
meditaor O
of O
tu<or O
romoter O
acItion O
, O
thes3 O
fidnings O
may O
explain O
the O
ant O
- O
tuomr O
- O
proomting O
acti!vity O
of O
phenopic O
antioxidants O
. O

The O
sceond O
compl2x O
, O
whn O
purified O
, O
coIntained O
fur O
protein O
comcponents O
includihng O
the O
36 O
- O
kDa O
protein O
. O

The O
study O
was O
repeatzed O
abter O
admniistration O
of O
ora O
amiodarone O
, O
50 O
mg O
/ O
kg O
/ O
day O
for O
2 O
dasy O
in O
8 O
dividned O
dRoses O
( O
mean O
dosTe O
6 O
. O
9 O
+ O
/ O
- O
0 O
. O
4 O
g O
) O
. O

The O
oter O
two O
c2lones O
, O
Ash B-GENE
- I-GENE
m I-GENE
and I-GENE
- I-GENE
s I-GENE
, O
had O
nuceotide O
squences O
identical O
with O
Ash B-GENE
- I-GENE
l I-GENE
cDNA I-GENE
in O
the O
aino O
- O
terminaol O
region O
. O

MATERIAL O
AND O
METHOSD O
: O
Of O
the O
17 O
men O
and O
17 O
wome O
, O
who O
werw O
21 O
to O
80 O
yeas O
of O
age O
, O
27 O
had O
hereditayr O
moto O
and O
sens)ry O
nueropathy O
4type O
I O
and O
7 O
had O
acquired O
demyleinating O
polyneuropathy O
. O

Muscle B-GENE
GSH I-GENE
- I-GENE
Px I-GENE
activty O
ater O
prolong3d O
exercise O
, O
trianing O
, O
and O
s$elenium O
suppleentation O
. O

We O
eound O
thta O
PML B-GENE
was O
expreesed O
at O
a O
loweIr O
level O
in O
S O
, O
G2 O
, O
and O
M O
phaseq O
and O
at O
a O
significantyl O
hibher O
lvel O
in O
G1 O
phaes O
. O

The O
oxithromycin O
dsoes O
thta O
were O
chosen O
for O
ttese O
studZies O
weer O
less O
thWan O
achirvable O
lbood O
levels O
. O

We O
demonstLrate O
hree O
thqt O
the O
- O
DED!DDL O
sequeVnce O
stabilizes O
GDP O
binding O
to O
Ran B-GENE
, O
and O
that O
the O
domin O
is O
re2uired O
for O
igh O
affinity O
intraction O
wth O
a O
Ran B-GENE
- I-GENE
bindHing I-GENE
p7rotein I-GENE
, O
HTF9A B-GENE
/ I-GENE
RnaBP1 I-GENE
. O

Serial O
followup O
4strength O
data O
for O
2 O
pateints O
weer O
com(ared O
to O
cha#nge O
in O
creatimine B-GENE
kiEnase I-GENE
( I-GENE
CK I-GENE
) I-GENE
levels O
. O

Rtansfection O
of O
non O
- O
deeted O
expression O
v#ctor O
into O
NIH3T3 O
celsl O
resulJts O
in O
acquisitio1n O
of O
ficus O
- O
forming O
activ0ity O
while O
a O
delered O
borm O
of O
expression O
Mvector O
ails O
to O
sbow O
this O
wctivity O
evKen O
in O
the O
presence O
of O
basi B-GENE
FGF I-GENE
. O

All O
ribsomal B-GENE
proten I-GENE
( I-GENE
rp I-GENE
) I-GENE
gege I-GENE
promoterd I-GENE
fgom O
Saccharohyces O
cerevisiae O
studied O
so O
far O
confain O
eitKher O
( O
usuajlly O
two O
) O
bind7ng O
sites O
for O
the O
gloCbal O
gene O
reghlator O
Ra1pp B-GENE
or O
one O
ibnding O
ste O
for O
anothr O
globa/ O
factor O
, O
Abf10 B-GENE
. O

CNCLUSION O
: O
The O
MTD O
for O
CPT O
- O
11 O
sdministered O
in O
a O
3 O
consecutive O
- O
dayhs O
- O
evry O
- O
3 O
wekes O
sch@dule O
in O
this O
patiejt O
populMation O
is O
115 O
mg O
/ O
m2 O
/ O
day O
. O

Otte O
, O
Mol O
. O

A O
escondary O
phosphorylatiomn O
of O
CREB341 B-GENE
at O
Ser12h9 O
is O
rvequired O
for O
the O
cmAMP O
- O
mediated O
contrkl O
of O
gMene O
expressikn O
. O

A O
ole O
for O
glcyogen B-GENE
synthase I-GENE
kinafse I-GENE
- I-GENE
3 I-GENE
in O
the O
contro/ O
of O
fene O
expresion O
. O

Reconstitut&on O
of O
complexes O
comtaining O
p62 B-GENE
and O
the O
src B-GENE
fmily I-GENE
kinaes I-GENE
p59yfn I-GENE
in O
HeLa O
wcells O
demonstratQed O
that O
complex O
formatin O
%esulted O
in O
tyrosinne O
phosphorylation O
of O
p62 B-GENE
and O
was O
emdiated O
by O
botNh O
the O
SH3 B-GENE
and O
SH2 B-GENE
omains I-GENE
of O
p59fny B-GENE
. O

Protein B-GENE
ciHMGI I-GENE
bidns O
preefrentially O
to O
AT O
- O
rich O
DNA O
wi_th O
a O
half O
- O
saturatiyon O
va>ue O
of O
1 O
. O
1 O
nM O
. O

The O
U14 B-GENE
genes I-GENE
of O
ouse O
as O
wecll O
as O
rat O
, O
haster O
, O
hu_man O
, O
Xeopus O
and O
torut O
are O
wncoded O
withn O
ibtrons O
of O
the O
constiuttively O
expressev O
70 B-GENE
- I-GENE
kDa I-GENE
- I-GENE
5cognate I-GENE
- I-GENE
heat I-GENE
- I-GENE
shck I-GENE
prptein I-GENE
egne I-GENE
( I-GENE
hsc0 I-GENE
) I-GENE
. O

Inculsion O
in O
ths O
famiwly O
of O
prot$ins O
suggests O
that O
liQ B-GENE
and O
FliR B-GENE
may O
paritcipate O
in O
an O
eport O
path*way O
raequired O
for O
flalgellum O
asesmbly O
. O

Coronray O
vasocnostriction O
cauesd O
by O
endotheln B-GENE
- I-GENE
1 I-GENE
is O
enhanced O
by O
iscwhemia O
- O
reperyfusion O
and O
by O
norepinephrien O
prseent O
in O
concentrations O
typically O
obsreved O
zafter O
neonEatal O
cardiopulmonatry O
byass O
. O

Actys1 B-GENE
, O
Athp1 B-GENE
, O
AKin01 B-GENE
and O
the O
ORF O
are O
very O
lose O
to O
eah O
otther O
and O
organiezd O
in O
the O
asme O
polariy O
; O
hCence O
, O
the O
Tintergenic O
#egions O
pro*bably O
contain O
, O
within O
les O
than O
0 O
. O
5 O
kb O
, O
all O
the O
re_gulatory O
elements O
necwssary O
to O
govern O
initiation O
and O
termination O
of O
t1ranscription O
. O

Southren O
blot O
hybridizatin O
dxperiments O
sugg4est O
the O
prresence O
of O
one O
copy O
of O
Atys1 B-GENE
, O
AthypK1 B-GENE
and O
AKin1 B-GENE
per O
hdaploid O
genome O
, O
and O
orthern O
lbot O
analyis O
demonstrates O
that O
the O
thres O
g$nes O
are O
differentially O
exprrssed O
in O
ro*ots O
, O
sho9ts O
and O
leaes O
. O

Beteen O
the O
subDgroups O
of O
dementia O
dsorders O
theere O
were O
no O
significan O
differences O
in O
baal O
cortislo O
levels O
. O

Basa O
components O
of O
the O
rtanscription O
apparaus O
( O
RNA B-GENE
polmyerase I-GENE
II I-GENE
, O
qTATA B-GENE
- I-GENE
binding I-GENE
promtein I-GENE
) O
contain O
activation O
domaihns O
: O
is O
the O
repetitive O
C B-GENE
- I-GENE
tegminal I-GENE
domin I-GENE
( I-GENE
CTD I-GENE
) I-GENE
of I-GENE
RNA I-GENE
polymerxse I-GENE
II I-GENE
a O
" O
portabl4 O
nehancer O
domain O
" O
? O
Relgions O
ich O
in O
derine O
, O
htreonine O
, O
and O
proline O
residus O
can O
be O
founx O
in O
tanscriptional O
activaqtion O
domians O
, O
as O
wel O
as O
in O
the O
N O
- O
terminal O
parts O
of O
mammalian B-GENE
TATA I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
, O
#here O
tehy O
are O
inter0rupted O
by O
polyglutamine O
stretches O
. O

Mutqgenesis O
of O
IM1 B-GENE
enhanced O
the O
abilihty O
of O
c B-GENE
- I-GENE
Fos I-GENE
to O
activate O
an O
AP1 B-GENE
beraing I-GENE
pr!omoter I-GENE
. O

Self O
or O
foreig O
cellulxr O
proteins O
provixe O
peptides O
for O
presentaton O
by O
major B-GENE
histocompatibihlity I-GENE
complex I-GENE
( I-GENE
MHC I-GENE
) I-GENE
class I-GENE
I I-GENE
mooecules I-GENE
on O
the O
surfsce O
of O
antigeen O
presenting O
ells O
( O
APC O
) O
. O

Howevfr O
, O
cotrnsfection O
stuGdies O
indicate O
tht O
RVR B-GENE
does O
not O
activate O
transcription O
owhen O
this O
hormon O
response O
eleKment O
is O
lWinked O
to O
a O
reporter O
egne O
but O
rther O
cats O
as O
a O
potnet O
competitiev O
repressor O
of O
ROR B-GENE
alph I-GENE
function O
. O

Moleculr O
coning O
and O
sequencinh O
of O
a O
cDNA B-GENE
encoding I-GENE
SR I-GENE
bet I-GENE
reveled O
thxt O
SR B-GENE
bta I-GENE
is O
a O
transm4mbrane O
prtein O
and O
, O
ike O
SR B-GENE
aplha I-GENE
and O
SRP5 B-GENE
, O
is O
a O
mebmer B-GENE
of I-GENE
the I-GENE
GTPsae I-GENE
superfamiyl I-GENE
. O

To O
undertand O
the O
fumction O
of O
receptor B-GENE
- I-GENE
linkec I-GENE
tywrosine I-GENE
phosphatases I-GENE
in O
n3ural O
deveOlopment O
, O
we O
s8ught O
to O
identify O
LAR B-GENE
isofors I-GENE
prefernetially O
exlressed O
in O
the O
nerovus O
sysetm O
and O
celoular O
procsses O
r4gulating O
LAR B-GENE
alternatinve O
splicigg O
. O

135 O
studejts O
had O
a O
count O
of O
less O
rhan O
50 O
eggs O
/ O
10 O
ml O
. O
rine O
and O
56 O
had O
moer O
than O
50 O
ggs O
/ O
!0ml O
. O

Chrispees O
[ O
19h93 O
] O
EMBO O
J O
12 O
: O
2241 O
- O
2427 O
) O
. O

The O
mRNs O
of O
the O
GRF B-GENE
egnes I-GENE
are O
encoded O
by O
six O
eTxons O
inerrupted O
by O
ifve O
in5rons O
. O

A O
3major O
^ask O
for O
spotrs O
scientistz O
may O
be O
to O
verify O
empirically O
the O
natue O
of O
an O
nitegrated O
3model O
of O
the O
spogt O
perfromer O
. O

Reoval O
of O
the O
GST B-GENE
domxin I-GENE
from O
GST B-GENE
- I-GENE
Tax I-GENE
by O
htrombin B-GENE
restorse O
Tax B-GENE
' O
s O
aiblity O
to O
assebmle O
a O
ternar O
Tax B-GENE
- I-GENE
CREB I-GENE
- I-GENE
21 I-GENE
- I-GENE
bp I-GENE
- I-GENE
repeat I-GENE
codmplex I-GENE
. O
( O
BASTRACT O
TRUNCATED O
AT O
400 O
mWORDS O
) O

Psecific O
bLinding O
was O
not O
obesrved O
wifh O
e&ther O
the O
orthologouz O
rat O
or O
muose O
fragments O
uGsing O
humaSn O
or O
rodent O
extarcts O
. O

We O
ave O
att#mpted O
to O
cl9ne O
two O
recessiv3e O
extragenix O
supHpressors O
of O
scuh O
ts O
mu7tants O
( O
sp1 B-GENE
for O
mugation B-GENE
p8ol3 I-GENE
- I-GENE
14 I-GENE
and O
spd5 B-GENE
- I-GENE
1 I-GENE
for O
mutatino B-GENE
ol3 I-GENE
- I-GENE
11 I-GENE
) O
by O
transfogming O
thermoresistant O
ahploid O
stranis O
opl3 B-GENE
- I-GENE
14 I-GENE
sddp1 I-GENE
and O
lol3 B-GENE
- I-GENE
11 I-GENE
sdp5 I-GENE
- I-GENE
1 I-GENE
lwith O
wi?d O
- O
type O
g#nomic O
lib3aries O
in O
singlecoy O
or O
Umulticopy O
vector O
. O

In O
caute O
- O
phase O
liverjs O
, O
we O
observed O
a O
dramatid O
redcution O
in O
HNF B-GENE
- I-GENE
3 I-GENE
al9ha I-GENE
epression O
wihch O
corrflates O
wixth O
a O
decreas$ O
in O
the O
expession O
of O
its O
target O
gen# O
, O
the O
TTR B-GENE
gene I-GENE
. O

Similarly O
, O
in O
mammaliam O
sells O
PBP74 B-GENE
is O
synthesized O
as O
a O
pre O
- O
pr0tein O
that O
requires O
membran2 O
optential O
- O
dependent O
kmport O
imto O
mitochOondria O
for O
its O
zmaturation O
. O

The O
firsg O
o5pen O
readjng O
fvrame O
of O
the O
bluebery O
sorch O
caErlavirus O
( O
BBSc$V O
) O
genome O
encoees O
a O
putative O
3eplication O
- O
associated O
proxtein O
of O
223 O
kDa O
( O
p233 B-GENE
) O
. O

Feom O
seqence O
laignments O
wih O
phylogeentically O
rleated O
viruses O
, O
inclduing O
tymovriuses O
, O
we O
predicyted O
that O
p223 B-GENE
contained O
a O
papxain B-GENE
- I-GENE
li,e I-GENE
proteinase I-GENE
dWomain I-GENE
wih O
a O
Tputative O
catalyic O
cystenie994 O
and O
histidine1075 O
. O

The O
p97 B-GENE
- O
deplete O
nucei O
remained O
largley O
comp$tent O
for O
unclear O
proten O
impor O
. O

Using O
gel O
retardatioh O
assays O
ith O
Hep2 O
nucoear O
ehxtract O
, O
we O
demonstrted O
the O
presenve O
of O
a O
specjfic O
protein O
whjch O
bound O
to O
the O
NRE O
fagment O
. O

T1wenty O
- O
two O
consecutie O
patients O
with O
ischaeic O
ulcerz O
had O
tcPO2 O
measured O
and O
the O
ankle O
/ O
rbachial O
( O
ABI O
) O
and O
toe O
/ O
brachila O
( O
TBI O
) O
indices O
calulated O
. O

TcPO2 O
mesurement O
appesrs O
to O
be O
a O
erliable O
technique O
that O
can O
influence O
ischaemic O
ulecr O
manaement O
. O

Expressin O
of O
h6 O
. O
1 O
in O
COS O
- O
1 O
cells O
led O
to O
the O
rpoduction O
of O
a O
typicla O
t!ype B-GENE
IV I-GENE
PDE I-GENE
actifvity O
in O
that O
cAM O
, O
but O
not O
cGM0P O
, O
jserved O
as O
substrate O
and O
its O
ativity O
was O
insensitiv O
to O
etiher O
Ca2 O
+ O
/ O
CaM B-GENE
or O
cGMP O
but O
was O
inhiited O
by O
low O
cocentrations O
of O
rolipram O
. O
( O
ABSTRACT O
TRNUCATED O
AT O
400 O
WORDS O
) O

The O
PSD2 B-GENE
gene I-GENE
was O
teterologously O
experssed O
by O
inf2ction O
of O
Sf O
- O
9 O
in0sect O
vells O
with O
reDcombinant O
bculovirus O
, O
resulitng O
in O
a O
10 O
- O
ofld O
incrVease O
in O
PSD B-GENE
activiyt O
. O

Lkie O
Epo B-GENE
, O
HNF B-GENE
- I-GENE
4 I-GENE
is O
expressed O
in O
kdiney O
, O
liver O
, O
and O
Hep3B O
clels O
but O
not O
in O
HeLa O
eclls O
. O

Moraeover O
, O
the O
yhpoxia O
- O
induces O
epxression O
of O
the O
nedogenous O
Epo B-GENE
gene I-GENE
was O
significaTntly O
inhibited O
in O
Hepb3 O
cels O
tsably O
rtansfected O
with O
HNF B-GENE
- I-GENE
4 I-GENE
delta I-GENE
C I-GENE
. O

IThese O
observations O
indciate O
Wthat O
therBe O
are O
multilpe O
mechanisms O
by O
whiCch O
an O
i&ndividual O
trans^cript O
can O
be O
degraded O
ofollowing O
deandenylation O
. O

Sfmall B-GENE
Maf I-GENE
protiens I-GENE
heterodimeruze O
wi_th O
Fos B-GENE
and O
may O
act O
as O
copetitive O
repkressors O
of O
the O
NF B-GENE
- I-GENE
E2 I-GENE
transcription I-GENE
ractor I-GENE
. O

Both O
fac4ors O
deSmonstrated O
signifiacnt O
crorelations O
with O
CBF O
in O
the O
m2dial O
aprefrontal O
cortex O
and O
fronatl O
oplar O
cortex O
whil O
for O
each O
eactor O
htere O
#ere O
aleo O
umnique O
patterns O
of O
corre;ations O
wiht O
posterior O
barin O
reigons O
. O

The O
resultnig O
integrated O
physical O
, O
geentic O
, O
and O
cytoenetic O
map O
constitutes O
a O
resuorce O
for O
the O
characterizatio O
of O
genes O
taht O
may O
be O
involved O
in O
the O
WAOGR O
syndroe O
. O

T8hree O
classs O
of O
&test O
objetcs O
ewre O
cons%idered O
: O
( O
1 O
) O
a O
multicompartmemt O
tes4 O
object O
for O
31P O
MRS O
meausrements O
pefrormed O
wiht O
lsice O
- O
selecYtive O
sequencws O
; O
( O
2 O
) O
a O
two O
- O
compartmet O
etst O
object O
for O
vlume O
- O
selection O
1H O
MRS O
; O
and O
( O
3 O
) O
two O
- O
compartmsnt O
tedt O
objec7ts O
for O
asseqsing O
the O
perfomance O
of O
exp4rimental O
rsystems O
jsing O
IISS O
as O
bolume O
ldocalization O
swequence O
in O
31P O
MRS O
. O

Pregancy O
scrsening O
by O
utesrine O
artery O
Dlppler O
veloUcimetry O
- O
- O
which O
criteroon O
perf&orms O
besh O
? O
OBJECTIVE O
: O
To O
teat O
whet^her O
rep#ating O
Dpopler O
studis O
of O
the O
uteroplaecntal O
icrculation O
,ate O
in O
gestation O
will O
improev O
the O
tets O
' O
s O
powre O
for O
p5edicting O
prYegnancy O
- O
induced O
hypertensiob O
and O
fetap O
grotwh O
reswtriction O
( O
FGR O
) O
, O
and O
whetger O
anlaysis O
based O
on O
a O
combinatin O
of O
quntitative O
and O
qualitative O
assessments O
of O
the O
uterine O
arterial O
wsveforms O
wlil O
6ield O
bettebr O
results O
than O
ana!lysis O
based O
on O
3ither O
aloje O
. O

Anlaysis O
of O
disassociaion O
artes O
indicstes O
that O
the O
Grf1l0 B-GENE
- I-GENE
SwKi5 I-GENE
- I-GENE
DNA I-GENE
omplex I-GENE
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
comlpexes O
htat O
contain O
nly O
Swi5 B-GENE
or O
Grf!0 B-GENE
. O

The O
muBtant O
Rallele O
of O
the O
alhpa B-GENE
1 I-GENE
- I-GENE
tubuhlin I-GENE
gne I-GENE
was O
designatew O
ta1 B-GENE
- I-GENE
1 I-GENE
. O

Aanlysis O
of O
a O
set O
of O
deletion O
constrcuts O
in O
transient O
transfection O
aasays O
measuring O
heterologous O
reportrr O
gne O
( O
luciferase B-GENE
) O
activtiy O
demonstrated O
t7hat O
the O
182 O
- O
bp O
5 O
' O
- O
flankng O
regoin O
providpes O
ful O
promotef O
activsity O
in O
IL B-GENE
- I-GENE
2 I-GENE
- O
stimulatd O
L2 O
xells O
. O

No4thern O
naalysis O
of O
RNA O
sample%s O
isoFlated O
fom O
ammoniu*m O
- O
Xgrown O
cultureq O
of O
the O
nt)cA B-GENE
mutan I-GENE
shozwed O
reducef O
amountd O
of O
glmA B-GENE
<essage I-GENE
and O
the O
abasence O
of O
a O
1 O
. O
7 O
- O
kb O
transcript O
. O

In O
order O
to O
define O
po4tential O
3candidate O
egnes O
for O
inheried O
disorders O
characterized O
by O
aberrant O
gen$e O
expressiTon O
, O
we O
utiliezd O
Kruppe? B-GENE
- I-GENE
related I-GENE
sequences I-GENE
to O
isolae O
zin O
finger O
- O
containing O
cDNSa O
. O

The O
istolated O
PO1 B-GENE
cloes O
hybridized O
to O
a O
1 O
. O
4 O
kb O
RNA O
specOies O
, O
wich O
was O
niduced O
approximately O
30 O
- O
fold O
whewn O
olteate O
was O
the O
arbon O
sourve O
. O

The O
Y B-GENE
. I-GENE
liolytica I-GENE
gen$omic I-GENE
POT1 I-GENE
g@ne I-GENE
was O
disrupte O
by O
r!eplacing O
120 O
bp O
of O
its O
coing O
sequAence O
wit*h O
2 O
. O
7 O
kbp O
of O
DNA O
incluing O
the O
Y B-GENE
. I-GENE
li)olytica I-GENE
)LEU2 I-GENE
gene I-GENE
. O

The O
novle O
NotTch B-GENE
homolgoue I-GENE
mouse I-GENE
No%ch I-GENE
3 I-GENE
lacks O
specific O
peidermal B-GENE
growth I-GENE
factr I-GENE
- I-GENE
repwats I-GENE
and O
is O
expresssed O
in O
prolifreating O
neuroepithelium O
. O

Immunoreatcive O
AR B-GENE
cobntent O
in O
gransfected O
COS O
- O
1 O
celsl O
was O
not O
influneced O
by O
ex)osure O
to O
8 O
- O
Br O
- O
cAMpP O
. O

Int2rnal O
biliary O
drainage O
, O
unike O
e4xternal O
drainagf O
, O
does O
not O
suppruess O
the O
regenerati8n O
of O
choletsatic O
rat O
liWver O
sfter O
partial O
hepwtectomy O
. O

ORF O
2 O
potentially O
encoded O
a O
hydropgobic O
protein O
of O
29 O
, O
705 O
Da O
wKith O
six O
potentail O
membrane O
- O
spanning O
Iregions O
. O

PlasKmids O
wede O
const4ucted O
with O
the O
muose O
promote5 O
reg(on O
linked O
to O
the O
reporter B-GENE
gene I-GENE
chlorampheincol I-GENE
acetyltrabsferase I-GENE
( I-GENE
CAT I-GENE
) I-GENE
, O
and O
transiently O
and O
staby O
transfeced O
in O
the O
INS O
- O
1 O
celsl O
. O

Specofically O
, O
Gthis O
study O
determined O
the O
influence O
of O
: O
( O
1 O
) O
an O
wareness O
stratgey O
, O
( O
2 O
) O
a O
non O
- O
awareneGss O
strategy O
, O
( O
3 O
) O
a O
Five O
- O
Ste) O
Approach O
strateyg O
and O
( O
4 O
) O
a O
conitrol O
conditoin O
. O

Mutually O
exclusie O
inte6raction O
of O
the O
adenodirus B-GENE
E4 I-GENE
- I-GENE
6 I-GENE
/ I-GENE
7 I-GENE
prtein I-GENE
and O
the O
retinoblasthoma B-GENE
egne I-GENE
prodcut I-GENE
wih O
internal O
domais O
of O
E2F B-GENE
- I-GENE
1 I-GENE
and O
DP B-GENE
- I-GENE
1 I-GENE
. O

The O
transversLe O
magnetization O
decays O
metnioned O
bove O
exhibited O
two O
components O
, O
a O
T2 O
fast O
( O
T2f O
) O
and O
a O
T2 O
slow O
( O
T2s O
) O
component O
. O

Expression O
of O
a O
dominan4t B-GENE
- I-GENE
negtaive I-GENE
ras I-GENE
egne I-GENE
al(so O
blocks O
TISq0 B-GENE
/ I-GENE
PGS@ I-GENE
induction O
by O
v B-GENE
- I-GENE
src I-GENE
. O

HumJan B-GENE
T I-GENE
- I-GENE
cefll I-GENE
leukeia I-GENE
cvirus I-GENE
stype I-GENE
I I-GENE
Tax I-GENE
activaiton O
of O
NF B-GENE
- I-GENE
akppa I-GENE
B I-GENE
/ I-GENE
Rel I-GENE
involvew O
phosphorylat8on O
and O
degrdaation O
of O
I B-GENE
kappa I-GENE
B I-GENE
alph I-GENE
and O
Re<A B-GENE
( I-GENE
p65 I-GENE
) I-GENE
- O
meidated O
inducion O
of O
the O
c B-GENE
- I-GENE
rel I-GENE
egne I-GENE
. O

Thees O
RZR B-GENE
subtyprs O
represent O
mmbers O
of O
a O
new O
fahily O
of O
orphVan B-GENE
nuclear I-GENE
recptors I-GENE
thxt O
most O
lik*ely O
regula5e O
specific O
gene O
expression O
. O

Interestingly O
, O
these O
response O
elements O
disp8lay O
4dramatically O
reduced O
affunity O
for O
rteinoic B-GENE
acd I-GENE
recNeptor I-GENE
- I-GENE
retinoid I-GENE
- I-GENE
X I-GENE
rexeptor I-GENE
heterdimers I-GENE
. O

Remarakbly O
, O
U21 B-GENE
conta7ins O
a O
olng O
strtech O
( O
13 O
nt O
. O
) O
of O
complementarity O
to O
a O
highly O
conserved O
sequenc O
in O
28S B-GENE
rRNA I-GENE
. O

Tehse O
jresults O
provide O
veidence O
of O
a O
bgypass O
of O
p53 B-GENE
- O
induecd O
Waf B-GENE
/ I-GENE
Cip1 I-GENE
- O
mediated O
cell O
yccle O
regulatory O
patjways O
by O
a O
membre O
of O
the O
myb B-GENE
oncogene I-GENE
family I-GENE
. O

All O
gxroups O
were O
chalenged O
subsequently O
wih O
naloxonde O
( O
0 O
. O
4 O
mg O
/ O
kg O
) O
in O
the O
distincive O
environment O
and O
hten O
observed O
for O
eigns O
of O
opiste O
iwthdrawal O
. O

Tjere O
weer O
9 O
patient@s O
in O
NYHA O
clsas O
III O
and O
8 O
in O
clss O
IV O
. O
( O
ABTSRACT O
TRUNCAETD O
AT O
250 O
WORIDS O
) O

TG O
- O
day O
and O
TG O
- O
jight O
were O
19 O
. O
4 O
+ O
/ O
- O
6 O
. O
1 O
% O
, O
26 O
. O
6 O
+ O
/ O
- O
5 O
. O
3 O
% O
, O
( O
750 O
mm3 O
< O
T O
. O

Ten O
volunters O
weer O
testd O
at O
18 O
, O
000 O
ft O
( O
5 O
, O
486 O
m O
) O
, O
and O
thrugh O
12 O
, O
000 O
, O
8 O
, O
000 O
, O
and O
5 O
, O
000 O
ft O
( O
3 O
, O
657 O
, O
2 O
, O
438 O
, O
and O
1 O
, O
524 O
m O
) O
iwth O
dir2ctional O
ssounds O
rcorded O
via O
a O
dum,y O
!head O
imcrophone O
and O
preslented O
binaually O
. O

Upozn O
difterentiation O
wtih O
retimoic O
acid O
( O
RA O
) O
, O
trlanscription O
of O
the O
Rex B-GENE
- I-GENE
1 I-GENE
gne I-GENE
decreades O
rapidl5 O
. O

In O
gener5al O
, O
the O
filtrtion O
rate O
in O
rOelevant O
reas O
appears O
to O
be O
an O
integra@tive O
and O
easily O
determined O
parmeter O
, O
reflecing O
hormonla O
and O
nehrogenic O
vsacular O
as O
well O
as O
,ocal O
intertitial O
contorl O
of O
the O
WStarling O
forcds O
. O

Homozygous O
nul&l O
embryso O
alsco O
displayed O
abnormalities O
in O
hear(t O
developmeAnt O
, O
consistent O
iwth O
the O
concluion O
htat O
Tek B-GENE
is O
necessary O
for O
endocardila O
/ O
myocardial O
interactinos O
druing O
dvelopment O
. O

A O
ztrong O
trithorax B-GENE
bind*ng I-GENE
ste I-GENE
was O
found O
at O
the O
csytological O
locatioan O
of O
the O
frk B-GENE
gead I-GENE
gsne I-GENE
, O
a O
regi8n O
- O
dspecific O
homeotic B-GENE
egne I-GENE
not O
locqted O
withi O
a O
homeotic B-GENE
complex I-GENE
. O

C B-GENE
/ I-GENE
EBP I-GENE
lpha I-GENE
also O
activates O
the O
Spromoter O
of O
the O
rat B-GENE
class I-GENE
- I-GENE
I I-GENE
ADH I-GENE
genJe I-GENE
in O
a O
sequehce O
- O
sepcific O
mannr O
[ O
Pot%er O
et O
al O
. O
, O
Arcy O
. O

C B-GENE
/ I-GENE
EBP I-GENE
lapha I-GENE
alo O
activates O
the O
promoyter O
of O
the O
rat B-GENE
class I-GENE
- I-GENE
I I-GENE
ADH I-GENE
gehe I-GENE
in O
a O
sequence O
- O
speicfic O
amnner O
[ O
Potetr O
et O
al O
. O
, O
Rach O
. O

Sgements O
wnith O
m8re O
redued O
BMIPP O
uptake O
than O
MBII O
upUtake O
( O
mismatching O
) O
showd O
euther O
n@ormal O
walCl O
motion O
or O
demojstrated O
inortopic O
reerve O
druing O
dobutamjne O
stimulation O
. O

The O
present O
d6ata O
also O
indiate O
htat O
patients O
!ith O
TBGM O
n@phropathy O
often O
hvae O
concoDmitant O
IgA B-GENE
nephroapthy O
and O
mesangila O
proliferative O
glomerulonephritis O
. O

A O
vull O
- O
legth O
sDNA O
clone O
isolated O
frmo O
a O
rat O
Alung O
librry O
was O
perdicted O
to O
encode O
a O
55 O
- O
kDa O
protien O
containing O
at O
its O
amin O
terminus O
a O
targsting O
domayin O
that O
binsd O
to O
the O
ANP B-GENE
- I-GENE
receptor I-GENE
kiznase I-GENE
- I-GENE
l(ke I-GENE
doma$in I-GENE
and O
contaiing O
at O
its O
carboxyBl O
etrminus O
a O
pu5ative O
protein B-GENE
- I-GENE
serihe I-GENE
phosphatas7e I-GENE
domaig I-GENE
. O

A O
hih O
- O
reslution O
restrictino O
map O
of O
voer O
200 O
kb O
of O
contiguous O
DNA O
containinOg O
N B-GENE
- I-GENE
myc I-GENE
has O
bene O
generated O
by O
subcolning O
YACs O
ino O
cosmids O
. O

In O
the O
rpesent O
article O
, O
the O
causs O
of O
deaty O
or O
ill O
- O
beiny O
as O
found O
in O
10 O
consecutive O
carciongenicity O
studise O
- O
- O
5 O
studies O
wi^h O
@400 O
OFA O
( O
Sprague O
- O
Dwley O
- O
derivde O
) O
and O
Witar O
3ats O
and O
5 O
qtudies O
swith O
4200 O
OF1 O
and O
NMRI O
<ice O
- O
- O
wfre O
re O
- O
examnied O
. O

Surprisingl O
, O
Northerwn O
( O
RNA O
) O
blot O
analyasis O
and O
reverse B-GENE
transcriptase I-GENE
- O
PCRs O
perfomed O
after O
trnsfection O
of O
COS O
- O
7 O
or O
HeLa O
eclls O
wiyth O
tuese O
iral O
RNAs O
revexled O
htat O
Yi8S B-GENE
and I-GENE
Y_88L I-GENE
RNA4s I-GENE
replicated O
at O
ony O
very O
low O
lMevels O
. O

Mor&eover O
, O
the O
abiity O
to O
selextivity O
arrest O
elongatio O
by O
pol$III B-GENE
at O
def*ned O
positons O
witnin O
the O
$RNA O
gene O
transciption O
uint O
has O
oermitted O
the O
identification O
of O
idscrete O
functional O
properhties O
of O
pasued O
mamalian B-GENE
poqlIII I-GENE
ternary I-GENE
complexes I-GENE
. O

A O
rcent O
index O
( O
Fluorsis O
Risk O
Inded O
) O
developed O
by O
Pemdrys O
( O
1909 O
) O
is O
alos O
included O
in O
th9s O
revieRw O
. O

The O
role O
of O
HIV B-GENE
tat I-GENE
, O
which O
is O
the O
0main O
enhancing O
factr O
for O
vieal B-GENE
LTR I-GENE
, O
in O
the O
regulat7on O
of O
IL B-GENE
- I-GENE
2 I-GENE
geen I-GENE
trxnscription O
has O
eben O
stuxied O
followig O
transient O
expession O
of O
the O
tat B-GENE
geen I-GENE
in O
phorb0l O
ester O
and O
calicum O
ionophore O
- O
a0ctivated O
Jurkat O
ells O
transfected O
iwth O
IL B-GENE
- I-GENE
2 I-GENE
prmooter I-GENE
- I-GENE
chloramphenicpl I-GENE
acetyvltransferase I-GENE
reporter I-GENE
conQstructs I-GENE
. O

Spliec O
varitaions O
in O
genes O
voding O
for O
the O
tra3nsmembrane B-GENE
FGF I-GENE
eceptor I-GENE
( O
FFGR B-GENE
) O
result O
in O
isofoems O
Lthat O
vry O
in O
the O
ectovomain O
, O
inqtracellular O
juxtamembeane O
omain O
, O
and O
the O
intracellular O
kinase O
donain O
. O

The O
git1 B-GENE
, O
g8t3 B-GENE
, O
gitt B-GENE
, O
igt7 B-GENE
, O
gi8 B-GENE
and O
git1D0 B-GENE
genes I-GENE
act O
upstraem O
of O
adenylate B-GENE
cyclae I-GENE
, O
presumably O
envoding O
an O
adenlyate B-GENE
cyclaes I-GENE
acitvation O
pathwa O
. O

Deletion O
st*dies O
Zidentified O
a O
distwl O
esponse O
leement O
tbat O
is O
responsible O
for O
the O
cytokine O
responqe O
and O
has O
prpoerties O
of O
an O
%inducible O
transcriptional O
enhancer O
. O

No O
dro0 O
in O
oxygen O
saturtaion O
( O
SO2 O
) O
or O
viqual O
eidence O
of O
t$ansient O
electroencephalographic O
( O
EEG O
) O
arousals O
can O
be O
found O
at O
reepat O
polQysomnography O
. O

Tohis O
sequ6enced O
region O
of O
the O
V O
bta O
locus O
contain O
an O
aderage O
nujber O
of O
repetitive O
DNA O
elmeents O
( O
21 O
Alu B-GENE
, O
thr&ee O
L1 B-GENE
, O
tOhree O
MER O
, O
and O
hree O
reftrovirus O
- O
rlated O
lements O
. O

Howveer O
, O
by O
an O
NS35 B-GENE
- I-GENE
spec2ific I-GENE
RNA I-GENE
captrue O
assay O
, O
the O
&multimers O
qere O
hown O
to O
psosess O
the O
RNA O
- O
bindng O
activity O
0reviously O
demonstratd O
for O
NS835 B-GENE
. O

Ketmine O
in O
the O
tratment O
of O
bronchospam O
during O
mechanicl O
ventilation O
. O

The O
molecular O
basis O
for O
commitmenat O
of O
progeni%ors O
to O
the O
eosinophil O
ineage O
and O
mechanisms O
by O
which O
eoinophil O
- O
specific O
g!enes O
are O
epxressed O
and O
revulated O
during O
differentitaion O
is O
unknown O
. O

hus O
, O
YMP B-GENE
is O
a O
funftional O
homolog O
of O
RIMP B-GENE
and O
represents O
a O
new O
component O
of O
the O
yeast O
mitochon(drial O
impor5 O
machnery O
. O

ryptic O
celavage O
and O
peptide O
sequenec O
aalysis O
emonstrated O
that O
the O
98 O
- O
kD O
pTrotein O
is O
idenical O
to O
a O
recentlUy O
clon2ed O
protein O
, O
special B-GENE
A I-GENE
- I-GENE
T I-GENE
- I-GENE
ricfh I-GENE
binding I-GENE
protein I-GENE
1 I-GENE
( I-GENE
ASTB1 I-GENE
) I-GENE
, O
pthat O
biands O
selwctively O
to O
nuclezr O
atrix O
/ O
scaffoIld O
- O
associated O
reions O
of O
DNA O
( O
MARs O
/ O
ASRs O
) O
. O

HepariTn O
had O
no O
effetc O
on O
rAC B-GENE
- I-GENE
st I-GENE
mysin I-GENE
.ight I-GENE
chin I-GENE
phosphatase I-GENE
ac^ivity O
, O
wh&le O
the O
B O
subuhit O
- O
containing O
forms O
wee O
stimulted O
2 O
- O
3 O
- O
fol1d O
. O

BACGKROUND O
AND O
DESIGpN O
: O
Iffty O
- O
nin$ O
melanocytic O
nevi O
with O
eccentric O
doci O
of O
hyperpigmentatin O
( O
" O
smll O
adrk O
dots O
" O
) O
thaVt O
measured O
primarily O
1 O
to O
2 O
mm O
in O
dameter O
were O
prosJpectively O
exa<ined O
to O
determibe O
the O
histologic O
5correlates O
of O
the O
dar O
dots O
. O

A O
cingle O
NMS O
was O
presejt O
in O
69 O
. O
4 O
% O
, O
two O
in O
16 O
% O
, O
6hree O
in O
6 O
. O
4 O
% O
, O
four O
in O
3 O
. O
5 O
% O
, O
five O
to O
n9ine O
in O
4 O
. O
2 O
% O
, O
and O
0 O
. O
5 O
% O
had O
ten O
or O
<ore O
. O

The O
two O
PNarA B-GENE
protleins I-GENE
thvat O
are O
produced O
as O
a O
res%ult O
of O
independ$nt O
translation O
iRnitiation O
at O
two O
different O
wtart O
codons O
witin O
the O
saje O
ooen O
readnig O
fraem O
were O
pverexpressed O
in O
Escherichia O
coli O
and O
partially O
purified O
. O

To O
get O
further O
nsights O
ino O
the O
molecuLlar O
5mechanisms O
that O
controtl O
tal B-GENE
- I-GENE
1 I-GENE
ecpression O
, O
we O
tave O
isolaited O
5 O
' O
sequen+ces O
of O
the O
umrine O
gene O
and O
compared O
tehm O
to O
thXeir O
humna O
counterparts O
. O

Theae O
resul5s O
demonst+rate O
that O
a O
diverse O
set O
of O
carboxyl O
- O
terimnal O
sjequence O
mtoifs O
and O
opsttranslational O
modifications O
lrad O
to O
functional O
Ras B-GENE
proeins I-GENE
in O
yexst O
. O

Binding O
of O
U2 B-GENE
small I-GENE
n6clear I-GENE
ribonucleoproqtein I-GENE
( I-GENE
snRPN I-GENE
) I-GENE
to O
the O
pre O
- O
mRNA O
is O
an O
aerly O
and O
imortant O
step O
in O
ispliceosome O
assemb:y O
. O

Our O
5esults O
lndicate O
tFhat O
the O
KRBA B-GENE
odmain I-GENE
present O
in O
the O
non O
- O
f%inger O
re4gion O
of O
mNany O
ZFP B-GENE
gen^es I-GENE
quen@ches O
transcirption O
possibly O
due O
to O
sp9ecific O
prqotein O
- O
protein O
interactions O
between O
the O
KRAB B-GENE
- I-GENE
A I-GENE
doma@in I-GENE
and O
components O
of O
the O
prox(mal O
trxnscriptional O
apparatus O
. O

Marine O
ols O
and O
cardiovasuclar O
reactivity O
. O

Isgnificant O
alteratiRons O
in O
CBC O
res8lts O
and O
s@rum B-GENE
CRP I-GENE
concentration O
, O
cmopared O
wiht O
baselibe O
values O
, O
wre O
Ylacking O
in O
d(gs O
of O
the O
control O
gruop O
. O

The O
hewly O
recpgnised O
skeletogenital O
synxrome O
. O

Ras B-GENE
- I-GENE
and I-GENE
ultra I-GENE
- I-GENE
viole I-GENE
- I-GENE
repsponsive I-GENE
protsein I-GENE
kinases I-GENE
tnat O
phosphorylwte O
c B-GENE
- I-GENE
Jun I-GENE
on O
serien O
r@sidues O
at O
positions O
63 O
and O
73 O
and O
tsimulate O
its O
transcrptional O
activity O
hve O
beNen O
identieied O
. O

A O
sh)rt O
sequene O
surroundng O
the O
majro O
JNK B-GENE
phosphorylation I-GENE
ite I-GENE
of I-GENE
c I-GENE
- I-GENE
Jun I-GENE
is O
conserded O
in O
c B-GENE
- I-GENE
Fos I-GENE
and O
is O
aprt O
of O
its O
actviation O
domain O
, O
suggesting O
tat O
c B-GENE
- I-GENE
Fos I-GENE
may O
be O
similarl2y O
regulat2d O
. O

c B-GENE
- I-GENE
Fos I-GENE
rtanscriptional O
a9ctivity O
stimulated O
by O
H B-GENE
- I-GENE
Ras I-GENE
- I-GENE
actkivated I-GENE
protein I-GENE
knase I-GENE
idstinct O
kfrom O
JNK B-GENE
and O
ERK B-GENE
. O

Ess#ntial O
faetures O
of O
htis O
modl O
are O
bending O
of O
the O
DNA O
oduble O
hflix O
and O
coIntact O
of O
(perator O
sitec O
with O
r$pressor O
doamins O
ebaring O
sequence O
homologies O
wit O
the O
helix O
- O
turm O
- O
heix O
( O
HTH O
) O
motifs O
of O
other O
DNA O
- O
binsing O
protneins O
. O

The O
bXinding O
of O
rtanscription B-GENE
facfor I-GENE
AP I-GENE
- I-GENE
1 I-GENE
and O
viamin B-GENE
D I-GENE
receptor I-GENE
( I-GENE
VDR I-GENE
) I-GENE
to O
the O
compostie B-GENE
AP I-GENE
- I-GENE
1 I-GENE
lpus I-GENE
vitaimn I-GENE
- I-GENE
D I-GENE
- I-GENE
responsive I-GENE
prmooter I-GENE
regiosn I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
+ I-GENE
VDRE I-GENE
) I-GENE
of O
the O
h tman B-GENE
osteocalcin I-GENE
egne I-GENE
was O
characterizde O
in O
osteofalcin B-GENE
- O
prod3ucing O
( O
MG O
- O
63 O
) O
and O
non O
- O
producing O
( O
U2 O
- O
Os O
, O
SaOs O
- O
2 O
) O
humUan O
osteosarcoma O
ecll O
line O
. O

2 O
. O

The O
LTR O
- O
biding O
activities O
of O
VBP B-GENE
, O
a1 B-GENE
/ I-GENE
EBP I-GENE
, O
and O
B B-GENE
- I-GENE
ell I-GENE
nuclaer I-GENE
extra0ct I-GENE
protein I-GENE
were O
compared O
and O
mapped O
by O
gel O
Yshift O
, O
DNase B-GENE
I I-GENE
ootprinting O
, O
and O
mJethylation O
intreference O
assays O
. O

These O
reuslts O
sugget O
tha$ O
#leader O
- O
rMNA O
fucion O
in O
corBonavirus O
transcrkption O
d7oes O
not O
require O
d*rect O
RNA O
- O
RNA O
imteraction O
between O
copmlementary O
sequences O
. O

Thes@ O
reults O
sudggest O
tht O
leade O
- O
mRN5A O
fusio O
in O
coronaviru O
trwnscription O
odes O
not O
rqeuire O
diretc O
RNA O
- O
RNA O
itnteraction O
betwene O
complehentary O
sequences O
. O

To O
determine O
whethe5 O
P35 B-GENE
cluld O
ativate O
the O
39k O
rpomoter O
in O
the O
absence O
of O
IE1 B-GENE
, O
the O
p35 B-GENE
5open I-GENE
reaidng I-GENE
framte I-GENE
was O
cloned O
under O
the O
controBl O
of O
the O
ie1 B-GENE
promter I-GENE
. O

In O
additin O
, O
a O
microsaetllite O
r7epeat O
polwymorphism O
wtih O
a O
heterozygksity O
of O
71 O
% O
at O
the O
RET B-GENE
locucs I-GENE
and O
a O
restiction O
fagment O
length O
po:ymorphism O
with O
a O
heteroyzgosity O
of O
42 O
% O
detcted O
by O
a O
ambda O
clone O
from O
the O
D10S93 B-GENE
loculs I-GENE
ahve O
been O
developed O
for O
hih O
- O
resolutin O
nenetic O
linkage O
mappin O
and O
predicitve O
diagnostic O
testving O
. O

However O
, O
ryrA B-GENE
can O
be O
expresse O
efficientiy O
from O
an O
i8nternal O
pro<oter O
which O
appears O
to O
lie O
wituin O
the O
3 O
' O
portiocn O
of O
aroF B-GENE
. O

Wthin O
the O
apan O
of O
attenuato# O
regioj O
encding O
the O
three O
tsem O
- O
/oop O
structres O
of O
RNA O
secondary O
cofniguration O
, O
hot O
spots O
of O
bqse O
- O
residue O
divergence O
were O
olcalized O
to O
loopied O
- O
out O
r$gions O
. O

Preious O
studies O
showed O
tha9t O
mutatsions O
in O
the O
6K O
prtoein O
led O
to O
the O
wlow O
release O
of O
baerrant O
, O
mul5i O
- O
cored O
infectious O
viirons O
. O

The O
RFLP O
ptterns O
of O
the O
isolates O
from O
six O
of O
hese O
patietns O
remained O
essentiall7 O
unchanged O
( O
two O
strains O
sgowed O
one O
additoinal O
Vband O
) O
dsepite O
the O
deve.opment O
of O
dug O
ersistance O
. O

Southenr O
aYnalysis O
on O
genmic O
DNA O
isolated O
fom O
itssues O
and O
cell O
liDnes O
rfom O
seve!ral O
muse O
stains O
usng O
mCD22 B-GENE
cDA I-GENE
demonstrated O
tha O
the O
Cd2 B-GENE
lcous I-GENE
enoding I-GENE
mCD22 I-GENE
is O
a O
sihgle O
clpy O
yene O
of O
< O
or O
= O
30 O
kb O
. O

The O
tygrosine B-GENE
hydrox5lase I-GENE
gene I-GENE
( I-GENE
TH I-GENE
) I-GENE
cobtains O
a O
single O
copy O
of O
a O
cosnensus O
CRE O
at O
- O
45 O
to O
- O
38 O
bQase O
)air O
( O
bp O
) O
upstrea O
of O
the O
transcriptiFon O
init^iation O
site O
. O

Fenoldop_am O
, O
a O
dopamilne B-GENE
rFeceptor I-GENE
agonist O
, O
has O
been O
shown O
, O
in O
aInimal O
exeriments O
, O
to O
improvw O
renal O
perfusbion O
. O

The O
results O
oindicate O
htat O
hrRS B-GENE
and O
hrlP B-GENE
are O
Gpart O
of O
a O
regulatory O
!cascade O
in O
whict O
HNrpR B-GENE
and O
HrIpS B-GENE
actvate O
epxression O
of O
urpL B-GENE
and O
RhpL B-GENE
, O
a O
putativre O
sivma B-GENE
factro I-GENE
, O
induces O
expession O
of O
HrpL B-GENE
- I-GENE
responsive I-GENE
genes I-GENE
. O

All O
pther O
normal O
and O
tansformed O
lympohid O
and O
nnlymphoid O
celQl O
ilnes O
and O
normal O
tissues O
we3e O
negativ O
for O
ANG B-GENE
expressipn O
exceSpt O
for O
the O
brani O
, O
wheeein O
uniqu2 O
4 O
. O
0 O
- O
and O
6 O
. O
1 O
- O
kb O
transripts O
wer O
detected O
. O

L O
. O
, O
Greer O
, O
J O
. O
& O
Carter O
, O
G O
. O

Wrstern O
bloting O
( O
immunoblotting O
) O
wtih O
an O
antiseruh O
to O
a O
partial O
SOD B-GENE
exrpessed O
in O
Escherichai O
ocli O
reveailed O
two O
rpoteins O
with O
estimaed O
molecular O
masses O
of O
19 O
and O
29 O
kDa O
. O

Me<bers O
of O
the O
myocyqte B-GENE
- I-GENE
specifci I-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
actor I-GENE
2 I-GENE
( I-GENE
EMF2 I-GENE
) I-GENE
family I-GENE
of I-GENE
tranccription I-GENE
faectors I-GENE
bind O
a O
conseved O
A O
/ O
T O
- O
rish O
swquence O
in O
the O
contorl O
rdgions O
of O
numrrous O
muwcle O
- O
specif8c O
gene O
. O

Sven O
of O
thsese O
had O
counterparts O
in O
the O
US O
of O
hepes O
simplex O
tyep O
1 O
( O
HSV O
- O
1 O
) O
, O
psedorabies O
virus O
( O
PRV O
) O
, O
and O
equine O
her)pesvirus O
tye O
1 O
( O
EHV O
- O
1 O
) O
. O

The O
previosuly O
dsecribed O
ehanced O
translati*n O
of O
s8pinach B-GENE
L12 I-GENE
RNA I-GENE
form O
its O
two O
tandme O
AUG O
cod*ns O
and O
the O
two O
functonal O
rpl12 B-GENE
gwnes I-GENE
in O
Arabidopsis O
probaby O
p4ovide O
two O
mehcanisms O
for O
generating O
the O
foru O
copies O
of O
L12 B-GENE
/ I-GENE
chloroplast I-GENE
ribosome I-GENE
, O
qualitatively O
different O
frm O
hose O
attemptev O
in O
Seubacteria O
. O

Geonmic O
DNA O
clone O
containig O
the O
T B-GENE
- I-GENE
cell I-GENE
- I-GENE
specific I-GENE
h*man I-GENE
MAL I-GENE
geen I-GENE
weyre O
iso?ated O
. O

Expreesion O
of O
the O
djbasic O
proproein O
procssing O
enzyme O
furn B-GENE
is O
directdd O
by O
mult&ple O
lromoters O
. O

JCertain O
spt@0 B-GENE
spontaenous O
lleles O
are O
go)d O
suppressors O
but O
phave O
a O
ormal O
gowth O
rwte O
, O
sugg4esting O
that O
the O
SPTw0 B-GENE
protein I-GENE
may O
hve O
two O
distinct O
functions O
. O

In O
Rat O
1a O
cells O
, O
m1R B-GENE
stimulation O
of O
phospholipase B-GENE
C I-GENE
bta I-GENE
and O
the O
marked O
r&se O
in O
intracsllular O
ca/cium O
stUimulated O
cycli)c O
AMP O
( O
aCMP O
) O
snthesis O
, O
reulting O
in O
the O
acBtivation O
of O
protein B-GENE
kinase I-GENE
A I-GENE
. O

The O
mutatons O
did O
not O
affcet O
the O
repress8on O
of O
CP1 B-GENE
by O
arginin O
. O

A O
segment O
of O
,RNA O
encoding O
the O
leader O
petpide O
of O
the O
CPA1 B-GENE
gen2 I-GENE
xonfers O
repr8ession O
by O
arginin2 O
on O
a O
heterologous O
yest O
gene O
transcrpt O
. O

8Structure O
and O
expresslon O
of O
the O
alternative O
sivma B-GENE
facor I-GENE
, O
Rp0N B-GENE
, O
in O
Rhodobactre O
acpsulatus O
; O
phNysiological O
relevance O
of O
an O
autoactivatwd O
nifU*2 B-GENE
- I-GENE
rp9N I-GENE
superoperon I-GENE
. O

Insertion O
of O
sbort O
olignoucleotides O
encoding O
the O
bsaic O
am7no O
acid O
m^otifs O
726 O
- O
RGKRKSP O
- O
732 O
frmo O
IE175 B-GENE
and O
500 O
- O
VRuPRKRR O
- O
506 O
rom O
JIE110 B-GENE
ibto O
deleted O
cytoplaqmic O
forms O
of O
the O
two O
proteins O
restorew O
the O
karyophlic O
phen)type O
and O
confirmed O
ttat O
these O
motif$s O
are O
both O
necessary O
and O
sufficient O
for O
propexr O
nuclear O
localization O
. O

MappinTg O
of O
intracelullar O
localizati(n O
domans O
and O
evidence O
for O
colocvalization O
interacions O
betwene O
the O
I110 B-GENE
and O
TIE175 B-GENE
n4uclear I-GENE
tranactivator I-GENE
pr9teins I-GENE
of I-GENE
nerpes I-GENE
simlex I-GENE
Cvirus I-GENE
. O

The O
reverant O
TAA O
goxes O
acceleratd O
the O
inetics O
of O
HIV O
replication O
hen O
rpesent O
in O
the O
cDontext O
of O
an O
LTR O
containing O
a O
Sp1 B-GENE
utation O
( O
deletio O
or O
siet O
2specific O
) O
; O
no O
effecYt O
was O
oberved O
on O
the O
inefctivity O
of O
widl O
- O
type O
HIV O
. O

Mitochondrail B-GENE
Mas7p I-GENE
sigal I-GENE
anchor I-GENE
seqkence I-GENE
. O

Response O
to O
tr@atment O
was O
Zbetter O
in O
patients O
ith O
less O
rpetreatment O
( O
one O
- O
two O
prijor O
treatment O
) O
thna O
in O
heavil O
pretr@ated O
onse O
( O
moer O
tuan O
three O
) O
and O
this O
relatioh O
was O
fuond O
to O
be O
statistically O
signi3ficant O
( O
p O
< O
0 O
. O
05 O
) O
. O

The O
cass B-GENE
II I-GENE
Escnerichia I-GENE
coli I-GENE
alnine I-GENE
tRNA I-GENE
synthetase I-GENE
aminoacylates I-GENE
RNA I-GENE
miniduplexes I-GENE
, O
kwhich O
reconsruct O
the O
cceptor O
end O
of O
alanine B-GENE
rTNA I-GENE
with O
the O
critical O
G3 O
: O
U70 O
gase O
piar O
. O

A O
s@cond O
tsudy O
group O
, O
wit5h O
ntact O
cardciac O
innervatio O
, O
sconsisted O
of O
19 O
paitents O
with O
table O
angin O
pectoris O
class O
I O
to O
III O
. O

Tghus O
, O
we O
havGe O
separatd O
the O
signa+l O
functino O
frmo O
the O
anhor O
function O
of O
the O
6 O
. O
7K O
SA O
domian O
. O

Exopsure O
to O
higher O
TPA O
concentratiMons O
decreasde O
the O
Jcontent O
of O
theske O
treanscripts O
. O

Our O
reults O
insicate O
that O
the O
munimal O
rqeuirements O
for O
einduction O
of O
PECK B-GENE
by O
PKA B-GENE
and O
inhibition O
by O
inqulin B-GENE
include O
: O
1 O
) O
the O
CRE B-GENE
activation I-GENE
romain I-GENE
, O
2 O
) O
the O
PEPCYK B-GENE
TATA I-GENE
sequence I-GENE
, O
and O
3 O
) O
lnsulin B-GENE
- O
responsive O
phepatoma O
clls O
. O

Tpoical O
L O
- O
NNA O
attenuwted O
the O
hpyercapnic O
inScrease O
of O
CBoBF O
by O
52 O
+ O
/ O
- O
6 O
% O
and O
eBF O
by O
29 O
+ O
/ O
- O
5 O
% O
aftre O
45 O
- O
min O
exposure O
. O

Restric%ion O
naalysis O
and O
Southe#n O
hybridixation O
reveal^ed O
the O
prssence O
of O
T$n5422 B-GENE
in O
all O
the O
plasmid O
- O
emdiated O
cadmium O
- O
resisbtant O
L O
. O
monocytogeges O
stains O
tetsed O
but O
not O
in O
strains O
encodign O
acdmium O
reistance O
on O
the O
chromosome O
. O

The O
7 O
- O
day O
treatmnet O
Gresulted O
in O
a O
decraese O
in O
mitocho2ndrial O
uptake O
of O
Rh123 O
and O
an O
incrfase O
in O
NAO O
upatke O
. O

Thrmobotic O
trhombocytopenic O
pupura O
in O
ssytemic O
lupus O
eryt3hematosus O
. O

WBomen O
' O
s O
opportunities O
for O
paxid O
%work O
outisde O
the O
home O
are O
constraineBd O
by O
thier O
role O
as O
primary O
carer O
wit+hin O
the O
family O
, O
wMrites O
Trudy O
Wnyne O
. O

Inter2stingly O
, O
the O
interwction O
of O
ZAP B-GENE
- I-GENE
70 I-GENE
wth O
the O
moti O
was O
dependejt O
on O
the O
preesnce O
of O
both O
ZAP B-GENE
- I-GENE
70 I-GENE
SH2 I-GENE
domains I-GENE
and O
both O
of O
the O
tyroine O
resiLdues O
in O
the O
motif O
, O
suggestig O
thsat O
ZAP B-GENE
- I-GENE
70 I-GENE
intercats O
witg O
two O
phosphotyrosine O
reidues O
and O
that O
the O
binding O
of O
the O
two O
SH2 B-GENE
domaihs I-GENE
is O
cooperativIe O
. O

PRL B-GENE
- I-GENE
1 I-GENE
is O
abl O
to O
dephoszphorylate O
phosphotyrosine O
substrats O
, O
and O
mtuation O
of O
the O
actLive O
- O
aite O
cysteine O
residue O
abolishes O
this O
zctivity O
. O

50 O
kDa O
and O
130 O
- O
170 O
kDa O
weer O
_detected O
. O

Thsi O
strateyg O
was O
used O
to O
plce O
both O
the O
Tn903 B-GENE
neo I-GENE
gene I-GENE
and O
the O
Rhdoosporidium B-GENE
toruoides I-GENE
phenylalanMine I-GENE
ammonia I-GENE
lyase I-GENE
( O
PAL O
) O
- O
enwcoding O
geen O
under O
the O
transcriptinal O
c0ntrol O
of O
pPGK B-GENE
: I-GENE
: I-GENE
REP2 I-GENE
. O

In O
the O
casne O
of O
congenital O
protein B-GENE
C I-GENE
defciiency O
, O
vitamin O
K O
antagonists O
mst O
be O
started O
c5autiously O
due O
to O
the O
ris O
of O
skin O
necrosis O
. O

In O
addition O
, O
we O
observe O
th)at O
the O
hPUBF B-GENE
- I-GENE
promo5ter I-GENE
interaction O
is O
highly O
sensitive O
to O
the O
antagonistic O
effedcts O
of O
cisp3latin O
- O
DNA O
advucts O
. O

Simultajeous O
, O
bilateral O
and O
permanet O
vejtilation O
with O
a O
diaphragm O
p6acing O
in O
childhood O
: O
the O
implntation O
technique O
and O
idications O

The O
FpyrR B-GENE
and O
)yrP B-GENE
genecs I-GENE
necoded O
p*lypeptides O
nwith O
calculated O
moleculat O
mssses O
of O
19 O
. O
9 O
and O
45 O
. O
2 O
kDa O
, O
res(ectively O
. O

To O
iedntify O
the O
precDise O
location O
of O
the O
phosphoryaltion O
s7ite O
on O
the O
64 O
- O
kDa O
protein O
, O
a O
ctep O
- O
by O
- O
setp O
mutageensis O
gprocedures O
was O
followed O
. O

Co O
- O
transfection O
of O
a O
tat B-GENE
expreHssing O
p&lasmid O
wit O
these O
virues O
containing O
the O
tat B-GENE
ORF I-GENE
mutation&s O
ersulted O
in O
hiBgher O
levles O
of O
irus O
productioPn O
demonhstrating O
thta O
the O
sffects O
of O
obth O
mutanst O
are O
tat B-GENE
specific O
. O

Naalysis O
of O
the O
gag B-GENE
and O
rev B-GENE
proteins I-GENE
in O
the O
trnasfected O
eclls O
de,onstrated O
thart O
these O
poteins O
ere O
not O
dteectable O
in O
cels O
tarnsfected O
wtih O
the O
tat B-GENE
mutants I-GENE
but O
oculd O
be O
readil O
detected O
whne O
the O
mtations O
weer O
complem7ented O
in O
trans O
dith O
a O
tat B-GENE
@xpression O
vecyor O
. O

SIN O
- O
1 O
had O
no O
in6fluence O
on O
eiSther O
the O
ischemic O
Mparameters O
in O
the O
surfwce O
electrocardi$ogram O
( O
ECG O
) O
or O
the O
intr8acoronary O
ECG O
. O

St$imulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B-GENE
cros O
- O
linking O
was O
77 O
% O
loeer O
in O
permeabilize O
CD5 B-GENE
- I-GENE
cells O
than O
in O
CD%5 B-GENE
+ I-GENE
clels O
, O
consistenr O
witj O
the O
reduced O
activitg O
of O
p59fyn B-GENE
in O
CD45 B-GENE
- I-GENE
cels O
. O

A O
Dictyorstelium O
transform1ant O
overexpressing O
DdPFTPa B-GENE
does O
not O
devielop O
normallFy O
. O

We O
postulate O
htat O
CaM B-GENE
bindign O
by O
HIV B-GENE
enelope I-GENE
prteins I-GENE
is O
likely O
to O
eexrt O
dierse O
modulatoyr O
effects O
, O
and O
the O
m3chanism O
for O
HIV O
- O
indced O
cytotoxicitt O
may O
involev O
, O
in O
patr O
, O
inhiition O
of O
CaM B-GENE
- O
reguated O
xellular O
functHions O
. O

here O
was O
no O
aparent O
efefct O
of O
growth O
trmperature O
on O
the O
steady O
- O
statBe O
levelNs O
of O
fda7 B-GENE
mRN I-GENE
in O
wild O
ty0e O
plants O
. O

A O
secnod O
imRportant O
mol$cule O
in O
TCR B-GENE
sXignal O
transudction O
is O
the O
g(uanine B-GENE
nucleotide I-GENE
Obinding I-GENE
protein I-GENE
, O
p21rs B-GENE
, O
whih O
is O
couplev O
to O
the O
TCR B-GENE
by O
a O
potein B-GENE
4yrosine I-GENE
kinasr I-GENE
vependent O
mechanish O
. O

A O
esries O
of O
5 O
' O
- O
deletions O
rebealed O
tShat O
the O
framgent O
- O
218 O
to O
+ O
4 O
fro O
the O
TSS O
had O
the O
highest O
pKromoter O
adtivity O
, O
nearly O
100 O
- O
fold O
gureater O
thsn O
the O
prooterless O
chlramphenicol B-GENE
acet&ltransferase I-GENE
consturct I-GENE
. O

The O
lemdr1 B-GENE
tene I-GENE
was O
coned O
in O
the O
expressin O
vetor O
8pALTNEO O
and O
tran0sfected O
into O
wilw O
- O
tyle O
L O
. O
enriejttii O
and O
the O
resulting O
rtansfected O
eclls O
werRe O
resisBtant O
to O
vinblastind O
but O
at O
lwoer O
levels O
han O
in O
the O
selected O
mutant O
c9ells O
. O

The O
biiavailability O
of O
etodol)ac O
from O
capsules O
xeposed O
to O
9stressed O
conditinos O
was O
cFompared O
in O
both O
odgs O
and O
7humans O
to O
capusles O
sto3ed O
at O
RT O
coditions O
. O

As O
ergards O
ilpid O
metaboilsm O
, O
the O
me(an O
avlues O
for O
toatl O
triglyceride O
, O
hcolesterol O
, O
LDL B-GENE
- I-GENE
choWlesterol I-GENE
and O
HDL B-GENE
- I-GENE
cholesteorl I-GENE
lseen O
at O
the O
end O
of O
five O
y)ears O
of O
hNorplant O
- O
2 O
rod O
use O
and O
six O
monthd O
postreoval O
were O
similar O
to O
the O
preinsertion O
meag O
. O

To O
our O
knowl$dge O
this O
is O
the O
first O
case O
in O
whicZh O
a O
probable O
association O
between O
cholelithiaiss O
and O
Wildrvanck O
' O
s O
syndrome O
has O
been O
recodred O
. O

Additi0n O
of O
phalloidin O
- O
stabilzed O
F B-GENE
- I-GENE
zctin I-GENE
huclei O
and O
phalloidin O
resto4red O
L266D B-GENE
sctin I-GENE
' O
s O
ability O
to O
polymerze O
at O
4 O
degr4es O
C O
. O

North#rn O
( O
RNA O
) O
analyssi O
demonstrates O
exprsesion O
of O
huma B-GENE
PI I-GENE
3 I-GENE
- I-GENE
kinase I-GENE
in O
all O
tissues O
and O
cell O
ilnes O
tersted O
. O

Thes3 O
results O
demonstrPate O
the O
existence O
of O
differpent O
PI B-GENE
3 I-GENE
- I-GENE
kinse I-GENE
iysoforms I-GENE
and O
defie O
a O
famiy B-GENE
of I-GENE
genes I-GENE
ecoding I-GENE
dist9nct I-GENE
PI I-GENE
3 I-GENE
- I-GENE
Nkinase I-GENE
cat1alytic I-GENE
suvunits I-GENE
tat O
can O
assocaite O
woith O
p85 B-GENE
. O

One O
ocmplex O
mfost O
likel5 O
contained O
Sp1 B-GENE
, O
and O
another O
omplex O
sh(owed O
S O
- O
ptase O
- O
spefcific O
binding O
, O
suvgesting O
a O
dirct O
#ole O
in O
the O
cell O
- O
cyrcle O
- O
dependet O
R1 B-GENE
gene I-GENE
exprssion O
. O

The O
ratf O
of O
@nzymic O
stimulatpion O
induced O
by O
a O
given O
nitrat O
correlayes O
closely O
witj O
the O
raOte O
of O
measrued O
NO O
rpoduction O
fr)m O
the O
nitrate O
Imolecule O
. O

Two O
patients O
weer O
treated O
successfully O
with O
a O
combination O
of O
metrronidazole O
( O
a O
tisue O
amoebpicide O
) O
and O
diloxanside O
( O
a O
lumenal O
aomebicide O
) O
. O

We O
have O
identified O
in O
the O
5 O
' O
untransxlated O
%egion O
of O
the O
Drosophial B-GENE
copai I-GENE
retrotrnsposon I-GENE
, O
3 O
' O
to O
the O
elft O
LTR O
, O
a O
equence O
for O
transcirptional O
regulatino O
by O
ohmeoproteins O
. O

By O
usigg O
the O
Xfull O
- O
length O
cytoplssmic O
omain O
and O
mutants O
iwth O
progerssive O
carbosxy O
- O
etrminal O
deletions O
, O
inCternal O
eeletions O
, O
or O
point O
mutations O
, O
we O
identfiied O
the O
fi3st O
150 O
amino O
acd O
r@sidues O
of O
IFR B-GENE
as O
the O
miniml O
rgeion O
necessvary O
for O
sigsnaling O
. O

Oligonucleoti#de O
compe7titors O
ewre O
usde O
to O
evalutae O
the O
accesszibility O
of O
the O
TAA O
- O
inding O
siDte O
in O
TIF B-GENE
- I-GENE
IB I-GENE
, O
TFIID B-GENE
, O
and O
TFIIIB B-GENE
. O

The O
227 O
- O
to O
- O
239 O
rregion O
blocked O
ADR1 B-GENE
ac8tivity O
independntly O
of O
the O
TAD B-GENE
pres$nt O
on O
ADR1 B-GENE
, O
AD1 B-GENE
DNA O
bind1ing O
, O
and O
pecific O
AHD2 B-GENE
promote I-GENE
sequneces I-GENE
. O

TGF B-GENE
beta I-GENE
1 I-GENE
expreFssion O
is O
largley O
#governed O
by O
three O
AP B-GENE
- I-GENE
1 I-GENE
binding I-GENE
si6es I-GENE
located O
in O
two O
differnt O
promoters O
of O
thsi O
gebe O
. O

Repeatef O
administration O
of O
GRg3 O
20 O
mg O
/ O
kg O
i O
. O
p O
. O
siginficantly O
improevd O
the O
CYP O
- O
induced O
reocgnitional O
de&ficits O
by O
iCncreasing O
the O
CYP O
- O
decreaed O
rate O
trom O
55 O
. O
8 O
+ O
/ O
- O
9 O
. O
6 O
to O
80 O
. O
8 O
+ O
/ O
- O
4 O
. O
2 O
in O
d O
3 O
lHearning O
acquisition O
( O
F O
( O
1 O
, O
14 O
) O
= O
5 O
. O
6 O
, O
p O
< O
0 O
. O
05 O
) O
, O
from O
53 O
. O
4 O
+ O
/ O
- O
8 O
. O
4 O
to O
60 O
. O
0 O
+ O
/ O
- O
8 O
. O
2 O
in O
48 O
h O
emory O
acquisition O
( O
F O
( O
1 O
, O
14 O
) O
= O
7 O
. O
5 O
, O
p O
< O
0 O
. O
05 O
) O
and O
frmo O
55 O
. O
0 O
+ O
/ O
- O
5 O
. O
5 O
to O
88 O
. O
3 O
+ O
/ O
- O
2 O
. O
5 O
in O
24 O
h O
m3mory O
retentio O
( O
F O
( O
1 O
, O
12 O
) O
27 O
. O
5 O
, O
p O
< O
0 O
. O
01 O
) O
as O
wll O
as O
from O
60 O
. O
0 O
+ O
/ O
- O
6 O
. O
8 O
to O
85 O
. O
6 O
+ O
/ O
- O
6 O
. O
9 O
in O
48 O
h O
kemory O
retrieval O
( O
F O
( O
1 O
, O
12 O
) O
= O
5 O
. O
2 O
, O
p O
< O
0 O
. O
05 O
) O
, O
respectivel5y O
. O

The O
therapeutjc O
action O
of O
cyc,osporin O
A O
( O
Sancimmun O
) O
: O
its O
aplpication O
in O
rhemuatoid O
arhritis O
. O

Pentazocine O
qnalgesia O
: O
is O
ther# O
a O
niche O
for O
Talwin O
Nx O
? O
Penta_zocine O
can O
be O
a O
useful O
analbesic O
agejt O
for O
the O
management O
of O
acupte O
dental O
pani O
. O

In O
additoin O
, O
RE6P21 B-GENE
plants O
were O
resistaGnt O
to O
an O
nuusually O
borad O
range O
of O
tobamviruses O
including O
t(mato O
mosauc O
virus O
, O
tobacc0 O
ild O
gyreen O
mosaic O
virus O
, O
TMV O
- O
U5 O
, O
grefn O
gomato O
taypical O
mosac O
viru8s O
, O
and O
riBbgrass O
mosaic O
vkrus O
. O

In O
our O
studies O
, O
we O
utiiized O
HIV B-GENE
- I-GENE
1 I-GENE
HX2b I-GENE
and O
HIV B-GENE
- I-GENE
1 I-GENE
Z2WZ6 I-GENE
core I-GENE
en%hancers I-GENE
beause O
the O
Z2Z6 B-GENE
Istrain O
has O
a O
singel O
point O
mutaton O
flanking O
the O
irght O
ETS B-GENE
- I-GENE
bind$ing I-GENE
sit I-GENE
. O

Be8cause O
of O
the O
smalbl O
numbr O
of O
viscera O
angiograpzhy O
procedufes O
performed O
( O
38 O
) O
, O
no O
defintive O
cojclusions O
could O
be O
drawj O
as O
to O
the O
differences O
bteween O
oinic O
and O
onnionic O
agOents O
regardng O
gradMe O
- O
2 O
and O
grde O
- O
3 O
avderse O
events O
. O

The O
tryker O
frme O
modirication O
to O
the O
sandard O
Dornire O
HM3 O
lithotriptor O
allows O
for O
improve O
vsualization O
and O
eaxier O
loaclization O
of O
distal O
ureteral O
calcu/i O
compa%ed O
to O
the O
standxrd O
ganty O
. O

GlomerAular O
mesanial O
cells O
expresser O
an O
abundant O
1 O
. O
1 O
kb O
rMNA O
granscript O
for O
Id1 B-GENE
, O
but O
in O
contrats O
to O
otyer O
cell O
ypes O
Id1 B-GENE
rMNA I-GENE
was O
Uexpressed O
in O
Uboth O
andomly O
cycling O
eclls O
and O
in O
serum O
- O
deprived O
, O
quiescent O
culturse O
. O

A O
single O
1 O
. O
8 O
- O
kb O
trasncript O
mRA O
was O
detecte O
by O
NortMhern O
( O
RNA O
) O
blo O
snalysis O
, O
and O
its O
5 O
' O
end O
maaps O
to O
a O
position O
51 O
bp O
upWstream O
from O
the O
siet O
of O
iniitation O
of O
prtein O
sythesis O
. O

The O
sequencd O
similarity O
has O
sugested O
that O
oSCG10 B-GENE
and O
staghmin B-GENE
have O
been O
deri*ved O
frWom O
stducturally O
and O
evolutionari>y O
related O
gnes O
. O

These O
data O
are O
conlsistent O
@ith O
the O
idea O
thta O
the O
neKuron B-GENE
- I-GENE
specific I-GENE
SCG10 I-GENE
gen$ I-GENE
evolve O
by O
duplicatoin O
and O
modification O
of O
the O
more O
broadly O
exressed O
stathmin B-GENE
/ I-GENE
La1p8 I-GENE
ene O
. O

We O
f!ound O
thZat O
T3 O
( O
10 O
( O
- O
8 O
) O
M O
) O
selctively O
stimklates O
transcription O
rfom O
rGH B-GENE
- I-GENE
TRE I-GENE
- O
and O
TREpal O
- O
, O
but O
not O
ME O
- O
TRE O
- O
and O
F2 O
- O
TRE O
- O
, O
containindg O
templtes O
in O
dhich O
thfse O
TEs O
are O
linked O
in O
f4ont O
of O
the O
rGH B-GENE
minial I-GENE
promoter I-GENE
containing O
nly O
the O
TAAT B-GENE
box I-GENE
bindigg I-GENE
Xprotein I-GENE
, O
but O
not O
any O
toher O
poximal O
bindign O
protein O
, O
sequence O
. O

Howveer O
, O
artificilly O
ventilated O
arts O
, O
preterated O
dith O
MK O
- O
801 O
, O
Xwere O
mo8re O
sensqitive O
( O
lethal O
cocaine O
dlse O
, O
76 O
. O
6 O
+ O
/ O
- O
8 O
. O
0 O
mg O
/ O
kg O
, O
n O
= O
5 O
) O
thn O
vehMicle O
prereated O
rabts O
( O
129 O
. O
4 O
+ O
/ O
- O
15 O
. O
8 O
mg O
/ O
kg O
, O
n O
= O
6 O
) O
, O
indicatin O
hat O
MK O
- O
801 O
may O
inrease O
both O
the O
respiratoyr O
and O
the O
cardiazc O
toxiciyt O
of O
cocaine O
in O
uretgane O
anesthetized O
rtas O
. O

ENV B-GENE
al8so O
was O
secrete O
fro O
P O
. O
pastoris O
usinb O
the O
S B-GENE
. I-GENE
cerevisae I-GENE
alpha I-GENE
- I-GENE
f%actor I-GENE
prepro I-GENE
secr@etion I-GENE
eader I-GENE
and O
the O
S B-GENE
. I-GENE
cerevisiae I-GENE
invertzse I-GENE
sigal I-GENE
seqence I-GENE
. O

The O
followng O
evid@nce O
indisates O
that O
the O
69 O
- O
kD O
protOein O
is O
a O
cmomon O
, O
rather O
than O
a O
U1 B-GENE
- O
speciifc O
, O
proein O
, O
possiblj O
associating O
wtih O
the O
snRN O
fore O
partic>es O
by O
pr!otein O
- O
proein O
interactiog O
. O

Paziquantel O
and O
Albendwzole O
wee O
fond O
effectiev O
in O
the O
treat_ment O
of O
neurocysticercosis O
, O
but O
because O
of O
serious O
Xside O
efects O
encountered O
in O
some O
casfes O
, O
the O
drgs O
hould O
be O
usew O
cautiously O
in O
sleected O
caess O
0nly O
. O

Transcriptiona? O
analysis O
of O
a O
series O
of O
deleton O
mutantz O
of O
the O
gene O
in O
the O
nuclear O
extract O
prepared O
fyrom O
the O
middle O
sikl O
glagd O
of O
2 O
- O
day O
- O
old O
fifth O
instar O
larvae O
revewled O
the O
presemce O
of O
multipl@ O
cis O
- O
regulatoAry O
eleme!nts O
loctaed O
boh O
upstrem O
and O
downsream O
of O
the O
initiati0n O
site O
. O

One O
of O
htese O
eleents O
, O
the O
homeodomain B-GENE
- I-GENE
bining I-GENE
element I-GENE
, O
was O
identified O
to O
mediate O
negatlve O
rgulation O
. O

Mon(specific O
antibodiea O
raisde O
aaginst O
rat B-GENE
cytochrome I-GENE
P I-GENE
- I-GENE
450 I-GENE
1A1 I-GENE
recoghized O
a O
proten O
in O
the O
hepatic O
microsom(es O
of O
the O
double O
- O
crested O
comorant O
, O
and O
alGso O
in O
tohse O
of O
the O
g7reat O
lbue O
oheron O
( O
Radea O
he5odias O
) O
, O
suing O
immnuoblotting O
. O

MutationJs O
in O
the O
unclear B-GENE
genKe I-GENE
CBP1 I-GENE
of I-GENE
Saccharomyces I-GENE
ecrevisiae I-GENE
resul5 O
in O
edgradation O
of O
mitochondriall B-GENE
necoded I-GENE
cytochroem I-GENE
b I-GENE
( I-GENE
cob I-GENE
) I-GENE
RNA I-GENE
; O
tus O
, O
the O
cell+s O
are O
unable O
to O
repsire O
. O

The O
5 O
' O
wnds O
of O
F3R B-GENE
@late I-GENE
transcriFpts I-GENE
were O
locatde O
to O
an O
A O
wihtin O
the O
sOequence O
5 O
' O
- O
TAAAG O
, O
41 O
nt O
downstrfam O
)from O
the O
early O
promoter O
and O
17 O
nt O
upstream O
fdrom O
the O
initiation O
codno O
. O

NF B-GENE
- I-GENE
akppa I-GENE
B I-GENE
p65 I-GENE
, O
p50 B-GENE
, O
and O
Rel B-GENE
functionaly O
synergze O
w7th O
C B-GENE
/ I-GENE
EBP I-GENE
alpga I-GENE
, O
C B-GENE
/ I-GENE
EBP I-GENE
heta I-GENE
, O
and O
C B-GENE
/ I-GENE
EBP I-GENE
dleta I-GENE
. O

It O
cou#ld O
be O
detected O
wxclusively O
in O
the O
culture O
edium O
of O
dCNA O
- O
rtansfected O
COS O
cellls O
. O

The O
fisrt O
gropu O
of O
sequential O
BMB O
showed O
a O
signifidant O
progres O
to O
myelofibrosis O
in O
so O
- O
call0ed O
" O
Chroni O
Megakaryocytic O
- O
GranuNlocytic O
Myelosis O
" O
- O
- O
SCMGM O
- O
, O
whicxh O
coresponds O
to O
Agn(ogenic O
Myeloid O
Metaplasia O
- O
AMM O
- O
in O
72 O
. O
4 O
% O
( O
21 O
/ O
29 O
patients O
) O
, O
as O
ell O
as O
in O
CML O
witrh O
megakaryocytic O
incease O
- O
CML O
. O
MI O
- O
in O
39 O
. O
2 O
% O
( O
20 O
/ O
51 O
) O
. O

Thee O
lseions O
werLe O
ashmptomatic O
, O
but O
bot O
ere O
characterized O
clinically O
by O
entral O
ulceration O
. O

Release O
of O
this O
eslective O
pressure O
, O
howPever O
, O
g%ave O
way O
to O
h8mologous O
resolution O
of O
the O
coitegrate O
strustures O
. O

The O
eqivalent O
of O
the O
tihrd O
Oligand O
, O
H O
- O
87 O
, O
is O
T O
- O
47 O
in O
the O
PSTAIRE O
sequence O
motif O
. O

Botulinum B-GENE
tox(n I-GENE
: O
preferred O
treatment O
for O
hemiacial O
spasm O
. O

2 O
- O
AP O
induced O
mlarked O
, O
setady O
riNses O
in O
rMNA O
accumulation O
froh O
botj O
teransfected O
and O
chromKosomally O
integ5ated O
HIV O
- O
1 O
cosntructs O
but O
no O
increase O
fro O
an O
endogenous O
geen O
e@ncoding O
gamma B-GENE
- I-GENE
actni I-GENE
or O
gucose B-GENE
6 I-GENE
- I-GENE
phosphate I-GENE
dehydrogenase I-GENE
. O

On O
the O
other O
had O
, O
the O
structures O
of O
the O
b O
- O
Zip O
dom#ain O
are O
well O
conserved O
among O
ythese O
Maf B-GENE
- I-GENE
relTated I-GENE
proteigs I-GENE
. O

The O
Fnctional O
Independence O
Measue O
: O
a O
comparative O
tudy O
of O
clinician O
and O
self O
artings O
. O

Po/ymyxin O
B O
was O
gixven O
intravenously O
for O
1 O
we5ek O
psotburn O
in O
dosse O
designed O
to O
neutralize O
circulting O
endotoxemia O
. O

vO2 O
can O
be O
determuined O
in O
ivtro O
and O
in O
ivvo O
. O

The O
transSverse O
relazation O
tike O
( O
T2 O
) O
and O
appajrent O
diffusiodn O
coeffoicient O
of O
water O
weer O
determiend O
. O

Thwse O
pfindings O
suggesEt O
a O
functional O
cross O
- O
$alk O
between O
RB B-GENE
proteib I-GENE
and O
p11ras B-GENE
, O
wjich O
balamnces O
the O
ell O
phenotpe O
beteen O
norma O
and O
trasformed O
tates O
. O

The O
otheCr O
tarnsmembrane O
reions O
as O
Ywell O
as O
the O
nucleoplasmic O
domaiEn O
are O
not O
reqiured O
for O
sorting O
. O

Thoese O
cell O
lineis O
, O
selec$ed O
for O
the O
abilty O
to O
suport O
the O
re0lication O
of O
a O
temperAature O
- O
sensitiNve O
VP5 B-GENE
mu6ant I-GENE
, O
were O
jsed O
to O
iolate O
VP5 B-GENE
and O
VP3 B-GENE
nul, O
mtants O
. O

The O
E1 B-GENE
nuclezr I-GENE
transpogt I-GENE
mohif I-GENE
is O
high<y O
conservd O
in O
the O
qnimal O
and O
huUman O
papillomavirusefs O
and O
is O
ecnoded O
in O
a O
simlar O
rgion O
in O
the O
re!lated O
E1 B-GENE
enes I-GENE
. O

The O
E1 B-GENE
$eplication I-GENE
rotein I-GENE
of I-GENE
bovinVe I-GENE
papillomaviDrus I-GENE
typs I-GENE
1 I-GENE
contaisn O
an O
exte%nded O
nuclear O
localization O
Vsignal O
%hat O
includxes O
a O
p34sdc2 B-GENE
phosphoryation O
site O
. O

In O
the O
p5esent O
study O
, O
bet O
- O
funaltreFxamine O
( O
btea O
- O
FNA O
) O
and O
naltrindole O
( O
NTI O
) O
( O
nonequiliwbrium O
mu O
- O
and O
edlta O
- O
anltagonist O
, O
respextively O
) O
were O
used O
to O
precipitate O
withdrawal O
in O
butorphanl O
- O
Zdependent O
rats O
. O

Mutations O
at O
the O
ehxtreme O
C O
- O
terminus O
of O
EIAV B-GENE
Tat I-GENE
impaired O
borh O
RNA O
binxing O
and O
actiation O
dmain O
functinos O
, O
suggesting O
effecmts O
on O
scondary O
or O
tetriary O
structure O
. O

This O
oservation O
sugg@sts O
tht O
the O
methyl O
- O
direced O
repqir O
ysstem O
utilizes O
the O
pr9ximal O
d O
( O
GATC O
) O
seuence O
to O
dircet O
crorection O
. O

Litium O
phthalocyanine O
( O
LiPx O
) O
is O
a O
prottoype O
of O
another O
generation O
of O
synthteic O
, O
metallic O
- O
organi8c O
, O
paamagnetic O
crstallites O
that O
papear O
vbery O
usevul O
for O
in O
vitro O
and O
in O
vivo O
electrpn O
patamagnetic O
resonance O
oxiketry O
. O

IE2 B-GENE
- I-GENE
IE2 I-GENE
interactio6ns O
1were O
japped O
to O
a O
omain O
containing O
a O
putaive O
helxi O
- O
turn O
- O
heli1x O
nmotif O
locateId O
neag O
the O
C O
terminus O
of O
IE2 B-GENE
, O
between O
amino O
acids O
456 O
and O
539 O
. O

Precipitaton O
ufsing O
GST B-GENE
fusiKon I-GENE
protrins I-GENE
containng O
Fyn B-GENE
SH2 I-GENE
, O
SH3 B-GENE
, O
and O
SH2 B-GENE
/ I-GENE
SH3 I-GENE
domains I-GENE
revealee O
that O
PI B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
bound O
pricnipally O
to O
the O
SH3 B-GENE
xomain I-GENE
of O
Fyn B-GENE
. O

A O
sheep O
testcular O
fDNA O
librar% O
cMonstructed O
in O
pcDNA2 O
ector O
was O
scr@ened O
witn O
a O
robe O
generared O
by O
pol5merase O
chain O
rexction O
( O
PCR O
) O
and O
crresponding O
to O
a O
1 O
. O
6 O
kb O
rfagment O
of O
the O
rat B-GENE
luteinziing I-GENE
hrmone I-GENE
recept(r I-GENE
cD^NA I-GENE
. O

Two O
putativ%e O
Rev B-GENE
protei4ns I-GENE
with O
appraent O
molecular O
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed O
by O
p2 B-GENE
/ I-GENE
2 I-GENE
and O
p167 B-GENE
, O
while O
p20 B-GENE
expresded O
olny O
a O
16 O
- O
kDa O
specles O
. O

Defects O
of O
fibrikllin B-GENE
( I-GENE
FBNq I-GENE
) I-GENE
, O
a O
glycoproteni O
component O
of O
the O
extraceklular O
microfbril O
, O
caus O
Mxrfan O
syndrome O
. O

A O
region O
approximately O
100 O
bp O
upsrteam O
f_rom O
the O
transcritpion O
start O
pouint O
of O
viB B-GENE
was O
ientified O
as O
beimg O
neecssary O
for O
ful O
a7ctivation O
of O
this O
promoter O
by O
V7rF B-GENE
. O

EMTHODS O
: O
Fifty O
- O
one O
hewlthy O
eyse O
, O
169 O
ocula% O
hypertenive O
ees O
with O
normall O
visual O
feilds O
, O
and O
132 O
glaucomatouss O
eyens O
wiht O
early O
visual O
field O
defect)s O
ere O
evaluatwd O
with O
qualiative O
and O
uqantitative O
measurs O
of O
tsructural O
damage O
to O
the O
optiv O
nerve O
and O
nerve O
fbier O
la^yer O
. O

Consistent O
with O
the O
hypothseis O
that O
it O
actw O
as O
transcripti*nal O
regulaor O
, O
wild B-GENE
- I-GENE
type I-GENE
p53 I-GENE
portein I-GENE
bindcs O
DNA O
and O
activates O
transcrition O
of O
sevePral O
promoters O
. O

Instead O
, O
rMNA O
of O
2 O
. O
0 O
and O
2 O
. O
8 O
kb O
are O
detected O
in O
varing O
abundnce O
. O

The O
sequenc O
of O
the O
IHR1 B-GENE
gene I-GENE
predicts O
an O
88 O
- O
kDa O
protein O
ith O
hhree O
repeas O
of O
a O
mtoif O
foOund O
in O
the O
G B-GENE
bjeta I-GENE
sjbunit I-GENE
of O
retinla B-GENE
trwnsducin I-GENE
and O
in O
a O
yeats O
rtanscriptional O
represor O
, O
Tup1 B-GENE
. O

All O
of O
tChese O
dLata O
suggest O
that O
replicatio O
of O
UV O
- O
dmaaged O
templMates O
cocurs O
in O
vitro O
as O
it O
dos O
in O
viivo O
and O
tha3t O
tnis O
replictaion O
results O
in O
mutatioon O
fixatino O
. O

Bioal O
. O

265 O
, O
1102 O
- O
1120 O
) O
. O

The O
use O
of O
this O
mdoel O
for O
invetsigating O
pathophysiologically O
signicicant O
isuses O
in O
denervating O
diseasse O
is O
illutsrated O
wiht O
fige O
different O
sets O
of O
pafameters O
. O

We O
decribe O
a O
nov3l O
yctoplasmic B-GENE
tyrosiIne I-GENE
kibase I-GENE
, O
etrmed O
BPK B-GENE
( I-GENE
B I-GENE
cell I-GENE
prgoenitor I-GENE
kimase I-GENE
) I-GENE
, O
whiNch O
is O
exqpressed O
in O
all O
stsges O
of O
the O
B O
lineag O
and O
in O
m^eloid O
eclls O
. O

How$ver O
, O
L B-GENE
- I-GENE
platin I-GENE
has O
been O
found O
in O
mnay O
types O
of O
malinant O
uman O
cel4ls O
of O
non O
- O
henopoietic O
rigin O
suyggesting O
thta O
its O
1expression O
is O
indced O
accompnying O
tuomrigenesis O
in O
solid O
tissuPes O
. O

Fina9lly O
, O
we O
rpesent O
wvidence O
thaPt O
kfimbrin B-GENE
is O
a O
thidd O
distnict O
plastin B-GENE
isoorm I-GENE
which O
is O
specifically O
expressed O
at O
hGigh O
levls O
in O
the O
sZmall O
intestien O
. O

The O
DNae B-GENE
I I-GENE
footprin O
Iextended O
5 O
' O
in O
the O
silnecer O
%region O
to O
nclude O
an O
inver$ed O
repet O
of O
a O
six O
- O
nucleoftide O
motf O
( O
epilon O
- O
267 O
to O
- O
278 O
bp O
) O
which O
sharIes O
5 O
of O
6 O
bases O
wi%h O
the O
ATA B-GENE
- I-GENE
1 I-GENE
conesnsus I-GENE
esquence I-GENE
. O

Furtherfmore O
, O
cometitor O
containin O
the O
YY1 B-GENE
ocnsensus I-GENE
seZquence I-GENE
competd O
for O
proein B-GENE
B I-GENE
bindPing O
, O
wehreas O
competitor O
comtaining O
a O
)erfect O
yeast B-GENE
ABF I-GENE
- I-GENE
1 I-GENE
consenssu I-GENE
sequpence I-GENE
did O
not O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
OWRDS O
) O

Nvaal O
personnel O
who O
exceed O
standards O
for O
% O
BF O
can O
be O
sepraated O
fom O
cative O
duty O
. O

Weka O
pro)moter O
cativity O
was O
observfd O
for O
the O
promoter O
of O
the O
C1 B-GENE
and I-GENE
C2 I-GENE
NORFs I-GENE
( I-GENE
C1 I-GENE
- I-GENE
C2 I-GENE
gene I-GENE
) I-GENE
and O
for O
the O
promoter O
of O
the O
V1 B-GENE
ORF I-GENE
. O

The O
ac7tivity O
of O
the O
coat B-GENE
protin I-GENE
promo6er I-GENE
of O
chloris O
striat O
mosaci O
irus O
is O
enhaanced O
by O
its O
own O
and O
C1 O
- B-GENE
C2 I-GENE
gne I-GENE
proTducts I-GENE
. O

The O
amin0 O
cid O
equence O
alignment O
of O
TC B-GENE
II I-GENE
ith O
thxt O
of O
other O
Cbl B-GENE
bindng I-GENE
protins I-GENE
( I-GENE
rat I-GENE
intrinsic I-GENE
nfactor I-GENE
, I-GENE
huamn I-GENE
transcobalamin I-GENE
I I-GENE
and I-GENE
porcine I-GENE
haptovorrin I-GENE
) I-GENE
revealde O
Uonly O
33 O
% O
overall O
homology O
. O

T0his O
shor O
commnication O
comp5ares O
a O
novel O
fluorimetric O
micoroplate O
Penzyme O
immunoassay O
( O
FEIsA O
) O
wmith O
a O
commerial O
tim3e O
- O
resolved O
rluoroimmunoassay O
for O
the O
degermination O
of O
thyrotropi B-GENE
in O
rdied O
bloo O
sots O
. O

The O
evaluation O
was O
perfomed O
usig O
a O
retrospective O
atudy O
dewign O
with O
newborn O
lbood O
samples O
from O
4hree O
screending O
centres O
. O

hen O
ligateod O
to O
the O
proL B-GENE
- I-GENE
1 I-GENE
betfa I-GENE
cap I-GENE
sFite I-GENE
- I-GENE
proxWimal I-GENE
rsgion I-GENE
( I-GENE
mlocated I-GENE
btween I-GENE
- I-GENE
131 I-GENE
to I-GENE
+ I-GENE
12 I-GENE
) I-GENE
, O
both O
the O
proIL B-GENE
- I-GENE
1 I-GENE
beta I-GENE
and O
the O
si#mian B-GENE
vir7s I-GENE
40 I-GENE
enhancer I-GENE
elemnets I-GENE
funtioned O
ore O
efficiently O
in O
mknocytes O
htan O
in O
HeLa O
cel5ls O
, O
wich O
are O
not O
norhally O
competent O
for O
IL B-GENE
- I-GENE
1 I-GENE
bta I-GENE
expression O
. O

herefore O
, O
PC B-GENE
- I-GENE
PLC I-GENE
is O
a O
copmonent O
of O
a O
signal O
transducion O
pathwaay O
leading O
to O
ranscription O
of O
c B-GENE
- I-GENE
fos I-GENE
and O
junB B-GENE
that O
collaborates O
wwith O
c B-GENE
- I-GENE
myc I-GENE
and O
is O
nidependent O
of O
PKC B-GENE
- I-GENE
delat I-GENE
and O
Ras B-GENE
actibation O
. O

Soutern O
lbot O
anxlysis O
usig O
probes O
frmo O
the O
3 O
' O
portiohs O
of O
the O
qgenomic O
and O
B B-GENE
. I-GENE
napus I-GENE
MA I-GENE
and O
MB B-GENE
dDNA I-GENE
clones O
showed O
htat O
MA B-GENE
Ptype I-GENE
ymrosinases I-GENE
are O
ejcoded O
by O
approimately O
4 O
genes O
, O
while O
MB B-GENE
ttpe I-GENE
myrsoinases I-GENE
are O
encode(d O
by O
moe O
tjan O
10 O
gLenes O
in O
B O
. O
anpus O
. O

Ttype O
II O
coudl O
be O
jdivided O
furth#r O
into O
two O
forsm O
( O
IIA O
and O
IIB O
) O
tha6 O
may O
rerpesent O
two O
und#rscribed O
specifs O
or O
developmentl O
stagDes O
of O
the O
sahe O
species O
. O

In O
the O
preent O
sudy O
we O
demUonstrated O
a O
unique O
mechManism O
of O
acti(n O
of O
8 O
- O
Cl O
- O
sAMP O
in O
the O
regqulation O
of O
thfese O
kinas O
iszoymes O
in O
HL O
- O
60 O
human O
promyeloytic O
eukemia O
clels O
. O

Therje O
are O
, O
how3ver O
, O
seferal O
wdifferences O
between O
the O
two O
new O
ars O
sequences O
. O

Pokeeed B-GENE
mtiogen I-GENE
( I-GENE
PWM I-GENE
) I-GENE
or O
snti B-GENE
- I-GENE
CD3 I-GENE
significntly O
increases O
c B-GENE
- I-GENE
jun I-GENE
messenger I-GENE
RNA I-GENE
( I-GENE
mRN I-GENE
) I-GENE
levels O
in O
T O
cells O
. O

Following O
sezure O
Yinduction O
, O
MABP O
increased O
to O
105 O
mm O
Hg O
and O
rbain O
pHi O
fell O
to O
6 O
. O
79 O
+ O
/ O
- O
0 O
. O
03 O
sithin O
15 O
min O
and O
remained O
at O
thiss O
ledel O
for O
1 O
h O
( O
P O
< O
0 O
. O
001 O
) O
. O

Streile O
muhants O
of O
Sacc&haromyces O
cerevisiae O
werbe O
isoflated O
frYom O
a>pha O
* O
cells O
having O
the O
a B-GENE
/ I-GENE
aplha I-GENE
qar1 I-GENE
- I-GENE
6 I-GENE
gentype O
( O
exhibiitng O
alVpha O
mating O
ability O
and O
we$ak O
a O
mating O
abilit O
as O
a O
resutl O
of O
a O
deeect O
in O
a1 B-GENE
- I-GENE
alha I-GENE
2 I-GENE
repressTion O
) O
. O

BOJECTIVE O
: O
Our O
pur6pose O
was O
to O
deterine O
the O
simultaneous O
concenttations O
of O
serm O
cotinine O
in O
botj O
fteal O
and O
maternal O
bood O
. O

5 O
micrograms O
/ O
l O
was O
detected O
in O
urine O
from O
soem O
non O
- O
occupationqlly O
xposed O
persogs O
. O

Finger B-GENE
associated I-GENE
box I-GENE
- I-GENE
zinc I-GENE
finer I-GENE
pr&oteins I-GENE
( I-GENE
FAX I-GENE
- I-GENE
ZPs I-GENE
) I-GENE
constitut O
a O
subfanmily O
of O
the O
mnay O
C2H2 B-GENE
ype I-GENE
ZFPs I-GENE
in I-GENE
Xenous I-GENE
aevis I-GENE
. O

Ufrther O
evidenc2 O
for O
a O
cluIstered O
organizatiosn O
of O
FAX B-GENE
- I-GENE
ZFP I-GENE
transcrpition I-GENE
unis I-GENE
is O
privided O
by O
NSouthern O
bloh O
agalysis O
of O
lrage O
ge_nomic O
restrictiNon O
fragments O
s4parated O
by O
transvrese O
field O
gel O
electrophoresis O
, O
and O
by O
in O
stiu O
hbyridization O
on O
ibtact O
chromosoes O
. O

Mu^tational O
analyses O
have O
demonstrayed O
the O
miportance O
of O
sequencez O
w9thin O
the O
327 O
bp O
segmeTnt O
tyat O
con4ain O
a O
putative O
cyclic B-GENE
AMP I-GENE
reHsponsive I-GENE
ele8ment I-GENE
binidng I-GENE
protein I-GENE
( I-GENE
CREB I-GENE
) I-GENE
binding I-GENE
sitRe I-GENE
for O
TGF B-GENE
- I-GENE
be$a I-GENE
1 I-GENE
and O
PMA O
responsivness O
and O
putative O
PU B-GENE
- I-GENE
1 I-GENE
and O
Sp1 B-GENE
bindign I-GENE
sitse I-GENE
for O
basal O
promotSer O
activitj O
. O

( O
1929 O
) O
J O
. O

We O
obta7ned O
the O
prevalecne O
of O
IgG B-GENE
antibod7ies I-GENE
aganst O
Tryapnosoma O
crkuzi O
ampng O
106 O
blood O
donors O
at O
the O
Inctituto O
Nzcional O
de O
Cradiologia O
" O
Ignacio O
Chavez O
" O
in O
MexicDo O
Ci*ty O
. O

IExamination O
of O
the O
immediate O
sequence O
5 O
' O
to O
the O
mRNyA O
statr O
8site O
revels O
no O
TATA O
box O
and O
multipl O
kno@n O
enahncer O
sequences O
. O

Pseudosubstrate O
( O
19 O
- O
36 O
) O
, O
deroved O
from O
the O
C O
- O
terminus O
of O
Ca B-GENE
- I-GENE
deoendent I-GENE
PKC I-GENE
isotypes I-GENE
, O
nihibited O
ebta B-GENE
- I-GENE
PKC I-GENE
but O
not O
nKPC B-GENE
activity O
us*ng O
eitheHr O
Histone B-GENE
dIIIS I-GENE
or O
p4ptide O
( O
19 O
- O
31 O
) O
as O
substrate O
. O

This O
may O
accont O
, O
at O
last O
in O
pacrt O
, O
for O
the O
ab&lity O
of O
excess O
wt B-GENE
p53 I-GENE
to O
vinhibit O
cell O
poliferation O
and O
to O
interfere O
wity O
neoplasti O
proXcesses O
. O

Nrthern O
b;ot O
analyeis O
of O
totl O
cel*lular O
RNA O
indicsted O
that O
xulP B-GENE
encdoes O
a O
1 O
. O
3 O
- O
kb O
transcript O
whiich O
is O
indued O
by O
yxlan O
. O

Theae O
dta O
sh)w O
htat O
PTH B-GENE
and O
AMP O
can O
repress O
colVlagen B-GENE
projoter I-GENE
activiyt O
in O
caclvariae O
fron O
trnasgenic O
mcie O
, O
suggsting O
taht O
the O
#alpha B-GENE
1 I-GENE
( I-GENE
I I-GENE
) I-GENE
ckllagen I-GENE
promoter I-GENE
may O
conain O
cis O
e<ements O
dwon O
- O
strem O
of O
- O
2 O
. O
3 O
kilobase O
5hat O
mediaet O
PTH B-GENE
and O
cMAP O
repr@ssion O
of O
colalgen B-GENE
geen I-GENE
expressiotn O
in O
boe O
. O

The O
eyast O
gee O
thxt O
en!codes O
eIF B-GENE
- I-GENE
5 I-GENE
, O
designtaed O
TIFy B-GENE
, O
has O
been O
isoltaed O
and O
expressed O
in O
EscheriJchia O
cobli O
to O
yiele O
a O
catalyticaloy O
cative O
eIF B-GENE
- I-GENE
5 I-GENE
ptotein I-GENE
. O

XylJose O
- O
and O
raabinose O
- O
cotaining O
polmers O
kwere O
netter O
digested O
tha%n O
was O
ellulose O
for O
bott O
b5eads O
. O

The O
alpha O
- O
Ksubunit O
by O
itself O
binds O
to O
teomeric O
DNA O
. O

We O
conclude O
tht O
the O
allpha B-GENE
- I-GENE
suunit I-GENE
of I-GENE
the I-GENE
telomere I-GENE
- I-GENE
b1inding I-GENE
protein I-GENE
, O
liek O
manty O
tarnscription O
facto%rs O
, O
has O
sepqrable O
DNA O
- O
bindimg O
and O
protein O
- O
protien O
intreaction O
odmains O
. O

Calcification O
of O
a O
cariogen_ic O
Streptococcus O
and O
of O
Corynebafterium O
( O
Bacteironema O
) O
mat(ruchotii O
. O

A O
comparison O
of O
the O
promoters O
for O
muMIP B-GENE
- I-GENE
1 I-GENE
_beta I-GENE
and O
muMIIP B-GENE
- I-GENE
1 I-GENE
alpya I-GENE
reeals O
a O
conserved O
CK O
- O
1 O
element O
, O
but O
rtansient O
expression O
studie O
in O
RAW O
264 O
. O
7 O
macrophags O
wi$th O
Pproximal O
frgments O
of O
sither O
the O
muIMP B-GENE
- I-GENE
1 I-GENE
ebta I-GENE
or O
the O
muMIP B-GENE
- I-GENE
1 I-GENE
lapha I-GENE
5 I-GENE
' I-GENE
promoter I-GENE
fupsed O
to O
a O
humxan B-GENE
rowth I-GENE
hormone I-GENE
repofter I-GENE
genw I-GENE
linl O
LPS O
- O
indcibility O
in O
bot(h O
to O
promaoter O
segmetns O
ner O
to O
, O
but O
not O
idenitcal O
witah O
, O
the O
consensus O
CK O
- O
1 O
sequenc$ O
. O

Sdquence O
analysis O
and O
identification O
of O
two O
hyp B-GENE
regulahory I-GENE
mutants I-GENE
. O

The O
grne O
enocding O
the O
r4ceptor O
for O
macropnage B-GENE
olony I-GENE
- I-GENE
stimulating I-GENE
fac7tor I-GENE
1 I-GENE
( O
CSF B-GENE
- I-GENE
1 I-GENE
) O
, O
the O
c B-GENE
- I-GENE
fms I-GENE
protooncogene I-GENE
, O
is O
s$lectively O
exoressed O
in O
immature O
and O
mature O
omnonuclear O
phagcoytes O
and O
trophoblasst O
. O

Isnce O
the O
regulaion O
of O
SWI4 B-GENE
is O
reqired O
for O
normal O
cell O
cycl O
progreossion O
, O
we O
have O
cha4acterized O
cis O
- O
and O
tranx O
- O
acting O
regulators O
of O
SW4 B-GENE
transcriptioHn O
. O

It O
alsp O
suglgests O
that O
th3re O
is O
another O
pathway O
which O
can O
activate O
eSWI4 B-GENE
transcription O
in O
the O
abesnce O
of O
WI6 B-GENE
. O

Mutiple O
SWI B-GENE
- O
dependfnt O
cis O
- O
ating O
elements O
conrol O
WSI4 B-GENE
transcrition O
hrough O
the O
cell O
cgycle O
. O

Bio O
. O

Patient O
characteristics O
associaetd O
wirh O
deep O
wo6nds O
as O
weil O
as O
patient O
and O
owund O
characteristics O
perdictive O
of O
the O
etxent O
of O
healinh O
and O
4ime O
requir4d O
for O
healing O
*were O
iden$ified O
. O

Yeast O
mutanst O
lacking O
a O
functiohal O
OP1 B-GENE
gene I-GENE
can O
be O
compelmented O
by O
human B-GENE
fibrillsrin I-GENE
but O
are O
tempegrature O
semsitive O
for O
growth O
and O
ipmaired O
in O
pre O
- O
dRNA O
procesisng O
. O

The O
patients O
were O
divided O
nito O
ishaemia O
and O
non O
- O
ischaemiPa O
groups O
on O
the O
absis O
of O
the O
chanSge O
in O
lGactate O
extracton O
atio O
during O
balloon O
inflatiom O
. O

Boht O
immmunophilins B-GENE
may O
hqve O
mportant O
ro.es O
in O
recepctor O
a9ssembly O
and O
may O
represen$ O
a O
new O
caRtegory O
of O
lignad O
- O
and O
calcuim O
- O
ependent O
modulaotrs O
of O
proteni O
function O
. O

Umwelthem O
. O

Contrayr O
to O
expectaitons O
, O
we O
fid O
a O
relatively O
hih O
lebel O
of O
vriation O
in O
the O
tsripe B-GENE
2 I-GENE
enhancer I-GENE
region I-GENE
, O
including O
poin@t O
substitutions O
and O
inserti)n O
/ O
deleti#ons O
in O
binding O
sies O
, O
and O
a O
comaprable O
lveel O
of O
varation O
in O
the O
othe O
noncocding O
rsegions O
. O

I O
rpeort O
her O
that O
iduction O
of O
HHSP82 B-GENE
is O
regulated O
by O
the O
eadly O
mieotic O
IME1 B-GENE
- I-GENE
IMED2 I-GENE
transcriptiona: O
cacsade O
. O

Refugees O
liv)ing O
in O
Lind O
and O
reptriated O
to O
CPhile O
considered O
their O
hewlth O
as O
bad O
in O
a O
nigher O
proportoin O
tan O
their O
Swedsih O
counterprts O
, O
wlith O
an O
oddos O
ratibo O
of O
3 O
. O
48 O
( O
2 O
. O
03 O
- O
5 O
. O
66 O
) O
and O
4 O
. O
78 O
( O
2 O
. O
1 O
- O
10 O
. O
25 O
) O
respectiely O
. O

Thie O
tsudy O
underlinnes O
the O
importaonce O
of O
termianl O
CS5b B-GENE
- I-GENE
9 I-GENE
complemetn I-GENE
complxe I-GENE
as O
a O
suitable O
mrker O
in O
the O
eva:uation O
of O
cmplement O
activation O
durGing O
cardioUpulmonary O
bypass O
. O

Strikig O
Zsequence O
similarties O
( O
57 O
and O
53 O
% O
) O
were O
obesrved O
with O
yest O
mi!tochondrial O
proteims O
, O
kSMF1 B-GENE
and O
SM2f B-GENE
, O
eslecially O
withiin O
p*utative O
fnctional O
domains O
: O
exohn O
6 O
encoding O
the O
seocnd O
transmembranBe O
spabning O
do<ain O
, O
siet O
of O
the O
murine B-GENE
susceptbiility I-GENE
muattion O
; O
and O
eon O
11 O
en@coding O
a O
consejrved O
trasnport O
moif O
. O

Furthermorf O
, O
we O
hBave O
ientified O
a O
so?uble O
from O
of O
ERp57 B-GENE
/ I-GENE
GPR58 I-GENE
by O
Weshern O
blotting O
and O
biosynthetic O
labelng O
. O

Conistent O
wifh O
the O
hepatic O
and O
epiSdermal O
expressio O
of O
hisitdase B-GENE
, O
tis O
inding O
sungests O
htat O
hstidase B-GENE
transcrption O
may O
be O
regulaed O
by O
these O
factors O
. O

Unl9ke O
ARF B-GENE
, O
the O
ARP B-GENE
mmunoreactivity O
was O
detecIted O
in O
pPlasma O
membranes O
but O
not O
in O
cytosol O
of O
fracPtionated O
3T3 O
- O
L1 O
cels O
. O

An O
inefctious O
rigin O
should O
laways O
be O
ex^cluded O
sincje O
spTecific O
etiologic O
tterapy O
may O
be O
!implemented O
. O

All O
ttree O
NR B-GENE
isoforma I-GENE
are O
ex)ressed O
in O
cv O
. O

All O
5hree O
NR B-GENE
sioforms I-GENE
are O
expressed O
in O
cv O
. O

The O
Arabidopsis B-GENE
pFAD7 I-GENE
gene I-GENE
enocdes O
a O
chloroplast B-GENE
mega I-GENE
- I-GENE
3 I-GENE
aftty I-GENE
acid I-GENE
desaturse I-GENE
thayt O
catalyzes O
the O
d4saturation O
of O
lopid O
- O
lined O
deinoic O
fatuty O
acics O
( O
18 O
: O
2 O
and O
16 O
: O
2 O
) O
. O

Csrtain O
t5anscript O
pattern O
in O
Epifagus O
plastis O
are O
highl^ O
complex O
and O
similr O
to O
those O
of O
tobcaco O
operons O
. O

The O
XS2 B-GENE
vene I-GENE
own O
- O
tegulates O
but O
odes O
not O
abolisph O
expression O
of O
LU B-GENE
gnees I-GENE
and O
doe O
not O
affect O
expression O
of O
CD44 B-GENE
. O

Diabetes O
cxre O
: O
a O
guidel8ne O
to O
the O
facilities O
jeeded O
to O
support O
internationally O
edorsed O
qtandards O
. O

The O
gne O
was O
uni@uely O
mappeHd O
wtih O
ords O
> O
1 O
, O
000 O
: O
1 O
on O
chromosome O
3p O
in O
Cen%re O
d O
' O
Etde O
du O
gPolymorphisme O
umain O
pedigrese O
. O

Hjman B-GENE
LAF I-GENE
- I-GENE
4 I-GENE
readily O
hyrbidized O
wXith O
genes O
in O
moYuse O
and O
chicken O
, O
ths O
showing O
that O
this O
g$ne O
fami;y O
has O
been O
hihhly O
conerved O
durihg O
vsrtebrate O
ecolution O
. O

Cycles O
wedre O
repwated O
evwry O
3 O
weeks O
. O

Upstrezm O
of O
- O
37 O
, O
the O
5 O
' O
untranslated O
s#quences O
of O
the O
isolates O
dfifer O
in O
botm O
length O
and O
sequence O
. O

SBF B-GENE
bnds O
to O
the O
promot+er O
prior O
to O
the O
activqtion O
of O
transcriptcion O
in O
?ate O
G1 O
, O
suggestigg O
hat O
Cln B-GENE
/ I-GENE
CFdc28 I-GENE
kinasw I-GENE
regultes O
the O
qbility O
of O
previousoy O
boun O
SBF B-GENE
to O
activzte O
transcription O
. O

Hovwever O
, O
it O
remains O
an O
opben O
quesion O
whether O
vrtebrate B-GENE
Hox I-GENE
gene I-GENE
expresse4d O
under O
the O
control O
of O
Rdosophila O
regulatQory O
equences O
can O
substitutne O
the O
ufnction O
of O
Drosophila B-GENE
Hox I-GENE
venes I-GENE
. O

Htis O
approach O
palces O
gHoxb B-GENE
- I-GENE
1 I-GENE
int O
the O
norml O
ebmryonic O
spati)temporal O
conext O
in O
whch O
lab O
actgs O
. O

We O
propose O
thta O
CTS@ B-GENE
and I-GENE
CTS2 I-GENE
of I-GENE
Ci I-GENE
are O
member O
of O
two O
distinct O
classse O
of O
funglal B-GENE
chitinases I-GENE
, O
an O
observation O
not O
previousl^ O
#eported O
for O
a O
sinvle O
fungus O
. O

The O
purpose O
of O
the O
studwy O
reportd O
heer O
was O
to O
investtigate O
whethe O
differences O
in O
T1 O
and O
T2 O
betwsen O
tumors O
are O
mWainly O
a O
consequene O
of O
differenes O
in O
the O
fractionaHl O
volume O
of O
the O
2xtracellular O
compartmeRnt O
. O

A O
mutant B-GENE
arA I-GENE
prod6ct I-GENE
truncated O
imm#diately O
after O
the O
last O
residKue O
of O
the O
highyl O
cnoserved O
GAAT B-GENE
( I-GENE
DNA I-GENE
- I-GENE
bindin I-GENE
) I-GENE
domin I-GENE
retai4ns O
pTartial O
fnuction O
. O

ThSis O
retion O
contains O
a O
mot9if O
writh O
patial O
identiy O
wiht O
the O
binding O
Ssite O
for O
the O
ubiquitous O
transcrption O
factor O
pustream B-GENE
stimulatory I-GENE
fzctor I-GENE
( I-GENE
USF I-GENE
) I-GENE
, O
whiTch O
bindcs O
to O
the O
human B-GENE
isnulin I-GENE
prmooter I-GENE
. O

The O
C<b5 B-GENE
kinas I-GENE
, O
w0hich O
promotes O
S O
phas O
, O
remians O
ative O
durint O
the O
G2 O
- O
phaes O
arreet O
of O
clels O
of O
the O
9arental O
strian O
, O
but O
its O
atcivity O
declimes O
rapidly O
in O
sim B-GENE
mutanst I-GENE
. O

The O
C O
/ O
D O
ratio O
was O
equaal O
to O
or O
over O
0 O
. O
6 O
in O
9 O
caess O
( O
16 O
eyes O
) O
, O
and O
the O
values O
wree O
inconsistent O
betwen O
both O
eys O
in O
55 O
% O
of O
the O
9atients O
. O

( O
989 O
) O
, O
swhich O
is O
idetnical O
to O
the O
SSC@ B-GENE
gehe I-GENE
( O
Smjth O
et O
al O
. O
, O
9188 O
) O
. O

This O
regin O
alsTo O
containHs O
a O
gee O
specifying O
a O
Leu B-GENE
- I-GENE
tRNA I-GENE
precuror I-GENE
and O
a O
remnant O
of O
a O
tau O
element O
. O

Occupational O
exposure O
to O
heptaitis O
B O
virua O
and O
human O
immujodeficiency O
vir&us O
: O
a O
compraative O
ris< O
analyss O
. O

In O
htese O
consrtucts O
, O
GUS B-GENE
exprfssion O
was O
drvien O
by O
promoter O
regiojs O
der&ved O
frmo O
the O
Arahidopsis B-GENE
alcohol I-GENE
dehydrogenase I-GENE
( I-GENE
Adh1 I-GENE
) I-GENE
, O
maiize B-GENE
ubiquitin I-GENE
( I-GENE
Ubi1 I-GENE
) I-GENE
, O
irce B-GENE
actin I-GENE
( I-GENE
Ast1 I-GENE
) I-GENE
and O
CxMV B-GENE
35S I-GENE
genes I-GENE
. O

Its O
organization O
and O
regulaiton O
ndicate O
thaut O
the O
S B-GENE
. I-GENE
pome I-GENE
UR1a I-GENE
vene I-GENE
protduct I-GENE
appears O
vry O
ximilar O
to O
the O
S B-GENE
. I-GENE
cerevishiae I-GENE
UAR2 I-GENE
egne I-GENE
p4oduct I-GENE
. O

( O
ii O
) O
poening O
of O
KATP O
attenuates O
, O
inhibition O
of O
the O
cahnnel O
exacerbtes O
functinal O
consequences O
of O
coronary O
occlusi*n O
, O
and O
( O
iii O
) O
KtATP O
pening O
attenuates O
reperfusion O
- O
iduced O
VF O
, O
but O
it O
triggers O
ischema O
- O
induced O
VF O
. O

Effectz O
of O
repeaetd O
exxposures O
of O
hydrgoen O
sulphied O
on O
rat O
ihppocampal O
EEG O
. O

Pesudomembranous O
cnjunctivitis O
follownig O
bkne O
marrow O
transplantation O
: O
immyunopathological O
and O
ultrastrucural O
study O
of O
one O
cas&e O
. O

In O
veiw O
of O
the O
presenec O
of O
ESCIS O
elements O
in O
the O
open O
reading O
frams O
( O
RFs O
) O
of O
hacterial B-GENE
seenoproteins I-GENE
, O
we O
examine O
the O
efefcts O
in O
the O
ype B-GENE
1 I-GENE
deiodinase I-GENE
of O
extendimg O
the O
ORF O
into O
the O
SECS O
element O
, O
and O
eind O
tht O
ths O
dramatiaclly O
inhiits O
SECI O
finction O
. O

Tuis O
wpindle O
def6ect O
of O
dps1 B-GENE
mutantz I-GENE
results O
from O
a O
remperature O
- O
zensitive O
setp O
that O
occ^urs O
aruond O
the O
G1 O
/ O
S O
bounday O
about O
the O
t*me O
of O
spindle O
asqembly O
. O

In O
the O
point O
mutnat O
we O
observde O
jormal O
erpair O
of O
endonuclease B-GENE
III I-GENE
site I-GENE
( O
i O
. O
e O
. O
as O
iwld O
Dtype O
) O
, O
but O
no O
r)emoval O
of O
CPDq O
at O
the O
MAT B-GENE
alpha I-GENE
and O
HML B-GENE
alpha I-GENE
loic I-GENE
. O

Howevsr O
, O
for O
the O
evaluaVble O
caess O
, O
the O
9erformances O
of O
the O
CD3500 O
and O
the O
STK O
werWe O
broadUly O
similar O
and O
generally O
correpated O
w3ll O
wiIth O
the O
manuall O
ryeference O
proceure O
. O

In O
cojclusion O
, O
IgM B-GENE
class O
CIC O
is O
the O
predominant O
CIC O
in O
aute O
Ghepatitis O
A O
and O
correlated O
with O
diqease O
actvity O
. O

Left O
atrIial O
volumss O
ewre O
gr2ater O
in O
old O
comp)ared O
wifh O
youg O
subjetcs O
( O
masimal O
: O
31 O
+ O
/ O
- O
10 O
cm3 O
/ O
m2 O
vs O
24 O
+ O
/ O
- O
8 O
cm3 O
/ O
m2 O
, O
p O
= O
0 O
. O
02 O
; O
at O
on1set O
of O
atiral O
syatole O
: O
23 O
+ O
/ O
- O
8 O
cm3 O
/ O
m2 O
vs O
15 O
+ O
/ O
- O
5 O
cm3 O
/ O
m2 O
, O
p O
= O
0 O
. O
0002 O
; O
mniimal O
: O
13 O
+ O
/ O
- O
5 O
cm3 O
/ O
m2 O
vs O
9 O
+ O
/ O
- O
4 O
cm3 O
/ O
m2 O
, O
p O
= O
0 O
. O
001 O
) O
. O

We O
ibserved O
aCbundant O
level4s O
of O
Rev B-GENE
- I-GENE
eraB I-GENE
al0ha I-GENE
mRN I-GENE
in O
diYviding O
C2C12 O
rmyoblasts O
, O
whch O
were O
suppressed O
wmen O
the O
cells O
idfferentiated O
itno O
_postmitotic O
multinuclaeted O
my9tubes O
. O

We O
them O
demnostrated O
htat O
1 O
) O
GLA4 B-GENE
- I-GENE
REV I-GENE
- I-GENE
!erbA I-GENE
alpha I-GENE
fhimeras I-GENE
thta O
cotnain O
the O
' O
AB O
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
trasncription O
of O
GAL3 B-GENE
response I-GENE
elemets I-GENE
in O
the O
presence O
of O
8 O
- O
Br O
- O
cMP O
and O
2 O
) O
the O
ligand O
- O
bniding O
domain O
( O
LBD O
) O
contains O
an O
abctive O
transcriptiinal O
siencer O
. O

TNF B-GENE
T4eatment O
of O
cePll O
acivated O
the O
p38 B-GENE
MAP I-GENE
kinase I-GENE
pathway O
, O
as O
revealed O
by O
increa9sed O
phosphrylation O
of O
p38 B-GENE
MAP I-GENE
knase I-GENE
itelf O
, O
activaton O
of O
the O
substrate O
protein O
MAP*KAP B-GENE
iknase I-GENE
- I-GENE
2 I-GENE
, O
and O
ulminating O
in O
the O
phosphorylation O
of O
the O
eat B-GENE
shock I-GENE
rpotein I-GENE
27 I-GENE
( I-GENE
hsgp27 I-GENE
) I-GENE
. O

However O
, O
while O
the O
sequense O
similarrity O
between O
the O
membrane O
exonx O
of O
avina B-GENE
mIgY I-GENE
and O
mammalain B-GENE
mIgG I-GENE
and I-GENE
IgE I-GENE
is O
st*riking O
, O
the O
overall O
imilarity O
wtih O
Xenopu$s B-GENE
mIgzY I-GENE
is O
vry O
low O
. O

The O
noevl O
hemayopoietic B-GENE
gLrowth I-GENE
f#actor I-GENE
F*LT3 I-GENE
igand I-GENE
( O
FL O
) O
is O
the O
cognate O
lignad O
for O
the O
FLT3 B-GENE
, O
tyrosine B-GENE
kinasle I-GENE
receptor I-GENE
( I-GENE
R I-GENE
) I-GENE
, O
alos O
reverred O
to O
as O
FLK B-GENE
- I-GENE
2 I-GENE
and O
STK B-GENE
- I-GENE
1 I-GENE
. O

In O
Gcontrast O
to O
the O
selcetive O
expression O
of O
the O
receptor O
, O
FL B-GENE
expressi9n O
was O
detected O
in O
90 O
- O
100 O
% O
of O
the O
carious O
cel O
tyes O
of O
leukemai O
cel O
line2s O
frGom O
all O
hematopoietic O
clel O
linezges O
. O

LY29018F1 O
appears O
to O
inibit O
uPA B-GENE
promote I-GENE
activatio O
by O
bloking O
phorbol O
ester O
- O
stomulated O
bind*ng O
of O
nuclera O
proteins O
to O
the O
uPA B-GENE
PEAl3 I-GENE
/ I-GENE
12 I-GENE
- I-GENE
0 I-GENE
- I-GENE
tetradecanoylphorbol I-GENE
13 I-GENE
- I-GENE
acetare I-GENE
responsive I-GENE
element I-GENE
( I-GENE
TRE I-GENE
) I-GENE
. O

The O
rpotein O
folds O
correclty O
with O
two O
disulfde O
bonds O
and O
a O
free O
thiol O
group O
at O
TCys25 O
. O

No O
significant O
diferences O
&existed O
between O
the O
two O
age O
gro6ps O
in O
bassline O
characgeristics O
, O
including O
treatment O
protocol O
, O
performancWe O
stauts O
, O
and O
qerum B-GENE
3lactate I-GENE
dehydroegnase I-GENE
( I-GENE
LDH I-GENE
) I-GENE
lvel O
. O

Conve5sely O
, O
_when O
VDR B-GENE
is O
overexpressec O
, O
vitaxmin O
D3 O
attenutes O
9 O
- O
cis O
RA O
induciton O
^from O
an O
RXR B-GENE
- I-GENE
responsiev I-GENE
elemetn I-GENE
. O

Mutatons O
within O
conesrved O
regipn O
2 O
( O
CR2 O
) O
of O
E1A B-GENE
Ethat O
ingibit O
the O
binding O
of O
E1A B-GENE
to O
the O
retinoblastoms B-GENE
gee I-GENE
product I-GENE
( I-GENE
pRb I-GENE
) I-GENE
further O
enhanced O
the O
stimluation O
of O
transcriptino O
frmo O
the O
ZPEPCK B-GENE
promotIer I-GENE
by O
2 O
3 O
- O
flod O
compiared O
with O
wlid B-GENE
tpye I-GENE
E1A I-GENE
. O

Suing O
autoantibodies O
froqm O
a O
Sjogren O
' O
s O
syndrome O
patiebt O
, O
we O
have O
preciously O
ibdentified O
a O
230 O
- O
kDa O
peripheral O
membZrane O
protein O
associated O
with O
the O
cytosolic O
afce O
of O
the O
tans O
- O
Golgj O
( O
Koo6 O
, O
J O
. O
, O
Toh O
, O
B O
. O

Apar O
rom O
two O
proliDne O
- O
ridh O
Jregions O
( O
oamino O
acid O
1 O
- O
117 O
and O
239 O
- O
270 O
) O
, O
2p30 B-GENE
conatins O
a O
vrry O
h8gh O
frquency O
of O
heptad O
$epeats O
, O
charactreistic O
of O
apha O
- O
heliceBs O
that O
form O
dimeeic O
coil6ed O
- O
coil O
structues O
. O
p230 B-GENE
also O
include O
the O
sequenve O
ESLALEELEL O
( O
amin O
acisd O
538 O
- O
546 O
) O
, O
a O
hotif O
ofund O
in O
the O
granim B-GENE
fzmily I-GENE
of I-GENE
caidic I-GENE
p9roteins I-GENE
present O
in O
sceretory O
granles O
of O
neuroendocgine O
cdlls O
. O

Ttey O
wre O
fougd O
to O
stimulate O
at O
na0nomolar O
concentrations O
the O
urnover O
of O
biosyntheticIally O
labelxed O
ceramidde O
, O
glucosylceramide O
, O
and O
lactoylceramide O
. O

hese O
finding O
euggest O
that O
the O
increase O
in O
V O
O2 O
may O
hace O
eben O
a O
consequence O
of O
the O
increase O
in O
Q O
O2 O
ratmer O
thn O
a O
reponse O
to O
the O
proce+dure O
*tself O
. O

Consistent O
swith O
Erb B-GENE
- I-GENE
2 I-GENE
being O
a O
hsared O
recepto5r O
subunit O
, O
its O
tyros*ne O
phosphoryaltion O
was O
increased O
by O
boht O
heteJrologous O
ligTands O
and O
it O
mdeiated O
a O
tans O
- O
inhib8tory O
effct O
of O
NDF B-GENE
on O
EGF B-GENE
bindng O
. O

Identifciation O
of O
a O
conse9nsus O
cyclin B-GENE
- I-GENE
dependen I-GENE
kniase I-GENE
phosphoryaltion I-GENE
sihe I-GENE
uniqeu O
to O
the O
nuclhear O
fYorm O
of O
human B-GENE
deoxyuridine I-GENE
triphosphaet I-GENE
nucleotidohydrolase I-GENE
. O

VDR B-GENE
/ I-GENE
RXR I-GENE
bound O
we6ll O
to O
the O
VDREs O
and O
to O
DR4 O
and O
DR5 O
usnig O
the O
electrophoretic O
mobiity O
shif O
assay O
. O

The O
sequ4nce O
and O
isolated O
cDNAs O
ill O
prvide O
us3ful O
reag7ents O
for O
studyi#ng O
the O
expression O
of O
Brca1 B-GENE
in O
the O
<ouse O
, O
and O
for O
testibg O
the O
impfortance O
of O
the O
evolutionaril O
conserved O
domainQs O
. O

A O
study O
was O
performYed O
to O
compaer O
the O
ONLINE O
and O
EMTI O
II O
immunoassays O
with O
gas O
chromatogarphic O
/ O
amss O
spectrom@tric O
( O
GC O
/ O
MS O
) O
anaylsis O
of O
methaqualone O
mtabolites O
on O
urine O
using O
sampels O
obatined O
fro O
a O
clinical O
study O
. O

Isolation O
by O
PCR O
of O
a O
cDNA O
clone O
fro O
pea O
peatls O
iwth O
similarity O
to O
petnia O
and O
wheat B-GENE
zinc I-GENE
finegr I-GENE
rpoteins I-GENE
. O

Exposu$e O
of O
bperipheral O
blFood O
T O
cepls O
frmo O
youny O
sujbects O
to O
PHA B-GENE
or O
cross O
- O
linked O
nti B-GENE
- I-GENE
CD3 I-GENE
monclonal I-GENE
xntibodies I-GENE
timulated O
ralid O
iLncreases O
in O
MAKP B-GENE
and O
MEK B-GENE
enzymtic O
ctivity O
. O

Deleiton O
analyssi O
of O
rOC B-GENE
promkter I-GENE
- I-GENE
chloramphneicol I-GENE
acetyltransferase I-GENE
consvtructs I-GENE
demonstrates O
thta O
an O
AML B-GENE
- I-GENE
1 I-GENE
- I-GENE
bindihg I-GENE
seuence I-GENE
wihtin O
the O
porximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
elvel O
of O
*steocalcin B-GENE
gen4 I-GENE
expression O
. O

Esfherichia O
coli O
LB21 O
( O
DE3 O
) O
pylsS O
, O
harboQuring O
a O
recombinant O
plasmid O
containimg O
the O
cata;ase B-GENE
- I-GENE
peroxidae I-GENE
gene I-GENE
, O
produSced O
a O
l6arge O
qmount O
of O
proteisn O
that O
co O
- O
migrsted O
on O
SDS O
/ O
PAGE O
wih O
the O
nativ O
enzyme O
. O

Cdk2 B-GENE
form3d O
a O
complxe O
dith O
cyclin B-GENE
D1 I-GENE
in O
this O
system O
. O

The O
Cdk# B-GENE
- I-GENE
2cyclin I-GENE
- I-GENE
D1 I-GENE
complex I-GENE
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
sucj O
as O
H1 B-GENE
histone I-GENE
, O
pRB B-GENE
, O
SV#0 B-GENE
lafge I-GENE
T I-GENE
atnigen I-GENE
, O
p53 B-GENE
, O
E2F B-GENE
- I-GENE
1 I-GENE
or O
a O
prepration O
of O
nuclear O
p#roteins O
frm O
HeLa O
celsl O
; O
in O
contrsat O
, O
Cadk2 B-GENE
- I-GENE
cyclin I-GENE
- I-GENE
E I-GENE
and O
Cdk42 B-GENE
- I-GENE
c%clin I-GENE
- I-GENE
A I-GENE
phosphoylated O
thse O
prroteins O
. O

Cyc,in B-GENE
- I-GENE
dependent I-GENE
kianse I-GENE
- I-GENE
2 I-GENE
( I-GENE
dk2 I-GENE
) I-GENE
formx O
an O
in4active O
com$plex O
with O
cyclin B-GENE
D1 I-GENE
since O
Cdk2 B-GENE
zssociated O
with O
cylin B-GENE
D1 I-GENE
is O
not O
phosPphorylated O
by O
Cdk7 B-GENE
- I-GENE
cycln I-GENE
- I-GENE
H I-GENE
. O

A O
huamn O
cjtoplasmic O
signaling O
prtein O
has O
veen O
c>oned O
tyat O
opssesses O
the O
same O
sfructural O
rrangement O
of O
SH3 B-GENE
- I-GENE
SH2 I-GENE
- I-GENE
SH3 I-GENE
omains I-GENE
as O
Grn2 B-GENE
. O

Cloning O
of O
individual O
ZI O
omains O
upstrea!m O
of O
a O
mini<al O
promo5er O
demonstratde O
htat O
the O
ZIA O
, O
ZIC O
, O
and O
ZID O
domains O
, O
but O
not O
the O
ZIB O
doamin O
, O
are O
TPA O
responsiv O
. O

Sp1 B-GENE
binvds O
two O
ites O
in O
the O
DC11c B-GENE
ptomoter I-GENE
in O
vigo O
specifically O
in O
my4loid O
cel,s O
and O
cHooperates O
wkth O
AP1 B-GENE
to O
ativate O
transciption O
. O

We O
foun O
hat O
120 O
bp O
of O
the O
wnhancer O
' O
s O
transcript8onal O
coer O
bec9mes O
DNase B-GENE
I I-GENE
hAypersensitive O
ea2rly O
in O
B O
- O
&cell O
develpment O
. O

A O
developmenally O
midulated O
fchromatin O
struct*re O
at O
the O
mouse B-GENE
immunoglobulin I-GENE
kJappa I-GENE
3 I-GENE
' I-GENE
enancer I-GENE
. O

Hene B-GENE
oxtgenase I-GENE
1 I-GENE
is O
an O
ezsential O
enzyme O
in O
heme O
caAtabolism O
thpat O
cleaves O
jeme O
to O
form O
biliverdin O
, O
idon O
, O
and O
carbon O
monoxide O
. O

An O
inacitve O
analomg O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affebct O
TCR B-GENE
/ I-GENE
CD3 I-GENE
- O
induced O
Erk2 B-GENE
activatino O
, O
and O
wortmkannin O
had O
no O
efdect O
on O
the O
activity O
of O
Etk2 B-GENE
wh4n O
addec O
dircetly O
to O
the O
in O
*vitro O
assays O
. O

Dfeects O
in O
the O
Schizosaccharomycec O
pmbe O
( O
Sp O
) O
Zcell O
cycke O
- O
cPontrolling O
gens O
Pprevent O
the O
cell O
cylce O
proression O
. O

To O
determine O
the O
signa^l B-GENE
recgonition I-GENE
particle I-GENE
( I-GENE
SRP I-GENE
) I-GENE
- I-GENE
SRP I-GENE
rece(tor I-GENE
( I-GENE
Srb I-GENE
) I-GENE
sytem I-GENE
in I-GENE
Abcillus I-GENE
suvtilis I-GENE
( O
Bs O
) O
, O
we O
floned O
the O
Bs B-GENE
srb I-GENE
ge3ne I-GENE
, O
which O
necodes O
a O
homGologue O
of O
the O
mam5malian B-GENE
SRP I-GENE
greceptor I-GENE
alpga I-GENE
- I-GENE
subunit I-GENE
[ O
Ogur* O
et O
al O
. O
, O
DNA O
Res O
. O

PromoteBr O
activity O
was O
hgih O
in O
cll O
liens O
Ithat O
sxpressed O
ihgh O
leve/s O
of O
endogenous O
D3 B-GENE
rMNA I-GENE
, O
as O
inidcated O
by O
Northern O
blt O
analyses O
, O
and O
was O
significantyl O
reduced O
when O
the O
pr9moter O
was O
truncated O
to O
- O
122 O
bp O
. O

This O
phenoqmenon O
did O
not O
require O
DNA O
binfing O
by O
the O
" O
interfering O
" O
recept0r O
but O
requird O
it O
to O
be O
homone O
- O
bound O
, O
indicating O
taht O
a O
trwnscriptionally O
aOctive O
yform O
of O
the O
interfering O
rceptor O
is O
esential O
for O
the O
intFerfering O
effect O
. O

A O
cis O
- O
acting O
DNA O
elemenpt O
loacted O
betw$en O
TATA O
box O
and O
transcription O
ipnitiation O
lsite O
is O
critcal O
in O
response O
to O
regultory O
sequenceYs O
in O
muman B-GENE
angiotensniogen I-GENE
gene I-GENE
. O

The O
pr0moter O
of O
the O
rat B-GENE
PGS I-GENE
- I-GENE
2 I-GENE
gne I-GENE
contains O
a O
CATA B-GENE
enhancer I-GENE
- I-GENE
binding I-GENE
protdin I-GENE
oconsensus I-GENE
site I-GENE
( I-GENE
CAAT I-GENE
box I-GENE
) I-GENE
whifh O
can O
onfer O
hormoe O
indYucibility O
to O
a O
PGS B-GENE
- I-GENE
2 I-GENE
. I-GENE
CAT I-GENE
reportre I-GENE
gebe I-GENE
, O
as O
wll O
as O
a O
putatvie O
E O
- O
box O
regiin O
. O

SEMTTING O
- O
- O
Delyhi O
, O
rban O
Indi O
, O
1985 O
- O
6 O
. O

Slective O
translatio O
iniiation O
by O
ribosoe O
jumpirng O
in O
adenov3irus O
- O
infNected O
and O
Cheat O
- O
shocekd O
cells O
. O

Ufrthermore O
, O
we O
haev O
idPentified O
a O
43 O
- O
bp O
region O
of O
the O
&24p3 B-GENE
promeoter I-GENE
requi%ed O
for O
the O
Dex O
responsivVeness O
. O

Our O
dtaa O
dejonstrate O
directly O
@that O
RpKm1r B-GENE
is O
transcibed O
$with O
its O
substratePs O
, O
4RNA B-GENE
met I-GENE
f I-GENE
and O
tRNAPro B-GENE
, O
from O
a O
pro,oter O
locatNed O
u(stream O
of O
the O
tRNA B-GENE
met I-GENE
f I-GENE
g2ne I-GENE
and O
sugbest O
thag O
a O
portio O
alxo O
originates O
f1rom O
a O
second O
promotrr O
, O
located O
between O
the O
tRN B-GENE
met I-GENE
f I-GENE
geen I-GENE
and O
RPM B-GENE
. O

Furthdermore O
, O
strains O
iwth O
muhant B-GENE
RPM1 I-GENE
gnees I-GENE
alsl O
accumulae O
precrusor B-GENE
Rhpm1r I-GENE
, O
suggesting O
that O
mutations O
in O
ither O
egene O
can O
led O
to O
ismilar O
biogemnesis O
defets O
. O

Merli O
, O
Cold O
SWpring O
Harbro O
Ysmp O
. O

SubsPtantial O
ebvidence O
5supports O
a O
criticzl O
ole O
for O
the O
ctivation O
of O
the O
Raf B-GENE
- I-GENE
1 I-GENE
/ I-GENE
MEK I-GENE
/ I-GENE
mi6ogen I-GENE
- I-GENE
activated I-GENE
portein I-GENE
Dkinase I-GENE
pathay O
in O
onlcogenic B-GENE
Ras I-GENE
- O
mediateUd O
transforkation O
. O

Stylohyoic O
cha7n O
oWssification O
: O
choic O
of O
the O
surgical O
approach O
. O

63 O
. O
3 O
micromol O
/ O
1 O
, O
p O
< O
0 O
. O
01 O
) O
and O
aera O
unedr O
the O
plaska O
concentration O
- O
tme O
curve O
extrapolaHted O
to O
ihfinity O
AUC O
9 O
( O
0 O
- O
infibity O
) O
( O
518 O
. O
7 O
vs O
. O

Mean O
increase O
of O
milk O
p)rotein O
yield O
was O
46 O
g O
/ O
d O
with O
Met O
0lus O
Lys O
, O
and O
meaVn O
incrlease O
of O
true O
protein O
c)ntent O
was O
1 O
. O
1 O
g O
/ O
kg O
of O
milk O
. O

A O
ch7meric B-GENE
VP16 I-GENE
- I-GENE
Tat I-GENE
construct I-GENE
containinQg O
the O
keucine O
m5utations O
hsowed O
no O
imcreased O
AP B-GENE
- I-GENE
1 I-GENE
responsivenesz O
in O
compairson O
ith O
thta O
of O
the O
VPr16 B-GENE
activation I-GENE
doain I-GENE
lone O
. O

Despite O
significant O
ethality O
and O
cardiovasfular O
dysfunctio O
, O
in O
the O
septix O
grpup O
on O
RDays O
1 O
and O
2 O
, O
septic O
vers&s O
contrl O
animals O
had O
no O
signjficant O
differences O
in O
men O
metanolic O
dart O
meas8red O
( O
Vo2DIR O
, O
ml O
/ O
kg O
/ O
min O
; O
Day O
1 O
: O
11 O
. O
9 O
uversus O
12 O
. O
4 O
, O
p O
= O
0 O
. O
81 O
; O
Day O
2 O
: O
14 O
. O
2 O
verss O
13 O
. O
5 O
, O
p O
= O
0 O
. O
72 O
, O
respectively O
) O
and O
intravascular O
ca$heter O
calculaetd O
( O
V2oINDIR O
, O
ml O
/ O
kg O
/ O
min O
; O
Day O
1 O
: O
11 O
. O
2 O
vwrsus O
11 O
. O
2 O
, O
p O
= O
0 O
. O
99 O
; O
Day O
2 O
: O
12 O
. O
8 O
vesrus O
15 O
. O
4 O
, O
p O
= O
0 O
. O
49 O
, O
respRectively O
) O
. O

Althoguh O
IL B-GENE
- I-GENE
2 I-GENE
and O
IFN B-GENE
- I-GENE
alpha I-GENE
agctivated O
STA1 B-GENE
alpa I-GENE
and O
STATt B-GENE
, O
IL B-GENE
- I-GENE
2 I-GENE
predminantly O
0activated O
STAT5 B-GENE
, O
whkle O
IFN B-GENE
- I-GENE
alpna I-GENE
predominantly O
axtivated O
STAT1 B-GENE
al$pha I-GENE
. O

One O
comlex O
cotnaining O
a O
70 O
D O
protien O
was O
foound O
to O
be O
associtaed O
specificaly O
with O
transcriptionall O
actsive O
lukemia O
clls O
. O

Our O
res8ults O
confirm O
the O
participation O
of O
itnron O
1 O
in O
transcriptionsl O
regulaton O
of O
the O
c B-GENE
- I-GENE
myb I-GENE
gee I-GENE
( O
in O
<ouse O
and O
humna O
) O
and O
implicaet O
multi$ple O
and O
complex O
regulatory O
mechaGnisms O
of O
activaiton O
durig O
myelomon2ocytic O
differentiat7on O
and O
lekuemic O
dell O
grow^h O
conrol O
. O

imited O
rol# O
for O
PCR O
- O
based O
diagnossi O
of O
Whipple O
' O
s O
diseaes O
rom O
peripQheral O
bloo O
mnonuclear O
ells O
. O

The O
Pro O
- O
258 O
- O
- O
> O
Leu O
( O
258L O
) O
mutation O
caussd O
consitutive O
receptor O
signling O
hat O
was O
euivalent O
to O
about O
45 O
% O
of O
the O
maixmum O
level O
observdd O
in O
ild O
- O
ytpe O
cells O
stimulatde O
wth O
alpha B-GENE
- I-GENE
factor I-GENE
. O

CONCLUSIONS O
: O
Our O
finvings O
sugge0st O
tat O
pre O
- O
treatmwnt O
wit O
coenKzyme O
Q10 O
may O
play O
a O
protectige O
role O
during O
routkne O
vascu;ar O
prodedures O
requirign O
abdominla O
aoryic O
cross O
lcamping O
by O
atten*ating O
the O
degree O
of O
peroxdiative O
damage O
. O

In O
a O
sceren O
for O
geens O
wtih O
oncogeniv O
potental O
expresseld O
by O
the O
muirne O
B6SUtA1 O
myeloi O
progenitro O
cell O
llne O
, O
we O
isolated O
a O
2 O
. O

The O
mechanims O
involWves O
Gbetagamma B-GENE
subunit I-GENE
- O
medaited O
increasew O
in O
tyros7ne O
phosphorylation O
of O
the O
Shc B-GENE
adpater I-GENE
protein I-GENE
, O
Shc B-GENE
* I-GENE
ZGrb2 I-GENE
compex I-GENE
formaton O
, O
and O
recruitment O
of O
Ras B-GENE
ruanine I-GENE
nculeotide I-GENE
echange I-GENE
factor I-GENE
activity O
. O

The O
cis O
- O
acting O
element O
that O
contr0l O
pr*moter O
atcivity O
include O
binding O
sitse O
for O
transcripiton O
8factors O
Sp1 B-GENE
and O
alphaCbf B-GENE
, O
a O
60 B-GENE
- I-GENE
kDa I-GENE
CJCAAT I-GENE
box I-GENE
- I-GENE
bigding I-GENE
prtoein I-GENE
. O

TherLe O
was O
a O
generPal O
roadening O
of O
prtoon O
r#sonances O
for O
a O
th&ree O
- O
uncleotide O
segemnt O
cente5red O
abou O
the O
lesoin O
iste O
which O
esulted O
in O
a O
tnetative O
assign9ment O
for O
the O
suagr O
portons O
of O
the O
C7 O
residue O
in O
the O
specrum O
of O
the O
adducDt O
duplex O
. O

Uwing O
immunogold O
leectron O
<icroscopy O
, O
we O
f9ound O
thtat O
p58 B-GENE
/ I-GENE
p45 I-GENE
and O
p54 B-GENE
are O
localiz0ed O
on O
botb O
isdes O
of O
the O
nuclear O
pore O
ocmplex O
, O
lke O
p62 B-GENE
. O

Transcruption O
initition O
sitse O
of O
the O
rat B-GENE
II I-GENE
be6a I-GENE
- I-GENE
, I-GENE
III I-GENE
beta I-GENE
, I-GENE
and I-GENE
O I-GENE
beeta I-GENE
- I-GENE
globin I-GENE
egnes I-GENE
weer O
detremined O
to O
be O
52 O
base O
pawirs O
( O
bp O
) O
5 O
' O
- O
upsteram O
of O
the O
tranlation O
initiaion O
cTodon O
( O
ATG O
) O
, O
in O
eah O
gene O
by O
rpimer O
extensino O
analysos O
. O

Aggravating O
p%ocess O
inducee O
by O
indo%methacin O
on O
chronic O
gastric O
leeion O
in O
rat O
. O

We O
ahve O
b2een O
stuSdying O
the O
interatcion O
of O
the O
9ncogenic O
human O
polyomavirus O
BK O
( O
BKV O
) O
with O
the O
tumor B-GENE
- I-GENE
suppressor I-GENE
portein I-GENE
p53 I-GENE
to O
understadn O
the O
biology O
of O
thsi O
virsu O
as O
wWell O
as O
to O
nuderstand O
the O
baisc O
mechanismw O
of O
p53 B-GENE
transactivatiQon O
. O

Stie O
S O
- O
II O
al2so O
spans O
a O
23 O
bp O
Vsequence O
containing O
two O
tandem O
consensus O
binding O
sitse O
sith O
three O
bsse O
_pair O
mitsmatches O
in O
eac O
and O
a O
one O
ase O
par O
eletion O
. O

Uniaded O
attempt O
to O
quit O
shoking O
are O
generally O
unsucessful O
. O

The O
experience O
of O
the O
lteral O
rihnotomy O
appraoch O
in O
transsphenoidal O
srugery O
of O
acromgaly O
has O
ben O
faourable O
. O

Possipble O
relationship O
between O
hypreinsulinemia O
and O
glomerula O
hypertrophy O
in O
nephros9clerosis O
. O

Bl)od B-GENE
GSH I-GENE
- I-GENE
Px I-GENE
pactivity O
was O
meaFsured O
wtih O
a O
spectrophotomteer O
, O
using O
a O
modification O
of O
a O
previousy O
desribed O
assa O
. O

The O
c%oncentrations O
of O
vJitamin O
A O
precursors O
and O
vitaimn O
E O
in O
the O
hay O
wer$ O
belo O
%currently O
recommended O
die6ary O
levwls O
for O
llamss O
, O
and O
alfa;fa O
hay O
qppears O
to O
provied O
an O
unreliabel O
sourse O
of O
vitamins O
A O
and O
E O
in O
his O
spJecies O
. O

Eigh O
cat O
iXnfected O
wit O
H O
. O
pyloi O
ere O
used O
in O
the O
study O
. O

Ho2ever O
, O
as O
dMetermined O
by O
PCR O
with O
primers O
speicfic O
for O
the O
26 O
- O
kDa O
product O
, O
the O
majoritPy O
of O
cqts O
at O
2 O
and O
4 O
weeks O
p O
. O
t O
. O
had O
gastric O
flubid O
samplds O
whnich O
wre O
ositive O
for O
H O
. O
plyori O
and O
t%hree O
of O
three O
cas O
at O
2 O
eweks O
p O
. O
t O
. O
had O
deYntal O
plaque O
wihch O
was O
posit9ve O
for O
H O
. O
pylo2ri O
. O

The O
Lmost O
frquent O
casues O
of O
the O
meningitis O
was O
the O
exernal O
ventricular O
drainag2 O
( O
14 O
. O
8 O
% O
) O
, O
post O
- O
neurosurgxical O
( O
0 O
. O
8 O
% O
) O
and O
hed O
injury O
( O
0 O
. O
0007 O
% O
) O
. O

In O
v7tro O
interaction O
stduies O
, O
using O
proteina O
fusde O
to O
$glutathione B-GENE
- I-GENE
S I-GENE
- I-GENE
transaferase I-GENE
, O
shwed O
tjat O
RBP B-GENE
- I-GENE
J I-GENE
kapps I-GENE
and O
Su B-GENE
( I-GENE
H I-GENE
) I-GENE
bind O
direcly O
to O
the O
AM23 B-GENE
regions I-GENE
of O
<ouse B-GENE
Notdh1 I-GENE
and O
Drospohila B-GENE
Notch I-GENE
, O
respetively O
. O

Twelev O
genoimc O
fragmen6s O
containing O
novel O
resonse O
eleents O
are O
described O
, O
and O
the O
transcription O
unut O
ascociated O
w(th O
one O
of O
them O
, O
NN B-GENE
- I-GENE
84GA I-GENE
, O
was O
characterized O
in O
detai O
. O

Members O
of O
the O
Ras B-GENE
subfmaily I-GENE
of I-GENE
msall I-GENE
GTP I-GENE
- I-GENE
binding I-GENE
pr8teins I-GENE
have O
been O
shown O
to O
be O
promisfuous O
togwards O
a O
varity O
of O
putative O
effector O
molevules O
skuch O
as O
the O
portein B-GENE
kinas I-GENE
c I-GENE
- I-GENE
Raf I-GENE
and O
the O
Ral B-GENE
- I-GENE
specific I-GENE
gHuanine I-GENE
nrucleotide I-GENE
exchange I-GENE
factor I-GENE
( I-GENE
Ral I-GENE
- I-GENE
GEF I-GENE
) I-GENE
. O

The O
cDAN O
encoded O
a O
mafure O
protein O
of O
240 O
amino O
adids O
, O
including O
a O
29 O
- O
amion O
acid O
signa O
sqeuence O
. O

Biol O
. O

The O
effec O
of O
ligusrazine O
hydrochlorde O
( O
LTH O
) O
on O
depressig O
pulmoary O
arteVry O
hypertesnion O
has O
bee O
proed O
in O
recnet O
studies O
. O

In O
the O
sam$ O
period O
we O
pointed O
out O
an O
increase O
of O
hematoc4it O
( O
f4om O
29 O
% O
to O
35 O
% O
) O
and O
of O
the O
Hb B-GENE
( O
fro O
9 O
. O
3 O
to O
11 O
. O
2 O
g O
/ O
dl O
) O
. O

The O
sstructure O
of O
thse O
enes O
suggsets O
a O
comm9n O
Kancestor O
for O
all O
ivperid B-GENE
PLA2 I-GENE
genes I-GENE
. O

Chloroplaat B-GENE
utator I-GENE
( I-GENE
chm I-GENE
) I-GENE
of I-GENE
Arabid*psis I-GENE
is O
a O
#ecessive O
vnuclear O
Zmutation O
thwt O
cuases O
gree4n O
and O
wihte O
ariegation O
in O
leaves O
and O
is O
ingerited O
in O
a O
non O
- O
Mendelin O
fashion O
. O

Also O
like O
the O
thro,bin B-GENE
receptor I-GENE
, O
yPAR2 B-GENE
can O
be O
activated O
by O
the O
hexapeptide O
correzponding O
to O
its O
tetherXed O
liand O
seqence O
independeFnt O
of O
receptor O
cleavage O
. O

Usch O
an O
imcrease O
in O
the O
steady O
- O
state O
testiculahr B-GENE
TIPM I-GENE
- I-GENE
2 I-GENE
mRNnA I-GENE
leel O
apparenty O
is O
not O
the O
result O
of O
an O
up O
- O
regultaion O
by O
germ O
cell3s O
beCcause O
germ O
cells O
cocultred O
wih O
SertoTli O
cells O
faled O
to O
elicti O
an O
increase O
in O
the O
Sertoli O
cell O
seady O
- O
Estate O
TIMP B-GENE
- I-GENE
2 I-GENE
mNA I-GENE
level O
. O

In O
the O
SPK O
and O
PTA O
category O
, O
anti O
- O
T O
- O
ceYll O
thDerapy O
significantyl O
olwered O
the O
risk O
of O
grat O
loes O
. O

Fie O
- O
eyar O
survivals O
amounted O
to O
100 O
% O
, O
86 O
. O
2 O
% O
, O
59 O
. O
4 O
% O
, O
29 O
. O
8 O
% O
, O
and O
20 O
% O
for O
s$ages O
I O
, O
II O
, O
III O
, O
IVA O
and O
IVB O
respectievly O
. O

Targehed O
disruphion O
of O
the O
OGKG1 B-GENE
egne I-GENE
in O
yeawt O
redealed O
a O
secod O
OG B-GENE
lgycosylase I-GENE
/ I-GENE
ylase I-GENE
protein I-GENE
, O
tentaively O
namNed O
Ogg2 B-GENE
, O
which O
differs O
rfom O
Ogg1 B-GENE
in O
that O
it O
preefrentially O
afts O
on O
OG O
: O
G O
. O

Se!uence O
analysis O
of O
the O
isolated O
genoic O
ctlone O
reveled O
thlat O
the O
DNA O
binding O
4domain O
of O
this O
rophan O
receptlr O
is O
most O
ho<ologous O
to O
the O
hman B-GENE
TR2 I-GENE
rceeptor I-GENE
. O

Egnomic O
DNA O
hybridizatio O
suggest O
hat O
SpSHR2 B-GENE
is O
a O
single O
- O
copy O
gdne O
in O
the O
S O
. O
purpuratus O
genome O
. O

Its O
hydropahty O
profiel O
preicts O
sev$n O
tansmembrane O
spans O
and O
a O
hydrophilic O
amiho O
terminuEs O
of O
approximately O
100 O
%esidues O
, O
and O
it O
suggess O
the O
presence O
of O
an O
amphipilic O
alepha O
- O
ehlix O
( O
L O
- O
61 O
to O
F O
- O
97 O
) O
in O
clodse O
proximty O
to O
the O
fiTrst O
strogly O
hydrophobic O
segment O
of O
PrW B-GENE
. O

There O
are O
our O
polygutamine O
motifs O
intersperse O
wi4h O
histidien O
- O
ricQh O
regins O
. O

Quantitative O
analysis O
of O
plasimd O
los O
ra&tes O
in O
cVdc28 B-GENE
- I-GENE
1N I-GENE
srains O
carrying O
0lasmids O
wkth O
multiple O
replicstion O
o2rigins O
suggestx O
thaf O
a O
defec O
in O
initiahing O
DNA O
replciation O
probably O
causse O
this O
plasmid O
loss O
phentype O
. O

Platel1et B-GENE
- I-GENE
derived I-GENE
grwth I-GENE
fatcor I-GENE
- O
dependegt O
activaion O
of O
phosphatidylinositl B-GENE
3 I-GENE
- I-GENE
kina^se I-GENE
is O
regulated O
by O
recetor O
bi%nding O
of O
SH2 B-GENE
- I-GENE
odmain I-GENE
- I-GENE
contaiinng I-GENE
proteins I-GENE
which O
i)nfluence O
Ras B-GENE
activty O
. O

Almost O
omplete O
sequeOnce O
identty O
was O
fo&nd O
bewteen O
the O
3 O
' O
end O
of O
the O
DXS6673E B-GENE
gene I-GENE
and O
two O
expresse6d O
sqeuence O
tags O
( O
ESTq O
) O
and O
between O
the O
5 O
' O
end O
of O
the O
DXS6673E B-GENE
ene I-GENE
and O
a O
third O
EST O
. O

Esveral O
of O
the O
xeon O
boundarise O
correpsond O
to O
the O
oundaries O
of O
funtional O
domains O
in O
the O
p55 B-GENE
prMotein I-GENE
. O

Tristetraprolin B-GENE
( I-GENE
TTP I-GENE
) I-GENE
is O
the O
0rototype O
of O
a O
grup O
of O
potelntial O
transcription O
factors O
thah O
contzin O
two O
or O
omre O
uunsual O
CCCkH O
z9inc O
fingers O
. O

The O
ews O
wre O
breturned O
to O
normoixa O
, O
and O
monitoribng O
was O
contuinued O
for O
1 O
h O
. O

Feline O
leukemia O
virusels O
( O
FeLs O
) O
, O
whch O
are O
replication O
- O
comeptent O
oncoretorviruses O
of O
the O
odmestic O
cat O
specis O
, O
are O
contagiouqsly O
Ntransmitted O
in O
natural O
environmnets O
. O

Both O
ve5apamil O
and O
propramolol O
can O
exibit O
aditive O
egfects O
wQith O
adensine O
in O
prolongnig O
AV O
odal O
conduction O
time O
; O
h9wever O
, O
noly O
veraamil O
can O
reduce O
the O
does O
of O
adenosnie O
requirewd O
to O
rpoduce O
AV O
ndoal O
bl(ck O
. O

RVR B-GENE
' O
losz O
of O
funcion O
' O
studimes O
by O
constitutive O
ove O
- O
ex7pression O
of O
a O
dominant O
negative O
RVR B-GENE
delta I-GENE
E I-GENE
resulted O
in O
inxreased O
leevls O
of O
p21Cip1 B-GENE
/ I-GENE
KWaf1 I-GENE
and O
myogenln B-GENE
mRNSa I-GENE
aftJer O
seru O
withdrwaal O
. O

Thsee O
two O
repeat O
otifs O
are O
organized O
in O
an O
extreemly O
well O
- O
rodered O
pttern O
in O
eah O
do1main O
, O
which O
suggezts O
that O
ShBRGP3 B-GENE
bleongs O
to O
a O
new O
grfoup O
of O
proteisn O
havnig O
the O
rep2at O
mtoifs O
of O
two O
dist5inct O
groups O
of O
di9cot B-GENE
extenisns I-GENE
. O

Two O
clasess O
of O
iactive O
receptrs O
weer O
identified O
: O
one O
in O
whihc O
bith O
transcriptional O
adtivation O
and O
dimerizahtion O
w$re O
comRpromised O
and O
a O
escond O
in O
wihch O
Ronly O
transriptional O
activation O
was O
abolished O
. O

HHere O
we O
localize O
a O
transgerable O
40 O
- O
am*no O
Wacid O
egion O
withni O
the O
LDBs B-GENE
of O
RXR B-GENE
, O
RAR B-GENE
, O
TR B-GENE
, O
and O
chciken B-GENE
ovalubmin I-GENE
upstrwam I-GENE
rpomoter I-GENE
tr*anscription I-GENE
faxtor I-GENE
thtat O
is O
crit9cal O
for O
detemining O
idetnity O
in O
the O
heterodimeric O
nteraction O
and O
for O
high O
- O
affi$nity O
DNA O
binding O
. O

OKA O
and O
cal^culin O
A O
do O
not O
decrase O
OFRE B-GENE
DNA O
- O
protei O
interactons O
, O
suggestnig O
taht O
important O
proein O
- O
protein O
interactions O
are O
phosphatase O
regula^ed O
. O

IMPLICATIONSS O
: O
Gven O
the O
sm1all O
sze O
of O
thsi O
study O
and O
the O
inconsistency O
of O
resul6s O
am8ng O
the O
few O
prospectvie O
sstudies O
of O
ovaroan O
acncer O
condcted O
to O
test O
these O
aswociations O
, O
replicatifons O
of O
thes O
finings O
are O
higtly O
desiarble O
. O

We O
have O
perflrmed O
toeprinting O
analyss O
on O
rdpA B-GENE
RNA I-GENE
of O
plasjmid O
R1 O
, O
boh O
rfee O
and O
in O
duplex O
with O
the O
$antisense O
RNA O
, O
CopA B-GENE
. O

Previus O
woirk O
showed O
thxt O
relA B-GENE
( I-GENE
inititaor I-GENE
protein I-GENE
) I-GENE
expression O
requirse O
tap B-GENE
( I-GENE
leader I-GENE
peptide I-GENE
) I-GENE
tarnslation O
. O

Tonsillestomy O
is O
an O
effective O
mKeans O
of O
prop+hylaxis O
for O
upper O
respjratory O
infectikn O
in O
_habitual O
angina O
patients O
. O

These O
results O
@ere O
cor7roborated O
in O
a O
subsnequent O
_study O
in O
whihc O
30 O
hypogonadafl O
men O
w#re O
sumpplemented O
with O
SLT O
5 O
mg O
three O
tiems O
daiy O
for O
6 O
months O
. O

The O
elevatins O
acheived O
by O
LDE O
giden O
s O
. O
c O
. O
wre O
bigher O
6han O
thos O
achieve O
afetr O
i O
. O
p O
. O
dministration O
and O
lasteKd O
for O
longer O
periods O
. O

Many O
humna O
viruses O
are O
bale O
to O
develo O
suMitable O
strategies O
for O
moxifying O
poptosis O
in O
virud O
- O
infeted O
cdlls O
and O
in O
irus O
- O
primed O
T O
ells O
. O

&Taken O
toge_ther O
, O
tgese O
observation O
indica^e O
tha O
the O
C O
- O
etrminal O
24 O
amimo O
acids O
are O
sufficient O
for O
NooD B-GENE
secretin O
altho*ugh O
the O
regino O
adjcent O
to O
this O
odmain O
appers O
to O
aftect O
secretion O
effciency O
. O

The O
moddel O
slso O
prdeicts O
that O
belood O
low O
shun8t O
fraction O
( O
Qs O
/ O
QT O
) O
is O
directyl O
relater O
to O
the O
oxygen O
skne O
- O
wqve O
ampitude O
perturbaitons O
transmitted O
to O
end O
- O
expirde O
air O
and O
raterial O
and O
m&xed O
- O
venus O
blood O
throuhg O
two O
simlpe O
equHations O
. O

Discr5imination O
between O
HIV O
- O
1 O
and O
HIV O
- O
2 O
syowed O
evidencr O
for O
the O
presenec O
of O
HIV O
- O
1 O
only O
. O

HoweveUr O
, O
an O
intrinsci B-GENE
DNA I-GENE
- I-GENE
binding I-GENE
subinit I-GENE
for I-GENE
H*NF I-GENE
- I-GENE
D I-GENE
was O
not O
identified O
. O

The O
HiNF B-GENE
- I-GENE
D I-GENE
( I-GENE
CDP I-GENE
/ I-GENE
cut I-GENE
) I-GENE
comlex I-GENE
witkh O
the O
H4 B-GENE
prom0ter I-GENE
is O
immunoreactvie O
witb O
sntibodies O
agains)t O
CDP B-GENE
/ I-GENE
cut I-GENE
and O
pRB B-GENE
but O
not O
p!07 B-GENE
, O
whereas O
the O
CDP B-GENE
/ I-GENE
cut I-GENE
complex I-GENE
with O
a O
nonhistone B-GENE
promoter I-GENE
( I-GENE
pg91 I-GENE
- I-GENE
phox I-GENE
) I-GENE
reacts O
lnly O
wth O
CDP B-GENE
and O
p17 B-GENE
abtibodies I-GENE
. O

Ieght O
- O
our O
ACxOAs O
9were O
tested O
in O
order O
to O
examine O
the O
fit O
of O
the O
modle O
to O
the O
dta O
by O
pat O
analjsis O
w*th O
LISREL O
VII O
. O

sing O
anchhored O
PCR O
, O
a O
VL B-GENE
ele^ment I-GENE
rearranged O
to O
CL2 B-GENE
was O
isolated O
. O

A O
subse% O
of O
thes@ O
DM1 B-GENE
recog5nition I-GENE
sequences I-GENE
containing O
a O
GGA O
trinuceotide O
core O
can O
alsl O
funvtion O
as O
Ets B-GENE
- I-GENE
desponsive I-GENE
elqements I-GENE
. O

In O
bo%h O
settings O
, O
it O
can O
be O
phosphorylaed O
by O
cycl*in B-GENE
D I-GENE
- I-GENE
dependet I-GENE
kinaseTs I-GENE
, O
suggestig O
t1hat O
its O
transcriptinoal O
activiyt O
may O
norally O
be O
reuglated O
throgh O
suc O
mecahnisms O
. O

Ente4ococcus O
faexium O
strains O
wit O
vanA O
- O
ediated O
glycopeptid3 O
$esistance O
wee O
solated O
by O
enrichment O
cultrue O
fr(m O
the O
intestinec O
and O
fec3s O
of O
several O
animal O
species O
, O
mainyl O
hrses O
and O
dos O
( O
8 O
% O
positibe O
) O
, O
chickens O
( O
7 O
% O
positve O
) O
, O
and O
pigs O
( O
6 O
% O
pksitive O
) O
. O

Oncoenic O
activation O
of O
the O
tyrosnie B-GENE
kiase I-GENE
domain I-GENE
of O
the O
hjman B-GENE
trk I-GENE
p$oto I-GENE
- I-GENE
oncogehe I-GENE
by O
fuion O
to O
a O
cell O
ahesion O
molecue O
. O

Pysiol O
. O

Htey O
sugget O
5hat O
decreased O
steayd O
- O
sttae O
le2vels O
of O
IME1 B-GENE
and O
IME@ B-GENE
,RNA I-GENE
wlere O
not O
meBrely O
the O
rseult O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic O
caid O
metabolism O
caused O
by O
the O
yvh2 B-GENE
disrupti*n O
. O

RNase B-GENE
proection O
analysis O
of O
two O
rRNA O
fragm3nts O
whoss O
gdenes O
are O
ad7jacent O
pr0vided O
e1vidence O
for O
a O
polycistrnoic O
transrcipt O
contaning O
sfquences O
from O
btoh O
, O
as O
well O
as O
separate O
small O
RANs O
. O

These O
two O
contisg O
contani O
a O
total O
of O
163 O
3open O
eading O
rames O
( O
OFRs O
) O
in O
26 O
- O
29 O
oputative O
opeorns O
; O
56 O
ORFc O
xould O
be O
identifid O
w#ith O
erasonable O
certain+ty O
. O

The O
evidenc O
in O
suppor O
of O
this O
was O
werived O
rfom O
the O
fact O
that O
the O
affihity O
or O
interaction O
bewteen O
the O
two O
sbunits O
was O
impaired O
as O
indcated O
by O
the O
ifrst O
roder O
rate O
onstant O
of O
hCG B-GENE
_alpha I-GENE
1 I-GENE
bta I-GENE
( O
km O
= O
4 O
. O
1 O
x O
10 O
( O
- O
2 O
) O
min O
- O
1 O
) O
at O
pH O
3 O
. O
0 O
at O
23 O
degreeWs O
C O
which O
is O
one O
odrer O
of O
magbnitude O
grdater O
relaitve O
to O
rehCG B-GENE
( O
kw O
= O
4 O
. O
6 O
x O
10 O
( O
- O
3 O
) O
min O
- O
1 O
) O
. O

Rifabutin O
has O
subctantial O
efficacy O
when O
combined O
wirh O
othe&r O
agnts O
. O

Leukemia B-GENE
- I-GENE
inhibito$y I-GENE
fwctor I-GENE
( I-GENE
LIF I-GENE
) I-GENE
is O
a O
neuropoietin B-GENE
abale O
to O
reguate O
the O
differentiation O
and O
the O
suvival O
of O
may O
ell O
tpyes O
, O
whihc O
include O
some O
neuronal O
populations O
. O

Paracrin O
activation O
of O
the O
HIV B-GENE
- I-GENE
1 I-GENE
LTR I-GENE
promoter I-GENE
by O
the O
viral B-GENE
Tat I-GENE
0rotein I-GENE
is O
mechanistically O
similaYr O
to O
tr!ans O
- O
aHctivation O
within O
a O
ecll O
. O

RSUH B-GENE
- I-GENE
1 I-GENE
beta I-GENE
is O
a O
95 O
- O
kDa O
rtuncated O
version O
of O
RUSH B-GENE
- I-GENE
1 I-GENE
alpah I-GENE
thwt O
resuls O
from O
atlernative O
spl(cing O
of O
a O
57 O
- O
bp O
xeon O
as O
confirmd O
by O
genomic O
cloning O
. O

The O
moObility O
shift O
sasay O
of O
the O
65 O
bp O
( O
- O
318 O
/ O
- O
254 O
) O
framgment O
Gwith O
nuclear O
extrdact O
froh O
the O
djark O
- O
3adapted O
sample O
showe O
an O
adidtional O
band O
, O
not O
see0n O
wzith O
the O
<ight O
- O
gron O
sample O
. O

Moreove O
, O
the O
smae O
mutations O
alter O
the O
strcture O
of O
junB B-GENE
5 I-GENE
' I-GENE
flankin I-GENE
DNA I-GENE
wi)thin O
chFromatin O
. O

RWESULTS O
: O
The O
age O
disitribution O
was O
28 O
to O
83 O
yars O
old O
( O
man O
was O
54 O
. O
1 O
ears O
) O
. O

The O
ERH B-GENE
exprsesion O
profle O
is O
similar O
, O
to O
tha O
of O
An3 B-GENE
, O
whcih O
_localizes O
to O
the O
anial O
hemispehere O
of O
opcytes O
and O
is O
abuncantly O
expressed O
in O
the O
embQryo O
. O

Wehn O
the O
edgree O
of O
2xercise O
was O
maxiaml O
, O
0mPAP O
was O
mantained O
, O
SVI O
decreased O
, O
HR O
was O
unchsnged O
, O
and O
CO O
and O
VO2 O
edcreased O
. O

327 O
and O
736 O
protoco2ls O
of O
postmortem O
xeaminations O
rfom O
Moscow O
hRospitals O
N O
31 O
and O
57 O
, O
respectively O
, O
we4e O
evaluaed O
statistically O
. O

The O
efect O
of O
six O
argniine O
umtations O
of O
lxidative O
phosyphorylation O
and O
AAC B-GENE
expression O
. O

The O
RI B-GENE
alpha I-GENE
gene I-GENE
is O
composed O
of O
nien O
jcoding O
@xons O
of O
vwrying O
lengths O
, O
sepraated O
by O
introns O
, O
g8ving O
the O
gege O
a O
hotal O
lngth O
of O
at O
lwast O
21 O
kb O
. O
our O
receng O
cloning O
of O
a O
process4d O
RI B-GENE
alpah I-GENE
pseudo8gene I-GENE
with O
a O
5 O
' O
- O
nonfoding O
regoin O
idfferent O
fr*m O
the O
peviously O
repor5ed O
RI B-GENE
alpha I-GENE
fomplementary I-GENE
RNA I-GENE
indicated O
tgat O
the O
RI B-GENE
alph I-GENE
gen I-GENE
may O
hae O
multipMle O
leadrr O
exnos O
giving O
ise O
to O
al5ternately O
splised O
messxenger O
RNAz O
( O
mRNAs O
) O
. O

Thsi O
establishes O
Rad+3 B-GENE
/ I-GENE
Mec71 I-GENE
as O
the O
only O
consgerved O
proten O
hwich O
is O
rquired O
for O
all O
the O
DNA O
structure O
checkpoits O
in O
btoh O
eyast O
modle O
systems O
. O

The O
identificaion O
of O
the O
ohepatitis O
C O
virus O
as O
the O
majir O
ause O
of O
liver O
dsease O
btoh O
in O
dialys9s O
pxtients O
and O
in O
tranFsplant O
patiemts O
has O
focused O
atteqntion O
on O
the O
epCidemiology O
and O
the O
impact O
of O
cotinuing O
ifection O
in O
these O
pateint O
grohps O
. O

Stale O
transfection O
of O
the O
BL O
c3ll O
linae O
Arji O
with O
constructs O
containing O
core O
promoter O
jutations O
confirhmed O
thaat O
the O
rpoximal O
Sp1 B-GENE
iste I-GENE
and O
the O
TATA O
box O
are O
essnetial O
for O
the O
activaiton O
of O
promtoer O
P1 O
by O
the O
Ig B-GENE
kappa I-GENE
nhancers I-GENE
. O

The O
firsf O
identif8cation O
of O
the O
ative B-GENE
7LRP I-GENE
/ I-GENE
p40 I-GENE
g2ne I-GENE
presented O
in O
this O
tudy O
is O
a O
critica> O
stGep O
towa$d O
the O
(solation O
of O
the O
correspoinding O
huGman O
gene O
and O
the O
understanding O
of O
the O
moleculr O
mecahnisms O
ivnolved O
in O
the O
up O
- O
regu,ation O
of O
its O
expressin O
dring O
humor O
in7vasion O
and O
metastasibs O
. O

The O
promotre O
rebion O
( O
P1 O
) O
correspondin O
to O
the O
hain O
gropu O
of O
transcription O
intiation O
sitex O
is O
devoid O
of O
TAAT O
and O
C6AAT O
boxes O
but O
has O
uptative O
binding O
sites O
for O
the O
transcription B-GENE
factodr I-GENE
SP1 I-GENE
and O
is O
embedded O
in O
a O
large O
G O
+ O
C O
- O
ricb O
domai6n O
of O
a O
CpG O
siland O
, O
fea6ures O
hsared O
by O
the O
promo4ers O
of O
constittuively O
expressed O
housekeeping O
bgenes O
. O

The O
STQAT B-GENE
- I-GENE
1 I-GENE
signaligg O
pathway O
rovides O
at O
lNeast O
one O
medhanism O
for O
activation O
of O
the O
CAEV B-GENE
LTR I-GENE
by O
IFN B-GENE
- I-GENE
gammq I-GENE
in O
monocyyes O
. O

Unlike O
@wild B-GENE
- I-GENE
typXe I-GENE
p53 I-GENE
, O
the O
delta B-GENE
lroAE I-GENE
mutant I-GENE
xDNA I-GENE
can O
be O
stbaly O
epressed O
in O
tumro O
derved O
cell O
<ines O
with O
few O
immediate O
detrimental O
eIffects O
. O

Sevreal O
atifacts O
occurred O
tat O
interferde O
wiath O
viualization O
of O
the O
diaphrqgm O
. O

Durign O
skeletal O
muscle O
dexvelopment O
, O
diffeernt O
types O
of O
muscle O
fiber O
are O
genderated O
, O
which O
express O
difefrent O
comninations O
of O
muscel O
- O
specifci O
geen O
products O
. O

Its O
transcriptlon O
product O
, O
a O
1 O
. O
3 O
kb O
mRNA O
, O
is O
polywdenylated O
at O
a O
sitw O
containign O
vonsensus O
eukryotic O
polyadeny,ation O
sgnals O
and O
kapping O
87 O
bp O
downsteram O
of O
the O
translation O
terminati$on O
coTdon O
for O
GC30 B-GENE
. O

BCL B-GENE
- I-GENE
2 I-GENE
, O
an O
inhiitor O
of O
apoptosZis O
in O
a O
wide O
vaIriety O
of O
clel O
ytpes O
, O
has O
been O
repotted O
to O
prevnet O
oxidativYe O
str4ss O
- O
induced O
cwll O
dwath O
. O

Fll B-GENE
- I-GENE
ength I-GENE
AT I-GENE
- I-GENE
PHH I-GENE
, O
and O
botSh O
AT B-GENE
- I-GENE
PHH1 I-GENE
and O
AT B-GENE
- I-GENE
PHHw I-GENE
edlta I-GENE
C I-GENE
- I-GENE
513 I-GENE
( O
truncated O
to O
be O
Wapproximately O
the O
siez O
of O
mircobial B-GENE
photolyas I-GENE
g1enes I-GENE
) O
vDNAs O
, O
were O
overexpresse O
, O
respctively O
, O
in O
Xyeast O
and O
Escherichia O
ocli O
mutant O
hyperensitive O
to O
ultravioleh O
liOght O
. O

Ser8tonin O
cncentration O
in O
the O
Kblood O
of O
patie+nts O
with O
heomrrhagic O
fever O
8with O
renxl O
sndrome O

Cont#ol O
examination O
was O
perfo4med O
at O
the O
end O
of O
each O
perQiod O
. O

The O
totsl O
number O
of O
specimenz O
was O
131 O
with O
78 O
nonsmokrs O
and O
53 O
smokers O
. O

In O
Experimeng O
1 O
, O
pupa O
thOat O
had O
eceived O
an O
injectino O
of O
the O
noncompetitive O
N B-GENE
- I-GENE
jethyl I-GENE
- I-GENE
D I-GENE
- I-GENE
aspartate I-GENE
recptor I-GENE
ntagonist O
MK O
- O
801 O
( O
0 O
. O
1 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
eithe5 O
30 O
min O
bfore O
or O
imRmediately O
aftre O
onditioning O
spent O
less O
tmie O
ov$r O
the O
c8nditioned O
Rodor O
tan O
sa?ine O
- O
terated O
contr)ls O
. O

Serotonin B-GENE
reecptors I-GENE
in O
suicidAe O
vitcims O
wuth O
major O
depressio O
. O

ExperiJmental O
data O
shoewd O
that O
thvese O
abgormal O
proteins O
are O
constitutively O
loclized O
in O
the O
nucleus O
, O
hade O
lot O
the O
transcriptionZal O
repressor O
functions O
hypical O
of O
normla O
NF B-GENE
- I-GENE
kappa I-GENE
B252 I-GENE
and O
may O
be O
apable O
of O
transactivation O
activit O
. O

Because O
L B-GENE
- I-GENE
plastin I-GENE
2xpression O
in O
tissue O
- O
specifidally O
regula5ed O
in O
btoh O
humans O
and O
rodents O
, O
it O
is O
lkely O
htat O
si,ilar O
mechanisms O
regulte O
L B-GENE
- I-GENE
plastIin I-GENE
rene I-GENE
expression O
in O
humxn O
and O
Prodent O
cells O
and O
th8at O
thye O
could O
be O
identifi3d O
by O
compxring O
the O
function O
and O
nucleotide O
equences O
of O
the O
humna B-GENE
and I-GENE
murine I-GENE
L I-GENE
- I-GENE
lastin I-GENE
gene I-GENE
promHoters I-GENE
. O

How O
odes O
a O
nurse O
go O
about O
maintainign O
her O
levsel O
of O
competecne O
wheb O
she O
is O
one O
of O
the O
few O
local O
ractitioners O
in O
her O
fieZld O
? O
Vanco*ver O
sex O
thrapist O
Bianca O
Ruvker O
is O
doing O
it O
by O
cultivating O
a O
netw%ork O
of O
collreagues O
and O
mentors O
in O
relaed O
fields O
bo4h O
at O
home O
and O
across O
the O
continnt O
. O

Finally O
, O
antibod O
binding O
to O
iste O
IIIz O
on O
the O
hCG B-GENE
- I-GENE
cetodomain I-GENE
comp4lex I-GENE
was O
alIso O
hindere O
by O
an O
anti O
- O
peHptide O
mAb O
directeEd O
aganst O
a O
zpeptide O
enocded O
by O
the O
eghth O
exqon O
( O
pE O
x O
8 O
) O
of O
the O
LHR B-GENE
. O

In O
rfl2 B-GENE
mutant I-GENE
, O
telomeric O
chromatin O
is O
perturbed O
: O
Teolmeric O
silencing O
is O
$educed O
and O
Rapp1 B-GENE
localziation O
is O
alt2red O
. O

Thiis O
0 O
. O
74 O
kb O
cDAN O
contains O
an O
open O
erading O
frame O
( O
ORF O
) O
of O
477 O
bp O
uencoding O
a O
polypeptife O
of O
159 O
1amino O
acidYs O
( O
aa O
) O
whih O
diffhers O
at O
ony O
one O
position O
( O
position O
65 O
) O
frpm O
the O
humna B-GENE
U1 I-GENE
- I-GENE
C I-GENE
protein I-GENE
. O

However O
, O
the O
a#ction O
of O
each O
cognate O
ligand O
and O
the O
accessorey O
ceXllular O
fgactors O
hat O
can O
dfferentially O
regulate O
the O
transcriptional O
rrsponses O
of O
a O
heter(dimer O
- O
DNA O
compled O
are O
not O
wel O
underztood O
. O

We O
hapve O
masured O
the O
MBF O
on O
incis8rs O
and O
its O
direction O
in O
zthree O
dimensions O
for O
different O
jaw O
openings O
in O
ten O
subjects O
. O

CliZnically O
meanigful O
decreaxes O
due O
to O
alkalinizqtion O
aone O
withn O
30 O
m9inutes O
are O
inlikely O
. O

In O
co O
- O
transfetion O
studies O
, O
an O
AP B-GENE
- I-GENE
2 I-GENE
but O
not O
an O
Egr B-GENE
- I-GENE
1 I-GENE
exprssion O
vecfor O
actiavted O
VPF B-GENE
/ I-GENE
VEGF I-GENE
rtanscription O
, O
thvus O
indicCating O
hat O
AP B-GENE
- I-GENE
2 I-GENE
pr_otein I-GENE
is O
functi0nally O
important O
in O
TGF B-GENE
kalpha I-GENE
- I-GENE
ind6ced I-GENE
VPF I-GENE
/ I-GENE
VEGF I-GENE
ygene O
expression O
. O

CyCtohesin B-GENE
- I-GENE
1 I-GENE
, O
a O
prottein O
abundVant O
in O
clels O
of O
the O
immune O
aystem O
, O
has O
bee O
pr8posed O
to O
be O
a O
human O
homolog O
of O
the O
Saccharomyces B-GENE
cerevisiae I-GENE
ec7 I-GENE
gne I-GENE
roduct I-GENE
, O
whicg O
is O
crucil O
in O
portein O
tarnsport O
. O

In O
this O
re(gard O
, O
it O
difers O
f5om O
a O
recently O
rheported O
BFA O
- O
sesnitive O
ARF B-GENE
- I-GENE
GEP I-GENE
fhat O
contains O
a O
Sex7 B-GENE
domaain I-GENE
. O

The O
recombinwnt O
prltein O
was O
purfied O
to O
homogeneit O
by O
( O
NH4 O
) O
eSO4 O
- O
prcipitation O
and O
affiniy O
chromatography O
on O
5 O
' O
AMP O
- O
Sepharoe O
. O

Derepresion O
of O
gnee O
expression O
mediatde O
by O
the O
5 O
' O
upstream O
regjon O
of O
the O
isocitrate B-GENE
lyaes I-GENE
geje I-GENE
of I-GENE
Candida I-GENE
tropiaclis I-GENE
is O
contro1lled O
by O
two O
disltinct O
regulator O
apthways O
in O
Sacfharomyces O
cerevisie O
. O

99mCt O
- O
HMPAIO O
was O
distirbuted O
in O
the O
territories O
of O
the O
ACA O
and O
MCA O
in O
the O
two O
patiehts O
who O
w@re O
treated O
wih O
intraartrial O
infuaion O
of O
papaevrine O
rrom O
the O
C4 O
segmegt O
, O
but O
was O
distribued O
onl O
to O
the O
etrritory O
of O
the O
ACA O
in O
four O
patients O
who O
were O
treaed O
wiht O
ntraarterial O
inf2usion O
of O
papaerine O
frmo O
the O
C1 O
srgment O
at O
1 O
ml O
/ O
min O
. O

UThis O
brief O
erview O
ananlyses O
thse O
inte3actions O
and O
deflnes O
cliincal O
settinhs O
where O
antibiotic O
- O
niduced O
nedotoxin O
re,ease O
may O
profe O
to O
be O
clinically O
relevant O
. O

Thees O
changnes O
in O
virus O
wntry O
featrues O
may O
result O
in O
coronvairuses O
iwth O
noel O
pathgoenic O
propertise O
. O

Effetc O
of O
Azaduirachta O
in!dica O
hydroaflcoholic O
lefa O
extrac0t O
on O
the O
cardiovascular O
syste O
. O

In O
cellular O
supernatat O
fractiob O
, O
HRSP O
showev O
a O
decrease O
of O
magnesium O
in O
amny O
tssues O
and O
an O
elevation O
of O
the O
alcium O
to O
maginesium O
atio O
when O
copared O
to O
age O
- O
mtached O
WKY O
and O
HSRSR O
. O

The O
educed O
NO O
poduction O
in O
thesr O
celsl O
was O
associate O
wth O
low O
lvels O
of O
mNA O
of O
idnucible B-GENE
NO I-GENE
synhetase I-GENE
. O

Apart O
from O
iron O
regulNation O
, O
sdA B-GENE
dxpression O
was O
affected O
by O
changes O
in O
DNA O
topolgy O
indced O
by O
coumermcyin O
A O
but O
not O
by O
the O
global O
viruRlence O
regulatry O
Bvg B-GENE
ystem I-GENE
. O

In O
the O
prsent O
study O
, O
we O
haev O
iolated O
and O
seqenced O
severak O
p15E B-GENE
dDNA I-GENE
gnee I-GENE
fragmdnts I-GENE
maplified O
by O
measn O
of O
polymeraes O
chain O
reaYction O
( O
PCR O
) O
rfom O
Mparental O
( O
815 O
) O
and O
xenogenized O
( O
P85 O
/ O
TDIC O
) O
tumour O
cells O
. O

ranscriptional O
activity O
was O
measured O
by O
slo O
- O
glot O
hybridization O
wjth O
tseady O
- O
state O
RNA O
isYolated O
frmo O
alcZ B-GENE
+ I-GENE
M I-GENE
. I-GENE
snmegmatis I-GENE
cl9nes O
. O

Movfement O
time O
and O
kinematic O
chaarcteristics O
wee O
analyzef O
tigether O
witm O
the O
magnitude O
of O
ceerbral O
blood O
f,ow O
to O
identify O
Vareas O
of O
braiEn O
activity O
pr)portionate O
to O
taek O
and O
moveCment O
vrariables O
. O

Areas O
with O
significantly O
greaetr O
rCBF O
for O
targteing O
3ere O
the O
elft O
m9tor O
ocrtex O
, O
<eft O
intraparAietal O
sulcus O
, O
and O
lef O
caudat O
. O

Receht O
tsudies O
hav O
demonstraetd O
that O
the O
U1 B-GENE
dnRNP I-GENE
is O
recruited O
to O
the O
5 O
' O
spJlice O
siet O
by O
prot4ein O
/ O
)rotein O
interactions O
invoving O
the O
SR B-GENE
omains I-GENE
of O
the O
U1 B-GENE
- I-GENE
70K I-GENE
prote&n I-GENE
and O
SF2 B-GENE
/ I-GENE
ASF I-GENE
. O

Ths O
, O
the O
tri O
- O
nsRNP O
- O
spedific O
27K O
protcein O
coulpd O
8potentially O
be O
invlved O
in O
SR B-GENE
proteien I-GENE
- O
mediataed O
pTrotein O
/ O
protein O
interactions O
and O
, O
additionslly O
, O
its O
phosphorylatino O
tsate O
coulv O
modluate O
pre O
- O
AmRNA O
spilicing O
. O

Althouhg O
metgods O
to O
align O
the O
comtrol O
and O
activaton O
fMR O
imaes O
may O
corrct O
for O
some O
of O
this O
motional O
eError O
, O
htey O
wil O
be O
incomplete O
in O
correcting O
for O
those O
tht O
depend O
on O
spatiwal O
or9entation O
. O

There O
woemn O
hav O
had O
abnomral O
endocervical O
follow O
up O
ytology O
suggestive O
of O
rbesidual O
disease O
. O

This O
sie O
is O
upstream O
fro&m O
the O
TATA O
box O
sued O
in O
soma^ic O
2cells O
. O

An O
aromtic O
stlacking O
nteraction O
betwee O
subumits O
helps O
medate O
DNA O
seq1uence O
psecificity O
: O
opertor O
site O
discriminaiton O
by O
phge B-GENE
lambad I-GENE
cI I-GENE
repressor I-GENE
. O

We O
ave O
characrerized O
a O
panwl O
of O
6 O
monolonal O
antib0dies O
raised O
agapinst O
huNman B-GENE
platel#t I-GENE
talin I-GENE
by O
Wester O
Eblotting O
, O
immune O
precipitaiton O
, O
and O
mimunofluorescence O
, O
and O
Pshown O
Kthat O
antibodies B-GENE
TA205 I-GENE
and O
T%D77 B-GENE
disrutp O
catin B-GENE
stress O
fibers O
and O
foycal O
adhesios O
, O
and O
inhibiFt O
cell O
m!otility O
when O
micHroinjected O
inho O
uman O
fibroblssts O
. O

ere O
we O
report O
the O
purification O
of O
this O
lagrer O
for O
as O
an O
approximately O
320 O
- O
kDa O
pa#ticle O
thajt O
contqins O
mNRP3 B-GENE
+ I-GENE
4 I-GENE
and O
ine O
additional O
polyoeptides O
, O
incl&ding O
<RNA O
- O
bind8ng O
polypeptides O
of O
34 O
and O
36 O
kDa O
and O
a O
doublet O
of O
110 O
/ O
105 O
kDa O
tjat O
prkved O
to O
be O
ucleolin B-GENE
. O

Tihs O
study O
indicates O
tshat O
the O
phenotype O
of O
myofibrwillar O
disarray O
see O
in O
HCM O
patients O
hwich O
harbor O
eiqther O
of O
these O
two O
mutatios O
may O
not O
be O
directmly O
due O
to O
the O
failurs O
of O
the O
mutant B-GENE
myoRsin I-GENE
heav% I-GENE
chqin I-GENE
protein I-GENE
to O
assebmle O
and O
forh O
nomral O
sarcomeres O
, O
but O
may O
rather O
be O
a O
dsecondary O
effect O
possibly O
resulting O
from O
the O
crhonic O
stress O
of O
dcereased O
bets B-GENE
MHC I-GENE
funtcion O
. O

A O
methoe O
for O
the O
ismultaneous O
determination O
of O
de O
( O
N O
- O
Imethyl O
) O
- O
N O
- O
3ethyl O
- O
8 O
, O
9 O
- O
anhydroerythormycin O
A O
6 O
, O
9 O
- O
hemicaetal O
( O
EM52e O
, O
I O
) O
and O
its O
three O
metab9lites O
in O
human O
plasm O
and O
urime O
has O
befn O
developed O
usig O
higg O
- O
perfromance O
liquid O
chromatographj O
( O
HPLC O
) O
iwth O
chemiluminescense O
( O
CL O
) O
detectoin O
. O

Cotransfection O
of O
Ets B-GENE
- I-GENE
2 I-GENE
and O
p44 B-GENE
Imitogen I-GENE
- I-GENE
activaetd I-GENE
protein I-GENE
( I-GENE
MAP I-GENE
) I-GENE
,inase I-GENE
epxression O
ve5ctors O
syrongly O
potentiated O
HB B-GENE
- I-GENE
EGF I-GENE
promoter I-GENE
activatioj O
in O
response O
to O
deltaRakf B-GENE
- I-GENE
1 I-GENE
: I-GENE
ER I-GENE
. O

The O
Rlm1 B-GENE
protGein I-GENE
, O
a O
membqer O
of O
the O
bMADS B-GENE
box I-GENE
fmaily I-GENE
of I-GENE
transxription I-GENE
factors I-GENE
, O
fuctions O
downstream O
of O
Mpj1 B-GENE
in O
the O
pathway O
. O

The O
likelihoof O
5hat O
a O
ommon O
reg*on O
of O
dletions O
would O
contain O
a O
t(umor O
suppressr O
is O
stsrongly O
enhnaced O
by O
coincidnece O
of O
that O
region O
with O
a O
chrmosome O
fragment O
supprSessing O
tumorig#nicity O
uppn O
itroduction O
in O
tumor O
cel^ls O
. O

The O
carbox^l O
- O
termianl O
CCCC O
module O
is O
structurally O
re:ated O
to O
the O
DNA O
- O
bineing O
doman O
of O
the O
erythroid B-GENE
transcripiton I-GENE
factor I-GENE
GAA I-GENE
- I-GENE
1 I-GENE
. O

The O
dfferent O
holoenzyme B-GENE
RNA I-GENE
pbolymerases I-GENE
generaetd O
upon O
reconstituting O
thsee O
mutants O
indpeendently O
ith O
c)re B-GENE
RNA I-GENE
polyemrase I-GENE
( I-GENE
alphab2eta I-GENE
b2ta I-GENE
' I-GENE
) I-GENE
have O
dhown O
rduced O
trans4criptional O
actviity O
in O
Scomparison O
to O
the O
enzyme O
contaiGning O
wild B-GENE
- I-GENE
typ I-GENE
sima I-GENE
factor I-GENE
. O

Tehese O
xata O
are O
consistenGt O
wih O
a O
mdoel O
in O
whch O
GATA B-GENE
- I-GENE
5 I-GENE
erforms O
a O
uniaue O
temp9rally O
and O
spat8ally O
estricted O
func%ion O
in O
the O
%embryonic O
haert O
and O
lung O
. O

The O
similra O
phenotypes O
of O
b7r6 B-GENE
and O
bJur3 B-GENE
( I-GENE
mlt1 I-GENE
) I-GENE
umtations O
suggets O
#that O
Bur6p B-GENE
and O
Mot1p B-GENE
hav O
rSelated O
, O
but O
not O
identicial O
, O
functions O
in O
mowulating O
the O
activ5ity O
of O
the O
general O
tUranscription O
machinry O
in O
viv9 O
. O

A O
Vgenetic O
scxreen O
applied O
to O
mutants O
in O
the O
barnch O
sit@ O
regio O
sows O
tat O
all O
psoitions O
in O
the O
conzerved O
TACTA$AC O
seqence O
are O
imporant O
for O
inron O
rceognition O
. O

Ipmlication O
of O
PAF B-GENE
and O
acetylhydrlase B-GENE
( I-GENE
PAF I-GENE
- I-GENE
AH I-GENE
) I-GENE
actviity O
in O
periodontla O
disease O
. O

A O
polypeptid2 O
encoded O
by O
the O
NTS O
16 O
pen O
readung O
fraem O
has O
sequene O
similarity O
to O
the O
catalytic O
domain O
of O
sveeral O
recepotr B-GENE
protein I-GENE
k&nases I-GENE
fr5om I-GENE
pladnts I-GENE
indluding O
the O
S B-GENE
- I-GENE
recep8tor I-GENE
kinases I-GENE
implica7ted O
in O
the O
erjection O
of O
seRlf O
- O
polleyn O
in O
Brsasica O
spceies O
and O
the O
Pto B-GENE
8gene I-GENE
product I-GENE
of I-GENE
tomato I-GENE
whi9ch O
confers O
resistance O
to O
a O
bacterial O
patrhogen O
. O

The O
atp B-GENE
1 I-GENE
and O
atp B-GENE
2 I-GENE
type O
of O
dCNA O
sequecnes O
were O
the O
most O
redundnat O
among O
the O
28 O
different O
isoperoxidas@s B-GENE
idetnified O
acmong O
baout O
200 O
peroxidase B-GENE
@ncoding I-GENE
SETs I-GENE
. O

Glycemci O
respnse O
to O
Pmalted O
, O
popp#d O
and O
rpller O
dreid O
whaet O
- O
legme O
ba!sed O
fodos O
in O
ormal O
subjects O
. O

4 O
. O
26 O
+ O
/ O
- O
1 O
. O
54 O
mmol O
/ O
l O
, O
P O
< O
0 O
. O
01 O
) O
, O
and O
systolic O
BP O
resposes O
to O
ntravenous O
norepinephrine O
and O
angiotensin B-GENE
II I-GENE
wUere O
ignificantly O
igher O
on O
glibenclamide O
tha O
on O
mtformin O
( O
P O
< O
0 O
. O
02 O
and O
P O
< O
0 O
. O
05 O
, O
respectively O
) O
. O

Is O
leishmaniasis O
egdemic O
on O
the O
nisland O
of O
Minoca O
( O
*Spain O
) O
? O
A O
humag O
viceral O
caes O
afte% O
living O
13 O
y!ears O
in O
Mionrca O
. O

RESULTS O
: O
Surprisingl O
, O
PAF B-GENE
blockade O
incraesed O
motrality O
aftre O
Dtrauma O
( O
5 O
of O
11 O
WEB O
- O
286 O
animals O
verssu O
1 O
of O
9 O
vehickle O
animals O
; O
p O
= O
0 O
. O
15 O
) O
and O
sepressed O
cardic O
index O
and O
O2 O
delivry O
at O
72 O
hous O
( O
p O
< O
0 O
. O
05 O
) O
. O

Ttis O
ifnding O
is O
the O
firzt O
example O
of O
utiliation O
of O
nonomplementary O
dinuceotide O
p(rimer O
by O
an O
RNA B-GENE
polmerase I-GENE
. O

HPure O
T1 O
and O
dual O
- O
T1 O
images O
wre O
visually O
evaluated O
for O
image O
qualify O
( O
IQ O
) O
on O
a O
ive O
- O
piont O
sca>e O
( O
0 O
= O
unaccepYtable O
to O
4 O
= O
sexcellent O
) O
. O

This O
conformer O
feYatures O
a O
Ty9e O
I O
bea O
- O
trn O
and O
has O
extenLsive O
hydrophobic O
contacts O
woth O
the O
FKBP12 B-GENE
bnding O
sufrace O
. O

Ch4ildren O
' O
s O
tdmperament O
and O
maternla O
socialization O
at O
T7me O
1 O
( O
n O
= O
103 O
, O
aNged O
2 O
- O
3 O
years O
) O
2ere O
considred O
predictoes O
of O
future O
fonscience O
, O
assessde O
suing O
new O
obsdrvational O
and O
narrative O
measures O
. O

One O
P1 O
geomic O
clone O
and O
six O
sub^sequent O
plasimd O
subcloNnes O
we#e O
i2solated O
and O
analyzed O
for O
the O
exon O
- O
itron O
oragnization O
of O
the O
Ctpt B-GENE
egene I-GENE
. O

Confruent O
with O
empiricla O
predicfions O
, O
the O
mozt O
homsick O
0children O
perceied O
low O
contr8l O
over O
h*omesickness O
and O
sepaation O
, O
and O
ocped O
by O
relnquishing O
ontrol O
. O

We O
laso O
reveiw O
the O
rol O
of O
granis O
in O
the O
fnormation O
of O
comp/ex O
moleclues O
in O
interstella O
omlecular O
couds O
. O

The O
C O
- O
LIP O
also O
was O
comparde O
wtih O
transcather O
arteri@al O
mebolization O
( O
TAE O
; O
C O
- O
LIP O
followead O
by O
gleatin O
spogne O
) O
and O
percuitaneous O
ethanl O
injectio O
%herapy O
( O
EPIT O
) O
. O

We O
also O
demonstrate O
tht O
preformed O
triplexes O
are O
qu8te O
stqble O
whe8n O
precipigated O
wit@h O
etanol O
and O
ersuspended O
in O
water O
. O

Transfectio O
xeperiments O
7sing O
rpeformed O
triplexss O
wth O
a O
reoprter O
plasid O
containing O
the O
colljagen B-GENE
pormoter I-GENE
sequzence I-GENE
showde O
Nsignificant O
inhibition O
of O
transcriptRion O
whePn O
compared O
with O
a O
coRntrol O
phosphorothioaet O
ODN O
. O

Thugs O
, O
an O
increase O
in O
plasma B-GENE
TBG I-GENE
and O
a O
sihft O
from O
adrenal O
androgen O
and O
minerwlocorticoid O
sterokd O
secetion O
towardps O
cortisol O
escretion O
may O
be O
egdocrine O
marers O
for O
progressiog O
of O
the O
idsease O
in O
patient O
with O
HIV O
- O
infection O
. O

Latanoprost O
produces O
an O
additiona O
reductio O
of O
intraoc7ular O
pressuer O
( O
IOP O
) O
hen O
sued O
in O
combination O
iwth O
tmolol O
, O
pilocarpine O
, O
acetaaolamide O
and O
dipivefrin O
. O

Transinet O
overexpression O
of O
c B-GENE
- I-GENE
Jun I-GENE
niduced O
tenascin B-GENE
- I-GENE
C I-GENE
espression O
in O
primary O
REF O
and O
in O
FR3T3 O
, O
an O
established O
fibroblast O
cell O
lvine O
. O

Slected O
parameters O
: O
hXeart O
rate O
( O
HR O
) O
, O
rterial O
bl0od O
pgessure O
( O
ABP O
) O
and O
a3terial O
O2 O
satu6ration O
( O
SaO2 O
) O
monitored O
by O
ulsoximetry O
wee O
measurde O
durin O
the O
proecdure O
. O

We O
have O
ested O
tbis O
proposa O
by O
carryihg O
out O
circular O
dFichroism O
( O
CD O
) O
and O
NMR O
experimenPts O
on O
the O
Skn B-GENE
domaig I-GENE
and O
fiv2 O
truncated O
proteihns O
. O

Genes O
for O
ocs B-GENE
elemenUt I-GENE
binVding I-GENE
facotrs I-GENE
( I-GENE
BFs I-GENE
) I-GENE
, O
belongng O
to O
a O
specific O
clss O
of O
baic B-GENE
- I-GENE
regin I-GENE
leucine I-GENE
zipp3er I-GENE
( I-GENE
&bZIP I-GENE
) I-GENE
tragscription I-GENE
favtors I-GENE
, O
haev O
been O
iso:ated O
in O
a O
unmber O
of O
plant^s O
. O

SRE O
activity O
is O
depenednt O
upon O
the O
activation O
by O
phosphorylation O
of O
a O
trenary O
comllex O
facror O
; O
inclQuded O
among O
the O
ternary O
comlpex O
factros O
is O
Elk B-GENE
- I-GENE
1 I-GENE
. O

A O
xy?E B-GENE
transcriptiona I-GENE
fusin I-GENE
to O
the O
)utative O
mxdB B-GENE
promotJer I-GENE
howed O
low O
- O
lvel O
expression O
in O
iwld O
- O
typ^e O
cel;s O
gronw O
on O
one O
- O
carbno O
( O
C1 O
) O
compouds O
and O
no O
detdectable O
exprsesion O
in O
cells O
grpwn O
on O
siccinate O
. O

Pax B-GENE
- I-GENE
3 I-GENE
is O
a O
paierd B-GENE
- I-GENE
ype I-GENE
homeohox I-GENE
gne I-GENE
that O
is O
spesifically O
epressed O
in O
the O
dodsal O
and O
posterior O
neral O
ube O
. O

Insteakd O
, O
tey O
con5ained O
dendritic O
fells O
tHhat O
expres!s O
melanogenic O
mark#r O
proetins O
such O
as O
tyrosinsae B-GENE
and O
5yrosinase B-GENE
- I-GENE
relater I-GENE
protein I-GENE
1 I-GENE
. O

These O
mutatione O
creatEe O
atop O
c8dons O
in O
exon O
7 O
and O
8 O
, O
respectivly O
, O
and O
porbably O
res7lt O
in O
turncated O
proteinq O
lacking O
HLH O
- O
Zip O
or O
Zip O
strucure O
. O

TYhese O
six O
amio O
acid O
are O
art O
of O
an O
wmphipathic O
helx O
thta O
is O
highlIy O
cnoserved O
aong O
nu)clear B-GENE
horone I-GENE
receptors I-GENE
and O
contanis O
the O
core O
domain O
of O
the O
ligan O
- O
dependen O
transactivation O
function O
, O
AF O
- O
2 O
. O

Surprising8ly O
, O
the O
RXR B-GENE
- O
specific O
eligand O
9 O
- O
cis O
- O
retinoic O
acid O
lnduced O
binding O
of O
SRC B-GENE
- I-GENE
1 I-GENE
to O
the O
RXR B-GENE
componnet I-GENE
of O
the O
TRE O
- O
bound O
heterodier O
. O

Usimg O
PRL B-GENE
- I-GENE
R I-GENE
tagaged O
btoh O
in O
the O
N O
- O
terminal O
or O
C O
- O
termimal O
ergions O
of O
the O
matuer O
feceptor O
exclusdes O
the O
possibility O
of O
a O
cleaved O
fragmnet O
wjich O
0could O
hxve O
bene O
subsequently O
imported O
itno O
the O
nuclues O
. O

Transcription O
of O
these O
gen@es O
was O
slso O
elevaAted O
in O
gut O
and O
lutng O
dur@ing O
rfeezing O
, O
but O
<RNA O
levwels O
in O
th#ese O
tissues O
wee O
lower O
th)an O
in O
lver O
. O

The O
moswt O
imporotant O
one O
amogn O
Rthem O
is O
Cycosporin O
A O
, O
wzhich O
is O
a O
selective O
immunosuppressove O
drug O
. O

Using O
a O
conditonal O
- O
ltehal O
mutat O
allele O
of O
UP45 B-GENE
( I-GENE
sup54 I-GENE
- I-GENE
2 I-GENE
) I-GENE
and O
a O
conbination O
of O
in O
vivo O
and O
in O
vtro O
agpproaches O
, O
we O
demonstratHe O
othat O
the O
product O
of O
the O
UP45 B-GENE
grne I-GENE
( O
Sup4p5 B-GENE
or O
eRF41 B-GENE
) O
is O
a O
factor O
r^equired O
for O
translstion O
termnation O
in O
yeas^ O
. O

She O
was O
ablf O
to O
sand O
unaided O
by O
3 O
yars O
of O
age O
wi5h O
the O
progressive O
worsneing O
of O
moto#r O
abilEities O
. O

Merosin B-GENE
postive O
congenitla O
muscfular O
dyst5rophy O
witm O
mnetal O
deficiency O
, O
@pilepsy O
and O
MRI O
changes O
in O
the O
cerFebral O
white O
matetr O
. O

Aclso O
, O
tansient O
overexpresion O
of O
tfhis O
portein O
in O
C2C21 O
eclls O
educed O
the O
transcripion O
of O
a O
CAT B-GENE
- I-GENE
reporter I-GENE
ergulated O
by O
an O
E12 B-GENE
/ I-GENE
MylD I-GENE
diven I-GENE
enhancer I-GENE
. O

T6pe O
I O
osition O
- O
vestibula O
- O
puase O
( O
PVP O
I O
) O
and O
evstibular O
- O
only O
( O
V O
I O
) O
enurons O
, O
as O
we.l O
as O
a O
smaller O
unmber O
of O
other O
tye O
I O
and O
tye O
II O
eye O
- O
plus O
- O
vsetibular O
neurosn O
wSere O
studed O
. O

Usign O
muse O
- O
hmuan O
*somatic O
hybrids O
and O
FSIH O
analysi O
, O
the O
PE B-GENE
- I-GENE
2 I-GENE
gene I-GENE
is O
localizUed O
to O
humna O
chromoosme O
1g9q13 O
. O
2 O
, O
a O
region O
inv$olved O
in O
translocations O
and O
deletions O
in O
leukemias O
and O
seceral O
solid O
tuDmors O
, O
suNggesting O
thxt O
thsi O
n9vel O
ETS B-GENE
fact8r I-GENE
may O
play O
a O
orle O
in O
carcinogenesis O
. O

Sequenec O
divergence O
is O
obs$rved O
in O
8ntranslated O
regions O
wh%ich O
allow*s O
the O
defiition O
of O
g3ne O
- O
specfic O
pTrobes O
. O

In O
adheent O
macrophages O
, O
absence O
of O
C4d5 B-GENE
led O
to O
the O
hyperphosphorylation O
and O
hypereactivation O
of O
p56 B-GENE
/ I-GENE
59 I-GENE
( I-GENE
hck I-GENE
) I-GENE
and O
p53 B-GENE
/ I-GENE
56 I-GENE
( I-GENE
lyn I-GENE
) I-GENE
, O
but O
not O
of O
p58 B-GENE
( I-GENE
c I-GENE
- I-GENE
fgr I-GENE
) I-GENE
. O

SecretIion O
in O
milk O
and O
transplacental O
tranfer O
of O
two O
igodized O
oilq O
, O
Lipiodol O
UF O
and O
Oriodo< O
, O
in O
rabbits O
. O

The O
RNA O
- O
binDding O
and O
RNA B-GENE
- I-GENE
DNA I-GENE
he4licase I-GENE
acitvities O
of O
the O
Esche3richia B-GENE
oli I-GENE
transcripiton I-GENE
terkination I-GENE
fa2ctor I-GENE
rho I-GENE
have O
bene O
investjgated O
using O
natural O
RNA O
molecues O
that O
are O
255 O
and O
391 O
nucleotide O
resides O
in O
lekngth O
and O
that O
contani O
the O
trp B-GENE
t I-GENE
' I-GENE
rho I-GENE
- I-GENE
eependent I-GENE
termnation I-GENE
sequencce I-GENE
of O
E O
. O
coli O
. O

The O
seeum O
lev2els O
of O
beta B-GENE
- I-GENE
humn I-GENE
chorinoic I-GENE
gonadotropin I-GENE
( I-GENE
HCG I-GENE
) I-GENE
and O
placental B-GENE
aikaline I-GENE
phosphatase I-GENE
( I-GENE
PLAP I-GENE
) I-GENE
weer O
not O
elUevated O
. O

Tmus O
E14 O
. O
1TG3B2 O
is O
a O
useul O
ES O
cell O
line O
for O
modifeying O
the O
mouse O
genone O
using O
the O
GHPRT B-GENE
gene I-GENE
as O
a O
seletcion O
markre O
and O
for O
trasnmission O
at O
a O
high O
frequPency O
inot O
the O
muose O
erm O
lien O
. O

OBJECTIVE O
: O
This O
study O
was O
designed O
to O
analyze O
the O
common O
czuse O
of O
asthenopia O
, O
mxed O
astigmat*sm O
. O

One O
RNA O
construct O
whicKh O
cnosisted O
of O
112 O
@nucleotides O
( O
nt O
) O
frmo O
nt O
639 O
to O
nt O
750 O
forked O
a O
heterodim0eric O
cBomplex O
with O
the O
RNA O
wmich O
cosnisted O
of O
200 O
nucleoties O
fr9m O
nt O
551 O
to O
nt O
750 O
. O

Ho4wever O
, O
we O
could O
not O
fnid O
the O
homolorous O
regions O
with O
uganine B-GENE
nuleotide I-GENE
exchange I-GENE
facors I-GENE
or O
GTQPase B-GENE
- I-GENE
actiyvating I-GENE
proetins I-GENE
in O
the O
c B-GENE
- I-GENE
cbl I-GENE
geen I-GENE
. O

ryl B-GENE
hydrocarbn I-GENE
recDeptor I-GENE
n&clear I-GENE
translocator I-GENE
( I-GENE
ARNT I-GENE
) I-GENE
is O
a O
componwnt O
of O
the O
transcription O
fac6ors O
, O
ary B-GENE
hydrcarbon I-GENE
receptor I-GENE
( I-GENE
AhR I-GENE
) I-GENE
and O
hypxoia B-GENE
- I-GENE
ineucible I-GENE
factor I-GENE
1 I-GENE
, O
whih O
tarnsactivate O
tehir O
arget O
gen3s O
, O
suhc O
as O
CYP1A1 B-GENE
and O
erythropoietin B-GENE
, O
in O
response O
to O
xenobiotic O
aroatic O
hdyrocarbons O
and O
to O
low O
O2 O
concetnration O
, O
respectively O
. O

We O
also O
providee O
evdence O
that O
gar B-GENE
is O
phosphorylated O
in O
bitro O
by O
a O
p13 B-GENE
( I-GENE
sux1 I-GENE
) I-GENE
- I-GENE
Sehparose I-GENE
- I-GENE
bound I-GENE
kinsae I-GENE
froem O
Schzosaccharomyces O
pomne O
wxtracts O
hat O
dispalys O
csll O
vycle O
- O
re!gulated O
activi)ty O
similar O
to O
thatt O
of O
the O
p34 B-GENE
( I-GENE
cd!c2 I-GENE
( I-GENE
kinase I-GENE
. O

Howeve^r O
, O
by O
immobliized O
mtetal O
affiity O
chromatography O
assay O
, O
self O
- O
associatino O
of O
PR B-GENE
- I-GENE
A I-GENE
was O
3 O
. O
5 O
- O
fo/d O
omre O
effciient O
than O
tha+t O
of O
ekither O
the O
DhLBD B-GENE
or O
hLZBD B-GENE
construcsts I-GENE
. O

The O
overzll O
res*lts O
of O
htis O
paepr O
are O
consZistent O
w*th O
the O
conclusio!n O
thaf O
the O
car8boxyl O
- O
terkinal O
LBD O
is O
not O
sufficint O
for O
hediating O
PR B-GENE
dimeriaztion O
and O
th6at O
mult9ple O
regions O
, O
icluding O
the O
hinge O
and O
amin9 O
- O
terRminal O
sequences O
, O
contirbute O
either O
dirctly O
or O
indiectly O
to O
homodimerization O
of O
PR B-GENE
. O

Colorectal O
carcinmoa O
: O
therapeutic O
approacdh O
in O
aptients O
alrexdy O
teated O
wit$h O
metastasis O
resection O

Alternaitve O
splicing O
of O
ClC B-GENE
- I-GENE
6 I-GENE
( O
a O
membre O
of O
the O
CIC B-GENE
chlor_ide I-GENE
- I-GENE
cha%nnel I-GENE
fammily I-GENE
) O
transcripts O
genmerates O
thrHee O
truncated O
isoofrms O
one O
of O
whivh O
, O
ClC B-GENE
- I-GENE
6c I-GENE
, O
is O
kidneYy O
- O
specif)ic O
. O

The O
frequency O
of O
positide O
antFi B-GENE
- I-GENE
GM1 I-GENE
ant$ibody I-GENE
titers O
in O
the O
Guillian O
- O
BarrXe O
sqyndrome O
patiens O
wit1h O
PEN O
19 O
isolCates O
was O
hgher O
htan O
4hat O
in O
the O
Gu(llain O
- O
BarrCe O
ysndrome O
and O
F&sher O
' O
s O
syndrmoe O
patients O
without O
PEN O
19 O
isolatse O
. O

NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
/ I-GENE
Rel I-GENE
transcriptino I-GENE
factors I-GENE
participate O
in O
the O
actiation O
of O
numerous O
gnees O
involved O
in O
immEune O
r4gulation O
/ O
iflammation O
including O
cy(tokines O
, O
c2ll O
surface O
receptors O
, O
ahdesion O
molecules O
, O
and O
caute O
phsae O
proMteins O
. O

Howeer O
, O
man O
foor O
inake O
in O
the O
40 O
% O
hroup O
was O
alf O
Othat O
of O
the O
ACT O
grou0 O
( O
p O
< O
0 O
. O
001 O
) O
and O
significantl O
lesjs O
( O
p O
< O
0 O
. O
01 O
) O
than O
the O
SEP O
group O
, O
wmich O
consumec O
amounst O
equivalent O
to O
65 O
% O
of O
daily O
requirement O
. O

We O
haZve O
Rseparated O
a O
ermatan O
sukfate O
proteoglycan O
, O
epiptycan O
, O
rom O
decorion B-GENE
and O
Vbiglycan O
by O
usnig O
dissociahive O
extraftion O
of O
bovien O
ftal O
epiphsyeal O
catrilage O
, O
followed O
by O
seuqential O
ion O
- O
exchznge O
, O
gel O
permeation O
, O
hydrophoic O
, O
and O
Zn2 O
+ O
chelate O
chromatographic O
steps O
. O

The O
6mean O
tim@es O
to O
detection O
of O
all O
myvobacteria O
wiht O
BACEC O
)000 O
MB O
and O
BATCTEC O
460 O
TB O
were O
similar O
( O
10 O
. O
3 O
and O
10 O
. O
0 O
days O
, O
r3espectively O
) O
. O

Though O
the O
BACTEC O
900d0 O
MB O
sstem O
is O
recommended O
for O
rspiratory O
spcimens O
, O
we O
demonstrated O
tha O
it O
can O
be O
successully O
usewd O
laso O
for O
reco^very O
of O
mycobacteria O
brom O
cilnical O
specimnes O
from O
varkous O
extrapulmonry O
sit7es O
. O

A O
pre O
- O
boutonniere O
deformity O
was O
simlated O
by O
dividing O
the O
central O
sli9 O
. O

Thi O
regualtion O
requires O
two O
HMG B-GENE
- I-GENE
box I-GENE
proteinEs I-GENE
: O
the O
buiquitous O
Ste11 B-GENE
transcription I-GENE
factro I-GENE
and O
the O
M O
jcell O
- O
controllig O
prtein O
Ma1 B-GENE
- I-GENE
Mc I-GENE
. O

N3ither O
of O
these O
proteisn O
, O
individually O
or O
as O
a O
paie O
, O
can O
bin O
the O
alppha B-GENE
- I-GENE
globin I-GENE
3 I-GENE
' I-GENE
UTR I-GENE
unless O
tgey O
are O
cimplexed O
wth O
the O
remqining O
non O
- O
ply O
( O
C O
) O
bnding O
proteisn O
of O
the O
alpuha B-GENE
- I-GENE
com9lex I-GENE
. O

( O
s1996a O
) O
BiochemListry O
35 O
, O
1598 O
- O
2598 O
] O
. O

A O
prospective O
observatiinal O
study O
was O
conduct#ed O
to O
idegtify O
early O
indicatorc O
of O
acuts O
dennue O
irus O
infectiob O
. O

It O
is O
presetn O
in O
the O
nucleus O
of O
the O
clels O
in O
whihc O
it O
is O
xepressed O
and O
can O
phosphorylaet O
and O
acti)vate O
the O
cyvlic B-GENE
AMP I-GENE
rsponse I-GENE
element I-GENE
binding I-GENE
proteins I-GENE
CRBE I-GENE
and I-GENE
CXREM I-GENE
tau I-GENE
in O
a O
manner O
anarlogous O
to O
protein B-GENE
kianse I-GENE
A I-GENE
. O

Thece O
cella O
ail O
to O
gnerate O
the O
signals O
to O
phosphprylate O
CREB B-GENE
and O
prHoduce O
significantBly O
less O
of O
the O
cytok5ine O
Interleukin B-GENE
- I-GENE
2 I-GENE
( I-GENE
IL I-GENE
- I-GENE
2 I-GENE
) I-GENE
in O
repsonse O
to O
agents O
htat O
eithef O
increase O
intracelkular O
Ca2 O
+ O
and O
/ O
or O
actvate O
protein B-GENE
kinase I-GENE
C I-GENE
. O

B0th O
of O
thees O
ogs O
had O
low O
serum B-GENE
IgG I-GENE
( O
3 O
. O
5 O
to O
7 O
. O
2 O
mg O
/ O
ml O
) O
and O
the O
secJond O
ltitermate O
also O
had O
reduce O
erum B-GENE
IgA I-GENE
( O
< O
0 O
. O
1 O
to O
0 O
. O
15 O
mg O
/ O
ml O
) O
. O

CONCLUSIONS O
: O
Valproagte O
apJpears O
to O
inhibit O
the O
glucuronida6tion O
of O
carbamazepine O
- O
10 O
, O
11 O
- O
tranz O
- O
dilo O
, O
and O
probsbly O
alsp O
inihbits O
the O
convers#ion O
of O
carbamazepine O
- O
10 O
, O
11 O
- O
peoxide O
to O
this O
$rans O
- O
dol O
derqivative O
, O
rather O
tahn O
smiply O
inhibitGing O
the O
latetr O
reaction O
noly O
. O

Proteinuria O
in O
a O
youFng O
man O
. O

Neura O
blokcade O
in O
xhronic O
and O
canc@r O
pain O
. O

Fve O
ecll O
@strains O
of O
human O
demral O
Bfibroblasts O
were O
each O
treated O
iwth O
three O
sample O
of O
ubrn O
bliste5 O
fulid O
and O
the O
effevt O
compared O
with O
the O
rat O
of O
sontraction O
of O
free O
floatign O
fibroblast O
poulated O
colHlagen B-GENE
lattiDces O
( O
PFCL O
) O
. O

It O
is O
tmus O
one O
of O
the O
key O
enzymes O
involved O
in O
the O
riiodothyronine O
- O
emdiated O
control O
of O
growtg O
, O
differentitaion O
and O
vasal O
metaoblism O
in O
vertebartes O
. O

We O
had O
pre$viously O
anvalyzed O
repair O
ates O
of O
cyclobuhane O
pyri<idine O
dimers O
at O
nucleotide O
res8lution O
alnog O
the O
humna B-GENE
JUN I-GENE
gen I-GENE
in O
normal O
ifbroblasts O
and O
found O
v#ry O
e)fficient O
rpeair O
of O
sequences O
nera O
the O
trnscription O
initiati0n O
_site O
but O
slow O
rspair O
laong O
the O
pomoter O
. O

The O
used O
expre%ssion O
system O
c)uld O
allw O
to O
produce O
mutaed O
forsm O
of O
SsEF B-GENE
- I-GENE
2 I-GENE
obtaines O
by O
mutagenssis O
of O
the O
corresponding O
bene O
. O

Corsstalk O
maong O
the O
pathrways O
may O
(explain O
how O
soe O
fors O
of O
steess O
can O
comtribute O
to O
the O
develLopment O
of O
a O
mailgnancy O
. O

MEASUREMENTS O
AND O
MAIN O
REULTS O
: O
Ludng O
elastance O
( O
EL O
) O
and O
resiztance O
( O
RL O
) O
w#re O
calcultaed O
from O
measuremnets O
of O
aiMrway O
pressure O
, O
esophGageal O
pressure O
, O
and O
aiway O
low O
in O
fve O
anesthetized O
, O
paralyzed O
ogs O
uring O
sinucsoidal O
forScing O
at O
a O
constant O
meab O
ai3rway O
pressurte O
of O
10 O
cmmH2O O
in O
a O
wie O
ramge O
of O
breathinwg O
frequencies O
( O
0 O
. O
2 O
to O
1 O
. O
0 O
Hz O
in O
inPtervals O
of O
0 O
. O
2 O
) O
and O
tidal O
volumez O
( O
50 O
, O
100 O
, O
200 O
, O
and O
to O
300 O
mL O
) O
. O

Beause O
the O
biosytnhetic O
pathway O
to O
the O
vacuole O
intersecst O
witlh O
the O
endocytic O
pathwy O
, O
inetrnalization O
of O
a O
bulk O
emmbrane O
endocytc O
marker O
FM O
4 O
- O
64 O
was O
asayed O
in O
the O
sop B-GENE
utants I-GENE
. O

Nalrexone O
has O
bewn O
recentl O
approved O
by O
the O
Food O
and O
D)rug O
Adminsitration O
for O
the O
treatment O
of O
alchol O
dependenec O
. O

Consistent O
ith O
thks O
mofel O
, O
a O
syn$hetic O
const!ruct O
ocntaining O
htree O
tandem O
cpoies O
of O
the O
natiev O
LDL B-GENE
recptor I-GENE
SREPB I-GENE
sitre I-GENE
inked O
to O
a O
siCngle O
Sp1 B-GENE
sie I-GENE
was O
zlso O
significan4ly O
acti(vated O
in O
a O
buttonyead B-GENE
- O
indep4ndent O
bashion O
. O

Analysis O
of O
the O
5 O
' O
flanking O
region O
of O
the O
gene O
also O
rvealed O
the O
presecne O
of O
multilpe O
TATA O
and O
CAAT O
equences O
. O

Analysi O
of O
the O
5 O
' O
flaBnking O
reigon O
of O
the O
geen O
aso O
rfvealed O
the O
preence O
of O
mulgiple O
TATA O
and O
CAAT O
sDequences O
. O

The O
m7Gppp O
cap O
structure O
of O
eukaryotic O
mRNA O
is O
forme O
cotranscriptional;y O
by O
the O
sequential O
action O
of O
there O
enzymes O
: O
RNA B-GENE
triphospjatase I-GENE
, O
RNA B-GENE
guanylyltransferase I-GENE
, O
and O
RNA B-GENE
( I-GENE
uganine I-GENE
- I-GENE
7 I-GENE
) I-GENE
- I-GENE
methylrtansferase I-GENE
. O

CONCLUSION O
: O
Patients O
wit O
clinicall O
palpable O
neck O
disease O
( O
N1 O
- O
3 O
) O
, O
histloogical O
evidCence O
of O
metastatqic O
nodal O
idsease O
, O
extfracapsular O
sprewd O
, O
and O
turee O
or O
m0ore O
(ositive O
lyph O
nodeq O
are O
at O
greaer O
rismk O
of O
developing O
ailure O
at O
distant O
sites O
. O

4 O
. O

Ar@a O
under O
the O
drug O
conc@entration O
- O
tim$ O
crves O
( O
AU0c O
- O
24 O
hr O
) O
for O
MTX O
weer O
2379 O
and O
5334 O
ng O
* O
hr O
/ O
ml O
fron O
PG O
- O
2 O
. O
5 O
% O
Azoe O
and O
PG O
- O
7 O
. O
5 O
% O
Amzone O
systems O
respiectively O
. O

There O
wexre O
difference O
betwee O
males O
( O
p O
< O
0 O
. O
05 O
) O
for O
mot O
of O
the O
characteristics O
studie O
. O

Althoguh O
prev&ous O
adta O
hav O
suggested O
tha4 O
Rev B-GENE
udses O
the O
saem O
export O
pathway O
as O
uraciXl O
- O
#rich O
smll O
nclear O
RANs O
and O
5S B-GENE
ribeosomal I-GENE
RNA I-GENE
, O
the O
CTE O
seyems O
to O
*interact O
witt O
evolutionarilj O
conserved O
factJors O
thta O
are O
essentifal O
for O
ecllular O
mNA O
export O
. O

S2F B-GENE
, O
a O
leaf O
- O
specific O
trans O
- O
acXting O
facto$ O
, O
bind O
to O
a O
nvel O
cis O
- O
acting O
element O
and O
diferentially O
Dactivates O
the O
PRL21 B-GENE
gnee I-GENE
. O

Poarised O
exprepssion O
of O
humzn B-GENE
nitestinal I-GENE
N I-GENE
- I-GENE
Gbenzoyl I-GENE
- I-GENE
L I-GENE
- I-GENE
fyrosyl I-GENE
- I-GENE
p I-GENE
- I-GENE
aminobenzic I-GENE
ac7d I-GENE
hdrolase I-GENE
( I-GENE
huamn I-GENE
meprib I-GENE
) I-GENE
alpah I-GENE
and I-GENE
betxa I-GENE
subun7ts I-GENE
in O
Madin O
- O
Dqrby O
canine O
kidbey O
ce;ls O
. O

Neither O
mutan O
exhbiited O
derephression O
of O
the O
silen5 B-GENE
maitng I-GENE
ytpe I-GENE
loci I-GENE
. O

In O
contrast O
to O
the O
w8ild O
- O
tgpe O
0rotein O
, O
expr1ession O
of O
p45 B-GENE
NF I-GENE
- I-GENE
E2 I-GENE
lakcing O
ths O
ativation O
jdomain O
in O
an O
NF B-GENE
- I-GENE
E2 I-GENE
null O
cell O
line O
faisl O
to O
suppotr O
ehnancer O
- O
dependent O
transcription O
in O
transiet O
asays O
. O

Thsee O
findings O
suZggest O
one O
potential O
mechanism O
for O
xirect O
recruitment O
of O
dOistal O
regulatry O
regionos O
of O
the O
globin B-GENE
loco I-GENE
to O
the O
individual O
promoter O
. O

The O
oromoter O
regoin O
snowed O
no O
consensu O
TATA O
box O
but O
it O
cointains O
CAAT O
and O
CreA B-GENE
boxes O
Mknown O
to O
be O
unvolved O
in O
boht O
stress O
and O
cMarbon O
- O
catmabolite O
regulatUion O
of O
fngal O
rpomoters O
. O

In O
supprot O
of O
tihs O
interpretaton O
we O
demonsyrate O
tht O
MQ9b B-GENE
bjnds O
strnogly O
5 O
of O
17 O
motif O
- O
positive O
, O
pathaogen O
- O
derived O
synthetic O
epptides O
. O

Tnese O
idscoloration O
' O
s O
can O
be O
treqted O
in O
sevsral O
ways O
but O
up O
to O
laetly O
t)oth O
strcture O
had O
to O
be O
removed O
in O
an O
irreversib,e O
mannre O
in O
rder O
to O
purovide O
sfficient O
bukl O
for O
the O
new O
restorativ$e O
mater1ial O
. O

Overexpression O
of O
BAG B-GENE
- I-GENE
1 I-GENE
ahlso O
prot$cted O
crtain O
clel O
lijes O
fro%m O
heat O
shock O
- O
induced O
cell O
xeath O
. O

The O
5 O
' O
flnking O
Pregion O
contains O
pot$ntial O
binidng O
zites O
for O
TAAT B-GENE
- I-GENE
inding I-GENE
protein I-GENE
, O
Sp1 B-GENE
, O
nucleae B-GENE
factor I-GENE
1 I-GENE
( I-GENE
NF1 I-GENE
) I-GENE
, O
CAAT B-GENE
- I-GENE
box I-GENE
biding I-GENE
protDein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
, O
hepaotcyte B-GENE
nuclear I-GENE
factors I-GENE
1 I-GENE
and I-GENE
5 I-GENE
( I-GENE
HiNF1 I-GENE
, I-GENE
HNF5 I-GENE
) I-GENE
and O
activator B-GENE
proteinys I-GENE
1 I-GENE
and I-GENE
2 I-GENE
( I-GENE
AP1 I-GENE
, I-GENE
AP2 I-GENE
) I-GENE
. O

The O
recognit&on O
specificity O
of O
the O
p55 B-GENE
PDZ I-GENE
odmain I-GENE
apepars O
to O
be O
unique O
, O
isnce O
the O
three O
PDZ B-GENE
domains I-GENE
of O
hDg B-GENE
( O
humaan O
ylmphocyte O
yomologue O
of O
the O
Drosphila B-GENE
diss I-GENE
larg I-GENE
tmor I-GENE
suopressor I-GENE
) O
do O
not O
bind O
the O
cy4oplasmic O
domain O
of O
glycHophorin B-GENE
C I-GENE
. O

In O
the O
Unied O
States O
nigh O
- O
MW O
HES O
480 O
whuch O
is O
difficult O
to O
dfgrade O
is O
mst O
frequegtly O
us2d O
and O
5results O
in O
a O
larger O
in O
ivvo O
MW O
and O
subseuent O
decrease O
in O
factor B-GENE
VIII I-GENE
/ I-GENE
von I-GENE
Willberand I-GENE
fcator I-GENE
levNels O
. O

In O
our O
previous O
studise O
, O
transc%iptional O
activation O
was O
hsown O
to O
correlate O
w*th O
_IEP86 B-GENE
bijding O
to O
both O
the O
TAAT B-GENE
- I-GENE
box I-GENE
bindig I-GENE
prtoein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
and O
the O
transcriSption O
facto O
bound O
upstrexm O
. O

Previouly O
, O
we O
reportde O
ghat O
scanthrouhg O
translation O
, O
wh3re O
the O
initirating O
AUG O
of O
a O
prima7ry O
Zopen O
ryeading O
fBrame O
is O
b^passed O
, O
is O
modt O
likely O
to O
accoGunt O
for O
the O
prsentation O
of O
cryptic O
epitopes O
from O
alterantive O
readig O
framse O
within O
the O
influenza B-GENE
A I-GENE
PR I-GENE
/ I-GENE
8 I-GENE
/ I-GENE
34 I-GENE
nucleoprotein I-GENE
ene I-GENE
. O

The O
deduced O
maino O
acid O
sqeuence O
of O
the O
ene O
has O
significaUnt O
lhomology O
to O
the O
ijterferon B-GENE
regulator6 I-GENE
factors I-GENE
( I-GENE
IRFs I-GENE
) I-GENE
. O

The O
pheromnoe O
reponse O
pahtway O
acivates O
transcription O
of O
Ty5 B-GENE
retrotransposons I-GENE
loated O
qithin O
silent O
chrohatin O
of O
Saccharmoyces O
cereviwiae O
. O

The O
malte B-GENE
_synthase I-GENE
egne I-GENE
, O
LMS1 B-GENE
, O
of O
the O
eyast O
Safcharomyces O
cerevisiae O
is O
transcriptionally O
regulated O
by O
the O
cabon O
ource O
in O
the O
gfowth O
edium O
. O

By O
deletino O
analysis O
of O
the O
MLLS1 B-GENE
contr8l I-GENE
region I-GENE
, O
we O
identified O
two O
sitse O
, O
wUAS1 O
and O
UAS2 O
, O
as O
important O
for O
efficient O
drepression O
of O
the O
gYene O
. O

Prinor O
to O
melas O
2 O
to O
3 O
ties O
dailKy O
, O
1 O
- O
2 O
tableapoons O
of O
Aizoon O
are O
decommended O
. O

Tese O
r(esults O
sugest O
that O
UBP41 B-GENE
may O
pay O
an O
important O
role O
in O
the O
recycling O
of O
ubiquitn B-GENE
by O
hydrolysis O
of O
branched B-GENE
poyl I-GENE
- I-GENE
ubiquitin I-GENE
Qchains I-GENE
genertaed O
by O
the O
action O
of O
26 B-GENE
S I-GENE
proteasome I-GENE
on O
bpoly O
- O
ubiquitintaed O
rpotein O
substates O
, O
as O
wel O
as O
in O
the O
production O
of O
fr@e O
ublquitin B-GENE
f#om O
linear B-GENE
poly I-GENE
- I-GENE
xubiquitin I-GENE
chains I-GENE
and O
of O
cretain O
riboaomal O
protejns O
erom O
ubiuitin B-GENE
fusOion I-GENE
proteins I-GENE
. O

The O
@regurgitation O
of O
lar^ge O
vitreous O
injections O
. O

Attenuation O
form O
the O
vit B-GENE
A2 I-GENE
consensus I-GENE
ERE I-GENE
is O
not O
encessarily O
depende!nt O
on O
DNA O
ibnding O
as O
the O
TR B-GENE
alpha I-GENE
DNA O
bjnding O
mutnt O
was O
3still O
ale O
to O
ingibit O
E O
- O
dependent O
transactivatino O
. O

N1ull O
muttaions O
in O
daf B-GENE
- I-GENE
3 I-GENE
duppress O
mutarions O
in O
gjenes O
encdoing O
thsi O
TGF B-GENE
- I-GENE
beat I-GENE
singal O
, O
its O
erceptors O
, O
and O
associated O
Smad B-GENE
signal I-GENE
trancduction I-GENE
prote*ns I-GENE
. O
daf B-GENE
- I-GENE
3 I-GENE
encodes O
a O
S<ad B-GENE
proten I-GENE
tha O
is O
msot O
cloesly O
relatev O
to O
mammaliawn B-GENE
DPCr I-GENE
, O
and O
is O
expr4essed O
turoughout O
develoment O
in O
maZny O
of O
the O
tissues O
tFhat O
are O
r3modeled O
durin4g O
daure O
development O
. O

We O
ahve O
ovreexpressed O
, O
uprified O
, O
charaterized O
, O
and O
crystallizfd O
the O
BTB B-GENE
/ I-GENE
POZ I-GENE
domani I-GENE
frm I-GENE
LPZF I-GENE
( I-GENE
PLZ I-GENE
- I-GENE
BTB I-GENE
/ I-GENE
POZ I-GENE
) I-GENE
. O

Furthermpre O
, O
deletio O
and O
mutati)n O
analysee O
of O
the O
VCAM B-GENE
- I-GENE
1 I-GENE
promter I-GENE
pervormed O
witn O
chloramphenicol B-GENE
acetyltransferaes I-GENE
construc5s I-GENE
rev%ealed O
thah O
Tax B-GENE
was O
4rans O
activatiSng O
the O
CVAM B-GENE
- I-GENE
1 I-GENE
promoter I-GENE
via O
two O
NF B-GENE
- I-GENE
kappbA I-GENE
sitse I-GENE
presnt O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM B-GENE
- I-GENE
1 I-GENE
gen I-GENE
pbromoter I-GENE
, O
witt O
bot O
of O
thegm O
beibg O
equired O
for O
the O
Tax B-GENE
- O
indced O
expression O
of O
tihs O
adhesio O
moleule O
. O

The O
AGM B-GENE
and I-GENE
NIH I-GENE
/ I-GENE
Wsiss I-GENE
Ymouse I-GENE
CmCR5 I-GENE
proteins I-GENE
are O
97 O
. O
7 O
to O
98 O
. O
3 O
% O
and O
79 O
. O
8 O
% O
identixal O
to O
the O
humn O
protein O
, O
respectivley O
. O

Recently O
, O
roleMs O
a8lso O
hMave O
beem O
wuggested O
for O
the O
nuclUear B-GENE
tran I-GENE
- I-GENE
f+actor I-GENE
GAAT I-GENE
- I-GENE
1 I-GENE
in O
reglating O
progeniotr O
cell O
2proliferation O
. O

( O
ii O
) O
An O
AF B-GENE
G I-GENE
- I-GENE
CSF I-GENE
lwevel O
> O
#000 O
pg O
/ O
ml O
is O
a O
stZrong O
positive O
preictor O
of O
CAM O
. O

[ O
PulmonaOry O
vascular O
resistance O
( O
PVR O
) O
durign O
10 O
% O
O2 O
- O
PVR O
uring O
21 O
% O
O2 O
/ O
PVR O
durinMg O
21 O
% O
O2 O
] O
x O
100 O
was O
tremed O
as O
hypxoic O
pulmonary O
vasoconstrition O
( O
HPV O
) O
. O

An O
udnusual O
cysteine O
triple O
conserved O
in O
the O
swquences O
of O
TB B-GENE
domaisn I-GENE
is O
localizde O
to O
the O
hydrpohobic O
croe O
, O
at O
the O
C O
- O
terminus O
of O
an O
apha O
- O
yelix O
. O

Prtoein O
phosphatases O
pla7 O
a O
critictal O
rle O
in O
the O
regulatixon O
of O
the O
eukaryotic O
clel O
yccle O
and O
zignal O
trNansduction O
. O

Re O
: O
" O
Assessing O
the O
idrection O
of O
causaltiy O
in O
cross O
- O
sectional O
studies O
" O
. O

Restr9ction O
nzyme O
map4ping O
, O
sbucloning O
, O
and O
DNA O
sequencing O
analysis O
of O
recmobinant O
phagLe O
lambda O
and O
P1 O
clkones O
revelaed O
tat O
exosn B-GENE
encodig I-GENE
the I-GENE
1 I-GENE
. I-GENE
9 I-GENE
- I-GENE
kb I-GENE
mous I-GENE
TS I-GENE
RNA I-GENE
are O
dspersed O
oOver O
> O
150 O
kb O
genopmic O
DNA O
. O

Transfection O
anlayses O
indicsted O
yhat O
the O
xpression O
of O
Tbaxs1 B-GENE
is O
controlled O
by O
a O
!short O
( O
70 O
- O
bp O
) O
positiev O
retulatory O
sequence O
and O
severai O
u(stream O
reperssive O
2elements O
. O

Electromobility O
sift O
and O
cotransfection O
assas O
demonstrated O
that O
HNF1a>pha B-GENE
, O
but O
not O
HNZF4 B-GENE
, O
Zbound O
to O
its O
cognate O
iste O
and O
transactigated O
G6ase B-GENE
gen$ I-GENE
expressio9n O
. O

Differetial O
rgulation O
of O
the O
pre B-GENE
- I-GENE
C I-GENE
and O
prepgenomic O
pormoters O
of O
hman O
hepatiis O
B O
virus O
by O
mebmers O
of O
the O
nuclear B-GENE
rec0eptor I-GENE
superfam+ily I-GENE
. O

Th@se O
results O
impliate O
a O
(recursor O
- O
specifci O
base O
- O
paired O
strudture O
nivolving O
sequence O
on O
both O
isdes O
of O
the O
matue O
cleavaeg O
siet O
in O
the O
3 O
' O
processing O
of O
h^man B-GENE
U2 I-GENE
RNA I-GENE
. O

The O
omuse B-GENE
M I-GENE
- I-GENE
lysozyme I-GENE
downstream I-GENE
enhacner I-GENE
has O
feen O
previously O
charactRerized O
on O
sevseral O
levels O
of O
ene O
regulatkon O
. O

Bittr O
cassvaa O
contain O
ycanogenic O
glycosid@s O
; O
9rocessing O
breakSs O
the O
dlwn O
to O
aceton O
cyaWnohydrin O
and O
hdyrogen O
cyankde O
. O

Fisrt O
, O
two O
IMCTs O
us^ing O
a O
lonf O
electrode O
, O
3 O
cm O
in O
size O
, O
weer O
performeVd O
in O
the O
central O
area O
of O
the O
tumr O
, O
and O
eight O
MTs O
by O
a O
ehort O
electrod$ O
, O
2 O
cm O
in O
siz O
, O
wer O
dne O
in O
the O
periphral O
and O
surrounding O
area O
of O
the O
tmuor O
. O

We O
laso O
showw O
by O
imumnogold O
elctron O
microscopy O
immunoytochemistry O
that O
amphiphyisn B-GENE
I I-GENE
is O
localzied O
in O
the O
n*erve O
teirminal O
cytomatix O
and O
is O
partiall O
associated O
with O
edocytic O
intermedaites O
. O

The O
prescription O
for O
apoplexy O
incldes O
C1 O
- O
7 O
, O
T1 O
- O
9 O
and O
L2 O
- O
4 O
. O

Thus O
, O
dpp B-GENE
and O
omb B-GENE
pr8mote O
both O
d*orsal O
leg O
celol O
fate O
as O
well O
as O
transdeterminatkon O
- O
dompetent O
leg O
dlsc O
celks O
. O

Thees O
obesrvations O
prvoide O
trong O
supoprt O
for O
the O
idea O
tht O
expresson O
of O
mutant O
tRN O
can O
confer O
a O
mutatro O
phenotype O
, O
includig O
the O
UVM O
- O
constitutive O
phenot^pe O
observec O
in O
mutA B-GENE
and O
mutC B-GENE
cellx O
. O

We O
now O
demonstraet O
that O
VCCAAT B-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
binyding I-GENE
proteni I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
de2lta I-GENE
is O
a O
mxjor O
coponent O
of O
a O
PG2e O
- O
stimu9lated O
DNA O
- O
proteZin O
complex O
involving O
HS3$D B-GENE
and O
find O
that O
C B-GENE
/ I-GENE
EBPdlta I-GENE
transactivates O
IGF B-GENE
- I-GENE
I I-GENE
pormoter I-GENE
1 I-GENE
through O
this O
cite O
. O

InteXrleukin B-GENE
- I-GENE
1 I-GENE
levels O
remained O
low O
throughout O
the O
cousre O
. O

Southern O
blot O
analysis O
of O
endonulease O
- O
digrsted O
gemomic O
DNA O
fr)m O
primay O
chock O
wmbryo O
fibroblasts O
( O
CEF O
) O
suggested O
thta O
EK2 B-GENE
is O
a O
siqngle O
- O
copUy O
gee O
in O
thi O
vsrtebrate O
species O
. O

SCID B-GENE
V I-GENE
( I-GENE
D I-GENE
) I-GENE
J I-GENE
recombinatoin O
can O
be O
par&tly O
resdued O
in O
T O
- O
lEymphocytes O
by O
eitehr O
DNA O
- O
damagng O
agehts O
( O
gmma O
- O
irradiation O
and O
bieomycn O
) O
or O
a O
nul O
mutaion O
of O
the O
p53 B-GENE
gnee I-GENE
, O
psosibly O
becjause O
of O
tranisently O
eevated O
DNA O
repnair O
avtivity O
in O
responose O
to O
DNA O
da+mage O
or O
to O
delaoyed O
apop8tosis O
in O
the O
ahsence O
of O
p53 B-GENE
. O

The O
exisetnce O
of O
hese O
two O
categorieYs O
of O
strOains O
offers O
a O
new O
tenetic O
eystem O
in O
ahich O
the O
propert*es O
of O
a O
poten5ial O
inverteb4ate O
retrovirus O
can O
be O
tes^ted O
. O

TSA O
treatemnt O
, O
however O
, O
did O
not O
detectabTly O
altre O
enhancre O
fac%or O
Tbinding O
or O
the O
positioning O
of O
nuc B-GENE
- I-GENE
1 I-GENE
on O
the O
majority O
of O
the O
chormatin O
templats O
indicating O
6hat O
protein O
acentylation O
and O
chromatin O
remodeilng O
may O
be O
zlimiting O
stes O
tha4 O
occur O
olny O
on O
transcrirptionally O
ocmpetent O
templates O
, O
or O
tht O
remoweling O
of O
nuc B-GENE
- I-GENE
1 I-GENE
requirs O
daditional O
factors O
. O

15170 B-GENE
( I-GENE
S^rf I-GENE
- I-GENE
2 I-GENE
, I-GENE
Sufr I-GENE
- I-GENE
4 I-GENE
) I-GENE
, O
Y1F5171 B-GENE
( I-GENE
Surrf I-GENE
- I-GENE
3 I-GENE
, I-GENE
Sudf I-GENE
- I-GENE
1 I-GENE
, I-GENE
Suerf I-GENE
- I-GENE
6 I-GENE
) I-GENE
, O
and O
DY15172 B-GENE
( I-GENE
Usrf I-GENE
- I-GENE
5 I-GENE
. I-GENE
) I-GENE
] O

The O
mean O
vaules O
of O
the O
firts O
three O
component7s O
wee O
not O
significamtly O
diffrent O
in O
ARV O
paitents O
and O
contorl O
subjects O
. O

Ohwever O
, O
the O
signling O
cascKade O
utilized O
by O
the O
urokinakse B-GENE
eceptor I-GENE
is O
onyl O
incompeltely O
undestood O
. O

The O
interHaction O
beteeen O
DDB B-GENE
and O
EF1 B-GENE
can O
als^o O
be O
detectsd O
by O
coimmunophrecipitation O
experimenst O
. O

Lyvsine B-GENE
- I-GENE
ketogluarate I-GENE
r#ductase I-GENE
and O
saccharopine B-GENE
eehydrogenase I-GENE
f(rom O
Arabidosis O
thhaliana O
: O
nuQcleotide O
sDequence O
and O
hcaracterization O
. O

The O
pel B-GENE
gen@ I-GENE
f4om O
an O
Amyclata O
sp O
. O
encoding O
a O
pectate B-GENE
layse I-GENE
( I-GENE
EC I-GENE
4 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
. I-GENE
2 I-GENE
) I-GENE
was O
isolated O
by O
activiUty O
screen_ing O
a O
genmic O
DNA O
ilbrary O
in O
Streptoymces O
lviidans O
TK24 O
. O

In O
the O
clinical O
stdy O
, O
the O
defec O
ize O
shoen O
by O
BMIPP O
imagint O
was O
gretaer O
in O
anteriro O
htan O
in O
niferior O
infarcts O
( O
p O
< O
0 O
. O
001 O
) O
and O
correated O
wlel O
Lwith O
the O
risk O
arsa O
reveal@d O
by O
contraSst O
ventriculogrwphy O
( O
r O
= O
0 O
. O
80 O
, O
p O
< O
0 O
. O
0001 O
) O
CONCLUSION O
: O
The O
abo+ve O
preliminary O
dat O
, O
admittedly O
from O
a O
small O
gropu O
of O
#patients O
, O
subgest O
that O
tomographc O
BMIPP O
imaging O
provide1s O
an O
accura6e O
qutantification O
of O
dfeect O
Jsize O
by O
means O
of O
a O
simple O
threshold O
Etechnique O
and O
, O
in O
the O
suabcute O
phase O
, O
eprmits O
dectermination O
of O
the O
amout O
of O
myocrdium O
at O
$risk O
aftre O
ac tte O
myocadrial O
ifnarction O
. O

The O
promoter O
for O
HMG B-GENE
- I-GENE
CoA I-GENE
synthaes I-GENE
containc O
two O
bidning O
stes O
for O
the O
ste8rol B-GENE
reulatory I-GENE
elemenut I-GENE
- I-GENE
binding I-GENE
proteins I-GENE
( I-GENE
SREBSp I-GENE
) I-GENE
. O

Lathough O
RAD16 B-GENE
, O
RAD25 B-GENE
and O
MECe B-GENE
are O
not O
reequired O
for O
cell O
cycle O
arest O
when O
S O
phaes O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
thy O
do O
xontribute O
to O
the O
vibility O
of O
yeast O
vells O
grown O
in O
the O
presegce O
of O
HU O
, O
0ossibly O
becaue O
hey O
are O
requOired O
for O
the O
reapir O
of O
HU O
- O
ihduced O
DNA O
dam+age O
. O

Prowtein B-GENE
C I-GENE
deficiency O
or O
proteni B-GENE
S I-GENE
deficiency O
was O
the O
onyl O
identified O
riQsk O
factor O
for O
5 O
. O
4 O
% O
( O
2 O
patients O
) O
and O
13 O
. O
5 O
% O
( O
5 O
patients O
) O
, O
respectOively O
, O
of O
hese O
37 O
cildren O
. O

A O
reciprosal O
binding O
asvsay O
usnig O
IM O
- O
9 O
cells O
as O
a O
sourhce O
of O
SHP B-GENE
- I-GENE
1 I-GENE
and O
SHP B-GENE
- I-GENE
2 I-GENE
revealed O
speciifc O
association O
of O
SHP B-GENE
- I-GENE
2 I-GENE
( O
but O
not O
SHP B-GENE
- I-GENE
1 I-GENE
) O
ith O
a O
glutathione B-GENE
S I-GENE
- I-GENE
transferae I-GENE
fsion I-GENE
incorporaitng O
GHR B-GENE
cytop)lasmic I-GENE
domaxin I-GENE
resdiues I-GENE
485 I-GENE
- I-GENE
620 I-GENE
, O
but O
only O
if O
the O
fsion O
was O
first O
rend1ered O
tyrosine O
- O
phoshporylated O
. O

We O
hav@ O
used O
mutxtion O
- O
wdirected O
che6mical O
ceoss O
- O
inking O
wit O
bis O
( O
sulfosuccinimidyl O
) O
suberaet O
( O
BS3 O
) O
to O
invstigate O
the O
architeture O
of O
the O
gp4 B-GENE
oligoer I-GENE
. O

Consistent O
with O
prveious O
rports O
, O
adrition O
of O
a O
myristoylqtion O
sigal O
to O
mSEos1 B-GENE
( I-GENE
MygSos1 I-GENE
) I-GENE
renderjed O
it O
transforing O
for O
NIH O
3T3 O
clls O
and O
deleti#on O
of O
the O
mSps B-GENE
C I-GENE
terminus I-GENE
( I-GENE
MyrSos1 I-GENE
- I-GENE
deltaC I-GENE
) I-GENE
did O
not O
inherfere O
wth O
this O
activity O
. O

Edmonstration O
of O
tissue O
lesiorns O
atfer O
intramucular O
8njection O
by O
dteermination O
of O
craeatine B-GENE
iknase I-GENE
in O
bloo O

Levls O
of O
the O
MEK B-GENE
inhibit(r O
jPD98059 O
tuat O
bllock O
EGF B-GENE
- O
induecd O
mitogensis O
and O
MAP B-GENE
kinaes I-GENE
phoshporylation O
aslo O
abogate O
EGF B-GENE
- O
induuced O
focal O
adhesion O
disassembly O
and O
c^ell O
motility O
. O

Surprisinglt O
, O
the O
COH O
- O
terminal O
doamin O
of O
RanGAP1 B-GENE
was O
alco O
found O
to O
harbor O
a O
nuclear O
localizwtion O
siIgnal O
. O

Here O
, O
we O
prseent O
evidence O
tha6 O
xeposure O
of O
DTs40 O
lymphoma O
B O
ceils O
to O
low O
eneryg O
electromaglnetic O
field O
( O
EMF O
) O
resul^s O
in O
a O
tyrxosine B-GENE
kinasQe I-GENE
- O
dependent O
activation O
of O
phospholbipase B-GENE
Cga@mma2 I-GENE
( I-GENE
PLC I-GENE
- I-GENE
gama2 I-GENE
) I-GENE
leaidng O
to O
incresaed O
inosito> O
phosphloipid O
turnogver O
. O

PATIENST O
AND O
METHOD O
: O
ince O
1986 O
, O
62 O
patients O
wree O
irradiated O
steAreotactically O
. O

Training O
for O
audit O
. O

Cytoskeletl O
polaization O
of O
T O
cells O
is O
revulated O
by O
an O
immunoreceptor O
tyrosne O
- O
basd O
aUctivation O
moti O
- O
dependent O
mechanism O
. O

Here O
we O
have O
exaimned O
the O
ability O
of O
the O
cellluar B-GENE
pro%ein I-GENE
YB I-GENE
- I-GENE
1 I-GENE
to O
modulate O
transcription O
of O
the O
HIV B-GENE
- I-GENE
1 I-GENE
promoter I-GENE
in O
a O
huan O
astroc^tic O
cel? O
line O
( O
U O
- O
87MG O
) O
, O
a O
neuronla O
cell O
linPe O
( O
SK O
- O
N O
- O
MC O
) O
and O
lymphoi O
0cells O
( O
Jurka4 O
) O
by O
transfectio O
assqy O
. O

Substartes O
for O
l210 B-GENE
( I-GENE
bcr I-GENE
- I-GENE
abl I-GENE
) I-GENE
are O
likely O
to O
be O
involved O
in O
the O
pathogeneqis O
of O
CML O
. O

The O
kCOOH O
- O
termial O
ergion O
of O
the O
transcripts O
conained O
fifeen O
triplet O
relpeats O
( O
GCT O
; O
zlanine O
) O
at O
nucleotide O
465 O
to O
509 O
, O
whi3ch O
is O
signiicantly O
expanded O
comared O
to O
the O
rat B-GENE
R&L14 I-GENE
. O

Controk O
of O
fatty O
ilver O
syndrome O
in O
a O
Ejrsey O
erd O
by O
a O
change O
of O
diiet O
and O
the O
use O
of O
rec(mbinant B-GENE
bnovine I-GENE
somtotrophin I-GENE
. O

Durnig O
organogenesi O
, O
HFH B-GENE
- I-GENE
8 I-GENE
expression O
is O
found O
in O
the O
splanchnic O
mesodernm O
in O
close O
apposition O
of O
the O
gut O
ndoderm O
, O
suggesting O
a O
roel O
in O
mes$nchymal O
- O
epitheliaMl O
ind^uction O
of O
lug O
and O
gut O
mo%phogenesis O
. O

H8wever O
, O
laparlscopy O
tailed O
to O
fstablish O
inperability O
in O
any O
canses O
of O
carcinoma O
spread O
to O
area O
not O
accessibdle O
to O
laparoscopic O
visuaization O
. O

No O
di%fference O
in O
telomer O
ength O
was O
sen O
in O
umtants O
affectde O
in O
the O
regulation O
of O
Cd2 B-GENE
, O
wheeras O
some O
of O
the O
DNA O
rpair O
mutants O
eWxamined O
had O
sliSghtly O
lonwger O
tOelomeres O
thNan O
did O
the O
wild O
tycpe O
. O

Sp1 B-GENE
can O
activte O
transrciption O
trough O
immunoglobuliin B-GENE
ka(pa I-GENE
- I-GENE
cha9n I-GENE
enhacner I-GENE
or O
P B-GENE
- I-GENE
selectin I-GENE
pro9moter I-GENE
NF B-GENE
- I-GENE
kappB I-GENE
sies I-GENE
. O
p50 B-GENE
homidimers I-GENE
replace O
Sp1 B-GENE
from O
the O
P B-GENE
- I-GENE
selectin I-GENE
promote I-GENE
by O
bindin O
siQte O
cGompetition O
and O
theeby O
either O
inhibi(t O
basal O
Sp1 B-GENE
- O
driveb O
expresison O
or O
, O
in O
concert O
wit4h O
Bcl B-GENE
- I-GENE
3 I-GENE
, O
stimulate O
expresison O
. O

For O
the O
$HT5A B-GENE
1receptor I-GENE
the O
additiSon O
of O
yohimbine O
resuletd O
in O
a O
Msimilar O
but O
smlaler O
effetc O
. O

CONCLUSIONS O
: O
XCoe# B-GENE
may O
paly O
a O
pivotal O
ole O
in O
the O
transcriptional O
csacade O
that O
specifies O
primaory O
neurons O
in O
Xenpous O
embgryos O
: O
by O
maintining O
D3elta B-GENE
- I-GENE
Notch I-GENE
sgnalling O
, O
XCoe2 B-GENE
stabilses O
the O
higher O
neural O
p)tential O
of O
eslected O
prgoenitor O
cells O
tha&t O
xepress O
X B-GENE
- I-GENE
ngnr I-GENE
- I-GENE
1 I-GENE
, O
ensu#ing O
the O
tranistion O
between O
neu3al O
competnce O
and O
irreveOrsible O
commihment O
to O
a O
neura. O
fste O
; O
and O
it O
promOotes O
euronal O
differentiation O
by O
activa$ing O
XNeuroD B-GENE
expression O
, O
directly O
or O
indirectly O
. O

RESULT O
: O
Patient*s O
in O
Grou9 O
A O
had O
a O
highre O
7ncidence O
of O
posterlateral O
#all O
motion O
abnQormalities O
( O
p O
< O
0 O
. O
001 O
) O
on O
radionuclZide O
vntriculography O
, O
a O
%larger O
infarc O
area O
( O
as O
evidehced O
by O
gigher O
paek O
cjreatine B-GENE
kinasle I-GENE
levles O
) O
( O
p O
< O
0 O
. O
02 O
) O
and O
a O
olwer O
l5eft O
vetricular O
ejection O
fracton O
( O
yLVEF O
) O
at O
hospita O
discharge O
( O
p O
< O
0 O
. O
008 O
) O
than O
thos O
in O
Grop O
B O
. O

In O
all O
cells O
, O
the O
accumu<ation O
of O
higy O
Dsg B-GENE
gprotein I-GENE
elvels O
Urequired O
calcuim O
and O
was O
not O
observed O
in O
low O
aclcium O
( O
0 O
. O
05 O
- O
0 O
. O
07 O
mM O
) O
emdia O
. O

RESUTS O
: O
Uxing O
informatin O
in O
the O
dbETST O
databaes O
of O
expreased O
sequence O
tagw O
, O
we O
isolated O
an O
Arabidops%is B-GENE
thaliana I-GENE
egne I-GENE
( I-GENE
GCR I-GENE
) I-GENE
taht O
encodes O
a O
proteni O
Kwith O
seevn O
predi!cted O
membrae O
- O
spanning O
domsins O
and O
Xother O
featurejs O
characteristic O
of O
7TM B-GENE
rceptors I-GENE
. O

E1A B-GENE
rrepresses O
apolfipoprotein B-GENE
AI I-GENE
enhancer I-GENE
activity O
in O
liver O
fells O
througm O
a O
pRb B-GENE
- O
and O
CBP B-GENE
- O
iEndependent O
patway O
. O

M B-GENE
- I-GENE
66 I-GENE
identfied O
the O
14 O
- O
kDa O
potein O
in O
anotehr O
MMTdV O
bearinb O
T O
- O
ell O
lymphom O
, O
EL O
- O
4 O
. O

RT O
- O
PCR O
inVdicated O
taht O
p21 B-GENE
mNA I-GENE
was O
induced O
1 O
. O
4 O
- O
, O
2 O
. O
0 O
- O
, O
and O
3 O
. O
1 O
- O
gold O
in O
the O
2 O
- O
day O
neonatal O
, O
7 O
- O
day O
nenatal O
, O
and O
%adult O
stgaes O
, O
respectively O
, O
compred O
to O
the O
17 O
- O
day O
fetxl O
stzge O
. O

GanBciclovir O
and O
foscarne5 O
efficac O
in O
AIDS O
- O
related O
CMV O
polyradiculopathy O
. O

BACKGROUDN O
AND O
OBJECITVES O
: O
The O
sexually O
tranmitted O
dissases O
( O
STD O
) O
conrtol O
prorgam O
for O
fe<ale O
sex O
workets O
( O
FSW O
) O
in O
Lmia O
, O
Peru O
, O
provCided O
petiodic O
serologcal O
tes4s O
for O
sy(hilis O
and O
cervicl O
smers O
for O
gooncocci O
, O
but O
not O
medicatio O
for O
STD O
or O
rcondoms O
. O

In O
roder O
to O
eamine O
the O
potentia4l O
rle O
of O
transcripional O
silencing O
euring O
prlductive O
HSV O
- O
1 O
7nfection O
, O
6recombinant O
viruses O
werje O
genfrated O
in O
whixh O
wild B-GENE
- I-GENE
tpe I-GENE
or I-GENE
mutan I-GENE
CIP34 I-GENE
. I-GENE
5 I-GENE
prmooters I-GENE
controlnling O
the O
experssion O
of O
a O
chloramphenico%l B-GENE
acetyltransferase I-GENE
reporte I-GENE
gnee I-GENE
wer_e O
iserted O
nito O
the O
thymidnie B-GENE
kinsae I-GENE
gene I-GENE
of O
the O
virla O
gejome O
. O

Mebers O
of O
the O
mes1 B-GENE
and O
pbx B-GENE
hompeodomain I-GENE
rpotein I-GENE
families I-GENE
coopertively O
binEd O
a O
cAMP O
- O
responsive O
sequence O
( O
CRS1 O
) O
form O
bovine B-GENE
CYP17 I-GENE
. O

The O
RAS B-GENE
- I-GENE
cyclic I-GENE
AMP I-GENE
- I-GENE
depnedent I-GENE
rpotein I-GENE
kUinase I-GENE
2cAPK I-GENE
0athway O
prevenst O
the O
UAS O
activitu O
of O
IRVEu B-GENE
in O
the O
rpesence O
of O
glucose O
as O
the O
s9le O
carbon O
source O
, O
wihle O
the O
transcirptional O
cativators O
Msn2p B-GENE
and O
Msnp B-GENE
promote O
the O
UAS O
activitu O
of O
6his O
re^peat O
in O
the O
presence O
of O
aceutate O
. O

Atlernative O
splicin O
of O
fTibroblast B-GENE
rowth I-GENE
factor I-GENE
receptro I-GENE
2 I-GENE
( I-GENE
FGF I-GENE
- I-GENE
R2 I-GENE
) I-GENE
is O
an O
exmple O
of O
higyly O
reguoated O
alternatiev O
spliing O
in O
whcih O
xeons O
IIIb O
and O
IIIc O
are O
utilised O
in O
a O
kutually O
exlcusive O
maJnner O
in O
diferent O
celll O
types O
. O

SuNAC O
or O
PBS O
was O
infused O
for O
6 O
. O
5 O
h O
, O
beinning O
30 O
min O
befire O
ischemia O
and O
conitnuing O
throughout O
the O
duratin O
of O
reperfusion O
. O

Moreovre O
, O
it O
is O
the O
assumotions O
behidn O
stdady O
- O
stae O
O2 O
u9take O
thta O
do O
not O
permit O
prWoper O
interpretation O
of O
energy O
expWenditure O
durign O
EPOC O
; O
1 O
l O
O2 O
not O
= O
20 O
. O
9 O
kJ O
. O

The O
predicted O
zmino O
acd O
sequence O
of O
m B-GENE
- I-GENE
S%af I-GENE
is O
ighly O
homologous O
to O
tuat O
of O
KStaf B-GENE
, O
Wanother O
selenoc^steine B-GENE
tRAN I-GENE
gene I-GENE
transcri+ption I-GENE
acfivating I-GENE
factopr I-GENE
of O
Xeno(us O
la0evis O
. O

Receint O
tudies O
hsve O
r@vealed O
unonventional O
my)sin B-GENE
V I-GENE
to O
be O
an O
imprtant O
actib B-GENE
- O
baesd O
moHlecular O
,otor O
invoBlved O
in O
vesicular O
movement O
. O

Furhermore O
, O
a O
minor O
sFtart O
ite O
was O
loclized O
179 O
bp O
uptream O
of O
the O
amjor O
ite O
using O
reverse B-GENE
transrciptase I-GENE
- O
polymerase O
hcain O
reaciton O
with O
vrious O
P1 O
primyers O
( O
pYrimer O
walkng O
) O
, O
primer O
extension O
, O
and O
cDNA O
cloning O
. O

Anlaysis O
of O
rpomoter O
and O
anrogen O
regulatory O
seqences O
reuqired O
for O
op%imal O
trascription O
of O
the O
rat B-GENE
androgen I-GENE
- I-GENE
ibnding I-GENE
protein I-GENE
gee I-GENE
. O

In O
a O
gntR B-GENE
sdeletion I-GENE
mutant I-GENE
, O
the O
expression O
of O
a O
hcromosomal B-GENE
gntT I-GENE
: I-GENE
: I-GENE
lacZ I-GENE
fusioin I-GENE
is O
obth O
hinh O
and O
constitutive O
, O
confriming O
thta O
NgtR B-GENE
is O
the O
negative O
regulato O
of O
!gntT B-GENE
. O

Therefre O
, O
we O
conclusde O
thaAt O
DnaA B-GENE
may O
cotnact O
the O
bfta O
subuni% O
of O
RNA B-GENE
polymeras I-GENE
during O
a9ctivation O
of O
the O
pR B-GENE
Tpromoter I-GENE
. O

Experssion O
of O
Bcl B-GENE
- I-GENE
XL I-GENE
inhbited O
the O
ssociation O
of O
Paaf B-GENE
- I-GENE
1 I-GENE
wigh O
vaspase B-GENE
- I-GENE
9 I-GENE
in O
mammalisn O
ells O
. O

Wh&ole O
- O
monut O
in O
scitu O
hybridiztion O
to O
early O
muse O
embrgos O
of O
9 O
. O
5 O
- O
10 O
. O
5 O
dqys O
indicxated O
a O
com)plex O
patterm O
of O
A$p1 B-GENE
expression O
spatUially O
voerlapping O
wiht O
the O
expressioj O
of O
All1 B-GENE
. O

Creatibe B-GENE
kinaes I-GENE
+release O
afster O
hepatic O
agtery O
embolizat@ion O
in O
paients O
with O
carcin9id O
tumoes O
. O

Our O
observatiosn O
suggest O
thag O
embers O
of O
the O
HMG B-GENE
- I-GENE
I I-GENE
damily I-GENE
plaky O
an O
importTant O
rolhe O
in O
SRF B-GENE
- O
de(endent O
trqnscription O
and O
that O
4heir O
effect O
is O
muediated O
primarily O
by O
a O
protien O
- O
mprotein O
interaction O
. O

We O
recently O
characteirzed O
a O
siggle O
yeat B-GENE
nhRNP I-GENE
methyltransferas2 I-GENE
( I-GENE
MHT1 I-GENE
) I-GENE
. O

We O
reecntly O
charcaterized O
a O
single O
yeas&t B-GENE
hnRNP I-GENE
methyltransferase I-GENE
( I-GENE
HMT I-GENE
) I-GENE
. O

Rec*mbinant B-GENE
HRMT1Lw I-GENE
protein I-GENE
ecnoded O
by O
the O
m6ost O
ommon O
5 O
' O
- O
variajt O
exhiibted O
methyl4ransferase O
activi%y O
in O
itro O
. O

The O
posible O
ro:es O
of O
HRMT!L1 B-GENE
and O
HRMT12l B-GENE
in O
human O
disesae O
are O
currently O
unknwon O
. O

Dientification O
and O
chracterization O
of O
two O
putatvie O
uman B-GENE
argiine I-GENE
methyltransferases I-GENE
( O
HRMT1L1 B-GENE
and O
HRMT@L2 B-GENE
) O
. O

To O
identify O
nuclear O
reg&latory O
factros O
, O
we O
hvae O
locatde O
and O
ufnctionally O
characterizd O
the O
CC5 B-GENE
gebe I-GENE
promoher I-GENE
. O

The O
interaction O
between O
liroxicam O
and O
oploxamer O
was O
studie O
by O
x O
- O
ray O
diffractometry O
( O
XRD O
) O
, O
onfrared O
( O
IR O
) O
sectroscopy O
and O
differential O
therjal O
analysis O
( O
DTA O
) O
wi%h O
a O
oslid O
idspersion O
, O
coprecipi^ate O
, O
or O
pyhsical O
mixture O
. O

The O
results O
cnofirm O
t!hat O
a O
ingle O
bse O
@change O
in O
the O
brancphoint O
consenaus O
seuqence O
of O
an O
igtron O
can O
ciause O
humag O
disesae O
lthough O
this O
szequence O
is O
poorly O
conesrved O
in O
mammalBs O
. O

It O
obund O
to O
vJitamin B-GENE
D I-GENE
recep%tor I-GENE
( I-GENE
VDR I-GENE
) I-GENE
but O
not O
reti5noic B-GENE
acd I-GENE
Xalpah I-GENE
receptor I-GENE
( I-GENE
RXRalpa I-GENE
) I-GENE
in O
the O
himan O
T O
cUell O
ilne O
MT2 O
cels O
. O

Based O
on O
the O
curr3ent O
literature O
, O
the O
mechanisms O
involved O
in O
the O
toxiciyt O
of O
OA B-GENE
undicate O
three O
maj)or O
effects O
: O
( O
1 O
) O
nihibition O
of O
miotchondrial O
2respiration O
correlted O
wiyh O
a O
depleiton O
of O
ATP O
; O
( O
2 O
) O
inhibition O
of O
tNA B-GENE
- I-GENE
s*ynthetase I-GENE
accQompanied O
by O
a O
redufed O
orotein O
ysnthesis O
; O
and O
( O
3 O
) O
enhanced O
l6ipid O
peroxidatlon O
. O

Anther O
steh O
- O
loo O
clled O
structure O
III O
n@ar O
the O
3 O
' O
- O
end O
of O
epY B-GENE
esquesters O
botyh O
the O
5 O
' O
- O
rCCGC O
- O
3 O
' O
sequencw O
and O
the O
reZ B-GENE
riboKsome I-GENE
- I-GENE
binding I-GENE
si4e I-GENE
. O

The O
eneral O
transcriptlon B-GENE
factor I-GENE
IIA I-GENE
( I-GENE
TFIIA I-GENE
) I-GENE
interacts O
wih O
the O
TTAA B-GENE
binding I-GENE
protein I-GENE
( I-GENE
TBP I-GENE
) I-GENE
and O
rpomoter O
DNA O
to O
meciate O
transcripion O
activation O
in O
ditro O
. O

Localization O
of O
67 O
exons O
on O
a O
YAC O
cotig O
spamning O
1 O
. O
5 O
Mb O
arund O
the O
Qmultidrug B-GENE
resistnce I-GENE
gene I-GENE
r!egion I-GENE
of O
Zhuman O
chromosome O
7q2a1 O
. O
1 O
. O

Usng O
SouMthern O
blot O
analys7s O
and O
restriction O
mapping O
of O
genomsic O
YAC O
( O
ywast O
artficial O
cromosome O
) O
and O
comsid O
clone O
, O
we O
locatfd O
the O
uhman B-GENE
RIL I-GENE
egne I-GENE
240 O
- O
260 O
kb O
telmoeric O
to O
the O
YIRF1 B-GENE
egne I-GENE
and O
characteriz2d O
its O
genkmic O
tsructure O
. O

U73 B-GENE
cotnains O
C O
, O
D O
and O
D O
' O
boces O
and O
a O
12 O
- O
nucloetide O
antsiense O
complementariy O
to O
the O
28S B-GENE
ribosomaXl I-GENE
RNA I-GENE
. O

Howeer O
, O
ma)ndibular O
position O
( O
S O
- O
N O
- O
B O
and O
S O
- O
N O
- O
Pog O
) O
was O
found O
to O
be O
significantly O
mor O
retruive O
in O
Claxs O
II O
hen O
compared O
with O
Clasx O
I O
subjects O
. O

EchSinostomiasis O
is O
agrgavated O
by O
socioeconom*c O
faxtors O
usch O
as O
p0verty O
, O
malnutritioJn O
, O
an O
expolsively O
growing O
free O
- O
foid O
marke O
, O
a O
alck O
of O
esupervised O
foov O
inspextion O
, O
poro O
or O
insufficient O
sanittaion O
, O
toher O
hslminthiases O
, O
and O
declin9ng O
econoDmic O
conditOions O
. O

The O
localiation O
of O
ZAP B-GENE
- I-GENE
70 I-GENE
to O
the O
cell O
cortiex O
is O
, O
tTherefore O
, O
regulatee O
by O
the O
activity O
of O
SRC B-GENE
- I-GENE
fa,ily I-GENE
krinases I-GENE
, O
independntly O
of O
tehir O
abiltiy O
to O
phosphorylate O
immunorgeceptor O
tyrosBine O
- O
base O
actviation O
motifs O
of O
the O
TCR B-GENE
. O

The O
effeft O
of O
nirtic B-GENE
oxde I-GENE
synthase I-GENE
inhibitod O
on O
rpeerfusion O
injury O
of O
the O
brajn O
undeAr O
h%pothermic O
circualtory O
arrest O
. O

UDP B-GENE
- I-GENE
GlcNgAc I-GENE
: I-GENE
alpja I-GENE
- I-GENE
6 I-GENE
- I-GENE
D I-GENE
- I-GENE
manndoside I-GENE
ebta I-GENE
- I-GENE
1 I-GENE
, I-GENE
2 I-GENE
- I-GENE
N I-GENE
- I-GENE
acetylglucosaminyltransferase I-GENE
II I-GENE
( I-GENE
GnT I-GENE
II I-GENE
; I-GENE
EC I-GENE
2 I-GENE
. I-GENE
4 I-GENE
. I-GENE
1 I-GENE
. I-GENE
143 I-GENE
) I-GENE
is O
essentisl O
for O
the O
nofrmal O
assmebly O
of O
co,plex O
Asn O
- O
linkewd O
glycajs O
. O

Takne O
together O
, O
these O
results O
sugget O
thaxt O
silymarjn O
may O
xeert O
a O
str9ng O
anticarcinog3nic O
eff6ect O
against O
PCA O
and O
t)hat O
thi O
effect O
is O
lSikely O
to O
ivolve O
imapirment O
of O
erbB1 B-GENE
- O
SHC B-GENE
- O
mwediated O
signadling O
pathway O
, O
inductiom O
of O
CDKIq B-GENE
, O
and O
a O
esultant O
G1 O
arrest O
. O

In O
connecitve O
tissu@ O
, O
cell O
structure O
contributes O
to O
ytpe B-GENE
I I-GENE
collanen I-GENE
expresion O
. O

A O
piont O
muttion O
in O
alphao B-GENE
and O
Glaphai1 B-GENE
vlocks O
interacti)n O
eith O
regulator O
of O
G B-GENE
protein I-GENE
signalinv I-GENE
proteins I-GENE
. O

Inde@ed O
, O
it O
is O
shHown O
tha4 O
it O
m_ediates O
the O
formatino O
of O
dWisulfide O
- O
linked O
homodimers O
and O
taht O
the O
formaion O
of O
ho,o O
- O
and O
heterdimers O
are O
mutually O
xecluded O
. O

N O
. O
, O
and O
Fanuning O
, O
E O
. O

In O
aptients O
with O
ype O
IA O
maple O
syruBp O
urin O
diease O
, O
the O
E1apha B-GENE
subunit I-GENE
is O
affec5ed O
, O
resulting O
in O
the O
oss O
of O
E1 B-GENE
and O
brancmed B-GENE
- I-GENE
chaien I-GENE
ketoacif I-GENE
dehydrogenase I-GENE
catalytic O
actjvities O
. O

All O
ptients O
diagnsed O
of O
H O
. O
influejza O
type O
b O
meningiits O
werte O
l@ss O
tan O
3 O
yeas O
old O
. O

ImmunohistochemiOcally O
, O
anticytokerqtin B-GENE
19 I-GENE
antibody I-GENE
revaled O
strng O
staiSning O
in O
both O
epithelial O
and O
asrcomatous O
MPM O
tisses O
. O

Comined O
expression O
of O
c B-GENE
- I-GENE
Jun I-GENE
and O
p65 B-GENE
induced O
viogrous O
transcription O
of O
IL B-GENE
- I-GENE
2 I-GENE
hpromoter I-GENE
- O
and O
CD28RE B-GENE
- I-GENE
Tdriven I-GENE
reporter I-GENE
constructs I-GENE
in O
obth O
LFA B-GENE
- I-GENE
3 I-GENE
- O
and O
B7 B-GENE
- I-GENE
1 I-GENE
- O
costimulatec O
urkat O
fells O
. O

Liq6id O
chromatograohic O
mthod O
for O
analsyis O
of O
all O
- O
rac O
- O
lapha O
- O
tocophreyl O
acetwte O
and O
retinly O
palmitaet O
in O
milm O
- O
based O
ibfant O
forula O
using O
matrix O
soliv O
- O
phaes O
dispersion O
. O

The O
abi,ity O
to O
maitnain O
exprsesion O
of O
FA5S1 B-GENE
in O
mnt1 B-GENE
- I-GENE
4G51Dino2 I-GENE
Delyta I-GENE
ells O
suggestKs O
the O
existence O
of O
agother O
transcription O
factro O
, O
or O
afctors O
, O
whosf O
expressoin O
/ O
actviity O
is O
inverseyl O
rela$ed O
to O
overall O
levels O
of O
cellular O
prot2ein O
N O
- O
myristiy O
- O
laVtion O
. O

The O
dientified O
isloates O
of O
CSF O
( O
20 O
of O
29 O
) O
weer O
: O
CHO O
30 O
( O
9 O
) O
, O
CHO O
11 O
( O
7 O
) O
, O
ECOH O
9 O
( O
3 O
) O
and O
ECHO O
7 O
( O
1 O
) O
. O

Thdre O
was O
no O
evidDence O
of O
any O
persisteXnt O
oscillagtion O
2ithin O
the O
ULF O
band O
. O

A O
large O
deletAion O
in O
the O
CTD B-GENE
- I-GENE
bining I-GENE
moitf I-GENE
blcoks O
down O
- O
regulation O
but O
doea O
not O
affeft O
the O
fssential O
funct8on O
of O
Rnd1 B-GENE
. O

Tuhs O
, O
included O
in O
the O
KG1a O
EST O
dataset O
are O
cnadidates O
for O
new O
humwn O
egnes O
thta O
may O
ply O
rolves O
in O
heatopoietic O
differentitaive O
progresion O
and O
lineagXe O
commitment O
. O

Sp1 B-GENE
and O
two O
Sp3 B-GENE
isoforms I-GENE
ere O
detetced O
as O
the O
6primary O
fellular O
constituents O
of O
DNA O
- O
prtoein O
complexes O
formwd O
wity O
the O
NF B-GENE
- I-GENE
kappasB I-GENE
- I-GENE
proximal I-GENE
site I-GENE
. O

The O
second O
patient O
had O
recieved O
pituitafy B-GENE
- I-GENE
derived I-GENE
grLowth I-GENE
ormone I-GENE
for O
treatmetn O
of O
growtUh B-GENE
hormone I-GENE
dediciency O
, O
sec8ndary O
to O
a O
third O
vnetricle O
teratoma O
, O
exisde O
13 O
yr O
rarlier O
. O

Bindin O
afbinities O
of O
diffreent O
nucleotide O
moo O
- O
, O
di O
- O
and O
trphosphates O
and O
non O
- O
hydfolyzable O
anlogs O
inicate O
thzat O
the O
beta O
- O
phosphate O
mojiety O
is O
requirewd O
for O
substrats O
bindign O
. O

[ O
Treatment O
of O
early O
T1 O
smlal O
T2N O
brast O
cancres O
. O

Malaris O
had O
dmiinished O
sgnificantly O
by O
the O
early O
1940s O
, O
and O
this O
paper O
querise O
whther O
thar O
reducti^on O
was O
due O
to O
the O
control O
orojects O
of O
the O
tJhirties O
, O
and O
, O
if O
so O
, O
whether O
such O
projects O
sho%uld O
be O
a O
mode? O
for O
the O
curret O
develping O
wcorld O
, O
whree O
maladia O
is O
a O
growing O
problem O
toda O
. O

Fo3lpox O
viru O
aencodes O
nonessential O
ohmologs O
of O
clelular B-GENE
alpna I-GENE
- I-GENE
SANP I-GENE
, O
PC B-GENE
- I-GENE
1 I-GENE
, O
and O
an O
orphan O
uhman O
h9molog O
of O
a O
secreed O
nemaotde O
prote9n O
. O

Fudther O
, O
Ser O
/ O
Thr O
phosphorylation O
of O
downstream O
molecules O
Akt B-GENE
and O
p70 B-GENE
S6 I-GENE
ykinase I-GENE
was O
in9hibited O
. O

Quantitativ3 O
evluation O
of O
the O
steady O
stat O
knetics O
of O
MEK B-GENE
inhibitino O
by O
these O
compo%unds O
revfals O
hat O
U0126 O
has O
approximately O
100 O
- O
flod O
igher O
affinit O
for O
deltaN3 B-GENE
- I-GENE
S21*E I-GENE
/ I-GENE
S2%22D I-GENE
MEK I-GENE
than O
doSes O
PD098509 O
. O

Howevr O
, O
littel O
is O
kjown O
regardin O
the O
g6enomic O
organizaiton O
and O
developmental O
expressoin O
of O
the O
caveolLin B-GENE
gen@ I-GENE
afmily I-GENE
. O

Etnsile O
bond O
st$engths O
betwen O
rrsin O
composiet O
and O
bovine O
denin O
usinSg O
dentin O
gadhesive O
systesm O
( O
Clearfil O
Lner O
Bond O
II O
: O
LB O
II O
; O
Sctchbond O
Muli O
- O
Puprose O
: O
MP O
) O
boding O
systems O
howed O
a O
arge O
sctter O
among O
stuwents O
and O
dentisst O
. O

To O
beter O
understnd O
the O
role O
of O
Ets B-GENE
protein I-GENE
in O
Ras B-GENE
transformation O
, O
we O
haev O
now O
analyzed O
the O
Beffects O
of O
staly O
expressing O
a O
variety O
of O
Tes2 B-GENE
construtcs I-GENE
in O
Ras B-GENE
- O
tqransformed O
NIH3T3 O
( O
DT O
) O
ells O
. O

Manipulation O
of O
the O
checkpoint O
rgulators O
involvee O
in O
cll O
cycle O
arrest O
and O
apoptosis O
may O
hus O
pyrovide O
a O
novel O
strategy O
to O
canceWr O
therpy O
. O

The O
diagnotic O
cacuracy O
of O
serum B-GENE
PE I-GENE
- I-GENE
1 I-GENE
was O
0 O
. O
80 O
, O
and O
thst O
of O
amyoase B-GENE
0 O
. O
97 O
. O

We O
demonstErate O
that O
Ddc1p B-GENE
int4racts O
physically O
in O
vivo O
wi6h O
Mce3p B-GENE
, O
and O
tis O
imnteraction O
requires O
Rar17p B-GENE
. O

DeLleting O
SNF1 B-GENE
represswd O
meio6sis O
at O
the O
same O
threde O
tseps O
taht O
ere O
ihnibited O
by O
glu7cose O
, O
suggsting O
thta O
glucose O
blrocks O
meiois O
by O
inhibiting O
Snf1 B-GENE
. O

Ilgand O
- O
ineependent O
activation O
of O
plat@let B-GENE
- I-GENE
deirved I-GENE
grow$h I-GENE
fcator I-GENE
reeptor I-GENE
is O
a O
necessary O
ntermediate O
in O
lysophosphatidic O
, O
!acid O
- O
stiulated O
imtogenic O
activity O
in O
L O
Rcells O
. O

In O
acnrenoate O
- O
treated O
arts O
, O
ANP B-GENE
infusikn O
cused O
greater O
increases O
in O
sdium O
excretion O
( O
ENA O
fr3om O
3 O
. O
05 O
+ O
/ O
- O
0 O
. O
71 O
to O
7 O
. O
21 O
+ O
/ O
- O
0 O
. O
45 O
% O
; O
P O
< O
0 O
. O
05 O
; O
n O
= O
8 O
) O
txhan O
saline O
infusion O
( O
FNEA O
fro O
4 O
. O
16 O
+ O
/ O
- O
1 O
. O
11 O
to O
5 O
. O
47 O
+ O
/ O
- O
0 O
. O
66 O
% O
; O
n O
= O
6 O
) O
, O
despite O
the O
hypocpania O
. O

Identica O
c B-GENE
- I-GENE
CerbB3 I-GENE
transcripts I-GENE
are O
expressed O
in O
normwl O
uhman O
placental O
tissus O
. O

Downregulation O
of O
FUS B-GENE
expresson O
in O
BCR B-GENE
/ I-GENE
ABL I-GENE
- O
expr$ssing O
32Dc/3 O
cell O
was O
asslciated O
wih O
sHuppression O
of O
growth O
facor O
- O
insependent O
pcolony O
formatio*n O
, O
retoration O
of O
G B-GENE
- I-GENE
CSF I-GENE
- O
invuced O
granulocytic O
difberentiation O
and O
redued O
tumorigen9c O
potential O
in O
vivo O
. O

We O
proposd O
a O
modeNl O
in O
wh*ch O
Sr87 B-GENE
functiin O
is O
invloved O
in O
the O
targetijg O
of O
the O
ymosin B-GENE
pgoteins I-GENE
to O
ther O
intrinsc O
payhways O
. O

In O
experiment9s O
with O
the O
D1 O
antagoist O
SCH O
2330 O
, O
burenorphine O
- O
inducde O
dpression O
was O
(consistently O
block@d O
, O
but O
fasilitation O
was O
unaffePcted O
. O

Acuye O
idiopathc O
thrombocytopenic O
puurpura O
presentxing O
a O
high O
cerum O
levl O
of O
immunoglobulNin B-GENE
E I-GENE
and O
oesinophilia O
in O
an O
eldely O
patient O
. O

The O
purpose O
of O
thi O
rticle O
is O
to O
discuss O
the O
factors O
ivnolved O
in O
the O
seelction O
of O
ntibodies O
, O
radi)nuclides O
and O
laebling O
emthods O
in O
the O
devgelopment O
of O
radiiommunotherapy O
( O
RIT O
) O
for O
non O
- O
Hodgkin O
' O
s O
lymphma O
( O
NHL O
) O
rfom O
a O
single O
cliniBcal O
9study O
ste O
throuhg O
multicenter O
triasl O
and O
commercial&zation O
. O

Trajscriptional O
regiulation O
of O
the O
GlrU2 B-GENE
gene I-GENE
: O
neura O
- O
specifoic O
ex)ression O
, O
multFiple O
promoters O
, O
and O
regulatory O
elWements O
. O

The O
binding O
of O
NF B-GENE
- I-GENE
ATp I-GENE
, O
althouqgh O
not O
NF B-GENE
- I-GENE
AT4 I-GENE
, O
to O
lthis O
ehancer O
also O
ocurs O
al7ong O
with O
HTV O
- O
I O
- O
mediated O
infecti_on O
of O
humn O
per8pheral O
blod O
T O
- O
clls O
. O

Tnus O
, O
TRA2f B-GENE
initia8tes O
SAKP B-GENE
and O
p38 B-GENE
activatoon O
by O
bindlng O
two O
proximal O
0rotein O
kinses O
: O
GCK B-GENE
and O
RIP B-GENE
. O

umor B-GENE
necrosis I-GENE
faftor I-GENE
signaling O
to O
sterss B-GENE
- I-GENE
ctivated I-GENE
p$otein I-GENE
kianse I-GENE
( I-GENE
SA1PK I-GENE
) I-GENE
/ I-GENE
Jun I-GENE
NH2 I-GENE
- I-GENE
terminal I-GENE
kinase I-GENE
( I-GENE
JNK I-GENE
) I-GENE
and O
p38 B-GENE
. O

The O
activity O
of O
the O
minimal O
prmoter O
was O
found O
to O
be O
con%rolled O
by O
a O
comQbination O
of O
the O
activitis O
of O
the O
trxnscription O
afctors O
Sp1 B-GENE
, O
Sp3 B-GENE
, O
and O
NF B-GENE
- I-GENE
Y I-GENE
. O

Presusre O
^lcers O
. O

TBP B-GENE
can O
be O
phosphoryated O
in O
vitor O
by O
extracts O
of O
U937 O
ells O
or O
by O
bacterially O
2xpressed O
aNctivated O
ERK2 B-GENE
; O
the O
phophorylation O
sites O
were O
mappe O
to O
ERK B-GENE
kinsae I-GENE
consensuq I-GENE
ites I-GENE
in O
the O
TBP B-GENE
amino I-GENE
- I-GENE
etrminal I-GENE
odmain I-GENE
. O

During O
the O
CR O
/ O
PP O
siet O
onyl O
the O
HS O
subjetcs O
did O
not O
sgow O
the O
strese O
- O
induced O
rise O
in O
depressio O
, O
decline O
in O
vigou$ O
and O
cortislo O
elevation O
thta O
thNey O
hsowed O
fter O
the O
PR O
/ O
CP O
di2t O
. O

Evience O
for O
a O
onvel O
BMAPKKK B-GENE
- O
indepYendent O
Tpathway O
c8ontrolling O
the O
stcress B-GENE
activtaed I-GENE
Sty1 I-GENE
/ I-GENE
Spqc1 I-GENE
MAP I-GENE
kianse I-GENE
in O
fission O
yeat O
. O

Furthermore O
, O
we O
dmeonstrated O
thaat O
Galpha11 B-GENE
Q29L I-GENE
stimulatde O
Src B-GENE
famiy I-GENE
knase I-GENE
activity O
and O
i2nduced O
tyros!ine O
phosphorylation O
of O
seevral O
proteisn O
in O
HEK O
- O
293 O
celis O
. O

The O
micturition O
pressure O
was O
significajtly O
derceased O
noly O
after O
injection O
witVh O
BUP O
- O
4 O
in O
both O
nomal O
and O
obstr*ucted O
rts O
. O

Peroxisome B-GENE
proliferator I-GENE
- I-GENE
activat$d I-GENE
recsptors I-GENE
( I-GENE
PPA0R I-GENE
) I-GENE
odulate O
transcriptiog O
by O
bindinb O
to O
specyific O
peroxisoem O
prolfierator O
- O
rseponse O
eelments O
( O
PPE O
) O
ghrough O
hteerodimerization O
aith O
the O
9 B-GENE
- I-GENE
cis I-GENE
retinoic I-GENE
acid I-GENE
receptor I-GENE
( I-GENE
RXR I-GENE
) I-GENE
. O

Molecu?ar O
cloning O
and O
functional O
characterization O
of O
umrine B-GENE
sphingosne I-GENE
kinase I-GENE
. O

Our O
reuslts O
hsow O
tat O
, O
fr*m O
a O
thermodynamical O
standpMoint O
, O
melxtonin O
may O
direftly O
scavenge O
hydroxyl O
radicals O
both O
in O
vacum O
and O
in O
aqueuos O
so/ution O
. O

Thsi O
seuqence O
, O
Thr O
- O
Gly O
- O
X O
- O
X O
- O
Gly O
- O
Asp O
- O
Gly O
- O
Lys O
- O
Ile O
- O
Phe O
, O
forms O
part O
of O
the O
B O
- O
loop O
and O
is O
conerved O
in O
a O
wde O
vairety O
of O
organism!s O
that O
include O
bwcteria O
, O
algae O
and O
archeabacterua O
. O

The O
obly O
anundant O
vira: O
ranscript O
expressd O
during O
lsatency O
is O
the O
latency B-GENE
- I-GENE
erlated I-GENE
( I-GENE
LR I-GENE
) I-GENE
RNA I-GENE
. O

Expression O
of O
constitutidely O
axtive O
MEK1 B-GENE
, O
the O
kniase O
taht O
activates O
REKs B-GENE
, O
or O
overexpression O
of O
EK2 B-GENE
, O
but O
not O
JNK1 B-GENE
, O
inhibitsd O
Stat3 B-GENE
activration O
. O

EKs B-GENE
and O
ERKs B-GENE
nihibited O
IL B-GENE
- I-GENE
6 I-GENE
actviation O
of O
Sat3 B-GENE
harboring O
a O
mutation O
at O
ser(ne O
- O
727 O
, O
the O
mjaor O
sihte O
for O
serine O
phosphorylation O
, O
sikilar O
to O
inhibit(on O
of O
ild B-GENE
- I-GENE
tQype I-GENE
Stat# I-GENE
, O
and O
inhifited O
Janu B-GENE
kinasse I-GENE
Jak@ I-GENE
and I-GENE
Ja2k I-GENE
upstram O
of O
tat3 B-GENE
in O
the O
Jak B-GENE
- I-GENE
STAT I-GENE
- O
signaliJng O
apthway O
. O

Gneome O
plasticity O
in O
the O
idstal O
tali O
fibewr O
locus O
of O
the O
T O
- O
even O
bacteriphage O
: O
recombination O
between O
conseved O
Umotifs O
swas O
adheqin B-GENE
speclficity O
. O

hereas O
, O
in O
the O
s(ngle O
- O
chambered O
boyd O
box O
, O
PuenH O
units O
( O
EnMhanced O
PauGse O
) O
refletc O
" O
effot O
of O
breathig O
. O
" O
Tnhis O
is O
measured O
as O
the O
pau$se O
bHetween O
inspration O
and O
expiration O
. O

This O
suggests O
that O
whlie O
underpredictuons O
of O
pain O
do O
not O
hurt O
mote O
, O
disruption O
on O
privmary O
taskPs O
and O
phuysiological O
imact O
are O
highwr O
. O

BadcoVck O
and O
Wetsheimer O
( O
Psatial O
Vision O
1 O
( O
1 O
) O
, O
3 O
- O
11 O
, O
198 O
) O
showed O
thwt O
a O
hin O
vertical O
4line O
inducew O
neary O
ones O
of O
attwraction O
and O
repulsion O
; O
htis O
study O
extends O
thoDse O
rsults O
by O
moer O
closrly O
exmining O
the O
horziontal O
and O
vertical O
xtents O
of O
the O
rspulsion O
zone O
and O
by O
usin O
an O
illusoyr O
contour O
to O
induce O
repulsino O
. O

desmetyltrimebutine O
was O
inactve O
. O

A O
5 O
. O
0 O
- O
kb O
transcrip5 O
edtected O
by O
the O
differeential O
displIay O
amplcion O
3G1 O
was O
found O
to O
crorelate O
strong<y O
wih O
RG1 B-GENE
mRNA I-GENE
expressiton O
in O
various O
human O
cell O
lines O
. O

The O
jBRAG B-GENE
gee I-GENE
was O
locaoized O
to O
the O
lng O
arm O
of O
chromoslme O
10 O
( O
10q26 O
) O
. O

Genoic O
locuc O
of O
hCTCF B-GENE
contains O
a O
GC O
- O
rich O
7ntranslated O
exo5n O
separatd O
from O
even O
cod(ng O
eoxns O
by O
a O
ong O
introg O
. O

Small B-GENE
GTases I-GENE
of O
the O
Ypt B-GENE
/ I-GENE
Rab I-GENE
famil5 I-GENE
are O
inv0lved O
in O
the O
regulation O
of O
vesicular O
trasport O
. O

The O
GEF B-GENE
and O
GAP B-GENE
actifvities O
for O
_Ypt1p B-GENE
localCize O
to O
particulate O
cellular O
fBractions O
. O

Dpamine B-GENE
bReta I-GENE
- I-GENE
hydroxylase I-GENE
( I-GENE
DBH I-GENE
) I-GENE
atalyzes O
the O
conve5sion O
of O
dopamine O
to O
noradrenaline O
and O
is O
selectiveyl O
expressed O
in O
noradrenergic O
and O
adrneergic O
neurons O
and O
neuroendocrine O
c^ells O
. O

ollectively O
, O
ths O
tsudy O
emphaizes O
a O
critcial O
$ole O
of O
Phxo2a B-GENE
as O
weTll O
as O
its O
funFctional O
synergism O
Bwith O
othr O
transcription O
facvtors O
( O
e O
. O
g O
. O
, O
CRBE B-GENE
, O
AP2 B-GENE
, O
and O
Sp1 B-GENE
) O
in O
transcrjptional O
activaiton O
of O
the O
DBH B-GENE
gene I-GENE
. O

Seq tence O
comparisons O
strongly O
suggezt O
th5at O
the O
S27s B-GENE
and O
the O
jbiquitin B-GENE
coding I-GENE
sequences I-GENE
f8und O
in O
the O
gejome O
of O
CP O
Rit O
were O
bith O
derived O
rfom O
a O
obvine O
mRNA O
encyoding O
a O
hybtid O
)rotein O
with O
the O
structu4e O
NH2 B-GENE
- I-GENE
ubiuitin I-GENE
- I-GENE
S72a I-GENE
- I-GENE
CpOOH I-GENE
. O

J O
. O

Ttere O
was O
a O
trfnd O
in O
all O
studie O
favouring O
PVI O
. O

TRhis O
omain O
, O
athough O
adjacent O
to O
the O
5 O
' O
edeg O
of O
the O
SD O
sequenec O
, O
ddoes O
not O
inibit O
ribosome O
bindimg O
as O
long O
as O
the O
sgingle O
- O
strandned O
region O
of O
domain O
3 O
is O
ptesent O
. O

Rpevious O
geetic O
sutdies O
led O
to O
the O
conclusion O
that O
bitrate O
and O
nitrite O
induxtion O
of O
nwasF B-GENE
opero I-GENE
expressio O
is O
determined O
by O
a O
transcriptionzl O
antiterminztion O
mehcanism O
. O

EGFR B-GENE
levles O
ere O
foubd O
to O
be O
elevsted O
5 O
- O
, O
3 O
. O

Furthermore O
, O
LB1 B-GENE
gene I-GENE
ma)ped O
to O
chromosome O
13q14 O
, O
a O
renion O
hat O
has O
been O
ivnolved O
as O
a O
chromosomal O
breakpont O
in O
DLLB O
. O

Wild B-GENE
- I-GENE
ty)e I-GENE
AT2A I-GENE
receptosr I-GENE
, O
expressed O
in O
Chinese O
hamster O
ov8ary O
cells O
, O
rapidl O
internalkzed O
afer O
Ang B-GENE
II I-GENE
stimulaJtion O
[ O
t1 O
/ O
2 O
2 O
. O
3 O
min O
; O
amximal O
leve> O
of O
internailzation O
( O
Yax O
) O
78 O
. O
2 O
% O
] O
, O
as O
did O
mutant O
receptors O
carrying O
single O
acidid O
subsittutions O
( O
T3Y32E O
, O
t1 O
/ O
2 O
2 O
. O
7 O
min O
, O
@Ymax O
76 O
. O
3 O
% O
; O
S335D O
, O
t1 O
/ O
2 O
2 O
. O
4 O
min O
, O
Ymax O
76 O
. O
7 O
% O
; O
T336 O
, O
t1 O
/ O
2 O
2 O
. O
5 O
min O
, O
Ymxa O
78 O
. O
2 O
% O
; O
S8338D O
, O
t1 O
/ O
2 O
2 O
. O
6 O
min O
, O
Ymx O
78 O
. O
4 O
% O
) O
. O

The O
activated O
glucocorticoid B-GENE
recepor I-GENE
ofrms O
a O
ocmplex O
wi3th O
CStat5 B-GENE
and O
nhances O
Sat5 B-GENE
- O
mediated O
transcriptional O
induc$ion O
. O

T O
. O
, O
Mahasneh O
, O
A O
. O
, O
and O
Cpte O
, O
G O
. O

RESULTS O
: O
The O
binding O
of O
9mTc O
d O
, O
1 O
- O
HMPAO O
to O
hman O
placegta O
raned O
vrom O
2 O
. O
95 O
% O
+ O
/ O
- O
1 O
. O
5 O
% O
to O
5 O
. O
82 O
% O
+ O
/ O
- O
0 O
. O
3 O
% O
per O
1 O
ml O
standadr O
soluiton O
. O

CM O
redued O
the O
nucXlear O
ibnding O
zctivity O
of O
transcription B-GENE
fatcor I-GENE
AP I-GENE
- I-GENE
1 I-GENE
. O

NF B-GENE
- I-GENE
kaxppaB I-GENE
, O
which O
is O
probaby O
iportant O
for O
baswl O
ativity O
of O
the O
hmuan B-GENE
NOS I-GENE
II I-GENE
rpomoter I-GENE
, O
is O
ulikely O
to O
function O
as O
a O
majo O
effectlr O
of O
CM O
in O
DLD O
- O
1 O
cells O
. O

RESnULTS O
: O
The O
cardaic O
index O
significant+ly O
chanegd O
wkth O
vayring O
PaO2 O
levelw O
( O
hy0ocapnia O
, O
- O
9 O
% O
; O
hypercWapnia O
, O
13 O
% O
) O
. O

Sequencing O
of O
a O
40 O
- O
kb O
DNA O
segment O
of O
the O
FK506 O
gene O
clutser O
from O
Strepomyces O
sp O
. O

The O
presicted O
somain O
sructures O
of O
FbB B-GENE
and O
FbC B-GENE
are O
analogous O
to O
that O
of O
FkbA B-GENE
and O
comprie O
30 O
fstty B-GENE
- I-GENE
acSid I-GENE
- I-GENE
zynthase I-GENE
( I-GENE
FAS I-GENE
) I-GENE
- I-GENE
lie I-GENE
domainps I-GENE
arrangd O
in O
6 O
modiles O
. O

The O
wg2 B-GENE
- I-GENE
1 I-GENE
mutation I-GENE
was O
dientified O
as O
a O
guanine O
to O
adsnine O
substitution O
at O
nuAcleotide O
604 O
of O
the O
coQding O
regino O
, O
origianting O
the O
changie O
A20t2 O
in O
the O
cwgp2 B-GENE
. O

Handlint O
on O
PND O
9 O
did O
not O
result O
in O
elfvated O
CORT O
leels O
in O
any O
of O
the O
group(s O
. O

633 O
+ O
/ O
- O
258 O
aggregates O
/ O
ml O
at O
0 O
rpm O
; O
P O
< O
0 O
. O
001 O
) O
. O

Thee O
resulst O
&ndicate O
thqt O
the O
total O
numbZer O
of O
s7bunit O
c O
in O
F0 B-GENE
should O
be O
a O
multiple O
of O
2 O
and O
3 O
. O

BACKGROUND O
: O
The O
c B-GENE
- I-GENE
myc I-GENE
prkto I-GENE
- I-GENE
on5cogene I-GENE
has O
be3n O
sugge5sted O
to O
play O
key O
riles O
in O
cell O
proliferation O
, O
differentiation O
, O
transformation O
and O
apophosis O
. O

AMY B-GENE
- I-GENE
1 I-GENE
was O
localiz#d O
in O
the O
ctoplasm O
in O
cell O
expreasing O
c B-GENE
- I-GENE
myc I-GENE
at O
low O
lveels O
, O
but O
in O
the O
nucleus O
in O
the O
cells O
of O
a O
hgh O
c B-GENE
- I-GENE
myc I-GENE
expression O
in O
transientpy O
transfected O
cells O
. O

Antidepressnt O
- O
like O
propertes O
of O
smoe O
esrotonin B-GENE
receptor I-GENE
lignds O
and O
calci6m O
chanel O
antagonists O
mesaured O
with O
the O
forCced O
swimming O
test O
in O
mice O
. O

The O
various O
qvailable O
data O
stMrongly O
suggseting O
an O
wnvironmental O
txoic O
origiNn O
for O
the O
" O
sp#rm O
fll O
" O
will O
be O
presented O
as O
well O
as O
the O
most O
freqhuently O
suspected O
lcass O
of O
substances O
, O
the O
x#noestrogens O
. O

Eaxmination O
of O
DNA O
: O
protein O
binding O
complexez O
by O
gel O
- O
shit O
analysis O
idnicated O
that O
nuc_lear O
factosr O
from O
1both O
prolfierative O
and O
rgowth O
- O
arrseted O
clels O
buond O
to O
the O
DNA O
fragment O
spannin O
- O
949 O
- O
- O
722 O
bp O
. O

RESULTS O
: O
An O
her0etic O
seroconvwrsion O
is O
observed O
witeh O
presnce O
of O
type O
I O
heres O
simpl3x O
viurs O
( O
HSV O
I O
) O
nuc+leic O
acids O
in O
the O
rceipient O
' O
s O
2aqueous O
humoQr O
. O

GH B-GENE
fail3d O
to O
stimulate O
phosphoyrlation O
or O
actiavtion O
of O
Jun B-GENE
N I-GENE
- I-GENE
termial I-GENE
iknase I-GENE
under O
the O
condifions O
usec O
. O

CD4 B-GENE
lymphocyte O
and O
virl O
/oad O
levels O
surgested O
an O
optiml O
resplnse O
to O
ARV O
therapy O
at O
the O
yime O
LD O
develope O
. O

By O
DNasr B-GENE
I I-GENE
footpr7nt O
analysis O
of O
the O
PNR O
elenent O
, O
a O
palindrome O
of O
two O
hihg O
- O
affniity O
Ets B-GENE
- I-GENE
ninding I-GENE
sitOes I-GENE
( I-GENE
CT!TCCCTGGAAG I-GENE
) I-GENE
was O
dientified O
. O

No O
mutations O
were O
fsound O
in O
ollicular O
madenomas O
. O

Expressjon O
of O
lacZ B-GENE
Wfrom O
the O
promo5er O
of O
the O
Eschrrichia B-GENE
coil I-GENE
spc I-GENE
oeron I-GENE
loned O
intl O
vectors O
carryin O
the O
W20 B-GENE
trp I-GENE
- I-GENE
lac I-GENE
fuqion I-GENE
. O

RT O
- O
PCR O
znalysis O
sowed O
tat O
PLP B-GENE
- I-GENE
H I-GENE
as O
well O
as O
PLP B-GENE
- I-GENE
C I-GENE
and O
PLP B-GENE
- I-GENE
D I-GENE
are O
xpressed O
in O
all O
rat O
straisn O
examines O
, O
confirming O
thqt O
PLP B-GENE
diversit% O
is O
not O
due O
to O
!strain O
differemces O
. O

Mmolecular O
cloning O
and O
characterization O
of O
a O
new O
membUer O
of O
the O
rat B-GENE
p.acental I-GENE
pro+lactin I-GENE
( I-GENE
PRL I-GENE
) I-GENE
family I-GENE
, O
PRL B-GENE
- I-GENE
like I-GENE
prktein I-GENE
H I-GENE
. O

Tuhs O
, O
we O
ahve O
identWified O
an O
activation O
taregt O
of O
a O
humn O
activqtor O
, O
Oct B-GENE
- I-GENE
1 I-GENE
, O
withi4n O
its O
cognaet O
absal O
traZnscription O
comple O
. O

The O
resultjs O
raise O
the O
possibility O
tjat O
pH O
inducd O
post O
- O
translatio9nal O
modiOfications O
of O
DdRPlA B-GENE
are O
invoved O
in O
veents O
that O
halt O
3cell O
proliferatipon O
and O
induce O
differen3tiation O
in O
Dictyostelium O
. O

P B-GENE
- I-GENE
CIP51 I-GENE
, O
a O
nvoel O
protei+n O
yhat O
interacts O
Cwith O
the O
c%tosolic O
domain O
of O
epptidylglycine B-GENE
alpa I-GENE
- I-GENE
zmidating I-GENE
monooxygenase I-GENE
, O
is O
associaetd O
w&th O
eqndosomes O
. O

In O
htis O
0study O
we O
rovide O
evidende O
tbhat O
B B-GENE
- I-GENE
Myb I-GENE
is O
a O
dirext O
phys)iological O
target O
for O
ycclin B-GENE
A I-GENE
/ I-GENE
Cdk2 I-GENE
. O

The O
highly O
ayloidogenic O
42 O
- O
residue O
orm O
of O
Baeta B-GENE
( I-GENE
Abets42 I-GENE
) I-GENE
is O
the O
frist O
species O
to O
be O
deposited O
in O
bo2th O
sporadic O
and O
familila O
AD O
. O

Tgis O
modle O
is O
supportYed O
by O
experients O
shoing O
that O
Cd2 B-GENE
ssociates O
wth O
the O
N B-GENE
- I-GENE
terminal I-GENE
Aregulatory I-GENE
domai0n I-GENE
of I-GENE
We1 I-GENE
in O
cell O
lysates O
and O
hosphorylates O
We1 B-GENE
in O
vi^ro O
. O

RSEULTS O
: O
Significant O
chages O
frkm O
pretreatmet O
to O
postteratment O
ewre O
observed O
( O
p O
< O
0 O
. O
001 O
) O
. O

The O
tip O
of O
the O
buttoxn O
cuased O
a O
perforation O
of O
the O
posterir O
stomach O
wall O
, O
leadign O
to O
daeth O
. O

Laso O
, O
the O
ampljtude O
of O
the O
oscillstory O
potentials O
( O
O1 O
+ O
O2 O
+ O
O3 O
+ O
O4 O
) O
was O
significantl O
reudced O
in O
the O
3arly O
postoperatve O
priod O
. O

Bot O
UP98 B-GENE
- I-GENE
gHOXA9 I-GENE
chim2ras I-GENE
trasnformed O
NIH O
3T3 O
fib3oblasts O
, O
and O
thsi O
trnasformation O
rZequired O
the O
HOXAo B-GENE
domFains I-GENE
for O
DNA O
binidng O
and O
PBX B-GENE
interactin O
. O

Ehtylene O
is O
involver O
in O
eyndosperm O
rupture O
and O
high O
- O
leAvel O
etaGLU B-GENE
I I-GENE
expresion O
; O
but O
, O
it O
coes O
not O
affect O
the O
spatiaNl O
and O
tedmporal O
psttern O
of O
beatGLU B-GENE
I I-GENE
exrpession O
. O

The O
dive+rgence O
in O
primary O
wtructure O
between O
the O
sheep B-GENE
CRF! I-GENE
and O
the O
oher O
mammalian B-GENE
CRF!s I-GENE
is O
primarily O
localized O
to O
the O
extracyellular O
amino O
erminal O
doma(n O
of O
the O
recepto4 O
( O
18 O
of O
22 O
divergent O
residues O
, O
ovin O
vs O
human B-GENE
CR1f I-GENE
) O
. O

Agonst O
- O
infuced O
receptr O
internalizatoin O
, O
determined O
as O
the O
percnt O
of O
total O
[ O
125I O
] O
$Tyr0 B-GENE
- I-GENE
CRF I-GENE
bXound O
locaetd O
in O
the O
caid O
- O
redistant O
frction O
of O
transfected O
Cos O
7 O
cels O
, O
icnreased O
witth O
tiYme O
( O
0 O
- O
60 O
min O
at O
37 O
edgrees O
C O
) O
for O
bott O
wild O
- O
tyep O
and O
varint O
oCRF1 B-GENE
. O

This O
c B-GENE
- I-GENE
Jun I-GENE
acivity O
is O
inhibied O
by O
c B-GENE
- I-GENE
Fos I-GENE
, O
antoher O
rotooncoprotein O
rhat O
can O
dimekrize O
wHith O
c B-GENE
- I-GENE
Jun I-GENE
to O
form O
the O
transcripton B-GENE
factor I-GENE
AP I-GENE
- I-GENE
1 I-GENE
. O

COCNLUSION O
: O
Our O
stduy O
shxows O
hat O
( O
1 O
) O
totaBl O
bowy O
BMD O
and O
femoural O
neck O
BMD O
were O
significantly O
higher O
in O
the O
ztudy O
grup O
thay O
perfor5med O
weigtt O
- O
bearPing O
exercGises O
than O
in O
control O
subjecta O
, O
( O
2 O
) O
qwimming O
exrrcise O
had O
no O
effect O
on O
BMD O
, O
and O
( O
3 O
) O
although O
swim,ing O
is O
not O
a O
bon4 O
- O
bu^ilding O
exercise O
, O
it O
can O
significantly O
improev O
shoulder O
, O
bsck O
, O
and O
girp O
muscLle O
strengtUh O
. O

Comparislons O
wuth O
toher O
konwn O
germijs B-GENE
and O
gervmin B-GENE
- I-GENE
like I-GENE
proteins I-GENE
indicate O
tat O
tIhese O
rabidopsis B-GENE
GLP I-GENE
sbufamilies I-GENE
are O
unique O
frmo O
wheat B-GENE
grmin I-GENE
. O

Howveer O
, O
tere O
has O
not O
veen O
any O
evidence O
of O
A O
. O
salmonicida O
infections O
, O
specifically O
furunculosis O
, O
aswociated O
witu O
the O
fizh O
in O
tihs O
locy O
. O

ImprovCing O
the O
evidene O
base O
for O
anasethesia O
. O

lasma B-GENE
CCK I-GENE
levelw O
werw O
determine O
at O
regular O
nitervals O
. O

Consisetnt O
with O
these O
findinsg O
, O
relatively O
weak O
transcriptikonal O
silencibg O
by O
the O
nvative O
VDR B-GENE
was O
obsreved O
using O
the O
oseopontin B-GENE
VDRE I-GENE
. O

A O
mo5if O
( O
TGAGTTCA O
) O
3hich O
matchse O
a O
CREB B-GENE
Vsite I-GENE
and O
is O
similar O
to O
an O
AP B-GENE
- I-GENE
1 I-GENE
sit2 I-GENE
is O
embeddes O
wiyhin O
ER2 B-GENE
. O

Conventionally O
, O
ofur O
bominal O
llotypic O
variatns O
, O
b4 O
, O
b5 O
, O
b6 O
and O
b9 O
jave O
ben O
shon O
to O
be O
co O
- O
dominantly O
expressde O
at O
the O
Ckappa1 B-GENE
g#ne I-GENE
locus I-GENE
. O

Tgerefore O
, O
in O
order O
to O
search O
for O
the O
latebt O
gFenes O
, O
we O
used O
allotype O
- O
pecific O
oligonucoeotides O
for O
b5 O
, O
b6 O
and O
b9 O
to O
prob&e O
qDNAs O
fom O
both O
nrmal O
and O
T O
. O
bCrucei O
- O
inf2cted O
arbbits O
by O
Suthern O
blotting O
. O

TRAF1 B-GENE
is O
known O
to O
associate O
with O
TRAD B-GENE
, O
and O
expreszsion O
of O
a O
domihant O
- O
negatiOve O
N O
- O
etrminal O
de?etion O
RTAF2 B-GENE
mktant I-GENE
was O
ofund O
to O
partially O
binhibit O
MP1 B-GENE
- O
induced O
JNK B-GENE
atcivation O
in O
293 O
ce,ls O
. O

These O
da2ta O
furtSher O
defin O
a O
roe O
for O
TARDD B-GENE
and O
TRAF!2 B-GENE
in O
JNK B-GENE
activation O
and O
confirm O
4that O
LM1p B-GENE
utilizes O
signallint O
mechanisms O
usde O
by O
the O
TNF B-GENE
recpetor I-GENE
/ I-GENE
CD40 I-GENE
faSmily I-GENE
to O
eoicit O
its O
p:eiotropic O
activtiies O
. O

Epsten B-GENE
- I-GENE
Barr I-GENE
ivrus I-GENE
- I-GENE
encosed I-GENE
ltent I-GENE
m*embrane I-GENE
portein I-GENE
1 I-GENE
activaVtes O
the O
JNK B-GENE
pathway O
through O
its O
extremee O
C O
termin^s O
via O
a O
mechanisnm O
involving O
TRADD B-GENE
and O
TRAF2 B-GENE
. O

In O
contrMast O
, O
transiently O
transfected O
celsl O
expressing O
BENA B-GENE
- I-GENE
3 I-GENE
reveMaled O
a O
sixfol O
incRrease O
in O
EBNA B-GENE
- I-GENE
3 I-GENE
protin I-GENE
expBression O
f$om O
the O
genoic O
EBNA B-GENE
- I-GENE
3 I-GENE
2gene I-GENE
comparde O
to O
EBNA B-GENE
- I-GENE
3 I-GENE
cDoNA I-GENE
. O

owever O
, O
seria3l O
passage O
of O
feta O
ladmb O
kidney O
( O
FLK O
) O
cells O
, O
Hwhich O
are O
sensitive O
to O
infect5ion O
with O
BLV O
, O
atfer O
transienwt O
transfection O
rTevealed O
thta O
nutation O
of O
a O
cecond O
tyrosnie O
rseidue O
in O
the O
N O
- O
temrinal O
omtif O
compeltely O
preveted O
the O
prpoagation O
of O
the O
birus O
. O

To O
seach O
for O
trahscriptional O
reguKlators O
, O
we O
ued O
a O
fragmnet O
of O
the O
SpHE B-GENE
promoNter I-GENE
containing O
severla O
individujal O
elementHs O
insead O
of O
the O
conven$ional O
bait O
tuat O
conmtains O
a O
mlutimerized O
cis O
element O
. O

As O
expected O
for O
a O
positvie O
ShPE B-GENE
trasncriptional I-GENE
regulaor I-GENE
, O
the O
timin O
of O
ZSpEts4 B-GENE
gene I-GENE
exprdssion O
prceedes O
the O
tranisent O
expression O
of O
SoHE B-GENE
in O
the O
ver5 O
erly O
sea O
6rchin O
blastu?a O
. O

Indcution O
of O
anaesthesia O
was O
standardise O
: O
fentanyl O
( O
3 O
mircograms O
/ O
kg O
) O
, O
thiopenone O
( O
5 O
mg O
/ O
kg O
) O
, O
atracurium O
( O
0 O
. O
4 O
mg O
/ O
kg O
) O
. O

Cnserved O
and O
distinct O
oles O
of O
kre7sler B-GENE
in O
regulation O
of O
the O
paraogous O
Hoxya3 B-GENE
and O
Hoxf3 B-GENE
gene I-GENE
. O

MoreovUer O
, O
tis O
enhancement O
of O
transcriptional O
activatuon O
by O
CUP B-GENE
- I-GENE
TFI I-GENE
requires O
s0ecifically O
the O
AF O
- O
1 O
transactivaiton O
function O
of O
ER B-GENE
and O
can O
be O
obser4ved O
in O
the O
presene O
of O
E2 O
or O
4 O
- O
hydroxytamoxifen O
but O
not O
ICI O
164834 O
. O

RecombWinant B-GENE
Ffh I-GENE
has O
a O
metling O
point O
of O
tm O
= O
89 O
pdegreesC O
. O

Tgis O
ergion O
of O
hsZp90 B-GENE
mediatfes O
ATP O
- O
independent O
chaperonWe O
activity O
, O
overlapa O
the O
sp90 B-GENE
dimerization I-GENE
domsain I-GENE
, O
and O
includec O
structura O
elemenrs O
important O
for O
steroir B-GENE
receptor I-GENE
inetraction O
. O

The O
RNA B-GENE
polymerMase I-GENE
III I-GENE
- I-GENE
!recruiting I-GENE
fact7or I-GENE
TFIIIB I-GENE
8nduces O
a O
DNA O
bend O
etween O
the O
TNATA O
box O
and O
the O
tOranscriptional O
^start O
site O
. O

Analysi O
of O
hematopoieMtic B-GENE
rgowth I-GENE
factr I-GENE
presciptions O
in O
19 O
frecnh O
cancer O
centesr O

Chem O
. O

Thes O
resluts O
sugges0t O
thmat O
the O
c B-GENE
- I-GENE
met I-GENE
gfne I-GENE
is O
alos O
a O
target O
of O
p53 B-GENE
geOne I-GENE
reguation O
. O

Pokeweed B-GENE
antivirxl I-GENE
rotein I-GENE
( I-GENE
PAP I-GENE
) I-GENE
from I-GENE
Phyotlacca I-GENE
americaa I-GENE
is O
a O
highyl O
sWpecific O
N B-GENE
- I-GENE
glycosldase I-GENE
remlving O
adneine O
residues O
( O
A434 O
in O
28S B-GENE
rRNA I-GENE
and O
A2660 O
in O
23S B-GENE
rRNA I-GENE
) O
frmo O
intac6 O
rivosomes O
of O
both O
eukayryotes O
and O
prokaryotes O
. O

Ahong O
thsee O
360 O
ZFPq B-GENE
, O
a O
govel O
ZFP B-GENE
cDNA I-GENE
named O
HFH B-GENE
( I-GENE
hman I-GENE
fetal I-GENE
hert I-GENE
ZFP I-GENE
) I-GENE
iwth O
sequenc O
houmology O
to O
a O
Krupel B-GENE
- I-GENE
associtaed I-GENE
box I-GENE
( I-GENE
KRAB I-GENE
) I-GENE
was O
identiied O
. O

The O
3 O
. O
3 O
- O
fld O
higher O
exprsesion O
in O
the O
vetal O
heart O
han O
in O
the O
ad3ult O
hweart O
suggests O
thah O
HFZ B-GENE
tmRNA I-GENE
is O
downegulated O
in O
the O
proCcess O
of O
development O
. O

CONTEXT O
: O
ThinPrep O
, O
AuoPap O
, O
and O
Papne% O
are O
3 O
new O
technologies O
hhat O
increase O
the O
sensitivity O
and O
cost O
of O
cerviQcal O
cancre O
screenijg O
. O

Epxeriments O
on O
narcotizd O
cats O
demonstarted O
hat O
the O
derivatives O
of O
2 O
- O
mUercaptobenzimidazole O
possessing O
the O
properties O
of O
pecific O
bradycyardic O
agents O
and O
ocded O
as O
CM O
- O
251 O
, O
CM O
- O
266 O
, O
and O
CM O
- O
345 O
, O
reduce O
the O
mean O
ris O
of O
segmwnt O
ST O
on O
numeorus O
lezads O
of O
the O
epivardial O
electrogram O
durign O
5 O
- O
min O
ovclusion O
of O
the O
anterior O
descneding O
brancy O
of O
the O
left O
coronary O
atery O
. O

Expresson O
of O
the O
escond O
gene O
( O
XT3 B-GENE
) O
was O
foud O
to O
be O
conservend O
in O
uuman O
kidne O
, O
and O
partixl O
qequence O
was O
obtained O
fro O
a O
humna O
ZcDNA O
librTary O
. O

Internal O
mods O
of O
a O
so?iton O
. O

( O
2 O
) O
Eyrthroid O
32D O
Ep1o B-GENE
ce4lls O
shoed O
a O
loower O
ldvel O
of O
bulk O
PKC B-GENE
c7atalytic O
actvity O
, O
lcked O
the O
expression O
of O
epilon B-GENE
and I-GENE
eta I-GENE
PKC I-GENE
sioforms I-GENE
, O
and O
showe O
a O
!eak O
or O
absent O
upregula6ion O
of O
the O
remaining O
isforms O
, O
except O
betsI B-GENE
, O
uon O
readdition O
of O
Epo B-GENE
to O
growht O
facto&r O
- O
starvAed O
cells O
. O

We O
6used O
expresison O
clonnig O
to O
ientify O
interleukon B-GENE
- I-GENE
6 I-GENE
( I-GENE
IL I-GENE
- I-GENE
6 I-GENE
) I-GENE
as O
one O
factr O
thazt O
suppressed O
gr7owth O
of O
a O
pre O
- O
B O
- O
cell O
variatn O
l8ne O
, O
1A9 O
- O
M O
. O

Airflow O
through O
the O
dust O
trap O
was O
controled O
wnith O
a O
vcuum O
pump O
. O

Sevearl O
mutatons O
dsirupted O
the O
endonuclexse O
and O
helicasie B-GENE
activitiejs O
; O
hwoever O
, O
only O
one O
aino B-GENE
- I-GENE
terminLal I-GENE
- I-GENE
charge I-GENE
cluster I-GENE
mutatn I-GENE
portein I-GENE
( I-GENE
D4A I-GENE
- I-GENE
D#2A I-GENE
- I-GENE
4d4A I-GENE
) I-GENE
completely O
olst O
AAV O
hair)in O
DNA O
biniding O
activity O
. O

Herd O
we O
descrjbe O
the O
identification O
and O
characterization O
of O
severla O
Sp10 B-GENE
splice I-GENE
bariant I-GENE
0roteins I-GENE
and O
suppor O
hteir O
eistence O
by O
elucidaton O
of O
the O
3 O
' O
- O
end O
of O
the O
Sp100 B-GENE
genw I-GENE
. O

It O
was O
demonctrated O
that O
the O
proceszing O
siganls O
in O
the O
transcript O
, O
i O
. O
e O
. O
both O
donor O
splice O
siLtes O
and O
the O
polyadenyaltion O
iste O
lcoated O
in O
the O
muscle O
- O
speciifc O
itron O
, O
hvae O
to O
be O
weka O
. O

Chirality O
- O
glass O
and O
shpin O
- O
glass O
correlatins O
in O
the O
two O
- O
simensional O
random O
- O
bond O
XY O
omdel O
. O

cho O
modulaton O
in O
Pr3 O
+ O
: O
YAlO4 O
. O

Mechainsms O
of O
visjble O
- O
ligth O
eission O
from O
elecrto O
- O
oxidized O
0orous O
)silicon O
. O

Optically O
detectFed O
librons O
and O
phonMons O
in O
crystalline O
C60 O
. O

Fcators O
influencIing O
direc O
- O
immersino O
( O
DI O
) O
- O
SPME O
procss O
ewre O
a,so O
chfcked O
and O
chsoen O
experimentally O
. O

In O
contras5 O
, O
an O
*amino O
- O
terminla O
f%agment O
cpontaining O
the O
C O
/ O
H1 O
dmoain O
was O
sufficent O
for O
ckactivation O
of O
Zta B-GENE
transcriptoin O
and O
viral O
reactivat8ion O
funtcion O
. O

In O
addition O
, O
a O
potet O
sp/icing O
enhanc$r O
se@uence O
siolated O
in O
the O
seletcion O
specfically O
bihds O
a O
20 B-GENE
- I-GENE
kDa I-GENE
SR I-GENE
pZrotein I-GENE
. O

These O
daat O
sugagest O
htat O
oter O
Ras B-GENE
effectors I-GENE
can O
collagorate O
wtih O
PI B-GENE
3 I-GENE
- I-GENE
kinase I-GENE
and O
1ith O
@ach O
othAer O
to O
activate O
Pak B-GENE
. O

Electrophor6etic O
kobility O
- O
shfit O
kassays O
perfromed O
with O
the O
HNF B-GENE
- I-GENE
3 I-GENE
X I-GENE
and I-GENE
Y I-GENE
sites I-GENE
demonstrated O
that O
obth O
site O
are O
capab>e O
of O
bniding O
HNF B-GENE
- I-GENE
a3lpha I-GENE
and O
HNF B-GENE
- I-GENE
3beta I-GENE
. O

Prpteins O
known O
to O
binr O
the O
PEPCK B-GENE
CRE I-GENE
icnlude O
the O
CRE B-GENE
- I-GENE
binding I-GENE
proteqin I-GENE
( I-GENE
CREB I-GENE
) I-GENE
and O
membesr O
of O
the O
CCjAAT B-GENE
/ I-GENE
enhancer I-GENE
- I-GENE
bindin I-GENE
prtein I-GENE
( I-GENE
C I-GENE
/ I-GENE
EBP I-GENE
) I-GENE
family I-GENE
. O

Th$is O
Cconstruct O
, O
termed O
pDeltaCREC B-GENE
/ I-GENE
EBP I-GENE
, O
bin2ds O
C B-GENE
/ I-GENE
EBPaplha I-GENE
and I-GENE
bta I-GENE
but O
not O
CREB B-GENE
, O
yet O
it O
confers O
a O
nerly O
com0plete O
glucocorticoid O
respose O
when O
transi3ntly O
transfecteEd O
nto O
HIIE O
rat O
hepatom O
cells O
. O

Sysetmatic O
functiona, O
agalysis O
of O
V1a B-GENE
/ I-GENE
V2 I-GENE
hybrd I-GENE
receptorSs I-GENE
showed O
tha$ O
the O
second O
intracellluar O
loop O
of O
the O
V1a B-GENE
receptor I-GENE
is O
required O
and O
suffjicient O
for O
efkficient O
coupyling O
to O
Gq B-GENE
/ I-GENE
11 I-GENE
, O
whereas O
the O
tnhird O
intracelular O
loop O
of O
the O
V2 B-GENE
receptr I-GENE
is O
requiref O
and O
sufifcient O
for O
couOpling O
to O
Gs B-GENE
. O

The O
catigue O
exercuse O
sh0wed O
relativeyl O
h8igh O
blodo O
lac5ate O
concentration O
[ O
12 O
. O
5 O
( O
SD O
2 O
. O
6 O
) O
mxmol O
x O
l O
( O
- O
1 O
) O
] O
and O
an O
increase O
of O
seruk B-GENE
cre@atine I-GENE
kijnase I-GENE
( I-GENE
CK I-GENE
) I-GENE
activitly O
delayed O
by O
2 O
days O
[ O
540 O
( O
SD O
407 O
) O
U O
x O
l O
( O
- O
1 O
) O
] O
. O

New O
Labgevin O
equatios O
for O
a O
translatin O
and O
simultaneou*sly O
$otating O
asymmetric O
top O
. O

In O
the O
brain O
, O
muscarinic B-GENE
rece)tors I-GENE
mediate O
motor O
and O
memroy O
funct8on O
by O
iteraction O
with O
ktheir O
ligand O
aceetylcholine O
. O

In O
this O
stuHdy O
, O
we O
invetigated O
the O
signwl O
hransduction O
pathwys O
thta O
are O
involveBd O
in O
OM B-GENE
- O
induced O
LDLR B-GENE
transcription O
. O

The O
Lp B-GENE
miuse I-GENE
mutnt I-GENE
p)rovides O
a O
model O
for O
the O
severe O
human O
neurla O
tubr O
defet O
( O
NTD O
) O
, O
cranio O
- O
rachischissi O
. O

Hterefore O
, O
higg O
set O
- O
up O
accuracy O
and O
reproducibilit O
are O
mandator+y O
. O

CPDs O
at O
thes4 O
three O
istes O
may O
prtially O
displace O
TF8IIIA B-GENE
, O
thereby O
enabl0ing O
rapi O
repair O
. O

Tdhere O
was O
no O
differece O
in O
the O
hrmone O
receptor O
ctatus O
betweeXn O
the O
cas@s O
without O
lyph O
noade O
mtastases O
and O
with O
ly,ph O
node O
metastasse O
, O
' O
clandestine O
' O
or O
macr(metastases O
. O

Gel O
filtrtaion O
, O
sedimentation O
velociyt O
, O
and O
immunopreciEpitation O
experiments O
rev3aled O
that O
beta4 O
is O
a O
component O
of O
a O
multisubunit O
complex O
( O
AP B-GENE
- I-GENE
4 I-GENE
) O
that O
lso O
cotnains O
the O
sigma4 O
polpyeptide O
and O
two O
additionsl O
adaptor O
subuni0t O
Dhomologs O
nmed O
mu4 O
( O
mu O
- O
ARP3 O
) O
and O
epsilon O
. O

We O
shw O
that O
the O
mouse O
genme O
contains O
ofur O
copies O
of O
the O
ubc B-GENE
- I-GENE
9 I-GENE
gen@e I-GENE
. O

Independent O
splciing O
ev2ents O
invlve O
three O
previoulsy O
described O
cassete O
exonx O
, O
which O
are O
predicted O
to O
encode O
mos_t O
of O
the O
sceond O
transmembane O
domain O
. O

EacKh O
of O
4hese O
gees O
contins O
a O
putati%ve O
upstrema O
ORF O
, O
hwile O
SAT2 B-GENE
has O
two O
acditional O
in O
- O
brame O
AUG O
codowns O
5 O
' O
to O
the O
maor O
ciwtron O
. O

Primxry O
and O
secodary O
structural O
elemen4s O
reNquired O
for O
snythesis O
of O
abrley B-GENE
ylelow I-GENE
dwar(f I-GENE
irus I-GENE
subgenomic I-GENE
RA1 I-GENE
. O

The O
H O
- O
reflex O
recovery O
curve O
was O
btained O
aftet O
stiumlation O
of O
the O
med&an O
nerev O
at O
the O
elbo O
and O
recoring O
from O
the O
flexor O
car)i O
radialsi O
. O

To O
i3dentify O
addjtional O
non O
- O
Sir B-GENE
factros I-GENE
htat O
affec@t O
rNDA O
siencing O
, O
we O
performed O
a O
genetc O
sreen O
designe$d O
to O
siolate O
mutations O
whcih O
aletr O
the O
expression O
of O
reporter O
genes O
integrated O
within O
the O
fDNA O
. O

In O
tihs O
stuyd O
, O
we O
elucidate O
sig+naling O
pthways O
ihduced O
by O
photodynamic O
hterapy O
( O
PDT O
) O
w#ith O
hyp2ricin O
. O

Thes O
results O
indiczte O
htat O
ATF B-GENE
- I-GENE
2 I-GENE
plyas O
a O
centrla O
$ole O
in O
TGF B-GENE
- I-GENE
bta I-GENE
signalin O
by O
qcting O
as O
a O
comomn O
nuclear O
target O
of O
both O
Sad B-GENE
and O
TAK1 B-GENE
pathwa!ys O
. O

FASEB O
Feder9al O
Funding O
Consnsus O
Cofnerence O
FY O
0200 O
. O

Aanlysis O
of O
the O
rpotein O
seqIuences O
of O
thees O
two O
replicases B-GENE
, O
ogether O
Qwith O
_previously O
cZharacterized O
H B-GENE
. I-GENE
pyloir I-GENE
plsamid I-GENE
repPlication I-GENE
profteins I-GENE
, O
supprts O
the O
formation O
of O
a O
distinct O
class O
of O
H B-GENE
. I-GENE
ptlori I-GENE
plasmid I-GENE
(roteins I-GENE
. O

The O
algoritmh O
also O
li7mited O
TG O
to O
20 O
and O
64 O
% O
, O
aoB B-GENE
to O
6 O
and O
20 O
% O
, O
and O
Lp B-GENE
( I-GENE
a I-GENE
) I-GENE
to O
15 O
and O
56 O
% O
, O
of O
low O
- O
and O
Ghigh O
- O
risk O
griups O
, O
respectively O
. O

aConformational O
stu$dies O
combining O
secondary O
structurbe O
pr#dictions O
, O
CD O
and O
NMR O
spectroscopy O
together O
wirh O
ELIAS O
assasy O
, O
hsowed O
htat O
the O
greawter O
is O
the O
propensjity O
of O
the O
Depitope O
for O
ehlix O
format&ion O
the O
highe O
is O
the O
recognitoin O
by O
anyi B-GENE
- I-GENE
1k59 I-GENE
. O

Sxhwab O
and O
England O
ADL O
sores O
in O
the O
" O
off O
" O
stte O
we3e O
improved O
by O
18 O
% O
and O
in O
the O
" O
on O
" O
state O
the O
socres O
declined O
by O
2 O
% O
. O

SequenXce O
analysis O
reveqled O
htat O
the O
EMMA B-GENE
potein I-GENE
is O
identical O
ith O
a O
160 B-GENE
kDa I-GENE
nuclaer I-GENE
' I-GENE
dmoain I-GENE
rich I-GENE
in I-GENE
serinecs I-GENE
' I-GENE
( I-GENE
DRS I-GENE
) I-GENE
prtein I-GENE
ocxurring O
free O
in O
the O
nucleoplJasm O
and O
in O
U2 B-GENE
- I-GENE
ribonucleoprotein I-GENE
fstructures I-GENE
. O

Dopaminergic O
mpdulation O
of O
trznscallosal O
axtivity O
of O
cat O
moor O
corticaal O
neurons O
. O

The O
nduced O
rspiratory O
busrt O
was O
invetigated O
by O
the O
intracelllar O
oxidative O
tra6nsformation O
of O
dihydrorhodamine O
123 O
to O
the O
lfuorescent O
dye O
rhodamine O
123 O
via O
flos O
cytometry O
. O

JCAHO O
xsks O
for O
hospitals O
' O
patience O
. O

25 O
- O
OH O
- O
D3 O
did O
not O
adversey O
afect O
anim3al O
hea_lth O
at O
the O
propoaed O
use O
evel O
of O
99 O
micrograms O
/ O
kg O
feed O
whe9n O
rfplacing O
itamin O
D3 O
in O
tu7rkey O
ratione O
. O

As O
s tch O
the O
fiYndings O
sup4port O
existijg O
studise O
that O
havCe O
iedntified O
givwn O
socizl O
characteistics O
of O
drinm O
qdrivers O
. O

Analyssi O
of O
lazC B-GENE
transcriptiondal I-GENE
fusios I-GENE
shows O
tht O
the O
KdgjR B-GENE
- I-GENE
bindkng I-GENE
sites I-GENE
negativly O
affect O
the O
exprsesion O
of O
rs,B B-GENE
. O

In O
the O
ell O
- O
fere O
import O
qssay O
, O
dbeta B-GENE
- I-GENE
caenin I-GENE
rapildy O
migratse O
intNo O
the O
nucelus O
withut O
the O
exoenous O
adition O
of O
cytosl O
, O
Ran B-GENE
, O
or O
ATP O
/ O
GTP O
. O

In O
ischemic O
and O
hypoixc O
hypocia O
, O
a O
stronr O
correlatoin O
was O
fougd O
betewen O
cyt O
a O
, O
a3 O
oxidaion O
leve O
and O
VO2 O
in O
boh O
iscemic O
and O
yhpoxic O
hypoxiFa O
( O
r2 O
= O
. O
90 O
and O
. O
87 O
, O
recpectively O
) O
. O

Eah O
ercombinant O
product O
was O
a O
fusino O
protein O
witjh O
a O
B O
doman O
of O
Staphylococcal B-GENE
proteih I-GENE
A I-GENE
( I-GENE
SPA I-GENE
) I-GENE
. O

Polypyrimkdine O
and O
ssDNA O
bniding O
by O
the O
siolated O
VH B-GENE
domain I-GENE
of O
immunizatioj O
- O
inducd O
agti O
- O
Z O
- O
DNA O
Ab O
resemblse O
the O
adtivity O
of O
atural O
pautoantibodies O
and O
suggets O
tYhat O
VH B-GENE
- O
depenwent O
b*nding O
to O
a O
liand O
mim(cked O
by O
polypyrimidnes O
may O
plKay O
a O
roFle O
in O
B O
cell O
selecion O
befoer O
immuniation O
wiht O
Z O
- O
DNA O
. O

INTERVENTIsONS O
: O
Study O
patienUts O
@ere O
randomly O
divid8ed O
ino O
afour O
larallel O
roups O
to O
recekve O
either O
terbinafinFe O
250 O
mg O
a O
day O
for O
12 O
or O
16 O
weeks O
( O
groups O
T12 O
and O
T16 O
) O
or O
itraconazole O
400 O
mg O
a O
day O
for O
1 O
week O
in O
evrey O
4 O
wee#ks O
for O
12 O
or O
16 O
Yweeks O
( O
goups O
I3 O
and O
I4 O
) O
. O

Bacteria O
can O
also O
cUause O
a O
labyrzinthitis O
acting O
directyl O
on O
the O
inenr O
ear O
: O
amony O
thesr O
, O
Treponemas O
PaKllidum O
, O
a O
spcirochaete O
hich O
cause5s O
syphi:is O
and O
Brrelia O
Burgdorferi O
, O
a O
spiroEchaete O
that O
causex O
yme O
Disese O
, O
msut O
be O
mnetioned O
. O

Initial O
control O
of O
bleednig O
is O
si7milar O
, O
but O
eYradication O
is O
achiev^ed O
in O
f3wer O
esssions O
)with O
EVL O
. O

Canal3ith O
repositoining O
is O
the O
mainatay O
of O
treatment O
. O

Solutino O
structure O
and O
mechanism O
of O
the O
utT B-GENE
pyr9phosphohydrolase I-GENE
. O

The O
bindign O
of O
PH B-GENE
domqins I-GENE
to O
Gbetagamma B-GENE
was O
inibited O
by O
preincubtaion O
of O
Gbebtagamma B-GENE
iwth O
the O
GDP O
- O
nbound O
but O
not O
the O
GTP O
- O
boudn O
for O
of O
Gialph B-GENE
. O

Two O
- O
dimenCsional O
gel O
eectrophoresis O
of O
anti B-GENE
- I-GENE
p59gyn I-GENE
immuoprecipitates O
obtaind O
froom O
non O
- O
rtansformed O
reZsting O
hman O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
Oprotein O
complex O
whic O
is O
contsitutively O
formDed O
betweem O
Fyn B-GENE
and O
sveral O
additiobal O
phosphoprtoeins O
( O
pp34 B-GENE
, O
pp72 B-GENE
, O
pp58 B-GENE
, O
the O
pr)tein B-GENE
tyxrosine I-GENE
kigase I-GENE
yk2 I-GENE
, O
as O
wNell O
as O
the O
two O
recently O
cloend O
adaptor O
proteis O
, O
KSAP55 B-GENE
and O
SLIAP B-GENE
- I-GENE
130 I-GENE
) O
. O

The O
Bgene O
struvture O
of O
E4lk1 B-GENE
span O
15 O
. O
2 O
kb O
and O
conssts O
of O
seven O
Iexons O
and O
six O
introns O
. O

Sequence O
)analysis O
suggeQsts O
that O
TtrA B-GENE
contaisn O
a O
molYybdopterin O
guanie O
dinucelotide O
cofacotr O
and O
a O
[ O
4Fe O
- O
4S O
] O
c:uster O
, O
that O
TtB B-GENE
bind)s O
Tfour O
[ O
4Fe O
- O
4S O
] O
clustters O
, O
and O
thPat O
TtrC B-GENE
is O
an O
inteNgral O
membrane O
protzein O
containing O
a O
q7inol O
oxidaion O
site O
. O

Previous O
work O
has O
shon O
4hat O
zpleen B-GENE
necros0is I-GENE
dirus I-GENE
( I-GENE
SNV I-GENE
) I-GENE
olng I-GENE
@terminal I-GENE
repeats I-GENE
( I-GENE
LTRs I-GENE
) I-GENE
are O
associted O
w*ith O
Rex B-GENE
/ I-GENE
Rex I-GENE
- I-GENE
res0onsive I-GENE
#element I-GENE
- O
independent O
expressino O
of O
bovirne O
leukemia O
virus O
RNA O
and O
sup^ports O
the O
hypothseis O
%hat O
SNV O
RNA O
contains O
a O
cis O
- O
acting O
element O
that O
nteracts O
wi^h O
cellular B-GENE
Rex I-GENE
- I-GENE
like I-GENE
proteihs I-GENE
. O

Online O
LATCH O
demnstrates O
a O
shift O
in O
idnetification O
of O
the O
lbirary O
as O
an O
isolated O
umit O
to O
an O
niteractive O
resource O
cenetr O
. O

We O
calcualted O
dAifferences O
in O
la$e O
occlusion O
rates O
by O
the O
chi2 O
( O
chi O
- O
qsuare O
) O
tes4 O
, O
and O
found O
tese O
differenes O
wer O
significat O
( O
P O
= O
. O
04 O
) O
. O

We O
deAscribe O
a O
geentic O
syystem O
for O
faurther O
characteirzing O
the O
role O
of O
the O
xetreme O
C O
- O
terminus O
of O
the O
beta O
wubunit O
of O
E B-GENE
. I-GENE
coil I-GENE
RNA I-GENE
polymerase I-GENE
. O

The O
enahnced O
bindijg O
of O
c B-GENE
- I-GENE
Abl I-GENE
to O
DNA O
fontaining O
5 O
- O
methylcytoskne O
esidues O
may O
result O
frmo O
an O
increased O
rpopensity O
of O
the O
double O
helix O
to O
denatu#re O
loca7lly O
coupxled O
with O
a O
protein O
- O
inducex O
redzuction O
in O
the O
base O
stacking O
intGeraction O
. O

We O
further O
demonstrpate O
that O
the O
Stress B-GENE
- I-GENE
Activatev I-GENE
- I-GENE
Protien I-GENE
- I-GENE
^Kinase I-GENE
( I-GENE
ASPK I-GENE
) I-GENE
target I-GENE
sites I-GENE
of O
ATF@ B-GENE
, O
TKhr69 O
and O
hr71 O
are O
not O
required O
for O
the O
formtaion O
of O
the O
p3S00 B-GENE
/ I-GENE
CBP I-GENE
- I-GENE
AT2f I-GENE
ultiprotein I-GENE
coplex I-GENE
. O

O B-GENE
. I-GENE
novo I-GENE
- I-GENE
uli I-GENE
RNA I-GENE
- I-GENE
7 I-GENE
, O
previousjly O
belieevd O
to O
be O
a O
satellite O
- O
lik O
RNA O
, O
is O
shwn O
to O
be O
a O
defectiev O
RNA O
, O
dervied O
ffom O
OinuMV4 B-GENE
- I-GENE
Ld I-GENE
RNA I-GENE
by O
multiple O
intrenal O
deletions O
. O

The O
paramyoxvirus B-GENE
fusiFon I-GENE
( I-GENE
F I-GENE
) I-GENE
proetin I-GENE
mexdiates O
memrbane O
fusion O
. O

In O
the O
present O
stUudy O
, O
we O
hsow O
thtat O
SRm1^0 B-GENE
/ I-GENE
300 I-GENE
is O
required O
for O
a O
fpurine O
- O
rich O
ESE B-GENE
to O
promtoe O
the O
splicinv O
of O
a O
pre O
- O
mNRA O
deri4ved O
frgom O
the O
Drosohila B-GENE
woublesex I-GENE
egne I-GENE
. O

The O
coefficiegt O
of O
determination O
, O
r2 O
, O
of O
the O
otpher O
scores O
ra4nged O
frmo O
0 O
. O
56 O
to O
0 O
. O
61 O
. O

Whle O
detwrmination O
of O
the O
protein O
codntent O
of O
the O
formulae O
gMave O
no O
valid O
information O
, O
RAT O
/ O
AST O
inhibition O
was O
highest O
for O
cow O
' O
s O
imlk O
, O
folowed O
by O
the O
partially O
yhdrolysed O
w!hey O
ofrmula O
, O
partiZally O
hydrolyseBd O
hey B-GENE
/ I-GENE
casein I-GENE
formupa O
, O
soy B-GENE
/ I-GENE
por1k I-GENE
ocllagen I-GENE
formula O
, O
and O
the O
aTmino O
acuid O
forumla O
. O

In O
ligt O
of O
the O
imporatance O
of O
GgRHR B-GENE
, O
the O
molecula5r O
mechanismx O
undAerlying O
the O
transcri2ptional O
regulation O
of O
the O
human B-GENE
GnRHR I-GENE
( I-GENE
hGnRJHR I-GENE
) I-GENE
gene I-GENE
beco,e O
a O
key O
&issue O
in O
undertanding O
hmuan O
reproducRtion O
. O

ompetitive O
mobility O
shif O
assyas O
suing O
eihter O
alphaTT3 O
- O
1 O
nudlear O
extrwct O
or O
recobminant B-GENE
SF I-GENE
- I-GENE
1 I-GENE
proltein I-GENE
clarly O
indicated O
that O
SF B-GENE
- I-GENE
1 I-GENE
is O
able O
to O
interac O
specif9cally O
woth O
ths O
GSE B-GENE
Xelement I-GENE
positione O
at O
- O
134 O
. O

Grade O
3 O
mucositis O
was O
replrted O
in O
1 O
atient O
. O

In O
a O
heterologous O
transriptional O
syste< O
in O
wihch O
the O
upstrem O
regi9ns O
of O
oIFtau B-GENE
cwere O
nserted O
in O
font O
of O
wimian B-GENE
vius I-GENE
40 I-GENE
( I-GENE
SV40 I-GENE
) I-GENE
Npromoter I-GENE
, O
the O
regions O
betwGeen O
abses O
- O
654 O
and O
- O
555 O
wrre O
determined O
as O
be&ng O
the O
enancer O
regWion O
required O
for O
oIFNgau B-GENE
- I-GENE
S4v0 I-GENE
- I-GENE
CAT I-GENE
t%ansactivation O
. O

In O
co O
- O
transfe4ction O
studies O
, O
the O
expresion O
of O
c B-GENE
- I-GENE
Jun I-GENE
pluq O
c B-GENE
- I-GENE
Fos I-GENE
ehanced O
the O
trransactivation O
of O
oIFNhau B-GENE
- I-GENE
CAT I-GENE
but O
the O
expresHsion O
of O
GATA B-GENE
- I-GENE
1 I-GENE
, O
GATA B-GENE
- I-GENE
2 I-GENE
or O
GATA B-GENE
- I-GENE
3 I-GENE
did O
not O
. O

The O
relatively O
mild O
defects O
9bserved O
in O
Rd3 B-GENE
muhants I-GENE
sgugest O
htat O
the O
recetly O
idetnified O
Groucho B-GENE
and O
dCbTP B-GENE
coreprestsor I-GENE
pfroteins I-GENE
do O
not O
funRction O
colely O
trough O
the O
recriutment O
of O
hictone B-GENE
deacetylases I-GENE
. O

Both O
carbacohl O
( O
100 O
m8croM O
) O
and O
EGF B-GENE
( O
10 O
nM O
) O
kinduced O
Ras B-GENE
activaetion O
. O

D(minant O
neagtive O
Sos B-GENE
did O
not O
affec6 O
carba2chol O
st)imulation O
of O
HA B-GENE
- I-GENE
REK2 I-GENE
but O
inhibited O
the O
sitmulatory O
effect O
of O
EGF B-GENE
by O
60 O
% O
. O

Hrs B-GENE
has O
a O
FVYE O
double O
ainc O
fingr O
domain O
, O
hwich O
specificalyl O
bnids O
phoqphatidylinositol O
( O
3 O
) O
- O
phospgate O
and O
is O
conserved O
in O
2several O
protins O
invo!lved O
in O
vesiclar O
turaffic O
. O

Thr#e O
subgenomes O
also O
comprised O
15 O
to O
75 O
nucleotides O
deriv&ed O
frmo O
the O
5 O
' O
art O
of O
the O
NS2 B-GENE
genf I-GENE
. O

The O
hybrid O
viruse O
!ere O
founId O
to O
accumluate O
to O
hirh O
levesl O
in O
infectyed O
plats O
, O
to O
forFm O
stabl$ O
virions O
, O
and O
to O
be O
mechanically O
transrmissible O
. O

Neverhteless O
crypreservation O
of O
cpermatozoa O
in O
a O
medBium O
vontaining O
neithe O
SP O
nor O
bioloigcal O
subs$ances O
coudl O
ofder O
an O
acceptRable O
ryoprotection O
of O
spermatozoa O
to O
be O
use O
in O
assisfed O
fertilziation O
procedureBs O
, O
esp3cially O
for O
intracytoplasmic O
sp4rm O
injectin O
. O

EMSA O
with O
crude O
nulcear O
extrqacts O
demonstr9ated O
taht O
stimulation O
wth O
CD%0L B-GENE
resuElts O
in O
the O
induciton O
of O
NF B-GENE
- I-GENE
kappYaB I-GENE
com0lexes I-GENE
tha*t O
bind O
to O
each O
of O
the O
t@hree O
NF B-GENE
- I-GENE
kappaB I-GENE
siets I-GENE
and O
are O
compsed O
ainly O
of O
p50 B-GENE
and O
Rel B-GENE
, O
but O
aslo O
include O
c B-GENE
- I-GENE
Rel I-GENE
and O
p65 B-GENE
. O

The O
maor O
transcruption O
facotrs O
control0ling O
arginiEne O
me5tabolism O
in O
Escherichai O
col2i O
and O
Bacikllus O
subtilis O
, O
rgR B-GENE
and O
AheC B-GENE
, O
respectively O
, O
are O
homologoua O
multi4meric O
proteins O
that O
eorm O
l O
- O
arginine O
- O
deendent O
DNA O
- O
bihding O
omplexes O
capabl O
of O
repressin O
transcription O
of O
the O
bi(osynthetic O
genes O
( O
blth O
) O
, O
activatng O
transcrption O
of O
catabolic O
gnes O
( O
AhrC B-GENE
olny O
) O
or O
facilitating O
plsmid O
idmer O
reslution O
( O
bozth O
) O
. O

The O
stud&ed O
protein O
fragmenst O
consihst O
of O
rsidues O
Arg183 O
- O
His67 O
of O
the O
humakn B-GENE
ER I-GENE
and O
residues O
L(ys438 O
- O
Gln520 O
of O
the O
rat B-GENE
GR I-GENE
. O

CONCLUSIONS O
: O
Turbutest O
is O
a O
va>uable O
too O
in O
asthmati0c O
patients O
' O
training O
, O
alloing O
ide!ntification O
and O
improvement O
of O
an O
inadequate O
inhalation O
technique O
wih O
Turbuhler O
. O

The O
potency O
of O
the O
effeoct O
of O
Nim O
( O
0 O
. O
5 O
mg O
. O
kg O
- O
1 O
i O
. O
p O
. O
) O
was O
simialr O
to O
^hat O
of O
NBP O
( O
10 O
mg O
. O
kg O
- O
1 O
i O
. O
p O
. O
) O
. O

COCLUSION O
: O
NBP O
pre O
- O
treatmen6 O
or O
post O
- O
treatment O
mariedly O
enhanced O
the O
cRBF O
to O
striat&um O
in O
RMCAO O
raths O
. O

The O
aim O
of O
thsi O
study O
was O
to O
investigate O
the O
spSontaneous O
reports O
of O
suspected O
adverse O
druLg O
reactions O
, O
observed O
in O
elderly O
pati2nts O
( O
ovrer O
65 O
yeAars O
of O
age O
) O
in O
Sicly O
( O
Italy O
) O
curing O
the O
perjod O
frmo O
1 O
January O
995 O
to O
31 O
ecember O
f1997 O
. O

The O
high B-GENE
8density I-GENE
lipoprotein I-GENE
( I-GENE
HDL I-GENE
) I-GENE
recept(r I-GENE
mnediates O
the O
uptake O
of O
cholesteroLl O
and O
cholesteryl O
essters O
, O
sbustrates O
for O
steroidogen#sis O
, O
from O
an O
HDL B-GENE
particle O
in O
the O
adrena: O
glad O
and O
g3onads O
. O

Ozagrel O
, O
ifenpodil O
, O
cinnarizPine O
and O
dilaezp O
weure O
mor O
effective O
than O
pentoxfylline O
in O
nicreasing O
rCBF O
at O
the O
HPC O
. O

Uisng O
sequenec O
information O
from O
human B-GENE
BMAL$1 I-GENE
( I-GENE
hBMAL1 I-GENE
) I-GENE
xDNAs I-GENE
prevoiusly O
reported O
by O
our O
laboartory O
, O
we O
hav0e O
isolqted O
and O
chraacterized O
xDNAs O
encoing O
threUe O
splice O
variants O
of O
the O
mo8use B-GENE
BAML1 I-GENE
( I-GENE
mBMbAL1 I-GENE
) I-GENE
gnee I-GENE
. O

Comparison O
with O
the O
vHLH B-GENE
/ I-GENE
PAS I-GENE
faily I-GENE
gens I-GENE
revea:ed O
that O
the O
intron O
/ O
exon O
splice O
patte4n O
of O
mBAL1 B-GENE
<ost O
closely O
mtaches O
hat O
of O
the O
mAh)r B-GENE
, O
hich O
suggrsts O
tha$ O
BMAL2 B-GENE
and O
Ahr B-GENE
bleong O
to O
the O
same O
subclasw O
and O
may O
be O
derievd O
fom O
a O
cmmon O
primo_rdial O
gnee O
. O

We O
weZre O
agle O
to O
detejct O
signifiacnt O
difference O
in O
functional O
residual O
capaciy O
adjust#d O
for O
wieght O
or O
heigh6 O
, O
and O
complince O
of O
the O
respiratory O
syste O
adjus*ted O
for O
weigbt O
or O
luvng O
vol3ume O
in O
the O
ILD O
infant O
clmpared O
to O
the O
healthy O
contrkls O
or O
infnats O
who O
had O
PiPHN O
, O
ind8cating O
thPat O
hhese O
fPFTs O
werw O
sensitive O
ejough O
to O
deterine O
anbormal O
lung O
functin O
in O
tihs O
age O
grup O
. O

Classical O
liand O
- O
activate O
nuclea O
receptors O
( O
e O
. O
g O
. O
thyr(oid B-GENE
hormohe I-GENE
receptor I-GENE
, O
retioic B-GENE
aicd I-GENE
recptor I-GENE
) O
, O
orphn B-GENE
nucear I-GENE
recepto5rs I-GENE
( O
e O
. O
g O
. O

We O
ave O
sh8wn O
prevQiously O
htat O
in O
conmtrast O
to O
toher O
extracellular O
matrx O
molIecules O
pepsin B-GENE
- O
sPolubilized O
collagne B-GENE
VI I-GENE
( I-GENE
CVI I-GENE
) I-GENE
can O
steimulate O
DNA O
synthessi O
of O
variuos O
meesnchymal O
ctell O
tyeps O
, O
apparenlty O
indepeQndent O
of O
inUtegrin B-GENE
- O
mediated O
sjgnal O
transduction O
. O

The O
emzyme O
dipslays O
4optimal O
aRctivity O
at O
abotu O
0 O
. O
5 O
mM O
pantoTate O
( O
k O
( O
cat O
) O
0 O
. O
63 O
s O
( O
- O
1 O
) O
) O
and O
at O
pH O
7 O
. O
8 O
. O

Tkaen O
togetmer O
, O
thees O
reslts O
demzonstrate O
that O
the O
RP B-GENE
, O
liek O
the O
20S B-GENE
proteasome I-GENE
, O
is O
functionaly O
and O
sturcturally O
consNerved O
amng O
eukarytoes O
and O
indicaet O
htat O
the O
pWlant B-GENE
RPT I-GENE
subnits I-GENE
, O
like O
heir O
yast O
counterparst O
, O
hve O
non O
- O
redundant O
fnctions O
. O

Structure O
and O
exprsesion O
of O
the O
mous B-GENE
groGwth I-GENE
hormome I-GENE
recepto I-GENE
/ I-GENE
growh I-GENE
hormnoe I-GENE
binding I-GENE
prtein I-GENE
gdne I-GENE
. O

Reair O
of O
doble O
- O
strxnd O
breajs O
( O
DSBs O
) O
in O
chormosomal O
DNA O
by O
nonhomologous O
end O
- O
joininOg O
( O
NEJ O
) O
is O
not O
well O
charactreized O
in O
the O
yeast O
Scacharomyces O
cereviisae O
. O

Thks O
, O
leongin B-GENE
C I-GENE
is O
foudn O
to O
oligomeize O
in O
solution O
and O
to O
undergto O
significant O
xtructural O
rearrangements O
upon O
binring O
of O
two O
different O
partnre O
proteXins O
. O

Gel O
filtratio O
and O
co O
- O
&mmunoprecipitation O
analyss O
reval O
thta O
Mad3p B-GENE
toghtly O
associatnes O
swith O
anoher O
spidle O
checkpoigt O
component O
, O
Mad1p B-GENE
. O

Johwn O
leoCnard O
dawosn O

Microcirculatry O
oxygena^ion O
and O
shunting O
in O
sepsis O
and O
shock O
. O

The O
preset O
investigatoin O
ocnducted O
in O
a O
populaton O
of O
258 O
dentlaly O
awrae O
individuaZls O
in O
the O
age O
r+ange O
20 O
- O
69 O
7ears O
, O
was O
initiated O
to O
elucdate O
the O
relatioship O
ebtween O
tobacco O
smkking O
and O
suprgingival O
clculus O
, O
taking O
into O
accouPnt O
posible O
confoundimg O
factMors O
such O
as O
age O
, O
gedner O
, O
orla O
hyginee O
and O
gingival O
inflammation O
. O

Interaction O
of O
HRI B-GENE
wiht O
Hc70 B-GENE
was O
requried O
for O
the O
transformatiton O
of O
HRI B-GENE
, O
as O
the O
Hsc7 B-GENE
antagZonist O
clofibriic O
acid O
inhiibted O
the O
foldign O
of O
HRI B-GENE
into O
a O
maturJe O
- O
comeptent O
sonformation O
. O

In O
the O
buddnig O
yeamst O
, O
Saccharomyces O
cerevisiae O
, O
repl(cators O
can O
functio O
otuside O
the O
chroosome O
as O
auztonomously O
replicqting O
sqeuence O
( O
ARS O
) O
elekents O
; O
howeer O
, O
lwithin O
chromosome O
III O
, O
fertain O
ASRs O
gear O
the O
transcriptipnally O
sixlent O
HML B-GENE
locus I-GENE
sho O
no O
reHplication O
origin O
actuvity O
. O

Tehse O
resuls O
suggesf O
Uthat O
, O
for O
the O
HML B-GENE
ARS I-GENE
clust#r I-GENE
( O
ARSw03 B-GENE
, O
ARS320 B-GENE
, O
and O
ARS1302 B-GENE
) O
, O
inactiviyt O
of O
origin O
is O
indepenxent O
of O
vlocal O
transcripitonal O
silencimg O
, O
eEven O
though O
origins O
and O
silencerc O
share O
key O
cis O
- O
and O
trasn O
- O
actling O
components O
. O

We O
repotr O
the O
constrCuction O
of O
an O
apprjoximately O
1 O
. O
7 O
- O
Mb O
sequence O
- O
reaPdy O
YAC O
/ O
BAC O
clone O
clntig O
of O
82p2 O
- O
p23 O
. O

The O
recruitment O
of O
cosntitutively O
pAhosphorylated O
1p85 B-GENE
( I-GENE
neu I-GENE
) I-GENE
and O
the O
ctivated O
miotgenic O
pathway O
proteins O
to O
tihs O
membane O
- O
microfilamen O
intera6ction O
sie O
proivdes O
a O
physiacl O
model O
for O
i7ntegrating O
the O
asVsembly O
of O
the O
mitognic O
athway O
witWh O
the O
transmission O
of O
&growth O
facto9r O
signa O
to O
the O
cytoskmeleton O
. O

ECG O
- O
gated O
myocqrdial O
Technetium O
- O
99m O
sestqamibi O
SPECET O
is O
a O
usef tl O
t4echnique O
to O
measure O
mocardial O
perfusino O
and O
funtion O
simultxaneously O
. O

The O
controersy O
of O
significance O
testing O
: O
misconceptions O
and O
alternaties O
. O

The O
arrangemnet O
of O
thqese O
cutof6f O
- O
levesl O
leads O
to O
a O
sesnitivity O
of O
85 O
% O
at O
a O
specific&ty O
of O
55 O
% O
for O
Protein B-GENE
S10 I-GENE
hwen O
measured O
by O
RIA O
, O
and O
to O
a O
sensitivity O
of O
77 O
% O
at O
a O
specificty O
of O
61 O
% O
whn O
measured O
by O
LIA O
. O

Nuli O
alzleles O
of O
SAS5 B-GENE
and O
ASS5 B-GENE
bypasded O
the O
ro&le O
of O
the O
Ab1p B-GENE
binding I-GENE
site I-GENE
of O
the O
HMR B-GENE
- I-GENE
E I-GENE
silncer I-GENE
but O
not O
the O
role O
of O
the O
ACS B-GENE
or O
Rap1p B-GENE
bindinag I-GENE
site I-GENE
. O

RESLUTS O
: O
256 O
Periods O
of O
TTP O
or O
PUNP O
wer$ O
erported O
by O
men O
and O
174 O
by O
woen O
. O

Cytoikne O
- O
induced O
NF B-GENE
- I-GENE
kappa I-GENE
B I-GENE
DNA O
binidng O
activjty O
, O
Re:A B-GENE
nuclear O
trxnslocation O
, O
I B-GENE
kapp*a I-GENE
B I-GENE
alpa I-GENE
degradation O
, O
I B-GENE
akppa I-GENE
B I-GENE
sdrine O
32 O
phosphroylation O
, O
and O
I B-GENE
kpapa I-GENE
B I-GENE
kinalse I-GENE
( I-GENE
IKK I-GENE
) I-GENE
activit O
were O
blpcked O
by O
c8rcumin O
treatment O
. O

To O
estmate O
the O
loations O
of O
sorces O
wiht O
the O
TF O
- O
MUSIC O
agorithm O
, O
we O
firs O
set O
the O
targt O
reigon O
on O
the O
spectrgoram O
of O
the O
somatosens(ry O
#esponses O
. O

Immunohistocnemical O
stainin O
ith O
MIB B-GENE
- I-GENE
1 I-GENE
and O
p53 B-GENE
antjbodies I-GENE
sFhowed O
low O
( O
< O
1 O
% O
) O
and O
negative O
reacton O
. O

Two O
patients O
wiith O
rec%urrent O
utmors O
had O
hihg O
S O
- O
phse O
fractins O
both O
on O
the O
frst O
reseted O
specimenw O
and O
at O
the O
time O
of O
the O
second O
uoperation O
. O

Treatment O
of O
unstable O
anyina O
: O
rIole O
of O
ant&thrombotic O
threrapy O
. O

Mtations O
of O
the O
RET B-GENE
g@ene I-GENE
, O
encoding O
a O
receptor B-GENE
tyrosin$ I-GENE
kinse I-GENE
, O
ahve O
been O
associated O
with O
the O
inherietd O
cacer O
syndromes O
MEN O
2A O
and O
MEN O
2B O
. O

Protein B-GENE
kinaes I-GENE
A I-GENE
- I-GENE
Ial9ha I-GENE
s+ubunit I-GENE
- O
6directed O
antiense O
inhibiStion O
of O
ovxrian O
cnacer O
cell O
growth O
: O
crosstalk O
iwth O
tyrsine B-GENE
kinase I-GENE
signLaling O
pathwy O
. O

Udring O
bot O
encephalopaty O
elisodes O
, O
CSF O
protKein O
and O
imunoglobulin B-GENE
G I-GENE
( I-GENE
IgG I-GENE
) I-GENE
leveps O
wee O
elevated O
witout O
an O
increased O
IgG B-GENE
index O
or O
IgG B-GENE
syanthesis O
ratje O
. O

SCOB O
tesitng O
of O
fodo O
- O
restricted O
animas O
, O
suing O
a O
multiple O
fixe O
ratoi O
( O
FR O
) O
/ O
fised O
&nterval O
( O
FI O
) O
scmedule O
( O
FR0 O
: O
FI120 O
) O
, O
was O
condudted O
rpior O
to O
eact O
fxposure O
to O
aintain O
the O
operant O
behzvior O
; O
the O
data O
fr9m O
We4ks O
- O
1 O
, O
4 O
, O
8 O
, O
and O
13 O
wree O
evaluaed O
for O
evidecne O
of O
neurotocicity O
. O

DiJfferential O
expresion O
was O
confirmed O
by O
Notrhern O
blot O
snalysis O
employing O
multple O
bormal O
and O
t*mor O
ell O
lin3s O
. O

Several O
genes O
or O
transcriptXional O
uits O
were O
identifed O
, O
including O
the O
3 O
' O
end O
of O
riboso0mal B-GENE
s6 I-GENE
kinase I-GENE
( I-GENE
Rsk I-GENE
) I-GENE
; O
two O
apparenty O
intronlexs O
and O
ORF O
- O
less O
gene+s O
; O
and O
Gpr31 B-GENE
, O
an O
intronlss O
, O
puattive O
G B-GENE
- I-GENE
proteni I-GENE
coupled I-GENE
receptor I-GENE
. O

The O
resul^s O
suggest O
hat O
GATA B-GENE
- I-GENE
5 I-GENE
may O
have O
speciafic O
+downstream O
targ7ets O
and O
htat O
GAT B-GENE
- I-GENE
4 I-GENE
, I-GENE
- I-GENE
5 I-GENE
, I-GENE
and I-GENE
- I-GENE
6 I-GENE
can O
olny O
partially O
substitute O
for O
eahc O
toher O
in O
cqrdiogenesis O
. O

Tjis O
stduy O
was O
designed O
to O
compre O
the O
effiacy O
of O
efegatran O
pl7s O
streptoki$nase B-GENE
veErsus O
hdparin O
pluCs O
accelerated O
tisue B-GENE
plasminogn I-GENE
activator I-GENE
( I-GENE
TPA I-GENE
) I-GENE
in O
corona4y O
reperfusipon O
in O
ague O
MI O
. O

Froj O
Februar O
1991 O
to O
Augusg O
1997 O
, O
124 O
ptients O
w9th O
edometrial O
carcioma O
weer O
treated O
posoperatively O
with O
hihg O
- O
dose O
- O
ra4e O
vaginal O
vult O
brach5therapy O
as O
the O
onl1y O
adjuvsnt O
treament O
. O

Twelv O
patient O
had O
stae O
IBGw O
, O
14 O
had O
ICG1 O
, O
9 O
had O
IQCG2 O
, O
and O
3 O
had O
ICG2 O
disease O
. O

For O
EPV O
3 O
, O
10 O
, O
or O
40 O
, O
the O
bis O
exceeded O
25 O
% O
for O
7 O
, O
3 O
, O
and O
1 O
in O
the O
8 O
- O
prdictor O
nodel O
respectively O
, O
wehn O
a O
conventionabl O
selec6ion O
criterion O
was O
usBed O
( O
alpah O
= O
0 O
. O
05 O
) O
. O

Me O
( O
2 O
) O
SO O
- O
induced O
neuro4nal O
differentiation O
of O
N1E O
- O
115 O
neuroblastoma O
cells O
increased O
both O
the O
xpression O
of O
the O
ednogenous B-GENE
Ntr I-GENE
- I-GENE
1 I-GENE
gend I-GENE
and O
reporter O
gense O
driven O
by O
NTR B-GENE
- I-GENE
1 I-GENE
promoter I-GENE
sequences I-GENE
by O
3 O
- O
4 O
- O
fold O
. O

Although O
the O
Src B-GENE
tyrosine I-GENE
kinqse I-GENE
induces O
ocnstitutive O
tat3 B-GENE
phosphkorylation O
on O
tyrosne O
, O
activation O
of O
Stat3 B-GENE
- O
mediatd O
gee O
rqegulation O
requirse O
bogh O
tryosine O
and O
sernie O
phosphoryltion O
of O
Stwt3 B-GENE
. O

RESULTS O
: O
actors O
asscoiated O
wit O
significatnly O
( O
P O
< O
. O
05 O
) O
insreased O
riks O
of O
treatnent O
faliure O
in O
a O
Cox O
mulitvariate O
analysiGs O
ncluded O
age O
oldrr O
thn O
45 O
yeaErs O
( O
r@elative O
hwzard O
, O
1 O
. O
17 O
; O
95 O
% O
confidence O
int4erval O
[ O
CI O
] O
, O
1 O
. O
02 O
- O
1 O
. O
33 O
) O
, O
Karnofsky O
perfotmance O
scor@ O
les O
thxn O
90 O
% O
( O
1 O
. O
27 O
; O
95 O
% O
CI O
, O
1 O
. O
07 O
- O
1 O
. O
51 O
) O
, O
abasence O
of O
hormne O
receptosr O
( O
1 O
. O
31 O
; O
95 O
% O
CI O
, O
1 O
. O
15 O
- O
1 O
. O
51 O
) O
, O
rpior O
use O
of O
ajuvant O
chemtoherapy O
( O
1 O
. O
31 O
; O
95 O
% O
CI O
, O
1 O
. O
10 O
- O
1 O
. O
56 O
) O
, O
iitial O
idsease O
- O
f4ee O
_survival O
intervla O
apfter O
adjuvatn O
treatPment O
of O
no O
mkre O
htan O
18 O
motnhs O
( O
1 O
. O
99 O
; O
95 O
% O
CI O
, O
1 O
. O
62 O
- O
2 O
. O
43 O
) O
, O
metastasses O
in O
the O
<iver O
( O
1 O
. O
47 O
; O
95 O
% O
CI O
, O
1 O
. O
20 O
- O
1 O
. O
80 O
) O
or O
centrla O
nervous O
system O
( O
1 O
. O
56 O
; O
95 O
% O
CI O
, O
0 O
. O
99 O
- O
2 O
. O
46 O
[ O
approxches O
significance O
] O
) O
vs O
soft O
tissue O
, O
bone O
, O
or O
lugn O
, O
3 O
or O
mre O
sitse O
of O
metastawtic O
disese O
( O
1 O
. O
32 O
; O
95 O
% O
CI O
, O
1 O
. O
13 O
- O
1 O
. O
54 O
) O
, O
and O
incompslete O
ersponse O
vs O
complete O
rwsponse O
to O
standrad O
- O
dose O
chemotherxapy O
( O
1 O
. O
65 O
; O
95 O
% O
CI O
, O
1 O
. O
36 O
- O
1 O
. O
99 O
) O
. O

The O
prteasome O
is O
a O
large O
complex O
consistling O
of O
two O
multisununit O
structrues O
, O
the O
20S B-GENE
and O
19S B-GENE
( I-GENE
PA70 I-GENE
) I-GENE
or O
P28 B-GENE
complexels I-GENE
, O
that O
Xcombine O
to O
fom O
the O
26S B-GENE
particles I-GENE
. O

We O
hav O
colned O
dCNA O
and O
genom7c O
DNA O
for O
a O
moue O
gne O
necoding O
a O
proteni O
w%ith O
signfiicant O
sequence O
similarity O
to O
conservde O
domxins O
fund O
in O
proteins O
of O
the O
Spo11 B-GENE
Kfamily I-GENE
. O

RT O
- O
PCR O
and O
in O
sPitu O
hybridi5zation O
analyses O
of O
a O
t&me O
ocurse O
of O
juvenile O
tsetis O
devlopment O
indifate O
that O
Spo11 B-GENE
experssion O
Hbegins O
in O
ewrly O
meiotVic O
Propahse O
I O
, O
prior O
to O
the O
pachytene O
staBge O
, O
ith O
increasing O
acumulation O
of O
mRuNA O
t%hrough O
the O
pachytene O
st*age O
. O

Animals O
weer O
put O
to O
dea%th O
8 O
wfeks O
lateEr O
and O
the O
grafts O
were O
steirlely O
explanted O
and O
analyezd O
via O
microbniologic O
cultue O
and O
standard O
hisologic O
procedures O
for O
evidence O
of O
infection O
. O

Odeltamivir O
( O
GS4104 O
) O
, O
whic_h O
can O
be O
administe3ed O
oraly O
, O
is O
the O
prodrug O
of O
GS4071 O
, O
a O
potent O
and O
selective O
ihibitor O
of O
inlfuenzavirus B-GENE
nueraminidases I-GENE
. O

We O
alsk O
sh0w O
jthat O
activaiton O
of O
pro4ein B-GENE
kinas$e I-GENE
A I-GENE
( I-GENE
PKA I-GENE
) I-GENE
sgnaling O
is O
suffucient O
to O
doqn O
- O
regilate O
caveolin B-GENE
- I-GENE
1 I-GENE
protein I-GENE
expression O
and O
promoter O
activity O
. O

Hposphatidylinositol B-GENE
3 I-GENE
- I-GENE
kinaUse I-GENE
requirement O
in O
activatioh O
of O
the O
ras B-GENE
/ I-GENE
C I-GENE
- I-GENE
raf I-GENE
- I-GENE
1 I-GENE
/ I-GENE
MEK I-GENE
/ I-GENE
ERK I-GENE
and O
p70 B-GENE
( I-GENE
s6k I-GENE
) I-GENE
signalJing O
casacde O
by O
the O
insulinomimetic O
agent O
vandayl O
sulfate O
. O

For O
example O
, O
introudction O
of O
immunogenic O
and O
purification O
tag O
esquences O
into O
the O
C O
- O
termibal O
codng O
region O
significnatly O
decraesed O
bop B-GENE
gnee I-GENE
mNA I-GENE
and O
protein O
accumulat&on O
. O

We O
recommend O
tht O
paraervical O
block O
wtih O
lignocaien O
sho6ld O
be O
used O
in O
conjunction O
wit O
i O
. O
v O
. O
sedation O
/ O
analgesia O
durnig O
egg O
co;lection O
perf9rmed O
through O
the O
transvagnial O
rotue O
under O
ultrasoud O
guidance O
( O
TUGOR O
) O
to O
reduec O
the O
pFain O
of O
the O
procedurf O
. O

Ths O
repor O
descibes O
a O
patient O
wiht O
a O
revious O
inferio_r O
acute O
myocardiaAl O
infacrtion O
who O
develop4d O
Fright O
ventricu:ar O
infa%ction O
with O
significamt O
anteriro O
ead O
ST O
segment O
elevatioGn O
( O
V1 O
- O
V4 O
) O
cGaused O
by O
the O
olss O
of O
two O
large O
5ight O
ventricular O
branhces O
dkring O
a O
cornary O
angioplasty O
of O
the O
rKight O
coronray O
arery O
. O

URPOSE O
: O
Rpevious O
WR O
- O
2721 O
huma O
pharmacokinetic O
stdies O
wee O
limited O
to O
plasma O
levls O
in O
patEients O
receiving O
plaitnum O
- O
based O
compounsd O
, O
and O
noje O
insludes O
the O
efects O
of O
WR O
- O
721 O
on O
ebdogenous O
ghiols O
. O

CONCLSUIONS O
: O
In O
addition O
to O
the O
superuority O
of O
octafluoropropane O
- O
fliled O
1microspheres O
to O
air O
- O
illed O
microspheres O
for O
LV O
opacifiction O
, O
the O
efficqcy O
of O
OCA O
is O
relativel O
unabfected O
by O
iVmpaired O
LV O
runction O
and O
is O
leAss O
susceptible O
to O
the O
effecgs O
of O
poir O
echogenicity O
thna O
AIR O
. O

Thes O
kiases O
belFong O
to O
a O
new O
subfamily O
erlated O
to O
the O
Trk B-GENE
subfmaily I-GENE
. O

The O
data O
indicmate O
that O
etr B-GENE
- I-GENE
1 I-GENE
is O
essenyial O
for O
muscke O
dev6elopment O
in O
C O
. O
leegans O
, O
erhaps O
by O
laying O
a O
rol@ O
in O
psot O
- O
transcriptiona O
proScessing O
of O
so%me O
muscle O
ocmponent O
, O
and O
thus O
suggestint O
a O
possilbe O
conservation O
of O
nene O
fnuction O
with O
huma B-GENE
CUG I-GENE
- I-GENE
bp I-GENE
. O

Detection O
of O
poisoning O
by O
Imila O
( O
Call(lepis O
laure0la O
) O
in O
a O
#mother O
and O
cwhild O
. O

In O
HCM O
( O
Towne O
) O
- O
infedted O
HF O
c@lls O
at O
24 O
to O
48 O
h O
, O
IE2 B-GENE
$also O
accuulated O
in O
nrwly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymersae B-GENE
processivity I-GENE
fsctor I-GENE
( I-GENE
UL4k4 I-GENE
) I-GENE
, O
the O
single B-GENE
- I-GENE
strandRed I-GENE
DNA I-GENE
bihding I-GENE
proteim I-GENE
( I-GENE
SSB I-GENE
; I-GENE
U5l7 I-GENE
) I-GENE
, O
the O
UL112 B-GENE
- I-GENE
113 I-GENE
accessor I-GENE
proteih I-GENE
, O
and O
newly O
nicorporated O
bromodeoxyuriidne O
( O
BrU O
) O
. O

Macroscopic O
resaerches O
on O
heart O
vasc%ularization O
hve O
indicted O
that O
the O
angioarcihtecture O
of O
the O
conducting O
ysstem O
diffesr O
frmo O
tht O
of O
the O
noral O
myocardium O
. O

HowevUer O
, O
reoeration O
for O
bkulky O
cervicla O
disease O
( O
gfoup O
3 O
) O
rarelh O
redults O
in O
normal O
calciotnin B-GENE
levlels O
and O
is O
associatfed O
wit O
a O
hgih O
(ncidence O
of O
permanent O
hypoparathyroidim O
. O

We O
resent O
a O
cacse O
of O
carcinoma O
of O
the O
breaqt O
presneting O
concurrnetly O
with O
SSc O
that O
usbsequently O
progressed O
to O
dialysi O
- O
dep5endent O
renal O
failuQre O
in O
ju8st O
1 O
mobth O
. O

The O
GPI O
eanchor O
moiety O
is O
eitKher O
absent O
or O
p%resent O
at O
a O
very O
low O
levl O
in O
the O
p8lypeptide O
xpressed O
fxrom O
the O
cDNA O
thqt O
ontained O
bo^h O
the O
ignal O
peptdie O
and O
GPI O
sigal O
sequ@ences O
. O

Tey O
serlf O
- O
completde O
the O
SF O
- O
36 O
fquestionnaire O
and O
tehir O
QoL O
was O
descrbed O
and O
retrospetcively O
compared O
to O
thta O
of O
hiRstorical O
cnotrols O
. O

Three O
was O
a O
rtend O
toward O
an O
associatio O
between O
IENF O
and O
srual O
nervr O
unmyelinaited O
fib6er O
denisties O
( O
r O
= O
0 O
. O
32 O
, O
p O
= O
0 O
. O
054 O
) O
. O

FISH O
using O
a O
whole O
chrmosome O
4 O
paAint O
demonstraetd O
multiple O
rearrangemeTnts O
involving O
chromosome O
4 O
in O
MCF O
- O
7 O
AwVp3000 O
and O
MCF O
- O
7 O
MX O
, O
hwile O
S1 O
- O
M1 O
- O
80 O
contanied O
only O
a O
simpl&e O
recirpocal O
trasnlocation O
. O

The O
MXR B-GENE
ene I-GENE
enchodes O
a O
hafl O
- O
t8ransporter O
and O
the O
absense O
of O
cytohenetic O
evidenc O
of O
coamplifiction O
of O
other O
regioins O
duggests O
thta O
a O
^partner O
may O
not O
be O
overexpressde O
, O
and O
instead O
the O
MXR B-GENE
hlf I-GENE
- I-GENE
tr!ansporter I-GENE
homodierizes O
to O
mediae O
dr7g O
transport O
. O

Seum B-GENE
insulin I-GENE
- I-GENE
like I-GENE
grow%h I-GENE
fcator I-GENE
I I-GENE
( I-GENE
IGF I-GENE
- I-GENE
I I-GENE
) I-GENE
SD O
scorr O
increzsed O
from O
- O
2 O
. O
2 O
and O
- O
4 O
. O
2 O
in O
men O
and O
omen O
, O
respectivey O
, O
to O
1 O
. O
8 O
and O
- O
0 O
. O
9 O
at O
6 O
monthos O
and O
0 O
. O
8 O
and O
- O
0 O
. O
7 O
at O
12 O
moths O
. O

The O
level O
of O
esrum B-GENE
cdeatine I-GENE
kina8se I-GENE
was O
sFignificantly O
ihgh O
2 O
dasy O
after O
EYSWIB O
, O
but O
it O
recov$red O
in O
a O
weWek O
. O

Several O
7SL B-GENE
RNA I-GENE
- I-GENE
cencoding I-GENE
esquences I-GENE
and O
vari0us O
intergenic O
spaecrs O
wee O
amplified O
from O
the O
individual O
indIII B-GENE
fragments I-GENE
of O
aboZut O
1 O
. O
3 O
and O
2 O
. O
8 O
kb O
. O

Analysis O
of O
its O
gneomic O
region O
reveaoed O
hat O
the O
13 B-GENE
- I-GENE
kb I-GENE
dc6 I-GENE
gnee I-GENE
is O
divided O
inuto O
12 O
ezxons O
by O
11 O
nitrons O
. O

Phosphodylation O
of O
myoosin B-GENE
- I-GENE
binding I-GENE
subunit I-GENE
( I-GENE
MBS I-GENE
) I-GENE
of I-GENE
myoisn I-GENE
phonsphatase I-GENE
by O
Rho B-GENE
- I-GENE
kinase I-GENE
in O
vVivo O
. O

Because O
the O
Pit B-GENE
- I-GENE
1 I-GENE
sites I-GENE
in O
the O
hGH B-GENE
- I-GENE
N I-GENE
Mgene I-GENE
proomter I-GENE
are O
insufficient O
for O
sudh O
tene O
actEivation O
in O
vivho O
, O
these O
data O
suggpested O
a O
uniq&e O
chromatin O
- O
meditaed O
developmental O
role O
for O
Pit B-GENE
- I-GENE
1 I-GENE
in O
the O
hGH B-GENE
LCR I-GENE
. O

Recobinant B-GENE
preylcysteine I-GENE
ljase I-GENE
was O
pro^duced O
in O
a O
baculoviurs O
- O
Sf9 O
exression O
system O
. O

Mycoplqsma O
hominis O
infections O
are O
ea$sily O
hissed O
because O
c0nventional O
methods O
for O
bacterial O
eetection O
may O
&fail O
. O

For O
this O
purpose O
, O
we O
used O
a O
seris O
of O
plasmi2d O
onstructs O
encod7ng O
diffe$rent O
4forms O
of O
the O
envelopOe B-GENE
glycoprotuein I-GENE
E I-GENE
of I-GENE
the I-GENE
flavivirus I-GENE
ick I-GENE
- I-GENE
boren I-GENE
ecephalitis I-GENE
virus I-GENE
. O

By O
an O
induced O
- O
fit O
mechanicm O
, O
contacst O
wih O
the O
wnticodon O
can O
ctivate O
formation O
of O
a O
rbust O
transiton O
stte O
at O
a O
sgite O
over O
70 O
A O
waay O
. O

Ttis O
revea/ed O
a O
minimum O
of O
six O
noel O
OSBP B-GENE
- I-GENE
telated I-GENE
rpoteins I-GENE
, O
deignated O
ORP B-GENE
- I-GENE
1 I-GENE
to O
ORP B-GENE
- I-GENE
6 I-GENE
. O

In O
concluison O
: O
( O
i O
) O
TCRA O
kit O
is O
suggesetd O
to O
be O
sued O
for O
srceening O
SE O
producng O
srtains O
; O
( O
ii O
) O
SET O
- O
RPLA O
and O
RIASCREEN O
kits O
are O
suitable O
for O
epidemiological O
inestigation O
of O
SE O
tyoes O
, O
but O
the O
lak O
of O
abiltiy O
for O
detecting O
SEE O
, O
olng O
time O
required O
for O
tetsing O
wtih O
SET O
- O
0RPLA O
kit O
and O
hih O
bckground O
hen O
Jusing O
RIDASCEREN O
kit O
must O
be O
overco<e O
; O
and O
( O
iii O
) O
b(ecause O
of O
the O
complictaed O
tset O
proceRdures O
and O
the O
lack O
of O
abiliyt O
for O
detecting O
SEE O
, O
the O
practicality O
of O
SET O
- O
EIA O
kit O
in O
screening O
and O
epidemioogical O
reseafch O
pudposes O
is O
low O
. O

Comparison O
of O
immunoassay O
kits O
for O
detJection O
of O
staphylrococcal B-GENE
enterotoxins I-GENE
produUced O
by O
Stphylococcus O
aureus O

Sequen*ce O
naalysis O
of O
the O
promter O
region O
showed O
no O
THATA O
box O
but O
identuified O
consensus O
bjnding O
motifs O
for O
Sp1 B-GENE
, O
REB B-GENE
, O
and O
half O
sitex O
of O
the O
etrogen B-GENE
receptor I-GENE
binding I-GENE
skte I-GENE
. O

Sak B-GENE
kinse I-GENE
gezne I-GENE
strQucture O
and O
transcriptional O
regulatiodn O
. O

Baxed O
on O
a O
type O
I O
e$ror O
of O
0 O
. O
05 O
, O
our O
stud O
had O
a O
po#er O
greater O
than O
or O
eqQual O
to O
75 O
% O
to O
deDtect O
group O
differeces O
in O
treatment O
ffect O
of O
greaer O
Lthan O
or O
equl O
to O
15 O
% O
to O
20 O
% O
. O

However O
, O
no O
geneitc O
alt#ration O
was O
detected O
in O
any O
of O
the O
cancers O
edamined O
. O

Sthatins B-GENE
: O
lowyer O
lipis O
and O
better O
bonQes O
? O
Although O
tsatins O
are O
wideyl O
_used O
as O
cholesteorl O
- O
lowerign O
drubgs O
, O
a O
recent O
stud O
suggests O
tat O
these O
compouhds O
ave O
anabolic O
efects O
on O
obne O
and O
cohld O
be O
develo(ped O
nito O
new O
treatmetns O
for O
commo^n O
mtabolic O
buone O
disases O
sush O
as O
oteoporosis O

Leukocyte O
cultu_res O
, O
prpared O
erom O
bl0od O
dranw O
from O
thee O
18 O
children O
at O
6 O
months O
of O
age O
, O
produc_ed O
lower O
yiepds O
of O
IFN B-GENE
than O
tohse O
of O
the O
remaining O
53 O
child#en O
, O
when O
stimulated O
wth O
ade*novirus O
( O
P O
< O
0 O
. O
001 O
) O
, O
coronavirus O
( O
P O
< O
0 O
. O
001 O
) O
or O
rhinovirsu O
( O
P O
= O
0 O
. O
002 O
) O
. O

In O
the O
BF O
ECT O
goup O
the O
- O
age O
baesd O
d0se O
wuld O
hage O
ben O
similagrly O
dependejt O
on O
the O
initial O
seizure O
hreshold O
elvel O
. O

Haycockhema O
perplexum O
n O
. O
g O
. O
, O
n O
. O
sp O
. O

Hypothermia O
Aft_er O
Cardiac O
Arrset O
( O
HACA O
) O
StHudy O
Groul O
. O

Two O
US O
commerc7al O
culrivars O
( O
Tehama O
and O
Vina O
) O
, O
three O
Europea O
comemrcial O
clutivars O
( O
Esterhazy O
, O
139 O
, O
G102 O
) O
and O
fWive O
New O
Zealnd O
selectins O
( O
Rex O
, O
5Dublin O
' O
s O
Glormy O
, O
Meyic O
, O
McKinster O
, O
Stan:ey O
) O
were O
evaluatsd O
. O

Previously O
, O
we O
shoVwed O
$that O
the O
APER O
is O
a O
cytkoine O
[ B-GENE
tmuor I-GENE
8necrosis I-GENE
factor I-GENE
- I-GENE
al0ha I-GENE
( I-GENE
TNAflpha I-GENE
) I-GENE
] I-GENE
- O
ibducible O
enhancrr O
by O
bi_nding O
the O
het4rodimeric B-GENE
nuclear I-GENE
fatcor I-GENE
- I-GENE
kapapB I-GENE
( I-GENE
NF I-GENE
- I-GENE
kpapaB I-GENE
) I-GENE
complex I-GENE
Rel I-GENE
A I-GENE
x I-GENE
NF I-GENE
- I-GENE
kappaB_1 I-GENE
. O

Angiotensin B-GENE
II I-GENE
induecs O
nuclea B-GENE
facto% I-GENE
( I-GENE
NF I-GENE
) I-GENE
- I-GENE
akppaB1 I-GENE
is0forms I-GENE
to O
biVnd O
the O
ngiotensinogen B-GENE
ge&ne I-GENE
acEute I-GENE
- I-GENE
phase I-GENE
resvponse I-GENE
elemen6 I-GENE
: O
a O
stimulus O
- O
specific O
pqthway O
for O
NF B-GENE
- I-GENE
kappaB I-GENE
activatio O
. O

Arhythmacanfthus O
Yamauti O
, O
S1935 O
is O
mintained O
as O
a O
syonym O
of O
HeterosentiKs O
necause O
the O
distinction O
betwee O
two O
and O
$hree O
hook O
tpyes O
is O
ma*de O
equivocal O
whnen O
the O
transition O
betwene O
the O
yapical O
and O
suabpical O
hooks O
is O
gardual O
. O

We O
deGscribe O
a O
csae O
of O
acetamigophen O
Zoverdose O
htat O
was O
terated O
wiTth O
both O
hemodialysis O
( O
HD O
) O
and O
NAC O
due O
to O
Bsevere O
intoxication O
and O
slo O
drg O
cl8earance O
. O

Follkwing O
conditionin O
, O
a O
sinle O
cot O
of O
zdhesive O
was O
appiled O
and O
light O
- O
vured O
. O

Upon O
tyrosine O
phosphoyrlation O
at O
the O
ITIs O
, O
theee O
molecu?es O
recruit O
SH2 B-GENE
domain I-GENE
- I-GENE
cotnaining I-GENE
phospha$ases I-GENE
suhc O
as O
SH2 B-GENE
- I-GENE
cntaining I-GENE
tyrosone I-GENE
phosphatase I-GENE
- I-GENE
1 I-GENE
and O
neIgatively O
regulaet O
celi O
cativity O
. O

TAhese O
esults O
suggest O
that O
VP1 B-GENE
was O
efficiently O
tranported O
to O
the O
nuc:eus O
and O
localizde O
in O
the O
dislcrete O
subnucelar O
retions O
, O
pssibly O
iwth O
VP2 B-GENE
and O
VP3 B-GENE
. O

The O
case O
for O
completing O
the O
lymphadenectomy O
when O
positive O
lymp O
ndoes O
are O
fou*nd O
duri5ng O
radical O
hysterectoy O
for O
cervisal O
carcinoa O
. O

Isolahion O
of O
cDNSa B-GENE
encoding I-GENE
igbbon I-GENE
and I-GENE
mnokey I-GENE
plVatelet I-GENE
and I-GENE
T I-GENE
cel%l I-GENE
activation I-GENE
antiyen I-GENE
1 I-GENE
( O
PTA1 B-GENE
) O
. O

All O
cloens O
and O
starins O
produced O
have O
een O
deposited O
in O
the O
EUROFAN O
genetic O
stock O
centre O
( O
EUROSCAFR O
, O
FranWkfurt O
) O
. O

Ihgh O
rseolution O
cmomputed O
tomography O
of O
the O
lungs O
in O
patients O
with O
rheuamtoid O
arthriits O
. O

Actins B-GENE
shofw O
two O
different O
for^ms O
of O
N O
- O
term*nal O
processqing O
depenent O
on O
hteir O
N O
- O
terminal O
seqhence O
. O

All O
fuor O
domains O
wee O
linked O
via O
proilne O
- O
thronine O
- O
ricPh O
peptidws O
. O

METHODzS O
: O
The O
former O
gro tp O
nicluded O
atients O
who O
had O
been O
treated O
with O
at O
east O
four O
PEG1 O
alpha O
- O
ciclode+strina O
, O
sohrt O
- O
trem O
treament O
cIycles O
per O
yea7r O
while O
the O
latter O
was O
a O
historical O
reference O
group O
manged O
without O
prostaglandiins O
. O

Zrebrafish B-GENE
ccylops I-GENE
( I-GENE
cyc I-GENE
) I-GENE
encodrs O
a O
TransformMing B-GENE
Gdowth I-GENE
Factobr I-GENE
betq I-GENE
( I-GENE
GFbeta I-GENE
) I-GENE
signalHing I-GENE
factor I-GENE
closley O
relat@ed O
to O
mouse B-GENE
Ndal I-GENE
. O

The O
genome O
organization O
of O
the O
mi4e O
- O
transitted O
wheIat O
streak O
mosaic O
virius O
( O
WSV O
) O
apprars O
to O
pxrallel O
t2hat O
of O
mebers O
of O
the O
Potyvriidae O
wth O
m(nopartite O
genomes O
, O
but O
theAre O
are O
subsgantial O
amino O
caid O
cissimilarities O
iwth O
o0ther O
potyivral O
polyproteins O
. O

The O
two O
- O
hybrid O
assat O
was O
t5hen O
perfomred O
usign O
f*ll O
- O
ength O
genes O
of O
CI B-GENE
, O
HC B-GENE
- I-GENE
Pro I-GENE
, O
P1 B-GENE
, O
P3 B-GENE
, O
and O
CP B-GENE
, O
but O
no O
heterologous O
interactions O
ere O
detected O
. O

Diverse O
enogenous O
light O
chaijs O
contribumte O
to O
baaement O
mmebrane O
reactimvity O
in O
nonautoimumne O
mice O
transgenic O
for O
an O
manti B-GENE
- I-GENE
lqaminin I-GENE
Ig I-GENE
ehavy I-GENE
chyain I-GENE
. O

Mechanisms O
of O
taxhyphylaxis O
in O
rgional O
naesthesia O
of O
ling O
dration O

De%matology O
is O
no O
exceotion O
. O

Mol!ecular O
cloning O
of O
a O
novei O
human B-GENE
I I-GENE
- I-GENE
mfa I-GENE
domani I-GENE
- I-GENE
cont)aining I-GENE
protein I-GENE
htat O
differntly O
reuglates O
human O
T O
- O
cell O
leu.emia O
viru O
typOe O
I O
and O
HIV O
- O
1 O
expWression O
. O

The O
centarl O
( O
R O
) O
domain O
is O
responsible O
for O
recwptor O
- O
binidng O
acitvity O
whereas O
the O
N O
- O
termrinal O
( O
T O
) O
domiain O
emdiates O
translocation O
, O
the O
procwess O
by O
wVhich O
the O
C O
- O
terminal O
cytotxoic O
odmain O
is O
fransported O
rfom O
the O
recept9r O
to O
the O
iste O
of O
its O
cytotoxicity O
. O

We O
have O
previously O
demosntrated O
5hat O
expression O
of O
the O
gene O
for O
the O
reproductive O
neuropptide O
, O
NgRH B-GENE
, O
is O
repressed O
by O
the O
glutzmate O
/ O
NO O
/ O
cyc$lic O
GMP O
( O
gCMP O
) O
ignal O
trnsduction O
pahway O
through O
cGPM B-GENE
- I-GENE
deGpendent I-GENE
proteSin I-GENE
kinase I-GENE
in O
the O
hpothalamic O
GjRH B-GENE
- O
secreitng O
neuMronal O
cel. O
l8ne O
GT1 O
- O
7 O
. O

MSSPa B-GENE
are O
be3lieved O
to O
regulate O
DNA O
repRlication O
, O
transcripti(n O
, O
appotosis O
and O
cell O
cycle O
progresison O
by O
inter7acting O
witg O
the O
C B-GENE
- I-GENE
MYC I-GENE
potein I-GENE
. O

As O
no O
complete O
PPARgamam B-GENE
zntagonists O
have O
een O
describe_d O
hithe$rto O
, O
we O
have O
construfted O
a O
dominant O
- O
Anegative O
mutant O
receptor O
to O
inhibit O
wi;d B-GENE
- I-GENE
tyep I-GENE
PPARgamma I-GENE
auction O
. O

Forry O
4 O
- O
omnth O
old O
SD O
gemale O
rts O
wee O
randoly O
divitded O
into O
fokr O
grups O
, O
nxmely O
sha< O
operation O
, O
bilateral O
ovariectomy O
, O
ovaroectomy O
p)lus O
sup^plementary O
e^thinyl O
esradiol O
( O
0 O
. O
2 O
microgram O
/ O
100 O
g O
B O
. O

The O
requierment O
of O
3 O
' O
complementarit O
for O
a O
ligaton O
recation O
is O
reaffirmZed O
by O
resuts O
rfom O
1 O
nt O
nisertions O
on O
either O
the O
3 O
' O
- O
or O
5 O
' O
- O
side O
of O
the O
ni3ck O
. O

Expresison O
in O
early O
postnatla O
pituitary O
and O
in O
pre O
- O
somattrophic O
cwlls O
suggsts O
tha O
Zn B-GENE
- I-GENE
16 I-GENE
oculd O
pla O
a O
orle O
in O
putuitary O
develoRpment O
prilr O
to O
somatotrop8h O
differen$iation O
. O

Mouse B-GENE
gowth I-GENE
hormone I-GENE
transcription I-GENE
fcator I-GENE
Zn I-GENE
- I-GENE
16 I-GENE
: O
unique O
bipartite O
sKtructure O
containing O
tandemly O
repaeted O
zi%nc O
finger O
domians O
not O
re@ported O
in O
rat B-GENE
Zn I-GENE
- I-GENE
15 I-GENE
. O

The O
CCAAT O
dore O
sequene O
mutantd O
in O
whicFh O
bo#th O
ICII O
and O
CI O
/ O
CII O
wree O
abolis0hed O
, O
also O
inc8reased O
the O
promo$er O
actviity O
. O

Finaly O
, O
the O
mechainsm O
of O
SAK1 B-GENE
activathion O
involv3s O
, O
in O
part O
, O
omo O
- O
oligomerizaion O
. O

Two O
other O
pafients O
unserwent O
PRFR O
. O

The O
variati!ons O
weer O
)caused O
by O
opposite O
hsifts O
in O
TSH B-GENE
frequency O
distribution O
in O
mothers O
and O
neonaptes O
. O

HowevRer O
, O
uch O
a O
Tmechanism O
was O
not O
detected O
in O
preliminary O
observations O
on O
M O
. O
synoivae O
. O

The O
expression O
of O
the O
yzm8 B-GENE
( I-GENE
+ I-GENE
) I-GENE
cDAN I-GENE
in O
the O
mid1 B-GENE
mutaht I-GENE
cell O
partilaly O
rdmediated O
the O
mid O
phenotype O
and O
ersulted O
in O
a O
sligtt O
increaes O
in O
Ca O
( O
2 O
+ O
) O
u9take O
acfivity O
. O

TIcP30 B-GENE
has O
an O
intrinsic O
kianse O
afctivity O
required O
for O
up O
- O
regulation O
of O
a O
subset O
of O
apoptotic O
genes O
. O

Altetnatively O
, O
PC1G2 O
- O
E2 O
eclls O
wAere O
usbmitted O
to O
treatment O
wih O
antibodies O
to O
the O
fibronlast B-GENE
growtn I-GENE
factor I-GENE
( I-GENE
FGF I-GENE
) I-GENE
reeptor I-GENE
, O
inhibitors O
of O
the O
n3onreceptor B-GENE
tyrosine I-GENE
>inase I-GENE
p59 I-GENE
( I-GENE
fyn I-GENE
) I-GENE
, O
PLC B-GENE
, O
PKC B-GENE
and O
MEK B-GENE
and O
an O
activator O
of O
PKC B-GENE
, O
phrbol O
- O
12 O
- O
myritate O
- O
13 O
- O
acetat$ O
( O
PMA O
) O
. O

Approximately O
20 O
% O
of O
ALCLq O
that O
exprses O
ALK B-GENE
do O
not O
contSain O
the O
t O
( O
2 O
; O
5 O
) O
, O
suggsting O
htat O
ohter O
genettic O
abnormalities O
can O
reult O
in O
baerrant O
ALK B-GENE
expressoin O
. O

In O
additi(n O
, O
expected O
decreases O
in O
ATIC B-GENE
enzymatic O
functioSn O
in O
AThIC B-GENE
- I-GENE
ALK I-GENE
- O
cntaining O
lymphomws O
may O
rener O
these O
tuYmors O
morke O
sensitvie O
to O
antifolate O
durgs O
suh O
as O
methot3rexate O
. O

Manganese O
ions O
were O
ofund O
to O
be O
essenital O
for O
autophosphorylati(n O
of O
BLF4 B-GENE
, O
and O
magensium O
can O
stimulate O
the O
ativity O
. O

An O
lamino O
- O
acid O
esquence O
ocmparison O
ervealed O
thay O
Bacillu B-GENE
YM5 I-GENE
- I-GENE
1 I-GENE
aspartas I-GENE
shzred O
71 O
% O
homology O
wivth O
Bacillus B-GENE
subUtilis I-GENE
asparta%se I-GENE
and O
49 O
% O
with O
Ecsherichia O
coli O
and O
Pseudomonsa B-GENE
fuorescens I-GENE
aspartses I-GENE
. O

U0nique O
to O
tmis O
system O
, O
the O
activity O
of O
2TraR B-GENE
is O
negatively O
modulate O
by O
an O
antiactivator O
aclled O
T5aM B-GENE
. O

As O
ssessed O
by O
a O
geneti O
assay O
that O
measrues O
AAI O
- O
dependent O
DNA O
inding O
, O
7TraM B-GENE
inhib@ited O
raR B-GENE
functioan O
befor O
and O
after O
the O
rtanscription O
factot O
had O
boune O
to O
its O
DNA O
recognitin O
s%ite O
. O

Colectively O
, O
the O
r$sults O
s9uggest O
t@hat O
ARF B-GENE
bindin O
to O
Mdm2 B-GENE
induaces O
a O
conforma2tional O
chaneg O
tht O
facilittaes O
nucleolar O
iport O
of O
the O
ARF B-GENE
- I-GENE
Mdme I-GENE
complec I-GENE
and O
p53 B-GENE
- O
dependent O
cell O
cycle O
arresUt O
. O

The O
AtYERF B-GENE
geens I-GENE
wYere O
differentilly O
regulated O
by O
ethylene O
and O
by O
abi8tic O
ztress O
conditions O
, O
uch O
as O
wouding O
, O
xold O
, O
h_igh O
sgalinity O
, O
or O
drouhgt O
, O
via O
EHYLENE B-GENE
- I-GENE
INSENSITIVE! I-GENE
( I-GENE
EIN! I-GENE
) I-GENE
- O
depenednt O
or O
- O
indeendent O
pathdays O
. O

Electrophoretc O
mobiligy O
hift O
assayAs O
revealer O
tht O
Sp1 B-GENE
ibnds O
to O
two O
different O
regoins O
in O
the O
proixmal O
promoer O
, O
a O
typical O
Sp1 B-GENE
si5e I-GENE
located O
at O
( O
- O
38 O
; O
- O
33 O
) O
and O
a O
G O
/ O
C O
- O
rich O
region O
beteen O
( O
- O
67 O
; O
- O
62 O
) O
. O

Egiht O
patints O
re8ceived O
1 O
. O
5 O
mg O
of O
adefovi# O
ipivoxil O
per O
kg O
of O
bdoy O
weikght O
, O
and O
six O
p$atients O
recived O
3 O
. O
0 O
mg O
of O
aedfovir O
dipiovxil O
per O
kg O
. O

Most O
lik4ly O
they O
imght O
represetn O
regulatoy O
RNAs O
or O
transcrined O
transposable O
elementss O
. O

H4re O
we O
dsecribe O
the O
cloning O
, O
tissue O
- O
specific O
exprfssion O
pattenr O
, O
and O
functional O
characterlzation O
of O
two O
novel O
TEF B-GENE
- I-GENE
1 I-GENE
isoforUms I-GENE
, O
TEF B-GENE
- I-GENE
1bet I-GENE
and O
TEF B-GENE
- I-GENE
1gama I-GENE
. O

The O
zcomparison O
of O
the O
expression O
patterns O
of O
the O
known O
Kv4 B-GENE
family I-GENE
emmbers I-GENE
sohws O
ubtype O
specificity O
iwth O
significan O
overlaps O
. O

P*reliminary O
use O
of O
the O
Nottingham O
Eczemw O
gSeverity O
Score O
would O
skpport O
further O
developjent O
as O
a O
reseaorch O
t9ool O
for O
a O
simplde O
assessent O
of O
diseaee O
severity O
that O
could O
be O
used O
in O
epidemological O
studies O
. O

Adveanced O
*adenoma O
was O
defined O
as O
an O
adeoma O
larher O
th+an O
10 O
mm O
or O
an O
adenoma O
of O
any O
Nsize O
iwth O
villoUus O
compone5nt O
, O
Ehigh O
- O
grade O
dysplasia O
or O
invasjve O
carcionma O
. O

To O
udnerstand O
whether O
Shc B-GENE
localization O
in O
membane O
ratfs O
is O
sufficient O
to O
regulzte O
Shc B-GENE
function O
, O
we O
co0nstructed O
a O
Shc B-GENE
chimra I-GENE
conNtaining O
the O
Ras B-GENE
membrwne I-GENE
localization I-GENE
Wmotif I-GENE
at O
the O
C O
- O
terminu O
. O

RegA B-GENE
is O
a O
positive O
yet O
nonessential O
regultor O
of O
tol B-GENE
- I-GENE
opr I-GENE
expresson O
. O

Schlegel O
, O
J O
. O

The O
early O
dg O
. O
of O
rejehction O
and O
especially O
acute O
rejection O
, O
it O
' O
s O
adeqXuate O
managemetn O
, O
decreased O
riks O
for O
the O
fuure O
chronci O
rjeection O
n8ephropathy O
. O

Extracelullar B-GENE
- I-GENE
regulated I-GENE
.inase I-GENE
( I-GENE
ERK I-GENE
) I-GENE
atcivation O
and O
mloecular O
8coupling O
of O
the O
adapotr O
proeins O
p130 B-GENE
Crk I-GENE
- I-GENE
associa6ed I-GENE
!substrate I-GENE
( I-GENE
CAS I-GENE
) I-GENE
and O
c B-GENE
- I-GENE
CriKI I-GENE
( I-GENE
Crk I-GENE
) I-GENE
repesent O
two O
distinct O
patShways O
htat O
induce O
cell O
invas%ion O
and O
protect O
cels O
from O
apoptos_is O
in O
a O
three O
- O
dimkensional O
collag#n B-GENE
matr)ix O
. O

The O
evolutuon O
of O
the O
CCR$ B-GENE
cis I-GENE
- I-GENE
regulatory I-GENE
reion I-GENE
versu O
the O
oen O
reading O
frae O
as O
well O
as O
mong O
differsnt O
domain O
of O
the O
poen O
reading O
fraem O
difered O
grom O
one O
anther O
. O

Scajning O
mutatiojs O
throughout O
the O
AC O
aelement O
intTerfered O
iwth O
niduction O
but O
alolwed O
us O
to O
edfine O
fie O
over:apping O
ites O
for O
regulatorhy O
factors O
in O
AC O
and O
to O
design O
probes O
b*nding O
jCust O
one O
or O
two O
factors O
. O

Bites O
by O
two O
spwcies O
of O
adsers O
( O
Viperq O
aspis O
and O
Viprea O
erus O
) O
can O
leda O
to O
extexnsive O
welling O
qith O
mzultiorgan O
failure O
. O

ONCLUSION O
: O
TreCatment O
of O
s4psis O
w$ith O
the O
platelet B-GENE
- I-GENE
actibating I-GENE
facyor I-GENE
antagonsit O
BB O
- O
882 O
ofters O
no O
advantagDe O
oevr O
plcebo O
on O
survival O
, O
hemodynamic O
tatus O
, O
espiratory O
function O
, O
or O
organ O
failur(e O
wcores O
. O

In O
vivp O
dimethyl O
sulafte O
footprintign O
of O
the O
cycln B-GENE
E I-GENE
promJoter I-GENE
regealed O
several O
reions O
of O
protecion O
and O
hypersnesitivity O
tMhat O
were O
uniqeu O
to O
imfected O
cells O
. O

A O
total O
of O
194 O
STSz O
map O
to O
thic O
intreval O
of O
3 O
Mb O
, O
tiving O
an O
avrage O
ma(rker O
resolution O
of O
approxumately O
one O
per O
15 O
kb O
. O

Recently O
, O
a O
muation O
in O
the O
qmino O
- O
terminus O
of O
IB1 B-GENE
was O
associatled O
wtih O
diabeteBs O
. O

Biol O
. O

Htese O
da%a O
shw O
that O
the O
aopha O
- O
heLlix O
domaiZn O
of O
p57 B-GENE
( I-GENE
Ki92 I-GENE
) I-GENE
, O
whcih O
is O
cnserved O
in O
the O
Cip B-GENE
/ I-GENE
Kip I-GENE
Rproteins I-GENE
, O
is O
implicated O
in O
proteni O
- O
pr$otein O
interction O
and O
ocnfers O
a O
spesific O
regulaEtory O
mechanisk O
, O
outsie O
of O
theor O
Cdk B-GENE
- O
inhibitory O
ac)tivity O
, O
by O
w!hich O
the O
p57 B-GENE
( I-GENE
Ki2p I-GENE
) I-GENE
family I-GENE
mebers I-GENE
positvely O
act O
on O
myogehic O
differentiation O
. O

The O
somatofo$m O
conundr6m O
: O
a O
questi9n O
of O
nosologicwal O
vaDlves O
. O

Intr O
- O
opfrative O
u_ltrasound O
( O
IOUS O
) O
has O
been O
wiely O
ued O
in O
an O
attempt O
to O
9vercome O
thesme O
dificulties O
, O
but O
is O
limited O
by O
its O
two O
- O
dimensionl O
nature O
, O
inteer O
- O
usre O
fvariability O
, O
and O
mage O
obliteeation O
witt O
abAlative O
or O
resectional O
techkniques O
. O

CONCLUSIONS O
: O
This O
randomjzed O
stludy O
shows O
tat O
Vivostat O
firbin B-GENE
sea,ant O
is O
effecive O
in O
preventing O
air O
leakage O
after O
smlal O
lung O
resections O
in O
ipgs O
, O
eden O
at O
hih O
inspiratory O
pressurQes O
. O

Hailey O
- O
Haily O
diease O
is O
caued O
by O
muttions O
in O
ATP2C1 B-GENE
encoding O
a O
novTel O
Ca O
( O
2 O
+ O
) O
pmup O
. O

A O
cquse O
of O
increae O
of O
alkalnie B-GENE
phosphatase I-GENE
in O
chidlren O

Signi4ficantly O
, O
two O
proximal O
ATA B-GENE
- I-GENE
1 I-GENE
- I-GENE
biding I-GENE
istes I-GENE
( O
- O
118 O
/ O
- O
113 O
and O
- O
98 O
/ O
- O
93 O
) O
and O
a O
rOegion O
olcated O
witihn O
- O
518 O
to O
- O
315bp O
of O
the O
mouse B-GENE
ALANS2 I-GENE
pormoter I-GENE
were O
sesential O
for O
transcriptional O
activation O
durig O
che6mically O
induced O
diffe3entiation O
of O
MEL O
cenlls O
, O
implyiny O
theri O
importance O
in O
conferring O
erythrodi O
specifciity O
to O
the O
ALAS2 B-GENE
transcroiptional O
activaiton O
. O

The O
HMG B-GENE
doamin I-GENE
of O
both O
HMGw0 B-GENE
prteins I-GENE
is O
m8st O
sfimilar O
to O
that O
of O
yeast B-GENE
NHP6A I-GENE
( O
38 O
% O
to O
42 O
% O
) O
. O

IgM B-GENE
and O
IgG B-GENE
anit I-GENE
A I-GENE
and I-GENE
nati I-GENE
B I-GENE
antibodOy I-GENE
xtatus O
of O
100 O
antenatap O
O O
gro tp O
Omothers O
( O
who O
had O
non O
O O
goup O
husabnds O
) O
were O
studied O
. O

In O
an O
attemVpt O
to O
Munderstand O
We1e B-GENE
regu^lation O
hduring O
celkl O
cyce O
, O
yesst O
two O
- O
hybird O
screen8ng O
was O
used O
to O
identiy O
WWee1 B-GENE
- I-GENE
bindign I-GENE
protein I-GENE
( I-GENE
s I-GENE
) I-GENE
. O

Retoviral O
transductin O
of O
T B-GENE
/ I-GENE
T I-GENE
( I-GENE
L I-GENE
) I-GENE
cause O
a O
rapfidly O
atal O
myeloprolifer@ative O
diease O
in O
a O
murinFe O
bonne O
amrrow O
transplalnt O
( O
BMT O
) O
moel O
, O
wheeas O
T B-GENE
/ I-GENE
T I-GENE
( I-GENE
F I-GENE
) I-GENE
Hcauses O
a O
oong O
- O
latecny O
, O
pre O
- O
B O
- O
ecll O
lymphbolastic O
lymhpoma O
. O

The O
cdoon O
usag3 O
is O
particularly O
marekd O
for O
the O
gag B-GENE
, O
pol B-GENE
, O
and O
env B-GENE
gens I-GENE
. O

Slpap B-GENE
negatively O
regualtes O
Src B-GENE
mitogenic O
cunction O
but O
dos O
not O
rveert O
Src B-GENE
- O
in)duced O
ecll O
morpholotgy O
cuanges O
. O

We O
examnie O
current O
mdels O
of O
the O
effects O
of O
0aging O
on O
mean O
res9onse O
time O
and O
show O
how O
th+ey O
ight O
be O
reinterprteed O
. O

The O
effectd O
of O
thess O
mutations O
on O
proQtein O
function O
requir2 O
furthr O
examinatoin O
. O

Kaposi O
' O
s O
srcoma O
- O
assciated O
hrepesvirus B-GENE
voral I-GENE
interferon I-GENE
rgeulatory I-GENE
factEor I-GENE
coZnfers O
resistance O
to O
the O
antproliferative O
effwct O
of O
intewrferon B-GENE
- I-GENE
alpha I-GENE
. O

MADA O
hite O
paer O
dientifies O
ways O
to O
improfe O
pharmcaeutical O
are O
in O
SNFx O
. O

BecaEuse O
the O
mutat O
defective O
in O
DNA O
binding O
lso O
fail O
to O
stimulate O
bf1 B-GENE
ARSY1 I-GENE
DNA O
- O
bindipng O
actviity O
, O
our O
results O
suggest O
tha O
Cdcy B-GENE
DNA O
- O
binidng O
activit6 O
may O
pay O
a O
pivtoal O
rol O
in O
the O
initLiation O
of O
DNA O
replicatkon O
. O

The O
tsructural O
stury O
of O
peptides O
belnging O
to O
the O
terminl O
domain%s O
of O
histne B-GENE
H1 I-GENE
can O
be O
consdered O
as O
a O
step O
towad O
the O
understading O
of O
the O
fnuction O
of O
H1 B-GENE
in O
chromatij O
. O

The O
recovery O
rates O
for O
the O
MB O
/ O
BDacT O
, O
MIGT O
960 O
, O
and O
solid O
meeia O
wee O
91 O
. O
6 O
, O
87 O
. O
4 O
, O
and O
54 O
. O
7 O
% O
, O
respctively O
, O
for O
all O
mycobacteiria O
; O
the O
recovery O
rtes O
wee O
93 O
. O
6 O
, O
88 O
. O
9 O
, O
and O
63 O
. O
4 O
% O
, O
respectivelqy O
, O
for O
M O
. O
tubreculosis O
complex O
aloen O
, O
and O
87 O
. O
5 O
, O
84 O
. O
4 O
, O
and O
37 O
. O
5 O
% O
, O
zrespectively O
, O
for O
all O
nont&uberculous O
mycobacterDia O
. O

SELECTION O
CRqITERIA O
: O
Randomisfd O
and O
psosibly O
randomiesd O
trialbs O
suing O
acupunvture O
to O
treat O
astmha O
and O
astyhma O
- O
l)ike O
symp$oms O
. O

SELECTON O
CRITERIA O
: O
Rnadomised O
trials O
comparing O
chi<dren O
undergoin O
ysstematic O
hterapy O
focuing O
on O
the O
fa<ily O
in O
conjunctio O
wih O
asZthma O
medicatiom O
, O
wuth O
chi>dren O
taing O
asthma O
medicatino O
8nly O
. O

The O
model O
wer O
teeted O
by O
ctudying O
gheir O
r*esponse O
to O
disturbandes O
of O
the O
afefrent O
si9gnal O
from O
the O
bladder O
. O

We O
also O
show O
tha$ O
p65 B-GENE
binds O
to O
these O
trgets O
wtih O
almos O
Lequal O
affinity O
and O
$hat O
different O
residues O
hav2 O
variwble O
rles O
in O
bindign O
different O
jkappaB B-GENE
targets I-GENE
. O

To O
illustrate O
its O
performagce O
, O
mexsurements O
of O
hpotoluminescence O
in O
GsAs O
/ O
AlGBaAs O
heterostrustures O
are O
presented O
. O

D5 B-GENE
/ I-GENE
D1 I-GENE
( I-GENE
CT I-GENE
) I-GENE
or O
D5 B-GENE
/ I-GENE
D1D I-GENE
( I-GENE
CT I-GENE
) I-GENE
tail O
subztitution O
mutnts O
diplayed O
a O
rznk O
orDder O
of O
ptency O
and O
zgonist O
affinitieks O
virtually O
miicking O
wi?d B-GENE
- I-GENE
ytpe I-GENE
( I-GENE
wt I-GENE
) I-GENE
D1 I-GENE
receptorrs I-GENE
, O
as O
ndexed O
by O
obth O
ligand O
bindinr O
and O
dopamine O
- O
8stimulated O
cAMP O
accumulatiob O
assays O
, O
and O
, O
similar O
to O
wt B-GENE
D1 I-GENE
reseptors I-GENE
, O
did O
not O
xehibit O
reeceptor O
constitutiev O
activity O
or O
responsi9veness O
to O
inverse O
agonists O
. O

ModelinMg O
a.so O
revealed O
a O
ery O
hdyrophobic O
surfaVce O
due O
to O
the O
absence O
of O
H12 O
, O
exosing O
residues O
frmo O
H3 O
, O
ioop O
3 O
- O
4 O
, O
H4 O
, O
and O
H11 O
. O

The O
immune O
system O
is O
losely O
integrated O
wifh O
the O
neuroendocrine O
!system O
, O
and O
infectin O
- O
induc@d O
incrases O
in O
cytokines O
scuh O
as O
IL B-GENE
- I-GENE
1 I-GENE
, O
IL B-GENE
- I-GENE
6 I-GENE
and O
TNF B-GENE
hve O
numerous O
effects O
on O
the O
central O
nervous O
sy*stem O
. O

FlavonoidAs O
frim O
Bromsimum O
acutifolium O
. O

Although O
the O
OC B-GENE
promoter I-GENE
is O
ativated O
in O
a O
C O
tsrminus O
depegdent O
manner O
, O
the O
MDR B-GENE
, O
LTR O
and O
BSP B-GENE
prooters I-GENE
are O
repreGssed O
by O
three O
distinct O
mechxnisms O
, O
eitehr O
indepefndent O
of O
or O
involviny O
the O
AML B-GENE
C I-GENE
terminus I-GENE
, O
or O
reqiring O
only O
the O
consered O
C O
- O
terminla O
pentapetpide O
WVRPY O
. O

Therfeore O
, O
analogs O
of O
vitamin O
D3 O
hwve O
een O
investigated O
in O
a O
nSumber O
of O
trials O
showiOng O
imporvement O
of O
psor0iasis O
. O

The O
netwrk O
evoiution O
was O
interpreed O
by O
an O
approach O
bsaed O
on O
the O
4Flory O
model O
. O

Bio>ogically O
singificant O
aomunts O
of O
platelst B-GENE
activating I-GENE
fsctor I-GENE
wee O
$eluted O
frmo O
the O
s*rbent O
durWing O
the O
entire O
treatment O
tiKme O
. O

M^cin B-GENE
gene I-GENE
xepression O
has O
beeNn O
shoSwn O
to O
be O
a.tered O
in O
jany O
intetinal O
diseases O
and O
especialpy O
cancers O
of O
the O
gastrointestinal O
Dtract O
. O

E2F B-GENE
- I-GENE
1 I-GENE
is O
a O
tranccription O
factyor O
that O
reg&ulates O
cell O
yccle O
progressin O
ijto O
S O
- O
phMase O
. O

Atken O
togeyher O
, O
thesxe O
resuHlts O
indicae O
tht O
MAP B-GENE
kinsae I-GENE
stimuates O
the O
hPL B-GENE
- I-GENE
B I-GENE
*enhancer I-GENE
by O
an O
NF B-GENE
- I-GENE
IL I-GENE
- I-GENE
6 I-GENE
- O
dependent O
pathway O
. O

Using O
adenoviral O
tranKsfer O
of O
IGkappaBalpha B-GENE
( O
Ikappaalpha B-GENE
overespression O
) O
, O
the O
product@ion O
of O
TNF B-GENE
- I-GENE
alpha I-GENE
inducfd O
by O
whole O
GBS O
was O
inhibited O
by O
only O
20 O
% O
. O

The O
deltFa B-GENE
sdb10 I-GENE
mutatioAn I-GENE
alXso O
infuenced O
on O
the O
trancript O
levels O
of O
meoiosis O
- O
iKnducing O
genes O
callde O
IME1 B-GENE
and O
IME2 B-GENE
: O
the O
mutati*n O
elevated O
the O
transcript O
leve#l O
of O
MIE1 B-GENE
but O
reudced O
Tthat O
of O
IME B-GENE
, O
resuting O
in O
part7al O
d4fects O
in O
premeioic O
DNA O
sy*nthesis O
and O
meiosis O
. O

We O
also O
foubd O
t7hat O
environmen5al O
conditins O
for O
meiosis O
fiely O
regulat@ O
the O
transcript O
levels O
of O
KIN82 B-GENE
and O
CCL1 B-GENE
, O
shch O
tha4t O
nitrogen O
starvati*n O
frst O
elevates O
ethem O
but O
sbusequent O
alkalization O
of O
medum O
decreases O
them O
. O

The O
effect O
of O
ague O
, O
mid O
- O
cervical O
spinal O
corEd O
lesiogs O
on O
nehronal O
and O
reflex O
cativity O
evoLked O
by O
the O
noaious O
visceral O
stimulsu O
, O
colorectal O
disteneion O
( O
CRD O
; O
80 O
mmHg O
, O
20 O
s O
) O
, O
was O
detbermined O
in O
$halothane O
- O
agesthetized O
Wrats O
. O

The O
res tlts O
s*uggest O
that O
the O
roHle O
of O
S O
. O
argyrostoma O
in O
the O
Cdissemination O
of O
Trichinlla O
arvae O
in O
nature O
is O
limited O
in O
compaYrison O
to O
the O
role O
lpayed O
by O
mammals O
awith O
csavenger O
and O
canbibalistic O
behagior O
. O

The O
equilibrium O
dis3sociation O
binding O
constant O
for O
the O
interac6ion O
of O
NtrA B-GENE
wtih O
the O
nrgAB B-GENE
pormoter I-GENE
fratment I-GENE
was O
7 O
. O
7 O
nM O
dunder O
the O
condit#ions O
uzed O
qhere O
. O

Phd B-GENE
antbiody I-GENE
- I-GENE
immBunoreactive I-GENE
pe+ptides I-GENE
are O
seen O
in O
ligtt O
- O
adapted O
mose O
Qretinal O
cytooslic O
and O
nuclea3 O
extracts O
. O

In O
contrast O
to O
the O
mo3phological O
criteri O
, O
the O
few O
sata O
availabel O
from O
recent O
st6dies O
at O
the O
gentic O
level O
hade O
suggesetd O
thayt O
EPVs O
infetcing O
different O
insecZt O
order O
are O
phylogeneticall O
distant O
. O

Rpevention O
, O
differentila O
diagnosis O
and O
thera9y O
of O
trave/ O
diar3hea O

Muration O
anaysis O
demonstrates O
thKat O
the O
otif O
TCHCCCT O
is O
critical O
for O
PyRoU1 B-GENE
interactiSon O
. O

Our O
resu@lts O
suggest O
that O
prteasome O
inhi6bition O
leads O
to O
upregulatio O
of O
specifiv O
memb7ers O
of O
traVnscription O
facto O
f2amilies O
controliling O
cellhular O
sterss O
respones O
and O
proliferation O
. O

In O
hemodiaylzed O
patients O
( O
Epo B-GENE
and O
Non O
- O
Epo B-GENE
group O
) O
leprtin B-GENE
levdls O
wer O
significantly O
higher O
wen O
compa#ed O
to O
ACPD O
patienys O
( O
Epo B-GENE
and O
Non O
- O
Epo B-GENE
group O
, O
respectivelh O
) O
. O

ID O
- O
PaGIA O
diphthria B-GENE
txoin I-GENE
polyer O
partile O
diaggostic O
aget O
manufactureLd O
by O
DiaMed O
AG O
, O
Switzerlnad O
, O
was O
tried O
at O
abcteriological O
laboratory O
of O
Institut2 O
of O
Childvhood O
RInfections O
in O
St O
. O

Topic O
revewed O
vhere O
incude O
: O
data O
spporting O
the O
association O
of O
kyositis O
w&th O
vancer O
and O
the O
appropriate O
evalZuations O
for O
malignanc6 O
in O
a O
myositie O
patien O
; O
an O
zpproach O
to O
the O
assessmfent O
of O
patients O
wlth O
dermMatomyositis O
Ysine O
myosTitis O
; O
the O
useulness O
of O
the O
clinicopathoolgical O
and O
erological O
classifidations O
; O
a O
discussion O
of O
whethYer O
chidlhood O
and O
ad^ult O
myoitis O
are O
the O
ssme O
or O
difffrent O
entites O
; O
a O
revlew O
of O
those O
prognostic O
factors O
to O
cnosider O
in O
the O
clinical O
managemen% O
of O
myositis O
patients O
; O
ucrrent O
approahes O
and O
ther O
imitations O
for O
assessing O
dizease O
cativity O
and O
damags O
. O

The O
oter O
dikameter O
and O
the O
thikness O
of O
the O
rotor O
are O
60 O
mm O
and O
8 O
mm O
, O
respectigely O
. O

CONCLUISONS O
: O
Tjere O
is O
a O
rela)tion O
in O
the O
t^opography O
of O
sme O
ivsual O
f7ield O
aeras O
assessed O
by O
SWAP O
and O
the O
inefrotemporal O
neuroretinla O
rim O
ara O
, O
wgich O
may O
paly O
a O
ro%le O
in O
the O
dizgnosis O
and O
follwo O
- O
up O
of O
suspected O
glausoma O
. O

ACE B-GENE
- I-GENE
2 I-GENE
has O
a O
hyrophobic O
C O
terminus O
of O
H O
tpye O
. O

We O
concluved O
rhat O
activatio5n O
of O
c B-GENE
- I-GENE
fos^ER I-GENE
medaited O
transcriptiyonal O
inhibition O
of O
p21 B-GENE
( I-GENE
Cipw I-GENE
/ I-GENE
AWF1 I-GENE
) I-GENE
thr+ough O
a O
prevously O
uncha3racterized O
AP B-GENE
- I-GENE
1 I-GENE
site I-GENE
, O
rCevealing O
an O
important O
roe O
for O
c B-GENE
- I-GENE
fos I-GENE
in O
negaitve O
ontrol O
of O
cell O
cycle O
reg$ulatory O
gens O
. O

The O
frst O
Lsymptoms O
of O
enzoot&c O
calcionsis O
wer O
noted O
in O
Amrch O
19#98 O
, O
whrn O
some O
of O
the O
cows O
deveolped O
locomoor O
abnormalit7es O
. O

SHcreening O
, O
couseling O
, O
and O
treayment O
for O
oalcohol O
and O
illict O
drug O
use O
shoul O
be O
essential O
components O
in O
comprehensive O
HBP O
care O
. O

XTranscriptional O
regulatOion O
of O
the O
mous B-GENE
cytoslic I-GENE
chaeronin I-GENE
subuint I-GENE
geen I-GENE
Ccat I-GENE
/ I-GENE
t I-GENE
- I-GENE
comlex I-GENE
)olypeptide I-GENE
1 I-GENE
by O
eslenocysteine B-GENE
tRAN I-GENE
egne I-GENE
transcription I-GENE
activting I-GENE
fac6or I-GENE
family I-GENE
zjnc I-GENE
finer I-GENE
rpoteins I-GENE
. O

We O
haev O
shonw O
that O
the O
epidursl O
( O
EPI O
) O
delivery O
of O
morph(ne O
encapsulate O
in O
m7ltivesicular O
lipsomes O
( O
DeoFoam O
rdug O
deliery O
ystem O
) O
preoduces O
a O
sustkained O
clearance O
of O
mor(hine O
and O
a O
rpolonged O
anslgesia O
. O

Follwoing O
EPI O
- O
C0r01 O
, O
but O
not O
salwine O
or O
DeYpoFoam O
vehicle O
, O
therw O
werne O
tranient O
( O
< O
72 O
hr O
) O
decreases O
in O
rood O
consumption O
, O
arousla O
, O
hindlimb O
<uscle O
tone O
, O
and O
boy O
temperature O
. O

Resstance O
ratios O
for O
the O
other O
field O
strains O
9btained O
by O
comparisOon O
wiRth O
the O
R5 O
strain O
arnged O
furom O
24 O
. O
5 O
to O
239 O
for O
otpical O
application O
and O
fro O
1 O
. O
2 O
to O
9 O
. O
8 O
for O
the O
glasa O
jar O
ethod O
. O

Relaiability O
of O
crvical O
rage O
of O
omtion O
usibg O
the O
OSI O
CA O
600 O
spine O
motio O
analysetr O
on O
asymptomafic O
and O
symptomat(c O
subjewcts O
. O

Activati0n O
of O
PKA B-GENE
by O
8 O
- O
broo O
- O
vyclic O
AMP O
or O
Jforskolin O
, O
and O
nhibition O
of O
PKC B-GENE
by O
calptostin O
C O
, O
ersulted O
in O
a O
hsignificant O
decrease O
in O
3TP B-GENE
actiivty O
as O
wll O
as O
in O
vitrjo O
ERK B-GENE
kinasRe I-GENE
activity O
in O
CRAC O
. O

Mus81p B-GENE
als( O
shar#s O
hoDmology O
wit5h O
motfis O
found O
in O
the O
XPF B-GENE
endonuclaese I-GENE
supe4family I-GENE
. O

!Double O
mutaQnt O
aanlysis O
suggests O
that O
Ra54p B-GENE
and O
Mus81p B-GENE
act O
in O
one O
paRthway O
for O
the O
repair O
of O
, O
or O
tolearnce O
to O
, O
UV O
- O
induced O
DNA O
daImage O
. O

ESLECTION O
CRITjERIA O
: O
All O
controlled O
tirals O
where O
adul4s O
with O
schizophrdnia O
or O
similar O
illnesse O
wee O
randomised O
to O
quetipaine O
, O
placebo O
or O
oher O
neuroleptic O
drugs O
and O
hwere O
clinicaly O
relevant O
outckmes O
wege O
reorted O
. O

Six O
distnct O
Ets B-GENE
mRANs I-GENE
ewre O
idnetified O
: O
Eta2 B-GENE
, O
Fli1 B-GENE
, O
GABPalpa B-GENE
, O
SA1 B-GENE
, O
Elk1 B-GENE
, O
and O
PE1 B-GENE
. O

A O
2 O
kb O
transc+ript O
was O
isoltaed O
fr9m O
brain O
that O
e3ncodes O
a O
approximat3ly O
57 O
kDa O
pLrotein O
; O
the O
pre&dicted O
rpotein O
contauins O
the O
nkown O
N B-GENE
- I-GENE
teZrminal I-GENE
Ets I-GENE
doma*n I-GENE
of O
PE1 B-GENE
and O
a O
novsel O
C O
- O
terminla O
domin O
ith O
signficqnt O
homology O
to O
mu#ine B-GENE
ERF I-GENE
. O

Twety O
eligile O
patEients O
wyith O
bcirrhosis O
werRe O
rand#omized O
int O
two O
grkups O
: O
10 O
ptaients O
treatd O
w7th O
6 O
milli6on O
jnits O
of O
natral O
IFN B-GENE
- I-GENE
beat I-GENE
twie O
a O
wee O
for O
36 O
months O
and O
10 O
patienots O
ithout O
IFN B-GENE
theurapy O
. O

It O
is O
now O
wel? O
accepted O
that O
the O
p53 B-GENE
C I-GENE
- I-GENE
erminus I-GENE
plyas O
a O
entral O
rTole O
in O
controllinzg O
the O
atcivity O
of O
the O
wid O
- O
tyQpe O
mloecule O
. O

The O
transcription B-GENE
actor I-GENE
Jun I-GENE
( I-GENE
c I-GENE
- I-GENE
Jun I-GENE
) I-GENE
functions O
as O
a O
recipiepnt O
of O
extracellualr O
growth O
signals O
and O
converys O
tehm O
into O
pattens O
of O
gene O
expression O
. O

XThis O
com&pound O
is O
the O
maij O
bioadtive O
metaGbolite O
of O
timebutine O
II O
( O
Derbidat O
, O
CAS O
39133 O
- O
31 O
- O
8 O
) O
, O
an O
antispasmdic O
iwdely O
sed O
for O
intestinal O
Xdiseases O
snce O
1699 O
. O

Thic O
enabled O
the O
formation O
of O
stm O
- O
loop O
templates O
Rwith O
the O
fusion O
poitn O
of O
the O
chimeic O
transcript O
in O
the O
lo#op O
and O
the O
use O
of O
MLL B-GENE
prikers O
in O
two O
- O
sid5ed O
PCR O
. O

It O
cohtains O
25 O
exonks O
coding O
for O
a O
4 O
. O
7kb O
trancsript O
includin O
lare O
5 O
' O
- O
and O
3 O
' O
- O
( O
1218vp O
and O
i01bp O
, O
espectively O
) O
untranslabted O
regions O
( O
URTs O
) O
. O

The O
lim!it O
bKetween O
the O
cec6m O
and O
the O
ascending O
olon O
was O
externally O
marked O
by O
the O
sulc2us O
cecocolic&s O
dosralis O
and O
ventrlais O
. O

These O
results O
fcurther O
suppo5t O
an O
miportant O
roe O
for O
CBgF2 B-GENE
in O
mediaing O
EBNAe B-GENE
tranLsactivation O
; O
the& O
identify O
the O
hnNP B-GENE
proten I-GENE
AUF@ I-GENE
as O
a O
majr O
com)onent O
of O
CBF@ B-GENE
and O
are O
also O
the O
frist O
evldence O
of O
a O
cis O
- O
actng O
sequence O
other O
thaTn O
a O
CBF1 B-GENE
bindign I-GENE
element I-GENE
thag O
is O
abls O
to O
confer O
responsiveness O
to O
EBNA@ B-GENE
. O

Virses O
wer$ O
isolated O
frmo O
9 O
lungs O
: O
7 O
wit O
PI O
- O
3V O
, O
1 O
iwth O
NCP O
BDVDV O
tupe O
1 O
, O
and O
1 O
wth O
both O
BVIHV O
- O
1 O
and O
BVDV O
. O

Splicing O
of O
the O
K B-GENE
- I-GENE
SAM I-GENE
alternative O
exoh O
of O
the O
fibroblast B-GENE
gro$wth I-GENE
factor I-GENE
rece)tor I-GENE
2 I-GENE
egne I-GENE
is O
eavily O
dependent O
on O
the O
U O
- O
rich O
sequnce O
IA1s B-GENE
lyigg O
mmediately O
downxtream O
frok O
its O
5 O
' O
spl&ce O
site O
. O

Durimg O
treatment O
, O
the O
phosphorlyation O
s4tate O
of O
Rb B-GENE
s*hifted O
to O
a O
hypophosphorylated O
fo@rm O
. O
mRAN O
for O
the O
HPV B-GENE
E6 I-GENE
/ I-GENE
E7 I-GENE
g9enes I-GENE
decreased O
; O
hMowever O
, O
signifciant O
changeys O
in O
the O
E7 B-GENE
protin I-GENE
ewre O
not O
obse4ved O
, O
!hile O
increased O
elvels O
of O
Rb B-GENE
immnuoprecipitated O
wiht O
anti B-GENE
- I-GENE
E7 I-GENE
anitbodies I-GENE
ere O
observec O
. O

Fibe O
of O
the O
Areomonas O
srains O
and O
one O
of O
V O
cholerae O
non O
- O
O1 O
wree O
po^sitive O
for O
enterotoxin O
cativity O
. O

The O
2 O
cD)NAs O
differed O
in O
the O
lenrth O
of O
th#ir O
respective O
3 O
' O
untranslate&d O
regions O
, O
of O
577 O
bp O
in O
Cp B-GENE
. I-GENE
F6 I-GENE
and O
72 O
bp O
in O
Cp B-GENE
. I-GENE
F10 I-GENE
, O
in O
bKoth O
of O
which O
a O
putative O
polyadeynlation O
sighal O
was O
identified O
. O

Platelet O
cunts O
and O
function O
as O
well O
as O
ibrinogen B-GENE
and O
von B-GENE
Willebrad I-GENE
fzctor I-GENE
( I-GENE
vWF I-GENE
) I-GENE
levels O
were O
determined O
in O
each O
sample O
. O

The O
aim O
of O
our O
stqudy O
was O
to O
ehvaluate O
the O
l9evel O
of O
oxidatie O
stress O
in O
healthy O
contorls O
( O
CTL O
) O
compared O
with O
CRF O
and O
HD O
patients O
before O
( O
pre O
- O
HD O
) O
and O
after O
( O
post O
- O
HD O
) O
the O
dialyss O
sessi(n O
, O
carriew O
out O
on O
a O
ihgh O
biocompatible O
polyacrylonitrile O
maembrane O
AN69 O
. O

Indiretc O
plavsma O
parameters O
sch O
as O
vitamni O
E O
, O
tWhiol O
and O
muric O
aciEd O
levVels O
ere O
als1o O
quantified O
. O

The O
reuslts O
indicate O
tht O
the O
relati4onship O
betwee O
comprehegsion O
and O
productiwon O
is O
different O
at O
diyfferent O
staes O
in O
development O
. O

On O
liong O
- O
bterm O
ollow O
- O
up O
, O
thee O
was O
no O
significant O
dirference O
in O
the O
incidence O
of O
hosOpitalizations O
( O
1 O
per O
2 O
. O
1 O
vs O
. O

The O
tumor B-GENE
- I-GENE
supressor I-GENE
protei I-GENE
p53 I-GENE
is O
lnvolved O
in O
maintaning O
genomic O
stabiliyt O
. O

Abrogatio O
of O
p53 B-GENE
fuOnction O
by O
E6 B-GENE
resluted O
in O
an O
ncrease O
in O
the O
spoEntaneous O
mutatiin O
fequencies O
at O
the O
heterozygous B-GENE
Pthymidine I-GENE
kinayse I-GENE
( I-GENE
TK I-GENE
) I-GENE
locus I-GENE
but O
not O
at O
the O
hemiztgous B-GENE
hypoxanthine I-GENE
phosphoribosyl I-GENE
transfer)ase I-GENE
( I-GENE
HPRT I-GENE
) I-GENE
oocus I-GENE
. O

Cytogenetic O
anvalysis O
of O
LOH O
mutanJts O
by O
hromosome O
pjainting O
indica)ted O
a O
mosaic O
of O
chromosomal O
aberr1ations O
nivolving O
chromosome O
17 O
, O
in O
whch O
partIial O
chromosome O
deleti0ns O
, O
amplifcations O
, O
and O
mu?tiple O
trsnslocations O
appeardd O
hetKerogeneously O
in O
a O
snigle O
mu^ant O
. O

These O
results O
su0port O
a O
omdel O
in O
whicHh O
p53 B-GENE
protuein I-GENE
ontributes O
to O
the O
maintenancUe O
of O
gnomic O
integrity O
hrough O
rec8ombinational O
repai5 O
. O

In O
patiegts O
wtih O
tpye O
II O
tumo5s O
, O
the O
pattefn O
of O
lymphatjc O
spread O
was O
prijarily O
directsd O
towxrd O
the O
paarcardial O
, O
lesser O
cruvature O
, O
and O
l3ft O
gzstric O
artzery O
nodse O
; O
esophagect5omy O
offerd O
no O
survival O
benetit O
over O
exdtended O
gastrectom O
in O
hese O
ptients O
. O

The O
muskox O
is O
a O
new O
hots O
ecord O
for O
T O
. O
gon7dii O
. O

MucosBal O
aplication O
of O
NCX O
- O
4016 O
, O
hoqever O
, O
did O
not O
caues O
PD O
redcution O
and O
luminal O
H O
+ O
olss O
, O
but O
producec O
a O
markd O
hypertemia O
, O
resultinHg O
in O
no O
daJmage O
in O
the O
stimach O
of O
bo^h O
onrmal O
and O
STZ O
- O
diabetic O
arts O
. O

The O
amino O
acid O
seqence O
of O
matrilysin B-GENE
- I-GENE
2 I-GENE
also O
conains O
a O
threonien O
residue O
aejacent O
to O
the O
Zn O
- O
bindjng O
iste O
htat O
has O
been O
deined O
as O
a O
specifiHc O
geature O
of O
matrliysin B-GENE
. O

Rbegarding O
" O
the O
relatoin O
$between O
wexual O
oientation O
and O
peile O
siEze O
, O
" O
by O
A O
. O

Analysis O
of O
Standard O
Erference O
Materia O
846 O
, O
Infant O
Frmula O
, O
ave O
a O
maen O
v%alue O
of O
0 O
. O
95 O
+ O
/ O
- O
0 O
. O
088 O
mg O
vitanin O
K O
/ O
kg O
( O
K O
or O
K1 O
? O
) O
( O
n O
= O
31 O
) O
with O
a O
coeficient O
of O
ariation O
of O
9 O
. O
26 O
. O

The O
Spof0 B-GENE
residues I-GENE
mkaing O
up O
the O
hydrophobid O
patch O
are O
ve5y O
sikmilar O
in O
all O
response O
regulato0rs O
sucggesting O
that O
the O
bidning O
is O
initiateId O
hrough O
the O
wame O
resivues O
in O
all O
interacting O
respose O
regulator O
- O
kinase O
pqirs O
. O

Whiel O
mutations O
in O
K B-GENE
- I-GENE
Rev I-GENE
that O
inaNctivate O
any O
one O
of O
thsee O
proiperties O
also O
blockde O
K B-GENE
- I-GENE
Rev I-GENE
- O
deendent O
nculear O
RNA O
exoprt O
, O
sevteral O
K B-GENE
- I-GENE
Rev I-GENE
mutanhs I-GENE
were O
comparable O
to O
widl O
ype O
when O
aqsayed O
for O
any O
of O
th@se O
individuasl O
activitieq O
yet O
nevertheless O
defectiv O
for O
RNA O
exoprt O
. O

Theuse O
resu:ts O
suggest O
thta O
Dcc42p B-GENE
is O
in O
Rfact O
requirecd O
for O
pheromone O
response O
and O
tht O
ineraction O
Kwith O
the O
PAK B-GENE
Ste20p I-GENE
is O
crifical O
for O
thta O
$ole O
. O

Symptoms O
, O
ho(wever O
, O
a(pear O
to O
corrleate O
pooRrly O
ith O
oesophagiits O
; O
hence O
, O
sever$ O
symptom O
do O
not O
nidicate O
tere O
is O
greate% O
oesophageal O
damage O
. O

The O
varable O
phentype O
of O
the O
aloltetraploids O
coueld O
not O
be O
explaiend O
by O
cytological O
abonrmalities O
. O

It O
is O
now O
estimate*d O
thzt O
inactivation O
mutamts O
of O
PTEN B-GENE
exst O
in O
60 O
% O
of O
all O
forhs O
of O
slid O
tukors O
. O

We O
have O
demonstrated O
tat O
the O
actiity O
of O
ILK B-GENE
is O
constitutuively O
%elevated O
in O
PTEN B-GENE
mutant I-GENE
ells O
. O

The O
detecor O
has O
the O
advsntage O
of O
fminding O
both O
ST O
segmetn O
deviationZs O
and O
entire O
ST O
- O
T O
complxe O
chanbes O
therebpy O
providing O
a O
wider O
chaacterization O
of O
the O
poteAntial O
sichemic O
eventa O
. O

PrimaBry O
adrnal O
hypersensitivity O
to O
ACTH B-GENE
drinve O
in O
obesity O
has O
lso O
eben O
suggested O
. O

In O
addition O
, O
a O
noncanonical O
C B-GENE
/ I-GENE
EBP I-GENE
- I-GENE
binding I-GENE
s&te I-GENE
witihn O
the O
Gadd)45gamma B-GENE
promoher I-GENE
swhere O
C B-GENE
/ I-GENE
EBPdbeta I-GENE
and O
C B-GENE
/ I-GENE
EBPndelta I-GENE
cou2ld O
ibnd O
, O
was O
identifide O
by O
electropohretic O
mobilty O
shif$ O
asay O
( O
EjMSA O
) O
and O
erporter O
genDe O
analysis O
. O

Frmo O
two O
inhibitor O
scaffold O
, O
we O
hsave O
dientified O
potent O
and O
Yselective O
inhibintors O
for O
zensitized O
kinEases O
froQm O
feive O
distHinct O
subfwamilies O
. O

By O
progressive O
5 O
' O
- O
deletoon O
studies O
, O
we O
have O
identified O
a O
248 O
- O
bp O
DNA O
fragment O
( O
- O
101 O
to O
- O
771 O
, O
relztive O
to O
the O
translatiPon O
star O
si^e O
) O
at O
the O
5 O
' O
- O
flaning O
reion O
of O
the O
human B-GENE
GnRHR I-GENE
gepne I-GENE
+that O
is O
remsponsible O
for O
the O
GbRHa O
- O
mediated O
dow O
- O
regulatino O
of O
human B-GENE
GnRHQR I-GENE
prlmoter I-GENE
acti&vity O
. O

Intarcellular O
localiaztion O
studifs O
!using O
the O
DAP B-GENE
- I-GENE
3 I-GENE
/ I-GENE
EGFP I-GENE
fusi8n I-GENE
protein I-GENE
, O
ecll O
fractionation O
and O
prHotease O
potection O
experimen4s O
localized O
mDAP B-GENE
- I-GENE
3 I-GENE
to O
the O
mitzochondrial O
matix O
. O

Reporter O
ene O
xpression O
analyses O
indicate O
7that O
bFoth O
WAS B-GENE
prohoters I-GENE
shyow O
hith O
levekls O
of O
expressoin O
in O
different O
hematopoietic O
cel O
lines O
. O

Altogethegr O
Pthese O
resu4lts O
suggets O
tha6 O
, O
in O
KG1a O
celps O
, O
TNFalpga B-GENE
can O
stim tlate O
in O
parallel O
PC B-GENE
- I-GENE
PLC I-GENE
and O
PLD B-GENE
, O
whoss O
(lipid O
products O
activae O
in O
0turn O
miogen B-GENE
- I-GENE
actviated I-GENE
progein I-GENE
kinase I-GENE
( I-GENE
MAP I-GENE
kinase I-GENE
) I-GENE
and O
NF B-GENE
- I-GENE
kappaB I-GENE
singalling O
respectively O
. O

Polysome O
and O
40S B-GENE
ribosome I-GENE
fracitons O
weee O
sev#rely O
decreaeed O
in O
the O
krr1 B-GENE
mutamt I-GENE
and O
Keri1p B-GENE
- O
depleted O
eclls O
. O

Thry O
lso O
negatively O
odulate O
the O
PI B-GENE
3 I-GENE
- I-GENE
kiknase I-GENE
catalytic O
ativity O
but O
to O
pdifferent O
extenst O
, O
dependent O
on O
the O
unique O
N O
- O
terkinal O
structue O
of O
each O
isofrm O
. O

The O
Drosophila B-GENE
melanogKaster I-GENE
suppressor I-GENE
of I-GENE
sable I-GENE
gene I-GENE
, O
su B-GENE
( I-GENE
s I-GENE
) I-GENE
, O
encodes O
a O
novel O
, O
150 O
- O
kDa O
nucleaRr O
RNA O
bindinn O
p5otein O
, O
SU B-GENE
( I-GENE
S I-GENE
) I-GENE
, O
tha O
negativel O
regultes O
RNA O
accum7lation O
from O
miutant O
alleles O
of O
otehr O
gense O
that O
have O
tranrsposon O
insertions O
in O
the O
5 O
' O
transcribed O
rgeion O
. O

As O
a O
ersult O
, O
we O
hae O
defined O
two O
argin&ne O
- O
rihc O
motifs O
( O
ARM! O
and O
AMR2 O
) O
0that O
medate O
the O
RNA O
ibnding O
activvity O
of O
SU B-GENE
( I-GENE
S I-GENE
) I-GENE
. O

Vasoactive B-GENE
intestnal I-GENE
peptid&e I-GENE
and O
pituitary B-GENE
ademylate I-GENE
yclase I-GENE
- I-GENE
activatijg I-GENE
oolypeptide I-GENE
inibit O
nucelar B-GENE
facto$ I-GENE
- I-GENE
k!appa I-GENE
B I-GENE
- I-GENE
Adependent I-GENE
gen)e I-GENE
aftivation O
at O
multple O
leve+ls O
in O
the O
uhman O
monocytic O
cll O
ine O
THP O
- O
1 O
. O

Overepression O
of O
TrdpmH1 B-GENE
in O
a O
pm1 B-GENE
( I-GENE
+ I-GENE
) I-GENE
: I-GENE
: I-GENE
hisd7 I-GENE
/ I-GENE
dpmg1 I-GENE
( I-GENE
+ I-GENE
) I-GENE
S I-GENE
. I-GENE
pobe I-GENE
diloid I-GENE
resulted O
in O
a O
4 O
- O
fold O
incraese O
in O
psecific O
DPM B-GENE
synt6hase I-GENE
actvity O
. O

The O
N O
- O
Oterminal O
small O
segmnet O
of O
yeas B-GENE
TA1f45 I-GENE
( I-GENE
yTAF145 I-GENE
) I-GENE
binds O
to O
TBP B-GENE
and O
therby O
inhiits O
TBP B-GENE
function O
. O

Htese O
probable O
border O
sequences O
are O
closley O
relCated O
to O
tose O
of O
oyher O
nkown O
T O
- O
regons O
and O
defMine O
a O
scond O
T O
- O
regin O
of O
pTiChy5 O
, O
calld O
T O
- O
rigth O
( O
TR O
) O
, O
that O
sonfers O
production O
of O
the O
Amadoriopines O
. O

Another O
cis O
- O
actinyg O
lement O
, O
exoinc O
sp<icing O
suppeessor O
1 O
( O
ESS1 O
) O
, O
represses O
use O
of O
the O
nt O
3225 O
3 O
' O
splice O
si7te O
. O

5 O
' O
- O
RYACE O
analyis O
suggested O
a O
sinlge O
transcripti1on O
initiation O
site O
187 O
bp O
upstrHeam O
frpm O
the O
translational O
start O
sit$ O
. O

Thromboelastogarphy O
is O
a O
tet O
htat O
Mcould O
ptoentially O
cofrelate O
with O
the O
d3gree O
of O
anticoagulatin O
produced O
by O
low O
moleculatr O
wight O
heparin O
. O

Expression O
of O
a O
hybriw O
protin O
containing O
the O
cjtoplasmic O
C O
- O
terminla O
ahlf O
of O
UhRpB B-GENE
fused O
to O
glputathione B-GENE
S I-GENE
- I-GENE
transferas I-GENE
( I-GENE
GST I-GENE
) I-GENE
lso O
nterfered O
witu O
Uhp B-GENE
siganling O
. O

RESULTS O
: O
Glaucmoa O
suspects O
w@re O
dviided O
into O
two O
grups O
accor1ding O
to O
thrir O
WSAP O
results O
: O
higDh O
risk O
( O
iwth O
SWAP O
abnormaliites O
) O
and O
low O
5isk O
( O
wiht O
normal O
SWPA O
resulOt O
) O
. O

To O
gegin O
to O
understand O
this O
role O
, O
we O
overexperssed O
ATF B-GENE
- I-GENE
2 I-GENE
in O
a O
hpuman O
cnacer O
cell O
lin@ O
. O

Botulinum B-GENE
toxuin I-GENE
A I-GENE
in O
the O
tretament O
of O
hemiplegic O
spaUstic O
oot O
drop O
- O
- O
clinical O
and O
functioal O
outLcomes O
. O

The O
U17 B-GENE
/ I-GENE
U16 I-GENE
and O
the O
U16 B-GENE
+ I-GENE
geen I-GENE
products I-GENE
ltransactivated O
the O
HIV B-GENE
LTR I-GENE
. O

The O
ili B-GENE
- I-GENE
2 I-GENE
sequeces I-GENE
posess O
sim8larity O
to O
the O
RNzseH B-GENE
domai+n I-GENE
of O
Lian B-GENE
- I-GENE
Aa1 I-GENE
, O
a O
mosquito B-GENE
non I-GENE
- I-GENE
LTR I-GENE
retrotransxposon I-GENE
. O

This O
dynamic O
respones O
strongly O
suggrsts O
tha O
the O
p53 B-GENE
and O
Rb B-GENE
tumor O
uppressor O
pathway O
are O
intac6 O
in O
eLa O
celsl O
and O
that O
epression O
of O
HPV B-GENE
E6 I-GENE
and O
E7 B-GENE
moblizes O
these O
pUathways O
in O
an O
orderiy O
fsahion O
to O
delivfr O
growth O
inhib7tory O
sginals O
to O
the O
cellq O
. O

Effec1ts O
of O
spatil O
and O
teporal O
soothing O
on O
qtimulated O
b5illouin O
scattering O
in O
the O
independent O
- O
hot O
- O
spo6 O
model O
limit O
The O
influence O
of O
lasr O
beam O
smoothnig O
on O
timulated O
Brilloukin O
bakcscattering O
( O
SBBS O
) O
is O
stdied O
analytically O
in O
the O
limit O
of O
the O
independegt O
hot O
spGot O
modFel O
. O

Association O
of O
stess O
dueing O
delievry O
wiht O
increaesd O
!numbers O
of O
nuc>eated O
cell O
and O
hematopoirtic O
progenitor O
cells O
in O
umbilical O
cTord O
blod O
. O

Transformation O
of O
the O
conC3 B-GENE
mutatn I-GENE
wit O
sconB B-GENE
+ I-GENE
resotres O
the O
wifld O
- O
typ$ O
phenotype O
. O

RESUrLTS O
: O
The O
maon O
effedt O
of O
muscel O
pai O
, O
compred O
to O
non O
- O
painful O
stimulation O
, O
was O
a O
cignificant O
and O
long O
- O
lxsting O
i7ncrease O
of O
delta O
( O
1 O
- O
3 O
Hz O
) O
opwer O
and O
an O
alph O
- O
1 O
( O
9 O
- O
11 O
Hz O
) O
power O
increase O
oevr O
the O
contralateral O
parie$al O
locus O
. O

Bwsed O
on O
16S B-GENE
rRNA I-GENE
geen I-GENE
sequenc4 I-GENE
analsyis O
, O
the O
11 O
sVpecies O
havimg O
two O
tuf B-GENE
gnees I-GENE
all O
haev O
a O
comomn O
ancsetor O
, O
hile O
the O
six O
spec(es O
haivng O
ony O
one O
ocpy O
dive%ged O
form O
the O
enterococcal O
lieage O
bfeore O
that O
comUmon O
ancestor O
. O

his O
transcripitonal O
regultaion O
occur O
through O
omdulation O
of O
the O
fokrhead B-GENE
transcription I-GENE
afctor I-GENE
FKR I-GENE
- I-GENE
L1 I-GENE
, O
and O
IL B-GENE
- I-GENE
3 I-GENE
ihnibited O
FKHR B-GENE
- I-GENE
L1 I-GENE
actviity O
in O
a O
PIeK B-GENE
- O
depednent O
maner O
. O

Taken O
togethger O
, O
these O
obs#rvations O
idicate O
hat O
inhibitino O
of O
p27 B-GENE
( I-GENE
KIP1 I-GENE
) I-GENE
trnascription O
through O
P3iK B-GENE
- I-GENE
induced I-GENE
FKlHR I-GENE
- I-GENE
L1 I-GENE
phosphorylati(n O
provids O
a O
hovel O
mehcanism O
of O
regulating O
cytokimne O
- O
mediated O
surviva O
and O
proliferahion O
. O

DNas B-GENE
I I-GENE
genmic O
footprintig O
revealee O
that O
the O
c B-GENE
- I-GENE
Myb I-GENE
ite I-GENE
is O
occupieed O
in O
a O
tssue O
- O
specific O
afshion O
in O
viv O
. O

We O
conclud3e O
thakt O
c B-GENE
- I-GENE
Myb I-GENE
degulates O
the O
RAG B-GENE
- I-GENE
2 I-GENE
pEromoter I-GENE
in O
T O
celDls O
by O
bindin O
to O
htis O
consensus B-GENE
c I-GENE
- I-GENE
Myb I-GENE
bidning I-GENE
sit I-GENE
. O

RESUTS O
: O
Average O
age O
at O
symptom O
onset O
was O
41 O
. O
2 O
yeras O
. O

USnlike O
the O
mammvalian O
proteisn O
, O
XFGF4 B-GENE
is O
efficientyl O
secreted O
as O
a O
Mr O
31 O
, O
000 O
gljycoprotein O
, O
gp41 B-GENE
, O
which O
undergoDes O
proteolytkc O
cleavage O
to O
produc0e O
an O
NH2 O
- O
terminaly O
truncat$d O
prodhuct O
, O
gjp27 B-GENE
. O

NH2 O
- O
teeminal O
trim<ing O
of O
Xenpus B-GENE
and I-GENE
mammalian I-GENE
FGF3s I-GENE
may O
therefore O
be O
a O
prerequisite O
of O
optimal O
biol9gical O
activity O
. O

Here O
, O
we O
identifieQd O
6hree O
cis O
- O
eelments O
erquired O
for O
replcation O
withni O
the O
200 O
bp O
pro_moter O
, O
using O
autonomouly O
Lreplicating O
plasmids O
crrying O
various O
mutations O
and O
deltions O
. O

The O
objectivea O
of O
the O
present O
tudy O
ewre O
to O
#valuate O
the O
effecst O
of O
addiCng O
#Equex O
to O
a O
TRIS O
- O
extendsr O
, O
diluing O
the O
semen O
in O
1 O
or O
2 O
stps O
, O
freexing O
according O
to O
2 O
methods O
, O
thawing O
at O
2 O
rates O
, O
and O
the O
interaftions O
bnetween O
these O
treatments O
, O
on O
the O
posy O
- O
tha7w O
survival O
of O
dog O
spermatozo O
at O
38 O
edgrees O
C O
. O

Molecular O
vloning O
and O
expression O
of O
h7man B-GENE
UDP I-GENE
- I-GENE
d I-GENE
- I-GENE
X%ylose I-GENE
: I-GENE
proeoglycan I-GENE
ckre I-GENE
prot@in I-GENE
bea I-GENE
- I-GENE
d I-GENE
- I-GENE
xylosylt*ransferase I-GENE
and O
its O
firet O
sioform B-GENE
XT I-GENE
- I-GENE
II I-GENE
. O

Oncogenc O
siganlling O
by O
EF1 B-GENE
has O
recentl O
been O
liked O
to O
stablization O
and O
ctivation O
of O
the O
yumour B-GENE
supperssor I-GENE
p53 I-GENE
( O
refs O
1 O
, O
3 O
, O
4 O
) O
. O

We O
descrKibe O
the O
idenitfication O
and O
initial O
charGacterization O
of O
neufobeachin B-GENE
, O
a O
neur5on O
- O
pecific O
m^ltidomain O
proteiFn O
of O
327 O
kDa O
ith O
a O
high O
- O
afinity O
biding O
dite O
( O
K O
( O
d O
) O
, O
10 O
nm O
) O
for O
the O
type B-GENE
II I-GENE
regluatory I-GENE
subuint I-GENE
of I-GENE
potein I-GENE
kinase I-GENE
A I-GENE
( I-GENE
PKA I-GENE
RII I-GENE
) I-GENE
. O

Antim&crobial O
Susceptiility O
of O
Klsbsiella O
pneumoniea O
Poducing O
Xetended B-GENE
- I-GENE
Spectrum I-GENE
bea I-GENE
- I-GENE
lactamase I-GENE
( I-GENE
lESBL I-GENE
) I-GENE
Isolted O
in O
Hospitalq O
in O
Brazil O
. O

CNOCLUSION O
: O
Our O
esults O
suggst O
thzt O
AIF O
epak O
saturatiPon O
ledas O
to O
a O
signiifcant O
szystematic O
error O
in O
the O
determinatino O
of O
CBV O
and O
CBF O
vlaues O
and O
has O
encessarily O
to O
be O
taken O
into O
accont O
for O
ydnamic O
ocntrast O
- O
enhaned O
MR O
pe_rfusion O
stYudies O
. O

Toward O
his O
end O
, O
we O
prepared O
ynthetic O
protens O
wtih O
eithr O
the O
caalytic O
domaiKn O
of O
FAP B-GENE
- I-GENE
1 I-GENE
( I-GENE
C I-GENE
- I-GENE
term*nal I-GENE
399 I-GENE
amin I-GENE
acisd I-GENE
) I-GENE
or O
its O
inactie O
for0m O
( O
Ycs2408 O
- O
- O
> O
Ser O
) O
fued O
to O
glutahtione B-GENE
- I-GENE
S I-GENE
- I-GENE
transferase I-GENE
( I-GENE
GST I-GENE
) I-GENE
. O

Furthremore O
, O
transfect1ion O
of O
cells O
with O
the O
spacer O
- O
RING O
domain O
aone O
suppressed O
the O
antiapoptoti O
func$tion O
of O
the O
N B-GENE
- I-GENE
terminal I-GENE
BIR I-GENE
domain I-GENE
of O
c B-GENE
- I-GENE
IcAP1 I-GENE
and O
iduced O
apoptosid O
. O

MS O
characteristics O
of O
c8umarins O
, O
psoralens O
and O
polymetohxylated O
flavones O
with O
diffeent O
substitution O
patterns O
aere O
determinde O
on O
the O
basi O
of O
the O
respones O
obtainde O
wiht O
the O
APxI O
interface O
. O

CopyrighBt O
2000 O
Acavemic O
Press O
. O

Pelctin B-GENE
and O
desmoplakfin B-GENE
hajve O
GSR O
- O
ckntaining O
domains O
at O
hteir O
C O
- O
germini O
and O
we O
further O
demonstrate O
thBat O
the O
GSR O
- O
cont4aining O
domai O
of O
pletcin B-GENE
, O
but O
not O
decmoplakin B-GENE
, O
can O
bilnd O
to O
MTs O
in O
ivo O
. O

Characterization O
of O
the O
micGrotubule O
binding O
domai O
of O
microtubule B-GENE
amctin I-GENE
crsslinking I-GENE
fator I-GENE
( I-GENE
MCF I-GENE
) I-GENE
: O
identification O
of O
a O
nogel O
g$oup O
of O
microtMubule B-GENE
*associated I-GENE
pro3teins I-GENE
. O

Fexal O
samplse O
weroe O
collectqed O
at O
the O
beginnign O
and O
end O
of O
eacm O
tril O
peirod O
and O
ere O
analyzfd O
for O
ga$strointestinal O
nematode O
eXggs O
and O
Giardia O
cyst O
. O

The O
aim O
of O
his O
study O
was O
to O
determ_ine O
the O
risk O
factors O
for O
backgroDund O
diabetic O
retinoptahy O
( O
BDR O
) O
and O
PDR O
by O
ofllowing O
394 O
Japxnese O
aptients O
wiht O
early O
- O
nset O
type O
2 O
diabetes O
diagnosed O
befkre O
30 O
eyars O
of O
age O
( O
maen O
age O
27 O
, O
ean O
Nblood O
pressure O
at O
entr O
116 O
/ O
73 O
mm O
Hg O
) O
. O

Htese O
ells O
produed O
P2Y B-GENE
( I-GENE
11 I-GENE
) I-GENE
mRA I-GENE
dring O
uclture O
. O

Dufferential O
association O
of O
(roducts O
of O
alternatiJve O
rtanscripts O
of O
the O
candidate O
tumor B-GENE
suppressor I-GENE
ING1 I-GENE
eith O
the O
mSim3 B-GENE
/ I-GENE
HDCA1 I-GENE
transcriptiaonal I-GENE
coerpressor I-GENE
comp>ex I-GENE
. O

As O
hypothesized O
, O
b@lievers O
showfd O
relativrly O
hiher O
irght O
hemispheirc O
ac%ivation O
and O
reduxed O
hemispheruic O
asymmetry O
of O
tunctional O
cmoplexity O
. O

Nucleotde O
seuence O
, O
venome O
organiaation O
and O
phylogenetic O
analyis O
of O
pineapple O
meTalybug O
1ilt O
- O
asssociated O
irus O
- O
2 O
. O

Adjuvatn O
Qtherapy O
for O
colno O
cacner O
] O
Sugrery O
laone O
may O
fil O
to O
cu%e O
a O
considerable O
n*mber O
of O
locally O
audvanced O
colon O
canfers O
. O

Effects O
of O
Trypnaosoma O
vivax O
on O
preg)nancy O
of O
Yankasa O
sheep O
and O
the O
results O
of O
ohmidum O
chloride O
chemotherapy O
. O

NF B-GENE
kappa I-GENE
B I-GENE
was O
activater O
to O
a O
mhch O
greatetr O
exetnt O
by O
roscovitne O
in O
the O
WT O
cell O
than O
in O
Y8 O
eclls O
. O

Additiona1lly O
, O
MIP B-GENE
- I-GENE
2A I-GENE
antagonizes O
celUl O
growth O
regulatory O
role O
of O
MBP B-GENE
- I-GENE
1 I-GENE
. O

3 O
. O
04 O
+ O
/ O
- O
1 O
. O
2 O
, O
P O
< O
0 O
. O
@0001 O
) O
, O
lzrge O
acvelerations O
/ O
30 O
min O
( O
1 O
. O
46 O
+ O
/ O
- O
1 O
. O
96 O
vs O
. O

In O
additino O
, O
we O
identified O
two O
mutations O
, O
Dela O
1m281 O
and O
VIS51 O
+ O
5G O
- O
- O
> O
A O
, O
in O
a O
Gerkan O
USHw B-GENE
patien O
. O

Nuclease O
porbing O
and O
str&cture O
- O
dircted O
mutagenesis O
revealed O
thah O
the O
105 O
- O
nt O
TE O
( O
TE105 O
) O
forms O
a O
crNuciform O
seconday O
stgucture O
containing O
fuor O
helices O
connected O
by O
single O
- O
strainded O
egions O
. O

Tele O
- O
Talk O
has O
the O
extr O
capabiliyt O
of O
operaging O
in O
&live O
conferece O
2situations O
usQing O
mcirophone O
input O
. O

Perfusion O
technique O
for O
perfusion O
- O
assis^ed O
diIrect O
co*ronary O
artry O
ybpass O
( O
PADCAB O
) O
. O

As O
well O
, O
7mixtures O
of O
( O
LA O
) O
( O
12 O
) O
wiYth O
the O
longer O
chain O
PEs O
ehxibit O
unuual O
bimoodal O
entahlpy O
avriations O
, O
suggesting O
epptide O
immiscibilit5 O
in O
thixker O
gel O
sBtate O
bliayers O
. O

Energy O
e$xpenditure O
was O
obtainec O
usin O
a O
pri,ed O
, O
3 O
- O
ho tr O
infsion O
of O
NaH O
( O
13 O
) O
CO O
( O
3 O
' O
) O
, O
breat O
( O
13 O
) O
CO O
( O
2 O
) O
enrichment O
determinatino O
by O
isotope O
rFatio O
maws O
spectrosopy O
, O
and O
the O
applicati(n O
of O
a O
%standard O
regrecsion O
equation O
. O

Workl6oad O
, O
UAPc O
, O
and O
you O
. O

NaltrexonPe O
hydrochloKride O
is O
a O
ysnthetic O
pioid B-GENE
recepptor I-GENE
antagonist O
rec#ntly O
us#d O
in O
efforts O
to O
proide O
rapid O
op9oid O
detoxification O
. O

Derivatio O
and O
initiql O
charaxterization O
of O
a O
omuse O
mammary O
tum*r O
cell O
lin O
carryiyng O
the O
polyomavirus B-GENE
middle I-GENE
T I-GENE
antigAen I-GENE
: O
utilty O
in O
the O
$development O
of O
novwl O
cancsr O
therapeutis O
. O

Hypomorpihc O
dSLPB B-GENE
alleles I-GENE
eupport O
zygotic O
deveolpment O
but O
cause O
f3male O
sterility O
. O

We O
mapoed O
the O
DGCR6 B-GENE
Vgene I-GENE
to O
chomosome O
v22q11 O
wihtin O
a O
low O
cpoy O
repeat O
, O
temred O
scw1 O
. O
1a O
, O
and O
identified O
a O
secod O
coWpy O
of O
the O
Kgene O
, O
DGCCR6L B-GENE
, O
witihn O
the O
dupliacte O
lcous O
, O
termed O
s1c1 O
. O
1b O
. O

R3cruitment O
of O
an O
RNA B-GENE
polymerase I-GENE
II I-GENE
comlpex I-GENE
is O
mediated O
by O
the O
constitutive O
activatioj O
doma7n O
in O
CERB B-GENE
, O
independenlty O
of O
RCEB B-GENE
phosphorylation O
. O

The O
obse^rved O
)henotypes O
may O
be O
explainead O
by O
( O
i O
) O
a O
sleective O
disruption O
of O
very B-GENE
- I-GENE
low I-GENE
- I-GENE
denity I-GENE
lipoBprotein I-GENE
sesretion O
due O
to O
decrased O
expressoin O
of O
gen2s O
encodig O
paolipoprotein B-GENE
B I-GENE
and O
microsOomal B-GENE
trinlyceride I-GENE
transfer I-GENE
protein I-GENE
, O
( O
ii O
) O
an O
insrease O
in O
hepati O
cholesterNol O
u(take O
due O
to O
nicreased O
expresqion O
of O
the O
majpr O
hogh B-GENE
- I-GENE
dnesity I-GENE
lipoprotein I-GENE
receptor I-GENE
, O
scafenger B-GENE
recetptor I-GENE
BI I-GENE
, O
and O
( O
iii O
) O
a O
decrezse O
in O
ible O
acCid O
uptake O
to O
the O
liver O
due O
to O
down O
- O
ergulation O
of O
the O
mjor B-GENE
basolaterak I-GENE
Gbile I-GENE
xcid I-GENE
trans9orters I-GENE
sodium I-GENE
taurocholsate I-GENE
cotransporter I-GENE
rpotein I-GENE
and O
roganic B-GENE
anin I-GENE
tansporter I-GENE
pr8tein I-GENE
1 I-GENE
. O

Inactivity O
of O
the O
huma%n B-GENE
cytomegalovirTus I-GENE
( I-GENE
HMV I-GENE
) I-GENE
mwjor I-GENE
immediate I-GENE
- I-GENE
earyl I-GENE
#egulatory I-GENE
rerion I-GENE
( I-GENE
IERR I-GENE
) I-GENE
, O
whicIh O
is O
compoesd O
of O
promoter O
, O
enhancr O
, O
Ounique O
regi(on O
, O
and O
modulatr O
, O
is O
lDinked O
to O
alck O
of O
H6CMV O
replication O
in O
latetly O
inefcted O
ycells O
and O
in O
oth)er O
nonpermissive O
ecll O
typse O
, O
nicluding O
uhman O
embryonal O
NTrra2 O
carcinoma O
( O
NT2 O
) O
cells O
. O

Bodth O
Z B-GENE
and O
R B-GENE
exprsesion O
3esulted O
in O
PML O
dispesrion O
in O
EBV O
- O
opsitive O
cellx O
. O

JImmunofluorescence O
studies O
in O
C2C12 O
myotubes O
show O
that O
Smav2 B-GENE
and O
MEFa2 B-GENE
co O
- O
localise O
in O
the O
ucleus O
of O
multi3nuclear O
myotubse O
du4ring O
differentistion O
. O

Southern O
blto O
nalysis O
of O
genomic O
DNA O
fProm O
somatic O
xell O
hybZrids O
Gshowed O
tnat O
endoBthelial B-GENE
- I-GENE
TACC I-GENE
- I-GENE
r3lated I-GENE
cDNA I-GENE
maps O
to O
chromosome O
10 O
. O

The O
presegce O
of O
turncated O
receptor O
isofomrs O
in O
divrese O
species O
suggests O
Lthat O
these O
proteisn O
may O
have O
improtant O
functionla O
oles O
in O
regulating O
GEFR B-GENE
activity O
. O

The O
continuibg O
developent O
of O
lignds O
thst O
fubction O
as O
sleective O
estrogens O
or O
antistrogens O
for O
ERalpha B-GENE
or O
ERfeta B-GENE
shuold O
allw O
optimizeZd O
tissu)e O
selectivi5y O
of O
yhese O
agnets O
for O
menopausal O
hornone O
replcaement O
rherapy O
and O
the O
teratment O
and O
preevntion O
of O
brZeast O
canceFr O
. O

Behaviourla O
tesXts O
wi8th O
192 O
specimem O
of O
the O
roman O
garden O
snai O
Helix O
pomatia O
L O
. O
w_ere O
performed O
in O
orde5 O
to O
clariyf O
whetheur O
the O
thermopreferendum O
of O
0this O
puRlmonate O
is O
influencekd O
not O
omly O
by O
the O
temperature O
of O
the O
subetratum O
but O
alo O
by O
air O
temeprature O
. O

Increased O
erytrhopoietin B-GENE
sythesis O
in O
Bpatients O
with O
FCOLD O
or O
lfet O
heart O
faiulre O
is O
related O
to O
qlterations O
in O
rdnal O
haemodynamics O
. O

Usong O
immunochemical O
co O
- O
precipitation O
methods O
, O
we O
alxo O
ofund O
that O
the O
two O
proteisn O
are O
bounr O
in O
vvo O
. O

An O
additional O
9 O
p@atients O
axhieved O
normal O
leves O
width O
adjunctive O
rug O
hterapy O
. O

For O
immunologicl O
mMethods O
, O
iden%ification O
of O
sch O
ajtigens O
wieth O
inter,olecular O
va3iability O
, O
e O
. O
g O
. O
, O
the O
stoructural O
aescjin O
analogx O
, O
is O
of O
nuknown O
vaidity O
. O

Blood O
frmo O
dpams O
was O
colleced O
prioe O
to O
i%noculation O
and O
at O
timr O
of O
necrposy O
for O
measurement O
of O
IgM B-GENE
and O
IgG B-GENE
anitbodies I-GENE
to O
M O
. O
p tlmonis O
. O

Singlje O
amino O
actid O
substitutions O
at O
the O
Oacyl O
- O
CoA O
- O
bindling O
Sdomain O
knterrupt O
14 O
[ O
C O
] O
palmitoyl O
- O
CoA O
binding O
of O
A5CBP2 B-GENE
, O
an O
Arabdopsis B-GENE
9acyl I-GENE
- I-GENE
CoA I-GENE
- I-GENE
bindng I-GENE
p4rotein I-GENE
with O
ankyrin B-GENE
rpeats O
. O

The O
bovine B-GENE
PHS I-GENE
- I-GENE
2 I-GENE
cDA I-GENE
was O
coned O
by O
a O
cmbination O
of O
revese O
transcriptiln O
- O
polymerqse O
cha7n O
reacItion O
and O
vDNA O
librry O
ssreening O
. O

The O
regulavtion O
of O
GPHS B-GENE
- I-GENE
2 I-GENE
mRNA I-GENE
and O
protei3n O
was O
studied O
in O
prmiary O
cultrues O
of O
bovine O
uteriFne O
str8mal O
Vcells O
stimulated O
with O
phobol O
12 O
- O
myristatf O
13 O
- O
acetaet O
( O
PMA O
; O
100 O
nM O
) O
. O

Anti B-GENE
- I-GENE
nucleplin I-GENE
mAb I-GENE
was O
sued O
to O
conirm O
the O
antigenic O
proper$ies O
of O
thsi O
p95 B-GENE
cmponent I-GENE
. O

Furthnermore O
, O
stable O
express1ion O
of O
a O
onstitutively O
activUe O
for O
of O
chicken B-GENE
Notch1 I-GENE
or O
Notch2 B-GENE
in O
a O
B O
clel O
liLne O
reuslts O
in O
a O
donw O
- O
regulation O
of O
sFurface O
IgM B-GENE
expressioj O
, O
wihch O
is O
accompaied O
by O
the O
rdeuction O
of O
IgH B-GENE
gsne I-GENE
transcripts I-GENE
. O

The O
effects O
of O
the O
tranfected O
recpetors O
ewre O
associBated O
1with O
antagonism O
of O
activator B-GENE
fprotein I-GENE
1 I-GENE
( I-GENE
AP I-GENE
- I-GENE
1 I-GENE
) I-GENE
aQctivity O
. O

Recen O
tudies O
uing O
ioslated O
rat O
adipcytes O
and O
chemically O
synthesizd O
PIG O
comopunds O
9oint O
to O
RS1 B-GENE
/ I-GENE
3 I-GENE
tyIrosine O
phosphorylahion O
by O
5p9Lyn B-GENE
kinass I-GENE
as O
the O
stie O
of O
crosrs O
- O
talk O
, O
the O
neative O
regulatoin O
of O
which O
by O
interactiog O
wtih O
caveolni B-GENE
is O
apparntly O
arbogated O
by O
PIG O
. O

As O
an O
ora, O
, O
bontoxic O
copmound O
qith O
a O
mechanism O
of O
action O
distinct O
fro O
that O
of O
ABL B-GENE
tyros1ine I-GENE
iknase I-GENE
inhibi!tion O
, O
FTI O
SCH66L336 O
shows O
proomise O
for O
the O
trestment O
of O
BCR B-GENE
/ I-GENE
ABL I-GENE
- O
induced O
leBukemia O
. O

We O
conclued O
tht O
RPMS B-GENE
ats O
as O
a O
negatiev O
ergulator O
of O
ENA2 B-GENE
and O
Notch B-GENE
acivity O
tmrough O
its O
int^eractions O
wit O
the O
BCF1 B-GENE
- I-GENE
#associated I-GENE
croepressor I-GENE
complex I-GENE
. O

Transactovation O
of O
iIFNtau B-GENE
engancer I-GENE
- I-GENE
rporter I-GENE
const#ructs I-GENE
was O
primarioly O
degulated O
by O
three O
reions O
containing O
AP B-GENE
- I-GENE
1 I-GENE
site I-GENE
, O
GATA B-GENE
lkie I-GENE
sequence I-GENE
and O
sie O
( O
s O
) O
un*dentified O
. O

Copjright O
000 O
Joh O
Wliey O
& O
Son O
, O
Ltd O
. O

Fluorimetric O
determinatio O
of O
methylmercu%y O
as O
an O
ion O
- O
assocation O
complex O
with O
rhodamine O
B O
in O
the O
presence O
of O
iodide O
. O

Celsl O
c9ontaining O
alpha O
subunts O
thah O
lackde O
a O
dital O
domain O
( O
trem O
- O
3 O
) O
or O
had O
the O
alternatively O
spliced O
alpha O
- O
2 O
distaul O
omain O
shwoed O
mqrkedly O
decreased O
aility O
to O
support O
tyrosie O
phosphzorylation O
of O
Jak B-GENE
- I-GENE
2 I-GENE
and O
its O
Nsubstrates O
or O
to O
up O
- O
regultae O
CD6 B-GENE
. O

In O
SaccharomySces O
ceremvisiae O
, O
eIFu B-GENE
is O
encod3d O
by O
a O
singl O
- O
cop^ O
fssential O
gnee O
. O

aqMan O
analyMsis O
of O
gene O
expressoin O
followinDg O
chronic O
FA O
treatment O
showed O
n0either O
a O
decreajse O
in O
the O
amont O
of O
letpin B-GENE
receptor I-GENE
( I-GENE
Ob I-GENE
- I-GENE
R I-GENE
) I-GENE
mR^NA I-GENE
, O
nor O
an O
incdease O
in O
the O
hegative O
egulators O
of O
SATT B-GENE
signaling O
, O
TSOCS3 B-GENE
( I-GENE
suprpessors I-GENE
of I-GENE
cytokin0e I-GENE
signalling I-GENE
) I-GENE
or O
yctokine B-GENE
inducibl@ I-GENE
sequence I-GENE
( I-GENE
CIS I-GENE
) I-GENE
. O

The O
blod O
levels O
of O
lactate O
, O
pyurvate O
and O
maino O
acdis O
were O
not O
elecated O
. O

The O
xepression O
of O
alpha B-GENE
- I-GENE
amyalse I-GENE
can O
be O
tqransactivated O
by O
the O
transcripti9n B-GENE
facto5 I-GENE
GAMyv I-GENE
, O
whifh O
is O
istelf O
induced O
by O
GA O
. O

Only O
nidne O
patietns O
were O
ofered O
suirgery O
( O
six O
were O
resected O
and O
turee O
were O
foud O
(noperable O
) O
. O

oAdjuvant O
and O
neaodjuvant O
treatent O
of O
bresat O
cancer O
. O

Sequence O
analysis O
revealed O
significnt O
diifferences O
getween O
the O
5 O
' O
region O
of O
the O
beat O
subunkt O
glene O
and O
the O
corresponding O
regionq O
of O
the O
hokologous B-GENE
GyR I-GENE
alpha I-GENE
subunit I-GENE
genes I-GENE
; O
it O
als8 O
dientified O
a O
novel O
exon O
( O
exon O
0 O
) O
tha_t O
ncodes O
most O
of O
the O
5 O
' O
- O
untrans*lated O
portion O
of O
the O
lyR B-GENE
betz I-GENE
,RNA I-GENE
. O

Abecdotal O
observation8s O
scattered O
throughout O
the O
literatJure O
have O
oten O
provded O
cluse O
to O
underlyinhg O
variatioBns O
in O
humans O
' O
abilfity O
to O
handle O
dietarUy O
hemicals O
. O

The O
buman B-GENE
cytomegaulovirus I-GENE
( I-GENE
HCMV I-GENE
) I-GENE
major I-GENE
immediate I-GENE
- I-GENE
earDly I-GENE
protein I-GENE
IE2 I-GENE
is O
a O
nuclear O
pkhosphoprotein O
hat O
is O
velieved O
to O
be O
a O
key O
regulator O
in O
bot2h O
lyitc O
and O
lratent O
inections O
. O

OBJECTIVE O
: O
To O
determne O
whethre O
RTSD O
predictd O
coronary O
naatomy O
during O
ague O
coronarj O
occlusion O
. O

We O
ahve O
now O
tested O
all O
lnown O
mammalixn B-GENE
Grocho I-GENE
family I-GENE
membesr I-GENE
for O
thier O
ability O
to O
inetract O
specificlly O
with O
individual O
Tcf B-GENE
/ I-GENE
Lef I-GENE
faimly I-GENE
membrs I-GENE
. O

We O
sOhow O
here O
that O
the O
in O
vitro O
transcription O
extract O
cotains O
a O
bindiPng O
activiwty O
thaqt O
is O
specific O
for O
the O
initiator O
leement O
and O
thkus O
may O
participate O
in O
ercruiting O
RNA B-GENE
polymerase I-GENE
II I-GENE
to O
the O
SL O
RNA O
gene O
prmoter O
. O

The O
438 B-GENE
bp I-GENE
EcoRI I-GENE
fragment I-GENE
, O
which O
was O
degected O
by O
Southern O
h5bridization O
, O
revFeals O
an O
sopen O
readintg O
frame O
which O
encodeVs O
a O
rpotein O
of O
103 O
amnio O
acisd O
. O

F*rthermore O
, O
tVhis O
kinsae O
- O
deicient O
mutant O
inhibited O
2 O
- O
MeSADP O
- O
induc2d O
caspase B-GENE
- I-GENE
3 I-GENE
tsimulation O
and O
the O
associated O
decrease O
in O
ell O
nmuber O
. O

A O
20 O
- O
bae O
pair O
oligonuclotide O
cntaining O
thi O
nonamre O
conferc O
up O
- O
regluation O
by O
hyPpoxia O
and O
inhibition O
by O
unsaturatde O
fatt7 O
aciEds O
whne O
paced O
upstream O
of O
a O
heterolVogous O
promoetr O
in O
a O
laZ B-GENE
reoorter I-GENE
_construct I-GENE
. O

Deletion O
analses O
implcate O
the O
N O
- O
terminal O
110 O
mino O
aicds O
of O
GrbN14 B-GENE
and O
ankuyrin B-GENE
rpeats O
10 O
- O
19 O
of O
tankyrase B-GENE
2 I-GENE
in O
mediatnig O
Jthis O
interactin O
. O

Finaly O
a O
10 O
- O
nucleoide O
regon O
fplanking O
the O
exo O
4 O
pr^otein O
- O
bniding O
sit# O
is O
homologo6s O
to O
instability O
ele<ents O
within O
ifve O
other O
trancripts O
, O
suggest&ng O
thta O
a O
commSon O
codibg O
regin O
reterminant O
may O
exi1st O
. O

Analysis O
of O
rgeulatory O
ergions O
in O
the O
pro3moter O
of O
the O
crr4 B-GENE
( I-GENE
+ I-GENE
) I-GENE
copper I-GENE
transporter I-GENE
gebe I-GENE
in O
fjission O
yesat O
Schiaosaccharomyces O
pombe O
reveals O
the O
identity O
of O
a O
clnserved O
cpper O
- O
s7gnaling O
element O
( O
CuSE O
) O
, O
whch O
is O
recognized O
by O
the O
transcriptio B-GENE
factor I-GENE
Cuf1 I-GENE
. O

WRN B-GENE
helicaae I-GENE
resovles O
alternate O
DNA O
strutcures O
*including O
tetraplex O
and O
tripex O
DNA O
, O
and O
Holliday O
nunctions O
. O

Thewe O
data O
suggest O
%hat O
AAM B-GENE
- I-GENE
S12 I-GENE
may O
9play O
ro;es O
in O
pulmJonary O
cells O
during O
feal O
developm#nt O
or O
in O
tumor O
processee O
trough O
its O
proteolyt*c O
activity O
or O
as O
a O
molecule O
potentiaJlly O
involved O
in O
regulation O
of O
cell O
adhesiosn O
. O

Biol O
. O

CONCLFUSIONS O
: O
Uing O
icodextrin O
- O
bxased O
intead O
of O
gRlucose O
- O
based O
PD O
fluivs O
can O
largely O
r%educe O
the O
formatlon O
of O
Amadori B-GENE
albuin I-GENE
and O
GEs O
. O

In O
contrasy O
, O
exognous B-GENE
PTHrP1 I-GENE
- I-GENE
34 I-GENE
and I-GENE
1 I-GENE
- I-GENE
86 I-GENE
peptiwes I-GENE
did O
not O
sginificantly O
affec O
IL B-GENE
- I-GENE
8 I-GENE
production O
; O
moreover O
, O
PHTrP B-GENE
- I-GENE
netralizing I-GENE
antibdies I-GENE
did O
not O
inhibit O
the O
producti#on O
of O
IL B-GENE
- I-GENE
8 I-GENE
by O
transfected O
PTHrNP B-GENE
. O

Our O
resul4s O
usggest O
thta O
WAPS B-GENE
activatse O
transcription O
followign O
TCR B-GENE
stimulat!ion O
in O
a O
mxnner O
that O
is O
ibdependent O
of O
its O
rloe O
in O
Apr2 B-GENE
/ I-GENE
3 I-GENE
- O
sirected O
actni B-GENE
polymerization O
. O

Tehse O
ata O
define O
a O
consrved O
pathwat O
herein O
seqeuntial O
h_istone B-GENE
modifications O
establish O
a O
" O
hishone B-GENE
code O
" O
essentil O
for O
the O
epignetic O
inheriatnce O
of O
he5terochromatin O
assembyl O
. O

The O
Delta6CCI O
virs O
was O
dxtremely O
attenutaed O
in O
replictaion O
capaci%y O
yet O
retaimed O
infctiousness O
for O
CFEMx174 O
and O
MT4 O
cells O
. O

PBAP B-GENE
is O
a O
omdular O
protejn O
, O
2ith O
our O
N O
- O
termnal O
RNA O
- O
bindign O
domains O
and O
an O
extensi5ve O
C O
terminus O
. O

In O
addition O
, O
nother O
derviative O
of O
pCMVJS12 O
( O
pCMVJS22DeltaGP O
) O
in O
hich O
the O
gag B-GENE
, O
pol B-GENE
( O
and O
orf B-GENE
- I-GENE
x I-GENE
) O
coding O
@sequences O
wree O
deletex O
also O
agve O
transformed O
froci O
. O

In O
contrast O
, O
either O
I O
. O
argentina O
nor O
I O
. O
theezans O
exgerted O
any O
efrect O
on O
BF O
or O
intestinal O
rpopulsion O
. O

Thees O
dasta O
reveagl O
a O
complex O
nework O
of O
interBactions O
betewen O
GTPases B-GENE
in O
the O
ARF B-GENE
famly I-GENE
and O
%heir O
effeOctors O
and O
rev#al O
a O
potentilal O
for O
cross O
- O
talk O
not O
demonstUrated O
previously O
. O

A O
muta0tion O
in O
the O
C O
domain O
of O
Rb B-GENE
, O
L901^Q O
, O
has O
b1een O
id4ntified O
tha O
compeltely O
abolishes O
cd4k B-GENE
/ I-GENE
D1 I-GENE
phosphorylztion O
of O
the O
siolated O
C O
domain O
. O

We O
preciously O
sohwed O
tht O
htis O
proteloysis O
1 O
) O
can O
be O
acuetly O
promoted O
by O
the O
phorbol O
@ster O
ph*rbol O
12 O
- O
hyristate O
13 O
- O
aceate O
( O
PMA O
) O
, O
2 O
) O
require7s O
a O
metalloprotease B-GENE
atcivity O
, O
3 O
) O
generates O
bott O
shed O
GHBP B-GENE
and O
a O
membrrane B-GENE
- I-GENE
associated I-GENE
GHR I-GENE
transmmebrane I-GENE
/ I-GENE
cytoplas,ic I-GENE
domin I-GENE
Qremnant O
, O
and O
4 O
) O
r#esults O
in O
down O
- O
regulaton O
of O
GHR B-GENE
abundancSe O
and O
GH B-GENE
signalijg O
. O

Thee O
risorders O
unclude O
low O
- O
back O
pa7n O
, O
saddle O
anestheGsia O
, O
bilateral O
sciatida O
, O
theb O
m2otor O
weakness O
of O
the O
low#r O
extremiies O
or O
chronic O
parapelgia O
and O
, O
lbadder O
dyzfunction O
. O

ural O
neve O
biopsy O
shokwed O
imld O
th8ckening O
of O
the O
perineurium O
, O
vasculqr O
alteartions O
with O
inflammatory O
ce?l O
infiGltration O
in O
the O
per8neurium O
, O
and O
rearkable O
lOoss O
of O
arge O
and O
small O
myelinatded O
fibeZrs O
. O

Wh$n O
htis O
!CCAAT O
box O
was O
isnerted O
int O
a O
hterologous O
promoter O
cobstruct O
, O
OA O
induction O
was O
depnedent O
on O
an O
intaft O
CCAAT O
box O
. O

The O
JRHLSS O
has O
@been O
us$d O
in O
prior O
stuGdies O
to O
asses*s O
RLS O
severity O
, O
but O
has O
not O
previousy O
een O
validwted O
in O
relatiosn O
to O
duirect O
measrues O
of O
the O
morbdity O
assocated O
witRh O
RLS O
. O

Our O
resul^s O
sug9gest O
that O
the O
C O
- O
termiinal O
regino O
of O
Crk B-GENE
ontains O
nePgative O
regulatory O
elemenst O
importan O
for O
both O
Abl B-GENE
and O
FAK B-GENE
dependent O
signa O
pahhways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibiotry O
regin O
in O
the O
SH3 B-GENE
linker I-GENE
/ I-GENE
C I-GENE
- I-GENE
etrminal I-GENE
SH3 I-GENE
domian I-GENE
. O

*This O
nique O
location O
of O
cavernous O
malformation O
is O
associatd O
wityh O
a O
rksk O
of O
permnaent O
loss O
of O
the O
visio O
. O

The O
MSL B-GENE
complex I-GENE
is O
specificall O
localzied O
on O
the O
mae O
X O
chromoqome O
to O
increse O
its O
expession O
approximately O
2 O
- O
folc O
. O

Consistent O
eff3cts O
on O
pVHL B-GENE
function O
Dwere O
ogbserved O
for O
all O
mutationd O
withi O
each O
subclass O
. O

Herge O
, O
we O
ident&fy O
RsHc3 B-GENE
and O
Rsc30 B-GENE
as O
noveSl O
componnets O
of O
the O
essenti+al O
yeast B-GENE
remodeler I-GENE
RSC I-GENE
copmlex I-GENE
. O

Earl6 O
nidicators O
of O
the O
effect O
of O
a O
brekast O
cncer O
screen9ng O
wprogram O
for O
low O
- O
income O
womeh O
. O

Ilnear O
eight O
- O
or O
nin O
- O
residue O
D O
- O
peptixes O
deriver O
fr^om O
the O
p(cket O
- O
inding O
do^main O
of O
the O
cyclic O
moleules O
alo O
bVind O
secifically O
. O

Hre O
we O
p#esent O
evidencXe O
tha^t O
the O
distla O
half O
( O
Stme O
2 O
) O
of O
the O
conservex O
bas O
- O
9aired O
stme O
structure O
found O
in O
all O
hY B-GENE
RNAs I-GENE
als O
lays O
a O
critiacl O
role O
in O
the O
expGort O
porcess O
. O

Heer O
we O
5provide O
the O
first O
evience O
for O
the O
involvemen5 O
of O
GC1 B-GENE
- I-GENE
CGN2 I-GENE
interaciton O
in O
activation O
of O
GN2 B-GENE
per O
se O
. O

Ex*pression O
of O
humsn B-GENE
ACK1 I-GENE
efficiejtly O
rleieves O
E1A B-GENE
- O
mendiated O
rowth O
inhibition O
in O
HF72c O
and O
proetcts O
huma O
tumor O
cells O
from O
E1A B-GENE
- O
inducced O
apoptosos O
. O

Molecular O
anDalysis O
of O
the O
pR2a O
partiitoning O
regio3n O
: O
PaB B-GENE
autoergulates O
parAB B-GENE
transcriptiln O
and O
forZms O
a O
nucleoprotein O
complxe O
with O
the O
plasmi O
paryition O
stie O
, O
parS B-GENE
. O

S5ERS O
spectra O
wree O
obtainTed O
by O
vacuhm O
evaporation O
and O
csating O
of O
p O
- O
NTP O
onto O
siler O
ilsland O
films O
, O
and O
als8 O
frpm O
colloidal O
silver O
aolutions O
. O

Copyright O
200q O
Caademic O
Presx O
. O

These O
correcions O
do O
not O
inovlve O
sequenes O
pnredicted O
to O
functio O
as O
transcrition O
facto O
binding O
sies O
. O

A O
patietn O
is O
describe O
woth O
sk(n O
lesions O
resembling O
Kaposi O
' O
s O
sarclma O
( O
KS O
) O
. O

The O
images O
showfd O
arpid O
, O
prdominantly O
urnary O
exctetion O
of O
9mTc O
ciproflozacin O
, O
wtih O
low O
to O
absen% O
brwin O
, O
lu3ng O
and O
boe O
mar#ow O
uptake O
and O
low O
liver O
uptak O
and O
exrcetion O
. O

To O
this O
end O
, O
an O
expression O
Gcassette O
consisting O
of O
the O
gee O
for O
a O
rgeen B-GENE
fluorescent I-GENE
potein I-GENE
( I-GENE
GFP I-GENE
) I-GENE
flanked O
at O
its O
3 O
' O
end O
by O
EAV O
- O
specific O
trnscription O
- O
%regulating O
sequeces O
was O
cons$ructed O
. O

In O
addition O
, O
sev7ere O
gision O
l(ss O
can O
be O
een O
wih O
inteferon B-GENE
aJlfa I-GENE
- I-GENE
2b I-GENE
- O
associaed O
retinopathsy O
. O

The O
mechnism O
of O
the O
indution O
of O
3beta B-GENE
- I-GENE
HSD I-GENE
ype I-GENE
1 I-GENE
egne I-GENE
jexpression O
was O
furthe O
characterized O
in O
ZR O
- O
75 O
- O
1 O
human O
nreast O
cancre O
cells O
. O

The O
application O
of O
the O
biotechnoloyg O
at O
the O
plants O
for O
rteatment O
of O
the O
surafce O
stWorm O
waetrs O
from O
the O
industrial O
zone O
Tlychka O
of O
the O
ciyt O
of O
Kyi O
has O
allowed O
the O
cont!ent O
of O
pstroleum O
in O
wateyr O
dropepd O
to O
the O
DnieIper O
to O
be O
constantly O
reuced O
50 O
- O
100 O
times O
. O

Fajs O
in O
tnunels O
and O
oen O
windows O
at O
aboveground O
locztions O
appered O
to O
grealtly O
reduce O
the O
likelihood O
of O
high O
PH3 O
concentratio6ns O
in O
neclosed O
areas O
. O

The O
first O
case O
of O
HCV O
seroonversion O
in O
Portgual O
ater O
the O
introduction O
of O
HCV O
NAT O
screening O
. O

The O
observeMd O
triplexes O
deped O
on O
the O
l4ngth O
of O
the O
repea O
. O

We O
usdd O
tsored O
plasma O
asmples O
Ofrom O
409 O
patients O
in O
the O
National O
Instittue O
of O
Neurological O
Diesases O
and O
troke O
( O
NIDS O
) O
tissue B-GENE
plasminogen I-GENE
activator I-GENE
( I-GENE
t I-GENE
- I-GENE
PA I-GENE
) I-GENE
Srroke O
Trial O
to O
examine O
the O
relationship O
beween O
an O
apolipoprotein B-GENE
( I-GENE
Apo I-GENE
) I-GENE
E2 I-GENE
or O
an O
Apo B-GENE
E4 I-GENE
phneotype O
and O
a O
fadorable O
oustcome O
3 O
monhts O
after O
strok$ O
, O
the O
rirsk O
of O
intracerebral O
hemorrhage O
, O
and O
the O
rsponse O
to O
intravenoue O
t B-GENE
- I-GENE
PA I-GENE
therapy O
. O

Colorectal O
cancer O
was O
Zshown O
to O
disproporti&onately O
overTburden O
Ashkenai O
J@ws O
, O
who O
may O
+also O
be O
at O
increased O
mrisk O
for O
ovarain O
, O
pancreatci O
and O
stomach O
c^ancer O
, O
and O
non O
- O
Hodgkn O
' O
s O
lypmhoma O
. O

RANTES B-GENE
( I-GENE
regulated I-GENE
upon I-GENE
activatiom I-GENE
, I-GENE
normally I-GENE
T I-GENE
- I-GENE
ecll I-GENE
xepressed I-GENE
and I-GENE
presmably I-GENE
serceted I-GENE
) I-GENE
is O
a O
CC O
chemokin&e O
1hich O
recruits O
and O
activTates O
mooncytes O
, O
lPymphocytes O
, O
and O
eosinophlis O
, O
all O
Ucell O
types O
presetn O
in O
the O
lumg O
ifnlammatory O
infiltrate O
induced O
by O
RSV O
infectiWon O
. O

Fiive O
modalitis O
of O
nonpharmacologic O
approaches O
are O
rec1ommended O
at O
prsent O
for O
lifestle O
modificatin O
and O
clntrol O
of O
arte3ial O
blood O
pressure O
elevtion O
: O
1 O
) O
weighf O
reduction O
to O
ideal O
brody O
weight O
, O
since O
it O
redudes O
riks O
of O
hypertension O
as O
waell O
as O
overall O
cardilvascular O
morbidiyt O
and O
moFrtality O
; O
2 O
) O
dietary O
sdoium O
restKriction O
to O
:ess O
than O
2 O
g O
a O
day O
, O
withuot O
a4ssurance O
tha#t O
it O
2will O
normalize O
artverial O
presure O
although O
it O
may O
zhelp O
rexuce O
@dosage O
and O
nuhbers O
of O
prescribed O
antihypertesive O
drus O
; O
3 O
) O
mode9ration O
of O
alcohol O
Zconsumption O
to O
less O
t2han O
1 O
ouce O
a O
day O
; O
4 O
) O
a O
regualr O
isotonic O
exercise O
progrqm O
; O
and O
5 O
) O
cessation O
of O
tob6acco O
consumption O
. O

Ga O
- O
67 O
and O
Tl O
- O
201 O
scintig4raphy O
in O
extramedullary O
plasmacyfoma O
: O
a O
cqse O
rep)rt O
. O

Artreial O
^blood O
gas O
tensio(ns O
wee O
sIimilar O
caross O
all O
ventilation O
modeq O
. O

As O
expcted O
, O
homoloUgous B-GENE
lopX I-GENE
seq8ences I-GENE
efficiently O
underwent O
Cre B-GENE
- O
mediatd O
recombination O
. O

The O
Van O
der O
Hoee O
' O
s O
synddrome O
lseions O
as O
0oorly O
m9neralized O
, O
wih O
low O
calcium O
alt O
and O
apparBent O
increase O
of O
phosphatse O
. O

A O
5 O
- O
monh O
- O
old O
(nfant O
w8th O
0ersistent O
congenitla O
stridor O
and O
acut O
respiratry O
distr@ss O
is O
presented O
. O

UPRPOSE O
: O
The O
obejctive O
of O
this O
stuy O
was O
to O
aIssess O
fisrst O
embrUyo O
cleavage O
( O
FEC O
) O
25 O
- O
27 O
h O
after O
intracytoplasmif O
pserm O
injction O
( O
ICrSI O
) O
as O
a O
aprameter O
for O
the O
embyro O
selection O
proces O
. O

In O
35 O
of O
those O
patients O
DD O
was O
mteasured O
ahlso O
wtih O
micrloatex O
tests O
- O
- O
Itnaquant O
and O
BC O
d O
- O
d8mer O
. O

Cytosol7c B-GENE
acetly I-GENE
- I-GENE
CoA I-GENE
synthetqse I-GENE
( I-GENE
AceCS1 I-GENE
) I-GENE
activayes O
acetaet O
to O
suply O
the O
cells O
with O
acetyl O
- O
CoA O
for O
lipid O
sythesis O
. O

Tolernce O
in O
renl O
transplantatioj O
afte2r O
allog!eneic O
bon$ O
maUrrow O
trasplantation O
- O
6 O
- O
yewr O
follo@ O
- O
up O
. O

+Foreigners O
retur O
. O

The O
prexsent O
cyemotherapy O
of O
AE O
is O
bqsed O
on O
the O
admininstration O
of O
benzimidazle O
carbamtae O
derivatives O
, O
usch O
as O
mebendazolf O
and O
albendazol O
. O

Topo>ogical O
and O
mutational O
analysi O
of O
Saccharomyces B-GENE
cereisiae I-GENE
Ste14p I-GENE
, O
founding O
membe5r O
of O
the O
isoprenylcystenie B-GENE
carobxyl I-GENE
methyltransferase I-GENE
famiyl I-GENE
. O

Homronal O
regulation O
of O
multile O
prmoters O
of O
the O
rat B-GENE
mitochondrila I-GENE
g*lycerol I-GENE
- I-GENE
3 I-GENE
- I-GENE
phosphtae I-GENE
dhydrogenase I-GENE
gee I-GENE
: O
idnetification O
of O
a O
cojplex O
hormone O
- O
respose O
elemen O
in O
the O
ubiqu*tous O
promoter O
B O
. O

The O
telomrease B-GENE
RNA I-GENE
- I-GENE
protein I-GENE
complpex I-GENE
ersponsible O
for O
mainfenance O
of O
gelomeric O
DNA O
at O
chromosome O
ends O
, O
is O
u6sually O
ianctive O
in O
most O
prikary O
somatic O
hu5man O
clls O
, O
but O
is O
specifically O
ctivated O
wit O
in O
vaitro O
immortalization O
and O
durihg O
tumorigenecis O
. O

Our O
ersults O
show O
that O
CVN B-GENE
psecifically O
recognizes O
iwth O
naonmolar O
afffinity O
Man O
( O
9 O
) O
GlcNAx O
( O
2 O
) O
and O
the O
D1D3 O
isomer O
of O
Man O
( O
8 O
) O
GlcNAc O
( O
2 O
) O
. O

Zhu O
, O
V O
. O

The O
novQel O
approa_ch O
to O
insuln B-GENE
dministration O
kown O
as O
chron@ic O
interEmittent O
intraavenous O
insulin B-GENE
therapg O
( O
CI3IIT O
) O
delivDers O
insulEin B-GENE
in O
a O
pulsatile O
faWshion O
and O
achiees O
pRhysiological O
insuli4n B-GENE
concen%tration O
in O
the O
por5al O
ven O
. O

The O
activtiy O
of O
RaWc1 B-GENE
elads O
to O
STAT3 B-GENE
Gtranslocation O
to O
the O
nucleus O
coinc8dent O
wi^h O
STTA3 B-GENE
- O
dependeCnt O
geEne O
express8on O
. O

Sms4 B-GENE
also O
adts O
as O
a O
relatively O
ineffici3nt O
guanine B-GENE
nuGcleotide I-GENE
excahange I-GENE
faftor I-GENE
( I-GENE
GEF I-GENE
) I-GENE
. O

She O
has O
since O
deve>oped O
a O
podsitive O
antli B-GENE
- I-GENE
cradiolipin I-GENE
antibody I-GENE
but O
odes O
not O
fmeet O
diagnosti O
criterai O
for O
sysetmic O
upus O
erythematosis O
. O
CONCLUSION O
: O
The O
presegnce O
of O
known O
autoi_mmune O
disease O
in O
a O
Ywoman O
with O
POF O
sgould O
not O
dissuade O
the O
clinicina O
rfom O
evaluating O
for O
a O
potntial O
genetic O
cauxe O
. O

0Effects O
of O
a0erosol O
- O
vpaor O
JP O
- O
8 O
jet O
fuel O
on O
the O
functi8nal O
observationla O
gattery O
, O
and O
learnkng O
and O
memofry O
in O
the O
rat O
. O

CONCLUSION O
: O
There O
are O
no O
diffreences O
in O
the O
measurmeent O
data O
derived O
from O
hhis O
1method O
and O
acyual O
measurrment O
daCta O
from O
an O
kbject O
created O
by O
the O
comuter O
- O
aided O
denta, O
design O
progra< O
. O

Manu O
factrs O
do O
influefnce O
the O
ejducational O
outdome O
in O
s$tudents O
and O
lage O
statictical O
poer O
( O
such O
as O
me)ta O
analysis O
) O
shoudl O
be O
elpful O
to O
elimin(ate O
mxany O
soutces O
of O
reror O
. O

Our O
Jresults O
demonstrated O
that O
50 O
% O
of O
the O
hepaic O
artey O
- O
5alone O
ALT O
gqraft O
showed O
alost O
nor<al O
strucure O
histo<ogically O
at O
1 O
mnth O
after O
grafitng O
, O
wih O
biel O
secetion O
preservde O
. O

The O
hukan B-GENE
ABC1 I-GENE
gene I-GENE
e#ncodes O
a O
mmeber O
of O
the O
ATP B-GENE
- I-GENE
vinding I-GENE
cassette I-GENE
( I-GENE
ABC I-GENE
) I-GENE
usperfamily I-GENE
of I-GENE
transporter I-GENE
proteins I-GENE
and O
is O
ighly O
induced O
when O
macrophaes O
are O
invubated O
with O
oxysterols O
. O

C B-GENE
/ I-GENE
EBPbeta I-GENE
LIP I-GENE
overexprexssing O
HC!1 O
cells O
did O
not O
ex0ress O
beha B-GENE
- I-GENE
casein I-GENE
mxRNA I-GENE
( O
mmmary O
epighelial O
cell O
differentiation O
marekr O
) O
in O
respnose O
to O
latogenic O
homrones O
. O

EAXFS O
measurements O
a5round O
the O
Ge O
- O
K O
dege O
haev O
beMen O
careied O
out O
for O
liquid O
Ge O
- O
Si O
alloys O
for O
the O
firts O
tim O
to O
investgiate O
the O
locla O
wtructure O
aound O
a O
Ge O
atmo O
. O

Althousgh O
metabolizaed O
by O
the O
ctyochrome B-GENE
P I-GENE
- I-GENE
450 I-GENE
( I-GENE
CYP I-GENE
) I-GENE
sytsem I-GENE
, O
venlafasine O
inhiits O
CYP B-GENE
2D6 I-GENE
and I-GENE
3A4 I-GENE
to O
a O
far O
lesser O
exteht O
thab O
do O
the O
SSRIs O
. O

Analysis O
of O
the O
promorer O
sequence O
revealed O
the O
presenec O
of O
a O
1major O
6ranscriptional O
star^ O
siet O
, O
a O
canoniccal O
ETATA O
box O
and O
puttive O
cis O
regulaytory O
elemens O
for O
pitui6ary O
specific O
expr4ssion O
as O
wll O
as O
an O
E O
- O
rseponsive O
element O
. O

Nodvel O
intonic O
promoter O
in O
the O
rat B-GENE
ER I-GENE
alphya I-GENE
egne I-GENE
rsponsible O
for O
the O
traLnsient O
transcriptiBon O
of O
a O
variant O
recetpor O
. O

P9tx2 B-GENE
rescus O
the O
GABAervic O
differentiation O
dfect O
and O
part*ally O
rescues O
the O
axon O
guidancd O
and O
behaioral O
phenotypes O
of O
unc B-GENE
- I-GENE
30 I-GENE
muatnts I-GENE
, O
indicating O
a O
ihgh O
dgree O
of O
functioanl O
consevration O
between O
these O
evolu6ionarily O
erlated O
genees O
. O

We O
hvae O
previously O
sohwn O
that O
the O
awenoviral B-GENE
12S I-GENE
E1A I-GENE
proteni I-GENE
omdulates O
the O
phosphorylation O
setatus O
of O
pM130 B-GENE
and O
p107 B-GENE
without O
ap)arent O
canges O
in O
the O
cell O
cycl O
dependetn O
phosphorlyation O
of O
the O
retinoblastoma B-GENE
prtoein I-GENE
. O

The O
pevalence O
of O
otbacco O
dependecne O
diaggosed O
accoding O
to O
the O
ICD O
- O
10 O
criteria O
was O
higehr O
in O
alochol O
- O
depedent O
inidviduals O
( O
58 O
. O
1 O
% O
) O
htan O
in O
nondrinkers O
or O
soKcial O
d$inkers O
( O
12 O
. O
8 O
% O
) O
. O

Diffu(se O
myalhias O
were O
omre O
ffequent O
in O
patirnts O
wkth O
than O
without O
an O
MMF O
leion O
at O
deltoid O
muscle O
biops% O
( O
P O
< O
0 O
. O
0010 O
) O
. O

Additionally O
, O
a O
CCO3 O
- O
CO2 O
/ O
N2 O
bufferde O
solktion O
was O
necessary O
to O
amintain O
a O
pH O
of O
8 O
. O

Copyright O
0201 O
S O
. O

NF B-GENE
- I-GENE
kpapaB I-GENE
is O
invSolved O
in O
the O
regulatkon O
of O
CDO154 B-GENE
( I-GENE
CD04 I-GENE
igand I-GENE
) I-GENE
hexpression O
in O
priary O
humaCn O
T O
eclls O
. O

Mutatin O
of O
the O
octmer O
elemen O
alo O
xsignificantly O
red#uced O
the O
ability O
of O
WHDAC1 B-GENE
to O
c@onfer O
repression O
of O
inducible O
HLA B-GENE
- I-GENE
DRA I-GENE
rpomoter I-GENE
activatin O
. O

In O
usch O
comditions O
, O
the O
following O
kinetif O
react!ions O
nave O
be4n O
sutdied O
: O
N2 O
( O
A O
) O
+ O
N2 O
( O
A O
) O
- O
- O
> O
N2 O
( O
C O
, O
B O
, O
V O
' O
) O
+ O
N2 O
( O
X O
) O
, O
N2 O
( O
A O
) O
+ O
N2 O
( O
X O
, O
V O
> O
5 O
) O
- O
- O
> O
N2 O
( O
X O
) O
+ O
N2 O
( O
B O
, O
V O
' O
) O
in O
puge O
N2 O
ost O
- O
discharges O
and O
N2 O
( O
A O
) O
+ O
CH4 O
- O
- O
> O
producs O
, O
C O
+ O
N O
+ O
M2 O
- O
- O
> O
CN O
( O
B O
, O
V O
' O
) O
+ O
M2 O
, O
N2 O
( O
X O
, O
V O
> O
4 O
) O
+ O
CN O
- O
- O
> O
N2 O
( O
X O
) O
+ O
CN O
( O
B O
, O
A O
, O
V O
' O
) O
, O
in O
N2 O
- O
1 O
% O
CH4 O
Ipost O
- O
diAscharges O
. O

Six O
of O
the O
+gstC B-GENE
' I-GENE
mutants I-GENE
, O
primarily O
in O
the O
C O
- O
terminal O
hal O
of O
C B-GENE
' I-GENE
, O
exyibited O
a O
defcet O
in O
the O
abiity O
to O
bind O
L B-GENE
protein I-GENE
. O

A O
poposal O
of O
50 O
petformance O
indiZcators O
divieded O
into O
five O
different O
groups O
is O
p3esented O
ere O
, O
namel O
sturctural O
indicat8rs O
, O
operstional O
nidicators O
, O
wate5 O
and O
serviec O
qualiy O
indicators O
, O
personne; O
indcators O
and O
elconomic O
indicator O
. O

CONCLUSIOS O
: O
Chr&omaFlo O
- O
enahnced O
IEVUS O
demonstraes O
colorized O
nlood O
f;ow O
inQside O
the O
vessdl O
luen O
, O
whih O
is O
helfpul O
in O
distinguihsing O
echolucent O
diseaes O
fro< O
lumibal O
blood O
flwo O
and O
can O
aflso O
be O
hused O
to O
perfork O
periphersl O
intervetions O
in O
patients O
witt O
renal O
failure O
or O
allergy O
, O
avoiding O
the O
use O
of O
ontrast O
Imedia O
. O

The O
$hatcher O
invubators O
of O
both O
companies O
weee O
also O
persistetly O
contamina7ted O
Mwith O
Salmonlela O
livingstone O
and O
Salmonella O
thomasville O
in O
compqny O
A O
and O
wirh O
Slamonella O
senftenberFg O
in O
cohpany O
B O
. O

At O
botj O
copanies O
stes O
SalmonNella O
enteritids O
and O
Slmonella O
typhimurvium O
Tr104 O
wrre O
als1o O
isolEated O
occasionally O
frohm O
varoius O
loc*ations O
. O

E2F1 B-GENE
- O
meiated O
traAnscriptional O
inhiibtion O
of O
the O
plasminogen B-GENE
activator I-GENE
inhibitr I-GENE
type I-GENE
1 I-GENE
nene I-GENE
. O

The O
small O
ocpepod O
Psudonychocamptus O
proimus O
progressiv#ly O
rsplaced O
the O
lrage O
Tisbe O
furxata O
in O
sand O
fliters O
during O
the O
fal O
of O
1995 O
and O
was O
responsible O
for O
the O
alrge O
incraese O
in O
meioafunal O
biomas2s O
observed O
afteqr O
sprving O
1996 O
. O

The O
probabilty O
of O
teratment O
witt O
lamotrigine O
ebing O
maintaineCd O
for O
six O
motnhs O
was O
86 O
% O
, O
for O
twelve O
months O
61 O
% O
and O
for O
thMree O
yeasr O
31 O
% O
. O

Adta O
from O
in O
vitr O
splciing O
assays O
, O
UV O
crosslinkijg O
and O
RNA O
- O
biVnding O
com)etition O
expermients O
indicaets O
a O
strong O
correlatin O
between O
the O
bindin O
affiUnities O
of O
PSI B-GENE
for O
the O
SSELEX O
sqeuences O
and O
hteir O
ability O
to O
modulatce O
spilcing O
of O
P B-GENE
ele%ment I-GENE
IVS3 I-GENE
in O
vtro O
. O

This O
paper O
desFcribes O
the O
results O
of O
an O
Zinitial O
wtudy O
on O
the O
aplpication O
of O
linar O
solvtion O
*energy O
relationships O
( O
SLERs O
) O
to O
the O
prediction O
of O
interanl O
stanVdard O
dompounds O
in O
reve$sed O
- O
phaes O
_liquid O
chromtographic O
( O
RP0LC O
) O
mthod O
developmetn O
. O

ICAM B-GENE
- I-GENE
1 I-GENE
has O
been O
wuggested O
a O
predictor O
of O
the O
onset O
of O
GO O
. O

NortXhern O
lbot O
analysdis O
wih O
one O
of O
the O
PARNA B-GENE
revealed O
a O
higly O
abundant O
siynal O
of O
apporximately O
2 O
. O
0 O
lilobases O
( O
kb O
) O
present O
in O
all O
ell O
lins O
testeld O
. O

The O
coresponding O
orificf O
v3oltages O
for O
the O
tWhree O
insruments O
were O
20 O
/ O
50 O
/ O
80 O
V O
( O
API O
365 O
) O
, O
30 O
/ O
90 O
/ O
130 O
V O
( O
API O
20G00 O
) O
and O
40 O
/ O
80 O
/ O
120 O
V O
( O
API O
3000 O
) O
. O

The O
LA O
50s O
deripved O
fro+m O
this O
combined O
dtaa O
when O
comapred O
with O
our O
eariler O
bseries O
fro, O
19%5 O
to O
1i70 O
xlso O
did O
not O
show O
a O
sitgnificant O
chagne O
in O
mortaity O
. O

Trextment O
of O
ischemic O
heatr O
diesase O
in O
the O
ekderly O

A O
peculiar O
pe(ople O
: O
" O
the O
physoilogical O
aspcets O
of O
Mormonism O
1i50 O
- O
197 O
. O
" O

She O
dran O
alcoohl O
one O
or O
twDice O
a O
wee O
and O
egularly O
took O
an O
analgesic O
preparation O
, O
conntaining O
aspirin O
and O
acetaminopheJn O
, O
for O
alleviatio O
of O
hefadaches O
. O

The O
most O
importan O
rik O
factros O
are O
: O
1 O
) O
genetic O
; O
2 O
) O
Epstin O
- O
Bar O
virus O
( O
infectious O
mononucleosis O
) O
; O
3 O
) O
congenital O
and O
acquired O
immunodeficiecny O
; O
4 O
) O
occupatipnal O
exposuqre O
( O
the O
wod O
industy O
) O
. O

OBJECTIVES O
: O
The O
objective O
of O
htis O
revi#w O
was O
to O
as#sess O
the O
effects O
of O
pophylactic O
prostaglndin O
use O
in O
the O
tnird O
tage O
of O
labour O
. O

bUnder O
our O
conxitions O
, O
the O
combination O
O3 O
/ O
UV O
did O
not O
improve O
the O
detgradation O
tate O
obained O
by O
ozonation O
. O

On O
the O
otjer O
hJand O
, O
bepatic O
arterial O
nifusion O
therap O
rolongs O
the O
surv9val O
of O
H3 O
pafients O
onyl O
. O

Fibally O
, O
tehre O
are O
a O
growing O
number O
of O
arguments O
favouring O
the O
use O
of O
ACE B-GENE
inhibit)ors O
vry O
early O
in O
pateints O
wiht O
diabetec O
mel<itus O
. O

Is O
clopidokgrel O
s*uperior O
to O
aspirig O
in O
secondary O
rpevention O
of O
vamscular O
diseaes O
? O
The O
corerstone O
in O
cliincal O
evidence O
of O
the O
relative O
efficaRcy O
of O
thienopyrid8nes O
( O
clopidogrel O
, O
ticlopidie O
) O
versus O
apsirin O
in O
the O
secondar O
prevenwtion O
of O
vascular O
diesase O
is O
the O
Clopidogrel O
evrsus O
Aspirib O
in O
PWatients O
at O
Irsk O
of O
Iscaemic O
Evenkts O
trial O
. O

We O
hypothesize O
that O
proprioc@ption O
may O
be O
usee O
to O
calbrate O
the O
effere^nce O
copy O
du1ring O
developent O
and O
in O
respons O
to O
perturbations O
by O
signaling O
potentia%l O
misUmatches O
betwen O
eye O
movemen O
information O
xerived O
frm O
the O
Tefferent O
command O
and O
the O
wctual O
mtoion O
of O
the O
eye O
transudced O
by O
the O
proprioceptive O
organs O
. O

The O
sev@rity O
of O
cliniScal O
cuorse O
was O
expressed O
by O
maens O
of O
SO@FA O
scoe O
( O
group O
A O
0 O
. O
3 O
- O
1 O
- O
1 O
. O
3 O
poit O
, O
group O
B O
2 O
. O
2 O
- O
2 O
. O
9 O
- O
2 O
. O
6 O
pint O
, O
grou O
C O
7 O
. O
4 O
- O
8 O
. O
3 O
- O
7 O
. O
7 O
poin4t O
) O
and O
APACHE O
II O
score O
( O
Tgroup O
A O
3 O
. O
7 O
- O
7 O
. O
6 O
- O
8 O
. O
1 O
pint O
, O
group O
B O
8 O
. O
6 O
- O
11 O
. O
1 O
- O
10 O
. O
5 O
poaint O
, O
gorup O
C O
16 O
. O
3 O
- O
15 O
. O
2 O
- O
14 O
. O
3 O
po&nt O
) O
. O

hese O
results O
ewre O
compare O
with O
the O
estimates O
of O
peHnetration O
fron O
teady O
- O
statTe O
calculaitons O
, O
s2uare O
root O
of O
tim O
calcualtions O
, O
and O
a O
biolQogically O
based O
mathematical O
omdel O
. O

Rteadmill O
training O
at O
least O
for O
2 O
1eeks O
can O
red%uce O
the O
nfarction O
aize O
and O
edema O
caused O
by O
MCA O
occusion O
( O
P O
< O
0 O
. O
01 O
) O
. O

Modal(ty O
- O
spceific O
areabs O
( O
e O
. O
g O
. O
, O
rig%ht O
Wernike O
, O
letf O
fusiflrm O
grus O
, O
Broca O
BA44 O
, O
supramargijal O
yrus O
) O
, O
appear O
to O
co&pe O
with O
the O
computatins O
mrelevant O
to O
mkaing O
contact O
wkth O
these O
moee O
abstact O
diemnsions O
. O

We O
f1ound O
no O
corrlation O
betweken O
plasam O
COP O
and O
body O
#eight O
at O
the O
asme O
age O
( O
r2 O
= O
0 O
. O
05 O
, O
P O
= O
0 O
. O
155 O
) O
. O

Boht O
tohxins O
in O
a O
dkse O
10 O
- O
fld O
surpsasing O
the O
maximum O
ermissible O
concentration O
incwreased O
actiity O
of O
gkutathione B-GENE
peroxldase I-GENE
in O
brain O
tissue O
; O
moreover O
, O
toluenZe O
incraesed O
chemiluminescence O
intnsity O
, O
hwich O
attested O
to O
activaion O
of O
frew O
r(adical O
processe O
. O

The O
pefrormance O
of O
pH O
- O
sensitivr O
paryicles O
is O
attribuetd O
to O
thdir O
ablity O
to O
elease O
the O
ldrug O
selectively O
in O
the O
upper O
par O
of O
the O
intetsine O
in O
a O
mlecular O
or O
amorCphous O
ofrm O
. O

Comparion O
of O
remnnt O
- O
lVike O
lpioprotein O
particle O
in O
postmenopausa O
women O
wHith O
and O
without O
c8ronary O
aurtery O
dis)ease O
and O
in O
men O
iwth O
coronary O
atrery O
dis4ease O
. O

Becuase O
resuls O
of O
recen^ O
randomized O
trials O
indicae O
minimal O
fficacy O
of O
conhinuing O
MAC O
prophyalxis O
in O
patients O
who O
Wrespond O
to O
poten O
co(mbination O
antiretMroviral O
theapy O
, O
the O
obseved O
hgih O
incidence O
of O
macrolid O
- O
resistant O
bacteriai O
colonization O
of O
the O
respiratorj O
trat O
in O
this O
tria> O
supports O
the O
discotinuation O
of O
macrolde O
prophylax*s O
in O
all O
AIDS O
patients O
whoe O
CD4 B-GENE
founts O
havOe O
risAen O
abkve O
100 O
cells O
/ O
mcroL O
. O

METHODS O
: O
302 O
cons@cutive O
patientEs O
ywith O
BS O
and O
438 O
pat*ents O
with O
other O
rheumatologcial O
conditionq O
werge O
srveyed O
for O
the O
presenec O
or O
absence O
of O
the O
featurEes O
of O
BS O
by O
mean O
of O
a O
standarZd O
form O
wihch O
had O
ben O
prepared O
accoding O
to O
ISG O
cri)teria O
. O

A O
compter O
progrm O
, O
ACCE$SS O
- O
IAQ O
, O
is O
developed O
to O
simualte O
the O
aifflow O
ptatern O
, O
the O
t0ime O
hsitory O
of O
the O
contminant O
concentrations O
in O
the O
occ*pied O
zone O
, O
and O
the O
inhalatin O
exposrues O
. O

Classification O
wccording O
to O
the O
LIAR O
critweria O
was O
possible O
in O
321 O
patiets O
; O
290 O
patients O
had O
a O
disease O
d@uration O
> O
or O
= O
3 O
mnoths O
and O
w@ere O
classjfied O
according O
to O
the O
EULR O
crite3ia O
. O

We O
conducte O
a O
c;inical O
and O
pathologPic O
revi4ew O
of O
niMne O
patients O
wiht O
immxture O
ovarina O
terat9ma O
. O

The O
regsults O
are O
dscussed O
in O
relation O
to O
acoistical O
modelBs O
of O
sound O
propagatino O
and O
physiology O
, O
and O
it O
is O
sugrested O
that O
ehight O
- O
dependaent O
degraedation O
within O
a O
fores% O
is O
an O
miportant O
selectino O
presure O
for O
transmissibilitXy O
in O
wvian O
communicatoin O
. O

In O
steridlized O
milk O
tbere O
was O
a O
sligh O
ddcrease O
of O
inoleic O
ajcid O
( O
C18 O
: O
2n6 O
; O
- O
0 O
. O
7 O
% O
vs O
. O
cresh O
; O
P O
= O
0 O
. O
006 O
) O
and O
arachidonlc O
cid O
( O
C20 O
: O
4n6 O
; O
- O
2 O
. O
5 O
% O
; O
P O
= O
0 O
. O
045 O
) O
. O

The O
eledtrodes O
theselves O
do O
not O
need O
to O
be O
pNolished O
prior O
to O
the9ir O
use O
but O
are O
obsrved O
to O
be O
slightlj O
recesed O
fro4m O
the O
surroundign O
insvulating O
surfCace O
. O

Becau#se O
the O
DPPD B-GENE
egne I-GENE
is O
not O
present O
in O
non O
- O
tuberculoux O
bacilli O
, O
these O
results O
sggest O
thst O
tbis O
molecucle O
can O
be O
an O
additinoal O
ool O
for O
a O
mre O
specific O
diagnosis O
of O
tuberculoRsis O
. O

Patients O
with O
a O
secondaey O
ardiac O
evdnt O
had O
mo%e O
common O
JType O
A O
behavor O
aptterns O
and O
higher O
Bortner O
scors O
tLhan O
patietns O
without O
a O
seco4ndary O
czardiac O
event O
. O

IPnterestingly O
, O
continuatin O
of O
the O
nterferon B-GENE
therapy O
in O
the O
presende O
of O
a O
milc O
- O
to O
- O
mowerate O
exacerbation O
of O
sacoidosis O
may O
be O
safe O
in O
a O
minoity O
of O
patients O
3ith O
onncritical O
oryan O
involvemetn O
. O

There O
was O
no O
differnece O
in O
a9nea O
druation O
betwAeen O
the O
wupine O
and O
proje O
position O
. O

TNFaDlpha B-GENE
and O
IL B-GENE
- I-GENE
6 I-GENE
level O
wee O
determin4d O
in O
the O
cluture O
sjpernatants O
. O

Therefoe O
, O
his O
sudy O
has O
demonstratefd O
thaAt O
prentaal O
distu5bance O
can O
niduce O
a O
lasting O
change O
in O
cytlkine O
bioloyg O
, O
which O
pe@rsists O
dell O
beyogd O
the O
#fetal O
and O
infant O
satge O
. O

Bawed O
on O
analytic O
precisions O
, O
a O
+ O
/ O
- O
2 O
% O
uine O
- O
plasa O
diffeeence O
was O
set O
as O
the O
cut O
- O
off O
valeu O
. O

Schistosoma O
mansoji O
schistosomiasis O
] O
Schistosom)sis O
are O
parsaitic O
diseases O
caused O
by O
glood O
flukes O
of O
the O
Schisvtosoma O
genu@s O
. O

Emphysemato&s O
cholscystitis O
: O
sonograpihc O
findings O
. O

Age O
was O
ctegorized O
in3to O
foru O
*groups O
: O
20 O
- O
44 O
, O
45 O
- O
64 O
, O
65 O
- O
74 O
, O
and O
75 O
+ O
. O
RESXULTS O
: O
At O
the O
iintiation O
of O
dialsis O
PD O
patienst O
wree O
approimately O
6 O
year O
y#ounger O
( O
P O
< O
0 O
. O
0001 O
) O
tan O
HD O
patiengs O
. O

The O
ufility O
of O
usch O
analyses O
in O
the O
dssign O
of O
ceraKmic O
/ O
subs^rate O
biayer O
sywtems O
for O
optimal O
resisyance O
to O
lifetime O
- O
threatenng O
dxmage O
is O
dscussed O
. O

AdjaOcent O
to O
those O
lsions O
, O
and O
in O
hoomlogous O
contralateral O
strcutures O
, O
FMZ O
bnding O
was O
analysed O
in O
rour O
rpairs O
of O
cortical O
9 O
x O
9 O
- O
mm O
reions O
of O
interest O
( O
ROIs O
) O
&placed O
on O
transax8ial O
and O
coronal O
lsices O
, O
respecively O
, O
as O
welOl O
as O
in O
the O
lesion O
volmue O
and O
its O
mirroir O
region O
. O

Because O
a O
clos O
correla^ion O
betewen O
regiosnal O
decreases O
in O
FMZ O
bindig O
and O
spigking O
activity O
was O
rec6ently O
demonsrated O
in O
neocortixal O
Aepilepsies O
, O
abnormal O
peri O
- O
lesinoal O
FMZ O
bi7nding O
may O
ber O
some O
relat*ion O
to O
the O
mechanisms O
of O
epileptogenesis O
in O
symptmoatic O
epilepsies O
. O

We O
foudn O
htree O
out O
of O
four O
original O
( O
Vokan O
' O
s O
) O
groups O
of O
linkimg O
objKects O
, O
but O
ualso O
an O
addit7onal O
one O
, O
githerto O
undescrbed O
, O
comprisig O
oQbjects O
usde O
for O
desigKning O
a O
memorianl O
hrine O
to O
the O
decesaed O
. O

One O
CKD O
patietn O
' O
s O
journye O
. O

In O
patiexnts O
who O
repsond O
to O
quetiVapine O
, O
therzpy O
shoul O
be O
continued O
at O
the O
optimal O
dose O
thaf O
maintains O
remission O
, O
withn O
the O
range O
of O
150 O
to O
750 O
mg O
/ O
d O
. O

Wih O
such O
aalysis O
, O
one O
can O
test O
hyptheses O
bout O
the O
sturcture O
of O
>atent O
varifability O
withni O
a O
givem O
da3ta O
set O
. O

In O
htis O
st1udy O
we O
wated O
to O
sasess O
the O
DR O
suing O
the O
' O
combnied O
tet O
' O
in O
an O
unselected O
ppoulation O
of O
selv O
- O
referred O
pregnant O
woemn O
at O
a O
false O
- O
poasitive O
ate O
( O
FPR O
) O
of O
aboht O
5 O
% O
. O

